data_2kt1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kt1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.569 ' HA2' ' HG2' ' A' ' 35' ' ' ARG . . . . . . . . 0 CA--C 1.523 0.578 0 CA-C-O 120.467 -0.074 . . . . 54.43 113.122 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.476 ' HE2' HH11 ' A' ' 35' ' ' ARG . 94.4 m-85 -141.82 157.84 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 110.901 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -118.58 132.85 56.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.287 0.565 . . . . 73.319999999999993 112.248 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.92 170.83 7.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.598 -0.728 . . . . 75.510000000000005 109.578 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 35.4 ttt180 -148.33 121.5 8.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.022 -0.424 . . . . 75.510000000000005 111.386 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -69.38 125.61 27.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.956 0.408 . . . . 63.409999999999997 111.938 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -94.7 -30.27 14.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.26 0.467 . . . . 73.549999999999997 112.26 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.87 141.41 40.44 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.56 0.219 . . . . 74.329999999999998 111.391 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 70.3 Cg_endo -76.78 119.31 5.1 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.35 2.033 . . . . 63.240000000000002 113.326 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 . . . . . 0 N--CA 1.468 0.428 0 CA-C-N 116.084 -0.507 . . . . 75.200000000000003 110.712 176.421 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.2 tp . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 121.226 0.536 . . . . 73.030000000000001 111.608 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -84.92 145.17 27.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.949 -0.569 . . . . 72.019999999999996 112.491 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.2 mt -119.13 127.9 53.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 111.771 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 4.3 mm? -123.36 143.44 41.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 122.559 0.344 . . . . 73.209999999999994 110.883 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.04 119.57 6.7 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.72 2.28 . . . . 75.219999999999999 113.443 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.45 -14.95 62.84 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.268 -0.424 . . . . 72.329999999999998 113.698 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -81.41 143.34 32.21 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.21 0.505 . . . . 64.420000000000002 111.744 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.64 141.19 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.318 0.58 . . . . 71.040000000000006 112.27 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.7 123.95 46.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.029 -0.532 . . . . 73.239999999999995 110.731 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.88 124.21 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 111.976 0.361 . . . . 74.109999999999999 111.976 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.28 139.79 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.952 0.405 . . . . 75.129999999999995 111.176 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 t -93.13 158.32 15.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.958 0.408 . . . . 70.319999999999993 111.835 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 17.3 mmm180 -55.34 -41.18 72.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.244 -0.435 . . . . 75.349999999999994 111.56 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.86 -45.84 71.08 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.01 0.374 . . . . 72.299999999999997 112.01 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.02 70.87 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.882 0.372 . . . . 75.209999999999994 111.707 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.25 -40.63 97.95 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.807 0.337 . . . . 75.209999999999994 111.826 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -66.16 -35.77 81.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.815 0.34 . . . . 74.420000000000002 111.225 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.36 73.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.035 0.445 . . . . 72.510000000000005 111.41 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -22.35 59.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.176 -0.465 . . . . 74.109999999999999 111.465 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.63 42.82 6.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.299 -0.477 . . . . 51.310000000000002 112.963 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.06 134.79 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.592 -0.358 . . . . 74.510000000000005 111.43 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.12 142.32 50.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.709 0.29 . . . . 75.340000000000003 111.133 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -60.93 108.33 0.85 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.051 0.453 . . . . 73.439999999999998 110.977 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 8.97 31.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.319 -0.467 . . . . 74.420000000000002 112.713 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.31 -29.55 6.3 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.612 -0.328 . . . . 61.229999999999997 112.644 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -31.63 64.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.971 0.508 . . . . 64.510000000000005 112.225 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -57.06 -16.43 7.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.172 0.434 . . . . 72.409999999999997 112.172 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.3 m -117.65 81.47 14.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.374 -0.375 . . . . 74.349999999999994 110.208 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.64 -36.15 97.9 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.942 2.428 . . . . 73.420000000000002 113.321 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -19.08 61.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.005 0.372 . . . . 74.319999999999993 112.005 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.2 t -82.77 -20.0 36.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.971 0.415 . . . . 62.340000000000003 111.462 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.38 -36.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.107 0.479 . . . . 72.019999999999996 111.283 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.26 -133.63 11.6 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.235 -0.439 . . . . 63.43 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.85 129.9 37.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.111 0.482 . . . . 74.299999999999997 111.274 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 69.1 mtm -131.46 140.37 38.22 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.483 -0.326 . . . . 73.140000000000001 111.615 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.47 118.97 4.0 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.689 2.259 . . . . 72.219999999999999 113.05 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.28 -174.71 23.89 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.863 -0.684 . . . . 73.150000000000006 113.892 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.06 130.48 55.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.635 0.374 . . . . 72.450000000000003 111.338 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.59 143.64 28.07 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.729 0.3 . . . . 72.239999999999995 111.414 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -79.05 -52.29 8.41 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.166 0.802 . . . . 73.109999999999999 113.166 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HD3' ' HG ' ' A' ' 26' ' ' LEU . 58.2 ttt180 -62.73 -40.47 97.29 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.843 0.683 . . . . 75.430000000000007 112.843 -175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -92.26 -17.11 25.23 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.068 0.395 . . . . 65.430000000000007 112.068 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.64 17.82 6.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.613 0.365 . . . . 74.219999999999999 111.57 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -98.71 159.14 15.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.29 0.567 . . . . 71.340000000000003 112.143 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -121.88 135.05 54.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.779 -0.646 . . . . 75.310000000000002 111.297 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.18 -171.73 44.08 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.669 -0.777 . . . . 74.140000000000001 113.04 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -88.95 121.69 31.57 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.794 -0.239 . . . . 51.299999999999997 111.228 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.536 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 50.4 p90 -111.92 143.74 29.3 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 120.566 0.222 . . . . 73.420000000000002 111.151 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.85 104.18 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.215 1.943 . . . . 71.129999999999995 111.88 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.78 36.71 1.03 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 114.255 0.462 . . . . 73.430000000000007 114.255 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -104.52 -30.22 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.125 -0.632 . . . . 64.439999999999998 111.23 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -93.43 11.25 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.614 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 11' ' ' ALA . 24.1 m -118.51 145.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.36 0.504 . . . . 74.239999999999995 112.36 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 15.0 pt-20 -93.07 170.72 9.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.928 0.394 . . . . 70.450000000000003 110.844 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -102.69 129.73 49.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.427 -0.351 . . . . 74.129999999999995 110.947 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.96 -51.15 3.94 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.101 0.408 . . . . 72.340000000000003 112.101 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.18 -175.1 33.27 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.714 -0.755 . . . . 72.140000000000001 113.584 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.45 146.99 12.44 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.006 2.471 . . . . 75.25 113.922 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 74.010000000000005 111.088 175.706 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.559 0 CA-C-O 120.731 0.073 . . . . 71.319999999999993 112.972 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 94.0 m-85 -110.01 153.57 24.4 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.886 0.374 . . . . 71.540000000000006 111.154 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -116.54 126.89 53.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.148 0.499 . . . . 75.299999999999997 111.575 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.77 168.25 9.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.91 -0.586 . . . . 73.219999999999999 110.717 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HB2' HD13 ' A' ' 78' ' ' LEU . 31.2 ttt85 -124.01 118.95 28.16 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.3 -0.25 . . . . 70.349999999999994 111.11 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.549 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -67.92 117.78 10.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.989 0.423 . . . . 72.129999999999995 111.567 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.406 HD21 ' HG2' ' A' ' 76' ' ' GLU . 51.9 mt -89.83 -41.02 12.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.006 0.432 . . . . 73.120000000000005 111.705 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -127.76 149.53 70.76 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.261 -0.427 . . . . 75.0 111.121 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.9 Cg_endo -72.68 152.75 53.73 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.511 2.14 . . . . 71.450000000000003 113.469 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.1 t80 . . . . . 0 CA--C 1.539 0.536 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.444 179.06 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 112.377 0.51 . . . . 74.040000000000006 112.377 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.62 ' HB2' HG23 ' A' ' 64' ' ' THR . 44.1 mt-10 -87.0 131.29 34.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.064 0.459 . . . . 65.430000000000007 111.564 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 64.3 mt -119.61 138.12 53.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.804 -0.634 . . . . 74.400000000000006 110.82 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.36 145.65 37.73 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 120.836 0.351 . . . . 71.530000000000001 110.834 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.61 106.26 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.319 2.013 . . . . 72.439999999999998 113.14 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.73 -21.35 4.47 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.329 -0.462 . . . . 61.140000000000001 113.245 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.67 142.28 58.46 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.552 0.575 . . . . 63.229999999999997 112.552 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.73 98.78 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.847 -0.615 . . . . 75.140000000000001 110.517 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.524 HD23 HG13 ' A' ' 75' ' ' VAL . 6.9 mp -78.78 116.54 19.19 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.91 0.386 . . . . 72.549999999999997 111.775 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.8 t -94.35 117.23 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.947 0.403 . . . . 74.430000000000007 111.5 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.437 HG22 ' HA3' ' A' ' 59' ' ' GLY . 96.1 t -115.84 123.23 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.299 -0.409 . . . . 74.439999999999998 111.132 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -66.45 131.08 45.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.832 -0.167 . . . . 53.009999999999998 110.829 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -54.68 -33.92 61.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.965 0.357 . . . . 74.209999999999994 111.965 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.79 66.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.888 0.375 . . . . 62.32 111.856 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -64.23 -34.88 79.12 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.430000000000007 111.686 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.93 -42.92 99.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.964 0.412 . . . . 75.340000000000003 111.096 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.68 -35.34 78.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.753 0.311 . . . . 72.129999999999995 110.931 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.41 -33.78 74.27 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.003 0.43 . . . . 75.129999999999995 111.489 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.625 HD22 ' HD3' ' A' ' 58' ' ' PRO . 96.1 mt -74.98 -28.75 60.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.893 0.377 . . . . 74.349999999999994 111.805 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.76 35.17 8.55 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.115 -0.564 . . . . 70.25 112.239 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.439 HG21 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -75.72 127.39 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 120.727 0.299 . . . . 70.129999999999995 111.184 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 146.16 54.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.984 0.421 . . . . 53.149999999999999 111.233 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.87 121.64 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.144 0.497 . . . . 75.209999999999994 111.223 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.39 -15.98 60.49 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.154 -0.546 . . . . 73.010000000000005 112.739 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.26 48.18 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.627 -0.321 . . . . 75.019999999999996 113.394 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -53.67 -21.11 6.3 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.461 0.648 . . . . 74.530000000000001 111.585 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.81 -11.26 25.5 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.517 0.562 . . . . 75.109999999999999 112.517 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 26.6 p -161.01 91.7 1.54 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.042 0.386 . . . . 70.329999999999998 112.042 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 50' ' ' CYS . 11.9 Cg_endo -55.05 -23.79 37.14 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.985 2.456 . . . . 74.120000000000005 112.94 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.27 74.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.747 0.308 . . . . 72.239999999999995 110.776 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.7 m -65.85 -15.37 62.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.381 0.511 . . . . 73.019999999999996 112.381 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.16 -30.33 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.991 0.424 . . . . 75.329999999999998 111.417 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.29 -92.24 1.78 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.116 -0.564 . . . . 74.540000000000006 113.145 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -108.56 131.51 54.77 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.935 0.398 . . . . 72.319999999999993 111.279 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 66.4 mtp -133.16 132.64 22.34 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.275 -0.421 . . . . 74.310000000000002 110.938 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.625 ' HD3' HD22 ' A' ' 41' ' ' LEU . 92.8 Cg_endo -87.28 118.07 1.32 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.677 2.251 . . . . 65.219999999999999 112.852 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.437 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.16 179.09 28.12 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.815 -0.707 . . . . 62.219999999999999 113.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.86 124.51 49.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.459 0.304 . . . . 71.219999999999999 111.394 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.8 t-20 -87.25 149.03 24.85 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.594 -0.275 . . . . 71.409999999999997 110.771 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -92.11 -28.61 17.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.537 0.94 . . . . 74.109999999999999 113.537 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -58.79 3.06 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.595 0.712 . . . . 75.209999999999994 110.808 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.62 HG23 ' HB2' ' A' ' 24' ' ' GLU . 64.4 p -81.87 -21.71 37.34 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.546 -0.752 . . . . 71.230000000000004 111.634 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 13.7 mmt85 57.54 31.21 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.562 . . . . 74.409999999999997 111.98 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.31 135.77 39.44 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.811 -0.631 . . . . 73.209999999999994 110.161 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -97.58 121.22 39.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.976 -0.379 . . . . 72.239999999999995 109.976 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.96 -172.11 36.14 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.647 -0.787 . . . . 62.420000000000002 113.568 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.86 132.21 35.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.847 0.356 . . . . 74.310000000000002 111.255 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB2' HD12 ' A' ' 25' ' ' LEU . 53.2 p90 -138.45 150.17 65.41 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.758 0.313 . . . . 73.349999999999994 111.482 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.79 110.26 2.31 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.188 1.925 . . . . 73.329999999999998 112.425 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.49 -11.5 35.05 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.598 0.599 . . . . 38.93 114.598 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -72.52 -8.18 53.82 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.517 0.658 . . . . 74.510000000000005 112.361 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -94.7 -2.91 50.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.065 0.395 . . . . 75.040000000000006 112.065 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 11' ' ' ALA . 18.9 m -127.24 149.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 112.437 0.532 . . . . 65.209999999999994 112.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.406 ' HG2' HD21 ' A' ' 12' ' ' LEU . 11.6 pt-20 -104.23 158.94 16.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.345 -0.388 . . . . 75.120000000000005 110.451 173.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -89.45 127.79 35.88 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.016 0.436 . . . . 73.519999999999996 111.702 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 10' ' ' ARG . 90.2 mt -98.66 -65.9 0.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.118 0.485 . . . . 74.239999999999995 110.968 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.18 169.23 32.27 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.212 -0.518 . . . . 61.25 112.989 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 82.6 Cg_endo -76.48 160.91 34.94 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.71 2.273 . . . . 74.230000000000004 112.985 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.862 0.839 . . . . 74.239999999999995 111.389 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 113.646 0.218 . . . . 64.510000000000005 113.646 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.08 158.41 41.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.048 0.452 . . . . 71.430000000000007 111.535 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.91 130.33 56.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.66 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -122.92 146.81 47.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.209 -0.451 . . . . 74.439999999999998 110.63 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HB2' HD13 ' A' ' 78' ' ' LEU . 15.0 ttp180 -104.75 126.71 52.1 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.102 -0.374 . . . . 73.200000000000003 111.388 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.8 114.73 12.42 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.999 0.428 . . . . 62.329999999999998 111.073 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.33 -61.06 1.92 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.299 -0.41 . . . . 72.219999999999999 112.07 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -128.32 147.25 62.92 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 116.628 -0.26 . . . . 74.510000000000005 111.007 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 27' ' ' PRO . 49.6 Cg_endo -69.02 119.65 6.62 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.182 1.921 . . . . 72.209999999999994 112.996 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.648 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 77.2 t80 . . . . . 0 CA--C 1.534 0.358 0 CA-C-N 116.235 -0.439 . . . . 65.239999999999995 110.461 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 61' ' ' ASN . 32.1 tp . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 120.856 0.36 . . . . 71.549999999999997 111.785 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.36 142.74 28.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.159 -0.473 . . . . 74.239999999999995 110.02 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.648 ' HB2' ' H ' ' A' ' 15' ' ' PHE . 80.9 mt -104.94 135.03 47.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.305 0.854 . . . . 75.030000000000001 113.305 -169.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.613 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.1 mm? -111.82 139.01 21.79 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 115.745 -0.661 . . . . 64.530000000000001 110.545 175.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 60.0 Cg_endo -70.47 126.3 12.7 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.35 2.033 . . . . 63.420000000000002 113.135 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.24 65.71 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.153 -0.476 . . . . 74.430000000000007 113.936 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.7 160.63 27.39 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.179 0.514 . . . . 64.319999999999993 112.071 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.82 133.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.26 0.553 . . . . 75.230000000000004 111.433 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -108.6 122.7 47.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 110.701 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.02 115.91 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.08 0.467 . . . . 71.010000000000005 111.069 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG22 ' HA3' ' A' ' 59' ' ' GLY . 62.0 t -113.15 106.68 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.013 0.435 . . . . 75.540000000000006 111.78 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 m -62.23 126.43 27.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.388 -0.369 . . . . 75.219999999999999 110.384 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -58.72 -20.5 49.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.176 0.436 . . . . 74.25 112.176 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.27 -36.11 51.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.987 0.422 . . . . 75.030000000000001 111.433 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.34 -39.4 71.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.261 -0.427 . . . . 74.129999999999995 111.098 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.97 -37.89 89.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.998 0.428 . . . . 71.109999999999999 111.17 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.25 -38.56 88.13 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.084 0.468 . . . . 71.540000000000006 110.595 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.43 80.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.128 -0.487 . . . . 72.140000000000001 111.229 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.439 HD13 ' HD3' ' A' ' 58' ' ' PRO . 89.2 mt -74.03 -27.76 61.1 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.941 0.4 . . . . 63.399999999999999 111.127 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.93 55.52 2.94 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.096 -0.502 . . . . 74.329999999999998 112.428 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.77 141.01 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.061 0.458 . . . . 75.299999999999997 111.532 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.78 145.42 34.38 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.033 0.444 . . . . 73.340000000000003 111.879 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 120.73 13.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 111.153 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.83 -13.57 49.76 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.007 -0.616 . . . . 73.400000000000006 112.086 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.0 -18.78 26.03 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.455 -0.402 . . . . 63.130000000000003 113.066 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -30.95 71.98 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.131 0.491 . . . . 63.25 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -76.47 8.42 3.5 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.32 -0.4 . . . . 74.349999999999994 111.879 175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.9 m -137.09 80.35 35.34 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 120.901 0.382 . . . . 71.200000000000003 111.135 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.12 -36.91 97.51 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.705 2.27 . . . . 71.120000000000005 113.082 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -61.25 -22.31 64.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.386 -0.37 . . . . 73.420000000000002 111.76 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.4 m -86.49 -24.16 25.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.662 -0.245 . . . . 64.340000000000003 111.588 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.81 -46.04 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.034 0.445 . . . . 75.349999999999994 111.533 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.09 -99.16 0.79 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.449 -0.405 . . . . 63.130000000000003 112.852 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -122.93 133.86 54.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.588 -0.36 . . . . 71.219999999999999 110.811 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 3.2 mpp? -133.86 151.65 77.27 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 122.19 -0.319 . . . . 74.340000000000003 111.507 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.439 ' HD3' HD13 ' A' ' 41' ' ' LEU . 3.2 Cg_endo -86.01 137.4 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.524 . . . . 75.010000000000005 112.092 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -159.39 -179.71 34.4 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.693 -0.765 . . . . 71.329999999999998 113.859 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -101.07 117.85 35.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.666 0.387 . . . . 74.150000000000006 111.017 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.499 ' HB2' HD22 ' A' ' 23' ' ' LEU . 25.4 t-20 -85.62 111.61 20.22 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.794 0.33 . . . . 72.420000000000002 111.239 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -62.16 -28.71 69.84 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.914 0.709 . . . . 74.430000000000007 112.914 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.613 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -60.52 -54.89 40.0 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.194 0.521 . . . . 75.510000000000005 111.519 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.3 p -99.55 -8.82 24.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.988 -0.551 . . . . 55.399999999999999 112.379 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 64.23 13.58 8.02 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.743 0.417 . . . . 74.109999999999999 111.362 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -96.45 166.69 11.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.296 0.569 . . . . 55.299999999999997 112.308 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -116.26 147.79 41.14 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.55 -0.75 . . . . 73.140000000000001 111.342 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.34 40.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.858 -0.686 . . . . 62.329999999999998 113.095 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 6.6 m-20 -88.73 139.93 29.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.935 0.398 . . . . 71.400000000000006 111.363 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.444 ' HB2' HD22 ' A' ' 25' ' ' LEU . 53.7 p90 -134.16 146.84 61.38 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.672 0.273 . . . . 74.219999999999999 111.635 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' HD13 ' A' ' 25' ' ' LEU . 17.4 Cg_exo -67.58 110.4 2.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.741 2.294 . . . . 75.129999999999995 112.714 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.468 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -62.19 -10.23 26.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.082 0.393 . . . . 75.430000000000007 114.082 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.3 p -76.23 -20.92 56.99 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.509 -0.406 . . . . 75.209999999999994 111.885 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -102.25 12.37 36.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.42 0.526 . . . . 74.209999999999994 112.42 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG22 ' HA2' ' A' ' 72' ' ' GLY . 32.4 m -130.23 151.09 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.123 0.487 . . . . 55.5 111.355 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -118.45 145.0 45.58 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.408 -0.36 . . . . 74.209999999999994 111.324 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -73.22 117.7 15.27 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.396 -0.365 . . . . 75.540000000000006 111.411 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 10' ' ' ARG . 85.5 mt -87.79 -58.3 2.62 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.043 0.449 . . . . 74.200000000000003 110.984 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.25 -169.75 42.46 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.137 -0.554 . . . . 73.420000000000002 112.946 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.11 -176.69 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.868 2.379 . . . . 74.510000000000005 113.411 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.538 0.506 0 CA-C-N 116.338 -0.392 . . . . 74.140000000000001 111.3 179.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.524 0.645 0 N-CA-C 115.695 1.038 . . . . 70.310000000000002 115.695 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -125.97 179.87 5.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.971 -0.614 . . . . 74.140000000000001 110.772 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -125.25 137.56 54.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.406 0.622 . . . . 74.329999999999998 112.016 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -120.17 154.66 34.48 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.596 -0.729 . . . . 74.030000000000001 110.271 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.426 ' HB2' HD13 ' A' ' 78' ' ' LEU . 51.6 ttp180 -123.02 121.9 37.21 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.099 -0.376 . . . . 74.409999999999997 111.663 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -73.78 123.42 24.12 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.022 0.439 . . . . 75.219999999999999 111.622 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.8 -49.77 10.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.004 0.43 . . . . 75.200000000000003 111.662 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -127.35 153.35 77.11 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.308 -0.405 . . . . 61.240000000000002 111.336 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -68.54 131.35 22.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.342 2.028 . . . . 73.340000000000003 113.74 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.433 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 t80 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 115.533 -0.758 . . . . 72.010000000000005 110.653 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.309 0.576 . . . . 74.329999999999998 111.521 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 40.8 mt-10 -90.64 164.59 14.11 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.969 -0.56 . . . . 70.439999999999998 111.875 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 80.2 mt -121.93 147.12 46.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 73.450000000000003 111.803 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 25' ' ' LEU . 4.0 mm? -122.91 155.61 63.52 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 122.544 0.337 . . . . 75.049999999999997 111.179 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.51 117.82 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.161 1.907 . . . . 75.129999999999995 112.495 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.16 28.28 45.7 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.151 -0.547 . . . . 70.140000000000001 112.589 -177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -93.44 156.59 16.68 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.499 0.319 . . . . 72.109999999999999 110.578 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.26 132.91 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.839 0.352 . . . . 73.030000000000001 110.731 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.5 mp -127.29 124.04 37.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.091 0.472 . . . . 74.140000000000001 111.418 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.21 119.09 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.334 -0.394 . . . . 74.010000000000005 110.73 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 59' ' ' GLY . 59.9 t -115.27 104.77 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.923 0.392 . . . . 74.310000000000002 111.651 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.552 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 70.5 m -60.99 119.8 8.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.439 -0.346 . . . . 74.230000000000004 110.15 174.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -63.02 -12.49 26.41 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.628 0.603 . . . . 64.409999999999997 112.628 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.92 71.16 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.266 0.555 . . . . 71.430000000000007 110.461 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.539 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -68.19 -35.85 78.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.797 -0.638 . . . . 74.340000000000003 111.136 175.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.56 -34.35 76.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.997 0.427 . . . . 75.319999999999993 110.511 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -63.74 -36.08 82.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.332 -0.395 . . . . 74.510000000000005 110.849 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.23 -25.02 64.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.996 0.426 . . . . 70.219999999999999 111.296 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD12 HG13 ' A' ' 54' ' ' VAL . 91.3 mt -80.72 -28.36 36.61 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.106 0.479 . . . . 73.0 111.106 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.75 45.18 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.022 -0.535 . . . . 71.109999999999999 112.504 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.56 133.89 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.59 0.589 . . . . 72.239999999999995 112.59 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.74 151.65 24.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.971 -0.559 . . . . 73.239999999999995 111.457 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -50.02 110.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.106 0.479 . . . . 74.319999999999993 111.463 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.28 -50.54 0.88 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 116.186 -0.461 . . . . 72.400000000000006 112.047 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.07 -27.18 68.45 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.072 -0.585 . . . . 70.230000000000004 112.848 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -57.5 -35.36 70.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.117 0.484 . . . . 75.230000000000004 111.432 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -100.64 4.01 42.97 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 64.219999999999999 111.606 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -142.91 82.52 12.08 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 120.875 0.369 . . . . 74.030000000000001 111.209 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 20.4 Cg_endo -58.92 -24.78 74.35 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.106 2.537 . . . . 70.530000000000001 113.228 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -57.37 -27.14 62.03 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.733 0.302 . . . . 75.310000000000002 111.743 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -82.96 -13.18 56.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.001 0.429 . . . . 74.420000000000002 111.761 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.554 HG13 HD12 ' A' ' 41' ' ' LEU . 46.6 t -98.44 -38.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.037 0.446 . . . . 74.219999999999999 111.422 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -93.12 1.77 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.125 -0.559 . . . . 75.140000000000001 112.697 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -93.53 136.7 33.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.648 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.472 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 81.5 mtp -139.76 129.15 13.79 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 111.923 0.342 . . . . 74.150000000000006 111.923 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HG2' ' HB1' ' A' ' 37' ' ' ALA . 73.1 Cg_endo -77.52 117.85 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.531 2.154 . . . . 70.540000000000006 112.786 174.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.18 -177.8 25.36 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.797 -0.716 . . . . 74.439999999999998 113.539 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.1 tp -111.96 116.11 30.05 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.867 0.365 . . . . 75.040000000000006 111.223 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.9 t-20 -76.98 134.94 38.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.42 -0.354 . . . . 70.109999999999999 110.841 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -84.25 -40.09 18.46 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.731 0.641 . . . . 74.420000000000002 112.731 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -67.5 -30.47 70.16 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.124 0.416 . . . . 75.120000000000005 112.124 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -114.81 -28.69 6.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.92 0.341 . . . . 72.420000000000002 111.92 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 14.7 mmt85 64.14 28.93 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.159 0.504 . . . . 73.200000000000003 112.18 -176.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -91.03 143.86 26.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.993 -0.549 . . . . 61.109999999999999 111.204 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.466 ' NH1' ' H ' ' A' ' 68' ' ' GLY . 10.0 mmm180 -96.43 164.42 12.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 75.409999999999997 111.858 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.466 ' H ' ' NH1' ' A' ' 67' ' ' ARG . . . 139.61 -165.89 25.72 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.453 -0.794 . . . . 74.120000000000005 112.121 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -108.14 132.92 53.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.675 -0.309 . . . . 73.310000000000002 110.801 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -118.86 147.35 42.17 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.739 0.304 . . . . 73.219999999999999 111.199 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.87 103.6 1.75 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.384 2.056 . . . . 72.439999999999998 112.642 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -60.07 -14.99 34.48 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.503 0.561 . . . . 73.340000000000003 114.503 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -62.43 -18.4 61.62 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.841 0.682 . . . . 73.400000000000006 112.841 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.35 3.32 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.913 -0.492 . . . . 75.200000000000003 112.155 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 11' ' ' ALA . 15.0 m -120.96 159.5 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.178 0.513 . . . . 74.340000000000003 112.073 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.98 152.41 28.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 110.905 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -83.84 106.56 15.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.708 0.289 . . . . 73.319999999999993 111.22 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.426 HD13 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -72.65 -53.45 11.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.038 0.447 . . . . 74.430000000000007 111.099 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.58 -175.07 27.11 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.215 -0.517 . . . . 65.409999999999997 113.11 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.88 164.94 24.88 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.308 2.672 . . . . 71.530000000000001 112.636 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.048 0.388 . . . . 70.439999999999998 112.048 178.489 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 112.777 -0.129 . . . . 74.299999999999997 112.777 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -127.1 158.18 37.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.296 0.57 . . . . 74.420000000000002 111.944 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.05 127.44 56.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.902 -0.59 . . . . 74.25 111.369 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.2 163.25 14.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 64.030000000000001 110.143 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.421 ' HB3' ' CG ' ' A' ' 76' ' ' GLU . 38.2 ttt180 -133.46 123.94 26.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.975 0.416 . . . . 74.109999999999999 111.59 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . . . -77.06 122.98 25.71 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.04 -0.527 . . . . 74.109999999999999 110.841 177.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.3 -60.11 2.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 75.349999999999994 111.915 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 91.8 m-85 -127.25 161.2 55.76 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-N 116.205 -0.452 . . . . 75.549999999999997 110.985 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_endo -63.7 135.15 47.33 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.01 1.806 . . . . 64.219999999999999 112.965 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 . . . . . 0 N--CA 1.468 0.458 0 CA-C-N 115.898 -0.592 . . . . 74.310000000000002 111.481 -177.089 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.6 tp . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.826 0.346 . . . . 65.430000000000007 111.304 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -62.48 119.97 10.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.087 0.47 . . . . 73.010000000000005 111.481 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 74.6 mt -100.35 143.11 30.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 111.613 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.3 mm? -110.99 148.0 37.71 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.438 -0.346 . . . . 70.510000000000005 110.651 176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 36.2 Cg_endo -63.57 106.22 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.506 2.138 . . . . 73.209999999999994 113.311 -175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.02 34.49 23.92 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.038 -0.528 . . . . 60.200000000000003 113.62 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 63' ' ' ARG . 33.2 t70 -105.56 158.91 16.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.175 0.487 . . . . 64.019999999999996 111.997 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -101.09 131.85 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 121.395 0.616 . . . . 75.319999999999993 112.391 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.0 mp -111.2 127.76 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.831 -0.622 . . . . 74.400000000000006 110.704 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.0 122.68 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.008 0.433 . . . . 72.329999999999998 111.517 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.79 116.46 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.277 -0.42 . . . . 75.120000000000005 111.253 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.488 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 55.4 m -89.23 156.65 18.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 72.430000000000007 111.176 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.526 ' HG2' HD11 ' A' ' 38' ' ' LEU . 36.1 mtm180 -71.48 -14.66 62.2 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.722 0.268 . . . . 74.150000000000006 111.722 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.46 -35.74 20.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.011 0.434 . . . . 75.329999999999998 111.523 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.52 13.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.984 0.421 . . . . 64.450000000000003 111.56 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' A' ' 35' ' ' ARG . 90.0 mt -56.82 -38.43 72.6 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 75.409999999999997 112.164 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 14.8 mm100 -65.3 -37.69 87.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.904 0.383 . . . . 73.540000000000006 110.997 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -34.06 76.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.026 0.441 . . . . 73.239999999999995 110.989 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.514 HD11 ' HD2' ' A' ' 58' ' ' PRO . 75.2 mt -69.99 -28.5 65.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.104 -0.498 . . . . 75.209999999999994 111.118 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 41.81 6.05 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.353 -0.451 . . . . 75.0 112.598 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.64 129.78 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.886 0.374 . . . . 74.219999999999999 111.757 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 148.69 37.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.955 0.407 . . . . 73.530000000000001 112.029 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.55 122.43 12.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.151 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.13 2.77 60.59 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.023 -0.608 . . . . 73.409999999999997 112.836 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.27 -28.49 10.62 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.3 -0.476 . . . . 62.130000000000003 112.855 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -34.53 72.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.042 0.386 . . . . 64.510000000000005 112.042 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -63.56 -12.02 29.34 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.168 0.432 . . . . 74.420000000000002 112.168 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -134.55 85.55 36.86 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 120.819 0.343 . . . . 75.430000000000007 110.515 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 17.7 Cg_endo -55.94 -28.1 66.79 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.154 2.569 . . . . 74.129999999999995 113.284 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -62.4 -23.36 66.79 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.326 -0.397 . . . . 62.310000000000002 111.75 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -68.1 -45.31 74.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.097 0.475 . . . . 72.439999999999998 111.358 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.17 -46.44 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 111.459 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.0 -90.22 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.258 -0.496 . . . . 54.240000000000002 113.285 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -112.06 114.76 27.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.956 0.408 . . . . 75.420000000000002 111.906 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.439 ' HE2' ' HA3' ' A' ' 72' ' ' GLY . 3.0 mpp? -124.26 138.43 30.86 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.436 -0.347 . . . . 75.450000000000003 111.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.514 ' HD2' HD11 ' A' ' 41' ' ' LEU . 71.6 Cg_endo -77.93 127.94 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.411 2.074 . . . . 70.329999999999998 112.393 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.69 168.83 27.33 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.812 -0.709 . . . . 71.319999999999993 113.288 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 tp -103.88 124.02 48.19 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.764 0.316 . . . . 74.200000000000003 111.204 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -84.45 118.13 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.714 0.293 . . . . 72.519999999999996 110.666 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.3 -31.62 72.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.747 0.647 . . . . 75.120000000000005 112.747 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -63.37 -51.62 65.12 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.045 0.45 . . . . 74.140000000000001 111.847 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 82.6 p -102.43 -18.79 15.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.295 0.85 . . . . 75.209999999999994 113.295 -172.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER 69.58 17.97 7.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.934 0.494 . . . . 75.329999999999998 111.631 -173.343 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -84.13 149.27 26.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.116 0.484 . . . . 75.409999999999997 111.507 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 67' ' ' ARG . 50.1 mtp180 -111.23 150.71 29.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.122 -0.49 . . . . 75.530000000000001 110.679 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.62 164.08 27.49 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.503 -0.855 . . . . 73.120000000000005 113.647 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.03 109.58 20.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -106.72 143.75 27.66 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.24 0.459 . . . . 72.109999999999999 112.24 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.37 104.69 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.54 2.16 . . . . 73.420000000000002 112.079 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -61.03 -18.57 55.01 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.082 0.793 . . . . 74.120000000000005 115.082 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -58.65 -24.83 61.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.683 0.742 . . . . 74.340000000000003 112.149 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -100.66 11.66 39.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.647 0.61 . . . . 74.349999999999994 112.647 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.86 150.32 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.778 0.323 . . . . 64.209999999999994 111.078 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 14.7 pt-20 -98.94 153.72 18.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.04 0.448 . . . . 63.409999999999997 111.294 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -92.76 116.34 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.289 -0.414 . . . . 74.150000000000006 111.385 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.77 -67.42 0.78 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.883 0.373 . . . . 73.519999999999996 111.438 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.24 179.74 41.94 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.205 -0.522 . . . . 62.439999999999998 112.802 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.96 165.14 33.47 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.855 2.37 . . . . 74.120000000000005 113.369 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.409 HD12 ' HA3' ' A' ' 6' ' ' GLY . 91.7 mt . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.994 0.426 . . . . 71.549999999999997 111.797 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.414 0 CA-C-O 120.634 0.019 . . . . 72.120000000000005 113.105 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -131.03 145.6 52.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.988 0.423 . . . . 74.200000000000003 111.507 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -93.05 134.03 35.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.146 -0.479 . . . . 64.409999999999997 111.534 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 123.99 41.17 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.524 -0.307 . . . . 72.409999999999997 110.987 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' HD12 ' A' ' 78' ' ' LEU . 43.5 ttm180 -97.85 115.59 28.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.346 -0.221 . . . . 73.319999999999993 111.113 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.96 108.99 3.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.805 0.336 . . . . 70.109999999999999 111.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.91 -29.57 27.04 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.167 0.432 . . . . 74.239999999999995 112.167 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -124.2 135.48 26.47 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 122.353 -0.217 . . . . 73.019999999999996 111.574 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.5 Cg_endo -69.21 119.86 6.79 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.296 1.998 . . . . 73.129999999999995 112.638 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 t80 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 116.104 -0.498 . . . . 74.129999999999995 111.364 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 120.782 0.325 . . . . 74.409999999999997 111.244 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.86 138.92 46.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.193 0.52 . . . . 74.129999999999995 111.987 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 94.6 mt -106.24 137.59 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.103 -0.499 . . . . 74.540000000000006 111.598 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -120.72 142.84 35.14 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 122.452 0.301 . . . . 62.140000000000001 110.839 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 46.0 Cg_endo -66.44 117.6 4.85 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.565 2.177 . . . . 73.340000000000003 112.814 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.79 45.43 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.263 -0.494 . . . . 51.32 113.265 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.92 138.8 39.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.008 0.404 . . . . 61.25 110.742 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.96 97.68 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.98 0.419 . . . . 71.430000000000007 110.965 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.0 mp -81.1 127.15 32.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.999 0.428 . . . . 73.420000000000002 111.498 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.0 113.53 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.345 -0.388 . . . . 70.219999999999999 111.595 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -109.71 134.57 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.388 -0.369 . . . . 73.400000000000006 110.645 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -74.77 149.35 39.77 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.02 0.438 . . . . 74.239999999999995 111.586 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.5 -38.19 88.92 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.166 0.508 . . . . 71.109999999999999 110.285 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.44 80.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.735 -0.666 . . . . 73.549999999999997 111.613 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.83 -47.0 86.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.936 0.398 . . . . 71.329999999999998 111.129 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.01 -41.25 96.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.394 -0.366 . . . . 74.310000000000002 111.227 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -60.34 -37.28 80.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.953 0.406 . . . . 75.129999999999995 111.047 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.41 93.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.038 0.447 . . . . 75.439999999999998 110.838 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.78 -21.4 64.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.083 -0.508 . . . . 71.140000000000001 111.816 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.01 36.42 6.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.307 -0.473 . . . . 52.109999999999999 113.144 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.57 130.21 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.903 0.382 . . . . 74.329999999999998 111.146 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.76 150.41 20.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 70.299999999999997 111.802 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -48.44 121.37 4.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.974 0.416 . . . . 72.129999999999995 111.522 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.17 57.48 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.24 -0.505 . . . . 71.430000000000007 112.995 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.78 -28.18 4.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.319 -0.467 . . . . 74.120000000000005 112.966 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -31.29 64.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.174 0.59 . . . . 72.349999999999994 111.974 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.42 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 12.8 ptp180 -59.06 -13.69 7.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.687 0.625 . . . . 73.319999999999993 112.687 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 26.6 p -127.32 84.0 64.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 121.02 0.438 . . . . 73.430000000000007 111.276 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 -33.3 97.79 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.719 2.279 . . . . 62.25 112.562 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.673 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 90.6 mt-30 -58.64 -28.86 66.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.105 -0.498 . . . . 72.219999999999999 111.513 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 t -76.25 -33.42 59.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.853 0.358 . . . . 43.539999999999999 111.38 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.93 -58.55 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.9 0.381 . . . . 72.329999999999998 111.414 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.13 -137.15 12.46 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.515 . . . . 63.100000000000001 112.709 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.94 132.91 39.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.2 0.524 . . . . 62.229999999999997 111.686 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -132.41 147.64 66.48 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 116.12 -0.491 . . . . 74.540000000000006 111.593 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 126.4 8.56 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.503 2.135 . . . . 74.430000000000007 112.403 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.81 -175.25 24.89 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.475 -0.869 . . . . 45.399999999999999 114.131 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.88 117.12 24.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.335 0.254 . . . . 64.140000000000001 111.253 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -79.92 129.65 34.66 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.568 0.223 . . . . 74.310000000000002 110.493 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -92.39 -6.53 49.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.181 1.178 . . . . 64.319999999999993 114.181 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.64 -23.64 18.93 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.718 -0.614 . . . . 74.540000000000006 111.363 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -111.36 -16.93 13.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.04 0.448 . . . . 61.32 111.223 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 62.59 22.44 13.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.577 0.751 . . . . 73.310000000000002 111.568 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -101.21 149.19 24.25 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.073 0.463 . . . . 72.219999999999999 112.157 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -92.63 156.39 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.007 -0.542 . . . . 75.340000000000003 111.107 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.55 -172.35 44.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.593 -0.813 . . . . 71.530000000000001 113.453 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.06 125.58 54.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.611 0.364 . . . . 74.040000000000006 110.252 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -132.12 142.77 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 N-CA-C 111.93 0.345 . . . . 72.409999999999997 111.93 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.32 113.9 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.398 2.066 . . . . 72.400000000000006 112.36 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.39 33.02 0.97 Allowed Glycine 0 CA--C 1.53 1.0 0 N-CA-C 114.424 0.529 . . . . 74.239999999999995 114.424 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.673 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 43.4 m -92.52 -28.92 16.49 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.399 -0.471 . . . . 73.340000000000003 110.936 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.46 5.29 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.198 -0.455 . . . . 71.430000000000007 112.01 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 11' ' ' ALA . 19.1 m -117.64 145.39 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.783 0.325 . . . . 75.209999999999994 111.486 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 14.6 pt-20 -99.87 152.32 20.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.996 0.427 . . . . 71.150000000000006 110.972 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 49' ' ' ARG . 68.3 t80 -84.82 107.41 16.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.09 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 10' ' ' ARG . 67.2 mt -76.93 -38.1 54.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.847 0.356 . . . . 73.329999999999998 111.24 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.68 -176.51 19.16 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.29 -0.481 . . . . 61.109999999999999 113.089 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.57 150.08 68.89 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.84 2.36 . . . . 74.239999999999995 112.259 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 81' ' ' LEU . 7.4 mp . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.13 0.49 . . . . 71.420000000000002 111.204 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 112.573 -0.211 . . . . 63.049999999999997 112.573 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -133.36 137.0 45.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.91 0.386 . . . . 75.319999999999993 111.159 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.509 ' HG2' HG22 ' A' ' 32' ' ' VAL . 98.0 mt-30 -94.95 126.92 40.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 112.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.87 123.98 49.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.961 -0.563 . . . . 75.450000000000003 110.091 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 10' ' ' ARG . 20.1 ttt180 -97.85 124.37 42.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.205 0.446 . . . . 74.109999999999999 112.205 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.515 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -69.13 126.63 30.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.915 0.388 . . . . 72.409999999999997 111.831 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.74 -55.37 4.01 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.233 0.457 . . . . 73.420000000000002 112.233 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -115.21 150.07 43.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 111.62 0.23 . . . . 73.409999999999997 111.62 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.2 Cg_endo -73.96 120.02 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.544 2.163 . . . . 73.209999999999994 113.872 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 74.209999999999994 111.053 175.393 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.9 tp . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 121.024 0.44 . . . . 74.299999999999997 111.292 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.26 149.89 33.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.165 0.507 . . . . 74.439999999999998 111.839 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 84.2 mt -127.18 125.74 41.62 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.007 -0.542 . . . . 73.450000000000003 111.444 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.52 152.62 44.77 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-O 120.72 0.295 . . . . 73.120000000000005 110.359 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 42.5 Cg_endo -65.82 105.53 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.058 1.839 . . . . 75.530000000000001 112.463 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.55 10.06 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.106 -0.568 . . . . 71.219999999999999 113.433 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.03 118.29 6.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 117.008 0.404 . . . . 53.109999999999999 111.616 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.48 92.64 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.129 0.49 . . . . 75.030000000000001 110.566 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 5.9 mp -78.8 120.55 23.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 60.210000000000001 111.968 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.509 HG22 ' HG2' ' A' ' 8' ' ' GLN . 48.3 t -93.09 111.95 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.105 -0.498 . . . . 74.209999999999994 111.654 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.07 122.45 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.328 -0.396 . . . . 74.140000000000001 110.937 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.9 p -68.07 139.73 56.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.995 0.426 . . . . 74.150000000000006 111.114 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -63.96 -32.37 73.88 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.874 0.369 . . . . 74.140000000000001 110.943 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.83 85.9 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.296 -0.411 . . . . 71.519999999999996 111.269 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.57 -43.5 93.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.002 0.43 . . . . 63.399999999999999 111.081 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.8 mt -58.98 -42.51 90.17 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.285 -0.416 . . . . 75.129999999999995 111.341 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.46 -37.12 86.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.933 0.397 . . . . 75.310000000000002 111.012 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.21 77.45 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.959 0.409 . . . . 75.409999999999997 111.484 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.534 HD13 ' HD2' ' A' ' 58' ' ' PRO . 88.9 mt -72.46 -20.86 61.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 111.526 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.61 28.61 35.04 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.323 -0.465 . . . . 71.530000000000001 112.763 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 41' ' ' LEU . 58.8 t -78.65 124.74 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.775 0.321 . . . . 75.450000000000003 111.356 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.71 139.29 53.39 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.998 0.428 . . . . 72.420000000000002 111.731 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.11 122.31 11.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.114 0.483 . . . . 62.340000000000003 111.121 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.82 -13.32 24.68 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.957 -0.64 . . . . 72.099999999999994 112.461 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.0 -25.27 49.77 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.347 -0.454 . . . . 74.400000000000006 113.408 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' OE2' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -58.91 -28.39 66.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.974 0.361 . . . . 74.549999999999997 111.974 -178.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HG3' ' OE2' ' A' ' 48' ' ' GLU . 50.1 mtm180 -56.48 -29.13 61.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.951 0.352 . . . . 74.010000000000005 111.951 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.0 m -133.28 84.85 46.05 Favored Pre-proline 0 N--CA 1.474 0.73 0 CA-C-O 120.953 0.406 . . . . 75.540000000000006 111.053 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.505 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 18.3 Cg_endo -57.94 -23.62 60.75 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.004 2.469 . . . . 73.239999999999995 113.491 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -60.25 -24.33 64.8 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.906 0.336 . . . . 74.519999999999996 111.906 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.3 t -66.48 -31.56 72.37 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.183 0.516 . . . . 74.019999999999996 111.609 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.12 -57.17 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.139 -0.482 . . . . 73.120000000000005 111.367 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.88 -88.88 0.5 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.257 -0.497 . . . . 71.25 113.185 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 7.4 m0 -103.18 107.33 18.1 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.343 0.497 . . . . 75.420000000000002 112.343 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -116.22 137.76 23.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.964 -0.562 . . . . 74.129999999999995 110.673 175.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.534 ' HD2' HD13 ' A' ' 41' ' ' LEU . 65.2 Cg_endo -74.67 117.76 5.07 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.311 2.008 . . . . 71.530000000000001 112.628 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.87 172.49 22.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.06 -0.59 . . . . 73.230000000000004 113.299 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 60.3 tp -97.66 114.36 26.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.93 0.395 . . . . 73.319999999999993 111.607 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 23.6 t-20 -74.53 123.08 24.12 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.382 -0.372 . . . . 61.240000000000002 111.711 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -72.63 -19.64 61.42 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.214 0.82 . . . . 71.549999999999997 113.214 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -66.05 -59.93 3.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.337 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.494 ' OG1' ' HG2' ' A' ' 66' ' ' GLN . 72.3 p -122.91 6.21 9.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.831 0.678 . . . . 71.25 112.831 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 0.1 OUTLIER 67.35 32.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.632 0.605 . . . . 73.310000000000002 112.632 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.494 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 83.7 mm-40 -79.19 130.57 35.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.742 0.306 . . . . 64.230000000000004 111.296 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -98.47 121.61 40.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.572 0.225 . . . . 74.5 110.707 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -175.03 -177.83 44.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.514 -0.85 . . . . 54.329999999999998 113.495 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 20.1 m-20 -88.23 119.94 29.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 75.420000000000002 111.194 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.5 p90 -114.8 145.77 34.65 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.432 -0.349 . . . . 72.209999999999994 111.07 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.53 109.46 2.76 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.426 2.084 . . . . 74.25 112.438 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.36 34.07 0.96 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.243 0.457 . . . . 64.019999999999996 114.243 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.0 p -102.87 -26.73 13.01 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.461 -0.435 . . . . 73.329999999999998 111.348 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.6 15.54 26.81 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 64.030000000000001 111.795 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 11' ' ' ALA . 24.2 m -118.73 161.3 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.933 0.397 . . . . 73.239999999999995 111.517 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.11 138.12 46.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.094 0.473 . . . . 72.409999999999997 110.919 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.457 ' CZ ' ' HA2' ' A' ' 79' ' ' GLY . 39.5 t80 -77.76 116.6 18.41 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.868 0.366 . . . . 62.340000000000003 110.963 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -86.43 -48.29 8.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.236 0.541 . . . . 74.329999999999998 110.78 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 77' ' ' PHE . . . 131.24 -165.22 23.2 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.849 -0.614 . . . . 64.310000000000002 112.502 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.55 166.36 19.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.332 2.022 . . . . 74.409999999999997 111.97 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 81' ' ' LEU . 6.3 mp . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 65.120000000000005 111.724 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.526 0.724 0 N-CA-C 113.026 -0.03 . . . . 72.219999999999999 113.026 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -130.12 148.22 51.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.616 0.366 . . . . 74.439999999999998 111.112 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.715 ' HG3' HD13 ' A' ' 81' ' ' LEU . 82.2 mt-30 -103.63 143.86 32.2 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.19 0.519 . . . . 70.400000000000006 112.018 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.518 ' HA ' ' O ' ' A' ' 76' ' ' GLU . 87.9 m-85 -132.05 125.86 32.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.934 -0.575 . . . . 74.010000000000005 110.692 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.416 ' HB2' HD13 ' A' ' 78' ' ' LEU . 43.5 ttp180 -98.58 116.52 30.99 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.005 -0.435 . . . . 75.010000000000005 111.82 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 113.88 7.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.919 0.39 . . . . 72.319999999999993 111.451 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 76' ' ' GLU . 84.0 mt -77.92 -39.11 43.92 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.43 0.53 . . . . 75.140000000000001 112.43 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -126.32 145.81 54.02 Favored Pre-proline 0 N--CA 1.469 0.505 0 N-CA-C 111.718 0.266 . . . . 72.129999999999995 111.718 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 36.9 Cg_endo -65.88 131.62 27.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.434 2.089 . . . . 75.319999999999993 112.345 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 92.1 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.48 -0.327 . . . . 75.450000000000003 111.618 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 66' ' ' GLN . 43.1 tp . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.171 0.51 . . . . 73.239999999999995 112.046 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.31 166.32 10.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.073 -0.512 . . . . 61.409999999999997 111.228 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 15' ' ' PHE . 90.9 mt -114.99 142.51 46.53 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.675 0.62 . . . . 71.310000000000002 112.675 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -121.63 151.2 56.7 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 122.944 0.498 . . . . 74.530000000000001 110.658 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.5 Cg_endo -71.44 129.17 15.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.382 2.055 . . . . 74.310000000000002 113.261 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.28 22.83 75.34 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.223 -0.513 . . . . 73.420000000000002 113.105 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -105.97 157.85 17.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 65.140000000000001 110.846 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.88 133.25 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.252 0.549 . . . . 63.210000000000001 111.895 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 31' ' ' LEU . 4.8 mp -121.38 139.23 53.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.094 -0.503 . . . . 74.519999999999996 110.533 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.26 124.86 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 120.983 0.42 . . . . 72.239999999999995 112.04 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.01 124.39 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.414 -0.357 . . . . 74.420000000000002 110.754 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.517 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 74.9 m -95.12 159.98 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.449 0.536 . . . . 65.129999999999995 112.449 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -50.79 -38.94 51.29 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.404 -0.362 . . . . 73.209999999999994 111.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.7 -37.44 41.38 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.122 0.416 . . . . 72.319999999999993 112.122 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -77.14 -49.14 15.88 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.933 0.397 . . . . 74.299999999999997 111.265 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 94.8 mt -58.52 -46.06 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.426 -0.352 . . . . 73.5 111.887 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -61.57 -35.71 78.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.602 0.239 . . . . 74.349999999999994 111.584 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.2 75.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.081 0.467 . . . . 74.450000000000003 111.046 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 60.5 mt -76.31 -28.7 57.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.2 0.524 . . . . 75.129999999999995 111.109 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.0 16.99 15.06 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.048 -0.523 . . . . 65.439999999999998 112.963 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 61.8 t -83.65 130.66 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.897 0.379 . . . . 73.129999999999995 111.094 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.54 152.61 25.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.252 -0.431 . . . . 60.43 111.811 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -40.62 111.97 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.786 0.435 . . . . 64.120000000000005 111.725 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.9 -17.11 7.71 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.401 -0.428 . . . . 73.319999999999993 112.501 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 -33.44 7.91 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.213 -0.518 . . . . 53.310000000000002 113.278 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -33.01 71.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.328 0.492 . . . . 74.329999999999998 112.328 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -68.06 -5.37 17.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.086 0.47 . . . . 73.349999999999994 112.009 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 89.7 m -141.37 81.94 14.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.271 -0.422 . . . . 75.140000000000001 110.444 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.13 -16.21 16.34 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.125 2.55 . . . . 63.439999999999998 113.461 -175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -59.11 -31.21 68.72 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.728 0.299 . . . . 72.319999999999993 111.665 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.3 t -82.7 -23.91 33.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.732 0.301 . . . . 74.530000000000001 111.215 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.69 -44.86 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.975 0.417 . . . . 75.510000000000005 110.456 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 76.48 -76.53 1.5 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.147 -0.478 . . . . 74.319999999999993 113.389 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -121.3 129.2 52.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.945 0.402 . . . . 73.140000000000001 111.445 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -152.82 145.0 16.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.264 0.468 . . . . 72.439999999999998 112.264 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -90.07 124.86 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.928 2.419 . . . . 53.520000000000003 112.974 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.92 176.6 25.72 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.003 -0.618 . . . . 72.140000000000001 113.39 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.5 tp -97.48 132.12 43.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 74.0 110.868 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 24.5 t-20 -95.03 143.36 26.56 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.388 -0.369 . . . . 72.129999999999995 111.14 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -84.77 -55.79 3.92 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.607 0.595 . . . . 74.519999999999996 112.607 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -64.63 -56.0 16.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.229 0.455 . . . . 71.530000000000001 112.229 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 p -81.45 -17.06 50.09 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.88 0.326 . . . . 70.409999999999997 111.88 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 77.1 mtp180 61.64 18.11 9.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.004 0.522 . . . . 73.439999999999998 112.406 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.424 ' HB2' HD12 ' A' ' 23' ' ' LEU . 96.5 mt-30 -86.53 164.68 16.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.256 0.551 . . . . 72.439999999999998 111.904 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -128.92 131.58 47.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.896 -0.593 . . . . 75.120000000000005 110.666 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.23 -170.28 43.31 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.381 -0.914 . . . . 64.409999999999997 113.764 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.18 123.19 33.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.424 0.29 . . . . 62.210000000000001 110.941 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.83 151.3 77.95 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.662 0.268 . . . . 61.200000000000003 111.432 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 88.1 Cg_endo -77.29 120.43 5.31 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.486 2.124 . . . . 64.549999999999997 112.91 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.64 16.17 6.83 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.391 -0.433 . . . . 61.200000000000003 113.943 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -81.3 -20.65 40.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.251 -0.558 . . . . 70.340000000000003 111.615 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -104.88 12.3 32.67 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.368 0.507 . . . . 74.209999999999994 112.368 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 33.2 m -121.95 146.03 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 113.366 0.876 . . . . 71.329999999999998 113.366 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 5.8 mm-40 -93.68 130.74 39.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.605 -0.725 . . . . 71.430000000000007 111.524 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -70.36 100.21 1.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.041 0.448 . . . . 75.450000000000003 110.416 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 10' ' ' ARG . 64.0 mt -74.8 -47.69 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.365 -0.38 . . . . 64.099999999999994 111.376 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.78 177.02 22.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.639 -0.791 . . . . 64.450000000000003 113.885 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.27 137.61 12.06 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.545 2.83 . . . . 74.200000000000003 112.871 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.715 HD13 ' HG3' ' A' ' 8' ' ' GLN . 5.8 mp . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 120.869 0.366 . . . . 71.420000000000002 111.634 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.423 0 N-CA-C 112.166 -0.373 . . . . 64.219999999999999 112.166 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -131.55 146.15 52.08 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.129 0.49 . . . . 75.209999999999994 111.946 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.574 HE21 ' HB3' ' A' ' 81' ' ' LEU . 77.9 mt-30 -101.43 128.33 47.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.048 -0.524 . . . . 74.25 111.416 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.37 128.15 53.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.318 -0.401 . . . . 72.040000000000006 110.715 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.544 ' HB2' HD13 ' A' ' 78' ' ' LEU . 55.8 ttp180 -98.11 120.97 39.45 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.144 0.424 . . . . 72.109999999999999 112.144 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 29' ' ' ASP . . . -74.07 114.72 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 111.313 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -82.21 -43.67 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.17 0.433 . . . . 75.150000000000006 112.17 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.65 140.93 28.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 N-CA-C 112.122 0.416 . . . . 61.329999999999998 112.122 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 35.5 Cg_endo -65.74 123.59 11.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.444 2.096 . . . . 60.130000000000003 112.935 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.6 t80 . . . . . 0 CA--C 1.536 0.43 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 111.313 179.816 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 61' ' ' ASN . 45.9 tp . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 111.78 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.53 142.41 30.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.431 -0.35 . . . . 64.200000000000003 110.84 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 66.2 mt -116.16 141.96 47.45 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.128 0.418 . . . . 74.530000000000001 112.128 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.86 153.51 46.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 122.721 0.408 . . . . 63.119999999999997 110.766 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 29.5 Cg_endo -61.69 117.21 4.01 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.602 2.202 . . . . 74.219999999999999 113.206 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.28 16.85 33.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.154 -0.476 . . . . 62.140000000000001 113.826 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 9.6 m-20 -77.22 135.67 38.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.877 0.695 . . . . 74.319999999999993 112.877 178.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.24 97.06 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.15 0.5 . . . . 70.310000000000002 110.24 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 31' ' ' LEU . 6.6 mp -81.98 132.89 35.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.097 0.475 . . . . 73.109999999999999 111.902 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG13 HD23 ' A' ' 81' ' ' LEU . 66.8 t -94.05 109.41 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.047 -0.524 . . . . 73.329999999999998 111.142 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 117.91 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.011 0.434 . . . . 70.040000000000006 111.281 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.7 p -68.02 141.46 56.21 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.801 0.334 . . . . 73.0 111.519 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -67.01 -23.75 65.95 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.023 0.44 . . . . 74.040000000000006 110.803 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.24 89.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.182 -0.463 . . . . 70.340000000000003 111.191 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.93 -44.16 97.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.38 . . . . 73.549999999999997 111.288 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.84 -45.14 90.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.983 0.421 . . . . 73.329999999999998 110.654 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -59.77 -40.39 88.08 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.239 -0.437 . . . . 71.230000000000004 111.265 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.23 79.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.028 0.442 . . . . 64.340000000000003 111.537 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.18 -17.63 60.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.159 -0.473 . . . . 74.230000000000004 111.192 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 18.18 38.04 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.499 -0.382 . . . . 63.340000000000003 113.396 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.57 114.43 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.024 0.379 . . . . 71.430000000000007 112.024 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.59 151.04 20.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.383 -0.371 . . . . 74.030000000000001 111.098 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 146.05 5.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.278 0.561 . . . . 75.340000000000003 111.794 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.14 -26.3 24.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.77 -0.532 . . . . 74.010000000000005 111.77 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.86 1.47 17.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.508 -0.377 . . . . 71.219999999999999 112.673 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -38.41 90.98 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.089 0.471 . . . . 73.439999999999998 111.611 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -81.5 9.84 6.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.291 0.478 . . . . 72.239999999999995 112.291 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.0 m -122.39 72.9 39.26 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 120.85 0.357 . . . . 75.340000000000003 111.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 34.1 Cg_endo -63.66 -23.08 70.01 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.67 2.247 . . . . 74.019999999999996 112.773 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.44 -34.56 69.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.314 -0.403 . . . . 74.400000000000006 111.357 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -71.77 -41.61 68.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.93 0.395 . . . . 73.120000000000005 111.229 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.46 -38.33 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.123 -0.49 . . . . 74.310000000000002 111.594 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.95 -79.06 0.88 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.244 -0.503 . . . . 73.129999999999995 112.913 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -121.14 142.36 49.94 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.674 -0.309 . . . . 71.540000000000006 110.9 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 56.6 mtm -138.88 140.68 27.85 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.247 -0.283 . . . . 72.230000000000004 111.488 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.19 117.51 2.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.584 2.189 . . . . 75.030000000000001 112.524 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.72 178.26 26.41 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.732 -0.747 . . . . 73.200000000000003 113.77 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.24 132.67 50.25 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.961 0.41 . . . . 74.030000000000001 111.733 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.512 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.9 t-20 -99.98 149.25 23.64 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 111.348 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -92.01 -35.78 13.76 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.587 0.588 . . . . 74.310000000000002 112.587 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.409 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 13.8 tpp180 -56.72 -51.61 68.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.204 0.526 . . . . 75.209999999999994 111.315 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.9 p -100.14 -15.04 18.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.688 -0.687 . . . . 75.430000000000007 111.885 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtp180 64.2 18.08 11.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.795 0.438 . . . . 73.439999999999998 112.131 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -103.39 157.5 16.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.151 0.501 . . . . 73.019999999999996 112.228 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 67' ' ' ARG . 19.5 mtp180 -98.3 149.68 22.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.206 -0.452 . . . . 74.019999999999996 111.247 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.27 -178.72 47.62 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.93 -0.652 . . . . 74.120000000000005 112.894 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.13 124.99 40.35 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.595 0.236 . . . . 74.519999999999996 110.752 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -123.65 143.0 40.59 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 120.838 0.351 . . . . 65.549999999999997 111.668 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.66 116.07 4.24 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.659 2.239 . . . . 75.420000000000002 112.361 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -59.59 -17.57 41.5 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.715 0.646 . . . . 64.549999999999997 114.715 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.402 HG21 ' CD1' ' A' ' 74' ' ' TYR . 3.4 t -57.0 -32.46 66.14 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.799 0.666 . . . . 62.399999999999999 112.799 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.402 ' CD1' HG21 ' A' ' 73' ' ' THR . 95.9 m-85 -81.31 -16.9 51.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.663 0.616 . . . . 74.400000000000006 112.663 -177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -108.92 145.42 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.419 0.526 . . . . 74.420000000000002 112.419 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.53 154.71 24.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.058 -0.519 . . . . 63.509999999999998 110.857 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.07 126.51 33.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.824 0.345 . . . . 73.519999999999996 111.612 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 10' ' ' ARG . 83.9 mt -100.03 -68.11 0.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.232 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.83 -178.69 46.78 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 60.549999999999997 113.103 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.84 166.21 30.61 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.293 2.662 . . . . 73.200000000000003 113.233 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.574 ' HB3' HE21 ' A' ' 8' ' ' GLN . 3.4 pp . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 112.306 0.484 . . . . 75.209999999999994 112.306 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.525 0.657 0 N-CA-C 114.421 0.529 . . . . 44.240000000000002 114.421 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.54 147.86 43.97 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.988 0.423 . . . . 73.310000000000002 111.412 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.465 ' HG2' HG22 ' A' ' 32' ' ' VAL . 45.9 mt-30 -92.75 133.11 36.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.899 0.38 . . . . 75.140000000000001 111.258 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -118.38 139.16 51.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.293 -0.412 . . . . 75.0 110.661 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.493 ' HB2' HD11 ' A' ' 78' ' ' LEU . 36.1 ttm180 -107.99 127.69 53.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.947 -0.47 . . . . 74.120000000000005 111.984 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.37 128.2 33.99 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.457 -0.338 . . . . 74.430000000000007 110.592 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.6 mt -68.28 -62.15 1.53 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.372 0.606 . . . . 74.219999999999999 111.821 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.54 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.0 m-85 -118.19 171.91 4.67 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.979 -0.555 . . . . 73.430000000000007 110.314 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -70.8 117.73 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 120.902 1.068 . . . . 74.540000000000006 111.261 170.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 83.8 m-85 . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.306 0.574 . . . . 73.340000000000003 111.763 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 tp . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 120.888 0.375 . . . . 72.319999999999993 110.936 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mp0 -75.95 155.8 34.76 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.006 0.432 . . . . 73.140000000000001 111.393 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 97.5 mt -112.12 143.05 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.48 -0.327 . . . . 75.420000000000002 111.277 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.66 154.34 46.74 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 122.596 0.359 . . . . 74.219999999999999 111.116 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 120.45 7.97 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.454 2.102 . . . . 75.450000000000003 113.207 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.07 69.9 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.165 -0.47 . . . . 73.329999999999998 113.58 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.82 155.57 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.377 -0.484 . . . . 72.519999999999996 111.349 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.35 129.57 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.233 0.539 . . . . 71.239999999999995 112.056 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 4.9 mp -124.37 121.31 34.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.112 -0.494 . . . . 74.310000000000002 110.527 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.503 HG13 HD12 ' A' ' 81' ' ' LEU . 48.9 t -94.12 124.09 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.332 0.493 . . . . 70.239999999999995 112.332 -175.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.97 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 120.979 0.418 . . . . 62.229999999999997 111.265 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.462 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 50.5 m -68.28 142.39 55.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.993 0.368 . . . . 74.049999999999997 111.993 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -60.55 -30.43 69.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.986 0.422 . . . . 74.209999999999994 111.452 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.4 81.32 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.131 0.491 . . . . 74.310000000000002 111.009 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.83 98.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.114 -0.494 . . . . 72.349999999999994 111.298 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.3 mt -56.84 -46.82 81.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.918 0.39 . . . . 75.230000000000004 111.021 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.64 -39.69 92.22 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.396 -0.366 . . . . 74.510000000000005 111.442 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.94 91.45 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.952 0.406 . . . . 74.439999999999998 111.005 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.506 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -66.77 -28.63 68.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.234 -0.439 . . . . 75.150000000000006 111.462 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.31 27.6 9.15 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.424 -0.417 . . . . 61.25 113.042 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.3 118.48 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.96 0.41 . . . . 70.439999999999998 111.097 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.52 149.81 29.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.305 -0.407 . . . . 73.319999999999993 111.866 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.18 119.19 6.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.01 0.434 . . . . 74.400000000000006 111.086 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.77 -4.82 18.97 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.049 -0.523 . . . . 64.299999999999997 112.327 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.04 -33.28 2.41 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.697 -0.287 . . . . 63.420000000000002 113.1 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -21.19 28.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.989 0.515 . . . . 74.230000000000004 112.222 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.81 -21.25 41.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.416 -0.356 . . . . 63.530000000000001 111.714 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.54 88.42 29.21 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.664 0.269 . . . . 72.420000000000002 110.951 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.69 -16.94 26.82 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.98 2.454 . . . . 62.229999999999997 113.318 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -57.64 -22.39 45.33 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.818 0.342 . . . . 64.420000000000002 111.889 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.0 t -77.81 -9.75 59.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.798 0.333 . . . . 74.010000000000005 111.813 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 t -106.55 -37.81 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.085 0.469 . . . . 74.310000000000002 111.626 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.43 -78.19 0.84 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.227 -0.511 . . . . 64.129999999999995 112.798 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.41 54.58 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.087 0.47 . . . . 74.120000000000005 111.223 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 71.1 mtp -139.49 139.39 22.37 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.221 -0.445 . . . . 74.349999999999994 111.623 -172.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.506 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.1 Cg_endo -82.16 117.4 2.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.304 2.003 . . . . 73.409999999999997 112.464 174.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.55 171.55 25.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.775 -0.726 . . . . 65.030000000000001 113.697 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 40.0 tp -96.74 109.15 21.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.594 0.358 . . . . 71.120000000000005 111.043 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -79.72 116.61 20.0 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.46 -0.336 . . . . 71.109999999999999 111.546 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.9 -21.49 63.3 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.733 0.642 . . . . 72.420000000000002 112.733 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 0.9 OUTLIER -60.58 -35.58 76.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.04 0.448 . . . . 73.540000000000006 111.325 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -119.57 -8.6 9.95 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.353 -0.385 . . . . 75.530000000000001 111.918 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 62.35 17.61 9.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 73.420000000000002 111.685 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -107.07 154.31 21.33 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.307 0.575 . . . . 72.310000000000002 111.931 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -101.18 134.67 43.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.948 -0.569 . . . . 72.239999999999995 111.219 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.0 172.11 34.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.979 -0.629 . . . . 73.109999999999999 112.985 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.7 113.18 25.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.906 0.384 . . . . 72.430000000000007 110.482 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -121.52 149.27 52.22 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.414 -0.357 . . . . 72.25 111.493 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 18.1 Cg_exo -66.29 95.15 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.355 2.037 . . . . 74.409999999999997 112.638 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.18 -19.69 40.0 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.085 -0.507 . . . . 63.030000000000001 113.534 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.0 t -61.79 -15.1 38.72 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.389 0.514 . . . . 63.219999999999999 112.389 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 35.8 m-85 -102.06 -1.54 31.44 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.623 0.601 . . . . 71.010000000000005 112.623 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.99 163.89 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.187 0.518 . . . . 74.140000000000001 112.153 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.08 148.75 41.25 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.106 -0.497 . . . . 73.510000000000005 111.714 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -79.02 118.22 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.071 -0.513 . . . . 75.019999999999996 111.642 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 10' ' ' ARG . 70.9 mt -89.97 -66.26 0.94 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 73.150000000000006 111.087 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.19 39.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.135 -0.555 . . . . 72.25 113.188 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.4 152.38 38.88 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.85 2.366 . . . . 61.310000000000002 113.083 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.503 HD12 HG13 ' A' ' 32' ' ' VAL . 4.9 mp . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.883 0.373 . . . . 75.200000000000003 111.201 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.417 0 CA-C-O 120.876 0.153 . . . . 73.040000000000006 113.328 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.22 171.3 12.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.093 0.473 . . . . 74.340000000000003 111.358 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.91 136.81 49.92 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.19 0.519 . . . . 53.32 111.811 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 94.5 m-85 -116.05 170.74 8.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.852 -0.613 . . . . 71.319999999999993 110.601 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.4 ttm180 -135.75 128.69 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.569 0.223 . . . . 63.130000000000003 111.275 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -66.08 114.67 5.4 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 63.119999999999997 111.858 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.45 -58.33 3.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.167 -0.47 . . . . 75.409999999999997 111.569 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.67 150.21 44.38 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.595 -0.275 . . . . 74.049999999999997 111.228 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 56.3 Cg_endo -70.91 118.05 5.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.16 1.906 . . . . 75.099999999999994 112.657 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.4 t80 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 72.549999999999997 110.979 -178.827 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.7 tp . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 120.908 0.385 . . . . 74.5 111.161 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.56 138.15 37.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.409 -0.36 . . . . 75.129999999999995 110.799 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 70' ' ' PHE . 69.0 mt -122.69 138.7 54.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.866 0.365 . . . . 64.310000000000002 111.898 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.537 ' HB2' ' NE ' ' A' ' 63' ' ' ARG . 3.9 mm? -122.11 140.73 32.86 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 122.666 0.386 . . . . 71.019999999999996 110.568 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.91 106.31 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.423 2.082 . . . . 72.340000000000003 113.257 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.56 -1.05 8.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.086 0.794 . . . . 75.010000000000005 115.086 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.79 156.4 16.39 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.703 1.252 . . . . 70.400000000000006 111.903 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -101.87 133.71 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.755 -0.657 . . . . 70.409999999999997 111.401 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.1 mp -106.59 110.28 22.44 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.014 -0.539 . . . . 74.5 110.591 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.51 120.18 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.907 0.384 . . . . 73.310000000000002 111.832 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.93 135.27 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.388 -0.369 . . . . 64.040000000000006 111.473 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.7 p -91.96 148.22 22.37 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.247 -0.283 . . . . 53.030000000000001 111.283 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -58.43 -28.43 65.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.953 0.353 . . . . 64.140000000000001 111.953 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.35 -39.48 70.1 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.924 0.392 . . . . 63.549999999999997 111.639 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.12 77.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 72.310000000000002 111.33 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.84 -42.48 93.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 63.020000000000003 111.211 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.9 -39.07 90.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.3 -0.409 . . . . 75.299999999999997 111.185 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.03 96.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.945 0.402 . . . . 71.540000000000006 111.346 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.403 HD13 ' HD2' ' A' ' 58' ' ' PRO . 84.2 mt -66.69 -24.72 66.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.177 0.513 . . . . 73.010000000000005 111.084 175.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.13 20.68 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.879 -0.601 . . . . 45.210000000000001 113.177 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.0 125.03 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.946 0.373 . . . . 62.340000000000003 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.38 131.2 45.24 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.577 -0.283 . . . . 63.329999999999998 111.491 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.06 126.96 28.24 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.326 0.584 . . . . 74.510000000000005 111.188 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.1 -2.89 51.36 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.071 -0.513 . . . . 74.099999999999994 112.157 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.87 -7.73 16.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.64 -0.314 . . . . 62.43 113.312 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -20.07 63.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.008 0.432 . . . . 75.129999999999995 111.732 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -71.2 -13.7 62.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.463 -0.335 . . . . 74.439999999999998 111.738 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.77 84.58 31.66 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.829 0.347 . . . . 73.099999999999994 111.437 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.73 -27.19 68.24 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.504 2.136 . . . . 75.319999999999993 112.937 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.604 ' HG3' ' HA ' ' A' ' 73' ' ' THR . 22.0 mp0 -67.18 -17.47 64.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.102 0.477 . . . . 74.219999999999999 111.285 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.0 m -87.31 -25.21 24.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.303 -0.408 . . . . 75.109999999999999 111.415 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.08 -55.16 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.95 0.405 . . . . 73.510000000000005 111.609 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.8 -92.23 0.5 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.17 -0.538 . . . . 35.939999999999998 112.573 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -121.14 141.44 50.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 73.140000000000001 111.788 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.494 ' HE3' ' HA3' ' A' ' 72' ' ' GLY . 3.4 mpp? -138.17 146.9 53.76 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 116.534 -0.303 . . . . 62.149999999999999 110.948 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' HD13 ' A' ' 41' ' ' LEU . 91.6 Cg_endo -79.19 126.65 7.1 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.341 2.028 . . . . 74.340000000000003 112.838 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.06 172.88 31.33 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.006 -0.616 . . . . 65.310000000000002 113.535 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.8 tp -97.47 119.12 35.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.263 0.225 . . . . 71.420000000000002 111.472 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.0 t-20 -90.95 121.42 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.573 -0.285 . . . . 71.140000000000001 110.593 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -73.65 -8.1 54.61 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.849 1.055 . . . . 74.239999999999995 113.849 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.537 ' NE ' ' HB2' ' A' ' 26' ' ' LEU . 57.7 mtt-85 -81.7 -54.39 5.42 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.569 -0.707 . . . . 75.239999999999995 111.117 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 64.3 p -86.81 -11.59 50.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.492 -0.322 . . . . 75.420000000000002 111.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.65 16.94 9.3 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.131 0.573 . . . . 74.439999999999998 111.681 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 64' ' ' THR . 68.3 mm-40 -107.41 152.84 23.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.049 0.452 . . . . 74.530000000000001 111.456 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 129.6 45.13 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.036 0.446 . . . . 73.540000000000006 111.199 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.91 173.62 34.56 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.156 -0.545 . . . . 73.430000000000007 113.146 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.41 118.82 28.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.903 0.382 . . . . 75.109999999999999 110.83 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.452 ' HB2' HD13 ' A' ' 25' ' ' LEU . 54.0 p90 -117.31 148.79 43.36 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.035 0.383 . . . . 75.340000000000003 112.035 -176.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.88 109.25 2.83 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.569 2.179 . . . . 74.040000000000006 112.347 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.494 ' HA3' ' HE3' ' A' ' 57' ' ' MET . . . -63.65 -17.95 60.89 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 115.079 0.791 . . . . 64.109999999999999 115.079 -173.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.604 ' HA ' ' HG3' ' A' ' 52' ' ' GLN . 12.6 t -65.55 -15.28 62.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.791 0.795 . . . . 54.420000000000002 112.408 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -99.79 2.98 44.56 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.126 0.417 . . . . 74.420000000000002 112.126 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.5 m -123.98 153.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.002 0.429 . . . . 72.209999999999994 112.102 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 12.9 pt-20 -100.38 154.59 18.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.474 -0.33 . . . . 54.240000000000002 111.304 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -89.93 113.74 25.43 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.722 0.296 . . . . 64.239999999999995 111.102 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.12 -61.72 1.7 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.981 0.419 . . . . 74.219999999999999 111.526 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.23 -155.01 26.1 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.241 -0.504 . . . . 73.239999999999995 112.784 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.33 152.62 39.49 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.7 2.266 . . . . 74.329999999999998 113.176 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 112.75 0.648 . . . . 70.519999999999996 112.75 -178.514 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.609 0 N-CA-C 112.727 -0.149 . . . . 73.239999999999995 112.727 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.14 135.55 49.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.965 0.412 . . . . 74.099999999999994 111.085 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -97.76 136.1 38.58 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.319 0.58 . . . . 72.299999999999997 112.456 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -113.26 169.28 9.06 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.735 -0.666 . . . . 74.430000000000007 110.382 174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 16.1 ttm-85 -119.23 127.76 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.985 -0.447 . . . . 74.019999999999996 111.692 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 31' ' ' LEU . . . -81.04 116.68 21.11 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.783 0.325 . . . . 64.040000000000006 110.564 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.09 -50.41 16.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 74.140000000000001 112.226 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -124.15 156.77 65.9 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 111.868 0.321 . . . . 74.040000000000006 111.868 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 55.9 Cg_endo -72.0 128.31 13.86 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.517 2.145 . . . . 75.019999999999996 113.496 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 CA--C 1.534 0.335 0 CA-C-N 116.037 -0.529 . . . . 74.030000000000001 110.915 178.245 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 61' ' ' ASN . 42.9 tp . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 112.407 0.521 . . . . 74.099999999999994 112.407 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -57.62 105.9 0.29 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.746 0.307 . . . . 72.340000000000003 111.776 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.7 mt -106.84 142.43 36.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.851 0.357 . . . . 75.450000000000003 111.38 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.3 150.69 44.87 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.473 -0.33 . . . . 75.329999999999998 111.394 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 44.9 Cg_endo -66.8 115.96 3.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.381 2.054 . . . . 75.409999999999997 112.629 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.23 21.76 53.88 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.109 -0.567 . . . . 73.209999999999994 112.815 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.5 162.17 14.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.008 0.432 . . . . 74.349999999999994 111.175 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.17 131.87 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.231 0.538 . . . . 75.310000000000002 111.334 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD11 ' HB1' ' A' ' 11' ' ' ALA . 6.1 mp -108.07 116.84 32.69 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.876 0.37 . . . . 73.430000000000007 110.998 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.9 t -93.68 108.73 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.996 0.427 . . . . 75.540000000000006 111.654 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.88 128.76 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.339 -0.392 . . . . 74.099999999999994 110.697 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -71.28 147.33 48.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.968 0.413 . . . . 70.439999999999998 111.74 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -59.04 -35.48 73.38 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.969 0.414 . . . . 73.530000000000001 110.21 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.28 89.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 62.43 111.379 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.411 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -57.73 -47.87 81.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.842 0.353 . . . . 74.099999999999994 111.557 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.83 -45.24 94.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.695 0.284 . . . . 75.129999999999995 111.453 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.48 -37.87 82.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.874 0.368 . . . . 71.430000000000007 110.972 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.46 87.64 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.893 0.378 . . . . 72.5 111.401 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 43' ' ' VAL . 90.8 mt -66.78 -20.16 65.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.986 0.422 . . . . 73.540000000000006 111.273 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.94 22.05 53.86 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.346 -0.454 . . . . 71.140000000000001 112.803 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 41' ' ' LEU . 60.3 t -68.43 104.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.036 0.446 . . . . 70.019999999999996 110.923 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 147.0 53.39 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.047 -0.524 . . . . 71.310000000000002 112.21 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -56.99 104.76 0.17 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.071 -0.513 . . . . 60.399999999999999 110.995 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.591 ' HA2' HH21 ' A' ' 49' ' ' ARG . . . 136.06 -18.77 3.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.877 -0.601 . . . . 64.150000000000006 112.372 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.18 -12.51 36.12 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.356 -0.449 . . . . 74.109999999999999 113.833 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -27.51 69.28 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.406 0.622 . . . . 74.099999999999994 111.331 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.591 HH21 ' HA2' ' A' ' 46' ' ' GLY . 36.1 mtm180 -80.27 9.15 6.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.963 -0.562 . . . . 74.129999999999995 112.069 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' NE2' ' A' ' 52' ' ' GLN . 50.0 t -138.37 75.2 39.73 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.16 0.505 . . . . 75.219999999999999 111.106 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.6 -34.4 74.84 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.687 2.258 . . . . 74.5 113.143 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.631 ' NE2' ' SG ' ' A' ' 50' ' ' CYS . 4.7 pp0? -64.88 -29.32 70.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.028 0.381 . . . . 74.420000000000002 112.028 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.495 ' HB2' ' SG ' ' A' ' 50' ' ' CYS . 31.7 t -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.848 0.356 . . . . 74.430000000000007 110.687 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.9 -40.26 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.925 0.393 . . . . 73.150000000000006 111.244 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.14 -133.09 11.39 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.2 -0.524 . . . . 75.219999999999999 113.456 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.511 ' HE3' ' HB3' ' A' ' 69' ' ' ASP . 37.3 m95 -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.011 0.434 . . . . 74.400000000000006 111.325 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.0 mtm -121.26 140.35 31.1 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.311 -0.404 . . . . 71.230000000000004 111.436 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.91 121.04 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.551 2.167 . . . . 74.430000000000007 112.657 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.46 170.23 27.55 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.722 -0.751 . . . . 71.409999999999997 113.98 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.81 132.16 43.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.802 0.441 . . . . 75.129999999999995 111.57 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.505 ' HB2' HD22 ' A' ' 23' ' ' LEU . 28.2 t-20 -88.6 116.45 26.85 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.48 -0.327 . . . . 72.209999999999994 110.698 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.51 -19.51 65.8 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.119 0.785 . . . . 73.450000000000003 113.119 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -73.55 -64.29 1.02 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.342 0.591 . . . . 72.519999999999996 111.536 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 78.7 p -89.01 -21.41 23.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.986 -0.552 . . . . 74.420000000000002 112.412 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 64' ' ' THR . 3.0 mpt_? 70.57 19.12 6.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.151 0.58 . . . . 74.439999999999998 111.832 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -86.25 134.6 33.75 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.344 -0.389 . . . . 71.010000000000005 110.611 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -95.02 126.51 40.41 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.54 -0.3 . . . . 75.120000000000005 110.884 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.81 -164.03 11.93 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.913 -0.66 . . . . 42.109999999999999 112.903 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.511 ' HB3' ' HE3' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -109.76 152.98 24.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.878 0.371 . . . . 72.340000000000003 110.926 176.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -154.24 138.36 11.08 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.391 -0.368 . . . . 72.430000000000007 111.3 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 56' ' ' TRP . 13.6 Cg_exo -70.05 118.98 6.0 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.543 2.162 . . . . 74.349999999999994 112.132 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.56 9.15 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.572 0.589 . . . . 54.100000000000001 114.572 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -60.84 -16.67 43.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.036 0.754 . . . . 73.420000000000002 113.036 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.423 ' HE2' ' HG2' ' A' ' 71' ' ' PRO . 74.6 m-85 -98.37 -4.05 35.68 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.607 0.595 . . . . 72.450000000000003 112.607 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.85 160.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.432 0.53 . . . . 64.049999999999997 112.432 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 11.4 pt-20 -110.06 151.99 26.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.348 -0.387 . . . . 75.329999999999998 110.776 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -82.62 119.03 23.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.849 0.357 . . . . 75.150000000000006 111.195 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.55 -61.57 1.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 111.151 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.5 -169.16 33.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.179 -0.534 . . . . 74.120000000000005 113.088 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.72 173.24 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.611 2.207 . . . . 75.319999999999993 113.075 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 81' ' ' LEU . 6.0 mp . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 75.120000000000005 111.438 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 N-CA-C 114.305 0.482 . . . . 50.520000000000003 114.305 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -106.75 155.98 19.13 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.74 0.416 . . . . 73.420000000000002 110.945 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.48 123.28 46.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.824 0.676 . . . . 75.340000000000003 112.824 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.79 170.4 8.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.93 -0.577 . . . . 72.310000000000002 110.04 170.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -150.52 121.24 7.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.423 0.527 . . . . 74.430000000000007 112.423 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 151.48 29.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.345 0.593 . . . . 74.209999999999994 112.159 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.64 -29.41 12.33 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.284 0.476 . . . . 64.400000000000006 112.284 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -135.35 145.3 53.24 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-O 120.619 0.247 . . . . 74.340000000000003 111.329 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.0 Cg_endo -74.04 126.06 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.445 2.097 . . . . 75.349999999999994 113.902 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 . . . . . 0 N--CA 1.472 0.654 0 CA-C-N 116.05 -0.523 . . . . 75.150000000000006 110.681 176.814 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.694 0.283 . . . . 64.310000000000002 110.386 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.11 106.85 3.89 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.883 0.373 . . . . 74.299999999999997 111.936 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 91.8 mt -99.78 144.86 28.36 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 111.712 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 25' ' ' LEU . 4.1 mm? -123.74 155.69 66.11 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 122.889 0.475 . . . . 65.540000000000006 111.033 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.9 Cg_endo -70.61 107.9 2.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.217 1.944 . . . . 74.040000000000006 112.993 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.69 40.97 11.5 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.147 -0.549 . . . . 63.530000000000001 113.183 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -99.72 175.12 5.91 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.57 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -119.89 134.78 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.827 0.346 . . . . 63.100000000000001 110.732 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.06 122.24 42.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.647 0.261 . . . . 73.209999999999994 111.036 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.43 111.07 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.075 0.464 . . . . 74.319999999999993 111.242 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' HA3' ' A' ' 59' ' ' GLY . 48.2 t -111.73 119.2 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.455 -0.339 . . . . 71.299999999999997 111.529 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -58.95 127.1 30.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.764 -0.198 . . . . 64.019999999999996 111.077 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -52.27 -35.86 51.22 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.848 0.314 . . . . 74.109999999999999 111.848 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.44 65.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.535 -0.302 . . . . 52.329999999999998 111.799 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.949 0.404 . . . . 64.519999999999996 111.1 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 90.3 mt -62.77 -44.86 95.09 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.291 -0.413 . . . . 75.129999999999995 110.908 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.89 -23.87 66.73 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 111.514 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.86 54.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.11 0.481 . . . . 71.040000000000006 110.882 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.8 mt -68.39 -28.37 67.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.02 -0.536 . . . . 74.409999999999997 111.404 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.7 9.95 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.225 -0.443 . . . . 64.430000000000007 113.129 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.3 t -77.28 100.58 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.03 0.443 . . . . 75.030000000000001 111.144 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.3 149.91 37.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.227 -0.442 . . . . 71.340000000000003 112.127 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -46.16 129.91 10.14 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.144 -0.48 . . . . 75.439999999999998 111.58 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.82 -50.15 0.93 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.173 -0.467 . . . . 64.450000000000003 112.097 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -21.99 65.6 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.261 -0.495 . . . . 55.109999999999999 112.253 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.93 -31.2 27.75 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.415 0.686 . . . . 63.509999999999998 111.621 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -85.65 7.04 24.84 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.538 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.522 ' SG ' ' HG2' ' A' ' 52' ' ' GLN . 48.5 t -146.17 68.64 12.62 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 121.019 0.437 . . . . 74.400000000000006 110.92 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.79 -15.15 47.21 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.005 2.47 . . . . 74.099999999999994 113.259 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.522 ' HG2' ' SG ' ' A' ' 50' ' ' CYS . 20.2 pt20 -61.05 -19.46 61.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.367 -0.378 . . . . 75.239999999999995 111.886 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -81.89 -12.14 58.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.402 0.519 . . . . 74.439999999999998 112.402 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.38 -59.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.114 0.483 . . . . 73.239999999999995 111.747 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.06 -81.89 0.32 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.056 -0.593 . . . . 74.329999999999998 113.028 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.5 m0 -118.88 117.72 29.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.132 0.466 . . . . 74.409999999999997 111.638 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.442 ' N ' ' SD ' ' A' ' 57' ' ' MET . 2.7 mpp? -120.86 138.75 28.08 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.756 -0.202 . . . . 70.439999999999998 111.038 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.37 116.97 4.22 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 71.349999999999994 112.909 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.457 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -143.68 171.21 25.42 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.71 -0.757 . . . . 73.120000000000005 114.021 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.8 tp -103.89 123.23 46.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.687 0.395 . . . . 74.409999999999997 110.992 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -85.23 128.73 34.79 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.561 0.219 . . . . 70.540000000000006 111.447 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -80.64 0.86 32.38 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.385 0.883 . . . . 73.040000000000006 113.385 -177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -100.78 -47.73 4.72 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.777 -0.577 . . . . 74.150000000000006 111.446 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -96.92 -24.97 15.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.24 0.459 . . . . 74.120000000000005 112.24 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 63.41 23.98 13.95 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.193 0.52 . . . . 75.549999999999997 111.77 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -94.32 142.96 26.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.98 -0.555 . . . . 72.400000000000006 110.545 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -99.98 128.45 46.06 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.356 -0.384 . . . . 71.129999999999995 111.344 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.06 -178.15 40.28 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.051 -0.595 . . . . 73.409999999999997 113.109 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 3.7 m-20 -95.29 109.64 21.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.895 0.379 . . . . 71.349999999999994 110.8 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -100.09 142.38 24.5 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 120.843 0.354 . . . . 74.409999999999997 111.936 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.31 111.51 2.52 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.695 2.264 . . . . 63.119999999999997 112.922 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.515 ' HA2' HG21 ' A' ' 75' ' ' VAL . . . -64.86 -8.71 35.84 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.498 0.559 . . . . 54.299999999999997 114.498 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.3 p -78.62 -13.83 59.62 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.2 0.5 . . . . 75.530000000000001 111.971 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.3 6.13 20.29 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.268 0.47 . . . . 74.120000000000005 112.268 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.515 HG21 ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -128.1 141.19 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.038 0.447 . . . . 74.299999999999997 112.187 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -92.23 159.76 15.48 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.331 -0.395 . . . . 64.329999999999998 110.428 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -105.09 124.38 49.43 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.017 0.437 . . . . 75.230000000000004 111.559 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.72 -59.62 2.13 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.146 0.498 . . . . 74.430000000000007 111.094 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.88 -172.65 27.32 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.427 -0.416 . . . . 51.039999999999999 112.749 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.3 134.92 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.23 1.953 . . . . 71.409999999999997 112.147 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 71.530000000000001 113.014 -177.055 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 CA-C-O 120.801 0.112 . . . . 65.530000000000001 113.064 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -139.8 155.33 47.33 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.317 -0.519 . . . . 73.120000000000005 111.14 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.441 ' HG3' HD11 ' A' ' 81' ' ' LEU . 48.3 mt-30 -112.36 136.62 51.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.3 0.571 . . . . 70.230000000000004 111.76 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 51' ' ' PRO . 87.9 m-85 -113.67 173.31 6.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.746 -0.661 . . . . 73.219999999999999 110.702 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -136.34 121.26 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.733 0.302 . . . . 74.430000000000007 111.372 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.464 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -70.92 125.5 27.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.026 0.441 . . . . 64.299999999999997 111.894 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.7 mt -81.21 -45.71 15.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.104 0.409 . . . . 73.200000000000003 112.104 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -137.33 158.5 72.18 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 116.467 -0.333 . . . . 75.409999999999997 111.061 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 37.8 Cg_endo -66.71 124.74 12.75 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.229 1.953 . . . . 73.140000000000001 113.377 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.5 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 74.030000000000001 110.77 179.018 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 61' ' ' ASN . 58.6 tp . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 120.862 0.363 . . . . 73.340000000000003 111.656 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -65.45 117.16 7.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.129 0.49 . . . . 71.140000000000001 111.769 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 55.1 mt -103.29 134.98 45.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 74.129999999999995 111.173 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.76 146.33 34.51 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 120.573 0.225 . . . . 74.239999999999995 110.989 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.04 125.04 14.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.396 2.064 . . . . 73.310000000000002 113.072 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.2 4.03 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 116.235 -0.439 . . . . 54.439999999999998 113.928 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -93.19 149.31 21.31 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 117.238 0.519 . . . . 75.510000000000005 111.105 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.59 132.5 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.321 0.582 . . . . 72.400000000000006 111.935 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.494 HD11 ' N ' ' A' ' 31' ' ' LEU . 4.9 mp -103.81 116.56 32.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.976 -0.556 . . . . 71.219999999999999 111.015 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.66 118.01 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.986 0.422 . . . . 65.420000000000002 111.672 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.65 120.47 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.938 0.399 . . . . 73.319999999999993 111.413 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -67.68 148.44 51.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.371 -0.377 . . . . 53.520000000000003 111.803 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 8.3 tpp180 -55.12 -47.35 75.15 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.453 -0.34 . . . . 73.120000000000005 111.544 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.34 -32.41 48.97 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.469 0.544 . . . . 75.010000000000005 112.469 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.48 73.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.883 0.373 . . . . 75.409999999999997 111.045 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD23 HD13 ' A' ' 41' ' ' LEU . 87.6 mt -65.18 -35.02 79.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.284 -0.416 . . . . 74.109999999999999 111.095 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 13.4 mm100 -60.58 -43.98 96.73 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.952 0.406 . . . . 72.409999999999997 110.699 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.32 -40.62 96.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.288 -0.415 . . . . 44.43 111.374 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.454 HD13 HD23 ' A' ' 38' ' ' LEU . 94.9 mt -62.98 -18.28 63.05 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.046 0.45 . . . . 73.549999999999997 111.343 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 38.71 20.94 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.088 -0.577 . . . . 73.230000000000004 112.639 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.45 122.83 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.016 0.436 . . . . 74.310000000000002 111.725 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.59 138.75 33.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.384 -0.371 . . . . 54.240000000000002 110.273 173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.18 117.57 3.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.208 0.528 . . . . 63.240000000000002 111.471 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.57 5.68 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.808 -0.633 . . . . 62.420000000000002 112.182 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.18 -38.62 3.74 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.7 -0.286 . . . . 72.299999999999997 112.779 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -23.8 56.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.771 0.428 . . . . 75.109999999999999 111.668 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -54.99 -21.96 13.65 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.484 -0.326 . . . . 74.099999999999994 111.715 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 53' ' ' SER . 22.1 p -115.84 81.5 9.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.966 0.412 . . . . 64.209999999999994 111.008 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 52.9 Cg_exo -54.94 -42.23 71.08 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.114 2.543 . . . . 75.140000000000001 113.183 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -60.97 -31.47 71.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.865 0.364 . . . . 75.319999999999993 111.371 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.568 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 39.3 t -73.79 -38.44 64.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.164 0.507 . . . . 74.109999999999999 111.095 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.23 -40.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.059 0.457 . . . . 75.530000000000001 110.995 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.67 -76.18 1.09 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.186 -0.53 . . . . 73.420000000000002 113.662 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -118.95 132.38 56.08 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.906 0.384 . . . . 74.200000000000003 111.33 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 68.5 mtm -144.91 131.98 10.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 O-C-N 122.208 -0.308 . . . . 72.299999999999997 111.668 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 69' ' ' ASP . 97.2 Cg_endo -80.48 127.66 6.63 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.388 2.059 . . . . 75.239999999999995 112.502 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.79 176.69 34.02 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.634 -0.793 . . . . 74.030000000000001 113.614 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.73 131.29 55.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.573 0.349 . . . . 74.340000000000003 111.107 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 28.6 t-20 -96.67 149.17 22.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.457 -0.338 . . . . 74.340000000000003 111.002 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -91.98 -33.86 14.68 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.608 0.596 . . . . 71.409999999999997 112.608 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -64.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.153 0.501 . . . . 73.409999999999997 110.635 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 p -75.21 -21.5 58.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.406 -0.361 . . . . 72.319999999999993 111.474 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 17.5 mtp180 58.34 20.54 7.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.63 0.604 . . . . 74.219999999999999 112.63 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.33 163.89 12.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.311 0.577 . . . . 64.349999999999994 111.712 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -107.9 129.65 55.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.672 -0.694 . . . . 73.299999999999997 110.682 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.04 -172.37 34.2 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.261 -0.971 . . . . 73.25 113.875 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.2 t70 -115.61 109.37 17.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.767 0.427 . . . . 72.409999999999997 109.881 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 25' ' ' LEU . 54.4 p90 -103.52 149.12 36.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 112.656 0.613 . . . . 73.420000000000002 112.656 -171.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 73' ' ' THR . 74.2 Cg_endo -76.11 113.48 3.71 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.713 2.275 . . . . 75.019999999999996 112.412 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.01 -16.1 16.72 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.734 0.654 . . . . 70.319999999999993 114.734 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 71' ' ' PRO . 6.1 t -59.21 -33.38 70.9 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.343 0.572 . . . . 75.239999999999995 112.505 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.418 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 54.8 m-85 -89.49 5.03 47.25 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.905 0.706 . . . . 75.209999999999994 112.905 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 11' ' ' ALA . 28.2 m -127.48 148.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.149 0.499 . . . . 73.540000000000006 112.222 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.85 146.44 28.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.121 -0.491 . . . . 73.0 110.401 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -78.34 128.64 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.908 0.385 . . . . 75.420000000000002 111.674 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.66 -67.53 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.929 0.395 . . . . 73.409999999999997 110.923 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.74 -174.06 41.42 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.035 -0.602 . . . . 43.149999999999999 113.093 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.99 -176.83 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.706 2.271 . . . . 74.200000000000003 112.745 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.441 HD11 ' HG3' ' A' ' 8' ' ' GLN . 4.6 mp . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 75.450000000000003 111.163 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.43 0 N-CA-C 112.707 -0.157 . . . . 54.329999999999998 112.707 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -119.94 160.92 21.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.302 0.572 . . . . 74.420000000000002 111.615 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 98.3 mt-30 -107.74 126.86 53.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.833 -0.621 . . . . 71.049999999999997 111.034 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.27 130.16 55.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.922 0.391 . . . . 73.109999999999999 110.674 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.542 ' HB2' HD13 ' A' ' 78' ' ' LEU . 37.1 ttt180 -97.59 123.32 41.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 111.846 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . . . -78.49 131.8 36.99 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.045 0.45 . . . . 72.319999999999993 110.978 176.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.27 -60.36 2.37 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.291 0.478 . . . . 64.140000000000001 112.291 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.513 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.6 m-85 -132.57 165.11 38.76 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.571 -0.286 . . . . 73.5 111.279 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 44.6 Cg_endo -68.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.813 1.675 . . . . 74.319999999999993 113.284 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 . . . . . 0 N--CA 1.47 0.552 0 CA-C-N 115.938 -0.574 . . . . 65.25 110.646 176.228 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 61' ' ' ASN . 18.9 tp . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 112.384 0.513 . . . . 75.150000000000006 112.384 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -65.22 151.92 44.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.328 0.585 . . . . 74.109999999999999 112.013 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.4 mt -118.31 134.51 54.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.818 -0.628 . . . . 63.020000000000003 110.34 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.94 154.99 47.02 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 120.828 0.347 . . . . 70.129999999999995 111.642 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.17 117.12 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.484 2.123 . . . . 72.230000000000004 113.22 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.68 79.83 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.2 -0.524 . . . . 73.230000000000004 113.304 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 63' ' ' ARG . 20.7 t0 -82.75 156.22 23.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.918 0.39 . . . . 72.409999999999997 111.782 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.7 t -117.36 118.89 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.103 0.477 . . . . 73.319999999999993 111.46 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -107.14 133.64 51.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.306 -0.406 . . . . 62.240000000000002 110.932 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.74 115.73 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.231 0.456 . . . . 74.450000000000003 112.231 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.38 118.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.835 0.35 . . . . 74.409999999999997 111.388 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -76.1 155.61 34.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.851 0.358 . . . . 70.409999999999997 111.947 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HA ' HD11 ' A' ' 38' ' ' LEU . 61.5 mtp180 -62.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.866 0.365 . . . . 74.140000000000001 110.369 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.47 80.75 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.914 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.62 86.34 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 71.099999999999994 110.909 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' HA ' ' A' ' 35' ' ' ARG . 95.8 mt -59.0 -49.18 78.89 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.207 -0.451 . . . . 73.200000000000003 111.355 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -61.76 -34.56 76.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.933 0.397 . . . . 75.019999999999996 111.101 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.37 -22.11 66.76 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.893 0.378 . . . . 71.439999999999998 111.539 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.507 HD11 ' HD2' ' A' ' 58' ' ' PRO . 96.4 mt -85.64 -5.66 59.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.707 0.289 . . . . 72.400000000000006 111.516 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.77 43.88 82.49 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.791 -0.719 . . . . 73.109999999999999 112.366 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 143.66 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.933 0.397 . . . . 74.329999999999998 111.338 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.39 150.94 48.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.113 -0.494 . . . . 75.409999999999997 112.208 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.93 101.5 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.307 0.575 . . . . 74.439999999999998 112.19 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . 99.29 -9.52 61.12 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 116.085 -0.507 . . . . 71.450000000000003 113.685 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 1.24 46.7 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.167 0.427 . . . . 60.130000000000003 114.167 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -60.25 -18.23 47.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.383 0.611 . . . . 52.109999999999999 111.723 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 8.0 ptt180 -84.91 8.46 17.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.653 -0.703 . . . . 65.299999999999997 112.162 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.6 m -133.66 76.86 65.51 Favored Pre-proline 0 N--CA 1.475 0.785 0 N-CA-C 112.302 0.482 . . . . 72.310000000000002 112.302 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.16 -32.89 62.6 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.656 2.237 . . . . 71.099999999999994 113.061 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.43 -37.66 84.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.939 0.399 . . . . 74.120000000000005 111.137 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.5 t -61.8 -39.95 93.51 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.257 -0.429 . . . . 73.219999999999999 111.661 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.439 HG13 HD12 ' A' ' 41' ' ' LEU . 45.3 t -75.75 -39.81 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.01 0.433 . . . . 74.209999999999994 111.546 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.22 -71.29 2.85 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.2 -0.524 . . . . 61.219999999999999 113.394 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -98.56 129.14 45.1 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.768 -0.254 . . . . 75.319999999999993 110.624 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 84.0 mtp -143.73 120.85 6.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 111.664 0.246 . . . . 72.519999999999996 111.664 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' ASP . 87.0 Cg_endo -81.79 138.38 10.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.552 2.168 . . . . 74.439999999999998 112.375 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.17 176.77 40.81 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.743 -0.741 . . . . 73.010000000000005 113.199 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.0 tp -100.84 118.87 37.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.637 -0.331 . . . . 74.0 110.95 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.509 ' HB2' HD22 ' A' ' 23' ' ' LEU . 28.5 t-20 -87.78 100.31 12.75 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.93 -20.46 65.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.124 0.416 . . . . 73.340000000000003 112.124 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.426 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.1 tpt180 -58.83 -49.48 77.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.073 0.463 . . . . 74.140000000000001 111.31 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -110.45 -1.93 16.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.058 -0.519 . . . . 74.120000000000005 112.137 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 63.55 20.52 12.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.759 0.423 . . . . 73.219999999999999 111.661 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -102.42 157.93 16.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.318 0.58 . . . . 61.039999999999999 111.792 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -103.8 151.25 23.28 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.96 -0.564 . . . . 75.409999999999997 110.501 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.66 -178.84 47.13 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.162 -1.018 . . . . 75.540000000000006 113.831 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.7 t70 -109.68 108.6 19.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.894 -0.41 . . . . 73.219999999999999 109.894 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 55.1 p90 -100.94 148.99 35.83 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 121.112 0.482 . . . . 72.310000000000002 112.253 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.5 101.1 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.436 2.091 . . . . 71.150000000000006 112.386 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.16 -17.45 30.73 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.242 0.457 . . . . 74.299999999999997 114.242 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -65.13 -14.2 59.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.731 0.641 . . . . 65.519999999999996 112.731 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.55 8.53 29.33 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.322 0.49 . . . . 65.430000000000007 112.322 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 m -125.22 155.86 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.157 0.503 . . . . 70.299999999999997 111.677 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -112.88 148.59 34.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.237 0.541 . . . . 64.219999999999999 111.51 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -78.16 119.25 21.28 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 111.046 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -90.17 -59.51 2.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.048 0.451 . . . . 73.329999999999998 111.291 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.23 -160.61 29.58 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.356 -0.449 . . . . 75.239999999999995 112.555 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.03 147.4 79.79 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.809 2.339 . . . . 71.430000000000007 112.775 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 8' ' ' GLN . 1.6 pp . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.654 0.613 . . . . 71.5 112.654 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 N-CA-C 112.086 -0.405 . . . . 71.099999999999994 112.086 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -136.78 156.93 47.86 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.334 0.587 . . . . 75.439999999999998 112.185 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -121.89 133.36 54.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.577 -0.738 . . . . 65.230000000000004 110.975 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.484 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 97.8 m-85 -122.91 137.51 54.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.59 -0.277 . . . . 73.099999999999994 110.879 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.53 ' HB2' HD23 ' A' ' 78' ' ' LEU . 9.4 ttm180 -98.65 122.6 42.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.836 0.35 . . . . 74.120000000000005 110.585 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.51 16.66 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.951 0.352 . . . . 75.340000000000003 111.951 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.7 -46.82 8.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.813 0.34 . . . . 74.430000000000007 111.512 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.21 137.96 20.72 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 111.974 0.361 . . . . 62.439999999999998 111.974 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 73.0 Cg_endo -78.89 146.12 20.4 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.58 2.187 . . . . 64.450000000000003 113.418 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . 0.511 ' HB2' HD12 ' A' ' 25' ' ' LEU . 92.1 m-85 . . . . . 0 N--CA 1.469 0.484 0 CA-C-N 116.203 -0.453 . . . . 75.030000000000001 110.828 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 HD23 HD22 ' A' ' 25' ' ' LEU . 37.3 tp . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.286 0.476 . . . . 74.109999999999999 112.286 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.44 117.75 13.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.569 -0.287 . . . . 73.209999999999994 110.66 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 15' ' ' PHE . 15.0 mt -135.7 136.39 40.82 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.848 0.684 . . . . 74.530000000000001 112.848 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.3 157.21 44.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.381 0.672 . . . . 73.510000000000005 110.655 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 21.9 Cg_exo -64.88 108.95 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.213 1.942 . . . . 63.520000000000003 112.633 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.19 15.35 14.44 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.462 -0.399 . . . . 73.409999999999997 113.993 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.4 151.35 30.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.182 0.491 . . . . 70.239999999999995 112.094 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.41 120.23 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.134 -0.484 . . . . 63.009999999999998 110.493 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.3 mp -103.37 124.08 48.03 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.814 0.34 . . . . 74.230000000000004 111.403 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG13 HD23 ' A' ' 81' ' ' LEU . 80.1 t -94.05 116.83 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.16 -0.473 . . . . 72.530000000000001 110.968 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.38 135.93 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.889 0.376 . . . . 71.140000000000001 111.229 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.1 p -86.82 133.78 33.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.698 0.285 . . . . 75.340000000000003 110.732 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -65.7 -25.4 67.3 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.097 -0.377 . . . . 75.310000000000002 111.07 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.25 -40.79 87.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.018 0.437 . . . . 74.530000000000001 111.19 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -62.73 -47.16 84.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.992 0.425 . . . . 74.209999999999994 111.029 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.53 -43.88 89.35 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 111.267 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -62.35 -38.26 88.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 111.124 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.76 68.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.002 0.43 . . . . 73.230000000000004 111.344 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 92.5 mt -81.54 -4.68 56.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.379 -0.373 . . . . 73.439999999999998 111.659 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.03 13.36 79.45 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.269 -0.491 . . . . 62.340000000000003 113.421 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.7 t -74.12 109.09 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.924 0.392 . . . . 74.040000000000006 111.531 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.78 148.29 44.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.982 0.42 . . . . 72.530000000000001 111.932 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.67 119.04 4.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.091 -0.504 . . . . 71.109999999999999 111.344 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.15 -14.16 16.26 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.481 -0.39 . . . . 64.340000000000003 112.234 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.52 -26.84 10.38 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.53 -0.367 . . . . 74.200000000000003 113.172 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -27.11 69.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.082 0.468 . . . . 73.209999999999994 111.791 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -67.41 -15.46 63.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.482 -0.326 . . . . 74.030000000000001 111.704 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.7 m -132.78 69.36 79.34 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 120.908 0.385 . . . . 51.030000000000001 110.661 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.51 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 29.1 Cg_endo -60.57 -21.57 69.2 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.101 2.534 . . . . 75.299999999999997 113.819 -172.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -55.82 -25.14 40.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.885 0.374 . . . . 72.340000000000003 111.945 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -77.71 -17.02 58.05 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.953 0.353 . . . . 65.409999999999997 111.953 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.15 -20.39 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.035 0.445 . . . . 72.409999999999997 111.524 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.67 -110.34 3.94 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.356 -0.449 . . . . 73.219999999999999 112.35 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -121.38 143.84 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.155 0.478 . . . . 71.120000000000005 110.995 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 46.7 mtm -134.44 149.42 71.04 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 111.89 0.329 . . . . 74.549999999999997 111.89 -173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.37 123.21 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.594 2.196 . . . . 64.5 113.109 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.81 163.51 28.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.035 -0.602 . . . . 71.129999999999995 113.586 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.429 HD23 HH21 ' A' ' 65' ' ' ARG . 52.8 tp -107.22 124.7 50.13 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.556 0.342 . . . . 74.329999999999998 111.788 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -87.48 122.91 31.81 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.583 -0.28 . . . . 72.040000000000006 110.676 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -72.1 -15.0 61.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.56 0.948 . . . . 71.340000000000003 113.56 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -86.86 -67.95 0.78 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.675 -0.641 . . . . 71.099999999999994 111.246 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.3 p -71.56 -22.95 61.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.242 -0.435 . . . . 74.420000000000002 112.004 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.429 HH21 HD23 ' A' ' 60' ' ' LEU . 22.8 mmm-85 65.97 8.68 5.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.519 0.728 . . . . 71.129999999999995 112.286 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -78.53 149.49 33.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.845 0.355 . . . . 74.219999999999999 110.958 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -113.07 134.61 54.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.518 -0.31 . . . . 75.340000000000003 110.402 176.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.26 176.19 45.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.834 -0.698 . . . . 53.039999999999999 112.627 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.57 107.9 19.14 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.921 0.391 . . . . 73.310000000000002 110.518 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -97.45 140.15 21.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.553 -0.294 . . . . 75.349999999999994 111.46 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.06 116.69 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.549 2.166 . . . . 73.430000000000007 112.46 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -71.57 26.53 0.6 Allowed Glycine 0 CA--C 1.536 1.397 0 N-CA-C 114.61 0.604 . . . . 51.340000000000003 114.61 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -104.02 -32.14 9.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.538 0.669 . . . . 75.400000000000006 112.452 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.487 ' CZ ' HD11 ' A' ' 25' ' ' LEU . 20.9 p90 -88.59 4.81 45.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 111.859 0.318 . . . . 75.109999999999999 111.859 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 17.9 m -112.94 146.84 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.725 0.639 . . . . 72.400000000000006 112.725 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.488 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 9.4 pt-20 -102.98 138.67 39.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.62 -0.718 . . . . 54.329999999999998 110.146 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -75.41 115.32 14.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.833 0.349 . . . . 74.230000000000004 111.506 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 10' ' ' ARG . 82.3 mt -85.3 -55.97 3.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.19 0.519 . . . . 73.030000000000001 111.481 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.02 -155.97 26.43 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.856 -0.611 . . . . 73.239999999999995 111.962 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.69 178.61 5.41 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.66 2.24 . . . . 74.450000000000003 113.17 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 32' ' ' VAL . 94.5 mt . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.786 0.327 . . . . 73.329999999999998 111.723 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.523 0.572 0 N-CA-C 112.82 -0.112 . . . . 71.510000000000005 112.82 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.99 155.99 38.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.194 0.521 . . . . 70.439999999999998 111.642 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.467 ' HG3' HD12 ' A' ' 81' ' ' LEU . 95.9 mt-30 -94.96 123.41 38.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.16 -0.473 . . . . 54.539999999999999 111.735 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.83 125.98 54.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.363 -0.381 . . . . 62.119999999999997 110.57 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HB2' HD13 ' A' ' 78' ' ' LEU . 70.6 ttt180 -97.79 120.49 38.27 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.682 0.277 . . . . 72.400000000000006 111.725 -176.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -68.4 119.99 13.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 53.140000000000001 111.47 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.86 -59.89 2.49 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.321 0.489 . . . . 74.409999999999997 112.321 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -127.09 156.83 73.81 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 116.362 -0.381 . . . . 71.439999999999998 111.149 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.62 119.16 6.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.089 1.86 . . . . 74.129999999999995 113.044 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 72.109999999999999 111.029 179.158 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 23.8 tp . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 120.924 0.392 . . . . 73.400000000000006 111.256 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.75 140.57 42.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.901 0.381 . . . . 62.439999999999998 111.661 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.0 mt -100.75 131.36 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.612 0.597 . . . . 63.340000000000003 112.612 -173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.16 148.99 41.89 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 122.721 0.408 . . . . 74.299999999999997 110.52 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.42 105.51 0.9 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.398 2.065 . . . . 72.230000000000004 113.168 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.42 -4.61 21.58 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.148 -0.549 . . . . 62.020000000000003 113.857 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 130.89 44.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.197 0.499 . . . . 73.209999999999994 111.916 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.9 105.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.905 -0.589 . . . . 74.540000000000006 110.721 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.7 mp -89.94 130.81 36.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.57 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.29 106.22 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.327 -0.397 . . . . 74.340000000000003 111.312 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.44 118.45 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.766 0.317 . . . . 61.210000000000001 110.819 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.433 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 87.3 p -69.41 140.91 54.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 65.0 111.846 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -60.27 -28.09 67.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.197 0.522 . . . . 74.340000000000003 110.702 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.4 -44.5 96.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.983 -0.553 . . . . 75.439999999999998 110.924 174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.38 -45.45 91.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.839 0.352 . . . . 73.310000000000002 110.915 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 96.1 mt -54.23 -43.42 70.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.398 -0.365 . . . . 74.340000000000003 111.426 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.67 -42.47 92.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.453 -0.34 . . . . 70.030000000000001 111.283 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.27 92.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.045 0.45 . . . . 74.409999999999997 111.261 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 78.6 mt -66.55 -25.88 66.86 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.01 -0.541 . . . . 73.409999999999997 111.642 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.0 23.23 18.19 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.229 -0.51 . . . . 75.5 112.62 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.7 t -84.15 107.29 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.985 0.422 . . . . 72.099999999999994 111.054 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.58 149.84 46.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.069 -0.514 . . . . 74.150000000000006 111.901 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.8 113.92 3.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.023 -0.535 . . . . 73.340000000000003 110.852 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.55 -10.61 11.42 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.397 -0.43 . . . . 71.049999999999997 112.521 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.45 5.46 23.1 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.514 -0.374 . . . . 64.120000000000005 112.97 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -23.75 65.77 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.223 0.453 . . . . 73.219999999999999 112.223 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -77.98 -2.68 38.19 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.201 0.445 . . . . 74.219999999999999 112.201 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -118.19 86.29 26.46 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 74.230000000000004 111.819 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.6 -21.84 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.118 1.878 . . . . 75.439999999999998 111.996 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.37 -48.82 79.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.904 -0.589 . . . . 74.409999999999997 110.982 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -63.88 -28.07 69.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 74.129999999999995 111.066 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 57' ' ' MET . 95.7 t -69.86 -37.99 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.96 -0.564 . . . . 72.299999999999997 111.541 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.96 -79.55 1.79 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.095 -0.574 . . . . 71.329999999999998 112.982 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -120.88 124.01 43.92 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.656 -0.32 . . . . 72.409999999999997 110.963 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.44 ' HB3' HG13 ' A' ' 54' ' ' VAL . 8.6 ptp -136.25 147.96 62.46 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 120.653 0.263 . . . . 74.239999999999995 111.449 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD2' HD11 ' A' ' 41' ' ' LEU . 81.7 Cg_endo -88.03 140.67 4.92 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.765 2.31 . . . . 74.129999999999995 112.802 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.27 -172.71 17.74 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.505 -0.855 . . . . 64.099999999999994 114.027 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 65.5 tp -132.83 108.68 9.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.619 0.367 . . . . 73.150000000000006 111.269 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -79.26 129.5 34.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.827 0.346 . . . . 71.329999999999998 111.205 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.07 -23.27 65.84 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.142 0.423 . . . . 72.319999999999993 112.142 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -75.38 -53.55 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.04 0.448 . . . . 72.519999999999996 111.808 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -68.37 -26.62 65.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.399 0.518 . . . . 74.540000000000006 112.399 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 64.78 10.58 6.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.105 0.479 . . . . 74.420000000000002 111.268 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -127.38 160.72 30.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.11 0.481 . . . . 73.510000000000005 111.734 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -91.29 176.85 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.656 -0.702 . . . . 73.409999999999997 110.993 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.599 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . 159.46 168.42 21.45 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.095 -0.574 . . . . 50.240000000000002 113.01 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.32 127.49 43.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.613 0.245 . . . . 73.109999999999999 111.375 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.43 156.19 79.95 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 120.698 0.285 . . . . 73.400000000000006 111.421 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.3 120.9 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.468 2.112 . . . . 74.030000000000001 112.488 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.73 1.48 15.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.382 -0.437 . . . . 70.049999999999997 114.05 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 p -74.71 -17.43 60.66 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.37 -0.488 . . . . 71.430000000000007 112.289 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -108.28 17.52 22.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.864 0.69 . . . . 74.019999999999996 112.864 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 11' ' ' ALA . 29.4 m -131.66 148.63 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.982 0.42 . . . . 72.140000000000001 112.119 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -108.65 151.08 26.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 110.892 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.06 115.26 21.12 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.806 0.336 . . . . 65.209999999999994 111.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 10' ' ' ARG . 92.8 mt -83.2 -59.73 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.916 0.389 . . . . 75.25 111.467 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.07 -176.56 36.76 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.089 -0.577 . . . . 64.510000000000005 113.185 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.79 157.0 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.923 2.416 . . . . 61.450000000000003 113.106 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 81' ' ' LEU . 4.6 mp . . . . . 0 N--CA 1.473 0.719 0 CA-C-N 116.447 -0.342 . . . . 73.319999999999993 111.086 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . . . . . . 0 CA--C 1.522 0.5 0 N-CA-C 112.214 -0.354 . . . . 52.219999999999999 112.214 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -130.46 143.97 51.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.225 0.536 . . . . 73.230000000000004 111.625 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -92.73 131.02 38.16 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.732 -0.667 . . . . 73.209999999999994 112.116 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -123.78 153.85 40.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 73.230000000000004 110.069 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.1 ttm180 -127.42 119.75 26.86 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.778 0.323 . . . . 73.219999999999999 111.805 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.452 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -71.54 124.08 23.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.309 -0.405 . . . . 71.319999999999993 110.961 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.5 -21.2 19.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.443 0.534 . . . . 74.120000000000005 112.443 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.98 147.57 65.94 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 55.7 Cg_endo -71.06 119.63 6.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.55 2.167 . . . . 74.329999999999998 112.172 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.3 t80 . . . . . 0 CA--C 1.538 0.506 0 CA-C-O 120.919 0.39 . . . . 73.140000000000001 111.49 -175.081 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.8 tp . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 110.415 -0.217 . . . . 74.239999999999995 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.0 113.32 3.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.127 0.489 . . . . 75.400000000000006 112.034 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.5 mt -103.26 138.74 39.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.245 -0.434 . . . . 71.549999999999997 111.25 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.429 HD22 ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -122.65 150.69 58.77 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 122.503 0.321 . . . . 71.319999999999993 110.933 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.94 117.83 4.64 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.685 2.257 . . . . 71.510000000000005 113.133 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.1 29.66 58.4 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.032 -0.531 . . . . 71.010000000000005 113.311 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.91 158.67 15.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.189 0.495 . . . . 71.239999999999995 111.155 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.04 132.56 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.135 0.493 . . . . 63.409999999999997 112.289 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.9 mp -121.88 111.42 17.08 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.249 -0.432 . . . . 72.25 110.975 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.552 HG13 HD21 ' A' ' 81' ' ' LEU . 18.0 t -94.96 106.05 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.839 0.352 . . . . 75.299999999999997 111.227 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.508 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.4 t -101.39 132.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.598 0.237 . . . . 75.310000000000002 111.591 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 143.07 45.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.272 0.558 . . . . 65.5 112.187 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -66.38 -33.05 74.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.056 -0.52 . . . . 73.439999999999998 111.124 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.09 73.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 74.409999999999997 111.392 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -69.68 -45.44 68.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.27 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.36 -39.83 80.62 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.354 -0.385 . . . . 61.119999999999997 111.507 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.27 -44.05 95.66 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.497 -0.32 . . . . 75.540000000000006 111.015 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.95 91.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.02 0.438 . . . . 75.030000000000001 111.227 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD11 ' HD2' ' A' ' 58' ' ' PRO . 81.2 mt -66.75 -29.2 69.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.251 -0.431 . . . . 74.340000000000003 111.498 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.57 31.87 12.5 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.265 -0.493 . . . . 63.329999999999998 112.833 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.37 123.26 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.924 0.392 . . . . 72.209999999999994 111.307 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.1 149.99 23.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.488 -0.324 . . . . 54.329999999999998 111.376 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.27 126.68 9.75 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 73.450000000000003 111.241 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -42.43 1.91 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.24 -0.505 . . . . 52.109999999999999 112.289 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.17 -26.25 61.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.035 -0.602 . . . . 74.209999999999994 112.198 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.589 ' HG3' ' HG3' ' A' ' 49' ' ' ARG . 9.3 pt-20 -52.05 -33.88 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.514 0.726 . . . . 75.510000000000005 111.297 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.589 ' HG3' ' HG3' ' A' ' 48' ' ' GLU . 28.2 mtp180 -89.65 -3.04 58.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.715 -0.675 . . . . 73.120000000000005 111.654 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 65.8 m -136.83 72.45 55.32 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.434 -0.348 . . . . 75.140000000000001 111.021 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.91 -26.82 83.43 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.797 2.331 . . . . 72.219999999999999 112.836 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.73 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 73.3 mt-30 -62.95 -25.51 68.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.329 -0.396 . . . . 73.040000000000006 111.541 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.5 m -83.86 -31.41 25.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.475 -0.33 . . . . 71.540000000000006 111.787 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.45 -44.71 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.522 . . . . 74.519999999999996 110.908 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.87 -78.31 0.89 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.298 -0.477 . . . . 71.530000000000001 113.701 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -111.81 114.38 27.3 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.324 0.49 . . . . 73.439999999999998 112.324 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -126.42 134.61 26.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.372 -0.376 . . . . 72.140000000000001 111.011 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.554 ' HD2' HD11 ' A' ' 41' ' ' LEU . 95.7 Cg_endo -81.94 123.85 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.546 2.164 . . . . 75.219999999999999 112.205 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -148.25 176.43 27.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.634 -0.793 . . . . 62.140000000000001 113.756 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 tp -97.4 121.69 39.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.621 0.368 . . . . 75.519999999999996 110.919 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.97 121.51 34.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.747 0.308 . . . . 72.150000000000006 111.142 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -72.7 -27.04 61.83 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.19 0.811 . . . . 75.409999999999997 113.19 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.429 ' HG2' HD22 ' A' ' 26' ' ' LEU . 4.2 tpm_? -58.58 -52.58 65.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.009 0.433 . . . . 75.430000000000007 111.329 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 p -92.4 -15.83 26.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.014 -0.539 . . . . 63.130000000000003 111.506 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 60.13 24.38 13.67 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.119 -0.491 . . . . 74.099999999999994 111.681 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -118.72 161.12 20.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 73.299999999999997 111.5 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -92.45 150.67 20.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 111.524 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.85 -175.29 44.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.257 -0.496 . . . . 64.209999999999994 112.747 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.46 143.54 32.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.972 0.386 . . . . 73.340000000000003 110.528 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 55.1 p90 -139.92 143.12 33.22 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.111 0.411 . . . . 75.439999999999998 112.111 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 10.6 Cg_exo -72.41 118.32 5.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.864 2.376 . . . . 72.430000000000007 112.267 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.408 ' HA2' HG21 ' A' ' 75' ' ' VAL . . . -60.32 -14.45 33.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.451 0.54 . . . . 71.040000000000006 114.451 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.73 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 10.3 t -71.48 -5.65 34.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.619 0.6 . . . . 74.010000000000005 112.619 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -111.03 1.04 17.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.138 0.422 . . . . 74.010000000000005 112.138 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 11' ' ' ALA . 25.7 m -128.41 148.6 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.46 0.541 . . . . 71.219999999999999 112.46 -175.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 13.9 pt-20 -98.77 167.18 10.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.838 0.352 . . . . 72.409999999999997 110.717 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -99.04 123.28 43.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.946 0.403 . . . . 74.340000000000003 111.001 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 10' ' ' ARG . 74.7 mt -94.26 -46.97 6.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.945 0.402 . . . . 71.150000000000006 111.347 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.72 -179.74 18.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.267 -0.492 . . . . 38.009999999999998 113.246 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.79 142.91 40.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.484 2.122 . . . . 63.210000000000001 112.478 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.552 HD21 HG13 ' A' ' 32' ' ' VAL . 6.2 mp . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.912 0.387 . . . . 75.439999999999998 111.569 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.723 0 N-CA-C 115.3 0.88 . . . . 70.010000000000005 115.3 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.53 163.44 14.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.931 0.396 . . . . 62.219999999999999 111.323 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -108.01 126.23 52.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.399 0.618 . . . . 72.230000000000004 112.264 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.75 169.64 9.43 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.449 -0.796 . . . . 74.219999999999999 110.179 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HB2' HD13 ' A' ' 78' ' ' LEU . 45.3 ttt85 -136.03 124.45 23.43 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.088 -0.382 . . . . 75.299999999999997 111.92 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.68 129.17 34.24 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.831 0.348 . . . . 73.420000000000002 111.391 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.0 mt -81.77 -49.61 10.21 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.371 0.508 . . . . 72.5 112.371 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.465 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 49.4 m-85 -124.87 164.4 31.51 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-O 120.481 0.182 . . . . 74.409999999999997 111.236 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.7 Cg_endo -74.34 119.91 6.01 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.264 1.976 . . . . 71.439999999999998 113.299 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 . . . . . 0 N--CA 1.471 0.625 0 CA-C-N 116.397 -0.365 . . . . 74.25 111.169 179.15 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 120.761 0.315 . . . . 72.340000000000003 110.975 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.63 154.6 35.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.67 0.748 . . . . 75.400000000000006 113.014 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 92.8 mt -116.13 139.02 50.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.213 -0.903 . . . . 63.310000000000002 110.581 175.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.31 154.92 59.16 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 122.458 0.303 . . . . 71.140000000000001 110.586 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.9 115.52 3.64 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.405 2.07 . . . . 73.049999999999997 112.852 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.55 22.11 35.21 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.372 -0.442 . . . . 72.340000000000003 113.393 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.39 136.27 33.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.994 0.426 . . . . 70.219999999999999 111.797 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.19 125.46 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 110.538 174.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 5.6 mp -121.05 127.5 51.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.974 0.416 . . . . 74.140000000000001 111.587 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.19 122.4 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.356 -0.384 . . . . 74.230000000000004 111.294 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 84.6 t -109.5 125.07 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.695 0.283 . . . . 63.229999999999997 110.769 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -60.07 129.68 42.94 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.774 0.321 . . . . 73.340000000000003 111.782 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 17.5 ptm180 -57.37 -30.39 64.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.634 0.255 . . . . 75.510000000000005 111.379 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.96 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.908 0.385 . . . . 64.239999999999995 111.371 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.46 87.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.923 0.392 . . . . 65.040000000000006 111.111 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.22 -46.23 69.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.262 0.554 . . . . 73.439999999999998 110.818 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 35' ' ' ARG . 77.2 mt-30 -59.28 -52.07 67.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.697 -0.683 . . . . 75.409999999999997 111.433 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.39 97.43 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.212 0.449 . . . . 74.239999999999995 112.212 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.7 -28.8 70.2 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.763 0.316 . . . . 75.310000000000002 111.644 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 23.78 10.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.185 -0.531 . . . . 38.340000000000003 113.424 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.93 110.49 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.017 0.437 . . . . 75.430000000000007 110.835 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.27 149.88 37.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.28 -0.418 . . . . 71.409999999999997 112.122 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -52.06 127.98 23.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.168 0.509 . . . . 71.230000000000004 110.99 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.56 -44.61 1.46 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.289 -0.725 . . . . 72.150000000000006 111.289 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.87 -20.63 66.74 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.511 -0.376 . . . . 71.030000000000001 112.455 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.76 -43.69 58.37 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.503 0.668 . . . . 64.540000000000006 111.178 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -77.66 -5.23 49.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.765 -0.652 . . . . 75.140000000000001 111.751 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.46 71.26 66.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.657 0.614 . . . . 62.240000000000002 112.657 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 -24.24 75.02 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.919 1.746 . . . . 73.340000000000003 110.324 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 22.1 pt20 -55.11 -26.14 36.2 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.744 -1.117 . . . . 71.239999999999995 111.95 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -89.06 -33.6 17.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.824 0.345 . . . . 73.140000000000001 111.746 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.56 -58.81 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.132 0.419 . . . . 71.200000000000003 112.132 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.9 -116.61 3.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.012 -0.613 . . . . 54.520000000000003 113.341 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -102.41 127.85 49.26 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.289 -0.536 . . . . 75.030000000000001 111.267 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -134.23 148.48 68.0 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 111.63 0.233 . . . . 71.310000000000002 111.63 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.2 124.68 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.705 2.27 . . . . 74.540000000000006 112.735 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.01 -174.0 22.94 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.942 -0.647 . . . . 53.409999999999997 113.796 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 29.0 tp -106.71 115.3 29.96 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.123 0.569 . . . . 62.039999999999999 112.094 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.469 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t-20 -82.62 104.02 12.57 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.773 0.321 . . . . 62.140000000000001 110.346 173.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -68.0 -9.01 42.17 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.28 0.844 . . . . 74.209999999999994 113.28 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.1 ttp85 -81.47 -29.13 33.84 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.659 -0.651 . . . . 74.129999999999995 110.902 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -113.12 -11.61 13.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.247 -0.433 . . . . 74.420000000000002 111.694 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.89 14.3 9.5 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.073 0.549 . . . . 74.319999999999993 112.008 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -96.77 145.65 25.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.105 0.479 . . . . 72.329999999999998 111.789 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -104.72 130.19 52.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.958 -0.564 . . . . 73.019999999999996 110.568 177.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.29 -175.75 39.34 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.685 -0.769 . . . . 74.310000000000002 113.379 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.12 117.14 27.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.723 0.297 . . . . 73.319999999999993 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.422 ' HB2' HD22 ' A' ' 25' ' ' LEU . 40.9 p90 -122.27 148.54 52.5 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 120.904 0.383 . . . . 73.409999999999997 111.31 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 17.0 Cg_exo -67.17 91.97 0.33 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.399 2.066 . . . . 75.120000000000005 112.657 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.536 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -66.74 -10.01 53.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.203 -0.453 . . . . 54.509999999999998 113.729 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 52' ' ' GLN . 60.3 m -61.54 -30.25 70.52 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.445 -0.444 . . . . 74.299999999999997 111.529 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -93.85 4.71 53.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.015 0.746 . . . . 72.439999999999998 113.015 -174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 72' ' ' GLY . 16.9 m -108.19 151.03 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.158 0.504 . . . . 74.299999999999997 111.965 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -102.14 158.26 16.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 73.420000000000002 110.692 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -89.6 124.19 34.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.919 0.39 . . . . 74.299999999999997 111.251 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 10' ' ' ARG . 85.6 mt -93.52 -45.14 7.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.093 0.473 . . . . 73.230000000000004 111.196 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.28 19.95 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.085 -0.579 . . . . 52.530000000000001 113.494 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.35 174.25 8.12 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.88 2.387 . . . . 74.239999999999995 112.696 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 116.279 -0.419 . . . . 71.099999999999994 110.567 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 CA-C-O 120.81 0.117 . . . . 61.140000000000001 112.856 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -127.03 138.11 53.18 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.505 -0.409 . . . . 75.439999999999998 110.635 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HG3' HD11 ' A' ' 81' ' ' LEU . 98.3 mt-30 -92.6 131.1 37.99 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.702 0.63 . . . . 75.030000000000001 112.702 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.93 163.25 17.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.393 -0.821 . . . . 70.140000000000001 109.76 170.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HB2' HD13 ' A' ' 78' ' ' LEU . 40.9 ttm180 -140.69 125.59 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.986 0.365 . . . . 75.109999999999999 111.986 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.43 127.55 32.74 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.265 0.555 . . . . 73.409999999999997 111.174 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.57 -39.01 28.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.002 0.429 . . . . 63.43 111.518 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -130.65 141.09 40.71 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.76 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.3 Cg_endo -65.88 120.9 8.14 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.451 2.101 . . . . 74.200000000000003 112.923 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.6 t80 . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 116.517 -0.311 . . . . 74.030000000000001 110.976 178.833 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 61' ' ' ASN . 40.6 tp . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.054 0.454 . . . . 52.119999999999997 111.295 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -97.58 127.87 43.86 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.466 -0.334 . . . . 73.400000000000006 111.172 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.92 149.04 25.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.535 0.569 . . . . 71.349999999999994 112.535 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.86 155.94 54.6 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 75.5 110.65 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.1 Cg_endo -71.32 105.19 1.68 Allowed 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 121.607 1.538 . . . . 73.450000000000003 112.387 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.48 3.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.228 -0.51 . . . . 41.140000000000001 113.195 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -106.84 174.68 5.78 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.867 0.365 . . . . 74.310000000000002 111.623 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.35 113.72 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.786 0.327 . . . . 72.340000000000003 111.388 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.2 mp -105.15 130.46 53.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.583 0.23 . . . . 74.129999999999995 111.169 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.75 111.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.896 0.379 . . . . 72.0 111.22 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.73 128.6 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 122.649 0.38 . . . . 74.340000000000003 111.246 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -72.6 142.59 48.38 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.519999999999996 111.906 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -54.76 -36.08 64.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.399 -0.364 . . . . 75.209999999999994 111.826 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.82 73.79 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 111.904 0.335 . . . . 74.319999999999993 111.904 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.788 0.328 . . . . 72.129999999999995 111.58 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -54.51 -43.36 71.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.072 0.463 . . . . 65.519999999999996 111.443 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -69.34 -33.79 73.64 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.303 -0.408 . . . . 75.209999999999994 111.515 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.48 65.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.213 0.53 . . . . 63.119999999999997 111.138 175.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.8 mt -86.78 -10.13 54.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.997 -0.547 . . . . 72.299999999999997 111.28 174.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.69 33.19 63.59 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 65.219999999999999 113.142 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.03 135.08 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.942 0.401 . . . . 71.430000000000007 111.355 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.66 130.25 35.09 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.338 -0.392 . . . . 64.420000000000002 111.586 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -49.27 116.32 1.66 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.496 . . . . 74.150000000000006 110.776 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.61 2.26 25.79 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.286 -0.483 . . . . 72.120000000000005 112.636 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.89 5.9 32.63 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.52 -0.372 . . . . 60.039999999999999 113.281 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.97 -29.7 67.38 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.02 0.378 . . . . 72.140000000000001 112.02 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -80.54 -2.7 47.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.358 0.503 . . . . 72.409999999999997 112.358 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.2 m -128.33 64.37 67.01 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 120.89 0.376 . . . . 75.540000000000006 111.811 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 38.3 Cg_endo -65.17 -22.43 61.26 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.438 2.092 . . . . 70.329999999999998 112.174 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -62.87 -21.06 65.71 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.882 -0.599 . . . . 74.319999999999993 111.909 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.9 t -87.37 -4.05 59.03 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 75.329999999999998 111.701 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.83 -54.51 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.89 0.376 . . . . 72.040000000000006 111.595 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.44 -120.28 4.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.305 -0.407 . . . . 74.140000000000001 112.39 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.3 m0 -92.09 111.59 23.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.814 0.34 . . . . 54.130000000000003 110.673 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 46.4 mtm -103.84 133.04 20.47 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.351 -0.218 . . . . 75.150000000000006 111.415 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 57' ' ' MET . 19.3 Cg_exo -67.23 117.67 4.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.871 2.381 . . . . 74.25 112.349 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.94 168.54 31.83 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.796 -0.716 . . . . 72.5 113.361 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.502 HD13 ' HE ' ' A' ' 67' ' ' ARG . 37.4 tp -112.63 114.1 26.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.744 0.307 . . . . 61.43 110.461 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.507 ' HB2' HD22 ' A' ' 23' ' ' LEU . 50.7 t-20 -81.96 104.33 12.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.672 0.272 . . . . 74.109999999999999 110.989 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.95 0.46 5.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.447 0.906 . . . . 71.409999999999997 113.447 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.516 ' HE ' ' HA ' ' A' ' 63' ' ' ARG . 2.6 tpm_? -81.42 -43.51 18.83 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.972 -0.455 . . . . 74.319999999999993 110.515 171.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.1 p -107.8 -6.78 16.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.297 -0.41 . . . . 64.329999999999998 111.677 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 59.22 19.44 7.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.695 0.798 . . . . 74.299999999999997 111.779 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -95.32 145.58 24.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.108 0.48 . . . . 73.530000000000001 111.825 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HE ' HD13 ' A' ' 60' ' ' LEU . 3.9 tpp180 -99.48 140.94 32.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.08 -0.509 . . . . 75.430000000000007 111.528 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.18 177.26 39.23 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.898 . . . . 72.129999999999995 113.657 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 5.4 m-20 -89.51 128.8 36.04 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.406 0.282 . . . . 73.420000000000002 110.597 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -119.02 141.29 30.01 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 122.107 -0.37 . . . . 74.230000000000004 111.844 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.88 113.38 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.729 2.286 . . . . 71.319999999999993 112.537 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.46 23.1 1.25 Allowed Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.027 0.771 . . . . 70.319999999999993 115.027 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.4 p -93.79 -18.6 21.87 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.807 0.803 . . . . 53.229999999999997 111.571 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -107.96 9.02 28.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.914 0.338 . . . . 71.450000000000003 111.914 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG22 ' HA2' ' A' ' 72' ' ' GLY . 25.3 m -122.51 151.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 112.632 0.604 . . . . 75.349999999999994 112.632 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.4 160.63 16.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.891 -0.595 . . . . 62.439999999999998 110.921 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -93.07 115.37 28.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.035 0.445 . . . . 73.209999999999994 111.632 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 10' ' ' ARG . 87.2 mt -84.61 -44.17 13.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.731 0.301 . . . . 72.510000000000005 111.548 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.05 178.04 15.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.136 -0.554 . . . . 52.420000000000002 113.623 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.54 164.17 27.25 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.081 2.521 . . . . 72.150000000000006 112.802 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 81' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.851 0.358 . . . . 73.230000000000004 111.384 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.736 0.303 . . . . 75.120000000000005 111.261 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.92 -42.49 17.61 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.91 0.386 . . . . 74.420000000000002 111.6 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 161.11 177.32 34.11 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.395 -0.431 . . . . 63.109999999999999 113.08 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.16 107.52 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.168 2.579 . . . . 75.120000000000005 112.522 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -74.44 -22.9 58.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.063 0.459 . . . . 73.5 111.875 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.569 ' HA2' ' HG2' ' A' ' 35' ' ' ARG . . . -177.05 -152.8 10.18 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.999 -0.62 . . . . 54.43 113.122 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.476 ' HE2' HH11 ' A' ' 35' ' ' ARG . 94.4 m-85 -141.82 157.84 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 110.901 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -118.58 132.85 56.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.287 0.565 . . . . 73.319999999999993 112.248 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.92 170.83 7.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.598 -0.728 . . . . 75.510000000000005 109.578 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 35.4 ttt180 -148.33 121.5 8.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.022 -0.424 . . . . 75.510000000000005 111.386 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -69.38 125.61 27.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.956 0.408 . . . . 63.409999999999997 111.938 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -94.7 -30.27 14.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.26 0.467 . . . . 73.549999999999997 112.26 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.87 141.41 40.44 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.56 0.219 . . . . 74.329999999999998 111.391 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 70.3 Cg_endo -76.78 119.31 5.1 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.35 2.033 . . . . 63.240000000000002 113.326 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -136.91 125.87 24.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.084 -0.507 . . . . 75.200000000000003 110.712 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -74.43 148.04 41.48 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.148 -0.478 . . . . 71.049999999999997 111.045 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.623 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 66.7 mtm180 -56.62 115.51 2.58 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.033 0.444 . . . . 72.340000000000003 111.922 176.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.33 -42.56 92.79 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.433 0.635 . . . . 72.420000000000002 110.48 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -124.99 153.58 71.19 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.504 -0.771 . . . . 73.099999999999994 109.962 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.75 -29.9 44.26 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 122.459 2.106 . . . . 73.25 113.521 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -92.68 5.9 49.36 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.188 0.44 . . . . 71.140000000000001 112.188 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.441 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 36.3 t70 -91.62 150.16 21.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.527 -0.546 . . . . 74.049999999999997 109.527 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.2 tp -105.56 134.46 48.65 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.226 0.536 . . . . 73.030000000000001 111.608 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.623 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 13.5 tt0 -84.92 145.17 27.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.949 -0.569 . . . . 72.019999999999996 112.491 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.2 mt -119.13 127.9 53.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 111.771 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 4.3 mm? -123.36 143.44 41.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 122.559 0.344 . . . . 73.209999999999994 110.883 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.04 119.57 6.7 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.72 2.28 . . . . 75.219999999999999 113.443 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.45 -14.95 62.84 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.268 -0.424 . . . . 72.329999999999998 113.698 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -81.41 143.34 32.21 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.21 0.505 . . . . 64.420000000000002 111.744 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.64 141.19 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.318 0.58 . . . . 71.040000000000006 112.27 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.5 mp -118.7 123.95 46.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.029 -0.532 . . . . 73.239999999999995 110.731 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.9 t -94.88 124.21 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 111.976 0.361 . . . . 74.109999999999999 111.976 -176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.28 139.79 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.952 0.405 . . . . 75.129999999999995 111.176 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 t -93.13 158.32 15.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.958 0.408 . . . . 70.319999999999993 111.835 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.569 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 17.3 mmm180 -55.34 -41.18 72.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.244 -0.435 . . . . 75.349999999999994 111.56 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.86 -45.84 71.08 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.01 0.374 . . . . 72.299999999999997 112.01 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.02 70.87 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.882 0.372 . . . . 75.209999999999994 111.707 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.25 -40.63 97.95 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.807 0.337 . . . . 75.209999999999994 111.826 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -66.16 -35.77 81.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.815 0.34 . . . . 74.420000000000002 111.225 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.36 73.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.035 0.445 . . . . 72.510000000000005 111.41 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -22.35 59.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.176 -0.465 . . . . 74.109999999999999 111.465 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.63 42.82 6.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.299 -0.477 . . . . 51.310000000000002 112.963 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.06 134.79 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.592 -0.358 . . . . 74.510000000000005 111.43 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.12 142.32 50.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.709 0.29 . . . . 75.340000000000003 111.133 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -60.93 108.33 0.85 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.051 0.453 . . . . 73.439999999999998 110.977 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 8.97 31.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.319 -0.467 . . . . 74.420000000000002 112.713 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.31 -29.55 6.3 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.612 -0.328 . . . . 61.229999999999997 112.644 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -31.63 64.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.971 0.508 . . . . 64.510000000000005 112.225 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -57.06 -16.43 7.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.172 0.434 . . . . 72.409999999999997 112.172 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.3 m -117.65 81.47 14.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.374 -0.375 . . . . 74.349999999999994 110.208 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.64 -36.15 97.9 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.942 2.428 . . . . 73.420000000000002 113.321 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -19.08 61.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.005 0.372 . . . . 74.319999999999993 112.005 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.2 t -82.77 -20.0 36.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.971 0.415 . . . . 62.340000000000003 111.462 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.38 -36.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.107 0.479 . . . . 72.019999999999996 111.283 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.26 -133.63 11.6 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.235 -0.439 . . . . 63.43 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.85 129.9 37.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.111 0.482 . . . . 74.299999999999997 111.274 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 69.1 mtm -131.46 140.37 38.22 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.483 -0.326 . . . . 73.140000000000001 111.615 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.47 118.97 4.0 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.689 2.259 . . . . 72.219999999999999 113.05 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.28 -174.71 23.89 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.863 -0.684 . . . . 73.150000000000006 113.892 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.06 130.48 55.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.635 0.374 . . . . 72.450000000000003 111.338 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.59 143.64 28.07 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.729 0.3 . . . . 72.239999999999995 111.414 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -79.05 -52.29 8.41 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.166 0.802 . . . . 73.109999999999999 113.166 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.435 ' HD3' ' HG ' ' A' ' 26' ' ' LEU . 58.2 ttt180 -62.73 -40.47 97.29 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.843 0.683 . . . . 75.430000000000007 112.843 -175.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -92.26 -17.11 25.23 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.068 0.395 . . . . 65.430000000000007 112.068 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.64 17.82 6.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.613 0.365 . . . . 74.219999999999999 111.57 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -98.71 159.14 15.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.29 0.567 . . . . 71.340000000000003 112.143 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -121.88 135.05 54.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.779 -0.646 . . . . 75.310000000000002 111.297 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.18 -171.73 44.08 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.669 -0.777 . . . . 74.140000000000001 113.04 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -88.95 121.69 31.57 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.794 -0.239 . . . . 51.299999999999997 111.228 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.536 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 50.4 p90 -111.92 143.74 29.3 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 120.566 0.222 . . . . 73.420000000000002 111.151 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.85 104.18 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.215 1.943 . . . . 71.129999999999995 111.88 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.78 36.71 1.03 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 114.255 0.462 . . . . 73.430000000000007 114.255 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -104.52 -30.22 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.125 -0.632 . . . . 64.439999999999998 111.23 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -93.43 11.25 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.614 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 11' ' ' ALA . 24.1 m -118.51 145.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.36 0.504 . . . . 74.239999999999995 112.36 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.489 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 15.0 pt-20 -93.07 170.72 9.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.928 0.394 . . . . 70.450000000000003 110.844 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -102.69 129.73 49.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.427 -0.351 . . . . 74.129999999999995 110.947 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.96 -51.15 3.94 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.101 0.408 . . . . 72.340000000000003 112.101 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.18 -175.1 33.27 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.714 -0.755 . . . . 72.140000000000001 113.584 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.45 146.99 12.44 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.006 2.471 . . . . 75.25 113.922 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 90.2 mt -78.02 116.91 18.85 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 74.010000000000005 111.088 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.255 1.382 0 CA-C-O 118.737 -0.649 . . . . 64.400000000000006 111.195 177.412 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.522 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 50.9 ttm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.644 0.259 . . . . 74.230000000000004 111.161 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.86 -57.61 3.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.904 0.383 . . . . 74.230000000000004 111.542 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.16 -175.45 23.24 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.387 -0.435 . . . . 55.130000000000003 112.975 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.94 47.64 1.78 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.072 2.515 . . . . 74.420000000000002 113.045 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -57.86 -33.24 68.46 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.264 0.554 . . . . 71.420000000000002 111.743 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.86 161.23 34.52 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.302 -0.475 . . . . 71.319999999999993 112.972 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 94.0 m-85 -110.01 153.57 24.4 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.886 0.374 . . . . 71.540000000000006 111.154 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -116.54 126.89 53.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.148 0.499 . . . . 75.299999999999997 111.575 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.77 168.25 9.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.91 -0.586 . . . . 73.219999999999999 110.717 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' HB2' HD13 ' A' ' 78' ' ' LEU . 31.2 ttt85 -124.01 118.95 28.16 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.3 -0.25 . . . . 70.349999999999994 111.11 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.549 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -67.92 117.78 10.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.989 0.423 . . . . 72.129999999999995 111.567 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.406 HD21 ' HG2' ' A' ' 76' ' ' GLU . 51.9 mt -89.83 -41.02 12.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.006 0.432 . . . . 73.120000000000005 111.705 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -127.76 149.53 70.76 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.261 -0.427 . . . . 75.0 111.121 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.9 Cg_endo -72.68 152.75 53.73 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.511 2.14 . . . . 71.450000000000003 113.469 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -143.42 129.95 20.12 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.444 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -104.06 160.12 15.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.06 0.457 . . . . 75.209999999999994 112.15 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.8 ' HG3' ' HG3' ' A' ' 24' ' ' GLU . 59.9 mtm180 -97.91 128.14 44.31 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.59 0.589 . . . . 75.099999999999994 112.59 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.774 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 10.5 pt-20 -87.03 -19.58 28.44 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.363 0.601 . . . . 72.329999999999998 110.315 169.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.774 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 89.2 mtt180 -132.77 153.25 80.99 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 115.797 -0.638 . . . . 75.120000000000005 111.111 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.12 -27.97 84.94 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.407 2.071 . . . . 71.430000000000007 112.816 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -78.42 -5.89 53.68 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.433 0.531 . . . . 71.140000000000001 112.433 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.565 ' HB3' ' HG2' ' A' ' 17' ' ' ARG . 4.3 t0 -84.87 177.36 8.0 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 110.121 -0.326 . . . . 61.240000000000002 110.121 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 tp -129.84 126.12 37.29 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.695 -0.628 . . . . 74.040000000000006 112.377 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.8 ' HG3' ' HG3' ' A' ' 17' ' ' ARG . 44.1 mt-10 -87.0 131.29 34.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.064 0.459 . . . . 65.430000000000007 111.564 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 64.3 mt -119.61 138.12 53.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.804 -0.634 . . . . 74.400000000000006 110.82 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -118.36 145.65 37.73 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 120.836 0.351 . . . . 71.530000000000001 110.834 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.61 106.26 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.319 2.013 . . . . 72.439999999999998 113.14 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.73 -21.35 4.47 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.329 -0.462 . . . . 61.140000000000001 113.245 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.67 142.28 58.46 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.552 0.575 . . . . 63.229999999999997 112.552 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.73 98.78 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.847 -0.615 . . . . 75.140000000000001 110.517 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.524 HD23 HG13 ' A' ' 75' ' ' VAL . 6.9 mp -78.78 116.54 19.19 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.91 0.386 . . . . 72.549999999999997 111.775 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.8 t -94.35 117.23 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.947 0.403 . . . . 74.430000000000007 111.5 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.437 HG22 ' HA3' ' A' ' 59' ' ' GLY . 96.1 t -115.84 123.23 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.299 -0.409 . . . . 74.439999999999998 111.132 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -66.45 131.08 45.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.832 -0.167 . . . . 53.009999999999998 110.829 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -54.68 -33.92 61.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.965 0.357 . . . . 74.209999999999994 111.965 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.79 66.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.888 0.375 . . . . 62.32 111.856 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -64.23 -34.88 79.12 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.430000000000007 111.686 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.93 -42.92 99.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.964 0.412 . . . . 75.340000000000003 111.096 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.68 -35.34 78.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.753 0.311 . . . . 72.129999999999995 110.931 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.41 -33.78 74.27 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.003 0.43 . . . . 75.129999999999995 111.489 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.625 HD22 ' HD3' ' A' ' 58' ' ' PRO . 96.1 mt -74.98 -28.75 60.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.893 0.377 . . . . 74.349999999999994 111.805 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.76 35.17 8.55 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.115 -0.564 . . . . 70.25 112.239 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.439 HG21 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -75.72 127.39 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 120.727 0.299 . . . . 70.129999999999995 111.184 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 146.16 54.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.984 0.421 . . . . 53.149999999999999 111.233 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.87 121.64 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.144 0.497 . . . . 75.209999999999994 111.223 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.39 -15.98 60.49 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.154 -0.546 . . . . 73.010000000000005 112.739 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.26 48.18 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.627 -0.321 . . . . 75.019999999999996 113.394 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -53.67 -21.11 6.3 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.461 0.648 . . . . 74.530000000000001 111.585 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.81 -11.26 25.5 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.517 0.562 . . . . 75.109999999999999 112.517 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 26.6 p -161.01 91.7 1.54 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.042 0.386 . . . . 70.329999999999998 112.042 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 50' ' ' CYS . 11.9 Cg_endo -55.05 -23.79 37.14 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.985 2.456 . . . . 74.120000000000005 112.94 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.27 74.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.747 0.308 . . . . 72.239999999999995 110.776 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.7 m -65.85 -15.37 62.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.381 0.511 . . . . 73.019999999999996 112.381 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.16 -30.33 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.991 0.424 . . . . 75.329999999999998 111.417 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.29 -92.24 1.78 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.116 -0.564 . . . . 74.540000000000006 113.145 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -108.56 131.51 54.77 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.935 0.398 . . . . 72.319999999999993 111.279 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 66.4 mtp -133.16 132.64 22.34 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.275 -0.421 . . . . 74.310000000000002 110.938 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.625 ' HD3' HD22 ' A' ' 41' ' ' LEU . 92.8 Cg_endo -87.28 118.07 1.32 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.677 2.251 . . . . 65.219999999999999 112.852 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.437 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.16 179.09 28.12 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.815 -0.707 . . . . 62.219999999999999 113.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.86 124.51 49.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.459 0.304 . . . . 71.219999999999999 111.394 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.8 t-20 -87.25 149.03 24.85 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.594 -0.275 . . . . 71.409999999999997 110.771 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -92.11 -28.61 17.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.537 0.94 . . . . 74.109999999999999 113.537 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -58.79 3.06 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.595 0.712 . . . . 75.209999999999994 110.808 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.62 HG23 ' HB2' ' A' ' 24' ' ' GLU . 64.4 p -81.87 -21.71 37.34 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.546 -0.752 . . . . 71.230000000000004 111.634 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 13.7 mmt85 57.54 31.21 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.562 . . . . 74.409999999999997 111.98 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.31 135.77 39.44 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.811 -0.631 . . . . 73.209999999999994 110.161 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -97.58 121.22 39.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.976 -0.379 . . . . 72.239999999999995 109.976 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.96 -172.11 36.14 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.647 -0.787 . . . . 62.420000000000002 113.568 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.86 132.21 35.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.847 0.356 . . . . 74.310000000000002 111.255 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.413 ' HB2' HD12 ' A' ' 25' ' ' LEU . 53.2 p90 -138.45 150.17 65.41 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.758 0.313 . . . . 73.349999999999994 111.482 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.79 110.26 2.31 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.188 1.925 . . . . 73.329999999999998 112.425 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.49 -11.5 35.05 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.598 0.599 . . . . 38.93 114.598 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -72.52 -8.18 53.82 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.517 0.658 . . . . 74.510000000000005 112.361 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -94.7 -2.91 50.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.065 0.395 . . . . 75.040000000000006 112.065 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.549 HG12 ' HA ' ' A' ' 11' ' ' ALA . 18.9 m -127.24 149.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 112.437 0.532 . . . . 65.209999999999994 112.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.406 ' HG2' HD21 ' A' ' 12' ' ' LEU . 11.6 pt-20 -104.23 158.94 16.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.345 -0.388 . . . . 75.120000000000005 110.451 173.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -89.45 127.79 35.88 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.016 0.436 . . . . 73.519999999999996 111.702 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 10' ' ' ARG . 90.2 mt -98.66 -65.9 0.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.118 0.485 . . . . 74.239999999999995 110.968 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.18 169.23 32.27 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.212 -0.518 . . . . 61.25 112.989 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 82.6 Cg_endo -76.48 160.91 34.94 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.71 2.273 . . . . 74.230000000000004 112.985 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.44 98.8 10.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.862 0.839 . . . . 74.239999999999995 111.389 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' HG3' ' N ' ' A' ' 1' ' ' MET . 14.4 tp10 . . . . . 0 C--O 1.253 1.257 0 CA-C-N 115.384 -0.826 . . . . 73.099999999999994 111.909 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 120.775 0.321 . . . . 73.239999999999995 111.473 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.85 130.17 11.3 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.889 0.376 . . . . 74.219999999999999 111.519 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . -132.55 -113.26 1.45 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 116.267 -0.424 . . . . 61.409999999999997 113.313 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 32.4 Cg_endo -103.34 35.76 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.707 2.938 . . . . 63.420000000000002 114.877 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -58.57 -32.01 68.53 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.807 0.669 . . . . 74.230000000000004 112.807 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.15 168.12 41.05 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.562 -0.828 . . . . 64.510000000000005 113.646 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.08 158.41 41.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.048 0.452 . . . . 71.430000000000007 111.535 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.91 130.33 56.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.66 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -122.92 146.81 47.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.209 -0.451 . . . . 74.439999999999998 110.63 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HB2' HD13 ' A' ' 78' ' ' LEU . 15.0 ttp180 -104.75 126.71 52.1 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.102 -0.374 . . . . 73.200000000000003 111.388 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.8 114.73 12.42 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.999 0.428 . . . . 62.329999999999998 111.073 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.33 -61.06 1.92 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.299 -0.41 . . . . 72.219999999999999 112.07 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -128.32 147.25 62.92 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 116.628 -0.26 . . . . 74.510000000000005 111.007 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 27' ' ' PRO . 49.6 Cg_endo -69.02 119.65 6.62 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.182 1.921 . . . . 72.209999999999994 112.996 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.648 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 77.2 t80 -112.34 111.4 22.23 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.235 -0.439 . . . . 65.239999999999995 110.461 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -73.47 134.78 44.0 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.318 0.58 . . . . 75.019999999999996 112.102 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -89.53 171.1 9.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.001 -0.545 . . . . 74.510000000000005 110.817 173.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.407 ' HB2' ' HD3' ' A' ' 19' ' ' ARG . 30.4 mm-40 -85.08 -51.51 6.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.307 -0.406 . . . . 75.430000000000007 110.454 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.526 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -130.73 160.77 64.83 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 116.343 -0.39 . . . . 73.439999999999998 110.792 178.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 19' ' ' ARG . 49.0 Cg_endo -66.83 5.42 0.79 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.968 2.445 . . . . 72.420000000000002 114.547 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.11 -32.63 74.19 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.042 -0.411 . . . . 72.530000000000001 111.331 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -103.83 -178.46 3.67 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.95 0.405 . . . . 73.040000000000006 111.294 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 61' ' ' ASN . 32.1 tp -100.16 132.35 45.58 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.856 0.36 . . . . 71.549999999999997 111.785 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.36 142.74 28.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.159 -0.473 . . . . 74.239999999999995 110.02 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.648 ' HB2' ' H ' ' A' ' 15' ' ' PHE . 80.9 mt -104.94 135.03 47.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.305 0.854 . . . . 75.030000000000001 113.305 -169.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.613 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.1 mm? -111.82 139.01 21.79 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 115.745 -0.661 . . . . 64.530000000000001 110.545 175.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.539 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 60.0 Cg_endo -70.47 126.3 12.7 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.35 2.033 . . . . 63.420000000000002 113.135 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.24 65.71 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.153 -0.476 . . . . 74.430000000000007 113.936 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.7 160.63 27.39 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.179 0.514 . . . . 64.319999999999993 112.071 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.82 133.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.26 0.553 . . . . 75.230000000000004 111.433 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -108.6 122.7 47.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 110.701 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.02 115.91 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.08 0.467 . . . . 71.010000000000005 111.069 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.453 HG22 ' HA3' ' A' ' 59' ' ' GLY . 62.0 t -113.15 106.68 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.013 0.435 . . . . 75.540000000000006 111.78 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 m -62.23 126.43 27.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.388 -0.369 . . . . 75.219999999999999 110.384 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -58.72 -20.5 49.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.176 0.436 . . . . 74.25 112.176 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.27 -36.11 51.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.987 0.422 . . . . 75.030000000000001 111.433 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.34 -39.4 71.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.261 -0.427 . . . . 74.129999999999995 111.098 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.97 -37.89 89.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.998 0.428 . . . . 71.109999999999999 111.17 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.25 -38.56 88.13 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.084 0.468 . . . . 71.540000000000006 110.595 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.43 80.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.128 -0.487 . . . . 72.140000000000001 111.229 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.439 HD13 ' HD3' ' A' ' 58' ' ' PRO . 89.2 mt -74.03 -27.76 61.1 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.941 0.4 . . . . 63.399999999999999 111.127 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.93 55.52 2.94 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.096 -0.502 . . . . 74.329999999999998 112.428 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.77 141.01 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.061 0.458 . . . . 75.299999999999997 111.532 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.78 145.42 34.38 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.033 0.444 . . . . 73.340000000000003 111.879 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 120.73 13.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 111.153 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.83 -13.57 49.76 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.007 -0.616 . . . . 73.400000000000006 112.086 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.0 -18.78 26.03 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.455 -0.402 . . . . 63.130000000000003 113.066 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -30.95 71.98 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.131 0.491 . . . . 63.25 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -76.47 8.42 3.5 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.32 -0.4 . . . . 74.349999999999994 111.879 175.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.9 m -137.09 80.35 35.34 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 120.901 0.382 . . . . 71.200000000000003 111.135 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.12 -36.91 97.51 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.705 2.27 . . . . 71.120000000000005 113.082 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -61.25 -22.31 64.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.386 -0.37 . . . . 73.420000000000002 111.76 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.4 m -86.49 -24.16 25.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.662 -0.245 . . . . 64.340000000000003 111.588 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.81 -46.04 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.034 0.445 . . . . 75.349999999999994 111.533 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.09 -99.16 0.79 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.449 -0.405 . . . . 63.130000000000003 112.852 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -122.93 133.86 54.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.588 -0.36 . . . . 71.219999999999999 110.811 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.424 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 3.2 mpp? -133.86 151.65 77.27 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 122.19 -0.319 . . . . 74.340000000000003 111.507 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.439 ' HD3' HD13 ' A' ' 41' ' ' LEU . 3.2 Cg_endo -86.01 137.4 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.524 . . . . 75.010000000000005 112.092 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.453 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -159.39 -179.71 34.4 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.693 -0.765 . . . . 71.329999999999998 113.859 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -101.07 117.85 35.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.666 0.387 . . . . 74.150000000000006 111.017 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.499 ' HB2' HD22 ' A' ' 23' ' ' LEU . 25.4 t-20 -85.62 111.61 20.22 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.794 0.33 . . . . 72.420000000000002 111.239 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -62.16 -28.71 69.84 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.914 0.709 . . . . 74.430000000000007 112.914 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.613 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -60.52 -54.89 40.0 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.194 0.521 . . . . 75.510000000000005 111.519 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.3 p -99.55 -8.82 24.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.988 -0.551 . . . . 55.399999999999999 112.379 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 64.23 13.58 8.02 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.743 0.417 . . . . 74.109999999999999 111.362 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -96.45 166.69 11.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.296 0.569 . . . . 55.299999999999997 112.308 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -116.26 147.79 41.14 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.55 -0.75 . . . . 73.140000000000001 111.342 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.34 40.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.858 -0.686 . . . . 62.329999999999998 113.095 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 6.6 m-20 -88.73 139.93 29.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.935 0.398 . . . . 71.400000000000006 111.363 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.444 ' HB2' HD22 ' A' ' 25' ' ' LEU . 53.7 p90 -134.16 146.84 61.38 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.672 0.273 . . . . 74.219999999999999 111.635 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' HD13 ' A' ' 25' ' ' LEU . 17.4 Cg_exo -67.58 110.4 2.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.741 2.294 . . . . 75.129999999999995 112.714 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.468 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -62.19 -10.23 26.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.082 0.393 . . . . 75.430000000000007 114.082 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.3 p -76.23 -20.92 56.99 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.509 -0.406 . . . . 75.209999999999994 111.885 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -102.25 12.37 36.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.42 0.526 . . . . 74.209999999999994 112.42 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG22 ' HA2' ' A' ' 72' ' ' GLY . 32.4 m -130.23 151.09 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.123 0.487 . . . . 55.5 111.355 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -118.45 145.0 45.58 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.408 -0.36 . . . . 74.209999999999994 111.324 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -73.22 117.7 15.27 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.396 -0.365 . . . . 75.540000000000006 111.411 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 10' ' ' ARG . 85.5 mt -87.79 -58.3 2.62 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.043 0.449 . . . . 74.200000000000003 110.984 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.25 -169.75 42.46 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.137 -0.554 . . . . 73.420000000000002 112.946 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.11 -176.69 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.868 2.379 . . . . 74.510000000000005 113.411 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.47 116.69 24.78 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.338 -0.392 . . . . 74.140000000000001 111.3 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 . . . . . 0 C--O 1.254 1.314 0 CA-C-O 119.27 -0.395 . . . . 75.319999999999993 111.893 178.997 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.465 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.966 0.413 . . . . 73.450000000000003 111.611 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.52 -68.92 0.48 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.403 -0.362 . . . . 74.030000000000001 110.943 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.92 -175.24 19.85 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.983 -0.627 . . . . 72.420000000000002 113.638 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -100.92 40.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.645 2.896 . . . . 73.349999999999994 113.766 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -32.17 66.02 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 122.181 -0.324 . . . . 54.399999999999999 111.464 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.552 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . 110.38 -163.22 12.38 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 115.695 1.038 . . . . 70.310000000000002 115.695 169.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -125.97 179.87 5.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.971 -0.614 . . . . 74.140000000000001 110.772 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -125.25 137.56 54.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.406 0.622 . . . . 74.329999999999998 112.016 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -120.17 154.66 34.48 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.596 -0.729 . . . . 74.030000000000001 110.271 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.426 ' HB2' HD13 ' A' ' 78' ' ' LEU . 51.6 ttp180 -123.02 121.9 37.21 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.099 -0.376 . . . . 74.409999999999997 111.663 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -73.78 123.42 24.12 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.022 0.439 . . . . 75.219999999999999 111.622 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.8 -49.77 10.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.004 0.43 . . . . 75.200000000000003 111.662 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -127.35 153.35 77.11 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.308 -0.405 . . . . 61.240000000000002 111.336 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -68.54 131.35 22.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.342 2.028 . . . . 73.340000000000003 113.74 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.433 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 t80 -111.37 131.19 55.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.533 -0.758 . . . . 72.010000000000005 110.653 176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 5.5 ppt_? -108.28 139.47 42.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.172 0.511 . . . . 74.230000000000004 111.617 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.598 ' HG2' ' HB2' ' A' ' 22' ' ' ASP . 28.8 tpt180 -117.08 142.39 47.04 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.262 -0.427 . . . . 75.340000000000003 111.194 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.61 7.81 2.76 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.238 0.459 . . . . 74.340000000000003 112.238 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.458 ' H ' ' HG3' ' A' ' 17' ' ' ARG . 53.4 mtt-85 -144.59 143.65 22.23 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 123.183 0.593 . . . . 75.140000000000001 110.665 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.41 -4.21 14.45 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.511 2.141 . . . . 73.430000000000007 112.73 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.84 -53.75 10.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 112.073 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.598 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 3.3 m-20 -70.65 169.44 14.36 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.0 0.429 . . . . 75.140000000000001 111.542 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp -100.05 119.91 39.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.309 0.576 . . . . 74.329999999999998 111.521 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 40.8 mt-10 -90.64 164.59 14.11 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.969 -0.56 . . . . 70.439999999999998 111.875 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 80.2 mt -121.93 147.12 46.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 73.450000000000003 111.803 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.418 HD23 ' C ' ' A' ' 25' ' ' LEU . 4.0 mm? -122.91 155.61 63.52 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 122.544 0.337 . . . . 75.049999999999997 111.179 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.51 117.82 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.161 1.907 . . . . 75.129999999999995 112.495 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.16 28.28 45.7 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.151 -0.547 . . . . 70.140000000000001 112.589 -177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -93.44 156.59 16.68 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.499 0.319 . . . . 72.109999999999999 110.578 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.26 132.91 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.839 0.352 . . . . 73.030000000000001 110.731 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.5 mp -127.29 124.04 37.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.091 0.472 . . . . 74.140000000000001 111.418 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.21 119.09 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.334 -0.394 . . . . 74.010000000000005 110.73 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG22 ' HA3' ' A' ' 59' ' ' GLY . 59.9 t -115.27 104.77 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.923 0.392 . . . . 74.310000000000002 111.651 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.552 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 70.5 m -60.99 119.8 8.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.439 -0.346 . . . . 74.230000000000004 110.15 174.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -63.02 -12.49 26.41 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.628 0.603 . . . . 64.409999999999997 112.628 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.92 71.16 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.266 0.555 . . . . 71.430000000000007 110.461 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.539 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -68.19 -35.85 78.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.797 -0.638 . . . . 74.340000000000003 111.136 175.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.56 -34.35 76.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.997 0.427 . . . . 75.319999999999993 110.511 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -63.74 -36.08 82.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.332 -0.395 . . . . 74.510000000000005 110.849 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.23 -25.02 64.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.996 0.426 . . . . 70.219999999999999 111.296 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD12 HG13 ' A' ' 54' ' ' VAL . 91.3 mt -80.72 -28.36 36.61 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.106 0.479 . . . . 73.0 111.106 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.75 45.18 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.022 -0.535 . . . . 71.109999999999999 112.504 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.56 133.89 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.59 0.589 . . . . 72.239999999999995 112.59 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.74 151.65 24.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.971 -0.559 . . . . 73.239999999999995 111.457 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -50.02 110.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.106 0.479 . . . . 74.319999999999993 111.463 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.28 -50.54 0.88 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 116.186 -0.461 . . . . 72.400000000000006 112.047 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.07 -27.18 68.45 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.072 -0.585 . . . . 70.230000000000004 112.848 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -57.5 -35.36 70.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.117 0.484 . . . . 75.230000000000004 111.432 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -100.64 4.01 42.97 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 64.219999999999999 111.606 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -142.91 82.52 12.08 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 120.875 0.369 . . . . 74.030000000000001 111.209 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 20.4 Cg_endo -58.92 -24.78 74.35 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.106 2.537 . . . . 70.530000000000001 113.228 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -57.37 -27.14 62.03 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.733 0.302 . . . . 75.310000000000002 111.743 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -82.96 -13.18 56.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.001 0.429 . . . . 74.420000000000002 111.761 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.554 HG13 HD12 ' A' ' 41' ' ' LEU . 46.6 t -98.44 -38.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.037 0.446 . . . . 74.219999999999999 111.422 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -93.12 1.77 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.125 -0.559 . . . . 75.140000000000001 112.697 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -93.53 136.7 33.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.648 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.472 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 81.5 mtp -139.76 129.15 13.79 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 111.923 0.342 . . . . 74.150000000000006 111.923 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.539 ' HG2' ' HB1' ' A' ' 37' ' ' ALA . 73.1 Cg_endo -77.52 117.85 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.531 2.154 . . . . 70.540000000000006 112.786 174.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.484 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.18 -177.8 25.36 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.797 -0.716 . . . . 74.439999999999998 113.539 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.1 tp -111.96 116.11 30.05 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.867 0.365 . . . . 75.040000000000006 111.223 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.9 t-20 -76.98 134.94 38.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.42 -0.354 . . . . 70.109999999999999 110.841 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -84.25 -40.09 18.46 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.731 0.641 . . . . 74.420000000000002 112.731 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -67.5 -30.47 70.16 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.124 0.416 . . . . 75.120000000000005 112.124 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -114.81 -28.69 6.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.92 0.341 . . . . 72.420000000000002 111.92 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.539 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 14.7 mmt85 64.14 28.93 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.159 0.504 . . . . 73.200000000000003 112.18 -176.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -91.03 143.86 26.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.993 -0.549 . . . . 61.109999999999999 111.204 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.466 ' NH1' ' H ' ' A' ' 68' ' ' GLY . 10.0 mmm180 -96.43 164.42 12.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 75.409999999999997 111.858 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.466 ' H ' ' NH1' ' A' ' 67' ' ' ARG . . . 139.61 -165.89 25.72 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.453 -0.794 . . . . 74.120000000000005 112.121 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -108.14 132.92 53.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.675 -0.309 . . . . 73.310000000000002 110.801 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -118.86 147.35 42.17 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.739 0.304 . . . . 73.219999999999999 111.199 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.87 103.6 1.75 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.384 2.056 . . . . 72.439999999999998 112.642 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -60.07 -14.99 34.48 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.503 0.561 . . . . 73.340000000000003 114.503 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -62.43 -18.4 61.62 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.841 0.682 . . . . 73.400000000000006 112.841 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.35 3.32 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.913 -0.492 . . . . 75.200000000000003 112.155 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 11' ' ' ALA . 15.0 m -120.96 159.5 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.178 0.513 . . . . 74.340000000000003 112.073 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.98 152.41 28.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 110.905 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -83.84 106.56 15.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.708 0.289 . . . . 73.319999999999993 111.22 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.426 HD13 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -72.65 -53.45 11.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.038 0.447 . . . . 74.430000000000007 111.099 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.58 -175.07 27.11 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.215 -0.517 . . . . 65.409999999999997 113.11 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.88 164.94 24.88 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.308 2.672 . . . . 71.530000000000001 112.636 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 pp -127.06 158.12 37.83 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.048 0.388 . . . . 70.439999999999998 112.048 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 . . . . . 0 C--O 1.253 1.245 0 CA-C-O 118.742 -0.647 . . . . 70.209999999999994 110.88 174.456 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.731 0.3 . . . . 75.25 111.129 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.65 104.09 16.22 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.915 0.388 . . . . 74.040000000000006 111.346 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.75 -171.95 44.98 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.974 -0.632 . . . . 70.129999999999995 113.403 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.17 39.54 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 123.087 2.525 . . . . 75.329999999999998 113.823 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -62.18 -28.57 69.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.019 0.378 . . . . 74.349999999999994 112.019 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . -128.32 147.14 17.28 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.119 -0.562 . . . . 74.299999999999997 112.777 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -127.1 158.18 37.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.296 0.57 . . . . 74.420000000000002 111.944 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.05 127.44 56.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.902 -0.59 . . . . 74.25 111.369 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.2 163.25 14.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 64.030000000000001 110.143 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.421 ' HB3' ' CG ' ' A' ' 76' ' ' GLU . 38.2 ttt180 -133.46 123.94 26.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.975 0.416 . . . . 74.109999999999999 111.59 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . . . -77.06 122.98 25.71 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.04 -0.527 . . . . 74.109999999999999 110.841 177.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.3 -60.11 2.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 75.349999999999994 111.915 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 91.8 m-85 -127.25 161.2 55.76 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-N 116.205 -0.452 . . . . 75.549999999999997 110.985 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_endo -63.7 135.15 47.33 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.01 1.806 . . . . 64.219999999999999 112.965 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -133.85 130.78 38.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.898 -0.592 . . . . 74.310000000000002 111.481 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -135.41 141.83 45.53 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.277 -0.419 . . . . 73.140000000000001 110.914 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.549 ' HG3' ' N ' ' A' ' 18' ' ' GLU . 19.1 tpp180 -107.87 167.41 10.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.825 0.345 . . . . 74.200000000000003 110.779 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.549 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 6.5 mm-40 -70.1 -10.99 60.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.027 0.442 . . . . 72.230000000000004 111.533 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.552 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 22.4 mmm180 -136.31 137.55 24.73 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.147 0.579 . . . . 74.400000000000006 110.531 177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.87 5.43 2.98 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.603 2.202 . . . . 65.420000000000002 113.207 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.552 ' HG2' ' HB3' ' A' ' 19' ' ' ARG . 6.9 mm-40 -62.42 -25.88 68.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.213 0.53 . . . . 75.129999999999995 110.688 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.52 -158.43 0.22 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.527 -0.76 . . . . 72.340000000000003 110.179 171.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.6 tp -133.11 118.92 19.29 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.088 -0.382 . . . . 65.430000000000007 111.304 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -62.48 119.97 10.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.087 0.47 . . . . 73.010000000000005 111.481 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.532 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 74.6 mt -100.35 143.11 30.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 111.613 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.486 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.3 mm? -110.99 148.0 37.71 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.438 -0.346 . . . . 70.510000000000005 110.651 176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.482 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 36.2 Cg_endo -63.57 106.22 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.506 2.138 . . . . 73.209999999999994 113.311 -175.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.02 34.49 23.92 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.038 -0.528 . . . . 60.200000000000003 113.62 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.417 ' CG ' ' HB2' ' A' ' 63' ' ' ARG . 33.2 t70 -105.56 158.91 16.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.175 0.487 . . . . 64.019999999999996 111.997 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -101.09 131.85 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 121.395 0.616 . . . . 75.319999999999993 112.391 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.0 mp -111.2 127.76 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.831 -0.622 . . . . 74.400000000000006 110.704 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.0 122.68 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.008 0.433 . . . . 72.329999999999998 111.517 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.79 116.46 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.277 -0.42 . . . . 75.120000000000005 111.253 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.488 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 55.4 m -89.23 156.65 18.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 72.430000000000007 111.176 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.526 ' HG2' HD11 ' A' ' 38' ' ' LEU . 36.1 mtm180 -71.48 -14.66 62.2 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.722 0.268 . . . . 74.150000000000006 111.722 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.46 -35.74 20.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.011 0.434 . . . . 75.329999999999998 111.523 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.52 13.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.984 0.421 . . . . 64.450000000000003 111.56 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' A' ' 35' ' ' ARG . 90.0 mt -56.82 -38.43 72.6 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 75.409999999999997 112.164 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 14.8 mm100 -65.3 -37.69 87.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.904 0.383 . . . . 73.540000000000006 110.997 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -34.06 76.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.026 0.441 . . . . 73.239999999999995 110.989 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.514 HD11 ' HD2' ' A' ' 58' ' ' PRO . 75.2 mt -69.99 -28.5 65.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.104 -0.498 . . . . 75.209999999999994 111.118 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 41.81 6.05 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.353 -0.451 . . . . 75.0 112.598 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.64 129.78 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.886 0.374 . . . . 74.219999999999999 111.757 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 148.69 37.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.955 0.407 . . . . 73.530000000000001 112.029 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.55 122.43 12.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.151 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.13 2.77 60.59 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.023 -0.608 . . . . 73.409999999999997 112.836 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.27 -28.49 10.62 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.3 -0.476 . . . . 62.130000000000003 112.855 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -34.53 72.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.042 0.386 . . . . 64.510000000000005 112.042 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -63.56 -12.02 29.34 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.168 0.432 . . . . 74.420000000000002 112.168 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -134.55 85.55 36.86 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 120.819 0.343 . . . . 75.430000000000007 110.515 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 17.7 Cg_endo -55.94 -28.1 66.79 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.154 2.569 . . . . 74.129999999999995 113.284 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -62.4 -23.36 66.79 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.326 -0.397 . . . . 62.310000000000002 111.75 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -68.1 -45.31 74.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.097 0.475 . . . . 72.439999999999998 111.358 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.17 -46.44 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 111.459 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.0 -90.22 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.258 -0.496 . . . . 54.240000000000002 113.285 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -112.06 114.76 27.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.956 0.408 . . . . 75.420000000000002 111.906 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.439 ' HE2' ' HA3' ' A' ' 72' ' ' GLY . 3.0 mpp? -124.26 138.43 30.86 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.436 -0.347 . . . . 75.450000000000003 111.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.514 ' HD2' HD11 ' A' ' 41' ' ' LEU . 71.6 Cg_endo -77.93 127.94 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.411 2.074 . . . . 70.329999999999998 112.393 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.69 168.83 27.33 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.812 -0.709 . . . . 71.319999999999993 113.288 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 tp -103.88 124.02 48.19 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.764 0.316 . . . . 74.200000000000003 111.204 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -84.45 118.13 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.714 0.293 . . . . 72.519999999999996 110.666 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.3 -31.62 72.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.747 0.647 . . . . 75.120000000000005 112.747 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.486 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -63.37 -51.62 65.12 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.045 0.45 . . . . 74.140000000000001 111.847 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 82.6 p -102.43 -18.79 15.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.295 0.85 . . . . 75.209999999999994 113.295 -172.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.445 ' HB2' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER 69.58 17.97 7.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.934 0.494 . . . . 75.329999999999998 111.631 -173.343 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -84.13 149.27 26.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.116 0.484 . . . . 75.409999999999997 111.507 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 67' ' ' ARG . 50.1 mtp180 -111.23 150.71 29.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.122 -0.49 . . . . 75.530000000000001 110.679 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.62 164.08 27.49 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.503 -0.855 . . . . 73.120000000000005 113.647 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.03 109.58 20.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -106.72 143.75 27.66 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.24 0.459 . . . . 72.109999999999999 112.24 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.37 104.69 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.54 2.16 . . . . 73.420000000000002 112.079 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -61.03 -18.57 55.01 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.082 0.793 . . . . 74.120000000000005 115.082 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -58.65 -24.83 61.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.683 0.742 . . . . 74.340000000000003 112.149 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -100.66 11.66 39.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.647 0.61 . . . . 74.349999999999994 112.647 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.86 150.32 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.778 0.323 . . . . 64.209999999999994 111.078 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 14.7 pt-20 -98.94 153.72 18.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.04 0.448 . . . . 63.409999999999997 111.294 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -92.76 116.34 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.289 -0.414 . . . . 74.150000000000006 111.385 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.77 -67.42 0.78 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.883 0.373 . . . . 73.519999999999996 111.438 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.24 179.74 41.94 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.205 -0.522 . . . . 62.439999999999998 112.802 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.96 165.14 33.47 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.855 2.37 . . . . 74.120000000000005 113.369 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.409 HD12 ' HA3' ' A' ' 6' ' ' GLY . 91.7 mt -78.18 149.4 33.74 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.994 0.426 . . . . 71.549999999999997 111.797 177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.255 1.368 0 CA-C-O 118.728 -0.653 . . . . 73.239999999999995 110.867 178.429 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.566 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.484 0.183 . . . . 75.140000000000001 111.157 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.43 177.84 7.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.933 0.397 . . . . 60.119999999999997 111.967 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.71 148.22 4.72 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.511 -0.376 . . . . 64.209999999999994 112.762 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.2 51.28 3.12 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.004 2.47 . . . . 74.329999999999998 112.594 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.31 -20.61 63.89 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.277 0.473 . . . . 64.219999999999999 112.277 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.7 -145.02 5.49 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.928 -0.653 . . . . 72.120000000000005 113.105 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -131.03 145.6 52.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.988 0.423 . . . . 74.200000000000003 111.507 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -93.05 134.03 35.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.146 -0.479 . . . . 64.409999999999997 111.534 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 123.99 41.17 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.524 -0.307 . . . . 72.409999999999997 110.987 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' HD12 ' A' ' 78' ' ' LEU . 43.5 ttm180 -97.85 115.59 28.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.346 -0.221 . . . . 73.319999999999993 111.113 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.96 108.99 3.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.805 0.336 . . . . 70.109999999999999 111.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.91 -29.57 27.04 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.167 0.432 . . . . 74.239999999999995 112.167 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -124.2 135.48 26.47 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 122.353 -0.217 . . . . 73.019999999999996 111.574 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.525 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.5 Cg_endo -69.21 119.86 6.79 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.296 1.998 . . . . 73.129999999999995 112.638 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -122.47 111.62 17.06 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.104 -0.498 . . . . 74.129999999999995 111.364 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -104.63 120.25 40.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.009 0.433 . . . . 75.239999999999995 110.641 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 17' ' ' ARG . 7.2 tpt180 -74.56 151.39 39.44 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.915 0.388 . . . . 71.430000000000007 111.558 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -55.26 -47.67 75.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.263 0.554 . . . . 72.519999999999996 110.92 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -106.39 151.34 40.26 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.643 -0.708 . . . . 75.329999999999998 111.442 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.9 5.61 3.36 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.821 2.347 . . . . 72.430000000000007 113.206 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.81 -34.4 77.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.96 0.504 . . . . 62.009999999999998 112.101 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.8 -160.5 0.49 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.701 0.401 . . . . 70.549999999999997 111.5 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.9 tp -125.99 123.91 39.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.782 0.325 . . . . 74.409999999999997 111.244 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.86 138.92 46.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.193 0.52 . . . . 74.129999999999995 111.987 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 94.6 mt -106.24 137.59 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.103 -0.499 . . . . 74.540000000000006 111.598 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -120.72 142.84 35.14 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 122.452 0.301 . . . . 62.140000000000001 110.839 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 46.0 Cg_endo -66.44 117.6 4.85 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.565 2.177 . . . . 73.340000000000003 112.814 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.79 45.43 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.263 -0.494 . . . . 51.32 113.265 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.92 138.8 39.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.008 0.404 . . . . 61.25 110.742 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.96 97.68 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.98 0.419 . . . . 71.430000000000007 110.965 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.0 mp -81.1 127.15 32.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.999 0.428 . . . . 73.420000000000002 111.498 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.0 113.53 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.345 -0.388 . . . . 70.219999999999999 111.595 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -109.71 134.57 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.388 -0.369 . . . . 73.400000000000006 110.645 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -74.77 149.35 39.77 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.02 0.438 . . . . 74.239999999999995 111.586 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.5 -38.19 88.92 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.166 0.508 . . . . 71.109999999999999 110.285 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.44 80.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.735 -0.666 . . . . 73.549999999999997 111.613 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.83 -47.0 86.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.936 0.398 . . . . 71.329999999999998 111.129 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.01 -41.25 96.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.394 -0.366 . . . . 74.310000000000002 111.227 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -60.34 -37.28 80.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.953 0.406 . . . . 75.129999999999995 111.047 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.41 93.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.038 0.447 . . . . 75.439999999999998 110.838 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.78 -21.4 64.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.083 -0.508 . . . . 71.140000000000001 111.816 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.01 36.42 6.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.307 -0.473 . . . . 52.109999999999999 113.144 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.57 130.21 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.903 0.382 . . . . 74.329999999999998 111.146 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.76 150.41 20.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 70.299999999999997 111.802 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -48.44 121.37 4.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.974 0.416 . . . . 72.129999999999995 111.522 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.17 57.48 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.24 -0.505 . . . . 71.430000000000007 112.995 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.78 -28.18 4.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.319 -0.467 . . . . 74.120000000000005 112.966 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -31.29 64.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.174 0.59 . . . . 72.349999999999994 111.974 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.42 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 12.8 ptp180 -59.06 -13.69 7.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.687 0.625 . . . . 73.319999999999993 112.687 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 26.6 p -127.32 84.0 64.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 121.02 0.438 . . . . 73.430000000000007 111.276 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 -33.3 97.79 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.719 2.279 . . . . 62.25 112.562 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.673 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 90.6 mt-30 -58.64 -28.86 66.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.105 -0.498 . . . . 72.219999999999999 111.513 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 t -76.25 -33.42 59.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.853 0.358 . . . . 43.539999999999999 111.38 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.93 -58.55 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.9 0.381 . . . . 72.329999999999998 111.414 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.13 -137.15 12.46 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.515 . . . . 63.100000000000001 112.709 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.94 132.91 39.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.2 0.524 . . . . 62.229999999999997 111.686 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -132.41 147.64 66.48 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 116.12 -0.491 . . . . 74.540000000000006 111.593 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 126.4 8.56 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.503 2.135 . . . . 74.430000000000007 112.403 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.81 -175.25 24.89 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.475 -0.869 . . . . 45.399999999999999 114.131 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.88 117.12 24.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.335 0.254 . . . . 64.140000000000001 111.253 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -79.92 129.65 34.66 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.568 0.223 . . . . 74.310000000000002 110.493 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -92.39 -6.53 49.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.181 1.178 . . . . 64.319999999999993 114.181 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.64 -23.64 18.93 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.718 -0.614 . . . . 74.540000000000006 111.363 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -111.36 -16.93 13.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.04 0.448 . . . . 61.32 111.223 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 62.59 22.44 13.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.577 0.751 . . . . 73.310000000000002 111.568 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -101.21 149.19 24.25 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.073 0.463 . . . . 72.219999999999999 112.157 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -92.63 156.39 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.007 -0.542 . . . . 75.340000000000003 111.107 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.55 -172.35 44.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.593 -0.813 . . . . 71.530000000000001 113.453 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.06 125.58 54.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.611 0.364 . . . . 74.040000000000006 110.252 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -132.12 142.77 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 N-CA-C 111.93 0.345 . . . . 72.409999999999997 111.93 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.32 113.9 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.398 2.066 . . . . 72.400000000000006 112.36 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.39 33.02 0.97 Allowed Glycine 0 CA--C 1.53 1.0 0 N-CA-C 114.424 0.529 . . . . 74.239999999999995 114.424 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.673 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 43.4 m -92.52 -28.92 16.49 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.399 -0.471 . . . . 73.340000000000003 110.936 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.46 5.29 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.198 -0.455 . . . . 71.430000000000007 112.01 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 11' ' ' ALA . 19.1 m -117.64 145.39 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.783 0.325 . . . . 75.209999999999994 111.486 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 14.6 pt-20 -99.87 152.32 20.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.996 0.427 . . . . 71.150000000000006 110.972 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 49' ' ' ARG . 68.3 t80 -84.82 107.41 16.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.09 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 HD12 ' HB2' ' A' ' 10' ' ' ARG . 67.2 mt -76.93 -38.1 54.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.847 0.356 . . . . 73.329999999999998 111.24 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.68 -176.51 19.16 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.29 -0.481 . . . . 61.109999999999999 113.089 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.57 150.08 68.89 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.84 2.36 . . . . 74.239999999999995 112.259 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 81' ' ' LEU . 7.4 mp -74.46 151.25 39.62 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.13 0.49 . . . . 71.420000000000002 111.204 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.256 1.398 0 CA-C-O 118.487 -0.768 . . . . 64.150000000000006 112.458 -178.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.757 0.313 . . . . 74.540000000000006 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.71 -42.56 17.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.791 0.329 . . . . 73.140000000000001 110.835 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 56.3 -113.12 3.82 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 114.626 0.61 . . . . 75.310000000000002 114.626 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.47 23.69 0.48 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.323 2.682 . . . . 64.519999999999996 114.922 -172.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -59.5 -30.97 68.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.187 0.518 . . . . 74.430000000000007 111.109 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.72 -146.71 12.49 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 116.088 -0.505 . . . . 63.049999999999997 112.573 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -133.36 137.0 45.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.91 0.386 . . . . 75.319999999999993 111.159 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.509 ' HG2' HG22 ' A' ' 32' ' ' VAL . 98.0 mt-30 -94.95 126.92 40.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 112.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.87 123.98 49.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.961 -0.563 . . . . 75.450000000000003 110.091 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 10' ' ' ARG . 20.1 ttt180 -97.85 124.37 42.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.205 0.446 . . . . 74.109999999999999 112.205 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.515 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -69.13 126.63 30.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.915 0.388 . . . . 72.409999999999997 111.831 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.74 -55.37 4.01 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.233 0.457 . . . . 73.420000000000002 112.233 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -115.21 150.07 43.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 111.62 0.23 . . . . 73.409999999999997 111.62 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.2 Cg_endo -73.96 120.02 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.544 2.163 . . . . 73.209999999999994 113.872 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -129.78 111.04 12.23 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 74.209999999999994 111.053 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.3 mtm-85 -86.98 160.48 18.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.196 -0.456 . . . . 64.120000000000005 110.821 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.601 ' HD3' ' HG2' ' A' ' 24' ' ' GLU . 2.0 mpt_? -107.76 135.34 49.34 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.235 0.828 . . . . 75.109999999999999 113.235 -174.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.38 -45.18 56.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.439 -0.801 . . . . 74.329999999999998 109.73 169.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -111.93 120.11 42.81 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.66 -0.7 . . . . 72.209999999999994 110.114 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.07 -1.41 0.84 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.06 2.507 . . . . 75.420000000000002 113.87 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -56.43 -39.51 73.2 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.95 0.405 . . . . 74.450000000000003 111.431 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.67 163.98 14.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.597 -0.52 . . . . 70.420000000000002 109.597 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.9 tp -99.54 133.26 44.13 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.692 -0.63 . . . . 74.299999999999997 111.292 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.601 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 39.0 mt-10 -78.26 149.89 33.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.165 0.507 . . . . 74.439999999999998 111.839 -176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 84.2 mt -127.18 125.74 41.62 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.007 -0.542 . . . . 73.450000000000003 111.444 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.52 152.62 44.77 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-O 120.72 0.295 . . . . 73.120000000000005 110.359 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 42.5 Cg_endo -65.82 105.53 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.058 1.839 . . . . 75.530000000000001 112.463 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.55 10.06 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.106 -0.568 . . . . 71.219999999999999 113.433 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.03 118.29 6.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 117.008 0.404 . . . . 53.109999999999999 111.616 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.48 92.64 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.129 0.49 . . . . 75.030000000000001 110.566 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.478 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 5.9 mp -78.8 120.55 23.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 60.210000000000001 111.968 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.509 HG22 ' HG2' ' A' ' 8' ' ' GLN . 48.3 t -93.09 111.95 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.105 -0.498 . . . . 74.209999999999994 111.654 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.07 122.45 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.328 -0.396 . . . . 74.140000000000001 110.937 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.9 p -68.07 139.73 56.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.995 0.426 . . . . 74.150000000000006 111.114 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -63.96 -32.37 73.88 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.874 0.369 . . . . 74.140000000000001 110.943 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.83 85.9 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.296 -0.411 . . . . 71.519999999999996 111.269 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.57 -43.5 93.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.002 0.43 . . . . 63.399999999999999 111.081 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.8 mt -58.98 -42.51 90.17 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.285 -0.416 . . . . 75.129999999999995 111.341 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.46 -37.12 86.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.933 0.397 . . . . 75.310000000000002 111.012 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.21 77.45 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.959 0.409 . . . . 75.409999999999997 111.484 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.534 HD13 ' HD2' ' A' ' 58' ' ' PRO . 88.9 mt -72.46 -20.86 61.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 111.526 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.61 28.61 35.04 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.323 -0.465 . . . . 71.530000000000001 112.763 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 41' ' ' LEU . 58.8 t -78.65 124.74 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.775 0.321 . . . . 75.450000000000003 111.356 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.71 139.29 53.39 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.998 0.428 . . . . 72.420000000000002 111.731 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.11 122.31 11.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.114 0.483 . . . . 62.340000000000003 111.121 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.82 -13.32 24.68 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.957 -0.64 . . . . 72.099999999999994 112.461 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.0 -25.27 49.77 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.347 -0.454 . . . . 74.400000000000006 113.408 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' OE2' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -58.91 -28.39 66.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.974 0.361 . . . . 74.549999999999997 111.974 -178.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' HG3' ' OE2' ' A' ' 48' ' ' GLU . 50.1 mtm180 -56.48 -29.13 61.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.951 0.352 . . . . 74.010000000000005 111.951 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.0 m -133.28 84.85 46.05 Favored Pre-proline 0 N--CA 1.474 0.73 0 CA-C-O 120.953 0.406 . . . . 75.540000000000006 111.053 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.505 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 18.3 Cg_endo -57.94 -23.62 60.75 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.004 2.469 . . . . 73.239999999999995 113.491 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -60.25 -24.33 64.8 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.906 0.336 . . . . 74.519999999999996 111.906 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.3 t -66.48 -31.56 72.37 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.183 0.516 . . . . 74.019999999999996 111.609 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.12 -57.17 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.139 -0.482 . . . . 73.120000000000005 111.367 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.88 -88.88 0.5 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.257 -0.497 . . . . 71.25 113.185 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 7.4 m0 -103.18 107.33 18.1 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.343 0.497 . . . . 75.420000000000002 112.343 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -116.22 137.76 23.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.964 -0.562 . . . . 74.129999999999995 110.673 175.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.534 ' HD2' HD13 ' A' ' 41' ' ' LEU . 65.2 Cg_endo -74.67 117.76 5.07 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.311 2.008 . . . . 71.530000000000001 112.628 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.87 172.49 22.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.06 -0.59 . . . . 73.230000000000004 113.299 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 60.3 tp -97.66 114.36 26.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.93 0.395 . . . . 73.319999999999993 111.607 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 23.6 t-20 -74.53 123.08 24.12 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.382 -0.372 . . . . 61.240000000000002 111.711 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -72.63 -19.64 61.42 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.214 0.82 . . . . 71.549999999999997 113.214 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -66.05 -59.93 3.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.337 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.494 ' OG1' ' HG2' ' A' ' 66' ' ' GLN . 72.3 p -122.91 6.21 9.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.831 0.678 . . . . 71.25 112.831 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 0.1 OUTLIER 67.35 32.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.632 0.605 . . . . 73.310000000000002 112.632 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.494 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 83.7 mm-40 -79.19 130.57 35.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.742 0.306 . . . . 64.230000000000004 111.296 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -98.47 121.61 40.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.572 0.225 . . . . 74.5 110.707 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -175.03 -177.83 44.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.514 -0.85 . . . . 54.329999999999998 113.495 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 20.1 m-20 -88.23 119.94 29.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 75.420000000000002 111.194 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.451 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.5 p90 -114.8 145.77 34.65 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.432 -0.349 . . . . 72.209999999999994 111.07 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.53 109.46 2.76 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.426 2.084 . . . . 74.25 112.438 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.36 34.07 0.96 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.243 0.457 . . . . 64.019999999999996 114.243 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.0 p -102.87 -26.73 13.01 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.461 -0.435 . . . . 73.329999999999998 111.348 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.6 15.54 26.81 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 64.030000000000001 111.795 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 11' ' ' ALA . 24.2 m -118.73 161.3 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.933 0.397 . . . . 73.239999999999995 111.517 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.11 138.12 46.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.094 0.473 . . . . 72.409999999999997 110.919 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.457 ' CZ ' ' HA2' ' A' ' 79' ' ' GLY . 39.5 t80 -77.76 116.6 18.41 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.868 0.366 . . . . 62.340000000000003 110.963 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -86.43 -48.29 8.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.236 0.541 . . . . 74.329999999999998 110.78 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.457 ' HA2' ' CZ ' ' A' ' 77' ' ' PHE . . . 131.24 -165.22 23.2 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.849 -0.614 . . . . 64.310000000000002 112.502 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.55 166.36 19.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.332 2.022 . . . . 74.409999999999997 111.97 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.458 HD13 ' N ' ' A' ' 81' ' ' LEU . 6.3 mp -84.4 159.01 20.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 65.120000000000005 111.724 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.257 1.469 0 CA-C-N 115.806 -0.634 . . . . 73.319999999999993 111.424 177.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 pmm? . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.578 0.228 . . . . 73.430000000000007 111.529 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.61 -47.71 73.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.021 0.378 . . . . 74.25 112.021 -176.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.14 166.16 16.46 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.009 -0.615 . . . . 63.049999999999997 113.468 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 16.6 Cg_exo -68.59 77.32 0.72 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.77 2.313 . . . . 72.409999999999997 112.837 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -67.42 -35.22 78.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.886 0.374 . . . . 72.510000000000005 111.665 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . -147.84 166.21 28.83 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.336 -0.459 . . . . 72.219999999999999 113.026 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -130.12 148.22 51.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.616 0.366 . . . . 74.439999999999998 111.112 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.715 ' HG3' HD13 ' A' ' 81' ' ' LEU . 82.2 mt-30 -103.63 143.86 32.2 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.19 0.519 . . . . 70.400000000000006 112.018 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.518 ' HA ' ' O ' ' A' ' 76' ' ' GLU . 87.9 m-85 -132.05 125.86 32.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.934 -0.575 . . . . 74.010000000000005 110.692 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.416 ' HB2' HD13 ' A' ' 78' ' ' LEU . 43.5 ttp180 -98.58 116.52 30.99 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.005 -0.435 . . . . 75.010000000000005 111.82 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 113.88 7.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.919 0.39 . . . . 72.319999999999993 111.451 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.439 HD23 ' HG3' ' A' ' 76' ' ' GLU . 84.0 mt -77.92 -39.11 43.92 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.43 0.53 . . . . 75.140000000000001 112.43 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -126.32 145.81 54.02 Favored Pre-proline 0 N--CA 1.469 0.505 0 N-CA-C 111.718 0.266 . . . . 72.129999999999995 111.718 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.527 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 36.9 Cg_endo -65.88 131.62 27.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.434 2.089 . . . . 75.319999999999993 112.345 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 92.1 t80 -133.53 117.82 17.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.48 -0.327 . . . . 75.450000000000003 111.618 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 16' ' ' ARG . 1.3 ptm180 -77.38 131.5 38.08 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.668 -0.493 . . . . 71.200000000000003 109.668 172.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.814 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -72.88 151.43 41.95 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.919 0.39 . . . . 74.219999999999999 111.983 -173.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.565 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 7.6 tp10 -46.53 -26.49 0.89 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.286 0.635 . . . . 72.340000000000003 111.581 173.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -157.05 131.9 5.33 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.692 -0.685 . . . . 75.319999999999993 110.16 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.67 -9.29 3.75 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 123.0 2.467 . . . . 73.430000000000007 113.851 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.18 -30.84 69.13 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.368 -0.378 . . . . 75.409999999999997 111.599 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -96.45 -164.35 1.14 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.14 0.495 . . . . 71.329999999999998 112.207 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 66' ' ' GLN . 43.1 tp -99.62 130.27 45.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.171 0.51 . . . . 73.239999999999995 112.046 -173.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.814 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 37.2 mt-10 -101.31 166.32 10.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.073 -0.512 . . . . 61.409999999999997 111.228 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 15' ' ' PHE . 90.9 mt -114.99 142.51 46.53 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.675 0.62 . . . . 71.310000000000002 112.675 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -121.63 151.2 56.7 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 122.944 0.498 . . . . 74.530000000000001 110.658 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.5 Cg_endo -71.44 129.17 15.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.382 2.055 . . . . 74.310000000000002 113.261 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.28 22.83 75.34 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.223 -0.513 . . . . 73.420000000000002 113.105 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -105.97 157.85 17.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 65.140000000000001 110.846 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.88 133.25 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.252 0.549 . . . . 63.210000000000001 111.895 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 31' ' ' LEU . 4.8 mp -121.38 139.23 53.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.094 -0.503 . . . . 74.519999999999996 110.533 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 57.1 t -106.26 124.86 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 120.983 0.42 . . . . 72.239999999999995 112.04 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.01 124.39 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.414 -0.357 . . . . 74.420000000000002 110.754 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.517 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 74.9 m -95.12 159.98 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.449 0.536 . . . . 65.129999999999995 112.449 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -50.79 -38.94 51.29 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.404 -0.362 . . . . 73.209999999999994 111.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.7 -37.44 41.38 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.122 0.416 . . . . 72.319999999999993 112.122 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -77.14 -49.14 15.88 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.933 0.397 . . . . 74.299999999999997 111.265 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 94.8 mt -58.52 -46.06 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.426 -0.352 . . . . 73.5 111.887 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -61.57 -35.71 78.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.602 0.239 . . . . 74.349999999999994 111.584 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.2 75.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.081 0.467 . . . . 74.450000000000003 111.046 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 60.5 mt -76.31 -28.7 57.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.2 0.524 . . . . 75.129999999999995 111.109 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.0 16.99 15.06 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.048 -0.523 . . . . 65.439999999999998 112.963 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 61.8 t -83.65 130.66 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.897 0.379 . . . . 73.129999999999995 111.094 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.54 152.61 25.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.252 -0.431 . . . . 60.43 111.811 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -40.62 111.97 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.786 0.435 . . . . 64.120000000000005 111.725 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.9 -17.11 7.71 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.401 -0.428 . . . . 73.319999999999993 112.501 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 -33.44 7.91 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.213 -0.518 . . . . 53.310000000000002 113.278 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -33.01 71.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.328 0.492 . . . . 74.329999999999998 112.328 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -68.06 -5.37 17.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.086 0.47 . . . . 73.349999999999994 112.009 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 89.7 m -141.37 81.94 14.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.271 -0.422 . . . . 75.140000000000001 110.444 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.13 -16.21 16.34 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.125 2.55 . . . . 63.439999999999998 113.461 -175.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -59.11 -31.21 68.72 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.728 0.299 . . . . 72.319999999999993 111.665 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.3 t -82.7 -23.91 33.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.732 0.301 . . . . 74.530000000000001 111.215 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.69 -44.86 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.975 0.417 . . . . 75.510000000000005 110.456 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 76.48 -76.53 1.5 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.147 -0.478 . . . . 74.319999999999993 113.389 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -121.3 129.2 52.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.945 0.402 . . . . 73.140000000000001 111.445 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -152.82 145.0 16.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.264 0.468 . . . . 72.439999999999998 112.264 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -90.07 124.86 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.928 2.419 . . . . 53.520000000000003 112.974 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.92 176.6 25.72 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.003 -0.618 . . . . 72.140000000000001 113.39 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.5 tp -97.48 132.12 43.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 74.0 110.868 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 24.5 t-20 -95.03 143.36 26.56 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.388 -0.369 . . . . 72.129999999999995 111.14 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -84.77 -55.79 3.92 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.607 0.595 . . . . 74.519999999999996 112.607 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -64.63 -56.0 16.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.229 0.455 . . . . 71.530000000000001 112.229 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 p -81.45 -17.06 50.09 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.88 0.326 . . . . 70.409999999999997 111.88 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 77.1 mtp180 61.64 18.11 9.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.004 0.522 . . . . 73.439999999999998 112.406 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.424 ' HB2' HD12 ' A' ' 23' ' ' LEU . 96.5 mt-30 -86.53 164.68 16.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.256 0.551 . . . . 72.439999999999998 111.904 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -128.92 131.58 47.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.896 -0.593 . . . . 75.120000000000005 110.666 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.23 -170.28 43.31 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.381 -0.914 . . . . 64.409999999999997 113.764 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.18 123.19 33.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.424 0.29 . . . . 62.210000000000001 110.941 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.83 151.3 77.95 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.662 0.268 . . . . 61.200000000000003 111.432 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 88.1 Cg_endo -77.29 120.43 5.31 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.486 2.124 . . . . 64.549999999999997 112.91 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.64 16.17 6.83 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.391 -0.433 . . . . 61.200000000000003 113.943 -178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -81.3 -20.65 40.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.251 -0.558 . . . . 70.340000000000003 111.615 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -104.88 12.3 32.67 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.368 0.507 . . . . 74.209999999999994 112.368 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.516 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 33.2 m -121.95 146.03 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 113.366 0.876 . . . . 71.329999999999998 113.366 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 5.8 mm-40 -93.68 130.74 39.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.605 -0.725 . . . . 71.430000000000007 111.524 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -70.36 100.21 1.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.041 0.448 . . . . 75.450000000000003 110.416 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.416 HD13 ' HB2' ' A' ' 10' ' ' ARG . 64.0 mt -74.8 -47.69 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.365 -0.38 . . . . 64.099999999999994 111.376 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.78 177.02 22.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.639 -0.791 . . . . 64.450000000000003 113.885 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' A' ' 4' ' ' PRO . 5.5 Cg_exo -80.27 137.61 12.06 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.545 2.83 . . . . 74.200000000000003 112.871 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.715 HD13 ' HG3' ' A' ' 8' ' ' GLN . 5.8 mp -80.11 148.32 31.04 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.869 0.366 . . . . 71.420000000000002 111.634 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.807 -0.616 . . . . 75.420000000000002 111.208 176.638 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.736 0.303 . . . . 72.439999999999998 111.501 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.14 -158.19 0.27 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 116.601 -0.272 . . . . 73.409999999999997 111.628 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.49 -82.21 0.05 OUTLIER Glycine 0 CA--C 1.537 1.463 0 C-N-CA 119.96 -1.115 . . . . 53.140000000000001 115.302 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.96 16.01 0.15 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.183 2.589 . . . . 73.349999999999994 116.457 -167.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -62.78 -31.38 72.33 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.809 0.731 . . . . 72.310000000000002 111.002 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.17 -174.73 42.03 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.608 -0.723 . . . . 64.219999999999999 112.166 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -131.55 146.15 52.08 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.129 0.49 . . . . 75.209999999999994 111.946 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.574 HE21 ' HB3' ' A' ' 81' ' ' LEU . 77.9 mt-30 -101.43 128.33 47.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.048 -0.524 . . . . 74.25 111.416 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.37 128.15 53.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.318 -0.401 . . . . 72.040000000000006 110.715 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.544 ' HB2' HD13 ' A' ' 78' ' ' LEU . 55.8 ttp180 -98.11 120.97 39.45 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.144 0.424 . . . . 72.109999999999999 112.144 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' HB2' ' HB2' ' A' ' 29' ' ' ASP . . . -74.07 114.72 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.229 -0.441 . . . . 74.230000000000004 111.313 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -82.21 -43.67 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.17 0.433 . . . . 75.150000000000006 112.17 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.65 140.93 28.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 N-CA-C 112.122 0.416 . . . . 61.329999999999998 112.122 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.52 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 35.5 Cg_endo -65.74 123.59 11.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.444 2.096 . . . . 60.130000000000003 112.935 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -116.38 113.6 23.12 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 111.313 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -89.2 147.61 24.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.471 -0.332 . . . . 75.140000000000001 110.401 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.611 ' HG2' ' HB2' ' A' ' 22' ' ' ASP . 29.3 tpt180 -119.23 124.34 46.5 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.753 0.311 . . . . 73.530000000000001 111.144 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.75 -28.07 67.06 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.213 0.53 . . . . 71.120000000000005 111.472 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -117.37 113.25 38.93 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.4 -0.364 . . . . 70.310000000000002 110.272 174.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.09 6.58 0.17 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.196 2.597 . . . . 72.420000000000002 114.551 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -71.93 -24.28 61.6 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.945 0.35 . . . . 72.040000000000006 111.945 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.611 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 6.0 m-20 -94.53 -169.72 2.1 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.753 0.311 . . . . 74.299999999999997 111.381 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 61' ' ' ASN . 45.9 tp -107.8 119.63 39.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 73.439999999999998 111.78 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.53 142.41 30.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.431 -0.35 . . . . 64.200000000000003 110.84 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 66.2 mt -116.16 141.96 47.45 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.128 0.418 . . . . 74.530000000000001 112.128 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.86 153.51 46.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 122.721 0.408 . . . . 63.119999999999997 110.766 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.52 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 29.5 Cg_endo -61.69 117.21 4.01 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.602 2.202 . . . . 74.219999999999999 113.206 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.28 16.85 33.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.154 -0.476 . . . . 62.140000000000001 113.826 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.514 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 9.6 m-20 -77.22 135.67 38.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.877 0.695 . . . . 74.319999999999993 112.877 178.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.24 97.06 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.15 0.5 . . . . 70.310000000000002 110.24 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.462 HD11 ' N ' ' A' ' 31' ' ' LEU . 6.6 mp -81.98 132.89 35.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.097 0.475 . . . . 73.109999999999999 111.902 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG13 HD23 ' A' ' 81' ' ' LEU . 66.8 t -94.05 109.41 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.047 -0.524 . . . . 73.329999999999998 111.142 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 117.91 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.011 0.434 . . . . 70.040000000000006 111.281 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.7 p -68.02 141.46 56.21 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.801 0.334 . . . . 73.0 111.519 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -67.01 -23.75 65.95 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.023 0.44 . . . . 74.040000000000006 110.803 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.24 89.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.182 -0.463 . . . . 70.340000000000003 111.191 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.93 -44.16 97.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.38 . . . . 73.549999999999997 111.288 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.84 -45.14 90.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.983 0.421 . . . . 73.329999999999998 110.654 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -59.77 -40.39 88.08 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.239 -0.437 . . . . 71.230000000000004 111.265 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.23 79.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.028 0.442 . . . . 64.340000000000003 111.537 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.18 -17.63 60.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.159 -0.473 . . . . 74.230000000000004 111.192 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 18.18 38.04 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.499 -0.382 . . . . 63.340000000000003 113.396 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.57 114.43 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.024 0.379 . . . . 71.430000000000007 112.024 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.59 151.04 20.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.383 -0.371 . . . . 74.030000000000001 111.098 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 146.05 5.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.278 0.561 . . . . 75.340000000000003 111.794 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.14 -26.3 24.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.77 -0.532 . . . . 74.010000000000005 111.77 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.86 1.47 17.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.508 -0.377 . . . . 71.219999999999999 112.673 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -38.41 90.98 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.089 0.471 . . . . 73.439999999999998 111.611 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -81.5 9.84 6.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.291 0.478 . . . . 72.239999999999995 112.291 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.0 m -122.39 72.9 39.26 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 120.85 0.357 . . . . 75.340000000000003 111.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.446 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 34.1 Cg_endo -63.66 -23.08 70.01 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.67 2.247 . . . . 74.019999999999996 112.773 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.44 -34.56 69.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.314 -0.403 . . . . 74.400000000000006 111.357 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -71.77 -41.61 68.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.93 0.395 . . . . 73.120000000000005 111.229 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.46 -38.33 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.123 -0.49 . . . . 74.310000000000002 111.594 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.95 -79.06 0.88 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.244 -0.503 . . . . 73.129999999999995 112.913 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -121.14 142.36 49.94 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.674 -0.309 . . . . 71.540000000000006 110.9 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 56.6 mtm -138.88 140.68 27.85 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.247 -0.283 . . . . 72.230000000000004 111.488 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.19 117.51 2.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.584 2.189 . . . . 75.030000000000001 112.524 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.72 178.26 26.41 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.732 -0.747 . . . . 73.200000000000003 113.77 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.24 132.67 50.25 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.961 0.41 . . . . 74.030000000000001 111.733 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.512 ' HB2' HD23 ' A' ' 23' ' ' LEU . 26.9 t-20 -99.98 149.25 23.64 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 111.348 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -92.01 -35.78 13.76 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.587 0.588 . . . . 74.310000000000002 112.587 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.409 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 13.8 tpp180 -56.72 -51.61 68.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.204 0.526 . . . . 75.209999999999994 111.315 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.9 p -100.14 -15.04 18.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.688 -0.687 . . . . 75.430000000000007 111.885 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.428 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtp180 64.2 18.08 11.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.795 0.438 . . . . 73.439999999999998 112.131 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -103.39 157.5 16.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.151 0.501 . . . . 73.019999999999996 112.228 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 67' ' ' ARG . 19.5 mtp180 -98.3 149.68 22.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.206 -0.452 . . . . 74.019999999999996 111.247 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.27 -178.72 47.62 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.93 -0.652 . . . . 74.120000000000005 112.894 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.13 124.99 40.35 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.595 0.236 . . . . 74.519999999999996 110.752 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -123.65 143.0 40.59 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 120.838 0.351 . . . . 65.549999999999997 111.668 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.66 116.07 4.24 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.659 2.239 . . . . 75.420000000000002 112.361 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.446 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -59.59 -17.57 41.5 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.715 0.646 . . . . 64.549999999999997 114.715 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.402 HG21 ' CD1' ' A' ' 74' ' ' TYR . 3.4 t -57.0 -32.46 66.14 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.799 0.666 . . . . 62.399999999999999 112.799 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.402 ' CD1' HG21 ' A' ' 73' ' ' THR . 95.9 m-85 -81.31 -16.9 51.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.663 0.616 . . . . 74.400000000000006 112.663 -177.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -108.92 145.42 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.419 0.526 . . . . 74.420000000000002 112.419 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.53 154.71 24.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.058 -0.519 . . . . 63.509999999999998 110.857 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.07 126.51 33.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.824 0.345 . . . . 73.519999999999996 111.612 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 10' ' ' ARG . 83.9 mt -100.03 -68.11 0.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.232 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.83 -178.69 46.78 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 60.549999999999997 113.103 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.84 166.21 30.61 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.293 2.662 . . . . 73.200000000000003 113.233 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.574 ' HB3' HE21 ' A' ' 8' ' ' GLN . 3.4 pp -127.62 151.18 49.25 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.306 0.484 . . . . 75.209999999999994 112.306 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.254 1.317 0 CA-C-O 118.328 -0.844 . . . . 74.340000000000003 112.04 179.016 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.588 0.232 . . . . 72.299999999999997 111.077 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.16 149.35 10.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.704 0.287 . . . . 75.340000000000003 111.73 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -120.87 91.12 0.48 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.54 -0.362 . . . . 55.219999999999999 112.832 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.644 ' HD2' HD22 ' A' ' 81' ' ' LEU . 60.4 Cg_endo -70.36 176.1 7.68 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.757 2.305 . . . . 75.340000000000003 114.105 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 12.3 mm-40 -77.35 12.59 1.46 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.519 -0.764 . . . . 73.219999999999999 112.576 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . -91.39 -167.5 40.91 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.999 -0.619 . . . . 44.240000000000002 114.421 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.54 147.86 43.97 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.988 0.423 . . . . 73.310000000000002 111.412 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.465 ' HG2' HG22 ' A' ' 32' ' ' VAL . 45.9 mt-30 -92.75 133.11 36.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.899 0.38 . . . . 75.140000000000001 111.258 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -118.38 139.16 51.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.293 -0.412 . . . . 75.0 110.661 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.493 ' HB2' HD11 ' A' ' 78' ' ' LEU . 36.1 ttm180 -107.99 127.69 53.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.947 -0.47 . . . . 74.120000000000005 111.984 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.37 128.2 33.99 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.457 -0.338 . . . . 74.430000000000007 110.592 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.6 mt -68.28 -62.15 1.53 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.372 0.606 . . . . 74.219999999999999 111.821 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.54 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.0 m-85 -118.19 171.91 4.67 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.979 -0.555 . . . . 73.430000000000007 110.314 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -70.8 117.73 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 120.902 1.068 . . . . 74.540000000000006 111.261 170.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.498 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 83.8 m-85 -112.86 122.1 46.65 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.306 0.574 . . . . 73.340000000000003 111.763 -177.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -82.76 153.93 25.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.238 -0.892 . . . . 64.329999999999998 111.901 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -116.73 154.81 29.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.903 0.382 . . . . 75.140000000000001 111.501 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.1 -42.33 84.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.898 0.38 . . . . 73.129999999999995 111.653 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 62.0 mtp85 -121.98 147.76 49.72 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.509 -0.314 . . . . 73.340000000000003 111.162 -177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.5 -2.15 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.976 2.451 . . . . 75.019999999999996 112.844 178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -80.38 -16.13 55.22 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.254 0.55 . . . . 64.340000000000003 111.355 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.81 -165.21 1.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.991 -0.55 . . . . 74.329999999999998 111.305 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 tp -125.13 123.7 40.25 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.888 0.375 . . . . 72.319999999999993 110.936 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mp0 -75.95 155.8 34.76 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.006 0.432 . . . . 73.140000000000001 111.393 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 97.5 mt -112.12 143.05 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.48 -0.327 . . . . 75.420000000000002 111.277 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.66 154.34 46.74 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 122.596 0.359 . . . . 74.219999999999999 111.116 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 120.45 7.97 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.454 2.102 . . . . 75.450000000000003 113.207 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.07 69.9 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.165 -0.47 . . . . 73.329999999999998 113.58 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.82 155.57 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.377 -0.484 . . . . 72.519999999999996 111.349 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.35 129.57 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.233 0.539 . . . . 71.239999999999995 112.056 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 4.9 mp -124.37 121.31 34.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.112 -0.494 . . . . 74.310000000000002 110.527 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG13 HD12 ' A' ' 81' ' ' LEU . 48.9 t -94.12 124.09 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.332 0.493 . . . . 70.239999999999995 112.332 -175.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.97 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 120.979 0.418 . . . . 62.229999999999997 111.265 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.462 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 50.5 m -68.28 142.39 55.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.993 0.368 . . . . 74.049999999999997 111.993 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 57.1 mtm180 -60.55 -30.43 69.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.986 0.422 . . . . 74.209999999999994 111.452 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.4 81.32 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.131 0.491 . . . . 74.310000000000002 111.009 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.83 98.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.114 -0.494 . . . . 72.349999999999994 111.298 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.3 mt -56.84 -46.82 81.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.918 0.39 . . . . 75.230000000000004 111.021 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.64 -39.69 92.22 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.396 -0.366 . . . . 74.510000000000005 111.442 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.94 91.45 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.952 0.406 . . . . 74.439999999999998 111.005 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.506 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -66.77 -28.63 68.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.234 -0.439 . . . . 75.150000000000006 111.462 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.31 27.6 9.15 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.424 -0.417 . . . . 61.25 113.042 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.3 118.48 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.96 0.41 . . . . 70.439999999999998 111.097 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.52 149.81 29.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.305 -0.407 . . . . 73.319999999999993 111.866 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.18 119.19 6.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.01 0.434 . . . . 74.400000000000006 111.086 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.77 -4.82 18.97 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.049 -0.523 . . . . 64.299999999999997 112.327 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.04 -33.28 2.41 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.697 -0.287 . . . . 63.420000000000002 113.1 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -21.19 28.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.989 0.515 . . . . 74.230000000000004 112.222 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.81 -21.25 41.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.416 -0.356 . . . . 63.530000000000001 111.714 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.54 88.42 29.21 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.664 0.269 . . . . 72.420000000000002 110.951 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.69 -16.94 26.82 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.98 2.454 . . . . 62.229999999999997 113.318 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -57.64 -22.39 45.33 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.818 0.342 . . . . 64.420000000000002 111.889 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.0 t -77.81 -9.75 59.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.798 0.333 . . . . 74.010000000000005 111.813 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 t -106.55 -37.81 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.085 0.469 . . . . 74.310000000000002 111.626 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.43 -78.19 0.84 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.227 -0.511 . . . . 64.129999999999995 112.798 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.41 54.58 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.087 0.47 . . . . 74.120000000000005 111.223 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 71.1 mtp -139.49 139.39 22.37 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.221 -0.445 . . . . 74.349999999999994 111.623 -172.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.506 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.1 Cg_endo -82.16 117.4 2.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.304 2.003 . . . . 73.409999999999997 112.464 174.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.55 171.55 25.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.775 -0.726 . . . . 65.030000000000001 113.697 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 40.0 tp -96.74 109.15 21.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.594 0.358 . . . . 71.120000000000005 111.043 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -79.72 116.61 20.0 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.46 -0.336 . . . . 71.109999999999999 111.546 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.9 -21.49 63.3 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.733 0.642 . . . . 72.420000000000002 112.733 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 0.9 OUTLIER -60.58 -35.58 76.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.04 0.448 . . . . 73.540000000000006 111.325 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -119.57 -8.6 9.95 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.353 -0.385 . . . . 75.530000000000001 111.918 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 62.35 17.61 9.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 73.420000000000002 111.685 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -107.07 154.31 21.33 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.307 0.575 . . . . 72.310000000000002 111.931 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -101.18 134.67 43.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.948 -0.569 . . . . 72.239999999999995 111.219 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.0 172.11 34.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.979 -0.629 . . . . 73.109999999999999 112.985 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.7 113.18 25.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.906 0.384 . . . . 72.430000000000007 110.482 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -121.52 149.27 52.22 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.414 -0.357 . . . . 72.25 111.493 -177.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 18.1 Cg_exo -66.29 95.15 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.355 2.037 . . . . 74.409999999999997 112.638 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.18 -19.69 40.0 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.085 -0.507 . . . . 63.030000000000001 113.534 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.0 t -61.79 -15.1 38.72 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.389 0.514 . . . . 63.219999999999999 112.389 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.446 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 35.8 m-85 -102.06 -1.54 31.44 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.623 0.601 . . . . 71.010000000000005 112.623 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.99 163.89 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.187 0.518 . . . . 74.140000000000001 112.153 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.08 148.75 41.25 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.106 -0.497 . . . . 73.510000000000005 111.714 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -79.02 118.22 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.071 -0.513 . . . . 75.019999999999996 111.642 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 10' ' ' ARG . 70.9 mt -89.97 -66.26 0.94 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 73.150000000000006 111.087 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.19 39.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.135 -0.555 . . . . 72.25 113.188 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.4 152.38 38.88 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.85 2.366 . . . . 61.310000000000002 113.083 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.644 HD22 ' HD2' ' A' ' 4' ' ' PRO . 4.9 mp -80.79 112.48 18.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.883 0.373 . . . . 75.200000000000003 111.201 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.874 -0.584 . . . . 73.420000000000002 110.113 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.719 0.295 . . . . 73.120000000000005 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.0 -71.11 0.15 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.24 0.459 . . . . 62.219999999999999 112.24 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 160.45 179.14 35.02 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.724 -0.751 . . . . 52.450000000000003 113.334 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.54 90.98 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.177 2.585 . . . . 74.019999999999996 113.066 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 mp0 -57.43 -29.77 64.44 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.396 0.517 . . . . 62.140000000000001 112.396 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.72 -172.75 44.51 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.879 -0.677 . . . . 73.040000000000006 113.328 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.22 171.3 12.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.093 0.473 . . . . 74.340000000000003 111.358 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.91 136.81 49.92 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.19 0.519 . . . . 53.32 111.811 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 94.5 m-85 -116.05 170.74 8.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.852 -0.613 . . . . 71.319999999999993 110.601 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.4 ttm180 -135.75 128.69 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.569 0.223 . . . . 63.130000000000003 111.275 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -66.08 114.67 5.4 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 63.119999999999997 111.858 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.45 -58.33 3.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.167 -0.47 . . . . 75.409999999999997 111.569 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.67 150.21 44.38 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.595 -0.275 . . . . 74.049999999999997 111.228 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 56.3 Cg_endo -70.91 118.05 5.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.16 1.906 . . . . 75.099999999999994 112.657 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.417 ' HZ ' ' NH2' ' A' ' 17' ' ' ARG . 87.4 t80 -121.44 133.3 55.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 72.549999999999997 110.979 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 16' ' ' ARG . 45.1 mtm180 -125.71 159.04 33.31 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.179 0.514 . . . . 73.310000000000002 111.598 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' NH2' ' HZ ' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -122.53 145.54 48.24 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.951 -0.568 . . . . 74.209999999999994 109.854 177.816 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.81 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 10.1 pt-20 -58.9 -21.48 57.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.053 0.454 . . . . 72.430000000000007 111.585 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.81 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 81.1 mtt180 -129.08 153.1 80.29 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.251 -0.431 . . . . 75.340000000000003 110.476 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.56 6.51 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.643 2.228 . . . . 74.439999999999998 113.032 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.19 -54.03 51.55 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.899 0.48 . . . . 44.43 112.116 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -84.76 -179.92 7.21 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.836 0.35 . . . . 60.520000000000003 111.042 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.7 tp -100.73 119.8 39.15 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.908 0.385 . . . . 74.5 111.161 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.56 138.15 37.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.409 -0.36 . . . . 75.129999999999995 110.799 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 70' ' ' PHE . 69.0 mt -122.69 138.7 54.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.866 0.365 . . . . 64.310000000000002 111.898 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.537 ' HB2' ' NE ' ' A' ' 63' ' ' ARG . 3.9 mm? -122.11 140.73 32.86 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 122.666 0.386 . . . . 71.019999999999996 110.568 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.91 106.31 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.423 2.082 . . . . 72.340000000000003 113.257 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.56 -1.05 8.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.086 0.794 . . . . 75.010000000000005 115.086 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.79 156.4 16.39 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.703 1.252 . . . . 70.400000000000006 111.903 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -101.87 133.71 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.755 -0.657 . . . . 70.409999999999997 111.401 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.1 mp -106.59 110.28 22.44 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.014 -0.539 . . . . 74.5 110.591 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.51 120.18 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.907 0.384 . . . . 73.310000000000002 111.832 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.93 135.27 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.388 -0.369 . . . . 64.040000000000006 111.473 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.7 p -91.96 148.22 22.37 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.247 -0.283 . . . . 53.030000000000001 111.283 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 24.7 ptt180 -58.43 -28.43 65.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.953 0.353 . . . . 64.140000000000001 111.953 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.35 -39.48 70.1 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.924 0.392 . . . . 63.549999999999997 111.639 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.12 77.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 72.310000000000002 111.33 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.84 -42.48 93.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 63.020000000000003 111.211 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -61.9 -39.07 90.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.3 -0.409 . . . . 75.299999999999997 111.185 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.03 96.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.945 0.402 . . . . 71.540000000000006 111.346 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.403 HD13 ' HD2' ' A' ' 58' ' ' PRO . 84.2 mt -66.69 -24.72 66.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.177 0.513 . . . . 73.010000000000005 111.084 175.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.13 20.68 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.879 -0.601 . . . . 45.210000000000001 113.177 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.0 125.03 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.946 0.373 . . . . 62.340000000000003 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.38 131.2 45.24 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.577 -0.283 . . . . 63.329999999999998 111.491 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.06 126.96 28.24 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.326 0.584 . . . . 74.510000000000005 111.188 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.1 -2.89 51.36 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.071 -0.513 . . . . 74.099999999999994 112.157 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.87 -7.73 16.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.64 -0.314 . . . . 62.43 113.312 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -20.07 63.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.008 0.432 . . . . 75.129999999999995 111.732 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -71.2 -13.7 62.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.463 -0.335 . . . . 74.439999999999998 111.738 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.77 84.58 31.66 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.829 0.347 . . . . 73.099999999999994 111.437 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.73 -27.19 68.24 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.504 2.136 . . . . 75.319999999999993 112.937 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.604 ' HG3' ' HA ' ' A' ' 73' ' ' THR . 22.0 mp0 -67.18 -17.47 64.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.102 0.477 . . . . 74.219999999999999 111.285 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.0 m -87.31 -25.21 24.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.303 -0.408 . . . . 75.109999999999999 111.415 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.08 -55.16 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.95 0.405 . . . . 73.510000000000005 111.609 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.8 -92.23 0.5 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.17 -0.538 . . . . 35.939999999999998 112.573 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -121.14 141.44 50.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 73.140000000000001 111.788 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.494 ' HE3' ' HA3' ' A' ' 72' ' ' GLY . 3.4 mpp? -138.17 146.9 53.76 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 116.534 -0.303 . . . . 62.149999999999999 110.948 177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' HD13 ' A' ' 41' ' ' LEU . 91.6 Cg_endo -79.19 126.65 7.1 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.341 2.028 . . . . 74.340000000000003 112.838 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.06 172.88 31.33 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.006 -0.616 . . . . 65.310000000000002 113.535 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.8 tp -97.47 119.12 35.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.263 0.225 . . . . 71.420000000000002 111.472 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.448 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.0 t-20 -90.95 121.42 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.573 -0.285 . . . . 71.140000000000001 110.593 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -73.65 -8.1 54.61 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.849 1.055 . . . . 74.239999999999995 113.849 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.537 ' NE ' ' HB2' ' A' ' 26' ' ' LEU . 57.7 mtt-85 -81.7 -54.39 5.42 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.569 -0.707 . . . . 75.239999999999995 111.117 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.411 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 64.3 p -86.81 -11.59 50.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.492 -0.322 . . . . 75.420000000000002 111.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.65 16.94 9.3 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.131 0.573 . . . . 74.439999999999998 111.681 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 64' ' ' THR . 68.3 mm-40 -107.41 152.84 23.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.049 0.452 . . . . 74.530000000000001 111.456 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 129.6 45.13 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.036 0.446 . . . . 73.540000000000006 111.199 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.91 173.62 34.56 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.156 -0.545 . . . . 73.430000000000007 113.146 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.41 118.82 28.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.903 0.382 . . . . 75.109999999999999 110.83 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.452 ' HB2' HD13 ' A' ' 25' ' ' LEU . 54.0 p90 -117.31 148.79 43.36 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.035 0.383 . . . . 75.340000000000003 112.035 -176.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.88 109.25 2.83 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.569 2.179 . . . . 74.040000000000006 112.347 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.494 ' HA3' ' HE3' ' A' ' 57' ' ' MET . . . -63.65 -17.95 60.89 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 115.079 0.791 . . . . 64.109999999999999 115.079 -173.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.604 ' HA ' ' HG3' ' A' ' 52' ' ' GLN . 12.6 t -65.55 -15.28 62.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.791 0.795 . . . . 54.420000000000002 112.408 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -99.79 2.98 44.56 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.126 0.417 . . . . 74.420000000000002 112.126 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.5 m -123.98 153.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.002 0.429 . . . . 72.209999999999994 112.102 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 12.9 pt-20 -100.38 154.59 18.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.474 -0.33 . . . . 54.240000000000002 111.304 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -89.93 113.74 25.43 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.722 0.296 . . . . 64.239999999999995 111.102 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.12 -61.72 1.7 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.981 0.419 . . . . 74.219999999999999 111.526 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.23 -155.01 26.1 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.241 -0.504 . . . . 73.239999999999995 112.784 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.33 152.62 39.49 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.7 2.266 . . . . 74.329999999999998 113.176 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.3 161.06 15.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.75 0.648 . . . . 70.519999999999996 112.75 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.352 -0.833 . . . . 73.319999999999993 111.74 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.043 0.449 . . . . 72.329999999999998 111.479 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.49 -64.23 1.31 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.002 -0.545 . . . . 74.450000000000003 110.496 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 76.12 -124.84 7.5 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 114.502 0.561 . . . . 72.209999999999994 114.502 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 13.1 Cg_exo -71.05 24.96 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 123.663 2.908 . . . . 74.439999999999998 115.0 -173.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -58.41 -30.92 67.24 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.208 0.527 . . . . 64.109999999999999 111.163 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.6 -168.51 34.76 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.0 -0.545 . . . . 73.239999999999995 112.727 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.14 135.55 49.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.965 0.412 . . . . 74.099999999999994 111.085 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -97.76 136.1 38.58 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.319 0.58 . . . . 72.299999999999997 112.456 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -113.26 169.28 9.06 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.735 -0.666 . . . . 74.430000000000007 110.382 174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 16.1 ttm-85 -119.23 127.76 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.985 -0.447 . . . . 74.019999999999996 111.692 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB1' HD11 ' A' ' 31' ' ' LEU . . . -81.04 116.68 21.11 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.783 0.325 . . . . 64.040000000000006 110.564 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.09 -50.41 16.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 74.140000000000001 112.226 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -124.15 156.77 65.9 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 111.868 0.321 . . . . 74.040000000000006 111.868 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 55.9 Cg_endo -72.0 128.31 13.86 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.517 2.145 . . . . 75.019999999999996 113.496 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -124.97 123.4 39.8 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.037 -0.529 . . . . 74.030000000000001 110.915 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -110.53 133.81 52.95 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.127 -0.488 . . . . 74.299999999999997 110.163 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 5.5 mmt85 -134.22 117.52 16.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.961 0.726 . . . . 75.25 112.961 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.75 -26.47 68.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.768 -0.651 . . . . 73.540000000000006 110.784 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 19' ' ' ARG . 11.8 mmt180 -88.65 112.0 47.63 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.831 -0.622 . . . . 73.340000000000003 111.18 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.94 -2.24 4.37 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.865 2.376 . . . . 72.530000000000001 113.346 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.5 -39.22 79.44 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.106 0.479 . . . . 72.340000000000003 110.906 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.555 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 10.3 t70 -92.55 -154.41 0.38 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.759 -0.655 . . . . 72.319999999999993 109.281 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 61' ' ' ASN . 42.9 tp -156.0 137.78 14.31 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.448 -0.782 . . . . 74.099999999999994 112.407 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -57.62 105.9 0.29 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.746 0.307 . . . . 72.340000000000003 111.776 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.463 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.7 mt -106.84 142.43 36.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.851 0.357 . . . . 75.450000000000003 111.38 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.3 150.69 44.87 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.473 -0.33 . . . . 75.329999999999998 111.394 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 44.9 Cg_endo -66.8 115.96 3.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.381 2.054 . . . . 75.409999999999997 112.629 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.23 21.76 53.88 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.109 -0.567 . . . . 73.209999999999994 112.815 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.5 162.17 14.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.008 0.432 . . . . 74.349999999999994 111.175 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.17 131.87 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.231 0.538 . . . . 75.310000000000002 111.334 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD11 ' HB1' ' A' ' 11' ' ' ALA . 6.1 mp -108.07 116.84 32.69 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.876 0.37 . . . . 73.430000000000007 110.998 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 60.9 t -93.68 108.73 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.996 0.427 . . . . 75.540000000000006 111.654 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.88 128.76 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.339 -0.392 . . . . 74.099999999999994 110.697 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -71.28 147.33 48.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.968 0.413 . . . . 70.439999999999998 111.74 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -59.04 -35.48 73.38 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.969 0.414 . . . . 73.530000000000001 110.21 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.28 89.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 62.43 111.379 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.411 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -57.73 -47.87 81.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.842 0.353 . . . . 74.099999999999994 111.557 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.83 -45.24 94.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.695 0.284 . . . . 75.129999999999995 111.453 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.48 -37.87 82.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.874 0.368 . . . . 71.430000000000007 110.972 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.46 87.64 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.893 0.378 . . . . 72.5 111.401 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' A' ' 43' ' ' VAL . 90.8 mt -66.78 -20.16 65.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.986 0.422 . . . . 73.540000000000006 111.273 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.94 22.05 53.86 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.346 -0.454 . . . . 71.140000000000001 112.803 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 41' ' ' LEU . 60.3 t -68.43 104.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.036 0.446 . . . . 70.019999999999996 110.923 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 147.0 53.39 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.047 -0.524 . . . . 71.310000000000002 112.21 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -56.99 104.76 0.17 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.071 -0.513 . . . . 60.399999999999999 110.995 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.591 ' HA2' HH21 ' A' ' 49' ' ' ARG . . . 136.06 -18.77 3.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.877 -0.601 . . . . 64.150000000000006 112.372 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.18 -12.51 36.12 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.356 -0.449 . . . . 74.109999999999999 113.833 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -27.51 69.28 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.406 0.622 . . . . 74.099999999999994 111.331 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.591 HH21 ' HA2' ' A' ' 46' ' ' GLY . 36.1 mtm180 -80.27 9.15 6.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.963 -0.562 . . . . 74.129999999999995 112.069 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' NE2' ' A' ' 52' ' ' GLN . 50.0 t -138.37 75.2 39.73 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.16 0.505 . . . . 75.219999999999999 111.106 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.6 -34.4 74.84 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.687 2.258 . . . . 74.5 113.143 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.631 ' NE2' ' SG ' ' A' ' 50' ' ' CYS . 4.7 pp0? -64.88 -29.32 70.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.028 0.381 . . . . 74.420000000000002 112.028 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.495 ' HB2' ' SG ' ' A' ' 50' ' ' CYS . 31.7 t -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.848 0.356 . . . . 74.430000000000007 110.687 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.9 -40.26 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.925 0.393 . . . . 73.150000000000006 111.244 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.14 -133.09 11.39 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.2 -0.524 . . . . 75.219999999999999 113.456 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.511 ' HE3' ' HB3' ' A' ' 69' ' ' ASP . 37.3 m95 -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.011 0.434 . . . . 74.400000000000006 111.325 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.0 mtm -121.26 140.35 31.1 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.311 -0.404 . . . . 71.230000000000004 111.436 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.91 121.04 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.551 2.167 . . . . 74.430000000000007 112.657 175.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.46 170.23 27.55 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.722 -0.751 . . . . 71.409999999999997 113.98 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.81 132.16 43.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.802 0.441 . . . . 75.129999999999995 111.57 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.505 ' HB2' HD22 ' A' ' 23' ' ' LEU . 28.2 t-20 -88.6 116.45 26.85 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.48 -0.327 . . . . 72.209999999999994 110.698 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.51 -19.51 65.8 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.119 0.785 . . . . 73.450000000000003 113.119 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -73.55 -64.29 1.02 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.342 0.591 . . . . 72.519999999999996 111.536 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 78.7 p -89.01 -21.41 23.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.986 -0.552 . . . . 74.420000000000002 112.412 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 64' ' ' THR . 3.0 mpt_? 70.57 19.12 6.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.151 0.58 . . . . 74.439999999999998 111.832 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -86.25 134.6 33.75 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.344 -0.389 . . . . 71.010000000000005 110.611 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -95.02 126.51 40.41 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.54 -0.3 . . . . 75.120000000000005 110.884 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.81 -164.03 11.93 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.913 -0.66 . . . . 42.109999999999999 112.903 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.511 ' HB3' ' HE3' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -109.76 152.98 24.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.878 0.371 . . . . 72.340000000000003 110.926 176.763 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -154.24 138.36 11.08 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.391 -0.368 . . . . 72.430000000000007 111.3 178.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.454 ' HG3' ' CE2' ' A' ' 56' ' ' TRP . 13.6 Cg_exo -70.05 118.98 6.0 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.543 2.162 . . . . 74.349999999999994 112.132 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.56 9.15 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.572 0.589 . . . . 54.100000000000001 114.572 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -60.84 -16.67 43.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.036 0.754 . . . . 73.420000000000002 113.036 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.423 ' HE2' ' HG2' ' A' ' 71' ' ' PRO . 74.6 m-85 -98.37 -4.05 35.68 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.607 0.595 . . . . 72.450000000000003 112.607 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.85 160.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.432 0.53 . . . . 64.049999999999997 112.432 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 11.4 pt-20 -110.06 151.99 26.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.348 -0.387 . . . . 75.329999999999998 110.776 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -82.62 119.03 23.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.849 0.357 . . . . 75.150000000000006 111.195 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.55 -61.57 1.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 111.151 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.5 -169.16 33.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.179 -0.534 . . . . 74.120000000000005 113.088 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.72 173.24 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.611 2.207 . . . . 75.319999999999993 113.075 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 81' ' ' LEU . 6.0 mp -96.11 161.4 13.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 75.120000000000005 111.438 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.646 -0.692 . . . . 74.219999999999999 111.451 178.196 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtm . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.793 0.33 . . . . 75.140000000000001 110.615 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.81 168.68 10.66 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.39 0.615 . . . . 71.310000000000002 112.414 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.02 88.96 0.18 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.793 -0.639 . . . . 65.430000000000007 111.928 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -37.8 105.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.474 3.449 . . . . 74.010000000000005 114.713 -172.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.47 -33.19 12.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.047 -0.524 . . . . 74.340000000000003 110.749 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.17 156.24 16.04 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.305 0.482 . . . . 50.520000000000003 114.305 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -106.75 155.98 19.13 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.74 0.416 . . . . 73.420000000000002 110.945 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.48 123.28 46.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.824 0.676 . . . . 75.340000000000003 112.824 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.79 170.4 8.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.93 -0.577 . . . . 72.310000000000002 110.04 170.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -150.52 121.24 7.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.423 0.527 . . . . 74.430000000000007 112.423 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 151.48 29.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.345 0.593 . . . . 74.209999999999994 112.159 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.64 -29.41 12.33 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.284 0.476 . . . . 64.400000000000006 112.284 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -135.35 145.3 53.24 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-O 120.619 0.247 . . . . 74.340000000000003 111.329 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.547 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.0 Cg_endo -74.04 126.06 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.445 2.097 . . . . 75.349999999999994 113.902 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -143.04 112.01 6.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.05 -0.523 . . . . 75.150000000000006 110.681 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.77 142.16 47.28 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.039 -0.413 . . . . 73.200000000000003 110.825 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.675 ' HE ' ' HA ' ' A' ' 17' ' ' ARG . 0.4 OUTLIER -134.73 146.92 49.87 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.465 0.543 . . . . 74.010000000000005 112.465 -175.188 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.47 -35.65 53.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.301 -0.863 . . . . 73.239999999999995 110.976 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -81.03 142.12 51.32 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.858 -0.61 . . . . 65.540000000000006 111.738 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.54 5.87 1.45 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.806 2.337 . . . . 75.420000000000002 114.433 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.77 -8.89 59.19 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.315 0.487 . . . . 74.329999999999998 112.315 177.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -136.63 174.73 10.3 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.539 0.685 . . . . 75.140000000000001 112.552 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 58.6 tp -129.92 148.23 51.76 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.522 -0.763 . . . . 64.310000000000002 110.386 174.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.11 106.85 3.89 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.883 0.373 . . . . 74.299999999999997 111.936 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 91.8 mt -99.78 144.86 28.36 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 72.109999999999999 111.712 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD23 ' C ' ' A' ' 25' ' ' LEU . 4.1 mm? -123.74 155.69 66.11 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 122.889 0.475 . . . . 65.540000000000006 111.033 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.9 Cg_endo -70.61 107.9 2.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.217 1.944 . . . . 74.040000000000006 112.993 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.69 40.97 11.5 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.147 -0.549 . . . . 63.530000000000001 113.183 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -99.72 175.12 5.91 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.57 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -119.89 134.78 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.827 0.346 . . . . 63.100000000000001 110.732 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.06 122.24 42.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.647 0.261 . . . . 73.209999999999994 111.036 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.43 111.07 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.075 0.464 . . . . 74.319999999999993 111.242 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.457 HG22 ' HA3' ' A' ' 59' ' ' GLY . 48.2 t -111.73 119.2 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.455 -0.339 . . . . 71.299999999999997 111.529 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -58.95 127.1 30.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.764 -0.198 . . . . 64.019999999999996 111.077 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -52.27 -35.86 51.22 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.848 0.314 . . . . 74.109999999999999 111.848 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.44 65.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.535 -0.302 . . . . 52.329999999999998 111.799 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.949 0.404 . . . . 64.519999999999996 111.1 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 90.3 mt -62.77 -44.86 95.09 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.291 -0.413 . . . . 75.129999999999995 110.908 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.89 -23.87 66.73 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 111.514 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.86 54.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.11 0.481 . . . . 71.040000000000006 110.882 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.8 mt -68.39 -28.37 67.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.02 -0.536 . . . . 74.409999999999997 111.404 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.7 9.95 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.225 -0.443 . . . . 64.430000000000007 113.129 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.3 t -77.28 100.58 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.03 0.443 . . . . 75.030000000000001 111.144 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.3 149.91 37.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.227 -0.442 . . . . 71.340000000000003 112.127 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -46.16 129.91 10.14 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.144 -0.48 . . . . 75.439999999999998 111.58 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.82 -50.15 0.93 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.173 -0.467 . . . . 64.450000000000003 112.097 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -21.99 65.6 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.261 -0.495 . . . . 55.109999999999999 112.253 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.93 -31.2 27.75 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.415 0.686 . . . . 63.509999999999998 111.621 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -85.65 7.04 24.84 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.538 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.522 ' SG ' ' HG2' ' A' ' 52' ' ' GLN . 48.5 t -146.17 68.64 12.62 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 121.019 0.437 . . . . 74.400000000000006 110.92 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.79 -15.15 47.21 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.005 2.47 . . . . 74.099999999999994 113.259 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.522 ' HG2' ' SG ' ' A' ' 50' ' ' CYS . 20.2 pt20 -61.05 -19.46 61.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.367 -0.378 . . . . 75.239999999999995 111.886 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -81.89 -12.14 58.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.402 0.519 . . . . 74.439999999999998 112.402 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.38 -59.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.114 0.483 . . . . 73.239999999999995 111.747 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.06 -81.89 0.32 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.056 -0.593 . . . . 74.329999999999998 113.028 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.5 m0 -118.88 117.72 29.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.132 0.466 . . . . 74.409999999999997 111.638 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.442 ' N ' ' SD ' ' A' ' 57' ' ' MET . 2.7 mpp? -120.86 138.75 28.08 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.756 -0.202 . . . . 70.439999999999998 111.038 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.37 116.97 4.22 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 71.349999999999994 112.909 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.457 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -143.68 171.21 25.42 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.71 -0.757 . . . . 73.120000000000005 114.021 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.8 tp -103.89 123.23 46.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.687 0.395 . . . . 74.409999999999997 110.992 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -85.23 128.73 34.79 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.561 0.219 . . . . 70.540000000000006 111.447 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -80.64 0.86 32.38 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.385 0.883 . . . . 73.040000000000006 113.385 -177.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -100.78 -47.73 4.72 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.777 -0.577 . . . . 74.150000000000006 111.446 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -96.92 -24.97 15.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.24 0.459 . . . . 74.120000000000005 112.24 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 63.41 23.98 13.95 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.193 0.52 . . . . 75.549999999999997 111.77 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -94.32 142.96 26.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.98 -0.555 . . . . 72.400000000000006 110.545 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -99.98 128.45 46.06 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.356 -0.384 . . . . 71.129999999999995 111.344 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.06 -178.15 40.28 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.051 -0.595 . . . . 73.409999999999997 113.109 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.444 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 3.7 m-20 -95.29 109.64 21.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.895 0.379 . . . . 71.349999999999994 110.8 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -100.09 142.38 24.5 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 120.843 0.354 . . . . 74.409999999999997 111.936 -177.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.31 111.51 2.52 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.695 2.264 . . . . 63.119999999999997 112.922 177.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.515 ' HA2' HG21 ' A' ' 75' ' ' VAL . . . -64.86 -8.71 35.84 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.498 0.559 . . . . 54.299999999999997 114.498 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.3 p -78.62 -13.83 59.62 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.2 0.5 . . . . 75.530000000000001 111.971 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.3 6.13 20.29 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.268 0.47 . . . . 74.120000000000005 112.268 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.515 HG21 ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -128.1 141.19 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.038 0.447 . . . . 74.299999999999997 112.187 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -92.23 159.76 15.48 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.331 -0.395 . . . . 64.329999999999998 110.428 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -105.09 124.38 49.43 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.017 0.437 . . . . 75.230000000000004 111.559 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.72 -59.62 2.13 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.146 0.498 . . . . 74.430000000000007 111.094 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.88 -172.65 27.32 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.427 -0.416 . . . . 51.039999999999999 112.749 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.3 134.92 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.23 1.953 . . . . 71.409999999999997 112.147 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.0 161.52 21.3 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 71.530000000000001 113.014 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 C--O 1.253 1.26 0 CA-C-N 115.722 -0.672 . . . . 64.409999999999997 112.509 -177.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 111.684 0.253 . . . . 74.5 111.684 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.9 88.91 4.7 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.62 0.6 . . . . 64.420000000000002 112.62 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.83 -161.65 24.85 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.334 -0.46 . . . . 71.430000000000007 113.904 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.31 148.91 24.3 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.923 2.416 . . . . 74.519999999999996 113.02 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -78.12 14.85 1.04 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.817 0.673 . . . . 72.329999999999998 112.817 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.14 -134.64 0.52 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.063 -0.589 . . . . 65.530000000000001 113.064 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -139.8 155.33 47.33 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.317 -0.519 . . . . 73.120000000000005 111.14 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.441 ' HG3' HD11 ' A' ' 81' ' ' LEU . 48.3 mt-30 -112.36 136.62 51.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.3 0.571 . . . . 70.230000000000004 111.76 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 51' ' ' PRO . 87.9 m-85 -113.67 173.31 6.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.746 -0.661 . . . . 73.219999999999999 110.702 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -136.34 121.26 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.733 0.302 . . . . 74.430000000000007 111.372 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.464 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -70.92 125.5 27.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.026 0.441 . . . . 64.299999999999997 111.894 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.7 mt -81.21 -45.71 15.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.104 0.409 . . . . 73.200000000000003 112.104 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -137.33 158.5 72.18 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 116.467 -0.333 . . . . 75.409999999999997 111.061 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 37.8 Cg_endo -66.71 124.74 12.75 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.229 1.953 . . . . 73.140000000000001 113.377 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -125.94 122.4 35.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 74.030000000000001 110.77 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.416 ' HD2' ' C ' ' A' ' 16' ' ' ARG . 4.1 ppt_? -135.12 156.92 48.18 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.627 0.251 . . . . 73.219999999999999 110.932 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.544 HH21 ' HD3' ' A' ' 19' ' ' ARG . 43.4 mtp180 -131.89 153.41 50.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.531 0.682 . . . . 75.219999999999999 112.803 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -69.0 -39.47 79.32 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.36 -0.836 . . . . 73.420000000000002 110.957 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.544 ' HD3' HH21 ' A' ' 17' ' ' ARG . 57.9 mtp180 -84.96 121.64 74.26 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.902 -0.59 . . . . 74.109999999999999 110.898 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.49 5.87 1.43 Allowed 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 123.454 2.77 . . . . 74.299999999999997 115.247 -168.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -76.75 -22.41 53.85 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.086 0.402 . . . . 72.510000000000005 112.086 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.3 -163.46 0.89 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.785 0.326 . . . . 72.239999999999995 111.718 -175.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 61' ' ' ASN . 58.6 tp -135.54 119.59 17.56 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.862 0.363 . . . . 73.340000000000003 111.656 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -65.45 117.16 7.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.129 0.49 . . . . 71.140000000000001 111.769 176.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 55.1 mt -103.29 134.98 45.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 74.129999999999995 111.173 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.76 146.33 34.51 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 120.573 0.225 . . . . 74.239999999999995 110.989 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.04 125.04 14.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.396 2.064 . . . . 73.310000000000002 113.072 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.2 4.03 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 116.235 -0.439 . . . . 54.439999999999998 113.928 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -93.19 149.31 21.31 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 117.238 0.519 . . . . 75.510000000000005 111.105 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.59 132.5 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.321 0.582 . . . . 72.400000000000006 111.935 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.494 HD11 ' N ' ' A' ' 31' ' ' LEU . 4.9 mp -103.81 116.56 32.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.976 -0.556 . . . . 71.219999999999999 111.015 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.66 118.01 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.986 0.422 . . . . 65.420000000000002 111.672 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.65 120.47 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.938 0.399 . . . . 73.319999999999993 111.413 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -67.68 148.44 51.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.371 -0.377 . . . . 53.520000000000003 111.803 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 8.3 tpp180 -55.12 -47.35 75.15 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.453 -0.34 . . . . 73.120000000000005 111.544 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.34 -32.41 48.97 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.469 0.544 . . . . 75.010000000000005 112.469 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.48 73.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.883 0.373 . . . . 75.409999999999997 111.045 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD23 HD13 ' A' ' 41' ' ' LEU . 87.6 mt -65.18 -35.02 79.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.284 -0.416 . . . . 74.109999999999999 111.095 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 13.4 mm100 -60.58 -43.98 96.73 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.952 0.406 . . . . 72.409999999999997 110.699 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.32 -40.62 96.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.288 -0.415 . . . . 44.43 111.374 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.454 HD13 HD23 ' A' ' 38' ' ' LEU . 94.9 mt -62.98 -18.28 63.05 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.046 0.45 . . . . 73.549999999999997 111.343 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 38.71 20.94 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.088 -0.577 . . . . 73.230000000000004 112.639 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.45 122.83 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.016 0.436 . . . . 74.310000000000002 111.725 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.59 138.75 33.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.384 -0.371 . . . . 54.240000000000002 110.273 173.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.18 117.57 3.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.208 0.528 . . . . 63.240000000000002 111.471 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.57 5.68 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.808 -0.633 . . . . 62.420000000000002 112.182 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.18 -38.62 3.74 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.7 -0.286 . . . . 72.299999999999997 112.779 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -23.8 56.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.771 0.428 . . . . 75.109999999999999 111.668 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -54.99 -21.96 13.65 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.484 -0.326 . . . . 74.099999999999994 111.715 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.568 ' SG ' ' HB3' ' A' ' 53' ' ' SER . 22.1 p -115.84 81.5 9.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.966 0.412 . . . . 64.209999999999994 111.008 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.443 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 52.9 Cg_exo -54.94 -42.23 71.08 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.114 2.543 . . . . 75.140000000000001 113.183 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -60.97 -31.47 71.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.865 0.364 . . . . 75.319999999999993 111.371 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.568 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 39.3 t -73.79 -38.44 64.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.164 0.507 . . . . 74.109999999999999 111.095 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.23 -40.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.059 0.457 . . . . 75.530000000000001 110.995 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.67 -76.18 1.09 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.186 -0.53 . . . . 73.420000000000002 113.662 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -118.95 132.38 56.08 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.906 0.384 . . . . 74.200000000000003 111.33 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 68.5 mtm -144.91 131.98 10.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 O-C-N 122.208 -0.308 . . . . 72.299999999999997 111.668 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.444 ' HD2' HD11 ' A' ' 41' ' ' LEU . 97.2 Cg_endo -80.48 127.66 6.63 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.388 2.059 . . . . 75.239999999999995 112.502 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.79 176.69 34.02 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.634 -0.793 . . . . 74.030000000000001 113.614 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.73 131.29 55.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.573 0.349 . . . . 74.340000000000003 111.107 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 28.6 t-20 -96.67 149.17 22.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.457 -0.338 . . . . 74.340000000000003 111.002 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -91.98 -33.86 14.68 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.608 0.596 . . . . 71.409999999999997 112.608 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -64.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.153 0.501 . . . . 73.409999999999997 110.635 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 p -75.21 -21.5 58.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.406 -0.361 . . . . 72.319999999999993 111.474 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 17.5 mtp180 58.34 20.54 7.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.63 0.604 . . . . 74.219999999999999 112.63 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.33 163.89 12.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.311 0.577 . . . . 64.349999999999994 111.712 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -107.9 129.65 55.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.672 -0.694 . . . . 73.299999999999997 110.682 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.04 -172.37 34.2 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.261 -0.971 . . . . 73.25 113.875 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.2 t70 -115.61 109.37 17.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.767 0.427 . . . . 72.409999999999997 109.881 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.414 ' HB2' HD12 ' A' ' 25' ' ' LEU . 54.4 p90 -103.52 149.12 36.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 112.656 0.613 . . . . 73.420000000000002 112.656 -171.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.453 ' HB2' HG22 ' A' ' 73' ' ' THR . 74.2 Cg_endo -76.11 113.48 3.71 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.713 2.275 . . . . 75.019999999999996 112.412 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.01 -16.1 16.72 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.734 0.654 . . . . 70.319999999999993 114.734 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 71' ' ' PRO . 6.1 t -59.21 -33.38 70.9 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.343 0.572 . . . . 75.239999999999995 112.505 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.418 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 54.8 m-85 -89.49 5.03 47.25 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.905 0.706 . . . . 75.209999999999994 112.905 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.464 HG13 ' HA ' ' A' ' 11' ' ' ALA . 28.2 m -127.48 148.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.149 0.499 . . . . 73.540000000000006 112.222 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.85 146.44 28.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.121 -0.491 . . . . 73.0 110.401 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -78.34 128.64 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.908 0.385 . . . . 75.420000000000002 111.674 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.66 -67.53 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.929 0.395 . . . . 73.409999999999997 110.923 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.74 -174.06 41.42 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.035 -0.602 . . . . 43.149999999999999 113.093 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.99 -176.83 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.706 2.271 . . . . 74.200000000000003 112.745 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.441 HD11 ' HG3' ' A' ' 8' ' ' GLN . 4.6 mp -116.06 150.35 37.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 75.450000000000003 111.163 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 N-CA-C 112.449 0.537 . . . . 75.140000000000001 112.449 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.6 mmm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.818 0.342 . . . . 73.420000000000002 111.632 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.91 -27.69 43.86 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.222 0.535 . . . . 73.230000000000004 110.827 174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.64 -168.59 14.08 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.943 -0.572 . . . . 70.409999999999997 113.216 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.94 85.1 1.39 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.351 2.034 . . . . 75.420000000000002 112.377 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.79 -41.2 95.11 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.197 0.522 . . . . 73.530000000000001 111.426 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.15 167.1 26.52 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 116.032 -0.531 . . . . 54.329999999999998 112.707 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -119.94 160.92 21.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.302 0.572 . . . . 74.420000000000002 111.615 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.486 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 98.3 mt-30 -107.74 126.86 53.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.833 -0.621 . . . . 71.049999999999997 111.034 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.27 130.16 55.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.922 0.391 . . . . 73.109999999999999 110.674 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.542 ' HB2' HD13 ' A' ' 78' ' ' LEU . 37.1 ttt180 -97.59 123.32 41.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 111.846 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 25' ' ' LEU . . . -78.49 131.8 36.99 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.045 0.45 . . . . 72.319999999999993 110.978 176.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.27 -60.36 2.37 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.291 0.478 . . . . 64.140000000000001 112.291 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.513 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.6 m-85 -132.57 165.11 38.76 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.571 -0.286 . . . . 73.5 111.279 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 44.6 Cg_endo -68.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.813 1.675 . . . . 74.319999999999993 113.284 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.31 152.73 37.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.938 -0.574 . . . . 65.25 110.646 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.492 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 15.4 ptt180 -135.16 140.08 45.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.485 -0.325 . . . . 73.129999999999995 111.758 -175.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -113.06 153.5 28.04 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.118 0.485 . . . . 73.010000000000005 111.619 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.508 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 12.0 pt-20 -64.76 -37.8 88.84 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.185 0.439 . . . . 73.230000000000004 112.185 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.508 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 74.9 mtp180 -110.36 126.92 27.91 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 122.334 0.254 . . . . 73.120000000000005 111.647 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 17.3 Cg_exo -68.28 -1.65 7.61 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.048 2.499 . . . . 72.040000000000006 113.505 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.5 -21.81 61.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.333 0.587 . . . . 74.540000000000006 110.546 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.81 -143.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.554 -0.748 . . . . 73.010000000000005 109.363 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.509 HD22 ' HB2' ' A' ' 61' ' ' ASN . 18.9 tp -156.22 119.86 4.35 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.389 -0.819 . . . . 75.150000000000006 112.384 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.492 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 6.5 mp0 -65.22 151.92 44.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.328 0.585 . . . . 74.109999999999999 112.013 175.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.4 mt -118.31 134.51 54.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.818 -0.628 . . . . 63.020000000000003 110.34 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -114.94 154.99 47.02 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 120.828 0.347 . . . . 70.129999999999995 111.642 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.17 117.12 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.484 2.123 . . . . 72.230000000000004 113.22 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.68 79.83 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.2 -0.524 . . . . 73.230000000000004 113.304 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 63' ' ' ARG . 20.7 t0 -82.75 156.22 23.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.918 0.39 . . . . 72.409999999999997 111.782 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.7 t -117.36 118.89 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.103 0.477 . . . . 73.319999999999993 111.46 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -107.14 133.64 51.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.306 -0.406 . . . . 62.240000000000002 110.932 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.74 115.73 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.231 0.456 . . . . 74.450000000000003 112.231 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.38 118.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.835 0.35 . . . . 74.409999999999997 111.388 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -76.1 155.61 34.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.851 0.358 . . . . 70.409999999999997 111.947 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HA ' HD11 ' A' ' 38' ' ' LEU . 61.5 mtp180 -62.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.866 0.365 . . . . 74.140000000000001 110.369 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.47 80.75 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.914 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.62 86.34 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 71.099999999999994 110.909 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.454 HD11 ' HA ' ' A' ' 35' ' ' ARG . 95.8 mt -59.0 -49.18 78.89 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.207 -0.451 . . . . 73.200000000000003 111.355 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -61.76 -34.56 76.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.933 0.397 . . . . 75.019999999999996 111.101 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.37 -22.11 66.76 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.893 0.378 . . . . 71.439999999999998 111.539 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.507 HD11 ' HD2' ' A' ' 58' ' ' PRO . 96.4 mt -85.64 -5.66 59.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.707 0.289 . . . . 72.400000000000006 111.516 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.77 43.88 82.49 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.791 -0.719 . . . . 73.109999999999999 112.366 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 143.66 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.933 0.397 . . . . 74.329999999999998 111.338 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.39 150.94 48.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.113 -0.494 . . . . 75.409999999999997 112.208 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.93 101.5 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.307 0.575 . . . . 74.439999999999998 112.19 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . 99.29 -9.52 61.12 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 116.085 -0.507 . . . . 71.450000000000003 113.685 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 1.24 46.7 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.167 0.427 . . . . 60.130000000000003 114.167 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -60.25 -18.23 47.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.383 0.611 . . . . 52.109999999999999 111.723 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 8.0 ptt180 -84.91 8.46 17.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.653 -0.703 . . . . 65.299999999999997 112.162 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.6 m -133.66 76.86 65.51 Favored Pre-proline 0 N--CA 1.475 0.785 0 N-CA-C 112.302 0.482 . . . . 72.310000000000002 112.302 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.16 -32.89 62.6 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.656 2.237 . . . . 71.099999999999994 113.061 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.43 -37.66 84.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.939 0.399 . . . . 74.120000000000005 111.137 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.5 t -61.8 -39.95 93.51 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.257 -0.429 . . . . 73.219999999999999 111.661 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.439 HG13 HD12 ' A' ' 41' ' ' LEU . 45.3 t -75.75 -39.81 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.01 0.433 . . . . 74.209999999999994 111.546 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.22 -71.29 2.85 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.2 -0.524 . . . . 61.219999999999999 113.394 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -98.56 129.14 45.1 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.768 -0.254 . . . . 75.319999999999993 110.624 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 84.0 mtp -143.73 120.85 6.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 111.664 0.246 . . . . 72.519999999999996 111.664 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.526 ' HA ' ' HA ' ' A' ' 69' ' ' ASP . 87.0 Cg_endo -81.79 138.38 10.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.552 2.168 . . . . 74.439999999999998 112.375 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.17 176.77 40.81 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.743 -0.741 . . . . 73.010000000000005 113.199 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.0 tp -100.84 118.87 37.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.637 -0.331 . . . . 74.0 110.95 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.509 ' HB2' HD22 ' A' ' 23' ' ' LEU . 28.5 t-20 -87.78 100.31 12.75 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.93 -20.46 65.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.124 0.416 . . . . 73.340000000000003 112.124 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.1 tpt180 -58.83 -49.48 77.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.073 0.463 . . . . 74.140000000000001 111.31 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -110.45 -1.93 16.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.058 -0.519 . . . . 74.120000000000005 112.137 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 63.55 20.52 12.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.759 0.423 . . . . 73.219999999999999 111.661 -177.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -102.42 157.93 16.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.318 0.58 . . . . 61.039999999999999 111.792 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -103.8 151.25 23.28 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.96 -0.564 . . . . 75.409999999999997 110.501 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.66 -178.84 47.13 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.162 -1.018 . . . . 75.540000000000006 113.831 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.7 t70 -109.68 108.6 19.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.894 -0.41 . . . . 73.219999999999999 109.894 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 55.1 p90 -100.94 148.99 35.83 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 121.112 0.482 . . . . 72.310000000000002 112.253 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.5 101.1 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.436 2.091 . . . . 71.150000000000006 112.386 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.16 -17.45 30.73 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.242 0.457 . . . . 74.299999999999997 114.242 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -65.13 -14.2 59.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.731 0.641 . . . . 65.519999999999996 112.731 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.55 8.53 29.33 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.322 0.49 . . . . 65.430000000000007 112.322 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 m -125.22 155.86 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.157 0.503 . . . . 70.299999999999997 111.677 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -112.88 148.59 34.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.237 0.541 . . . . 64.219999999999999 111.51 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -78.16 119.25 21.28 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 111.046 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -90.17 -59.51 2.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.048 0.451 . . . . 73.329999999999998 111.291 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.23 -160.61 29.58 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.356 -0.449 . . . . 75.239999999999995 112.555 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.03 147.4 79.79 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.809 2.339 . . . . 71.430000000000007 112.775 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.486 ' HB3' ' HG3' ' A' ' 8' ' ' GLN . 1.6 pp -92.65 150.62 20.58 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.654 0.613 . . . . 71.5 112.654 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 . . . . . 0 C--O 1.253 1.241 0 CA-C-N 115.565 -0.743 . . . . 73.349999999999994 110.576 176.303 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 112.349 0.5 . . . . 72.409999999999997 112.349 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.84 96.02 1.6 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.099 0.476 . . . . 60.310000000000002 112.229 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.52 -67.1 0.29 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 116.168 -0.469 . . . . 51.439999999999998 112.037 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.92 101.48 1.16 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.76 2.307 . . . . 73.310000000000002 111.967 170.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -57.35 -30.06 64.52 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.05 0.759 . . . . 75.230000000000004 113.05 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.03 163.48 27.88 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.791 -0.719 . . . . 71.099999999999994 112.086 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -136.78 156.93 47.86 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.334 0.587 . . . . 75.439999999999998 112.185 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -121.89 133.36 54.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.577 -0.738 . . . . 65.230000000000004 110.975 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.484 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 97.8 m-85 -122.91 137.51 54.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.59 -0.277 . . . . 73.099999999999994 110.879 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.53 ' HB2' HD23 ' A' ' 78' ' ' LEU . 9.4 ttm180 -98.65 122.6 42.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.836 0.35 . . . . 74.120000000000005 110.585 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.51 16.66 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.951 0.352 . . . . 75.340000000000003 111.951 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.7 -46.82 8.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.813 0.34 . . . . 74.430000000000007 111.512 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.21 137.96 20.72 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 111.974 0.361 . . . . 62.439999999999998 111.974 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.535 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 73.0 Cg_endo -78.89 146.12 20.4 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.58 2.187 . . . . 64.450000000000003 113.418 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . 0.511 ' HB2' HD12 ' A' ' 25' ' ' LEU . 92.1 m-85 -143.12 128.96 19.42 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.203 -0.453 . . . . 75.030000000000001 110.828 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -136.05 114.78 12.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.147 0.499 . . . . 74.400000000000006 110.885 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 17' ' ' ARG . 14.9 mmt180 -116.73 148.75 40.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.014 -0.539 . . . . 74.400000000000006 112.271 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.24 26.95 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.243 1.021 . . . . 61.399999999999999 110.234 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.459 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 34.1 mmt180 -133.78 129.02 20.11 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.551 -0.75 . . . . 73.439999999999998 110.461 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.6 -4.65 15.02 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.878 2.385 . . . . 72.200000000000003 114.453 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 19' ' ' ARG . 21.2 mp0 -75.84 -38.9 57.58 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.981 -0.449 . . . . 74.439999999999998 110.583 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.77 -175.55 4.94 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.848 -0.615 . . . . 74.239999999999995 109.98 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 HD23 HD22 ' A' ' 25' ' ' LEU . 37.3 tp -132.29 136.11 46.7 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.719 -0.613 . . . . 74.109999999999999 112.286 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.44 117.75 13.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.569 -0.287 . . . . 73.209999999999994 110.66 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 15' ' ' PHE . 15.0 mt -135.7 136.39 40.82 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.848 0.684 . . . . 74.530000000000001 112.848 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.3 157.21 44.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.381 0.672 . . . . 73.510000000000005 110.655 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 21.9 Cg_exo -64.88 108.95 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.213 1.942 . . . . 63.520000000000003 112.633 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.19 15.35 14.44 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.462 -0.399 . . . . 73.409999999999997 113.993 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.4 151.35 30.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.182 0.491 . . . . 70.239999999999995 112.094 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.41 120.23 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.134 -0.484 . . . . 63.009999999999998 110.493 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.3 mp -103.37 124.08 48.03 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.814 0.34 . . . . 74.230000000000004 111.403 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG13 HD23 ' A' ' 81' ' ' LEU . 80.1 t -94.05 116.83 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.16 -0.473 . . . . 72.530000000000001 110.968 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.38 135.93 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.889 0.376 . . . . 71.140000000000001 111.229 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.1 p -86.82 133.78 33.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.698 0.285 . . . . 75.340000000000003 110.732 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -65.7 -25.4 67.3 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.097 -0.377 . . . . 75.310000000000002 111.07 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.25 -40.79 87.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.018 0.437 . . . . 74.530000000000001 111.19 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -62.73 -47.16 84.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.992 0.425 . . . . 74.209999999999994 111.029 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.53 -43.88 89.35 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 111.267 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -62.35 -38.26 88.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 111.124 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.76 68.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.002 0.43 . . . . 73.230000000000004 111.344 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 92.5 mt -81.54 -4.68 56.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.379 -0.373 . . . . 73.439999999999998 111.659 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.03 13.36 79.45 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.269 -0.491 . . . . 62.340000000000003 113.421 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.7 t -74.12 109.09 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.924 0.392 . . . . 74.040000000000006 111.531 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.78 148.29 44.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.982 0.42 . . . . 72.530000000000001 111.932 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.67 119.04 4.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.091 -0.504 . . . . 71.109999999999999 111.344 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.15 -14.16 16.26 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.481 -0.39 . . . . 64.340000000000003 112.234 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.52 -26.84 10.38 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.53 -0.367 . . . . 74.200000000000003 113.172 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -27.11 69.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.082 0.468 . . . . 73.209999999999994 111.791 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -67.41 -15.46 63.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.482 -0.326 . . . . 74.030000000000001 111.704 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.7 m -132.78 69.36 79.34 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 120.908 0.385 . . . . 51.030000000000001 110.661 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.51 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 29.1 Cg_endo -60.57 -21.57 69.2 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.101 2.534 . . . . 75.299999999999997 113.819 -172.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -55.82 -25.14 40.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.885 0.374 . . . . 72.340000000000003 111.945 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -77.71 -17.02 58.05 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.953 0.353 . . . . 65.409999999999997 111.953 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.15 -20.39 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.035 0.445 . . . . 72.409999999999997 111.524 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.67 -110.34 3.94 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.356 -0.449 . . . . 73.219999999999999 112.35 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -121.38 143.84 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.155 0.478 . . . . 71.120000000000005 110.995 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 46.7 mtm -134.44 149.42 71.04 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 111.89 0.329 . . . . 74.549999999999997 111.89 -173.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.37 123.21 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.594 2.196 . . . . 64.5 113.109 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.81 163.51 28.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.035 -0.602 . . . . 71.129999999999995 113.586 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.429 HD23 HH21 ' A' ' 65' ' ' ARG . 52.8 tp -107.22 124.7 50.13 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.556 0.342 . . . . 74.329999999999998 111.788 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -87.48 122.91 31.81 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.583 -0.28 . . . . 72.040000000000006 110.676 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -72.1 -15.0 61.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.56 0.948 . . . . 71.340000000000003 113.56 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -86.86 -67.95 0.78 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.675 -0.641 . . . . 71.099999999999994 111.246 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.3 p -71.56 -22.95 61.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.242 -0.435 . . . . 74.420000000000002 112.004 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.429 HH21 HD23 ' A' ' 60' ' ' LEU . 22.8 mmm-85 65.97 8.68 5.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.519 0.728 . . . . 71.129999999999995 112.286 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -78.53 149.49 33.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.845 0.355 . . . . 74.219999999999999 110.958 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -113.07 134.61 54.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.518 -0.31 . . . . 75.340000000000003 110.402 176.756 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.26 176.19 45.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.834 -0.698 . . . . 53.039999999999999 112.627 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.57 107.9 19.14 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.921 0.391 . . . . 73.310000000000002 110.518 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -97.45 140.15 21.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.553 -0.294 . . . . 75.349999999999994 111.46 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.06 116.69 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.549 2.166 . . . . 73.430000000000007 112.46 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.51 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -71.57 26.53 0.6 Allowed Glycine 0 CA--C 1.536 1.397 0 N-CA-C 114.61 0.604 . . . . 51.340000000000003 114.61 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -104.02 -32.14 9.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.538 0.669 . . . . 75.400000000000006 112.452 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.487 ' CZ ' HD11 ' A' ' 25' ' ' LEU . 20.9 p90 -88.59 4.81 45.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 111.859 0.318 . . . . 75.109999999999999 111.859 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 17.9 m -112.94 146.84 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.725 0.639 . . . . 72.400000000000006 112.725 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.488 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 9.4 pt-20 -102.98 138.67 39.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.62 -0.718 . . . . 54.329999999999998 110.146 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -75.41 115.32 14.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.833 0.349 . . . . 74.230000000000004 111.506 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.53 HD23 ' HB2' ' A' ' 10' ' ' ARG . 82.3 mt -85.3 -55.97 3.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.19 0.519 . . . . 73.030000000000001 111.481 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.02 -155.97 26.43 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.856 -0.611 . . . . 73.239999999999995 111.962 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.69 178.61 5.41 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.66 2.24 . . . . 74.450000000000003 113.17 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.484 HD23 HG13 ' A' ' 32' ' ' VAL . 94.5 mt -75.86 144.29 41.3 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.786 0.327 . . . . 73.329999999999998 111.723 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.692 -0.67 . . . . 73.239999999999995 111.515 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.782 0.325 . . . . 73.010000000000005 111.695 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.24 -80.56 0.45 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.715 0.293 . . . . 70.209999999999994 111.193 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.91 130.88 2.96 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.212 -0.518 . . . . 74.329999999999998 113.14 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.7 102.62 1.2 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.439 2.093 . . . . 65.019999999999996 112.708 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.4 -24.4 66.48 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.244 0.545 . . . . 73.430000000000007 111.193 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . -169.55 -155.62 10.14 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.901 -0.59 . . . . 71.510000000000005 112.82 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.99 155.99 38.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.194 0.521 . . . . 70.439999999999998 111.642 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.467 ' HG3' HD12 ' A' ' 81' ' ' LEU . 95.9 mt-30 -94.96 123.41 38.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.16 -0.473 . . . . 54.539999999999999 111.735 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.83 125.98 54.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.363 -0.381 . . . . 62.119999999999997 110.57 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.5 ' HB2' HD13 ' A' ' 78' ' ' LEU . 70.6 ttt180 -97.79 120.49 38.27 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.682 0.277 . . . . 72.400000000000006 111.725 -176.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -68.4 119.99 13.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 53.140000000000001 111.47 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.86 -59.89 2.49 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.321 0.489 . . . . 74.409999999999997 112.321 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -127.09 156.83 73.81 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 116.362 -0.381 . . . . 71.439999999999998 111.149 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.62 119.16 6.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.089 1.86 . . . . 74.129999999999995 113.044 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -121.82 111.75 17.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 72.109999999999999 111.029 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -89.21 125.76 35.21 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.206 0.526 . . . . 71.319999999999993 110.885 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.601 ' HG2' ' HB2' ' A' ' 22' ' ' ASP . 22.7 tpt180 -70.7 153.78 42.48 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.174 -0.329 . . . . 75.5 110.949 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -45.06 -49.67 11.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.247 0.546 . . . . 72.209999999999994 110.992 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -131.0 147.33 65.88 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.47 -0.786 . . . . 71.099999999999994 110.025 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -58.38 -5.49 2.34 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 122.842 2.361 . . . . 53.530000000000001 113.742 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -53.26 -41.66 65.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.218 0.607 . . . . 73.140000000000001 112.579 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.601 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 10.7 m-20 -91.19 -162.18 0.89 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.045 0.45 . . . . 73.329999999999998 111.579 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 23.8 tp -99.92 134.77 42.35 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.924 0.392 . . . . 73.400000000000006 111.256 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.75 140.57 42.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.901 0.381 . . . . 62.439999999999998 111.661 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.0 mt -100.75 131.36 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.612 0.597 . . . . 63.340000000000003 112.612 -173.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.16 148.99 41.89 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 122.721 0.408 . . . . 74.299999999999997 110.52 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.42 105.51 0.9 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.398 2.065 . . . . 72.230000000000004 113.168 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.42 -4.61 21.58 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.148 -0.549 . . . . 62.020000000000003 113.857 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 130.89 44.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.197 0.499 . . . . 73.209999999999994 111.916 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.9 105.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.905 -0.589 . . . . 74.540000000000006 110.721 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.7 mp -89.94 130.81 36.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.57 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.29 106.22 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.327 -0.397 . . . . 74.340000000000003 111.312 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.44 118.45 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.766 0.317 . . . . 61.210000000000001 110.819 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.433 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 87.3 p -69.41 140.91 54.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 65.0 111.846 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -60.27 -28.09 67.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.197 0.522 . . . . 74.340000000000003 110.702 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.4 -44.5 96.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.983 -0.553 . . . . 75.439999999999998 110.924 174.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.437 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.38 -45.45 91.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.839 0.352 . . . . 73.310000000000002 110.915 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 96.1 mt -54.23 -43.42 70.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.398 -0.365 . . . . 74.340000000000003 111.426 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.67 -42.47 92.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.453 -0.34 . . . . 70.030000000000001 111.283 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.27 92.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.045 0.45 . . . . 74.409999999999997 111.261 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 78.6 mt -66.55 -25.88 66.86 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.01 -0.541 . . . . 73.409999999999997 111.642 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.0 23.23 18.19 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.229 -0.51 . . . . 75.5 112.62 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.426 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.7 t -84.15 107.29 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.985 0.422 . . . . 72.099999999999994 111.054 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.58 149.84 46.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.069 -0.514 . . . . 74.150000000000006 111.901 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.8 113.92 3.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.023 -0.535 . . . . 73.340000000000003 110.852 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.55 -10.61 11.42 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.397 -0.43 . . . . 71.049999999999997 112.521 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.45 5.46 23.1 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.514 -0.374 . . . . 64.120000000000005 112.97 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.21 -23.75 65.77 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.223 0.453 . . . . 73.219999999999999 112.223 -177.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -77.98 -2.68 38.19 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.201 0.445 . . . . 74.219999999999999 112.201 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -118.19 86.29 26.46 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 74.230000000000004 111.819 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.6 -21.84 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.118 1.878 . . . . 75.439999999999998 111.996 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.37 -48.82 79.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.904 -0.589 . . . . 74.409999999999997 110.982 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -63.88 -28.07 69.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 74.129999999999995 111.066 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' A' ' 57' ' ' MET . 95.7 t -69.86 -37.99 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.96 -0.564 . . . . 72.299999999999997 111.541 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.96 -79.55 1.79 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.095 -0.574 . . . . 71.329999999999998 112.982 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -120.88 124.01 43.92 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.656 -0.32 . . . . 72.409999999999997 110.963 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.44 ' HB3' HG13 ' A' ' 54' ' ' VAL . 8.6 ptp -136.25 147.96 62.46 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 120.653 0.263 . . . . 74.239999999999995 111.449 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD2' HD11 ' A' ' 41' ' ' LEU . 81.7 Cg_endo -88.03 140.67 4.92 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.765 2.31 . . . . 74.129999999999995 112.802 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.27 -172.71 17.74 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.505 -0.855 . . . . 64.099999999999994 114.027 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 65.5 tp -132.83 108.68 9.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.619 0.367 . . . . 73.150000000000006 111.269 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -79.26 129.5 34.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.827 0.346 . . . . 71.329999999999998 111.205 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.07 -23.27 65.84 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.142 0.423 . . . . 72.319999999999993 112.142 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -75.38 -53.55 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.04 0.448 . . . . 72.519999999999996 111.808 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -68.37 -26.62 65.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.399 0.518 . . . . 74.540000000000006 112.399 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 64.78 10.58 6.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.105 0.479 . . . . 74.420000000000002 111.268 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -127.38 160.72 30.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.11 0.481 . . . . 73.510000000000005 111.734 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -91.29 176.85 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.656 -0.702 . . . . 73.409999999999997 110.993 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.599 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . 159.46 168.42 21.45 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.095 -0.574 . . . . 50.240000000000002 113.01 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.32 127.49 43.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.613 0.245 . . . . 73.109999999999999 111.375 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.43 156.19 79.95 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 120.698 0.285 . . . . 73.400000000000006 111.421 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.3 120.9 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.468 2.112 . . . . 74.030000000000001 112.488 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.73 1.48 15.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.382 -0.437 . . . . 70.049999999999997 114.05 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 p -74.71 -17.43 60.66 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.37 -0.488 . . . . 71.430000000000007 112.289 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -108.28 17.52 22.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.864 0.69 . . . . 74.019999999999996 112.864 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 11' ' ' ALA . 29.4 m -131.66 148.63 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.982 0.42 . . . . 72.140000000000001 112.119 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -108.65 151.08 26.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.217 -0.447 . . . . 74.010000000000005 110.892 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.06 115.26 21.12 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.806 0.336 . . . . 65.209999999999994 111.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.5 HD13 ' HB2' ' A' ' 10' ' ' ARG . 92.8 mt -83.2 -59.73 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.916 0.389 . . . . 75.25 111.467 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.07 -176.56 36.76 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.089 -0.577 . . . . 64.510000000000005 113.185 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.79 157.0 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.923 2.416 . . . . 61.450000000000003 113.106 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 81' ' ' LEU . 4.6 mp -93.78 160.85 14.57 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.447 -0.342 . . . . 73.319999999999993 111.086 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.253 1.241 0 N-CA-C 112.038 0.385 . . . . 73.200000000000003 112.038 177.633 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.979 0.419 . . . . 71.299999999999997 111.355 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.05 -161.84 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.159 -0.473 . . . . 71.430000000000007 111.277 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.93 158.42 7.53 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.223 -0.513 . . . . 71.200000000000003 112.687 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 86.97 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.407 2.071 . . . . 71.329999999999998 113.245 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.69 -16.97 64.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.559 0.695 . . . . 75.549999999999997 110.471 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . 175.67 -140.86 5.38 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.523 -0.762 . . . . 52.219999999999999 112.214 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -130.46 143.97 51.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.225 0.536 . . . . 73.230000000000004 111.625 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -92.73 131.02 38.16 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.732 -0.667 . . . . 73.209999999999994 112.116 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -123.78 153.85 40.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 73.230000000000004 110.069 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.1 ttm180 -127.42 119.75 26.86 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.778 0.323 . . . . 73.219999999999999 111.805 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.452 ' HA ' HG13 ' A' ' 75' ' ' VAL . . . -71.54 124.08 23.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.309 -0.405 . . . . 71.319999999999993 110.961 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.5 -21.2 19.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.443 0.534 . . . . 74.120000000000005 112.443 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.98 147.57 65.94 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 112.131 0.419 . . . . 74.340000000000003 112.131 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 55.7 Cg_endo -71.06 119.63 6.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.55 2.167 . . . . 74.329999999999998 112.172 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -136.68 120.0 16.84 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.919 0.39 . . . . 73.140000000000001 111.49 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.407 ' HG2' ' N ' ' A' ' 17' ' ' ARG . 11.2 ttm180 -123.6 151.62 42.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.994 0.426 . . . . 74.329999999999998 110.999 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.457 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 18.7 mmm180 -134.24 142.23 47.29 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.466 -0.334 . . . . 71.209999999999994 110.759 177.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.32 -15.48 62.4 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.986 0.422 . . . . 64.400000000000006 111.58 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -110.76 157.35 38.75 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.385 0.274 . . . . 75.439999999999998 110.702 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.86 6.06 1.84 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.972 2.448 . . . . 74.349999999999994 113.229 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -54.95 -52.72 62.13 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.115 0.483 . . . . 72.25 111.122 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' CG ' ' HG3' ' A' ' 17' ' ' ARG . 3.4 m-20 -102.07 -173.71 2.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.566 -0.743 . . . . 54.210000000000001 111.46 -177.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.8 tp -132.56 144.62 50.52 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.387 -0.37 . . . . 74.239999999999995 110.415 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.0 113.32 3.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.127 0.489 . . . . 75.400000000000006 112.034 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.5 mt -103.26 138.74 39.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.245 -0.434 . . . . 71.549999999999997 111.25 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 HD22 ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -122.65 150.69 58.77 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 122.503 0.321 . . . . 71.319999999999993 110.933 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.94 117.83 4.64 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.685 2.257 . . . . 71.510000000000005 113.133 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.1 29.66 58.4 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.032 -0.531 . . . . 71.010000000000005 113.311 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.91 158.67 15.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.189 0.495 . . . . 71.239999999999995 111.155 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.04 132.56 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.135 0.493 . . . . 63.409999999999997 112.289 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.9 mp -121.88 111.42 17.08 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.249 -0.432 . . . . 72.25 110.975 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.552 HG13 HD21 ' A' ' 81' ' ' LEU . 18.0 t -94.96 106.05 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.839 0.352 . . . . 75.299999999999997 111.227 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.508 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.4 t -101.39 132.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.598 0.237 . . . . 75.310000000000002 111.591 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 143.07 45.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.272 0.558 . . . . 65.5 112.187 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -66.38 -33.05 74.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.056 -0.52 . . . . 73.439999999999998 111.124 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.09 73.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 74.409999999999997 111.392 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -69.68 -45.44 68.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.27 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.36 -39.83 80.62 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.354 -0.385 . . . . 61.119999999999997 111.507 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.27 -44.05 95.66 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.497 -0.32 . . . . 75.540000000000006 111.015 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.95 91.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.02 0.438 . . . . 75.030000000000001 111.227 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD11 ' HD2' ' A' ' 58' ' ' PRO . 81.2 mt -66.75 -29.2 69.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.251 -0.431 . . . . 74.340000000000003 111.498 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.57 31.87 12.5 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.265 -0.493 . . . . 63.329999999999998 112.833 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.37 123.26 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.924 0.392 . . . . 72.209999999999994 111.307 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.1 149.99 23.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.488 -0.324 . . . . 54.329999999999998 111.376 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.27 126.68 9.75 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 73.450000000000003 111.241 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -42.43 1.91 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.24 -0.505 . . . . 52.109999999999999 112.289 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.17 -26.25 61.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.035 -0.602 . . . . 74.209999999999994 112.198 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.589 ' HG3' ' HG3' ' A' ' 49' ' ' ARG . 9.3 pt-20 -52.05 -33.88 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.514 0.726 . . . . 75.510000000000005 111.297 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.589 ' HG3' ' HG3' ' A' ' 48' ' ' GLU . 28.2 mtp180 -89.65 -3.04 58.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.715 -0.675 . . . . 73.120000000000005 111.654 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 65.8 m -136.83 72.45 55.32 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.434 -0.348 . . . . 75.140000000000001 111.021 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.91 -26.82 83.43 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.797 2.331 . . . . 72.219999999999999 112.836 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.73 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 73.3 mt-30 -62.95 -25.51 68.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.329 -0.396 . . . . 73.040000000000006 111.541 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.5 m -83.86 -31.41 25.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.475 -0.33 . . . . 71.540000000000006 111.787 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.45 -44.71 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.522 . . . . 74.519999999999996 110.908 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.87 -78.31 0.89 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.298 -0.477 . . . . 71.530000000000001 113.701 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -111.81 114.38 27.3 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.324 0.49 . . . . 73.439999999999998 112.324 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -126.42 134.61 26.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.372 -0.376 . . . . 72.140000000000001 111.011 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.554 ' HD2' HD11 ' A' ' 41' ' ' LEU . 95.7 Cg_endo -81.94 123.85 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.546 2.164 . . . . 75.219999999999999 112.205 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -148.25 176.43 27.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.634 -0.793 . . . . 62.140000000000001 113.756 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 tp -97.4 121.69 39.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.621 0.368 . . . . 75.519999999999996 110.919 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.97 121.51 34.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.747 0.308 . . . . 72.150000000000006 111.142 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -72.7 -27.04 61.83 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.19 0.811 . . . . 75.409999999999997 113.19 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.429 ' HG2' HD22 ' A' ' 26' ' ' LEU . 4.2 tpm_? -58.58 -52.58 65.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.009 0.433 . . . . 75.430000000000007 111.329 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 p -92.4 -15.83 26.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.014 -0.539 . . . . 63.130000000000003 111.506 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 60.13 24.38 13.67 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.119 -0.491 . . . . 74.099999999999994 111.681 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -118.72 161.12 20.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 73.299999999999997 111.5 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -92.45 150.67 20.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.162 -0.472 . . . . 74.439999999999998 111.524 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.85 -175.29 44.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.257 -0.496 . . . . 64.209999999999994 112.747 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.46 143.54 32.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.972 0.386 . . . . 73.340000000000003 110.528 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.448 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 55.1 p90 -139.92 143.12 33.22 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.111 0.411 . . . . 75.439999999999998 112.111 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 10.6 Cg_exo -72.41 118.32 5.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.864 2.376 . . . . 72.430000000000007 112.267 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.408 ' HA2' HG21 ' A' ' 75' ' ' VAL . . . -60.32 -14.45 33.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.451 0.54 . . . . 71.040000000000006 114.451 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.73 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 10.3 t -71.48 -5.65 34.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.619 0.6 . . . . 74.010000000000005 112.619 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -111.03 1.04 17.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.138 0.422 . . . . 74.010000000000005 112.138 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG13 ' HA ' ' A' ' 11' ' ' ALA . 25.7 m -128.41 148.6 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.46 0.541 . . . . 71.219999999999999 112.46 -175.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 13.9 pt-20 -98.77 167.18 10.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.838 0.352 . . . . 72.409999999999997 110.717 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -99.04 123.28 43.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.946 0.403 . . . . 74.340000000000003 111.001 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.417 HD13 ' HB2' ' A' ' 10' ' ' ARG . 74.7 mt -94.26 -46.97 6.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.945 0.402 . . . . 71.150000000000006 111.347 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.72 -179.74 18.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.267 -0.492 . . . . 38.009999999999998 113.246 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.79 142.91 40.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.484 2.122 . . . . 63.210000000000001 112.478 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.552 HD21 HG13 ' A' ' 32' ' ' VAL . 6.2 mp -68.1 133.97 49.82 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.912 0.387 . . . . 75.439999999999998 111.569 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 119.046 -0.502 . . . . 75.549999999999997 111.087 178.403 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.724 0.297 . . . . 73.340000000000003 110.979 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.79 144.81 30.0 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.969 0.414 . . . . 71.329999999999998 111.87 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.45 -145.77 13.49 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.204 -0.522 . . . . 53.420000000000002 113.283 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -89.82 -174.69 0.89 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.277 2.652 . . . . 74.040000000000006 113.13 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -118.42 -26.86 6.12 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.616 0.599 . . . . 72.299999999999997 112.616 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . -80.02 -149.27 5.55 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 115.3 0.88 . . . . 70.010000000000005 115.3 -169.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.53 163.44 14.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.931 0.396 . . . . 62.219999999999999 111.323 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -108.01 126.23 52.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.399 0.618 . . . . 72.230000000000004 112.264 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.75 169.64 9.43 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.449 -0.796 . . . . 74.219999999999999 110.179 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HB2' HD13 ' A' ' 78' ' ' LEU . 45.3 ttt85 -136.03 124.45 23.43 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.088 -0.382 . . . . 75.299999999999997 111.92 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.68 129.17 34.24 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.831 0.348 . . . . 73.420000000000002 111.391 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.0 mt -81.77 -49.61 10.21 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.371 0.508 . . . . 72.5 112.371 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.465 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 49.4 m-85 -124.87 164.4 31.51 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-O 120.481 0.182 . . . . 74.409999999999997 111.236 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.554 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.7 Cg_endo -74.34 119.91 6.01 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.264 1.976 . . . . 71.439999999999998 113.299 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -125.15 143.1 51.1 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.397 -0.365 . . . . 74.25 111.169 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.412 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 5.9 mtp-105 -126.39 160.43 30.48 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.232 0.539 . . . . 72.239999999999995 112.415 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.413 ' HE ' ' CG ' ' A' ' 22' ' ' ASP . 10.3 tpp180 -104.86 149.95 25.25 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.939 -0.573 . . . . 74.150000000000006 110.142 168.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -57.69 -37.78 74.05 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.943 0.402 . . . . 72.340000000000003 111.493 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -115.87 146.49 37.04 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.487 -0.324 . . . . 74.129999999999995 110.966 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.93 6.85 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.179 2.586 . . . . 75.219999999999999 114.762 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -62.27 -40.54 96.58 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.273 0.471 . . . . 72.010000000000005 112.273 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.413 ' CG ' ' HE ' ' A' ' 17' ' ' ARG . 1.6 m-20 -82.0 -163.29 0.64 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.605 0.594 . . . . 74.420000000000002 112.605 -175.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp -123.98 120.15 31.62 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.065 -0.516 . . . . 72.340000000000003 110.975 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -64.63 154.6 35.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.67 0.748 . . . . 75.400000000000006 113.014 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 92.8 mt -116.13 139.02 50.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.213 -0.903 . . . . 63.310000000000002 110.581 175.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.31 154.92 59.16 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 122.458 0.303 . . . . 71.140000000000001 110.586 174.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.9 115.52 3.64 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.405 2.07 . . . . 73.049999999999997 112.852 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.55 22.11 35.21 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.372 -0.442 . . . . 72.340000000000003 113.393 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.39 136.27 33.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.994 0.426 . . . . 70.219999999999999 111.797 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.19 125.46 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.254 -0.43 . . . . 74.420000000000002 110.538 174.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 5.6 mp -121.05 127.5 51.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.974 0.416 . . . . 74.140000000000001 111.587 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.19 122.4 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.356 -0.384 . . . . 74.230000000000004 111.294 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 84.6 t -109.5 125.07 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.695 0.283 . . . . 63.229999999999997 110.769 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -60.07 129.68 42.94 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.774 0.321 . . . . 73.340000000000003 111.782 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 17.5 ptm180 -57.37 -30.39 64.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.634 0.255 . . . . 75.510000000000005 111.379 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.96 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.908 0.385 . . . . 64.239999999999995 111.371 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.46 87.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.923 0.392 . . . . 65.040000000000006 111.111 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.22 -46.23 69.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.262 0.554 . . . . 73.439999999999998 110.818 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.426 ' HG3' ' O ' ' A' ' 35' ' ' ARG . 77.2 mt-30 -59.28 -52.07 67.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.697 -0.683 . . . . 75.409999999999997 111.433 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.39 97.43 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.212 0.449 . . . . 74.239999999999995 112.212 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.7 -28.8 70.2 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.763 0.316 . . . . 75.310000000000002 111.644 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 23.78 10.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.185 -0.531 . . . . 38.340000000000003 113.424 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.93 110.49 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.017 0.437 . . . . 75.430000000000007 110.835 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.27 149.88 37.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.28 -0.418 . . . . 71.409999999999997 112.122 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -52.06 127.98 23.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.168 0.509 . . . . 71.230000000000004 110.99 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.56 -44.61 1.46 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.289 -0.725 . . . . 72.150000000000006 111.289 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.87 -20.63 66.74 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.511 -0.376 . . . . 71.030000000000001 112.455 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.76 -43.69 58.37 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.503 0.668 . . . . 64.540000000000006 111.178 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -77.66 -5.23 49.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.765 -0.652 . . . . 75.140000000000001 111.751 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.46 71.26 66.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.657 0.614 . . . . 62.240000000000002 112.657 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 -24.24 75.02 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.919 1.746 . . . . 73.340000000000003 110.324 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 22.1 pt20 -55.11 -26.14 36.2 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.744 -1.117 . . . . 71.239999999999995 111.95 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -89.06 -33.6 17.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.824 0.345 . . . . 73.140000000000001 111.746 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.56 -58.81 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.132 0.419 . . . . 71.200000000000003 112.132 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.9 -116.61 3.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.012 -0.613 . . . . 54.520000000000003 113.341 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -102.41 127.85 49.26 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.289 -0.536 . . . . 75.030000000000001 111.267 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -134.23 148.48 68.0 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 111.63 0.233 . . . . 71.310000000000002 111.63 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.2 124.68 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.705 2.27 . . . . 74.540000000000006 112.735 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.01 -174.0 22.94 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.942 -0.647 . . . . 53.409999999999997 113.796 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 29.0 tp -106.71 115.3 29.96 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.123 0.569 . . . . 62.039999999999999 112.094 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.469 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t-20 -82.62 104.02 12.57 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.773 0.321 . . . . 62.140000000000001 110.346 173.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -68.0 -9.01 42.17 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.28 0.844 . . . . 74.209999999999994 113.28 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.1 ttp85 -81.47 -29.13 33.84 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.659 -0.651 . . . . 74.129999999999995 110.902 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -113.12 -11.61 13.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.247 -0.433 . . . . 74.420000000000002 111.694 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.89 14.3 9.5 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.073 0.549 . . . . 74.319999999999993 112.008 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -96.77 145.65 25.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.105 0.479 . . . . 72.329999999999998 111.789 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.458 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -104.72 130.19 52.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.958 -0.564 . . . . 73.019999999999996 110.568 177.67 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.29 -175.75 39.34 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.685 -0.769 . . . . 74.310000000000002 113.379 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.12 117.14 27.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.723 0.297 . . . . 73.319999999999993 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.422 ' HB2' HD22 ' A' ' 25' ' ' LEU . 40.9 p90 -122.27 148.54 52.5 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 120.904 0.383 . . . . 73.409999999999997 111.31 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 17.0 Cg_exo -67.17 91.97 0.33 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.399 2.066 . . . . 75.120000000000005 112.657 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.536 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -66.74 -10.01 53.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.203 -0.453 . . . . 54.509999999999998 113.729 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.595 ' HA ' ' HA ' ' A' ' 52' ' ' GLN . 60.3 m -61.54 -30.25 70.52 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.445 -0.444 . . . . 74.299999999999997 111.529 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -93.85 4.71 53.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.015 0.746 . . . . 72.439999999999998 113.015 -174.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 72' ' ' GLY . 16.9 m -108.19 151.03 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.158 0.504 . . . . 74.299999999999997 111.965 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -102.14 158.26 16.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 73.420000000000002 110.692 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -89.6 124.19 34.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.919 0.39 . . . . 74.299999999999997 111.251 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 10' ' ' ARG . 85.6 mt -93.52 -45.14 7.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.093 0.473 . . . . 73.230000000000004 111.196 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.28 19.95 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.085 -0.579 . . . . 52.530000000000001 113.494 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.35 174.25 8.12 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.88 2.387 . . . . 74.239999999999995 112.696 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.468 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -121.8 132.16 54.45 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.279 -0.419 . . . . 71.099999999999994 110.567 177.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 81' ' ' LEU . 1.4 pt-20 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 113.261 0.838 . . . . 75.040000000000006 113.261 -176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.545 0.212 . . . . 74.319999999999993 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.31 152.7 12.81 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.279 0.474 . . . . 75.450000000000003 112.279 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.69 -165.49 51.36 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.196 -0.456 . . . . 54.43 113.324 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.5 98.87 0.98 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.263 1.976 . . . . 73.310000000000002 112.763 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.57 -45.6 75.1 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.389 0.614 . . . . 73.329999999999998 109.894 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.22 177.79 33.07 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.754 -0.657 . . . . 61.140000000000001 112.856 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -127.03 138.11 53.18 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.505 -0.409 . . . . 75.439999999999998 110.635 179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.444 ' HG3' HD11 ' A' ' 81' ' ' LEU . 98.3 mt-30 -92.6 131.1 37.99 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.702 0.63 . . . . 75.030000000000001 112.702 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.93 163.25 17.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.393 -0.821 . . . . 70.140000000000001 109.76 170.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HB2' HD13 ' A' ' 78' ' ' LEU . 40.9 ttm180 -140.69 125.59 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.986 0.365 . . . . 75.109999999999999 111.986 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.43 127.55 32.74 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.265 0.555 . . . . 73.409999999999997 111.174 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.57 -39.01 28.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.002 0.429 . . . . 63.43 111.518 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -130.65 141.09 40.71 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.76 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.44 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.3 Cg_endo -65.88 120.9 8.14 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.451 2.101 . . . . 74.200000000000003 112.923 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -131.72 123.68 28.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.517 -0.311 . . . . 74.030000000000001 110.976 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -103.58 99.08 8.88 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.34 0.496 . . . . 71.340000000000003 112.34 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.513 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 27.6 mtp180 64.32 140.53 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.585 1.698 . . . . 73.409999999999997 115.585 164.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.93 -50.91 3.27 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.508 -0.923 . . . . 75.510000000000005 108.508 160.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -89.1 159.4 45.25 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.712 -0.676 . . . . 74.140000000000001 109.471 166.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.76 -8.49 19.7 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 121.894 1.729 . . . . 73.109999999999999 113.148 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -96.77 -19.26 19.05 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 111.997 0.369 . . . . 74.129999999999995 111.997 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.513 ' HB2' ' HA ' ' A' ' 17' ' ' ARG . 23.1 m-20 -61.8 174.35 0.84 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.331 0.863 . . . . 72.239999999999995 113.331 -173.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.507 HD22 ' HB2' ' A' ' 61' ' ' ASN . 40.6 tp -99.8 151.62 21.06 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.638 -0.71 . . . . 52.119999999999997 111.295 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -97.58 127.87 43.86 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.466 -0.334 . . . . 73.400000000000006 111.172 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.92 149.04 25.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.535 0.569 . . . . 71.349999999999994 112.535 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.86 155.94 54.6 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 75.5 110.65 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.1 Cg_endo -71.32 105.19 1.68 Allowed 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 121.607 1.538 . . . . 73.450000000000003 112.387 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.48 3.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.228 -0.51 . . . . 41.140000000000001 113.195 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -106.84 174.68 5.78 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.867 0.365 . . . . 74.310000000000002 111.623 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.35 113.72 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.786 0.327 . . . . 72.340000000000003 111.388 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.493 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.2 mp -105.15 130.46 53.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.583 0.23 . . . . 74.129999999999995 111.169 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.75 111.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.896 0.379 . . . . 72.0 111.22 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.73 128.6 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 122.649 0.38 . . . . 74.340000000000003 111.246 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -72.6 142.59 48.38 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.519999999999996 111.906 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -54.76 -36.08 64.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.399 -0.364 . . . . 75.209999999999994 111.826 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.82 73.79 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 111.904 0.335 . . . . 74.319999999999993 111.904 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.788 0.328 . . . . 72.129999999999995 111.58 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -54.51 -43.36 71.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.072 0.463 . . . . 65.519999999999996 111.443 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -69.34 -33.79 73.64 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.303 -0.408 . . . . 75.209999999999994 111.515 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.48 65.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.213 0.53 . . . . 63.119999999999997 111.138 175.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 76.8 mt -86.78 -10.13 54.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.997 -0.547 . . . . 72.299999999999997 111.28 174.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.69 33.19 63.59 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 65.219999999999999 113.142 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.03 135.08 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.942 0.401 . . . . 71.430000000000007 111.355 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.66 130.25 35.09 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.338 -0.392 . . . . 64.420000000000002 111.586 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -49.27 116.32 1.66 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.496 . . . . 74.150000000000006 110.776 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.61 2.26 25.79 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.286 -0.483 . . . . 72.120000000000005 112.636 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.89 5.9 32.63 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.52 -0.372 . . . . 60.039999999999999 113.281 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.97 -29.7 67.38 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.02 0.378 . . . . 72.140000000000001 112.02 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -80.54 -2.7 47.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.358 0.503 . . . . 72.409999999999997 112.358 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.2 m -128.33 64.37 67.01 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 120.89 0.376 . . . . 75.540000000000006 111.811 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 38.3 Cg_endo -65.17 -22.43 61.26 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.438 2.092 . . . . 70.329999999999998 112.174 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -62.87 -21.06 65.71 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.882 -0.599 . . . . 74.319999999999993 111.909 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.9 t -87.37 -4.05 59.03 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 75.329999999999998 111.701 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.5 t -98.83 -54.51 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.89 0.376 . . . . 72.040000000000006 111.595 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.44 -120.28 4.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.305 -0.407 . . . . 74.140000000000001 112.39 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.3 m0 -92.09 111.59 23.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.814 0.34 . . . . 54.130000000000003 110.673 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 46.4 mtm -103.84 133.04 20.47 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.351 -0.218 . . . . 75.150000000000006 111.415 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 57' ' ' MET . 19.3 Cg_exo -67.23 117.67 4.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.871 2.381 . . . . 74.25 112.349 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.94 168.54 31.83 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.796 -0.716 . . . . 72.5 113.361 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.502 HD13 ' HE ' ' A' ' 67' ' ' ARG . 37.4 tp -112.63 114.1 26.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.744 0.307 . . . . 61.43 110.461 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.507 ' HB2' HD22 ' A' ' 23' ' ' LEU . 50.7 t-20 -81.96 104.33 12.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.672 0.272 . . . . 74.109999999999999 110.989 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -69.95 0.46 5.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.447 0.906 . . . . 71.409999999999997 113.447 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.516 ' HE ' ' HA ' ' A' ' 63' ' ' ARG . 2.6 tpm_? -81.42 -43.51 18.83 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.972 -0.455 . . . . 74.319999999999993 110.515 171.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.1 p -107.8 -6.78 16.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.297 -0.41 . . . . 64.329999999999998 111.677 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 44.4 mmm-85 59.22 19.44 7.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.695 0.798 . . . . 74.299999999999997 111.779 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -95.32 145.58 24.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.108 0.48 . . . . 73.530000000000001 111.825 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HE ' HD13 ' A' ' 60' ' ' LEU . 3.9 tpp180 -99.48 140.94 32.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.08 -0.509 . . . . 75.430000000000007 111.528 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.18 177.26 39.23 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.898 . . . . 72.129999999999995 113.657 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 5.4 m-20 -89.51 128.8 36.04 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.406 0.282 . . . . 73.420000000000002 110.597 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -119.02 141.29 30.01 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 122.107 -0.37 . . . . 74.230000000000004 111.844 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.88 113.38 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.729 2.286 . . . . 71.319999999999993 112.537 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.46 23.1 1.25 Allowed Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.027 0.771 . . . . 70.319999999999993 115.027 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.4 p -93.79 -18.6 21.87 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.807 0.803 . . . . 53.229999999999997 111.571 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -107.96 9.02 28.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.914 0.338 . . . . 71.450000000000003 111.914 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG22 ' HA2' ' A' ' 72' ' ' GLY . 25.3 m -122.51 151.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 112.632 0.604 . . . . 75.349999999999994 112.632 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.4 160.63 16.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.891 -0.595 . . . . 62.439999999999998 110.921 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -93.07 115.37 28.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.035 0.445 . . . . 73.209999999999994 111.632 -177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.466 HD13 ' HB2' ' A' ' 10' ' ' ARG . 87.2 mt -84.61 -44.17 13.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.731 0.301 . . . . 72.510000000000005 111.548 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.05 178.04 15.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.136 -0.554 . . . . 52.420000000000002 113.623 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.54 164.17 27.25 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.081 2.521 . . . . 72.150000000000006 112.802 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.483 ' N ' HD13 ' A' ' 81' ' ' LEU . 4.7 mp -99.56 151.35 21.26 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.851 0.358 . . . . 73.230000000000004 111.384 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.148 0 N-CA-C 112.0 0.37 . . . . 73.450000000000003 112.0 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.577 ' HA2' ' HG2' ' A' ' 35' ' ' ARG . . . . . . . . 0 CA--C 1.523 0.578 0 CA-C-O 120.467 -0.074 . . . . 53.420000000000002 113.122 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.5 ' HE2' HH11 ' A' ' 35' ' ' ARG . 94.4 m-85 -141.82 157.84 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 110.901 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -118.58 132.85 56.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.287 0.565 . . . . 73.319999999999993 112.248 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.92 170.83 7.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.598 -0.728 . . . . 75.510000000000005 109.578 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 35.4 ttt180 -148.33 121.5 8.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.022 -0.424 . . . . 73.349999999999994 111.386 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -69.38 125.61 27.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.956 0.408 . . . . 54.119999999999997 111.938 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -94.7 -30.27 14.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.26 0.467 . . . . 73.549999999999997 112.26 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.87 141.41 40.44 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.56 0.219 . . . . 74.329999999999998 111.391 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 70.3 Cg_endo -76.78 119.31 5.1 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.35 2.033 . . . . 63.240000000000002 113.326 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 . . . . . 0 N--CA 1.468 0.428 0 CA-C-N 116.084 -0.507 . . . . 75.200000000000003 110.712 176.421 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.2 tp . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 121.226 0.536 . . . . 73.030000000000001 111.608 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -84.92 145.17 27.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.949 -0.569 . . . . 70.200000000000003 112.491 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.2 mt -119.13 127.9 53.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 111.771 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' HG ' ' HD3' ' A' ' 63' ' ' ARG . 4.3 mm? -123.36 143.44 41.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 122.559 0.344 . . . . 54.299999999999997 110.883 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.04 119.57 6.7 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.72 2.28 . . . . 75.219999999999999 113.443 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.45 -14.95 62.84 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.268 -0.424 . . . . 34.420000000000002 113.698 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -81.41 143.34 32.21 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.21 0.505 . . . . 64.230000000000004 111.744 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.64 141.19 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.318 0.58 . . . . 71.040000000000006 112.27 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.5 mp -118.7 123.95 46.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.029 -0.532 . . . . 35.219999999999999 110.731 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 81' ' ' LEU . 57.9 t -94.88 124.21 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 111.976 0.361 . . . . 74.109999999999999 111.976 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.28 139.79 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.952 0.405 . . . . 71.400000000000006 111.176 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 t -93.13 158.32 15.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.958 0.408 . . . . 70.319999999999993 111.835 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 17.3 mmm180 -55.34 -41.18 72.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.244 -0.435 . . . . 61.119999999999997 111.56 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.86 -45.84 71.08 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.01 0.374 . . . . 41.439999999999998 112.01 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.02 70.87 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.882 0.372 . . . . 74.319999999999993 111.707 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.25 -40.63 97.95 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.807 0.337 . . . . 63.119999999999997 111.826 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -66.16 -35.77 81.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.815 0.34 . . . . 74.420000000000002 111.225 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.36 73.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.035 0.445 . . . . 54.340000000000003 111.41 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -22.35 59.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.176 -0.465 . . . . 71.329999999999998 111.465 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.63 42.82 6.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.299 -0.477 . . . . 51.310000000000002 112.963 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.06 134.79 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.592 -0.358 . . . . 74.510000000000005 111.43 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.12 142.32 50.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.709 0.29 . . . . 75.340000000000003 111.133 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -60.93 108.33 0.85 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.051 0.453 . . . . 72.0 110.977 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 8.97 31.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.319 -0.467 . . . . 74.420000000000002 112.713 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.31 -29.55 6.3 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.612 -0.328 . . . . 61.229999999999997 112.644 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -31.63 64.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.971 0.508 . . . . 63.409999999999997 112.225 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -57.06 -16.43 7.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.172 0.434 . . . . 72.409999999999997 112.172 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.3 m -117.65 81.47 14.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.374 -0.375 . . . . 74.349999999999994 110.208 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.64 -36.15 97.9 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.942 2.428 . . . . 73.420000000000002 113.321 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -19.08 61.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.005 0.372 . . . . 44.409999999999997 112.005 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.2 t -82.77 -20.0 36.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.971 0.415 . . . . 53.009999999999998 111.462 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.38 -36.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.107 0.479 . . . . 62.399999999999999 111.283 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.26 -133.63 11.6 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.235 -0.439 . . . . 41.43 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.85 129.9 37.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.111 0.482 . . . . 73.409999999999997 111.274 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 69.1 mtm -131.46 140.37 38.22 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.483 -0.326 . . . . 65.109999999999999 111.615 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.47 118.97 4.0 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.689 2.259 . . . . 72.219999999999999 113.05 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.28 -174.71 23.89 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.863 -0.684 . . . . 54.409999999999997 113.892 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.06 130.48 55.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.635 0.374 . . . . 52.219999999999999 111.338 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.59 143.64 28.07 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.729 0.3 . . . . 72.239999999999995 111.414 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -79.05 -52.29 8.41 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.166 0.802 . . . . 73.109999999999999 113.166 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HD3' ' HG ' ' A' ' 26' ' ' LEU . 58.2 ttt180 -62.73 -40.47 97.29 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.843 0.683 . . . . 71.099999999999994 112.843 -175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -92.26 -17.11 25.23 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.068 0.395 . . . . 63.25 112.068 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.64 17.82 6.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.613 0.365 . . . . 72.299999999999997 111.57 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -98.71 159.14 15.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.29 0.567 . . . . 64.140000000000001 112.143 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -121.88 135.05 54.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.779 -0.646 . . . . 73.230000000000004 111.297 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.18 -171.73 44.08 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.669 -0.777 . . . . 73.329999999999998 113.04 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -88.95 121.69 31.57 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.794 -0.239 . . . . 51.299999999999997 111.228 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.555 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 50.4 p90 -111.92 143.74 29.3 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 120.566 0.222 . . . . 73.420000000000002 111.151 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.85 104.18 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.215 1.943 . . . . 62.109999999999999 111.88 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.78 36.71 1.03 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 114.255 0.462 . . . . 73.430000000000007 114.255 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -104.52 -30.22 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.125 -0.632 . . . . 55.009999999999998 111.23 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -93.43 11.25 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.614 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 11' ' ' ALA . 24.1 m -118.51 145.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.36 0.504 . . . . 63.399999999999999 112.36 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 15.0 pt-20 -93.07 170.72 9.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.928 0.394 . . . . 70.450000000000003 110.844 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -102.69 129.73 49.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.427 -0.351 . . . . 72.230000000000004 110.947 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.96 -51.15 3.94 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.101 0.408 . . . . 71.150000000000006 112.101 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.18 -175.1 33.27 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.714 -0.755 . . . . 61.229999999999997 113.584 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.45 146.99 12.44 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.006 2.471 . . . . 75.209999999999994 113.922 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 32' ' ' VAL . 90.2 mt . . . . . 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 74.010000000000005 111.088 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.559 0 CA-C-O 120.731 0.073 . . . . 71.319999999999993 112.972 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 94.0 m-85 -110.01 153.57 24.4 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.886 0.374 . . . . 71.540000000000006 111.154 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -116.54 126.89 53.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.148 0.499 . . . . 64.400000000000006 111.575 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.77 168.25 9.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.91 -0.586 . . . . 64.549999999999997 110.717 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.502 ' HB2' HD11 ' A' ' 78' ' ' LEU . 31.2 ttt85 -124.01 118.95 28.16 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.3 -0.25 . . . . 70.349999999999994 111.11 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.556 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -67.92 117.78 10.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.989 0.423 . . . . 72.129999999999995 111.567 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 76' ' ' GLU . 51.9 mt -89.83 -41.02 12.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.006 0.432 . . . . 73.120000000000005 111.705 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -127.76 149.53 70.76 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.261 -0.427 . . . . 74.019999999999996 111.121 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.9 Cg_endo -72.68 152.75 53.73 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.511 2.14 . . . . 60.149999999999999 113.469 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.1 t80 . . . . . 0 CA--C 1.539 0.536 0 CA-C-N 116.201 -0.454 . . . . 73.340000000000003 110.444 179.06 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 112.377 0.51 . . . . 73.5 112.377 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.648 ' HB2' HG21 ' A' ' 64' ' ' THR . 44.1 mt-10 -87.0 131.29 34.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.064 0.459 . . . . 51.43 111.564 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 HD21 ' A' ' 31' ' ' LEU . 64.3 mt -119.61 138.12 53.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.804 -0.634 . . . . 74.400000000000006 110.82 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 25' ' ' LEU . 3.9 mm? -118.36 145.65 37.73 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 120.836 0.351 . . . . 71.530000000000001 110.834 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.61 106.26 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.319 2.013 . . . . 72.439999999999998 113.14 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.73 -21.35 4.47 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.329 -0.462 . . . . 61.140000000000001 113.245 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.67 142.28 58.46 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.552 0.575 . . . . 63.229999999999997 112.552 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.73 98.78 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.847 -0.615 . . . . 75.140000000000001 110.517 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 75' ' ' VAL . 6.9 mp -78.78 116.54 19.19 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.91 0.386 . . . . 72.549999999999997 111.775 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.8 t -94.35 117.23 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.947 0.403 . . . . 65.409999999999997 111.5 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG22 ' HA3' ' A' ' 59' ' ' GLY . 96.1 t -115.84 123.23 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.299 -0.409 . . . . 72.439999999999998 111.132 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -66.45 131.08 45.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.832 -0.167 . . . . 43.420000000000002 110.829 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -54.68 -33.92 61.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.965 0.357 . . . . 74.209999999999994 111.965 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.79 66.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.888 0.375 . . . . 62.030000000000001 111.856 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -64.23 -34.88 79.12 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.430000000000007 111.686 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.93 -42.92 99.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.964 0.412 . . . . 53.100000000000001 111.096 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.68 -35.34 78.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.753 0.311 . . . . 61.229999999999997 110.931 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.41 -33.78 74.27 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.003 0.43 . . . . 62.439999999999998 111.489 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.635 HD21 ' HD3' ' A' ' 58' ' ' PRO . 96.1 mt -74.98 -28.75 60.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.893 0.377 . . . . 73.129999999999995 111.805 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.76 35.17 8.55 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.115 -0.564 . . . . 63.310000000000002 112.239 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -75.72 127.39 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 120.727 0.299 . . . . 50.329999999999998 111.184 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 146.16 54.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.984 0.421 . . . . 41.240000000000002 111.233 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.87 121.64 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.144 0.497 . . . . 74.310000000000002 111.223 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.39 -15.98 60.49 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.154 -0.546 . . . . 73.010000000000005 112.739 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.26 48.18 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.627 -0.321 . . . . 75.019999999999996 113.394 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -53.67 -21.11 6.3 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.461 0.648 . . . . 74.530000000000001 111.585 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.81 -11.26 25.5 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.517 0.562 . . . . 75.109999999999999 112.517 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 26.6 p -161.01 91.7 1.54 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.042 0.386 . . . . 70.329999999999998 112.042 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 50' ' ' CYS . 11.9 Cg_endo -55.05 -23.79 37.14 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.985 2.456 . . . . 74.120000000000005 112.94 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.27 74.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.747 0.308 . . . . 72.239999999999995 110.776 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.7 m -65.85 -15.37 62.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.381 0.511 . . . . 63.310000000000002 112.381 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.16 -30.33 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.991 0.424 . . . . 71.310000000000002 111.417 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.29 -92.24 1.78 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.116 -0.564 . . . . 74.540000000000006 113.145 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -108.56 131.51 54.77 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.935 0.398 . . . . 70.549999999999997 111.279 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 66.4 mtp -133.16 132.64 22.34 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.275 -0.421 . . . . 74.310000000000002 110.938 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.635 ' HD3' HD21 ' A' ' 41' ' ' LEU . 92.8 Cg_endo -87.28 118.07 1.32 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.677 2.251 . . . . 65.219999999999999 112.852 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.16 179.09 28.12 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.815 -0.707 . . . . 22.219999999999999 113.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.86 124.51 49.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.459 0.304 . . . . 71.219999999999999 111.394 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.8 t-20 -87.25 149.03 24.85 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.594 -0.275 . . . . 65.030000000000001 110.771 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -92.11 -28.61 17.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.537 0.94 . . . . 74.109999999999999 113.537 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -58.79 3.06 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.595 0.712 . . . . 74.420000000000002 110.808 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 24' ' ' GLU . 64.4 p -81.87 -21.71 37.34 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.546 -0.752 . . . . 70.439999999999998 111.634 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 13.7 mmt85 57.54 31.21 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.562 . . . . 70.409999999999997 111.98 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.31 135.77 39.44 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.811 -0.631 . . . . 73.209999999999994 110.161 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -97.58 121.22 39.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.976 -0.379 . . . . 71.040000000000006 109.976 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -169.96 -172.11 36.14 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.647 -0.787 . . . . 52.509999999999998 113.568 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.86 132.21 35.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.847 0.356 . . . . 74.310000000000002 111.255 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 25' ' ' LEU . 53.2 p90 -138.45 150.17 65.41 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.758 0.313 . . . . 71.109999999999999 111.482 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.79 110.26 2.31 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.188 1.925 . . . . 64.040000000000006 112.425 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.49 -11.5 35.05 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.598 0.599 . . . . 32.219999999999999 114.598 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -72.52 -8.18 53.82 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.517 0.658 . . . . 74.510000000000005 112.361 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -94.7 -2.91 50.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.065 0.395 . . . . 75.040000000000006 112.065 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.557 HG11 HD22 ' A' ' 31' ' ' LEU . 18.9 m -127.24 149.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 112.437 0.532 . . . . 65.209999999999994 112.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG2' HD21 ' A' ' 12' ' ' LEU . 11.6 pt-20 -104.23 158.94 16.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.345 -0.388 . . . . 75.120000000000005 110.451 173.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -89.45 127.79 35.88 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.016 0.436 . . . . 71.340000000000003 111.702 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 10' ' ' ARG . 90.2 mt -98.66 -65.9 0.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.118 0.485 . . . . 74.239999999999995 110.968 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.18 169.23 32.27 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.212 -0.518 . . . . 61.25 112.989 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 82.6 Cg_endo -76.48 160.91 34.94 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.71 2.273 . . . . 74.230000000000004 112.985 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.862 0.839 . . . . 72.530000000000001 111.389 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 113.646 0.218 . . . . 35.439999999999998 113.646 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.08 158.41 41.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.048 0.452 . . . . 71.430000000000007 111.535 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.91 130.33 56.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.66 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -122.92 146.81 47.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.209 -0.451 . . . . 63.210000000000001 110.63 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HB2' HD11 ' A' ' 78' ' ' LEU . 15.0 ttp180 -104.75 126.71 52.1 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.102 -0.374 . . . . 71.530000000000001 111.388 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.8 114.73 12.42 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.999 0.428 . . . . 62.039999999999999 111.073 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.33 -61.06 1.92 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.299 -0.41 . . . . 72.219999999999999 112.07 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -128.32 147.25 62.92 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 116.628 -0.26 . . . . 65.400000000000006 111.007 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 27' ' ' PRO . 49.6 Cg_endo -69.02 119.65 6.62 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.182 1.921 . . . . 52.32 112.996 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.715 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 77.2 t80 . . . . . 0 CA--C 1.534 0.358 0 CA-C-N 116.235 -0.439 . . . . 64.239999999999995 110.461 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 61' ' ' ASN . 32.1 tp . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 120.856 0.36 . . . . 64.150000000000006 111.785 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.36 142.74 28.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.159 -0.473 . . . . 73.310000000000002 110.02 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.715 ' HB2' ' H ' ' A' ' 15' ' ' PHE . 80.9 mt -104.94 135.03 47.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.305 0.854 . . . . 61.350000000000001 113.305 -169.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.631 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.1 mm? -111.82 139.01 21.79 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 115.745 -0.661 . . . . 64.530000000000001 110.545 175.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.544 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 60.0 Cg_endo -70.47 126.3 12.7 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.35 2.033 . . . . 60.240000000000002 113.135 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.24 65.71 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.153 -0.476 . . . . 54.219999999999999 113.936 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.7 160.63 27.39 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.179 0.514 . . . . 41.340000000000003 112.071 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.82 133.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.26 0.553 . . . . 72.299999999999997 111.433 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -108.6 122.7 47.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 110.701 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.02 115.91 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.08 0.467 . . . . 71.010000000000005 111.069 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.477 HG22 ' HA3' ' A' ' 59' ' ' GLY . 62.0 t -113.15 106.68 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.013 0.435 . . . . 70.510000000000005 111.78 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 m -62.23 126.43 27.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.388 -0.369 . . . . 65.120000000000005 110.384 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -58.72 -20.5 49.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.176 0.436 . . . . 74.25 112.176 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.27 -36.11 51.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.987 0.422 . . . . 75.030000000000001 111.433 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.34 -39.4 71.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.261 -0.427 . . . . 74.129999999999995 111.098 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.97 -37.89 89.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.998 0.428 . . . . 71.109999999999999 111.17 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.25 -38.56 88.13 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.084 0.468 . . . . 63.200000000000003 110.595 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.43 80.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.128 -0.487 . . . . 72.140000000000001 111.229 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.476 HD11 ' HD3' ' A' ' 58' ' ' PRO . 89.2 mt -74.03 -27.76 61.1 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.941 0.4 . . . . 60.450000000000003 111.127 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.93 55.52 2.94 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.096 -0.502 . . . . 74.219999999999999 112.428 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.77 141.01 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.061 0.458 . . . . 53.420000000000002 111.532 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.78 145.42 34.38 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.033 0.444 . . . . 73.340000000000003 111.879 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 120.73 13.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 111.153 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.83 -13.57 49.76 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.007 -0.616 . . . . 60.140000000000001 112.086 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.0 -18.78 26.03 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.455 -0.402 . . . . 62.039999999999999 113.066 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -30.95 71.98 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.131 0.491 . . . . 63.25 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -76.47 8.42 3.5 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.32 -0.4 . . . . 71.099999999999994 111.879 175.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.9 m -137.09 80.35 35.34 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 120.901 0.382 . . . . 71.200000000000003 111.135 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.12 -36.91 97.51 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.705 2.27 . . . . 71.120000000000005 113.082 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -61.25 -22.31 64.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.386 -0.37 . . . . 73.420000000000002 111.76 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.4 m -86.49 -24.16 25.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.662 -0.245 . . . . 64.340000000000003 111.588 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.81 -46.04 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.034 0.445 . . . . 75.349999999999994 111.533 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.09 -99.16 0.79 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.449 -0.405 . . . . 63.130000000000003 112.852 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -122.93 133.86 54.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.588 -0.36 . . . . 71.219999999999999 110.811 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -133.86 151.65 77.27 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 122.19 -0.319 . . . . 74.340000000000003 111.507 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD3' HD11 ' A' ' 41' ' ' LEU . 3.2 Cg_endo -86.01 137.4 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.524 . . . . 65.040000000000006 112.092 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.477 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -159.39 -179.71 34.4 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.693 -0.765 . . . . 71.329999999999998 113.859 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -101.07 117.85 35.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.666 0.387 . . . . 74.150000000000006 111.017 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.523 ' HB2' HD21 ' A' ' 23' ' ' LEU . 25.4 t-20 -85.62 111.61 20.22 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.794 0.33 . . . . 55.240000000000002 111.239 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -62.16 -28.71 69.84 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.914 0.709 . . . . 74.140000000000001 112.914 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.631 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -60.52 -54.89 40.0 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.194 0.521 . . . . 75.510000000000005 111.519 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.3 p -99.55 -8.82 24.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.988 -0.551 . . . . 55.399999999999999 112.379 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 64.23 13.58 8.02 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.743 0.417 . . . . 74.109999999999999 111.362 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -96.45 166.69 11.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.296 0.569 . . . . 55.299999999999997 112.308 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -116.26 147.79 41.14 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.55 -0.75 . . . . 64.200000000000003 111.342 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.34 40.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.858 -0.686 . . . . 53.450000000000003 113.095 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 6.6 m-20 -88.73 139.93 29.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.935 0.398 . . . . 71.400000000000006 111.363 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 25' ' ' LEU . 53.7 p90 -134.16 146.84 61.38 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.672 0.273 . . . . 74.219999999999999 111.635 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD2' HD11 ' A' ' 25' ' ' LEU . 17.4 Cg_exo -67.58 110.4 2.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.741 2.294 . . . . 53.219999999999999 112.714 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -62.19 -10.23 26.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.082 0.393 . . . . 33.32 114.082 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.3 p -76.23 -20.92 56.99 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.509 -0.406 . . . . 75.209999999999994 111.885 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -102.25 12.37 36.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.42 0.526 . . . . 74.209999999999994 112.42 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.467 HG22 ' HA2' ' A' ' 72' ' ' GLY . 32.4 m -130.23 151.09 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.123 0.487 . . . . 25.43 111.355 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -118.45 145.0 45.58 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.408 -0.36 . . . . 74.209999999999994 111.324 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -73.22 117.7 15.27 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.396 -0.365 . . . . 75.540000000000006 111.411 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 10' ' ' ARG . 85.5 mt -87.79 -58.3 2.62 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.043 0.449 . . . . 74.200000000000003 110.984 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.25 -169.75 42.46 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.137 -0.554 . . . . 3.1400000000000001 112.946 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.11 -176.69 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.868 2.379 . . . . 74.510000000000005 113.411 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.538 0.506 0 CA-C-N 116.338 -0.392 . . . . 74.140000000000001 111.3 179.869 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.524 0.645 0 N-CA-C 115.695 1.038 . . . . 63.240000000000002 115.695 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -125.97 179.87 5.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.971 -0.614 . . . . 64.25 110.772 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.434 ' HG3' HD23 ' A' ' 81' ' ' LEU . 86.9 mt-30 -125.25 137.56 54.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.406 0.622 . . . . 74.329999999999998 112.016 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -120.17 154.66 34.48 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.596 -0.729 . . . . 74.030000000000001 110.271 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.44 ' HB2' HD11 ' A' ' 78' ' ' LEU . 51.6 ttp180 -123.02 121.9 37.21 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.099 -0.376 . . . . 72.219999999999999 111.663 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.78 123.42 24.12 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.022 0.439 . . . . 75.219999999999999 111.622 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.8 -49.77 10.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.004 0.43 . . . . 75.040000000000006 111.662 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -127.35 153.35 77.11 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.308 -0.405 . . . . 61.240000000000002 111.336 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -68.54 131.35 22.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.342 2.028 . . . . 73.340000000000003 113.74 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 t80 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 115.533 -0.758 . . . . 72.010000000000005 110.653 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.309 0.576 . . . . 61.340000000000003 111.521 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 40.8 mt-10 -90.64 164.59 14.11 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.969 -0.56 . . . . 70.439999999999998 111.875 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 80.2 mt -121.93 147.12 46.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 73.450000000000003 111.803 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.45 HD22 ' C ' ' A' ' 25' ' ' LEU . 4.0 mm? -122.91 155.61 63.52 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 122.544 0.337 . . . . 74.140000000000001 111.179 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.51 117.82 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.161 1.907 . . . . 75.129999999999995 112.495 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.16 28.28 45.7 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.151 -0.547 . . . . 70.140000000000001 112.589 -177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -93.44 156.59 16.68 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.499 0.319 . . . . 72.109999999999999 110.578 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.26 132.91 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.839 0.352 . . . . 63.420000000000002 110.731 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.5 mp -127.29 124.04 37.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.091 0.472 . . . . 74.140000000000001 111.418 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.21 119.09 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.334 -0.394 . . . . 74.010000000000005 110.73 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.511 HG22 ' HA3' ' A' ' 59' ' ' GLY . 59.9 t -115.27 104.77 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.923 0.392 . . . . 63.240000000000002 111.651 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.556 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 70.5 m -60.99 119.8 8.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.439 -0.346 . . . . 74.230000000000004 110.15 174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -63.02 -12.49 26.41 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.628 0.603 . . . . 64.409999999999997 112.628 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.92 71.16 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.266 0.555 . . . . 71.409999999999997 110.461 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.632 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -68.19 -35.85 78.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.797 -0.638 . . . . 43.109999999999999 111.136 175.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.56 -34.35 76.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.997 0.427 . . . . 75.319999999999993 110.511 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -63.74 -36.08 82.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.332 -0.395 . . . . 74.510000000000005 110.849 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.23 -25.02 64.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.996 0.426 . . . . 70.219999999999999 111.296 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.579 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -80.72 -28.36 36.61 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.106 0.479 . . . . 61.200000000000003 111.106 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.75 45.18 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.022 -0.535 . . . . 71.109999999999999 112.504 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.56 133.89 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.59 0.589 . . . . 72.239999999999995 112.59 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.74 151.65 24.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.971 -0.559 . . . . 73.239999999999995 111.457 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -50.02 110.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.106 0.479 . . . . 74.319999999999993 111.463 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.28 -50.54 0.88 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 116.186 -0.461 . . . . 72.400000000000006 112.047 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.07 -27.18 68.45 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.072 -0.585 . . . . 55.43 112.848 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -57.5 -35.36 70.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.117 0.484 . . . . 75.230000000000004 111.432 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -100.64 4.01 42.97 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 64.219999999999999 111.606 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -142.91 82.52 12.08 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 120.875 0.369 . . . . 72.319999999999993 111.209 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 20.4 Cg_endo -58.92 -24.78 74.35 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.106 2.537 . . . . 70.530000000000001 113.228 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -57.37 -27.14 62.03 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.733 0.302 . . . . 75.310000000000002 111.743 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -82.96 -13.18 56.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.001 0.429 . . . . 74.420000000000002 111.761 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 41' ' ' LEU . 46.6 t -98.44 -38.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.037 0.446 . . . . 64.219999999999999 111.422 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -93.12 1.77 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.125 -0.559 . . . . 75.140000000000001 112.697 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -93.53 136.7 33.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.648 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 81.5 mtp -139.76 129.15 13.79 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 111.923 0.342 . . . . 73.049999999999997 111.923 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.632 ' HG2' ' HB1' ' A' ' 37' ' ' ALA . 73.1 Cg_endo -77.52 117.85 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.531 2.154 . . . . 70.540000000000006 112.786 174.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.18 -177.8 25.36 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.797 -0.716 . . . . 74.439999999999998 113.539 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.1 tp -111.96 116.11 30.05 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.867 0.365 . . . . 74.129999999999995 111.223 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.9 t-20 -76.98 134.94 38.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.42 -0.354 . . . . 62.039999999999999 110.841 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -84.25 -40.09 18.46 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.731 0.641 . . . . 74.420000000000002 112.731 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -67.5 -30.47 70.16 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.124 0.416 . . . . 75.120000000000005 112.124 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -114.81 -28.69 6.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.92 0.341 . . . . 60.229999999999997 111.92 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 14.7 mmt85 64.14 28.93 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.159 0.504 . . . . 61.039999999999999 112.18 -176.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -91.03 143.86 26.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.993 -0.549 . . . . 61.109999999999999 111.204 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' NH1' ' H ' ' A' ' 68' ' ' GLY . 10.0 mmm180 -96.43 164.42 12.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 75.409999999999997 111.858 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.519 ' H ' ' NH1' ' A' ' 67' ' ' ARG . . . 139.61 -165.89 25.72 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.453 -0.794 . . . . 74.120000000000005 112.121 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -108.14 132.92 53.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.675 -0.309 . . . . 73.310000000000002 110.801 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -118.86 147.35 42.17 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.739 0.304 . . . . 73.219999999999999 111.199 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.87 103.6 1.75 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.384 2.056 . . . . 72.439999999999998 112.642 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -60.07 -14.99 34.48 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.503 0.561 . . . . 73.340000000000003 114.503 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -62.43 -18.4 61.62 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.841 0.682 . . . . 63.329999999999998 112.841 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.35 3.32 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.913 -0.492 . . . . 75.200000000000003 112.155 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 11' ' ' ALA . 15.0 m -120.96 159.5 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.178 0.513 . . . . 72.310000000000002 112.073 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.98 152.41 28.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 110.905 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -83.84 106.56 15.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.708 0.289 . . . . 73.219999999999999 111.22 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -72.65 -53.45 11.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.038 0.447 . . . . 74.430000000000007 111.099 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.58 -175.07 27.11 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.215 -0.517 . . . . 63.200000000000003 113.11 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.88 164.94 24.88 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.308 2.672 . . . . 70.219999999999999 112.636 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.434 HD23 ' HG3' ' A' ' 8' ' ' GLN . 2.3 pp . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.048 0.388 . . . . 70.439999999999998 112.048 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 112.777 -0.129 . . . . 41.299999999999997 112.777 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -127.1 158.18 37.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.296 0.57 . . . . 74.420000000000002 111.944 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.05 127.44 56.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.902 -0.59 . . . . 73.349999999999994 111.369 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.2 163.25 14.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 64.030000000000001 110.143 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 10' ' ' ARG . 38.2 ttt180 -133.46 123.94 26.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.975 0.416 . . . . 62.439999999999998 111.59 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 25' ' ' LEU . . . -77.06 122.98 25.71 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.04 -0.527 . . . . 74.109999999999999 110.841 177.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.3 -60.11 2.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 61.509999999999998 111.915 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.452 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 91.8 m-85 -127.25 161.2 55.76 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-N 116.205 -0.452 . . . . 72.049999999999997 110.985 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_endo -63.7 135.15 47.33 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.01 1.806 . . . . 52.039999999999999 112.965 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 . . . . . 0 N--CA 1.468 0.458 0 CA-C-N 115.898 -0.592 . . . . 74.310000000000002 111.481 -177.089 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.6 tp . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.826 0.346 . . . . 65.430000000000007 111.304 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -62.48 119.97 10.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.087 0.47 . . . . 73.010000000000005 111.481 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 74.6 mt -100.35 143.11 30.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.456 . . . . 73.120000000000005 111.613 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.3 mm? -110.99 148.0 37.71 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.438 -0.346 . . . . 65.109999999999999 110.651 176.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 36.2 Cg_endo -63.57 106.22 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.506 2.138 . . . . 73.109999999999999 113.311 -175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.02 34.49 23.92 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.038 -0.528 . . . . 60.200000000000003 113.62 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.43 ' CG ' ' HB2' ' A' ' 63' ' ' ARG . 33.2 t70 -105.56 158.91 16.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.175 0.487 . . . . 64.019999999999996 111.997 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -101.09 131.85 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 121.395 0.616 . . . . 61.420000000000002 112.391 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.0 mp -111.2 127.76 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.831 -0.622 . . . . 54.25 110.704 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.0 122.68 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.008 0.433 . . . . 63.439999999999998 111.517 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.79 116.46 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.277 -0.42 . . . . 75.120000000000005 111.253 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 55.4 m -89.23 156.65 18.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 72.409999999999997 111.176 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HG2' HD12 ' A' ' 38' ' ' LEU . 36.1 mtm180 -71.48 -14.66 62.2 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.722 0.268 . . . . 73.25 111.722 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.46 -35.74 20.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.011 0.434 . . . . 73.420000000000002 111.523 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.52 13.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.984 0.421 . . . . 64.450000000000003 111.56 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.542 HD12 ' HG2' ' A' ' 35' ' ' ARG . 90.0 mt -56.82 -38.43 72.6 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 75.409999999999997 112.164 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 14.8 mm100 -65.3 -37.69 87.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.904 0.383 . . . . 73.340000000000003 110.997 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -34.06 76.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.026 0.441 . . . . 62.409999999999997 110.989 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.556 HD11 ' HD2' ' A' ' 58' ' ' PRO . 75.2 mt -69.99 -28.5 65.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.104 -0.498 . . . . 75.099999999999994 111.118 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 41.81 6.05 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.353 -0.451 . . . . 75.0 112.598 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.64 129.78 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.886 0.374 . . . . 72.329999999999998 111.757 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 148.69 37.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.955 0.407 . . . . 60.409999999999997 112.029 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.55 122.43 12.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.151 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.13 2.77 60.59 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.023 -0.608 . . . . 73.409999999999997 112.836 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.27 -28.49 10.62 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.3 -0.476 . . . . 62.130000000000003 112.855 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -34.53 72.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.042 0.386 . . . . 64.510000000000005 112.042 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -63.56 -12.02 29.34 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.168 0.432 . . . . 74.420000000000002 112.168 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -134.55 85.55 36.86 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 120.819 0.343 . . . . 75.430000000000007 110.515 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 17.7 Cg_endo -55.94 -28.1 66.79 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.154 2.569 . . . . 74.129999999999995 113.284 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -62.4 -23.36 66.79 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.326 -0.397 . . . . 62.310000000000002 111.75 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -68.1 -45.31 74.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.097 0.475 . . . . 71.129999999999995 111.358 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.17 -46.44 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.155 -0.475 . . . . 61.439999999999998 111.459 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.0 -90.22 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.258 -0.496 . . . . 54.240000000000002 113.285 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -112.06 114.76 27.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.956 0.408 . . . . 75.420000000000002 111.906 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -124.26 138.43 30.86 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.436 -0.347 . . . . 61.109999999999999 111.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HD2' HD11 ' A' ' 41' ' ' LEU . 71.6 Cg_endo -77.93 127.94 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.411 2.074 . . . . 64.109999999999999 112.393 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.69 168.83 27.33 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.812 -0.709 . . . . 34.200000000000003 113.288 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 tp -103.88 124.02 48.19 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.764 0.316 . . . . 71.530000000000001 111.204 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -84.45 118.13 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.714 0.293 . . . . 72.519999999999996 110.666 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.3 -31.62 72.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.747 0.647 . . . . 63.43 112.747 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -63.37 -51.62 65.12 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.045 0.45 . . . . 72.230000000000004 111.847 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 82.6 p -102.43 -18.79 15.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.295 0.85 . . . . 75.209999999999994 113.295 -172.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER 69.58 17.97 7.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.934 0.494 . . . . 65.140000000000001 111.631 -173.343 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -84.13 149.27 26.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.116 0.484 . . . . 75.409999999999997 111.507 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 67' ' ' ARG . 50.1 mtp180 -111.23 150.71 29.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.122 -0.49 . . . . 74.049999999999997 110.679 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.62 164.08 27.49 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.503 -0.855 . . . . 72.439999999999998 113.647 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.03 109.58 20.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -106.72 143.75 27.66 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.24 0.459 . . . . 72.109999999999999 112.24 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.37 104.69 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.54 2.16 . . . . 71.329999999999998 112.079 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -61.03 -18.57 55.01 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.082 0.793 . . . . 74.120000000000005 115.082 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -58.65 -24.83 61.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.683 0.742 . . . . 74.340000000000003 112.149 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -100.66 11.66 39.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.647 0.61 . . . . 60.530000000000001 112.647 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.86 150.32 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.778 0.323 . . . . 64.209999999999994 111.078 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 14.7 pt-20 -98.94 153.72 18.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.04 0.448 . . . . 63.409999999999997 111.294 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -92.76 116.34 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.289 -0.414 . . . . 74.150000000000006 111.385 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.77 -67.42 0.78 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.883 0.373 . . . . 70.409999999999997 111.438 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.24 179.74 41.94 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.205 -0.522 . . . . 62.439999999999998 112.802 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.96 165.14 33.47 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.855 2.37 . . . . 63.200000000000003 113.369 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.994 0.426 . . . . 71.549999999999997 111.797 177.863 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.414 0 CA-C-O 120.634 0.019 . . . . 72.120000000000005 113.105 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -131.03 145.6 52.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.988 0.423 . . . . 64.120000000000005 111.507 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -93.05 134.03 35.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.146 -0.479 . . . . 61.32 111.534 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 123.99 41.17 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.524 -0.307 . . . . 72.409999999999997 110.987 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 78' ' ' LEU . 43.5 ttm180 -97.85 115.59 28.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.346 -0.221 . . . . 45.310000000000002 111.113 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.96 108.99 3.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.805 0.336 . . . . 61.109999999999999 111.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.91 -29.57 27.04 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.167 0.432 . . . . 61.329999999999998 112.167 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -124.2 135.48 26.47 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 122.353 -0.217 . . . . 73.019999999999996 111.574 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.5 Cg_endo -69.21 119.86 6.79 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.296 1.998 . . . . 61.43 112.638 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 t80 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 116.104 -0.498 . . . . 74.129999999999995 111.364 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 120.782 0.325 . . . . 44.130000000000003 111.244 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.86 138.92 46.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.193 0.52 . . . . 74.129999999999995 111.987 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 94.6 mt -106.24 137.59 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.103 -0.499 . . . . 72.239999999999995 111.598 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -120.72 142.84 35.14 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 122.452 0.301 . . . . 62.140000000000001 110.839 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 46.0 Cg_endo -66.44 117.6 4.85 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.565 2.177 . . . . 60.210000000000001 112.814 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.79 45.43 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.263 -0.494 . . . . 51.32 113.265 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.92 138.8 39.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.008 0.404 . . . . 61.25 110.742 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.96 97.68 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.98 0.419 . . . . 71.430000000000007 110.965 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.0 mp -81.1 127.15 32.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.999 0.428 . . . . 72.040000000000006 111.498 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.0 113.53 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.345 -0.388 . . . . 70.219999999999999 111.595 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -109.71 134.57 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.388 -0.369 . . . . 72.530000000000001 110.645 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -74.77 149.35 39.77 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.02 0.438 . . . . 52.149999999999999 111.586 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.5 -38.19 88.92 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.166 0.508 . . . . 64.420000000000002 110.285 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.44 80.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.735 -0.666 . . . . 73.549999999999997 111.613 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.83 -47.0 86.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.936 0.398 . . . . 71.239999999999995 111.129 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.01 -41.25 96.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.394 -0.366 . . . . 63.350000000000001 111.227 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -60.34 -37.28 80.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.953 0.406 . . . . 75.129999999999995 111.047 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.41 93.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.038 0.447 . . . . 60.350000000000001 110.838 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.78 -21.4 64.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.083 -0.508 . . . . 70.319999999999993 111.816 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.01 36.42 6.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.307 -0.473 . . . . 41.200000000000003 113.144 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.57 130.21 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.903 0.382 . . . . 44.219999999999999 111.146 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.76 150.41 20.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 62.130000000000003 111.802 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -48.44 121.37 4.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.974 0.416 . . . . 71.319999999999993 111.522 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.17 57.48 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.24 -0.505 . . . . 71.430000000000007 112.995 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.78 -28.18 4.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.319 -0.467 . . . . 74.120000000000005 112.966 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -31.29 64.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.174 0.59 . . . . 65.129999999999995 111.974 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.428 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 12.8 ptp180 -59.06 -13.69 7.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.687 0.625 . . . . 73.319999999999993 112.687 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 26.6 p -127.32 84.0 64.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 121.02 0.438 . . . . 63.439999999999998 111.276 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 -33.3 97.79 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.719 2.279 . . . . 52.210000000000001 112.562 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.679 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 90.6 mt-30 -58.64 -28.86 66.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.105 -0.498 . . . . 62.509999999999998 111.513 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 t -76.25 -33.42 59.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.853 0.358 . . . . 43.539999999999999 111.38 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.93 -58.55 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.9 0.381 . . . . 72.329999999999998 111.414 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.13 -137.15 12.46 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.515 . . . . 63.100000000000001 112.709 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.94 132.91 39.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.2 0.524 . . . . 61.520000000000003 111.686 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -132.41 147.64 66.48 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 116.12 -0.491 . . . . 55.509999999999998 111.593 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 126.4 8.56 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.503 2.135 . . . . 71.299999999999997 112.403 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.81 -175.25 24.89 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.475 -0.869 . . . . 45.399999999999999 114.131 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.88 117.12 24.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.335 0.254 . . . . 64.140000000000001 111.253 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -79.92 129.65 34.66 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.568 0.223 . . . . 62.329999999999998 110.493 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -92.39 -6.53 49.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.181 1.178 . . . . 64.319999999999993 114.181 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.64 -23.64 18.93 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.718 -0.614 . . . . 71.409999999999997 111.363 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -111.36 -16.93 13.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.04 0.448 . . . . 43.450000000000003 111.223 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 62.59 22.44 13.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.577 0.751 . . . . 73.310000000000002 111.568 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -101.21 149.19 24.25 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.073 0.463 . . . . 71.099999999999994 112.157 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -92.63 156.39 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.007 -0.542 . . . . 74.209999999999994 111.107 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.55 -172.35 44.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.593 -0.813 . . . . 70.150000000000006 113.453 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.06 125.58 54.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.611 0.364 . . . . 73.409999999999997 110.252 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -132.12 142.77 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 N-CA-C 111.93 0.345 . . . . 63.240000000000002 111.93 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.32 113.9 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.398 2.066 . . . . 72.340000000000003 112.36 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.39 33.02 0.97 Allowed Glycine 0 CA--C 1.53 1.0 0 N-CA-C 114.424 0.529 . . . . 74.239999999999995 114.424 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.679 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 43.4 m -92.52 -28.92 16.49 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.399 -0.471 . . . . 64.420000000000002 110.936 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.46 5.29 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.198 -0.455 . . . . 71.120000000000005 112.01 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 11' ' ' ALA . 19.1 m -117.64 145.39 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.783 0.325 . . . . 75.209999999999994 111.486 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 14.6 pt-20 -99.87 152.32 20.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.996 0.427 . . . . 71.150000000000006 110.972 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 49' ' ' ARG . 68.3 t80 -84.82 107.41 16.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.982 0.42 . . . . 74.299999999999997 111.09 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 10' ' ' ARG . 67.2 mt -76.93 -38.1 54.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.847 0.356 . . . . 55.329999999999998 111.24 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.68 -176.51 19.16 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.29 -0.481 . . . . 45.409999999999997 113.089 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.57 150.08 68.89 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.84 2.36 . . . . 61.329999999999998 112.259 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.4 mp . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.13 0.49 . . . . 71.420000000000002 111.204 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 112.573 -0.211 . . . . 63.049999999999997 112.573 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -133.36 137.0 45.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.91 0.386 . . . . 75.319999999999993 111.159 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.524 ' HG2' HG22 ' A' ' 32' ' ' VAL . 98.0 mt-30 -94.95 126.92 40.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 112.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.87 123.98 49.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.961 -0.563 . . . . 74.219999999999999 110.091 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 10' ' ' ARG . 20.1 ttt180 -97.85 124.37 42.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.205 0.446 . . . . 74.109999999999999 112.205 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -69.13 126.63 30.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.915 0.388 . . . . 53.509999999999998 111.831 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.74 -55.37 4.01 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.233 0.457 . . . . 71.120000000000005 112.233 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -115.21 150.07 43.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 111.62 0.23 . . . . 73.409999999999997 111.62 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.2 Cg_endo -73.96 120.02 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.544 2.163 . . . . 73.209999999999994 113.872 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 73.109999999999999 111.053 175.393 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.9 tp . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 121.024 0.44 . . . . 74.299999999999997 111.292 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.26 149.89 33.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.165 0.507 . . . . 71.310000000000002 111.839 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 84.2 mt -127.18 125.74 41.62 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.007 -0.542 . . . . 43.43 111.444 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.52 152.62 44.77 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-O 120.72 0.295 . . . . 61.310000000000002 110.359 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 42.5 Cg_endo -65.82 105.53 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.058 1.839 . . . . 75.530000000000001 112.463 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.55 10.06 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.106 -0.568 . . . . 71.219999999999999 113.433 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.03 118.29 6.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 117.008 0.404 . . . . 53.109999999999999 111.616 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.48 92.64 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.129 0.49 . . . . 71.109999999999999 110.566 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 5.9 mp -78.8 120.55 23.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 60.210000000000001 111.968 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 8' ' ' GLN . 48.3 t -93.09 111.95 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.105 -0.498 . . . . 74.129999999999995 111.654 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.07 122.45 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.328 -0.396 . . . . 73.209999999999994 110.937 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.9 p -68.07 139.73 56.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.995 0.426 . . . . 64.340000000000003 111.114 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -63.96 -32.37 73.88 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.874 0.369 . . . . 74.140000000000001 110.943 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.83 85.9 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.296 -0.411 . . . . 71.239999999999995 111.269 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.57 -43.5 93.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.002 0.43 . . . . 63.399999999999999 111.081 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.8 mt -58.98 -42.51 90.17 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.285 -0.416 . . . . 71.040000000000006 111.341 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.46 -37.12 86.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.933 0.397 . . . . 75.310000000000002 111.012 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.21 77.45 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.959 0.409 . . . . 75.409999999999997 111.484 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.572 HD11 ' HD2' ' A' ' 58' ' ' PRO . 88.9 mt -72.46 -20.86 61.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.248 -0.433 . . . . 71.129999999999995 111.526 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.61 28.61 35.04 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.323 -0.465 . . . . 71.530000000000001 112.763 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 41' ' ' LEU . 58.8 t -78.65 124.74 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.775 0.321 . . . . 61.130000000000003 111.356 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.71 139.29 53.39 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.998 0.428 . . . . 61.32 111.731 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.11 122.31 11.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.114 0.483 . . . . 61.329999999999998 111.121 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.82 -13.32 24.68 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.957 -0.64 . . . . 72.099999999999994 112.461 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.0 -25.27 49.77 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.347 -0.454 . . . . 74.400000000000006 113.408 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.433 ' OE2' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -58.91 -28.39 66.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.974 0.361 . . . . 71.510000000000005 111.974 -178.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HG3' ' OE2' ' A' ' 48' ' ' GLU . 50.1 mtm180 -56.48 -29.13 61.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.951 0.352 . . . . 72.209999999999994 111.951 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 71.0 m -133.28 84.85 46.05 Favored Pre-proline 0 N--CA 1.474 0.73 0 CA-C-O 120.953 0.406 . . . . 63.140000000000001 111.053 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.526 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 18.3 Cg_endo -57.94 -23.62 60.75 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.004 2.469 . . . . 73.239999999999995 113.491 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -60.25 -24.33 64.8 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.906 0.336 . . . . 74.519999999999996 111.906 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.3 t -66.48 -31.56 72.37 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.183 0.516 . . . . 74.019999999999996 111.609 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.12 -57.17 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.139 -0.482 . . . . 73.120000000000005 111.367 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.88 -88.88 0.5 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.257 -0.497 . . . . 51.329999999999998 113.185 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 7.4 m0 -103.18 107.33 18.1 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.343 0.497 . . . . 75.420000000000002 112.343 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -116.22 137.76 23.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.964 -0.562 . . . . 74.129999999999995 110.673 175.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.572 ' HD2' HD11 ' A' ' 41' ' ' LEU . 65.2 Cg_endo -74.67 117.76 5.07 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.311 2.008 . . . . 71.530000000000001 112.628 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.87 172.49 22.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.06 -0.59 . . . . 73.230000000000004 113.299 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 60.3 tp -97.66 114.36 26.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.93 0.395 . . . . 73.319999999999993 111.607 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 23.6 t-20 -74.53 123.08 24.12 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.382 -0.372 . . . . 61.240000000000002 111.711 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -72.63 -19.64 61.42 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.214 0.82 . . . . 71.549999999999997 113.214 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 1.5 tpm_? -66.05 -59.93 3.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.337 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 66' ' ' GLN . 72.3 p -122.91 6.21 9.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.831 0.678 . . . . 71.25 112.831 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 0.1 OUTLIER 67.35 32.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.632 0.605 . . . . 73.310000000000002 112.632 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 83.7 mm-40 -79.19 130.57 35.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.742 0.306 . . . . 64.129999999999995 111.296 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -98.47 121.61 40.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.572 0.225 . . . . 74.5 110.707 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -175.03 -177.83 44.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.514 -0.85 . . . . 52.119999999999997 113.495 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 20.1 m-20 -88.23 119.94 29.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 73.099999999999994 111.194 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.5 p90 -114.8 145.77 34.65 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.432 -0.349 . . . . 72.209999999999994 111.07 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.53 109.46 2.76 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.426 2.084 . . . . 71.25 112.438 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.36 34.07 0.96 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.243 0.457 . . . . 32.32 114.243 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.0 p -102.87 -26.73 13.01 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.461 -0.435 . . . . 71.510000000000005 111.348 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.6 15.54 26.81 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 53.439999999999998 111.795 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 11' ' ' ALA . 24.2 m -118.73 161.3 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.933 0.397 . . . . 73.239999999999995 111.517 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.11 138.12 46.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.094 0.473 . . . . 52.399999999999999 110.919 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.463 ' CZ ' ' HA2' ' A' ' 79' ' ' GLY . 39.5 t80 -77.76 116.6 18.41 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.868 0.366 . . . . 41.409999999999997 110.963 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -86.43 -48.29 8.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.236 0.541 . . . . 74.329999999999998 110.78 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' CZ ' ' A' ' 77' ' ' PHE . . . 131.24 -165.22 23.2 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.849 -0.614 . . . . 50.049999999999997 112.502 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.55 166.36 19.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.332 2.022 . . . . 65.209999999999994 111.97 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 81' ' ' LEU . 6.3 mp . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 65.120000000000005 111.724 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.526 0.724 0 N-CA-C 113.026 -0.03 . . . . 65.109999999999999 113.026 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -130.12 148.22 51.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.616 0.366 . . . . 74.439999999999998 111.112 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.775 ' HG3' HD11 ' A' ' 81' ' ' LEU . 82.2 mt-30 -103.63 143.86 32.2 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.19 0.519 . . . . 70.400000000000006 112.018 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.542 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 87.9 m-85 -132.05 125.86 32.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.934 -0.575 . . . . 74.010000000000005 110.692 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HB2' HD11 ' A' ' 78' ' ' LEU . 43.5 ttp180 -98.58 116.52 30.99 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.005 -0.435 . . . . 74.239999999999995 111.82 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 113.88 7.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.919 0.39 . . . . 72.319999999999993 111.451 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.469 HD21 ' HG3' ' A' ' 76' ' ' GLU . 84.0 mt -77.92 -39.11 43.92 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.43 0.53 . . . . 64.0 112.43 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -126.32 145.81 54.02 Favored Pre-proline 0 N--CA 1.469 0.505 0 N-CA-C 111.718 0.266 . . . . 72.129999999999995 111.718 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 36.9 Cg_endo -65.88 131.62 27.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.434 2.089 . . . . 72.230000000000004 112.345 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 92.1 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.48 -0.327 . . . . 71.519999999999996 111.618 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 66' ' ' GLN . 43.1 tp . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.171 0.51 . . . . 73.239999999999995 112.046 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.31 166.32 10.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.073 -0.512 . . . . 52.43 111.228 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' PHE . 90.9 mt -114.99 142.51 46.53 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.675 0.62 . . . . 51.450000000000003 112.675 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -121.63 151.2 56.7 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 122.944 0.498 . . . . 70.209999999999994 110.658 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.5 Cg_endo -71.44 129.17 15.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.382 2.055 . . . . 74.310000000000002 113.261 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.28 22.83 75.34 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.223 -0.513 . . . . 73.420000000000002 113.105 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -105.97 157.85 17.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 65.140000000000001 110.846 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.88 133.25 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.252 0.549 . . . . 63.210000000000001 111.895 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.8 mp -121.38 139.23 53.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.094 -0.503 . . . . 54.310000000000002 110.533 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.4 HG22 ' HG2' ' A' ' 8' ' ' GLN . 57.1 t -106.26 124.86 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 120.983 0.42 . . . . 72.239999999999995 112.04 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.01 124.39 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.414 -0.357 . . . . 74.420000000000002 110.754 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.543 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 74.9 m -95.12 159.98 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.449 0.536 . . . . 65.129999999999995 112.449 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -50.79 -38.94 51.29 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.404 -0.362 . . . . 54.119999999999997 111.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.7 -37.44 41.38 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.122 0.416 . . . . 40.119999999999997 112.122 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -77.14 -49.14 15.88 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.933 0.397 . . . . 74.299999999999997 111.265 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 94.8 mt -58.52 -46.06 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.426 -0.352 . . . . 73.5 111.887 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.57 -35.71 78.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.602 0.239 . . . . 74.349999999999994 111.584 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.2 75.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.081 0.467 . . . . 65.540000000000006 111.046 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 60.5 mt -76.31 -28.7 57.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.2 0.524 . . . . 75.129999999999995 111.109 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.0 16.99 15.06 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.048 -0.523 . . . . 65.439999999999998 112.963 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 61.8 t -83.65 130.66 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.897 0.379 . . . . 70.349999999999994 111.094 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.54 152.61 25.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.252 -0.431 . . . . 44.409999999999997 111.811 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -40.62 111.97 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.786 0.435 . . . . 63.299999999999997 111.725 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.9 -17.11 7.71 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.401 -0.428 . . . . 73.319999999999993 112.501 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 -33.44 7.91 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.213 -0.518 . . . . 53.310000000000002 113.278 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -33.01 71.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.328 0.492 . . . . 73.510000000000005 112.328 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -68.06 -5.37 17.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.086 0.47 . . . . 62.32 112.009 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 89.7 m -141.37 81.94 14.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.271 -0.422 . . . . 74.040000000000006 110.444 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 18.8 Cg_endo -56.13 -16.21 16.34 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.125 2.55 . . . . 52.340000000000003 113.461 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -59.11 -31.21 68.72 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.728 0.299 . . . . 65.329999999999998 111.665 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.3 t -82.7 -23.91 33.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.732 0.301 . . . . 62.020000000000003 111.215 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.69 -44.86 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.975 0.417 . . . . 75.510000000000005 110.456 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 76.48 -76.53 1.5 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.147 -0.478 . . . . 72.409999999999997 113.389 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -121.3 129.2 52.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.945 0.402 . . . . 71.239999999999995 111.445 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -152.82 145.0 16.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.264 0.468 . . . . 63.399999999999999 112.264 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -90.07 124.86 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.928 2.419 . . . . 51.119999999999997 112.974 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.92 176.6 25.72 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.003 -0.618 . . . . 72.140000000000001 113.39 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.5 tp -97.48 132.12 43.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 74.0 110.868 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 24.5 t-20 -95.03 143.36 26.56 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.388 -0.369 . . . . 72.129999999999995 111.14 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -84.77 -55.79 3.92 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.607 0.595 . . . . 45.340000000000003 112.607 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -64.63 -56.0 16.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.229 0.455 . . . . 63.219999999999999 112.229 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 p -81.45 -17.06 50.09 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.88 0.326 . . . . 70.409999999999997 111.88 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 77.1 mtp180 61.64 18.11 9.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.004 0.522 . . . . 71.329999999999998 112.406 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 23' ' ' LEU . 96.5 mt-30 -86.53 164.68 16.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.256 0.551 . . . . 72.310000000000002 111.904 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -128.92 131.58 47.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.896 -0.593 . . . . 75.120000000000005 110.666 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.23 -170.28 43.31 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.381 -0.914 . . . . 61.399999999999999 113.764 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.18 123.19 33.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.424 0.29 . . . . 62.210000000000001 110.941 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.83 151.3 77.95 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.662 0.268 . . . . 53.140000000000001 111.432 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 88.1 Cg_endo -77.29 120.43 5.31 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.486 2.124 . . . . 64.549999999999997 112.91 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 51' ' ' PRO . . . -77.64 16.17 6.83 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.391 -0.433 . . . . 61.200000000000003 113.943 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -81.3 -20.65 40.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.251 -0.558 . . . . 61.210000000000001 111.615 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -104.88 12.3 32.67 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.368 0.507 . . . . 73.540000000000006 112.368 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 33.2 m -121.95 146.03 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 113.366 0.876 . . . . 71.329999999999998 113.366 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 5.8 mm-40 -93.68 130.74 39.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.605 -0.725 . . . . 71.430000000000007 111.524 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -70.36 100.21 1.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.041 0.448 . . . . 74.540000000000006 110.416 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 10' ' ' ARG . 64.0 mt -74.8 -47.69 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.365 -0.38 . . . . 63.329999999999998 111.376 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.78 177.02 22.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.639 -0.791 . . . . 54.399999999999999 113.885 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.27 137.61 12.06 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.545 2.83 . . . . 54.439999999999998 112.871 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 8' ' ' GLN . 5.8 mp . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 120.869 0.366 . . . . 52.5 111.634 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.423 0 N-CA-C 112.166 -0.373 . . . . 32.329999999999998 112.166 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -131.55 146.15 52.08 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.129 0.49 . . . . 75.209999999999994 111.946 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -101.43 128.33 47.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.048 -0.524 . . . . 74.25 111.416 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.37 128.15 53.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.318 -0.401 . . . . 72.040000000000006 110.715 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.571 ' HB2' HD11 ' A' ' 78' ' ' LEU . 55.8 ttp180 -98.11 120.97 39.45 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.144 0.424 . . . . 62.310000000000002 112.144 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . . . -74.07 114.72 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.229 -0.441 . . . . 64.329999999999998 111.313 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -82.21 -43.67 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.17 0.433 . . . . 75.150000000000006 112.17 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.65 140.93 28.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 N-CA-C 112.122 0.416 . . . . 61.329999999999998 112.122 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 35.5 Cg_endo -65.74 123.59 11.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.444 2.096 . . . . 60.130000000000003 112.935 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.6 t80 . . . . . 0 CA--C 1.536 0.43 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 111.313 179.816 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 61' ' ' ASN . 45.9 tp . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 70.030000000000001 111.78 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.53 142.41 30.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.431 -0.35 . . . . 64.200000000000003 110.84 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 66.2 mt -116.16 141.96 47.45 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.128 0.418 . . . . 41.009999999999998 112.128 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.86 153.51 46.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 122.721 0.408 . . . . 45.020000000000003 110.766 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 29.5 Cg_endo -61.69 117.21 4.01 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.602 2.202 . . . . 74.219999999999999 113.206 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.28 16.85 33.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.154 -0.476 . . . . 60.210000000000001 113.826 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 9.6 m-20 -77.22 135.67 38.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.877 0.695 . . . . 50.329999999999998 112.877 178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.24 97.06 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.15 0.5 . . . . 63.32 110.24 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.6 mp -81.98 132.89 35.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.097 0.475 . . . . 71.129999999999995 111.902 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 81' ' ' LEU . 66.8 t -94.05 109.41 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.047 -0.524 . . . . 71.319999999999993 111.142 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 117.91 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.011 0.434 . . . . 70.040000000000006 111.281 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.7 p -68.02 141.46 56.21 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.801 0.334 . . . . 73.0 111.519 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -67.01 -23.75 65.95 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.023 0.44 . . . . 74.040000000000006 110.803 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.24 89.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.182 -0.463 . . . . 70.299999999999997 111.191 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.93 -44.16 97.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.38 . . . . 73.549999999999997 111.288 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.84 -45.14 90.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.983 0.421 . . . . 64.0 110.654 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -59.77 -40.39 88.08 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.239 -0.437 . . . . 71.230000000000004 111.265 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.23 79.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.028 0.442 . . . . 64.200000000000003 111.537 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.18 -17.63 60.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.159 -0.473 . . . . 74.150000000000006 111.192 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 18.18 38.04 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.499 -0.382 . . . . 63.340000000000003 113.396 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.57 114.43 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.024 0.379 . . . . 71.299999999999997 112.024 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.59 151.04 20.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.383 -0.371 . . . . 55.439999999999998 111.098 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 146.05 5.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.278 0.561 . . . . 73.319999999999993 111.794 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.14 -26.3 24.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.77 -0.532 . . . . 5.1200000000000001 111.77 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.86 1.47 17.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.508 -0.377 . . . . 71.219999999999999 112.673 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -38.41 90.98 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.089 0.471 . . . . 73.439999999999998 111.611 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -81.5 9.84 6.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.291 0.478 . . . . 61.130000000000003 112.291 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.0 m -122.39 72.9 39.26 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 120.85 0.357 . . . . 75.340000000000003 111.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 34.1 Cg_endo -63.66 -23.08 70.01 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.67 2.247 . . . . 74.019999999999996 112.773 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.44 -34.56 69.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.314 -0.403 . . . . 64.530000000000001 111.357 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -71.77 -41.61 68.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.93 0.395 . . . . 73.120000000000005 111.229 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.46 -38.33 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.123 -0.49 . . . . 55.049999999999997 111.594 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.95 -79.06 0.88 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.244 -0.503 . . . . 73.129999999999995 112.913 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -121.14 142.36 49.94 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.674 -0.309 . . . . 71.420000000000002 110.9 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 56.6 mtm -138.88 140.68 27.85 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.247 -0.283 . . . . 55.299999999999997 111.488 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.19 117.51 2.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.584 2.189 . . . . 75.030000000000001 112.524 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.72 178.26 26.41 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.732 -0.747 . . . . 73.200000000000003 113.77 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.24 132.67 50.25 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.961 0.41 . . . . 74.030000000000001 111.733 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.532 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.9 t-20 -99.98 149.25 23.64 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 111.348 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -92.01 -35.78 13.76 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.587 0.588 . . . . 74.310000000000002 112.587 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 13.8 tpp180 -56.72 -51.61 68.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.204 0.526 . . . . 75.209999999999994 111.315 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.9 p -100.14 -15.04 18.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.688 -0.687 . . . . 72.239999999999995 111.885 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtp180 64.2 18.08 11.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.795 0.438 . . . . 73.439999999999998 112.131 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -103.39 157.5 16.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.151 0.501 . . . . 72.209999999999994 112.228 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 67' ' ' ARG . 19.5 mtp180 -98.3 149.68 22.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.206 -0.452 . . . . 71.430000000000007 111.247 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.27 -178.72 47.62 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.93 -0.652 . . . . 74.120000000000005 112.894 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.13 124.99 40.35 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.595 0.236 . . . . 74.519999999999996 110.752 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -123.65 143.0 40.59 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 120.838 0.351 . . . . 63.439999999999998 111.668 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.66 116.07 4.24 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.659 2.239 . . . . 75.420000000000002 112.361 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -59.59 -17.57 41.5 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.715 0.646 . . . . 64.549999999999997 114.715 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.418 HG23 ' CD1' ' A' ' 74' ' ' TYR . 3.4 t -57.0 -32.46 66.14 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.799 0.666 . . . . 62.399999999999999 112.799 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.418 ' CD1' HG23 ' A' ' 73' ' ' THR . 95.9 m-85 -81.31 -16.9 51.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.663 0.616 . . . . 74.400000000000006 112.663 -177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -108.92 145.42 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.419 0.526 . . . . 54.420000000000002 112.419 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.53 154.71 24.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.058 -0.519 . . . . 52.0 110.857 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.07 126.51 33.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.824 0.345 . . . . 71.519999999999996 111.612 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 10' ' ' ARG . 83.9 mt -100.03 -68.11 0.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.056 0.455 . . . . 73.209999999999994 111.232 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.83 -178.69 46.78 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 60.229999999999997 113.103 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.84 166.21 30.61 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.293 2.662 . . . . 44.009999999999998 113.233 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.493 HD22 HG13 ' A' ' 32' ' ' VAL . 3.4 pp . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 112.306 0.484 . . . . 75.209999999999994 112.306 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.525 0.657 0 N-CA-C 114.421 0.529 . . . . 44.240000000000002 114.421 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.54 147.86 43.97 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.988 0.423 . . . . 73.310000000000002 111.412 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG2' HG22 ' A' ' 32' ' ' VAL . 45.9 mt-30 -92.75 133.11 36.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.899 0.38 . . . . 75.140000000000001 111.258 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -118.38 139.16 51.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.293 -0.412 . . . . 75.0 110.661 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 78' ' ' LEU . 36.1 ttm180 -107.99 127.69 53.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.947 -0.47 . . . . 74.120000000000005 111.984 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.37 128.2 33.99 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.457 -0.338 . . . . 74.430000000000007 110.592 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.6 mt -68.28 -62.15 1.53 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.372 0.606 . . . . 74.219999999999999 111.821 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.549 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.0 m-85 -118.19 171.91 4.67 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.979 -0.555 . . . . 63.119999999999997 110.314 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -70.8 117.73 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 120.902 1.068 . . . . 63.329999999999998 111.261 170.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 83.8 m-85 . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.306 0.574 . . . . 73.340000000000003 111.763 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 tp . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 120.888 0.375 . . . . 72.319999999999993 110.936 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mp0 -75.95 155.8 34.76 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.006 0.432 . . . . 65.200000000000003 111.393 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 97.5 mt -112.12 143.05 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.48 -0.327 . . . . 74.299999999999997 111.277 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.66 154.34 46.74 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 122.596 0.359 . . . . 71.439999999999998 111.116 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 120.45 7.97 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.454 2.102 . . . . 62.030000000000001 113.207 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.07 69.9 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.165 -0.47 . . . . 73.329999999999998 113.58 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.82 155.57 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.377 -0.484 . . . . 72.519999999999996 111.349 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.35 129.57 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.233 0.539 . . . . 41.549999999999997 112.056 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 4.9 mp -124.37 121.31 34.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.112 -0.494 . . . . 73.430000000000007 110.527 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.493 HG13 HD11 ' A' ' 81' ' ' LEU . 48.9 t -94.12 124.09 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.332 0.493 . . . . 65.329999999999998 112.332 -175.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.97 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 120.979 0.418 . . . . 44.340000000000003 111.265 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.492 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 50.5 m -68.28 142.39 55.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.993 0.368 . . . . 44.219999999999999 111.993 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -60.55 -30.43 69.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.986 0.422 . . . . 74.209999999999994 111.452 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.4 81.32 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.131 0.491 . . . . 74.310000000000002 111.009 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.83 98.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.114 -0.494 . . . . 72.349999999999994 111.298 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.3 mt -56.84 -46.82 81.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.918 0.39 . . . . 74.450000000000003 111.021 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.64 -39.69 92.22 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.396 -0.366 . . . . 54.43 111.442 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.94 91.45 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.952 0.406 . . . . 72.340000000000003 111.005 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -66.77 -28.63 68.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.234 -0.439 . . . . 73.510000000000005 111.462 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.31 27.6 9.15 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.424 -0.417 . . . . 61.25 113.042 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.3 118.48 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.96 0.41 . . . . 51.140000000000001 111.097 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.52 149.81 29.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.305 -0.407 . . . . 63.109999999999999 111.866 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.18 119.19 6.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.01 0.434 . . . . 73.299999999999997 111.086 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.77 -4.82 18.97 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.049 -0.523 . . . . 64.299999999999997 112.327 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.04 -33.28 2.41 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.697 -0.287 . . . . 62.25 113.1 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -21.19 28.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.989 0.515 . . . . 74.230000000000004 112.222 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.81 -21.25 41.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.416 -0.356 . . . . 63.530000000000001 111.714 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.54 88.42 29.21 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.664 0.269 . . . . 72.420000000000002 110.951 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.69 -16.94 26.82 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.98 2.454 . . . . 61.399999999999999 113.318 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -57.64 -22.39 45.33 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.818 0.342 . . . . 64.340000000000003 111.889 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.0 t -77.81 -9.75 59.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.798 0.333 . . . . 64.420000000000002 111.813 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 t -106.55 -37.81 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.085 0.469 . . . . 65.420000000000002 111.626 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.43 -78.19 0.84 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.227 -0.511 . . . . 53.229999999999997 112.798 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.41 54.58 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.087 0.47 . . . . 74.120000000000005 111.223 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 71.1 mtp -139.49 139.39 22.37 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 111.623 -172.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.1 Cg_endo -82.16 117.4 2.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.304 2.003 . . . . 65.310000000000002 112.464 174.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.55 171.55 25.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.775 -0.726 . . . . 65.030000000000001 113.697 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 40.0 tp -96.74 109.15 21.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.594 0.358 . . . . 61.140000000000001 111.043 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -79.72 116.61 20.0 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.46 -0.336 . . . . 71.109999999999999 111.546 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.9 -21.49 63.3 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.733 0.642 . . . . 72.420000000000002 112.733 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 0.9 OUTLIER -60.58 -35.58 76.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.04 0.448 . . . . 73.540000000000006 111.325 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -119.57 -8.6 9.95 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.353 -0.385 . . . . 75.530000000000001 111.918 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 62.35 17.61 9.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 64.409999999999997 111.685 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -107.07 154.31 21.33 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.307 0.575 . . . . 72.310000000000002 111.931 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -101.18 134.67 43.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.948 -0.569 . . . . 72.239999999999995 111.219 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.0 172.11 34.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.979 -0.629 . . . . 73.109999999999999 112.985 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.7 113.18 25.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.906 0.384 . . . . 54.119999999999997 110.482 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.2 p90 -121.52 149.27 52.22 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.414 -0.357 . . . . 72.25 111.493 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 18.1 Cg_exo -66.29 95.15 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.355 2.037 . . . . 74.409999999999997 112.638 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.18 -19.69 40.0 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.085 -0.507 . . . . 40.140000000000001 113.534 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.0 t -61.79 -15.1 38.72 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.389 0.514 . . . . 63.219999999999999 112.389 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 35.8 m-85 -102.06 -1.54 31.44 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.623 0.601 . . . . 71.010000000000005 112.623 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.99 163.89 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.187 0.518 . . . . 73.129999999999995 112.153 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.08 148.75 41.25 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.106 -0.497 . . . . 73.510000000000005 111.714 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -79.02 118.22 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.071 -0.513 . . . . 75.019999999999996 111.642 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 10' ' ' ARG . 70.9 mt -89.97 -66.26 0.94 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 71.140000000000001 111.087 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.19 39.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.135 -0.555 . . . . 72.25 113.188 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.4 152.38 38.88 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.85 2.366 . . . . 61.310000000000002 113.083 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.493 HD11 HG13 ' A' ' 32' ' ' VAL . 4.9 mp . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.883 0.373 . . . . 72.019999999999996 111.201 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.417 0 CA-C-O 120.876 0.153 . . . . 73.040000000000006 113.328 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.22 171.3 12.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.093 0.473 . . . . 64.109999999999999 111.358 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.91 136.81 49.92 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.19 0.519 . . . . 53.32 111.811 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 94.5 m-85 -116.05 170.74 8.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.852 -0.613 . . . . 71.319999999999993 110.601 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.4 ttm180 -135.75 128.69 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.569 0.223 . . . . 63.130000000000003 111.275 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -66.08 114.67 5.4 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 63.119999999999997 111.858 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.45 -58.33 3.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.167 -0.47 . . . . 75.409999999999997 111.569 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.67 150.21 44.38 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.595 -0.275 . . . . 73.25 111.228 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 56.3 Cg_endo -70.91 118.05 5.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.16 1.906 . . . . 75.099999999999994 112.657 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.4 t80 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 72.549999999999997 110.979 -178.827 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.7 tp . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 120.908 0.385 . . . . 74.5 111.161 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.56 138.15 37.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.409 -0.36 . . . . 75.129999999999995 110.799 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 70' ' ' PHE . 69.0 mt -122.69 138.7 54.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.866 0.365 . . . . 54.119999999999997 111.898 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.551 ' HB2' ' NE ' ' A' ' 63' ' ' ARG . 3.9 mm? -122.11 140.73 32.86 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 122.666 0.386 . . . . 42.219999999999999 110.568 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.91 106.31 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.423 2.082 . . . . 40.240000000000002 113.257 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.56 -1.05 8.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.086 0.794 . . . . 75.010000000000005 115.086 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.79 156.4 16.39 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.703 1.252 . . . . 70.400000000000006 111.903 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -101.87 133.71 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.755 -0.657 . . . . 55.399999999999999 111.401 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.1 mp -106.59 110.28 22.44 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.014 -0.539 . . . . 64.400000000000006 110.591 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.51 120.18 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.907 0.384 . . . . 73.310000000000002 111.832 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.93 135.27 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.388 -0.369 . . . . 54.439999999999998 111.473 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.7 p -91.96 148.22 22.37 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.247 -0.283 . . . . 53.030000000000001 111.283 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 24.7 ptt180 -58.43 -28.43 65.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.953 0.353 . . . . 53.25 111.953 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.35 -39.48 70.1 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.924 0.392 . . . . 61.130000000000003 111.639 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.12 77.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 51.030000000000001 111.33 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.84 -42.48 93.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 55.439999999999998 111.211 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 15.3 mm100 -61.9 -39.07 90.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.3 -0.409 . . . . 75.299999999999997 111.185 176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.03 96.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.945 0.402 . . . . 71.540000000000006 111.346 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD11 ' HD2' ' A' ' 58' ' ' PRO . 84.2 mt -66.69 -24.72 66.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.177 0.513 . . . . 61.509999999999998 111.084 175.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.13 20.68 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.879 -0.601 . . . . 32.119999999999997 113.177 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.0 125.03 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.946 0.373 . . . . 62.340000000000003 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.38 131.2 45.24 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.577 -0.283 . . . . 63.329999999999998 111.491 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.06 126.96 28.24 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.326 0.584 . . . . 74.150000000000006 111.188 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.1 -2.89 51.36 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.071 -0.513 . . . . 74.099999999999994 112.157 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.87 -7.73 16.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.64 -0.314 . . . . 62.43 113.312 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.5 -20.07 63.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.008 0.432 . . . . 62.109999999999999 111.732 -178.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -71.2 -13.7 62.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.463 -0.335 . . . . 74.439999999999998 111.738 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.77 84.58 31.66 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.829 0.347 . . . . 44.210000000000001 111.437 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.73 -27.19 68.24 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.504 2.136 . . . . 74.219999999999999 112.937 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 73' ' ' THR . 22.0 mp0 -67.18 -17.47 64.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.102 0.477 . . . . 52.240000000000002 111.285 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.0 m -87.31 -25.21 24.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.303 -0.408 . . . . 63.439999999999998 111.415 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.08 -55.16 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.95 0.405 . . . . 73.510000000000005 111.609 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.8 -92.23 0.5 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.17 -0.538 . . . . 33.549999999999997 112.573 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -121.14 141.44 50.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 72.549999999999997 111.788 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -138.17 146.9 53.76 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 116.534 -0.303 . . . . 62.0 110.948 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' HD11 ' A' ' 41' ' ' LEU . 91.6 Cg_endo -79.19 126.65 7.1 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.341 2.028 . . . . 64.310000000000002 112.838 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.06 172.88 31.33 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.006 -0.616 . . . . 65.310000000000002 113.535 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.8 tp -97.47 119.12 35.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.263 0.225 . . . . 71.420000000000002 111.472 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.468 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.0 t-20 -90.95 121.42 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.573 -0.285 . . . . 71.140000000000001 110.593 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -73.65 -8.1 54.61 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.849 1.055 . . . . 73.510000000000005 113.849 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.551 ' NE ' ' HB2' ' A' ' 26' ' ' LEU . 57.7 mtt-85 -81.7 -54.39 5.42 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.569 -0.707 . . . . 71.230000000000004 111.117 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 64.3 p -86.81 -11.59 50.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.492 -0.322 . . . . 75.420000000000002 111.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.65 16.94 9.3 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.131 0.573 . . . . 74.439999999999998 111.681 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 64' ' ' THR . 68.3 mm-40 -107.41 152.84 23.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.049 0.452 . . . . 74.530000000000001 111.456 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 129.6 45.13 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.036 0.446 . . . . 72.420000000000002 111.199 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.91 173.62 34.56 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.156 -0.545 . . . . 73.430000000000007 113.146 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.41 118.82 28.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.903 0.382 . . . . 75.109999999999999 110.83 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB2' HD11 ' A' ' 25' ' ' LEU . 54.0 p90 -117.31 148.79 43.36 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.035 0.383 . . . . 75.340000000000003 112.035 -176.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.88 109.25 2.83 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.569 2.179 . . . . 52.219999999999999 112.347 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.65 -17.95 60.89 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 115.079 0.791 . . . . 64.109999999999999 115.079 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.601 ' HA ' ' HG3' ' A' ' 52' ' ' GLN . 12.6 t -65.55 -15.28 62.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.791 0.795 . . . . 54.420000000000002 112.408 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -99.79 2.98 44.56 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.126 0.417 . . . . 74.420000000000002 112.126 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.5 m -123.98 153.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.002 0.429 . . . . 64.340000000000003 112.102 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 12.9 pt-20 -100.38 154.59 18.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.474 -0.33 . . . . 54.240000000000002 111.304 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -89.93 113.74 25.43 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.722 0.296 . . . . 54.020000000000003 111.102 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.12 -61.72 1.7 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.981 0.419 . . . . 74.109999999999999 111.526 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.23 -155.01 26.1 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.241 -0.504 . . . . 71.239999999999995 112.784 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.33 152.62 39.49 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.7 2.266 . . . . 74.329999999999998 113.176 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 112.75 0.648 . . . . 70.519999999999996 112.75 -178.514 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.609 0 N-CA-C 112.727 -0.149 . . . . 73.239999999999995 112.727 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.14 135.55 49.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.965 0.412 . . . . 74.099999999999994 111.085 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HG2' HG22 ' A' ' 32' ' ' VAL . 99.2 mt-30 -97.76 136.1 38.58 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.319 0.58 . . . . 72.299999999999997 112.456 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -113.26 169.28 9.06 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.735 -0.666 . . . . 73.219999999999999 110.382 174.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.538 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 16.1 ttm-85 -119.23 127.76 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.985 -0.447 . . . . 74.019999999999996 111.692 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.575 ' HB2' HD11 ' A' ' 31' ' ' LEU . . . -81.04 116.68 21.11 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.783 0.325 . . . . 64.040000000000006 110.564 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.09 -50.41 16.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 73.129999999999995 112.226 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -124.15 156.77 65.9 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 111.868 0.321 . . . . 72.329999999999998 111.868 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 55.9 Cg_endo -72.0 128.31 13.86 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.517 2.145 . . . . 62.25 113.496 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 CA--C 1.534 0.335 0 CA-C-N 116.037 -0.529 . . . . 64.219999999999999 110.915 178.245 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.539 HD21 ' HB2' ' A' ' 61' ' ' ASN . 42.9 tp . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 112.407 0.521 . . . . 74.099999999999994 112.407 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -57.62 105.9 0.29 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.746 0.307 . . . . 72.340000000000003 111.776 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.7 mt -106.84 142.43 36.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.851 0.357 . . . . 61.399999999999999 111.38 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.3 150.69 44.87 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.473 -0.33 . . . . 71.510000000000005 111.394 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 44.9 Cg_endo -66.8 115.96 3.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.381 2.054 . . . . 75.409999999999997 112.629 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.23 21.76 53.88 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.109 -0.567 . . . . 73.209999999999994 112.815 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.5 162.17 14.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.008 0.432 . . . . 74.349999999999994 111.175 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.17 131.87 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.231 0.538 . . . . 64.150000000000006 111.334 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mp -108.07 116.84 32.69 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.876 0.37 . . . . 64.420000000000002 110.998 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 8' ' ' GLN . 60.9 t -93.68 108.73 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.996 0.427 . . . . 72.230000000000004 111.654 -177.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.88 128.76 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.339 -0.392 . . . . 74.099999999999994 110.697 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -71.28 147.33 48.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.968 0.413 . . . . 70.439999999999998 111.74 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -59.04 -35.48 73.38 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.969 0.414 . . . . 73.530000000000001 110.21 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.28 89.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 53.399999999999999 111.379 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -57.73 -47.87 81.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.842 0.353 . . . . 74.099999999999994 111.557 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.83 -45.24 94.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.695 0.284 . . . . 63.420000000000002 111.453 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.48 -37.87 82.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.874 0.368 . . . . 71.430000000000007 110.972 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.46 87.64 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.893 0.378 . . . . 72.5 111.401 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB2' HG23 ' A' ' 43' ' ' VAL . 90.8 mt -66.78 -20.16 65.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.986 0.422 . . . . 73.540000000000006 111.273 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.94 22.05 53.86 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.346 -0.454 . . . . 71.140000000000001 112.803 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 41' ' ' LEU . 60.3 t -68.43 104.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.036 0.446 . . . . 70.019999999999996 110.923 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 147.0 53.39 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.047 -0.524 . . . . 71.310000000000002 112.21 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -56.99 104.76 0.17 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.071 -0.513 . . . . 44.329999999999998 110.995 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.606 ' HA2' HH21 ' A' ' 49' ' ' ARG . . . 136.06 -18.77 3.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.877 -0.601 . . . . 64.150000000000006 112.372 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.18 -12.51 36.12 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.356 -0.449 . . . . 73.239999999999995 113.833 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -27.51 69.28 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.406 0.622 . . . . 74.099999999999994 111.331 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.606 HH21 ' HA2' ' A' ' 46' ' ' GLY . 36.1 mtm180 -80.27 9.15 6.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.963 -0.562 . . . . 74.129999999999995 112.069 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' NE2' ' A' ' 52' ' ' GLN . 50.0 t -138.37 75.2 39.73 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.16 0.505 . . . . 62.299999999999997 111.106 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.6 -34.4 74.84 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.687 2.258 . . . . 74.5 113.143 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.631 ' NE2' ' SG ' ' A' ' 50' ' ' CYS . 4.7 pp0? -64.88 -29.32 70.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.028 0.381 . . . . 73.120000000000005 112.028 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.523 ' HB2' ' SG ' ' A' ' 50' ' ' CYS . 31.7 t -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.848 0.356 . . . . 74.430000000000007 110.687 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.9 -40.26 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.925 0.393 . . . . 64.540000000000006 111.244 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.14 -133.09 11.39 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.2 -0.524 . . . . 75.219999999999999 113.456 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.523 ' HE3' ' HB3' ' A' ' 69' ' ' ASP . 37.3 m95 -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.011 0.434 . . . . 74.400000000000006 111.325 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.0 mtm -121.26 140.35 31.1 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.311 -0.404 . . . . 71.230000000000004 111.436 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD2' HD11 ' A' ' 41' ' ' LEU . 92.2 Cg_endo -78.91 121.04 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.551 2.167 . . . . 53.530000000000001 112.657 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.46 170.23 27.55 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.722 -0.751 . . . . 71.409999999999997 113.98 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.81 132.16 43.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.802 0.441 . . . . 71.25 111.57 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.539 ' HB2' HD21 ' A' ' 23' ' ' LEU . 28.2 t-20 -88.6 116.45 26.85 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.48 -0.327 . . . . 72.209999999999994 110.698 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.51 -19.51 65.8 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.119 0.785 . . . . 73.450000000000003 113.119 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -73.55 -64.29 1.02 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.342 0.591 . . . . 72.519999999999996 111.536 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 78.7 p -89.01 -21.41 23.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.986 -0.552 . . . . 72.409999999999997 112.412 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 64' ' ' THR . 3.0 mpt_? 70.57 19.12 6.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.151 0.58 . . . . 74.439999999999998 111.832 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -86.25 134.6 33.75 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.344 -0.389 . . . . 54.329999999999998 110.611 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -95.02 126.51 40.41 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.54 -0.3 . . . . 73.430000000000007 110.884 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.81 -164.03 11.93 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.913 -0.66 . . . . 34.439999999999998 112.903 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -109.76 152.98 24.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.878 0.371 . . . . 72.340000000000003 110.926 176.763 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 50.3 p90 -154.24 138.36 11.08 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.391 -0.368 . . . . 62.409999999999997 111.3 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 56' ' ' TRP . 13.6 Cg_exo -70.05 118.98 6.0 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.543 2.162 . . . . 74.349999999999994 112.132 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.56 9.15 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.572 0.589 . . . . 54.100000000000001 114.572 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -60.84 -16.67 43.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.036 0.754 . . . . 73.420000000000002 113.036 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HE2' ' HG2' ' A' ' 71' ' ' PRO . 74.6 m-85 -98.37 -4.05 35.68 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.607 0.595 . . . . 72.209999999999994 112.607 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.85 160.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.432 0.53 . . . . 64.049999999999997 112.432 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 11.4 pt-20 -110.06 151.99 26.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.348 -0.387 . . . . 75.329999999999998 110.776 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -82.62 119.03 23.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.849 0.357 . . . . 71.230000000000004 111.195 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.55 -61.57 1.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 111.151 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.5 -169.16 33.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.179 -0.534 . . . . 70.150000000000006 113.088 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.72 173.24 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.611 2.207 . . . . 75.319999999999993 113.075 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.0 mp . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 65.349999999999994 111.438 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 N-CA-C 114.305 0.482 . . . . 50.520000000000003 114.305 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -106.75 155.98 19.13 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.74 0.416 . . . . 71.219999999999999 110.945 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.48 123.28 46.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.824 0.676 . . . . 73.299999999999997 112.824 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.79 170.4 8.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.93 -0.577 . . . . 72.310000000000002 110.04 170.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -150.52 121.24 7.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.423 0.527 . . . . 74.420000000000002 112.423 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 151.48 29.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.345 0.593 . . . . 62.310000000000002 112.159 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.64 -29.41 12.33 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.284 0.476 . . . . 64.400000000000006 112.284 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -135.35 145.3 53.24 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-O 120.619 0.247 . . . . 73.510000000000005 111.329 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.0 Cg_endo -74.04 126.06 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.445 2.097 . . . . 60.210000000000001 113.902 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 . . . . . 0 N--CA 1.472 0.654 0 CA-C-N 116.05 -0.523 . . . . 75.150000000000006 110.681 176.814 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 58.6 tp . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.694 0.283 . . . . 64.219999999999999 110.386 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.11 106.85 3.89 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.883 0.373 . . . . 74.299999999999997 111.936 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 91.8 mt -99.78 144.86 28.36 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 70.340000000000003 111.712 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 25' ' ' LEU . 4.1 mm? -123.74 155.69 66.11 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 122.889 0.475 . . . . 63.049999999999997 111.033 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.9 Cg_endo -70.61 107.9 2.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.217 1.944 . . . . 74.040000000000006 112.993 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.69 40.97 11.5 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.147 -0.549 . . . . 63.530000000000001 113.183 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -99.72 175.12 5.91 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.57 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -119.89 134.78 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.827 0.346 . . . . 63.100000000000001 110.732 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.06 122.24 42.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.647 0.261 . . . . 60.100000000000001 111.036 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.43 111.07 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.075 0.464 . . . . 64.310000000000002 111.242 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG22 ' HA3' ' A' ' 59' ' ' GLY . 48.2 t -111.73 119.2 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.455 -0.339 . . . . 52.130000000000003 111.529 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -58.95 127.1 30.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.764 -0.198 . . . . 64.019999999999996 111.077 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -52.27 -35.86 51.22 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.848 0.314 . . . . 71.230000000000004 111.848 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.44 65.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.535 -0.302 . . . . 51.240000000000002 111.799 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.949 0.404 . . . . 64.25 111.1 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 90.3 mt -62.77 -44.86 95.09 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.291 -0.413 . . . . 72.420000000000002 110.908 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.89 -23.87 66.73 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 111.514 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.86 54.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.11 0.481 . . . . 63.409999999999997 110.882 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.8 mt -68.39 -28.37 67.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.02 -0.536 . . . . 74.409999999999997 111.404 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.7 9.95 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.225 -0.443 . . . . 60.530000000000001 113.129 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.3 t -77.28 100.58 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.03 0.443 . . . . 73.120000000000005 111.144 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.3 149.91 37.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.227 -0.442 . . . . 31.420000000000002 112.127 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -46.16 129.91 10.14 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 111.58 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.82 -50.15 0.93 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.173 -0.467 . . . . 64.450000000000003 112.097 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -21.99 65.6 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.261 -0.495 . . . . 55.109999999999999 112.253 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.93 -31.2 27.75 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.415 0.686 . . . . 63.509999999999998 111.621 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -85.65 7.04 24.84 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.538 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.539 ' SG ' ' HG2' ' A' ' 52' ' ' GLN . 48.5 t -146.17 68.64 12.62 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 121.019 0.437 . . . . 74.400000000000006 110.92 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.79 -15.15 47.21 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.005 2.47 . . . . 63.32 113.259 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.539 ' HG2' ' SG ' ' A' ' 50' ' ' CYS . 20.2 pt20 -61.05 -19.46 61.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.367 -0.378 . . . . 53.240000000000002 111.886 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -81.89 -12.14 58.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.402 0.519 . . . . 74.439999999999998 112.402 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.38 -59.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.114 0.483 . . . . 73.239999999999995 111.747 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 118.06 -81.89 0.32 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.056 -0.593 . . . . 74.329999999999998 113.028 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.5 m0 -118.88 117.72 29.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.132 0.466 . . . . 74.409999999999997 111.638 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.442 ' N ' ' SD ' ' A' ' 57' ' ' MET . 2.7 mpp? -120.86 138.75 28.08 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.756 -0.202 . . . . 64.420000000000002 111.038 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.37 116.97 4.22 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 55.450000000000003 112.909 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.48 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -143.68 171.21 25.42 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.71 -0.757 . . . . 73.120000000000005 114.021 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.8 tp -103.89 123.23 46.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.687 0.395 . . . . 74.409999999999997 110.992 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -85.23 128.73 34.79 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.561 0.219 . . . . 70.540000000000006 111.447 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -80.64 0.86 32.38 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.385 0.883 . . . . 61.450000000000003 113.385 -177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -100.78 -47.73 4.72 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.777 -0.577 . . . . 74.150000000000006 111.446 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -96.92 -24.97 15.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.24 0.459 . . . . 53.409999999999997 112.24 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 63.41 23.98 13.95 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.193 0.52 . . . . 75.549999999999997 111.77 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -94.32 142.96 26.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.98 -0.555 . . . . 72.400000000000006 110.545 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -99.98 128.45 46.06 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.356 -0.384 . . . . 71.129999999999995 111.344 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.06 -178.15 40.28 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.051 -0.595 . . . . 32.149999999999999 113.109 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 3.7 m-20 -95.29 109.64 21.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.895 0.379 . . . . 71.349999999999994 110.8 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.2 p90 -100.09 142.38 24.5 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 120.843 0.354 . . . . 74.409999999999997 111.936 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 46.9 Cg_endo -68.31 111.51 2.52 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.695 2.264 . . . . 63.119999999999997 112.922 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -64.86 -8.71 35.84 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.498 0.559 . . . . 54.299999999999997 114.498 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.3 p -78.62 -13.83 59.62 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.2 0.5 . . . . 62.119999999999997 111.971 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.3 6.13 20.29 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.268 0.47 . . . . 73.430000000000007 112.268 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.534 HG22 ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -128.1 141.19 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.038 0.447 . . . . 74.299999999999997 112.187 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -92.23 159.76 15.48 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.331 -0.395 . . . . 61.100000000000001 110.428 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -105.09 124.38 49.43 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.017 0.437 . . . . 75.230000000000004 111.559 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.72 -59.62 2.13 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.146 0.498 . . . . 61.439999999999998 111.094 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.88 -172.65 27.32 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.427 -0.416 . . . . 51.039999999999999 112.749 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.3 134.92 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.23 1.953 . . . . 55.32 112.147 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 71.530000000000001 113.014 -177.055 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 CA-C-O 120.801 0.112 . . . . 64.439999999999998 113.064 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -139.8 155.33 47.33 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.317 -0.519 . . . . 71.5 111.14 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HG3' HD11 ' A' ' 81' ' ' LEU . 48.3 mt-30 -112.36 136.62 51.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.3 0.571 . . . . 62.210000000000001 111.76 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.456 ' CE1' ' HG3' ' A' ' 51' ' ' PRO . 87.9 m-85 -113.67 173.31 6.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.746 -0.661 . . . . 73.219999999999999 110.702 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -136.34 121.26 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.733 0.302 . . . . 74.430000000000007 111.372 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -70.92 125.5 27.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.026 0.441 . . . . 64.299999999999997 111.894 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.7 mt -81.21 -45.71 15.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.104 0.409 . . . . 73.200000000000003 112.104 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -137.33 158.5 72.18 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 116.467 -0.333 . . . . 64.099999999999994 111.061 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 37.8 Cg_endo -66.71 124.74 12.75 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.229 1.953 . . . . 73.140000000000001 113.377 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.5 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 63.409999999999997 110.77 179.018 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 61' ' ' ASN . 58.6 tp . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 120.862 0.363 . . . . 70.530000000000001 111.656 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HB2' HG21 ' A' ' 64' ' ' THR . 12.1 mp0 -65.45 117.16 7.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.129 0.49 . . . . 71.140000000000001 111.769 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 55.1 mt -103.29 134.98 45.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 111.173 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.76 146.33 34.51 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 120.573 0.225 . . . . 74.239999999999995 110.989 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.04 125.04 14.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.396 2.064 . . . . 73.310000000000002 113.072 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.2 4.03 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 116.235 -0.439 . . . . 54.439999999999998 113.928 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -93.19 149.31 21.31 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 117.238 0.519 . . . . 75.510000000000005 111.105 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.59 132.5 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.321 0.582 . . . . 62.340000000000003 111.935 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.9 mp -103.81 116.56 32.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.976 -0.556 . . . . 62.240000000000002 111.015 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.66 118.01 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.986 0.422 . . . . 65.420000000000002 111.672 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.65 120.47 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.938 0.399 . . . . 73.319999999999993 111.413 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -67.68 148.44 51.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.371 -0.377 . . . . 53.520000000000003 111.803 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 8.3 tpp180 -55.12 -47.35 75.15 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.453 -0.34 . . . . 62.5 111.544 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.34 -32.41 48.97 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.469 0.544 . . . . 75.010000000000005 112.469 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.48 73.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.883 0.373 . . . . 75.409999999999997 111.045 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 41' ' ' LEU . 87.6 mt -65.18 -35.02 79.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.284 -0.416 . . . . 71.230000000000004 111.095 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 13.4 mm100 -60.58 -43.98 96.73 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.952 0.406 . . . . 72.019999999999996 110.699 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.32 -40.62 96.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.288 -0.415 . . . . 35.109999999999999 111.374 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.473 HD11 ' HD2' ' A' ' 58' ' ' PRO . 94.9 mt -62.98 -18.28 63.05 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.046 0.45 . . . . 52.450000000000003 111.343 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 38.71 20.94 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.088 -0.577 . . . . 73.230000000000004 112.639 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.45 122.83 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.016 0.436 . . . . 74.310000000000002 111.725 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.59 138.75 33.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.384 -0.371 . . . . 54.240000000000002 110.273 173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.18 117.57 3.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.208 0.528 . . . . 63.240000000000002 111.471 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.57 5.68 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.808 -0.633 . . . . 30.039999999999999 112.182 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.18 -38.62 3.74 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.7 -0.286 . . . . 72.299999999999997 112.779 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -23.8 56.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.771 0.428 . . . . 75.109999999999999 111.668 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -54.99 -21.96 13.65 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.484 -0.326 . . . . 74.099999999999994 111.715 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 53' ' ' SER . 22.1 p -115.84 81.5 9.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.966 0.412 . . . . 64.209999999999994 111.008 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 52.9 Cg_exo -54.94 -42.23 71.08 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.114 2.543 . . . . 72.150000000000006 113.183 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -60.97 -31.47 71.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.865 0.364 . . . . 75.319999999999993 111.371 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 39.3 t -73.79 -38.44 64.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.164 0.507 . . . . 74.109999999999999 111.095 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.23 -40.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.059 0.457 . . . . 73.040000000000006 110.995 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.67 -76.18 1.09 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.186 -0.53 . . . . 73.420000000000002 113.662 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -118.95 132.38 56.08 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.906 0.384 . . . . 73.519999999999996 111.33 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 68.5 mtm -144.91 131.98 10.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 O-C-N 122.208 -0.308 . . . . 55.329999999999998 111.668 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' HD11 ' A' ' 41' ' ' LEU . 97.2 Cg_endo -80.48 127.66 6.63 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.388 2.059 . . . . 72.239999999999995 112.502 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.79 176.69 34.02 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.634 -0.793 . . . . 74.030000000000001 113.614 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.73 131.29 55.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.573 0.349 . . . . 72.409999999999997 111.107 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 28.6 t-20 -96.67 149.17 22.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.457 -0.338 . . . . 74.310000000000002 111.002 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -91.98 -33.86 14.68 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.608 0.596 . . . . 65.200000000000003 112.608 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -64.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.153 0.501 . . . . 73.409999999999997 110.635 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 24' ' ' GLU . 62.3 p -75.21 -21.5 58.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.406 -0.361 . . . . 72.319999999999993 111.474 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 17.5 mtp180 58.34 20.54 7.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.63 0.604 . . . . 74.219999999999999 112.63 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.33 163.89 12.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.311 0.577 . . . . 62.119999999999997 111.712 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -107.9 129.65 55.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.672 -0.694 . . . . 73.299999999999997 110.682 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.04 -172.37 34.2 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.261 -0.971 . . . . 63.310000000000002 113.875 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.2 t70 -115.61 109.37 17.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.767 0.427 . . . . 72.409999999999997 109.881 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HB2' HD11 ' A' ' 25' ' ' LEU . 54.4 p90 -103.52 149.12 36.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 112.656 0.613 . . . . 73.420000000000002 112.656 -171.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB2' HG22 ' A' ' 73' ' ' THR . 74.2 Cg_endo -76.11 113.48 3.71 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.713 2.275 . . . . 64.329999999999998 112.412 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.01 -16.1 16.72 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.734 0.654 . . . . 70.319999999999993 114.734 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 71' ' ' PRO . 6.1 t -59.21 -33.38 70.9 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.343 0.572 . . . . 75.239999999999995 112.505 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 54.8 m-85 -89.49 5.03 47.25 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.905 0.706 . . . . 75.209999999999994 112.905 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 11' ' ' ALA . 28.2 m -127.48 148.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.149 0.499 . . . . 72.439999999999998 112.222 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.85 146.44 28.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.121 -0.491 . . . . 73.0 110.401 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -78.34 128.64 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.908 0.385 . . . . 73.319999999999993 111.674 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.66 -67.53 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.929 0.395 . . . . 73.409999999999997 110.923 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.74 -174.06 41.42 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.035 -0.602 . . . . 35.009999999999998 113.093 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.99 -176.83 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.706 2.271 . . . . 74.200000000000003 112.745 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 8' ' ' GLN . 4.6 mp . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 62.310000000000002 111.163 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.43 0 N-CA-C 112.707 -0.157 . . . . 54.329999999999998 112.707 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -119.94 160.92 21.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.302 0.572 . . . . 74.420000000000002 111.615 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.503 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 98.3 mt-30 -107.74 126.86 53.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.833 -0.621 . . . . 53.340000000000003 111.034 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.27 130.16 55.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.922 0.391 . . . . 73.109999999999999 110.674 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.557 ' HB2' HD11 ' A' ' 78' ' ' LEU . 37.1 ttt180 -97.59 123.32 41.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.355 -0.384 . . . . 61.25 111.846 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.49 131.8 36.99 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.045 0.45 . . . . 72.319999999999993 110.978 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.27 -60.36 2.37 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.291 0.478 . . . . 64.140000000000001 112.291 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.6 m-85 -132.57 165.11 38.76 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.571 -0.286 . . . . 73.5 111.279 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 44.6 Cg_endo -68.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.813 1.675 . . . . 74.319999999999993 113.284 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 . . . . . 0 N--CA 1.47 0.552 0 CA-C-N 115.938 -0.574 . . . . 65.25 110.646 176.228 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 61' ' ' ASN . 18.9 tp . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 112.384 0.513 . . . . 64.150000000000006 112.384 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -65.22 151.92 44.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.328 0.585 . . . . 74.109999999999999 112.013 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.4 mt -118.31 134.51 54.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.818 -0.628 . . . . 61.439999999999998 110.34 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -114.94 154.99 47.02 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 120.828 0.347 . . . . 63.340000000000003 111.642 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.17 117.12 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.484 2.123 . . . . 72.230000000000004 113.22 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.68 79.83 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.2 -0.524 . . . . 65.540000000000006 113.304 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 63' ' ' ARG . 20.7 t0 -82.75 156.22 23.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.918 0.39 . . . . 72.409999999999997 111.782 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.7 t -117.36 118.89 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.103 0.477 . . . . 73.319999999999993 111.46 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -107.14 133.64 51.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.306 -0.406 . . . . 55.329999999999998 110.932 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.74 115.73 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.231 0.456 . . . . 72.140000000000001 112.231 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.38 118.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.835 0.35 . . . . 74.409999999999997 111.388 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -76.1 155.61 34.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.851 0.358 . . . . 70.409999999999997 111.947 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 38' ' ' LEU . 61.5 mtp180 -62.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.866 0.365 . . . . 74.140000000000001 110.369 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.47 80.75 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.221 -0.445 . . . . 73.439999999999998 110.914 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.62 86.34 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 71.099999999999994 110.909 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 35' ' ' ARG . 95.8 mt -59.0 -49.18 78.89 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.207 -0.451 . . . . 50.310000000000002 111.355 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -61.76 -34.56 76.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.933 0.397 . . . . 75.019999999999996 111.101 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.37 -22.11 66.76 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.893 0.378 . . . . 71.219999999999999 111.539 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD11 ' HD2' ' A' ' 58' ' ' PRO . 96.4 mt -85.64 -5.66 59.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.707 0.289 . . . . 72.400000000000006 111.516 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.77 43.88 82.49 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.791 -0.719 . . . . 71.510000000000005 112.366 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 143.66 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.933 0.397 . . . . 70.430000000000007 111.338 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.39 150.94 48.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.113 -0.494 . . . . 75.409999999999997 112.208 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.93 101.5 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.307 0.575 . . . . 74.439999999999998 112.19 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . 99.29 -9.52 61.12 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 116.085 -0.507 . . . . 71.450000000000003 113.685 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 1.24 46.7 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.167 0.427 . . . . 60.130000000000003 114.167 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -60.25 -18.23 47.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.383 0.611 . . . . 52.109999999999999 111.723 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 8.0 ptt180 -84.91 8.46 17.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.653 -0.703 . . . . 64.549999999999997 112.162 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.6 m -133.66 76.86 65.51 Favored Pre-proline 0 N--CA 1.475 0.785 0 N-CA-C 112.302 0.482 . . . . 72.310000000000002 112.302 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.16 -32.89 62.6 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.656 2.237 . . . . 71.099999999999994 113.061 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.43 -37.66 84.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.939 0.399 . . . . 74.120000000000005 111.137 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.5 t -61.8 -39.95 93.51 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.257 -0.429 . . . . 73.219999999999999 111.661 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 41' ' ' LEU . 45.3 t -75.75 -39.81 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.01 0.433 . . . . 74.209999999999994 111.546 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.22 -71.29 2.85 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.2 -0.524 . . . . 61.219999999999999 113.394 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -98.56 129.14 45.1 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.768 -0.254 . . . . 75.319999999999993 110.624 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 84.0 mtp -143.73 120.85 6.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 111.664 0.246 . . . . 71.230000000000004 111.664 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.544 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.0 Cg_endo -81.79 138.38 10.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.552 2.168 . . . . 74.439999999999998 112.375 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.17 176.77 40.81 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.743 -0.741 . . . . 71.530000000000001 113.199 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.0 tp -100.84 118.87 37.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.637 -0.331 . . . . 72.329999999999998 110.95 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.531 ' HB2' HD21 ' A' ' 23' ' ' LEU . 28.5 t-20 -87.78 100.31 12.75 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.93 -20.46 65.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.124 0.416 . . . . 64.140000000000001 112.124 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.431 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.1 tpt180 -58.83 -49.48 77.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.073 0.463 . . . . 73.349999999999994 111.31 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -110.45 -1.93 16.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.058 -0.519 . . . . 73.439999999999998 112.137 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 65' ' ' ARG . 4.7 mpt_? 63.55 20.52 12.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.759 0.423 . . . . 64.150000000000006 111.661 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -102.42 157.93 16.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.318 0.58 . . . . 61.039999999999999 111.792 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -103.8 151.25 23.28 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.96 -0.564 . . . . 75.409999999999997 110.501 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.66 -178.84 47.13 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.162 -1.018 . . . . 75.540000000000006 113.831 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.7 t70 -109.68 108.6 19.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.894 -0.41 . . . . 73.219999999999999 109.894 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 55.1 p90 -100.94 148.99 35.83 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 121.112 0.482 . . . . 72.310000000000002 112.253 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.5 101.1 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.436 2.091 . . . . 71.150000000000006 112.386 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.16 -17.45 30.73 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.242 0.457 . . . . 74.299999999999997 114.242 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -65.13 -14.2 59.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.731 0.641 . . . . 65.519999999999996 112.731 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.55 8.53 29.33 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.322 0.49 . . . . 65.430000000000007 112.322 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 m -125.22 155.86 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.157 0.503 . . . . 64.010000000000005 111.677 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -112.88 148.59 34.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.237 0.541 . . . . 64.219999999999999 111.51 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -78.16 119.25 21.28 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 111.046 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -90.17 -59.51 2.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.048 0.451 . . . . 52.439999999999998 111.291 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.23 -160.61 29.58 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.356 -0.449 . . . . 75.239999999999995 112.555 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.03 147.4 79.79 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.809 2.339 . . . . 71.430000000000007 112.775 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HB3' ' HG3' ' A' ' 8' ' ' GLN . 1.6 pp . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.654 0.613 . . . . 43.329999999999998 112.654 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 N-CA-C 112.086 -0.405 . . . . 54.140000000000001 112.086 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -136.78 156.93 47.86 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.334 0.587 . . . . 75.439999999999998 112.185 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -121.89 133.36 54.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.577 -0.738 . . . . 65.230000000000004 110.975 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.493 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 97.8 m-85 -122.91 137.51 54.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.59 -0.277 . . . . 73.099999999999994 110.879 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HB2' HD21 ' A' ' 78' ' ' LEU . 9.4 ttm180 -98.65 122.6 42.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.836 0.35 . . . . 74.120000000000005 110.585 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.51 16.66 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.951 0.352 . . . . 75.340000000000003 111.951 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.7 -46.82 8.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.813 0.34 . . . . 64.409999999999997 111.512 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.21 137.96 20.72 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 111.974 0.361 . . . . 62.439999999999998 111.974 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 73.0 Cg_endo -78.89 146.12 20.4 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.58 2.187 . . . . 51.409999999999997 113.418 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.544 ' HB2' HD12 ' A' ' 25' ' ' LEU . 92.1 m-85 . . . . . 0 N--CA 1.469 0.484 0 CA-C-N 116.203 -0.453 . . . . 71.209999999999994 110.828 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD23 HD21 ' A' ' 25' ' ' LEU . 37.3 tp . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.286 0.476 . . . . 74.109999999999999 112.286 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.44 117.75 13.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.569 -0.287 . . . . 72.129999999999995 110.66 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 15' ' ' PHE . 15.0 mt -135.7 136.39 40.82 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.848 0.684 . . . . 44.5 112.848 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.3 157.21 44.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.381 0.672 . . . . 73.510000000000005 110.655 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 21.9 Cg_exo -64.88 108.95 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.213 1.942 . . . . 63.520000000000003 112.633 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.19 15.35 14.44 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.462 -0.399 . . . . 73.409999999999997 113.993 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.4 151.35 30.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.182 0.491 . . . . 70.239999999999995 112.094 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.41 120.23 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.134 -0.484 . . . . 53.310000000000002 110.493 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.3 mp -103.37 124.08 48.03 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.814 0.34 . . . . 61.020000000000003 111.403 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 81' ' ' LEU . 80.1 t -94.05 116.83 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.16 -0.473 . . . . 62.140000000000001 110.968 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.38 135.93 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.889 0.376 . . . . 71.140000000000001 111.229 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.1 p -86.82 133.78 33.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.698 0.285 . . . . 75.340000000000003 110.732 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -65.7 -25.4 67.3 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.097 -0.377 . . . . 71.030000000000001 111.07 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.25 -40.79 87.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.018 0.437 . . . . 71.120000000000005 111.19 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -62.73 -47.16 84.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.992 0.425 . . . . 74.209999999999994 111.029 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.53 -43.88 89.35 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 111.267 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -62.35 -38.26 88.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 111.124 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.76 68.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.002 0.43 . . . . 73.230000000000004 111.344 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 92.5 mt -81.54 -4.68 56.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.379 -0.373 . . . . 73.349999999999994 111.659 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.03 13.36 79.45 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.269 -0.491 . . . . 62.340000000000003 113.421 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.7 t -74.12 109.09 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.924 0.392 . . . . 74.040000000000006 111.531 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.78 148.29 44.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.982 0.42 . . . . 72.530000000000001 111.932 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.67 119.04 4.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.091 -0.504 . . . . 71.109999999999999 111.344 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.15 -14.16 16.26 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.481 -0.39 . . . . 53.140000000000001 112.234 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.52 -26.84 10.38 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.53 -0.367 . . . . 74.200000000000003 113.172 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -27.11 69.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.082 0.468 . . . . 73.209999999999994 111.791 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -67.41 -15.46 63.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.482 -0.326 . . . . 51.530000000000001 111.704 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.7 m -132.78 69.36 79.34 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 120.908 0.385 . . . . 41.0 110.661 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.527 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 29.1 Cg_endo -60.57 -21.57 69.2 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.101 2.534 . . . . 62.240000000000002 113.819 -172.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -55.82 -25.14 40.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.885 0.374 . . . . 71.219999999999999 111.945 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -77.71 -17.02 58.05 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.953 0.353 . . . . 65.409999999999997 111.953 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.15 -20.39 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.035 0.445 . . . . 64.510000000000005 111.524 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.67 -110.34 3.94 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.356 -0.449 . . . . 73.219999999999999 112.35 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -121.38 143.84 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.155 0.478 . . . . 71.120000000000005 110.995 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 46.7 mtm -134.44 149.42 71.04 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 111.89 0.329 . . . . 63.329999999999998 111.89 -173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.37 123.21 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.594 2.196 . . . . 64.5 113.109 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.81 163.51 28.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.035 -0.602 . . . . 71.129999999999995 113.586 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.458 HD21 HH21 ' A' ' 65' ' ' ARG . 52.8 tp -107.22 124.7 50.13 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.556 0.342 . . . . 74.329999999999998 111.788 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -87.48 122.91 31.81 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.583 -0.28 . . . . 65.340000000000003 110.676 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -72.1 -15.0 61.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.56 0.948 . . . . 71.340000000000003 113.56 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -86.86 -67.95 0.78 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.675 -0.641 . . . . 71.099999999999994 111.246 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.3 p -71.56 -22.95 61.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.242 -0.435 . . . . 62.200000000000003 112.004 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.458 HH21 HD21 ' A' ' 60' ' ' LEU . 22.8 mmm-85 65.97 8.68 5.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.519 0.728 . . . . 65.299999999999997 112.286 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -78.53 149.49 33.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.845 0.355 . . . . 74.219999999999999 110.958 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -113.07 134.61 54.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.518 -0.31 . . . . 70.329999999999998 110.402 176.756 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.26 176.19 45.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.834 -0.698 . . . . 53.039999999999999 112.627 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.57 107.9 19.14 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.921 0.391 . . . . 73.310000000000002 110.518 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -97.45 140.15 21.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.553 -0.294 . . . . 75.349999999999994 111.46 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.06 116.69 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.549 2.166 . . . . 73.430000000000007 112.46 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -71.57 26.53 0.6 Allowed Glycine 0 CA--C 1.536 1.397 0 N-CA-C 114.61 0.604 . . . . 51.340000000000003 114.61 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -104.02 -32.14 9.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.538 0.669 . . . . 75.400000000000006 112.452 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.542 ' CZ ' HD13 ' A' ' 25' ' ' LEU . 20.9 p90 -88.59 4.81 45.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 111.859 0.318 . . . . 72.340000000000003 111.859 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 17.9 m -112.94 146.84 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.725 0.639 . . . . 72.400000000000006 112.725 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.504 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 9.4 pt-20 -102.98 138.67 39.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.62 -0.718 . . . . 52.509999999999998 110.146 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -75.41 115.32 14.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.833 0.349 . . . . 73.439999999999998 111.506 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 10' ' ' ARG . 82.3 mt -85.3 -55.97 3.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.19 0.519 . . . . 73.030000000000001 111.481 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.02 -155.97 26.43 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.856 -0.611 . . . . 73.239999999999995 111.962 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.69 178.61 5.41 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.66 2.24 . . . . 72.239999999999995 113.17 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.524 HD21 HG13 ' A' ' 32' ' ' VAL . 94.5 mt . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.786 0.327 . . . . 73.329999999999998 111.723 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.523 0.572 0 N-CA-C 112.82 -0.112 . . . . 63.520000000000003 112.82 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.99 155.99 38.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.194 0.521 . . . . 63.32 111.642 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB3' HD12 ' A' ' 78' ' ' LEU . 95.9 mt-30 -94.96 123.41 38.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.16 -0.473 . . . . 41.229999999999997 111.735 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.83 125.98 54.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.363 -0.381 . . . . 61.32 110.57 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HB2' HD11 ' A' ' 78' ' ' LEU . 70.6 ttt180 -97.79 120.49 38.27 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.682 0.277 . . . . 72.400000000000006 111.725 -176.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.4 119.99 13.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 53.140000000000001 111.47 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.86 -59.89 2.49 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.321 0.489 . . . . 63.149999999999999 112.321 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -127.09 156.83 73.81 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 116.362 -0.381 . . . . 63.420000000000002 111.149 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.62 119.16 6.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.089 1.86 . . . . 74.129999999999995 113.044 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 54.25 111.029 179.158 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.604 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 23.8 tp . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 120.924 0.392 . . . . 73.400000000000006 111.256 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.75 140.57 42.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.901 0.381 . . . . 62.439999999999998 111.661 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.0 mt -100.75 131.36 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.612 0.597 . . . . 52.140000000000001 112.612 -173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.16 148.99 41.89 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 122.721 0.408 . . . . 72.319999999999993 110.52 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.42 105.51 0.9 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.398 2.065 . . . . 72.230000000000004 113.168 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.42 -4.61 21.58 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.148 -0.549 . . . . 62.020000000000003 113.857 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 130.89 44.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.197 0.499 . . . . 73.209999999999994 111.916 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.9 105.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.905 -0.589 . . . . 61.439999999999998 110.721 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.7 mp -89.94 130.81 36.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.57 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.29 106.22 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.327 -0.397 . . . . 74.340000000000003 111.312 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.44 118.45 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.766 0.317 . . . . 51.340000000000003 110.819 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.464 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 87.3 p -69.41 140.91 54.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 54.420000000000002 111.846 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -60.27 -28.09 67.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.197 0.522 . . . . 74.340000000000003 110.702 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.4 -44.5 96.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.983 -0.553 . . . . 65.319999999999993 110.924 174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.38 -45.45 91.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.839 0.352 . . . . 42.409999999999997 110.915 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 96.1 mt -54.23 -43.42 70.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.398 -0.365 . . . . 74.340000000000003 111.426 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.67 -42.47 92.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.453 -0.34 . . . . 65.209999999999994 111.283 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.27 92.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.045 0.45 . . . . 74.409999999999997 111.261 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.468 HD11 ' HD2' ' A' ' 58' ' ' PRO . 78.6 mt -66.55 -25.88 66.86 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.01 -0.541 . . . . 72.420000000000002 111.642 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.0 23.23 18.19 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.229 -0.51 . . . . 75.5 112.62 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.7 t -84.15 107.29 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.985 0.422 . . . . 72.099999999999994 111.054 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.58 149.84 46.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.069 -0.514 . . . . 54.0 111.901 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.8 113.92 3.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.023 -0.535 . . . . 73.340000000000003 110.852 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.55 -10.61 11.42 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.397 -0.43 . . . . 71.049999999999997 112.521 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.45 5.46 23.1 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.514 -0.374 . . . . 55.119999999999997 112.97 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -67.21 -23.75 65.77 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.223 0.453 . . . . 73.219999999999999 112.223 -177.098 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -77.98 -2.68 38.19 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.201 0.445 . . . . 74.219999999999999 112.201 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -118.19 86.29 26.46 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 74.230000000000004 111.819 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.6 -21.84 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.118 1.878 . . . . 60.409999999999997 111.996 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.37 -48.82 79.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.904 -0.589 . . . . 63.030000000000001 110.982 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -63.88 -28.07 69.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 74.129999999999995 111.066 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 57' ' ' MET . 95.7 t -69.86 -37.99 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.96 -0.564 . . . . 65.209999999999994 111.541 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.96 -79.55 1.79 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.095 -0.574 . . . . 71.329999999999998 112.982 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -120.88 124.01 43.92 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.656 -0.32 . . . . 64.409999999999997 110.963 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.43 ' HB3' HG11 ' A' ' 54' ' ' VAL . 8.6 ptp -136.25 147.96 62.46 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 120.653 0.263 . . . . 72.109999999999999 111.449 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' HD11 ' A' ' 41' ' ' LEU . 81.7 Cg_endo -88.03 140.67 4.92 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.765 2.31 . . . . 74.129999999999995 112.802 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.27 -172.71 17.74 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.505 -0.855 . . . . 62.539999999999999 114.027 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 65.5 tp -132.83 108.68 9.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.619 0.367 . . . . 71.409999999999997 111.269 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -79.26 129.5 34.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.827 0.346 . . . . 71.329999999999998 111.205 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.07 -23.27 65.84 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.142 0.423 . . . . 52.119999999999997 112.142 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -75.38 -53.55 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.04 0.448 . . . . 72.430000000000007 111.808 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -68.37 -26.62 65.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.399 0.518 . . . . 74.540000000000006 112.399 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 64.78 10.58 6.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.105 0.479 . . . . 65.450000000000003 111.268 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -127.38 160.72 30.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.11 0.481 . . . . 73.510000000000005 111.734 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -91.29 176.85 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.656 -0.702 . . . . 70.120000000000005 110.993 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . 159.46 168.42 21.45 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.095 -0.574 . . . . 43.509999999999998 113.01 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.32 127.49 43.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.613 0.245 . . . . 73.109999999999999 111.375 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.43 156.19 79.95 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 120.698 0.285 . . . . 73.400000000000006 111.421 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.3 120.9 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.468 2.112 . . . . 74.030000000000001 112.488 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.73 1.48 15.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.382 -0.437 . . . . 70.049999999999997 114.05 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 p -74.71 -17.43 60.66 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.37 -0.488 . . . . 63.109999999999999 112.289 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -108.28 17.52 22.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.864 0.69 . . . . 74.019999999999996 112.864 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.4 m -131.66 148.63 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.982 0.42 . . . . 51.030000000000001 112.119 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -108.65 151.08 26.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.217 -0.447 . . . . 71.349999999999994 110.892 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.06 115.26 21.12 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.806 0.336 . . . . 65.209999999999994 111.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.8 mt -83.2 -59.73 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.916 0.389 . . . . 71.109999999999999 111.467 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.07 -176.56 36.76 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.089 -0.577 . . . . 64.510000000000005 113.185 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.79 157.0 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.923 2.416 . . . . 51.32 113.106 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 81' ' ' LEU . 4.6 mp . . . . . 0 N--CA 1.473 0.719 0 CA-C-N 116.447 -0.342 . . . . 73.230000000000004 111.086 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . . . . . . 0 CA--C 1.522 0.5 0 N-CA-C 112.214 -0.354 . . . . 52.219999999999999 112.214 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -130.46 143.97 51.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.225 0.536 . . . . 73.230000000000004 111.625 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -92.73 131.02 38.16 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.732 -0.667 . . . . 71.109999999999999 112.116 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -123.78 153.85 40.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 73.230000000000004 110.069 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.1 ttm180 -127.42 119.75 26.86 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.778 0.323 . . . . 71.340000000000003 111.805 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -71.54 124.08 23.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.309 -0.405 . . . . 71.319999999999993 110.961 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.5 -21.2 19.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.443 0.534 . . . . 74.120000000000005 112.443 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.98 147.57 65.94 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 112.131 0.419 . . . . 73.420000000000002 112.131 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 55.7 Cg_endo -71.06 119.63 6.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.55 2.167 . . . . 72.400000000000006 112.172 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.3 t80 . . . . . 0 CA--C 1.538 0.506 0 CA-C-O 120.919 0.39 . . . . 73.140000000000001 111.49 -175.081 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.8 tp . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 110.415 -0.217 . . . . 74.239999999999995 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.0 113.32 3.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.127 0.489 . . . . 75.239999999999995 112.034 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.5 mt -103.26 138.74 39.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.245 -0.434 . . . . 71.549999999999997 111.25 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.499 HD23 ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -122.65 150.69 58.77 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 122.503 0.321 . . . . 71.319999999999993 110.933 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.94 117.83 4.64 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.685 2.257 . . . . 71.510000000000005 113.133 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.1 29.66 58.4 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.032 -0.531 . . . . 71.010000000000005 113.311 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.91 158.67 15.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.189 0.495 . . . . 71.239999999999995 111.155 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.04 132.56 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.135 0.493 . . . . 61.549999999999997 112.289 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.448 HD21 HD22 ' A' ' 25' ' ' LEU . 5.9 mp -121.88 111.42 17.08 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.249 -0.432 . . . . 72.25 110.975 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.558 HG13 HD21 ' A' ' 81' ' ' LEU . 18.0 t -94.96 106.05 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.839 0.352 . . . . 74.549999999999997 111.227 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.518 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.4 t -101.39 132.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.598 0.237 . . . . 75.310000000000002 111.591 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 143.07 45.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.272 0.558 . . . . 63.109999999999999 112.187 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -66.38 -33.05 74.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.056 -0.52 . . . . 71.310000000000002 111.124 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.09 73.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 74.409999999999997 111.392 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -69.68 -45.44 68.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.27 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.36 -39.83 80.62 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.354 -0.385 . . . . 61.119999999999997 111.507 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.27 -44.05 95.66 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.497 -0.32 . . . . 75.540000000000006 111.015 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.95 91.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.02 0.438 . . . . 75.030000000000001 111.227 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.602 HD11 ' HD2' ' A' ' 58' ' ' PRO . 81.2 mt -66.75 -29.2 69.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.251 -0.431 . . . . 63.020000000000003 111.498 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.57 31.87 12.5 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.265 -0.493 . . . . 63.210000000000001 112.833 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -73.37 123.26 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.924 0.392 . . . . 72.209999999999994 111.307 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.1 149.99 23.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.488 -0.324 . . . . 54.329999999999998 111.376 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.27 126.68 9.75 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 73.450000000000003 111.241 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -42.43 1.91 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.24 -0.505 . . . . 52.109999999999999 112.289 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.17 -26.25 61.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.035 -0.602 . . . . 74.209999999999994 112.198 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.626 ' HG3' ' HG3' ' A' ' 49' ' ' ARG . 9.3 pt-20 -52.05 -33.88 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.514 0.726 . . . . 75.510000000000005 111.297 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HG3' ' HG3' ' A' ' 48' ' ' GLU . 28.2 mtp180 -89.65 -3.04 58.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.715 -0.675 . . . . 63.240000000000002 111.654 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 65.8 m -136.83 72.45 55.32 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.434 -0.348 . . . . 75.140000000000001 111.021 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.91 -26.82 83.43 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.797 2.331 . . . . 71.030000000000001 112.836 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.745 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 73.3 mt-30 -62.95 -25.51 68.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.329 -0.396 . . . . 40.420000000000002 111.541 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.5 m -83.86 -31.41 25.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.475 -0.33 . . . . 71.540000000000006 111.787 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.45 -44.71 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.522 . . . . 74.349999999999994 110.908 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.87 -78.31 0.89 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.298 -0.477 . . . . 71.530000000000001 113.701 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -111.81 114.38 27.3 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.324 0.49 . . . . 63.32 112.324 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -126.42 134.61 26.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.372 -0.376 . . . . 72.140000000000001 111.011 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD2' HD11 ' A' ' 41' ' ' LEU . 95.7 Cg_endo -81.94 123.85 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.546 2.164 . . . . 71.310000000000002 112.205 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -148.25 176.43 27.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.634 -0.793 . . . . 62.140000000000001 113.756 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 tp -97.4 121.69 39.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.621 0.368 . . . . 75.519999999999996 110.919 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.97 121.51 34.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.747 0.308 . . . . 71.409999999999997 111.142 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -72.7 -27.04 61.83 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.19 0.811 . . . . 75.409999999999997 113.19 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.499 ' HG2' HD23 ' A' ' 26' ' ' LEU . 4.2 tpm_? -58.58 -52.58 65.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.009 0.433 . . . . 75.430000000000007 111.329 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 p -92.4 -15.83 26.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.014 -0.539 . . . . 62.329999999999998 111.506 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 60.13 24.38 13.67 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.119 -0.491 . . . . 74.099999999999994 111.681 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -118.72 161.12 20.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 71.239999999999995 111.5 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -92.45 150.67 20.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.162 -0.472 . . . . 63.539999999999999 111.524 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.85 -175.29 44.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.257 -0.496 . . . . 64.209999999999994 112.747 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.46 143.54 32.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.972 0.386 . . . . 72.439999999999998 110.528 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 55.1 p90 -139.92 143.12 33.22 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.111 0.411 . . . . 44.439999999999998 112.111 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 10.6 Cg_exo -72.41 118.32 5.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.864 2.376 . . . . 53.439999999999998 112.267 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -60.32 -14.45 33.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.451 0.54 . . . . 71.040000000000006 114.451 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.745 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 10.3 t -71.48 -5.65 34.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.619 0.6 . . . . 72.409999999999997 112.619 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -111.03 1.04 17.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.138 0.422 . . . . 74.010000000000005 112.138 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 11' ' ' ALA . 25.7 m -128.41 148.6 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.46 0.541 . . . . 61.43 112.46 -175.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 13.9 pt-20 -98.77 167.18 10.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.838 0.352 . . . . 63.420000000000002 110.717 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -99.04 123.28 43.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.946 0.403 . . . . 74.340000000000003 111.001 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 10' ' ' ARG . 74.7 mt -94.26 -46.97 6.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.945 0.402 . . . . 71.150000000000006 111.347 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.72 -179.74 18.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.267 -0.492 . . . . 32.340000000000003 113.246 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.79 142.91 40.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.484 2.122 . . . . 63.210000000000001 112.478 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.558 HD21 HG13 ' A' ' 32' ' ' VAL . 6.2 mp . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.912 0.387 . . . . 74.319999999999993 111.569 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.723 0 N-CA-C 115.3 0.88 . . . . 70.010000000000005 115.3 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.53 163.44 14.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.931 0.396 . . . . 62.219999999999999 111.323 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -108.01 126.23 52.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.399 0.618 . . . . 72.230000000000004 112.264 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.75 169.64 9.43 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.449 -0.796 . . . . 74.219999999999999 110.179 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' HD11 ' A' ' 78' ' ' LEU . 45.3 ttt85 -136.03 124.45 23.43 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.088 -0.382 . . . . 75.299999999999997 111.92 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.68 129.17 34.24 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.831 0.348 . . . . 73.420000000000002 111.391 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.0 mt -81.77 -49.61 10.21 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.371 0.508 . . . . 53.119999999999997 112.371 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 49.4 m-85 -124.87 164.4 31.51 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-O 120.481 0.182 . . . . 73.140000000000001 111.236 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.7 Cg_endo -74.34 119.91 6.01 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.264 1.976 . . . . 71.140000000000001 113.299 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 . . . . . 0 N--CA 1.471 0.625 0 CA-C-N 116.397 -0.365 . . . . 74.25 111.169 179.15 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 120.761 0.315 . . . . 72.340000000000003 110.975 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.63 154.6 35.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.67 0.748 . . . . 71.5 113.014 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 92.8 mt -116.13 139.02 50.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.213 -0.903 . . . . 63.310000000000002 110.581 175.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD22 ' C ' ' A' ' 25' ' ' LEU . 3.9 mm? -121.31 154.92 59.16 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 122.458 0.303 . . . . 71.140000000000001 110.586 174.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.9 115.52 3.64 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.405 2.07 . . . . 73.049999999999997 112.852 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.55 22.11 35.21 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.372 -0.442 . . . . 72.340000000000003 113.393 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.39 136.27 33.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.994 0.426 . . . . 70.219999999999999 111.797 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.19 125.46 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.254 -0.43 . . . . 71.120000000000005 110.538 174.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.6 mp -121.05 127.5 51.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.974 0.416 . . . . 74.140000000000001 111.587 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.19 122.4 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.356 -0.384 . . . . 53.210000000000001 111.294 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.51 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 84.6 t -109.5 125.07 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.695 0.283 . . . . 63.219999999999999 110.769 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -60.07 129.68 42.94 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.774 0.321 . . . . 71.329999999999998 111.782 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 17.5 ptm180 -57.37 -30.39 64.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.634 0.255 . . . . 75.510000000000005 111.379 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.96 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.908 0.385 . . . . 63.310000000000002 111.371 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.46 87.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.923 0.392 . . . . 64.219999999999999 111.111 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.22 -46.23 69.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.262 0.554 . . . . 70.030000000000001 110.818 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 35' ' ' ARG . 77.2 mt-30 -59.28 -52.07 67.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.697 -0.683 . . . . 73.239999999999995 111.433 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.39 97.43 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.212 0.449 . . . . 74.239999999999995 112.212 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.7 -28.8 70.2 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.763 0.316 . . . . 75.310000000000002 111.644 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 23.78 10.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.185 -0.531 . . . . 34.119999999999997 113.424 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.93 110.49 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.017 0.437 . . . . 70.099999999999994 110.835 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.27 149.88 37.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.28 -0.418 . . . . 62.240000000000002 112.122 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -52.06 127.98 23.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.168 0.509 . . . . 71.230000000000004 110.99 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.56 -44.61 1.46 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.289 -0.725 . . . . 61.420000000000002 111.289 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.87 -20.63 66.74 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.511 -0.376 . . . . 63.310000000000002 112.455 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.76 -43.69 58.37 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.503 0.668 . . . . 64.540000000000006 111.178 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -77.66 -5.23 49.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.765 -0.652 . . . . 74.120000000000005 111.751 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.46 71.26 66.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.657 0.614 . . . . 62.240000000000002 112.657 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 -24.24 75.02 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.919 1.746 . . . . 72.540000000000006 110.324 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 22.1 pt20 -55.11 -26.14 36.2 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.744 -1.117 . . . . 70.510000000000005 111.95 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -89.06 -33.6 17.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.824 0.345 . . . . 65.129999999999995 111.746 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.56 -58.81 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.132 0.419 . . . . 71.200000000000003 112.132 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.9 -116.61 3.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.012 -0.613 . . . . 54.520000000000003 113.341 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -102.41 127.85 49.26 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.289 -0.536 . . . . 75.030000000000001 111.267 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -134.23 148.48 68.0 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 111.63 0.233 . . . . 62.25 111.63 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.2 124.68 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.705 2.27 . . . . 74.540000000000006 112.735 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.01 -174.0 22.94 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.942 -0.647 . . . . 44.350000000000001 113.796 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 29.0 tp -106.71 115.3 29.96 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.123 0.569 . . . . 62.039999999999999 112.094 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t-20 -82.62 104.02 12.57 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.773 0.321 . . . . 62.140000000000001 110.346 173.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -68.0 -9.01 42.17 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.28 0.844 . . . . 74.209999999999994 113.28 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.454 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.1 ttp85 -81.47 -29.13 33.84 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.659 -0.651 . . . . 74.129999999999995 110.902 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -113.12 -11.61 13.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.247 -0.433 . . . . 74.420000000000002 111.694 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.89 14.3 9.5 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.073 0.549 . . . . 74.319999999999993 112.008 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -96.77 145.65 25.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.105 0.479 . . . . 64.430000000000007 111.789 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -104.72 130.19 52.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.958 -0.564 . . . . 73.019999999999996 110.568 177.67 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.29 -175.75 39.34 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.685 -0.769 . . . . 70.450000000000003 113.379 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.12 117.14 27.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.723 0.297 . . . . 73.319999999999993 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 40.9 p90 -122.27 148.54 52.5 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 120.904 0.383 . . . . 73.409999999999997 111.31 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 17.0 Cg_exo -67.17 91.97 0.33 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.399 2.066 . . . . 75.120000000000005 112.657 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.558 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -66.74 -10.01 53.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.203 -0.453 . . . . 54.509999999999998 113.729 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 52' ' ' GLN . 60.3 m -61.54 -30.25 70.52 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.445 -0.444 . . . . 74.299999999999997 111.529 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HD2' ' HB2' ' A' ' 71' ' ' PRO . 59.3 m-85 -93.85 4.71 53.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.015 0.746 . . . . 72.439999999999998 113.015 -174.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 72' ' ' GLY . 16.9 m -108.19 151.03 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.158 0.504 . . . . 73.420000000000002 111.965 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -102.14 158.26 16.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 73.420000000000002 110.692 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -89.6 124.19 34.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.919 0.39 . . . . 74.299999999999997 111.251 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 10' ' ' ARG . 85.6 mt -93.52 -45.14 7.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.093 0.473 . . . . 70.040000000000006 111.196 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.28 19.95 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.085 -0.579 . . . . 52.530000000000001 113.494 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.35 174.25 8.12 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.88 2.387 . . . . 73.239999999999995 112.696 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 116.279 -0.419 . . . . 71.099999999999994 110.567 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 CA-C-O 120.81 0.117 . . . . 34.25 112.856 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' HB3' ' HE1' ' A' ' 77' ' ' PHE . 92.3 m-85 -127.03 138.11 53.18 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.505 -0.409 . . . . 75.439999999999998 110.635 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HG3' HD11 ' A' ' 81' ' ' LEU . 98.3 mt-30 -92.6 131.1 37.99 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.702 0.63 . . . . 72.409999999999997 112.702 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.93 163.25 17.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.393 -0.821 . . . . 70.140000000000001 109.76 170.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HB2' HD11 ' A' ' 78' ' ' LEU . 40.9 ttm180 -140.69 125.59 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.986 0.365 . . . . 75.109999999999999 111.986 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.43 127.55 32.74 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.265 0.555 . . . . 73.409999999999997 111.174 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.57 -39.01 28.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.002 0.429 . . . . 63.43 111.518 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -130.65 141.09 40.71 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.76 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.3 Cg_endo -65.88 120.9 8.14 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.451 2.101 . . . . 74.200000000000003 112.923 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.6 t80 . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 116.517 -0.311 . . . . 74.030000000000001 110.976 178.833 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.6 tp . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.054 0.454 . . . . 52.119999999999997 111.295 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -97.58 127.87 43.86 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.466 -0.334 . . . . 73.400000000000006 111.172 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.92 149.04 25.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.535 0.569 . . . . 62.039999999999999 112.535 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.86 155.94 54.6 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 75.5 110.65 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.1 Cg_endo -71.32 105.19 1.68 Allowed 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 121.607 1.538 . . . . 73.450000000000003 112.387 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.48 3.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.228 -0.51 . . . . 41.140000000000001 113.195 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -106.84 174.68 5.78 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.867 0.365 . . . . 74.310000000000002 111.623 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.35 113.72 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.786 0.327 . . . . 63.219999999999999 111.388 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.2 mp -105.15 130.46 53.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.583 0.23 . . . . 74.129999999999995 111.169 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.75 111.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.896 0.379 . . . . 72.0 111.22 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.73 128.6 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 122.649 0.38 . . . . 72.439999999999998 111.246 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -72.6 142.59 48.38 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.519999999999996 111.906 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -54.76 -36.08 64.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.399 -0.364 . . . . 74.239999999999995 111.826 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.82 73.79 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 111.904 0.335 . . . . 74.319999999999993 111.904 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.788 0.328 . . . . 55.200000000000003 111.58 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -54.51 -43.36 71.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.072 0.463 . . . . 62.0 111.443 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -69.34 -33.79 73.64 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.303 -0.408 . . . . 75.209999999999994 111.515 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.48 65.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.213 0.53 . . . . 61.539999999999999 111.138 175.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD13 HG11 ' A' ' 54' ' ' VAL . 76.8 mt -86.78 -10.13 54.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.997 -0.547 . . . . 64.239999999999995 111.28 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.69 33.19 63.59 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 23.32 113.142 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.03 135.08 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.942 0.401 . . . . 71.430000000000007 111.355 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.66 130.25 35.09 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.338 -0.392 . . . . 62.350000000000001 111.586 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -49.27 116.32 1.66 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.496 . . . . 74.120000000000005 110.776 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.61 2.26 25.79 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.286 -0.483 . . . . 72.120000000000005 112.636 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.89 5.9 32.63 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.52 -0.372 . . . . 60.039999999999999 113.281 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.97 -29.7 67.38 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.02 0.378 . . . . 72.140000000000001 112.02 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -80.54 -2.7 47.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.358 0.503 . . . . 71.329999999999998 112.358 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.2 m -128.33 64.37 67.01 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 120.89 0.376 . . . . 70.340000000000003 111.811 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 38.3 Cg_endo -65.17 -22.43 61.26 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.438 2.092 . . . . 70.329999999999998 112.174 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -62.87 -21.06 65.71 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.882 -0.599 . . . . 74.25 111.909 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.9 t -87.37 -4.05 59.03 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 75.329999999999998 111.701 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 41' ' ' LEU . 57.5 t -98.83 -54.51 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.89 0.376 . . . . 72.040000000000006 111.595 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.44 -120.28 4.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.305 -0.407 . . . . 74.140000000000001 112.39 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.3 m0 -92.09 111.59 23.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.814 0.34 . . . . 54.130000000000003 110.673 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 46.4 mtm -103.84 133.04 20.47 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.351 -0.218 . . . . 74.129999999999995 111.415 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 57' ' ' MET . 19.3 Cg_exo -67.23 117.67 4.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.871 2.381 . . . . 73.329999999999998 112.349 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.94 168.54 31.83 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.796 -0.716 . . . . 72.5 113.361 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.533 HD13 ' HE ' ' A' ' 67' ' ' ARG . 37.4 tp -112.63 114.1 26.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.744 0.307 . . . . 53.109999999999999 110.461 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 23' ' ' LEU . 50.7 t-20 -81.96 104.33 12.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.672 0.272 . . . . 74.109999999999999 110.989 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 19.0 mm-40 -69.95 0.46 5.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.447 0.906 . . . . 71.409999999999997 113.447 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' A' ' 63' ' ' ARG . 2.6 tpm_? -81.42 -43.51 18.83 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.972 -0.455 . . . . 74.319999999999993 110.515 171.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.1 p -107.8 -6.78 16.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.297 -0.41 . . . . 53.119999999999997 111.677 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 44.4 mmm-85 59.22 19.44 7.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.695 0.798 . . . . 74.299999999999997 111.779 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -95.32 145.58 24.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.108 0.48 . . . . 73.530000000000001 111.825 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.533 ' HE ' HD13 ' A' ' 60' ' ' LEU . 3.9 tpp180 -99.48 140.94 32.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.08 -0.509 . . . . 75.430000000000007 111.528 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.18 177.26 39.23 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.898 . . . . 62.0 113.657 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 5.4 m-20 -89.51 128.8 36.04 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.406 0.282 . . . . 73.420000000000002 110.597 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -119.02 141.29 30.01 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 122.107 -0.37 . . . . 74.230000000000004 111.844 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.88 113.38 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.729 2.286 . . . . 62.299999999999997 112.537 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.46 23.1 1.25 Allowed Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.027 0.771 . . . . 70.319999999999993 115.027 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.4 p -93.79 -18.6 21.87 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.807 0.803 . . . . 45.130000000000003 111.571 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -107.96 9.02 28.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.914 0.338 . . . . 71.450000000000003 111.914 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' HA2' ' A' ' 72' ' ' GLY . 25.3 m -122.51 151.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 112.632 0.604 . . . . 51.450000000000003 112.632 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.4 160.63 16.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.891 -0.595 . . . . 62.439999999999998 110.921 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 7' ' ' PHE . 26.6 t80 -93.07 115.37 28.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.035 0.445 . . . . 73.209999999999994 111.632 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 10' ' ' ARG . 87.2 mt -84.61 -44.17 13.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.731 0.301 . . . . 72.510000000000005 111.548 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.05 178.04 15.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.136 -0.554 . . . . 52.420000000000002 113.623 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.54 164.17 27.25 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.081 2.521 . . . . 54.009999999999998 112.802 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 81' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.851 0.358 . . . . 71.420000000000002 111.384 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.736 0.303 . . . . 75.120000000000005 111.261 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.92 -42.49 17.61 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.91 0.386 . . . . 63.200000000000003 111.6 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 161.11 177.32 34.11 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.395 -0.431 . . . . 63.109999999999999 113.08 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.16 107.52 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.168 2.579 . . . . 75.120000000000005 112.522 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -74.44 -22.9 58.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.063 0.459 . . . . 73.5 111.875 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.577 ' HA2' ' HG2' ' A' ' 35' ' ' ARG . . . -177.05 -152.8 10.18 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.999 -0.62 . . . . 53.420000000000002 113.122 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.5 ' HE2' HH11 ' A' ' 35' ' ' ARG . 94.4 m-85 -141.82 157.84 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 110.901 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -118.58 132.85 56.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.287 0.565 . . . . 73.319999999999993 112.248 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.92 170.83 7.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.598 -0.728 . . . . 75.510000000000005 109.578 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 35.4 ttt180 -148.33 121.5 8.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.022 -0.424 . . . . 73.349999999999994 111.386 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -69.38 125.61 27.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.956 0.408 . . . . 54.119999999999997 111.938 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -94.7 -30.27 14.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.26 0.467 . . . . 73.549999999999997 112.26 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.87 141.41 40.44 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.56 0.219 . . . . 74.329999999999998 111.391 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 70.3 Cg_endo -76.78 119.31 5.1 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.35 2.033 . . . . 63.240000000000002 113.326 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -136.91 125.87 24.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.084 -0.507 . . . . 75.200000000000003 110.712 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -74.43 148.04 41.48 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.148 -0.478 . . . . 54.530000000000001 111.045 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 66.7 mtm180 -56.62 115.51 2.58 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.033 0.444 . . . . 53.130000000000003 111.922 176.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.33 -42.56 92.79 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.433 0.635 . . . . 64.400000000000006 110.48 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -124.99 153.58 71.19 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.504 -0.771 . . . . 71.109999999999999 109.962 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.75 -29.9 44.26 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 122.459 2.106 . . . . 73.25 113.521 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -92.68 5.9 49.36 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.188 0.44 . . . . 71.140000000000001 112.188 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 36.3 t70 -91.62 150.16 21.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.527 -0.546 . . . . 72.349999999999994 109.527 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.2 tp -105.56 134.46 48.65 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.226 0.536 . . . . 73.030000000000001 111.608 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.615 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 13.5 tt0 -84.92 145.17 27.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.949 -0.569 . . . . 70.200000000000003 112.491 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.2 mt -119.13 127.9 53.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 111.771 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' HG ' ' HD3' ' A' ' 63' ' ' ARG . 4.3 mm? -123.36 143.44 41.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 122.559 0.344 . . . . 54.299999999999997 110.883 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.04 119.57 6.7 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.72 2.28 . . . . 75.219999999999999 113.443 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.45 -14.95 62.84 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.268 -0.424 . . . . 34.420000000000002 113.698 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -81.41 143.34 32.21 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.21 0.505 . . . . 64.230000000000004 111.744 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.64 141.19 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.318 0.58 . . . . 71.040000000000006 112.27 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.5 mp -118.7 123.95 46.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.029 -0.532 . . . . 35.219999999999999 110.731 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 81' ' ' LEU . 57.9 t -94.88 124.21 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 111.976 0.361 . . . . 74.109999999999999 111.976 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.28 139.79 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.952 0.405 . . . . 71.400000000000006 111.176 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 t -93.13 158.32 15.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.958 0.408 . . . . 70.319999999999993 111.835 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 17.3 mmm180 -55.34 -41.18 72.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.244 -0.435 . . . . 61.119999999999997 111.56 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.86 -45.84 71.08 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.01 0.374 . . . . 41.439999999999998 112.01 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.02 70.87 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.882 0.372 . . . . 74.319999999999993 111.707 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.25 -40.63 97.95 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.807 0.337 . . . . 63.119999999999997 111.826 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -66.16 -35.77 81.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.815 0.34 . . . . 74.420000000000002 111.225 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.36 73.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.035 0.445 . . . . 54.340000000000003 111.41 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -22.35 59.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.176 -0.465 . . . . 71.329999999999998 111.465 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.63 42.82 6.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.299 -0.477 . . . . 51.310000000000002 112.963 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.06 134.79 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.592 -0.358 . . . . 74.510000000000005 111.43 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.12 142.32 50.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.709 0.29 . . . . 75.340000000000003 111.133 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -60.93 108.33 0.85 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.051 0.453 . . . . 72.0 110.977 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 8.97 31.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.319 -0.467 . . . . 74.420000000000002 112.713 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.31 -29.55 6.3 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.612 -0.328 . . . . 61.229999999999997 112.644 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -31.63 64.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.971 0.508 . . . . 63.409999999999997 112.225 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -57.06 -16.43 7.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.172 0.434 . . . . 72.409999999999997 112.172 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.3 m -117.65 81.47 14.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.374 -0.375 . . . . 74.349999999999994 110.208 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.64 -36.15 97.9 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.942 2.428 . . . . 73.420000000000002 113.321 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -19.08 61.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.005 0.372 . . . . 44.409999999999997 112.005 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.2 t -82.77 -20.0 36.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.971 0.415 . . . . 53.009999999999998 111.462 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.38 -36.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.107 0.479 . . . . 62.399999999999999 111.283 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.26 -133.63 11.6 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.235 -0.439 . . . . 41.43 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.85 129.9 37.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.111 0.482 . . . . 73.409999999999997 111.274 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 69.1 mtm -131.46 140.37 38.22 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.483 -0.326 . . . . 65.109999999999999 111.615 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.47 118.97 4.0 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.689 2.259 . . . . 72.219999999999999 113.05 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.28 -174.71 23.89 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.863 -0.684 . . . . 54.409999999999997 113.892 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.06 130.48 55.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.635 0.374 . . . . 52.219999999999999 111.338 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.59 143.64 28.07 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.729 0.3 . . . . 72.239999999999995 111.414 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -79.05 -52.29 8.41 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.166 0.802 . . . . 73.109999999999999 113.166 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HD3' ' HG ' ' A' ' 26' ' ' LEU . 58.2 ttt180 -62.73 -40.47 97.29 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.843 0.683 . . . . 71.099999999999994 112.843 -175.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -92.26 -17.11 25.23 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.068 0.395 . . . . 63.25 112.068 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.64 17.82 6.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.613 0.365 . . . . 72.299999999999997 111.57 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -98.71 159.14 15.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.29 0.567 . . . . 64.140000000000001 112.143 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -121.88 135.05 54.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.779 -0.646 . . . . 73.230000000000004 111.297 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.18 -171.73 44.08 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.669 -0.777 . . . . 73.329999999999998 113.04 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -88.95 121.69 31.57 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.794 -0.239 . . . . 51.299999999999997 111.228 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.555 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 50.4 p90 -111.92 143.74 29.3 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 120.566 0.222 . . . . 73.420000000000002 111.151 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.85 104.18 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.215 1.943 . . . . 62.109999999999999 111.88 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.78 36.71 1.03 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 114.255 0.462 . . . . 73.430000000000007 114.255 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -104.52 -30.22 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.125 -0.632 . . . . 55.009999999999998 111.23 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -93.43 11.25 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.217 -0.447 . . . . 75.430000000000007 111.614 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 11' ' ' ALA . 24.1 m -118.51 145.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.36 0.504 . . . . 63.399999999999999 112.36 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 15.0 pt-20 -93.07 170.72 9.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.928 0.394 . . . . 70.450000000000003 110.844 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -102.69 129.73 49.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.427 -0.351 . . . . 72.230000000000004 110.947 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.96 -51.15 3.94 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.101 0.408 . . . . 71.150000000000006 112.101 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.18 -175.1 33.27 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.714 -0.755 . . . . 61.229999999999997 113.584 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.45 146.99 12.44 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.006 2.471 . . . . 75.209999999999994 113.922 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 32' ' ' VAL . 90.2 mt -78.02 116.91 18.85 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 74.010000000000005 111.088 175.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.255 1.382 0 CA-C-O 118.737 -0.649 . . . . 64.400000000000006 111.195 177.412 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 50.9 ttm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.644 0.259 . . . . 74.230000000000004 111.161 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.86 -57.61 3.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.904 0.383 . . . . 74.230000000000004 111.542 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.16 -175.45 23.24 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.387 -0.435 . . . . 55.130000000000003 112.975 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.94 47.64 1.78 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.072 2.515 . . . . 74.209999999999994 113.045 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -57.86 -33.24 68.46 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.264 0.554 . . . . 64.019999999999996 111.743 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.86 161.23 34.52 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.302 -0.475 . . . . 71.319999999999993 112.972 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 94.0 m-85 -110.01 153.57 24.4 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.886 0.374 . . . . 71.540000000000006 111.154 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -116.54 126.89 53.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.148 0.499 . . . . 64.400000000000006 111.575 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.77 168.25 9.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.91 -0.586 . . . . 64.549999999999997 110.717 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.502 ' HB2' HD11 ' A' ' 78' ' ' LEU . 31.2 ttt85 -124.01 118.95 28.16 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.3 -0.25 . . . . 70.349999999999994 111.11 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.556 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -67.92 117.78 10.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.989 0.423 . . . . 72.129999999999995 111.567 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 76' ' ' GLU . 51.9 mt -89.83 -41.02 12.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.006 0.432 . . . . 73.120000000000005 111.705 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -127.76 149.53 70.76 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.261 -0.427 . . . . 74.019999999999996 111.121 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.9 Cg_endo -72.68 152.75 53.73 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.511 2.14 . . . . 60.149999999999999 113.469 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -143.42 129.95 20.12 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.201 -0.454 . . . . 73.340000000000003 110.444 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 67.5 mtt180 -104.06 160.12 15.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.06 0.457 . . . . 64.530000000000001 112.15 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.816 ' HG3' ' HG3' ' A' ' 24' ' ' GLU . 59.9 mtm180 -97.91 128.14 44.31 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.59 0.589 . . . . 75.099999999999994 112.59 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.791 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 10.5 pt-20 -87.03 -19.58 28.44 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.363 0.601 . . . . 62.409999999999997 110.315 169.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.791 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 89.2 mtt180 -132.77 153.25 80.99 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 115.797 -0.638 . . . . 75.120000000000005 111.111 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.12 -27.97 84.94 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.407 2.071 . . . . 71.430000000000007 112.816 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -78.42 -5.89 53.68 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.433 0.531 . . . . 60.329999999999998 112.433 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.557 ' HB3' ' HG2' ' A' ' 17' ' ' ARG . 4.3 t0 -84.87 177.36 8.0 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 110.121 -0.326 . . . . 61.240000000000002 110.121 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 tp -129.84 126.12 37.29 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.695 -0.628 . . . . 73.5 112.377 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.816 ' HG3' ' HG3' ' A' ' 17' ' ' ARG . 44.1 mt-10 -87.0 131.29 34.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.064 0.459 . . . . 51.43 111.564 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 HD21 ' A' ' 31' ' ' LEU . 64.3 mt -119.61 138.12 53.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.804 -0.634 . . . . 74.400000000000006 110.82 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 25' ' ' LEU . 3.9 mm? -118.36 145.65 37.73 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 120.836 0.351 . . . . 71.530000000000001 110.834 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.61 106.26 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.319 2.013 . . . . 72.439999999999998 113.14 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.73 -21.35 4.47 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.329 -0.462 . . . . 61.140000000000001 113.245 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.67 142.28 58.46 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.552 0.575 . . . . 63.229999999999997 112.552 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.73 98.78 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.847 -0.615 . . . . 75.140000000000001 110.517 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 75' ' ' VAL . 6.9 mp -78.78 116.54 19.19 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.91 0.386 . . . . 72.549999999999997 111.775 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.8 t -94.35 117.23 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.947 0.403 . . . . 65.409999999999997 111.5 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG22 ' HA3' ' A' ' 59' ' ' GLY . 96.1 t -115.84 123.23 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.299 -0.409 . . . . 72.439999999999998 111.132 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -66.45 131.08 45.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.832 -0.167 . . . . 43.420000000000002 110.829 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -54.68 -33.92 61.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.965 0.357 . . . . 74.209999999999994 111.965 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.79 66.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.888 0.375 . . . . 62.030000000000001 111.856 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -64.23 -34.88 79.12 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.430000000000007 111.686 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.93 -42.92 99.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.964 0.412 . . . . 53.100000000000001 111.096 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.68 -35.34 78.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.753 0.311 . . . . 61.229999999999997 110.931 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.41 -33.78 74.27 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.003 0.43 . . . . 62.439999999999998 111.489 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.635 HD21 ' HD3' ' A' ' 58' ' ' PRO . 96.1 mt -74.98 -28.75 60.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.893 0.377 . . . . 73.129999999999995 111.805 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.76 35.17 8.55 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.115 -0.564 . . . . 63.310000000000002 112.239 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -75.72 127.39 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 120.727 0.299 . . . . 50.329999999999998 111.184 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 146.16 54.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.984 0.421 . . . . 41.240000000000002 111.233 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.87 121.64 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.144 0.497 . . . . 74.310000000000002 111.223 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.39 -15.98 60.49 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.154 -0.546 . . . . 73.010000000000005 112.739 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.26 48.18 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.627 -0.321 . . . . 75.019999999999996 113.394 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -53.67 -21.11 6.3 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.461 0.648 . . . . 74.530000000000001 111.585 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.81 -11.26 25.5 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.517 0.562 . . . . 75.109999999999999 112.517 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 26.6 p -161.01 91.7 1.54 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.042 0.386 . . . . 70.329999999999998 112.042 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 50' ' ' CYS . 11.9 Cg_endo -55.05 -23.79 37.14 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.985 2.456 . . . . 74.120000000000005 112.94 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.27 74.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.747 0.308 . . . . 72.239999999999995 110.776 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.7 m -65.85 -15.37 62.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.381 0.511 . . . . 63.310000000000002 112.381 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.16 -30.33 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.991 0.424 . . . . 71.310000000000002 111.417 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.29 -92.24 1.78 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.116 -0.564 . . . . 74.540000000000006 113.145 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -108.56 131.51 54.77 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.935 0.398 . . . . 70.549999999999997 111.279 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 66.4 mtp -133.16 132.64 22.34 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.275 -0.421 . . . . 74.310000000000002 110.938 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.635 ' HD3' HD21 ' A' ' 41' ' ' LEU . 92.8 Cg_endo -87.28 118.07 1.32 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.677 2.251 . . . . 65.219999999999999 112.852 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.16 179.09 28.12 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.815 -0.707 . . . . 22.219999999999999 113.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.86 124.51 49.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.459 0.304 . . . . 71.219999999999999 111.394 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.8 t-20 -87.25 149.03 24.85 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.594 -0.275 . . . . 65.030000000000001 110.771 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -92.11 -28.61 17.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.537 0.94 . . . . 74.109999999999999 113.537 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -58.79 3.06 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.595 0.712 . . . . 74.420000000000002 110.808 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 24' ' ' GLU . 64.4 p -81.87 -21.71 37.34 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.546 -0.752 . . . . 70.439999999999998 111.634 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 13.7 mmt85 57.54 31.21 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.562 . . . . 70.409999999999997 111.98 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.31 135.77 39.44 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.811 -0.631 . . . . 73.209999999999994 110.161 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -97.58 121.22 39.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.976 -0.379 . . . . 71.040000000000006 109.976 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -169.96 -172.11 36.14 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.647 -0.787 . . . . 52.509999999999998 113.568 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.86 132.21 35.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.847 0.356 . . . . 74.310000000000002 111.255 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 25' ' ' LEU . 53.2 p90 -138.45 150.17 65.41 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.758 0.313 . . . . 71.109999999999999 111.482 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.79 110.26 2.31 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.188 1.925 . . . . 64.040000000000006 112.425 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.49 -11.5 35.05 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.598 0.599 . . . . 32.219999999999999 114.598 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -72.52 -8.18 53.82 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.517 0.658 . . . . 74.510000000000005 112.361 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -94.7 -2.91 50.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.065 0.395 . . . . 75.040000000000006 112.065 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.557 HG11 HD22 ' A' ' 31' ' ' LEU . 18.9 m -127.24 149.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 112.437 0.532 . . . . 65.209999999999994 112.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG2' HD21 ' A' ' 12' ' ' LEU . 11.6 pt-20 -104.23 158.94 16.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.345 -0.388 . . . . 75.120000000000005 110.451 173.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -89.45 127.79 35.88 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.016 0.436 . . . . 71.340000000000003 111.702 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 10' ' ' ARG . 90.2 mt -98.66 -65.9 0.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.118 0.485 . . . . 74.239999999999995 110.968 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.18 169.23 32.27 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.212 -0.518 . . . . 61.25 112.989 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 82.6 Cg_endo -76.48 160.91 34.94 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.71 2.273 . . . . 74.230000000000004 112.985 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -95.44 98.8 10.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.862 0.839 . . . . 72.530000000000001 111.389 177.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 1' ' ' MET . 14.4 tp10 . . . . . 0 C--O 1.253 1.257 0 CA-C-N 115.384 -0.826 . . . . 72.209999999999994 111.909 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 120.775 0.321 . . . . 73.239999999999995 111.473 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.85 130.17 11.3 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.889 0.376 . . . . 74.219999999999999 111.519 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . -132.55 -113.26 1.45 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 116.267 -0.424 . . . . 61.409999999999997 113.313 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 32.4 Cg_endo -103.34 35.76 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.707 2.938 . . . . 62.210000000000001 114.877 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -58.57 -32.01 68.53 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.807 0.669 . . . . 62.140000000000001 112.807 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.15 168.12 41.05 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.562 -0.828 . . . . 35.439999999999998 113.646 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.08 158.41 41.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.048 0.452 . . . . 71.430000000000007 111.535 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.91 130.33 56.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.243 -0.435 . . . . 72.409999999999997 111.66 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -122.92 146.81 47.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.209 -0.451 . . . . 63.210000000000001 110.63 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HB2' HD11 ' A' ' 78' ' ' LEU . 15.0 ttp180 -104.75 126.71 52.1 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.102 -0.374 . . . . 71.530000000000001 111.388 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.8 114.73 12.42 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.999 0.428 . . . . 62.039999999999999 111.073 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.33 -61.06 1.92 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.299 -0.41 . . . . 72.219999999999999 112.07 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -128.32 147.25 62.92 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 116.628 -0.26 . . . . 65.400000000000006 111.007 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 27' ' ' PRO . 49.6 Cg_endo -69.02 119.65 6.62 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.182 1.921 . . . . 52.32 112.996 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.715 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 77.2 t80 -112.34 111.4 22.23 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.235 -0.439 . . . . 64.239999999999995 110.461 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -73.47 134.78 44.0 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.318 0.58 . . . . 72.409999999999997 112.102 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.418 HH21 ' HA ' ' A' ' 70' ' ' PHE . 26.9 mmt180 -89.53 171.1 9.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.001 -0.545 . . . . 74.510000000000005 110.817 173.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' HB2' ' HD3' ' A' ' 19' ' ' ARG . 30.4 mm-40 -85.08 -51.51 6.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.307 -0.406 . . . . 74.430000000000007 110.454 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.536 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -130.73 160.77 64.83 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 116.343 -0.39 . . . . 43.329999999999998 110.792 178.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 19' ' ' ARG . 49.0 Cg_endo -66.83 5.42 0.79 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.968 2.445 . . . . 61.219999999999999 114.547 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.11 -32.63 74.19 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.042 -0.411 . . . . 72.329999999999998 111.331 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -103.83 -178.46 3.67 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.95 0.405 . . . . 73.040000000000006 111.294 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 61' ' ' ASN . 32.1 tp -100.16 132.35 45.58 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.856 0.36 . . . . 64.150000000000006 111.785 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.36 142.74 28.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.159 -0.473 . . . . 73.310000000000002 110.02 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.715 ' HB2' ' H ' ' A' ' 15' ' ' PHE . 80.9 mt -104.94 135.03 47.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.305 0.854 . . . . 61.350000000000001 113.305 -169.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.631 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.1 mm? -111.82 139.01 21.79 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 115.745 -0.661 . . . . 64.530000000000001 110.545 175.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.544 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 60.0 Cg_endo -70.47 126.3 12.7 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.35 2.033 . . . . 60.240000000000002 113.135 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.24 65.71 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.153 -0.476 . . . . 54.219999999999999 113.936 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.7 160.63 27.39 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.179 0.514 . . . . 41.340000000000003 112.071 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.82 133.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.26 0.553 . . . . 72.299999999999997 111.433 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -108.6 122.7 47.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.206 -0.452 . . . . 72.120000000000005 110.701 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.02 115.91 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.08 0.467 . . . . 71.010000000000005 111.069 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.477 HG22 ' HA3' ' A' ' 59' ' ' GLY . 62.0 t -113.15 106.68 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.013 0.435 . . . . 70.510000000000005 111.78 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 m -62.23 126.43 27.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.388 -0.369 . . . . 65.120000000000005 110.384 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -58.72 -20.5 49.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.176 0.436 . . . . 74.25 112.176 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.27 -36.11 51.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.987 0.422 . . . . 75.030000000000001 111.433 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.34 -39.4 71.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.261 -0.427 . . . . 74.129999999999995 111.098 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.97 -37.89 89.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.998 0.428 . . . . 71.109999999999999 111.17 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.25 -38.56 88.13 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.084 0.468 . . . . 63.200000000000003 110.595 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.43 80.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.128 -0.487 . . . . 72.140000000000001 111.229 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.476 HD11 ' HD3' ' A' ' 58' ' ' PRO . 89.2 mt -74.03 -27.76 61.1 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.941 0.4 . . . . 60.450000000000003 111.127 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.93 55.52 2.94 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.096 -0.502 . . . . 74.219999999999999 112.428 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.77 141.01 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.061 0.458 . . . . 53.420000000000002 111.532 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.78 145.42 34.38 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.033 0.444 . . . . 73.340000000000003 111.879 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 120.73 13.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 111.153 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.83 -13.57 49.76 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.007 -0.616 . . . . 60.140000000000001 112.086 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.0 -18.78 26.03 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.455 -0.402 . . . . 62.039999999999999 113.066 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -30.95 71.98 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.131 0.491 . . . . 63.25 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -76.47 8.42 3.5 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.32 -0.4 . . . . 71.099999999999994 111.879 175.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.9 m -137.09 80.35 35.34 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 120.901 0.382 . . . . 71.200000000000003 111.135 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.12 -36.91 97.51 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.705 2.27 . . . . 71.120000000000005 113.082 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -61.25 -22.31 64.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.386 -0.37 . . . . 73.420000000000002 111.76 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.4 m -86.49 -24.16 25.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.662 -0.245 . . . . 64.340000000000003 111.588 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.81 -46.04 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.034 0.445 . . . . 75.349999999999994 111.533 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.09 -99.16 0.79 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.449 -0.405 . . . . 63.130000000000003 112.852 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -122.93 133.86 54.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.588 -0.36 . . . . 71.219999999999999 110.811 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -133.86 151.65 77.27 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 122.19 -0.319 . . . . 74.340000000000003 111.507 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD3' HD11 ' A' ' 41' ' ' LEU . 3.2 Cg_endo -86.01 137.4 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.524 . . . . 65.040000000000006 112.092 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.477 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -159.39 -179.71 34.4 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.693 -0.765 . . . . 71.329999999999998 113.859 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -101.07 117.85 35.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.666 0.387 . . . . 74.150000000000006 111.017 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.523 ' HB2' HD21 ' A' ' 23' ' ' LEU . 25.4 t-20 -85.62 111.61 20.22 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.794 0.33 . . . . 55.240000000000002 111.239 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -62.16 -28.71 69.84 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.914 0.709 . . . . 74.140000000000001 112.914 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.631 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -60.52 -54.89 40.0 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.194 0.521 . . . . 75.510000000000005 111.519 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.3 p -99.55 -8.82 24.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.988 -0.551 . . . . 55.399999999999999 112.379 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 64.23 13.58 8.02 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.743 0.417 . . . . 74.109999999999999 111.362 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -96.45 166.69 11.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.296 0.569 . . . . 55.299999999999997 112.308 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -116.26 147.79 41.14 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.55 -0.75 . . . . 64.200000000000003 111.342 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.34 40.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.858 -0.686 . . . . 53.450000000000003 113.095 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 6.6 m-20 -88.73 139.93 29.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.935 0.398 . . . . 71.400000000000006 111.363 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 25' ' ' LEU . 53.7 p90 -134.16 146.84 61.38 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.672 0.273 . . . . 74.219999999999999 111.635 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD2' HD11 ' A' ' 25' ' ' LEU . 17.4 Cg_exo -67.58 110.4 2.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.741 2.294 . . . . 53.219999999999999 112.714 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -62.19 -10.23 26.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.082 0.393 . . . . 33.32 114.082 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.3 p -76.23 -20.92 56.99 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.509 -0.406 . . . . 75.209999999999994 111.885 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -102.25 12.37 36.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.42 0.526 . . . . 74.209999999999994 112.42 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.467 HG22 ' HA2' ' A' ' 72' ' ' GLY . 32.4 m -130.23 151.09 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.123 0.487 . . . . 25.43 111.355 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -118.45 145.0 45.58 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.408 -0.36 . . . . 74.209999999999994 111.324 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -73.22 117.7 15.27 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.396 -0.365 . . . . 75.540000000000006 111.411 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 10' ' ' ARG . 85.5 mt -87.79 -58.3 2.62 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.043 0.449 . . . . 74.200000000000003 110.984 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.25 -169.75 42.46 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.137 -0.554 . . . . 3.1400000000000001 112.946 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.11 -176.69 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.868 2.379 . . . . 74.510000000000005 113.411 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.47 116.69 24.78 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.338 -0.392 . . . . 74.140000000000001 111.3 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 . . . . . 0 C--O 1.254 1.314 0 CA-C-O 119.27 -0.395 . . . . 63.039999999999999 111.893 178.997 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.966 0.413 . . . . 73.120000000000005 111.611 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.52 -68.92 0.48 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.403 -0.362 . . . . 54.229999999999997 110.943 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.92 -175.24 19.85 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.983 -0.627 . . . . 64.0 113.638 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -100.92 40.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.645 2.896 . . . . 73.25 113.766 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -32.17 66.02 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 122.181 -0.324 . . . . 54.399999999999999 111.464 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . 110.38 -163.22 12.38 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 115.695 1.038 . . . . 63.240000000000002 115.695 169.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -125.97 179.87 5.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.971 -0.614 . . . . 64.25 110.772 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.434 ' HG3' HD23 ' A' ' 81' ' ' LEU . 86.9 mt-30 -125.25 137.56 54.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.406 0.622 . . . . 74.329999999999998 112.016 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -120.17 154.66 34.48 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.596 -0.729 . . . . 74.030000000000001 110.271 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' HB2' HD11 ' A' ' 78' ' ' LEU . 51.6 ttp180 -123.02 121.9 37.21 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.099 -0.376 . . . . 72.219999999999999 111.663 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.78 123.42 24.12 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.022 0.439 . . . . 75.219999999999999 111.622 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.8 -49.77 10.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.004 0.43 . . . . 75.040000000000006 111.662 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -127.35 153.35 77.11 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.308 -0.405 . . . . 61.240000000000002 111.336 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -68.54 131.35 22.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.342 2.028 . . . . 73.340000000000003 113.74 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 t80 -111.37 131.19 55.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.533 -0.758 . . . . 72.010000000000005 110.653 176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.517 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 5.5 ppt_? -108.28 139.47 42.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.172 0.511 . . . . 74.230000000000004 111.617 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.602 ' HG2' ' HB2' ' A' ' 22' ' ' ASP . 28.8 tpt180 -117.08 142.39 47.04 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.262 -0.427 . . . . 74.340000000000003 111.194 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.61 7.81 2.76 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.238 0.459 . . . . 74.340000000000003 112.238 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' H ' ' HG3' ' A' ' 17' ' ' ARG . 53.4 mtt-85 -144.59 143.65 22.23 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 123.183 0.593 . . . . 75.140000000000001 110.665 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.41 -4.21 14.45 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.511 2.141 . . . . 73.430000000000007 112.73 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.84 -53.75 10.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.232 -0.44 . . . . 73.239999999999995 112.073 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.602 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 3.3 m-20 -70.65 169.44 14.36 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.0 0.429 . . . . 75.140000000000001 111.542 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp -100.05 119.91 39.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.309 0.576 . . . . 61.340000000000003 111.521 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 40.8 mt-10 -90.64 164.59 14.11 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.969 -0.56 . . . . 70.439999999999998 111.875 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 80.2 mt -121.93 147.12 46.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 73.450000000000003 111.803 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.45 HD22 ' C ' ' A' ' 25' ' ' LEU . 4.0 mm? -122.91 155.61 63.52 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 122.544 0.337 . . . . 74.140000000000001 111.179 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.51 117.82 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.161 1.907 . . . . 75.129999999999995 112.495 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.16 28.28 45.7 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.151 -0.547 . . . . 70.140000000000001 112.589 -177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -93.44 156.59 16.68 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.499 0.319 . . . . 72.109999999999999 110.578 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.26 132.91 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.839 0.352 . . . . 63.420000000000002 110.731 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.5 mp -127.29 124.04 37.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.091 0.472 . . . . 74.140000000000001 111.418 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.21 119.09 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.334 -0.394 . . . . 74.010000000000005 110.73 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.511 HG22 ' HA3' ' A' ' 59' ' ' GLY . 59.9 t -115.27 104.77 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.923 0.392 . . . . 63.240000000000002 111.651 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.556 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 70.5 m -60.99 119.8 8.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.439 -0.346 . . . . 74.230000000000004 110.15 174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -63.02 -12.49 26.41 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.628 0.603 . . . . 64.409999999999997 112.628 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.92 71.16 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.266 0.555 . . . . 71.409999999999997 110.461 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.632 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -68.19 -35.85 78.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.797 -0.638 . . . . 43.109999999999999 111.136 175.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.56 -34.35 76.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.997 0.427 . . . . 75.319999999999993 110.511 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -63.74 -36.08 82.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.332 -0.395 . . . . 74.510000000000005 110.849 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.23 -25.02 64.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.996 0.426 . . . . 70.219999999999999 111.296 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.579 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -80.72 -28.36 36.61 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.106 0.479 . . . . 61.200000000000003 111.106 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.75 45.18 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.022 -0.535 . . . . 71.109999999999999 112.504 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.56 133.89 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.59 0.589 . . . . 72.239999999999995 112.59 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.74 151.65 24.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.971 -0.559 . . . . 73.239999999999995 111.457 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -50.02 110.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.106 0.479 . . . . 74.319999999999993 111.463 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.28 -50.54 0.88 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 116.186 -0.461 . . . . 72.400000000000006 112.047 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.07 -27.18 68.45 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.072 -0.585 . . . . 55.43 112.848 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -57.5 -35.36 70.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.117 0.484 . . . . 75.230000000000004 111.432 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -100.64 4.01 42.97 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 64.219999999999999 111.606 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -142.91 82.52 12.08 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 120.875 0.369 . . . . 72.319999999999993 111.209 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 20.4 Cg_endo -58.92 -24.78 74.35 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.106 2.537 . . . . 70.530000000000001 113.228 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -57.37 -27.14 62.03 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.733 0.302 . . . . 75.310000000000002 111.743 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -82.96 -13.18 56.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.001 0.429 . . . . 74.420000000000002 111.761 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 41' ' ' LEU . 46.6 t -98.44 -38.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.037 0.446 . . . . 64.219999999999999 111.422 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -93.12 1.77 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.125 -0.559 . . . . 75.140000000000001 112.697 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -93.53 136.7 33.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.795 0.331 . . . . 74.129999999999995 110.648 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 81.5 mtp -139.76 129.15 13.79 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 111.923 0.342 . . . . 73.049999999999997 111.923 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.632 ' HG2' ' HB1' ' A' ' 37' ' ' ALA . 73.1 Cg_endo -77.52 117.85 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.531 2.154 . . . . 70.540000000000006 112.786 174.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.18 -177.8 25.36 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.797 -0.716 . . . . 74.439999999999998 113.539 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.1 tp -111.96 116.11 30.05 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.867 0.365 . . . . 74.129999999999995 111.223 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.9 t-20 -76.98 134.94 38.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.42 -0.354 . . . . 62.039999999999999 110.841 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -84.25 -40.09 18.46 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.731 0.641 . . . . 74.420000000000002 112.731 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -67.5 -30.47 70.16 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.124 0.416 . . . . 75.120000000000005 112.124 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -114.81 -28.69 6.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.92 0.341 . . . . 60.229999999999997 111.92 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 14.7 mmt85 64.14 28.93 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.159 0.504 . . . . 61.039999999999999 112.18 -176.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -91.03 143.86 26.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.993 -0.549 . . . . 61.109999999999999 111.204 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' NH1' ' H ' ' A' ' 68' ' ' GLY . 10.0 mmm180 -96.43 164.42 12.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 75.409999999999997 111.858 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.519 ' H ' ' NH1' ' A' ' 67' ' ' ARG . . . 139.61 -165.89 25.72 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.453 -0.794 . . . . 74.120000000000005 112.121 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -108.14 132.92 53.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.675 -0.309 . . . . 73.310000000000002 110.801 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -118.86 147.35 42.17 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.739 0.304 . . . . 73.219999999999999 111.199 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.87 103.6 1.75 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.384 2.056 . . . . 72.439999999999998 112.642 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -60.07 -14.99 34.48 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.503 0.561 . . . . 73.340000000000003 114.503 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -62.43 -18.4 61.62 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.841 0.682 . . . . 63.329999999999998 112.841 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.35 3.32 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.913 -0.492 . . . . 75.200000000000003 112.155 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 11' ' ' ALA . 15.0 m -120.96 159.5 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.178 0.513 . . . . 72.310000000000002 112.073 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.98 152.41 28.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 110.905 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -83.84 106.56 15.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.708 0.289 . . . . 73.219999999999999 111.22 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -72.65 -53.45 11.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.038 0.447 . . . . 74.430000000000007 111.099 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.58 -175.07 27.11 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.215 -0.517 . . . . 63.200000000000003 113.11 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.88 164.94 24.88 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.308 2.672 . . . . 70.219999999999999 112.636 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.434 HD23 ' HG3' ' A' ' 8' ' ' GLN . 2.3 pp -127.06 158.12 37.83 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.048 0.388 . . . . 70.439999999999998 112.048 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 . . . . . 0 C--O 1.253 1.245 0 CA-C-O 118.742 -0.647 . . . . 65.120000000000005 110.88 174.456 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.731 0.3 . . . . 74.430000000000007 111.129 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.65 104.09 16.22 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.915 0.388 . . . . 43.409999999999997 111.346 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.75 -171.95 44.98 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.974 -0.632 . . . . 70.129999999999995 113.403 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.17 39.54 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 123.087 2.525 . . . . 75.329999999999998 113.823 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -62.18 -28.57 69.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.019 0.378 . . . . 73.409999999999997 112.019 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . -128.32 147.14 17.28 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.119 -0.562 . . . . 41.299999999999997 112.777 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -127.1 158.18 37.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.296 0.57 . . . . 74.420000000000002 111.944 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.05 127.44 56.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.902 -0.59 . . . . 73.349999999999994 111.369 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.2 163.25 14.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 64.030000000000001 110.143 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 10' ' ' ARG . 38.2 ttt180 -133.46 123.94 26.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.975 0.416 . . . . 62.439999999999998 111.59 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 25' ' ' LEU . . . -77.06 122.98 25.71 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.04 -0.527 . . . . 74.109999999999999 110.841 177.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.3 -60.11 2.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 61.509999999999998 111.915 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.452 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 91.8 m-85 -127.25 161.2 55.76 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-N 116.205 -0.452 . . . . 72.049999999999997 110.985 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_endo -63.7 135.15 47.33 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.01 1.806 . . . . 52.039999999999999 112.965 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -133.85 130.78 38.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.898 -0.592 . . . . 74.310000000000002 111.481 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -135.41 141.83 45.53 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.277 -0.419 . . . . 71.340000000000003 110.914 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 18' ' ' GLU . 19.1 tpp180 -107.87 167.41 10.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.825 0.345 . . . . 74.200000000000003 110.779 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.543 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 6.5 mm-40 -70.1 -10.99 60.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.027 0.442 . . . . 72.230000000000004 111.533 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 22.4 mmm180 -136.31 137.55 24.73 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.147 0.579 . . . . 74.400000000000006 110.531 177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.87 5.43 2.98 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.603 2.202 . . . . 65.420000000000002 113.207 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG2' ' HB3' ' A' ' 19' ' ' ARG . 6.9 mm-40 -62.42 -25.88 68.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.213 0.53 . . . . 75.129999999999995 110.688 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.52 -158.43 0.22 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.527 -0.76 . . . . 64.239999999999995 110.179 171.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.6 tp -133.11 118.92 19.29 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.088 -0.382 . . . . 65.430000000000007 111.304 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -62.48 119.97 10.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.087 0.47 . . . . 73.010000000000005 111.481 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 74.6 mt -100.35 143.11 30.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.456 . . . . 73.120000000000005 111.613 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.3 mm? -110.99 148.0 37.71 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.438 -0.346 . . . . 65.109999999999999 110.651 176.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 36.2 Cg_endo -63.57 106.22 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.506 2.138 . . . . 73.109999999999999 113.311 -175.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.02 34.49 23.92 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.038 -0.528 . . . . 60.200000000000003 113.62 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.43 ' CG ' ' HB2' ' A' ' 63' ' ' ARG . 33.2 t70 -105.56 158.91 16.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.175 0.487 . . . . 64.019999999999996 111.997 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -101.09 131.85 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 121.395 0.616 . . . . 61.420000000000002 112.391 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.449 ' N ' HD12 ' A' ' 31' ' ' LEU . 6.0 mp -111.2 127.76 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.831 -0.622 . . . . 54.25 110.704 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.0 122.68 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.008 0.433 . . . . 63.439999999999998 111.517 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.79 116.46 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.277 -0.42 . . . . 75.120000000000005 111.253 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 55.4 m -89.23 156.65 18.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 72.409999999999997 111.176 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HG2' HD12 ' A' ' 38' ' ' LEU . 36.1 mtm180 -71.48 -14.66 62.2 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.722 0.268 . . . . 73.25 111.722 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.46 -35.74 20.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.011 0.434 . . . . 73.420000000000002 111.523 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.52 13.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.984 0.421 . . . . 64.450000000000003 111.56 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.542 HD12 ' HG2' ' A' ' 35' ' ' ARG . 90.0 mt -56.82 -38.43 72.6 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 75.409999999999997 112.164 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 14.8 mm100 -65.3 -37.69 87.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.904 0.383 . . . . 73.340000000000003 110.997 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -34.06 76.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.026 0.441 . . . . 62.409999999999997 110.989 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.556 HD11 ' HD2' ' A' ' 58' ' ' PRO . 75.2 mt -69.99 -28.5 65.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.104 -0.498 . . . . 75.099999999999994 111.118 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 41.81 6.05 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.353 -0.451 . . . . 75.0 112.598 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.64 129.78 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.886 0.374 . . . . 72.329999999999998 111.757 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 148.69 37.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.955 0.407 . . . . 60.409999999999997 112.029 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.55 122.43 12.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.205 -0.452 . . . . 71.239999999999995 111.151 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.13 2.77 60.59 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.023 -0.608 . . . . 73.409999999999997 112.836 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.27 -28.49 10.62 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.3 -0.476 . . . . 62.130000000000003 112.855 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -34.53 72.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.042 0.386 . . . . 64.510000000000005 112.042 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -63.56 -12.02 29.34 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.168 0.432 . . . . 74.420000000000002 112.168 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -134.55 85.55 36.86 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 120.819 0.343 . . . . 75.430000000000007 110.515 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 17.7 Cg_endo -55.94 -28.1 66.79 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.154 2.569 . . . . 74.129999999999995 113.284 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -62.4 -23.36 66.79 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.326 -0.397 . . . . 62.310000000000002 111.75 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -68.1 -45.31 74.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.097 0.475 . . . . 71.129999999999995 111.358 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.17 -46.44 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.155 -0.475 . . . . 61.439999999999998 111.459 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.0 -90.22 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.258 -0.496 . . . . 54.240000000000002 113.285 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -112.06 114.76 27.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.956 0.408 . . . . 75.420000000000002 111.906 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -124.26 138.43 30.86 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.436 -0.347 . . . . 61.109999999999999 111.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HD2' HD11 ' A' ' 41' ' ' LEU . 71.6 Cg_endo -77.93 127.94 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.411 2.074 . . . . 64.109999999999999 112.393 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.69 168.83 27.33 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.812 -0.709 . . . . 34.200000000000003 113.288 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 tp -103.88 124.02 48.19 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.764 0.316 . . . . 71.530000000000001 111.204 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -84.45 118.13 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.714 0.293 . . . . 72.519999999999996 110.666 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.3 -31.62 72.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.747 0.647 . . . . 63.43 112.747 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -63.37 -51.62 65.12 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.045 0.45 . . . . 72.230000000000004 111.847 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 82.6 p -102.43 -18.79 15.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.295 0.85 . . . . 75.209999999999994 113.295 -172.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER 69.58 17.97 7.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.934 0.494 . . . . 65.140000000000001 111.631 -173.343 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -84.13 149.27 26.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.116 0.484 . . . . 75.409999999999997 111.507 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 67' ' ' ARG . 50.1 mtp180 -111.23 150.71 29.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.122 -0.49 . . . . 74.049999999999997 110.679 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.62 164.08 27.49 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.503 -0.855 . . . . 72.439999999999998 113.647 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.03 109.58 20.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.126 -0.324 . . . . 73.230000000000004 110.126 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -106.72 143.75 27.66 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.24 0.459 . . . . 72.109999999999999 112.24 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.37 104.69 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.54 2.16 . . . . 71.329999999999998 112.079 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -61.03 -18.57 55.01 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.082 0.793 . . . . 74.120000000000005 115.082 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -58.65 -24.83 61.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.683 0.742 . . . . 74.340000000000003 112.149 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -100.66 11.66 39.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.647 0.61 . . . . 60.530000000000001 112.647 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.86 150.32 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.778 0.323 . . . . 64.209999999999994 111.078 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 14.7 pt-20 -98.94 153.72 18.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.04 0.448 . . . . 63.409999999999997 111.294 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -92.76 116.34 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.289 -0.414 . . . . 74.150000000000006 111.385 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.77 -67.42 0.78 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.883 0.373 . . . . 70.409999999999997 111.438 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.24 179.74 41.94 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.205 -0.522 . . . . 62.439999999999998 112.802 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.96 165.14 33.47 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.855 2.37 . . . . 63.200000000000003 113.369 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.18 149.4 33.74 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.994 0.426 . . . . 71.549999999999997 111.797 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.255 1.368 0 CA-C-O 118.728 -0.653 . . . . 72.239999999999995 110.867 178.429 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.484 0.183 . . . . 75.140000000000001 111.157 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.43 177.84 7.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.933 0.397 . . . . 60.119999999999997 111.967 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.71 148.22 4.72 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.511 -0.376 . . . . 62.310000000000002 112.762 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.2 51.28 3.12 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.004 2.47 . . . . 74.329999999999998 112.594 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.31 -20.61 63.89 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.277 0.473 . . . . 64.219999999999999 112.277 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.7 -145.02 5.49 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.928 -0.653 . . . . 72.120000000000005 113.105 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -131.03 145.6 52.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.988 0.423 . . . . 64.120000000000005 111.507 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -93.05 134.03 35.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.146 -0.479 . . . . 61.32 111.534 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 123.99 41.17 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.524 -0.307 . . . . 72.409999999999997 110.987 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 78' ' ' LEU . 43.5 ttm180 -97.85 115.59 28.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.346 -0.221 . . . . 45.310000000000002 111.113 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.96 108.99 3.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.805 0.336 . . . . 61.109999999999999 111.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.91 -29.57 27.04 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.167 0.432 . . . . 61.329999999999998 112.167 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -124.2 135.48 26.47 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 122.353 -0.217 . . . . 73.019999999999996 111.574 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.5 Cg_endo -69.21 119.86 6.79 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.296 1.998 . . . . 61.43 112.638 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -122.47 111.62 17.06 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.104 -0.498 . . . . 74.129999999999995 111.364 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -104.63 120.25 40.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.009 0.433 . . . . 64.040000000000006 110.641 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 17' ' ' ARG . 7.2 tpt180 -74.56 151.39 39.44 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.915 0.388 . . . . 71.430000000000007 111.558 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -55.26 -47.67 75.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.263 0.554 . . . . 72.519999999999996 110.92 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.423 ' H ' ' HG3' ' A' ' 17' ' ' ARG . 24.6 mmm180 -106.39 151.34 40.26 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.643 -0.708 . . . . 75.329999999999998 111.442 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.9 5.61 3.36 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.821 2.347 . . . . 72.430000000000007 113.206 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.81 -34.4 77.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.96 0.504 . . . . 62.009999999999998 112.101 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.8 -160.5 0.49 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.701 0.401 . . . . 70.549999999999997 111.5 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.9 tp -125.99 123.91 39.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.782 0.325 . . . . 44.130000000000003 111.244 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.86 138.92 46.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.193 0.52 . . . . 74.129999999999995 111.987 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 94.6 mt -106.24 137.59 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.103 -0.499 . . . . 72.239999999999995 111.598 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -120.72 142.84 35.14 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 122.452 0.301 . . . . 62.140000000000001 110.839 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 46.0 Cg_endo -66.44 117.6 4.85 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.565 2.177 . . . . 60.210000000000001 112.814 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.79 45.43 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.263 -0.494 . . . . 51.32 113.265 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.92 138.8 39.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.008 0.404 . . . . 61.25 110.742 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.96 97.68 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.98 0.419 . . . . 71.430000000000007 110.965 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.0 mp -81.1 127.15 32.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.999 0.428 . . . . 72.040000000000006 111.498 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.0 113.53 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.345 -0.388 . . . . 70.219999999999999 111.595 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -109.71 134.57 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.388 -0.369 . . . . 72.530000000000001 110.645 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -74.77 149.35 39.77 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.02 0.438 . . . . 52.149999999999999 111.586 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.5 -38.19 88.92 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.166 0.508 . . . . 64.420000000000002 110.285 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.44 80.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.735 -0.666 . . . . 73.549999999999997 111.613 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.83 -47.0 86.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.936 0.398 . . . . 71.239999999999995 111.129 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.01 -41.25 96.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.394 -0.366 . . . . 63.350000000000001 111.227 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -60.34 -37.28 80.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.953 0.406 . . . . 75.129999999999995 111.047 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.41 93.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.038 0.447 . . . . 60.350000000000001 110.838 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.78 -21.4 64.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.083 -0.508 . . . . 70.319999999999993 111.816 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.01 36.42 6.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.307 -0.473 . . . . 41.200000000000003 113.144 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.57 130.21 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.903 0.382 . . . . 44.219999999999999 111.146 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.76 150.41 20.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 62.130000000000003 111.802 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -48.44 121.37 4.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.974 0.416 . . . . 71.319999999999993 111.522 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.17 57.48 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.24 -0.505 . . . . 71.430000000000007 112.995 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.78 -28.18 4.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.319 -0.467 . . . . 74.120000000000005 112.966 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -31.29 64.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.174 0.59 . . . . 65.129999999999995 111.974 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.428 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 12.8 ptp180 -59.06 -13.69 7.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.687 0.625 . . . . 73.319999999999993 112.687 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 26.6 p -127.32 84.0 64.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 121.02 0.438 . . . . 63.439999999999998 111.276 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 -33.3 97.79 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.719 2.279 . . . . 52.210000000000001 112.562 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.679 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 90.6 mt-30 -58.64 -28.86 66.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.105 -0.498 . . . . 62.509999999999998 111.513 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 t -76.25 -33.42 59.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.853 0.358 . . . . 43.539999999999999 111.38 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.93 -58.55 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.9 0.381 . . . . 72.329999999999998 111.414 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.13 -137.15 12.46 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.515 . . . . 63.100000000000001 112.709 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.94 132.91 39.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.2 0.524 . . . . 61.520000000000003 111.686 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -132.41 147.64 66.48 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 116.12 -0.491 . . . . 55.509999999999998 111.593 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 126.4 8.56 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.503 2.135 . . . . 71.299999999999997 112.403 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.81 -175.25 24.89 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.475 -0.869 . . . . 45.399999999999999 114.131 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.88 117.12 24.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.335 0.254 . . . . 64.140000000000001 111.253 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -79.92 129.65 34.66 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.568 0.223 . . . . 62.329999999999998 110.493 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -92.39 -6.53 49.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.181 1.178 . . . . 64.319999999999993 114.181 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.64 -23.64 18.93 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.718 -0.614 . . . . 71.409999999999997 111.363 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -111.36 -16.93 13.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.04 0.448 . . . . 43.450000000000003 111.223 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 62.59 22.44 13.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.577 0.751 . . . . 73.310000000000002 111.568 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -101.21 149.19 24.25 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.073 0.463 . . . . 71.099999999999994 112.157 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -92.63 156.39 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.007 -0.542 . . . . 74.209999999999994 111.107 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.55 -172.35 44.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.593 -0.813 . . . . 70.150000000000006 113.453 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.06 125.58 54.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.611 0.364 . . . . 73.409999999999997 110.252 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -132.12 142.77 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 N-CA-C 111.93 0.345 . . . . 63.240000000000002 111.93 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.32 113.9 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.398 2.066 . . . . 72.340000000000003 112.36 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.39 33.02 0.97 Allowed Glycine 0 CA--C 1.53 1.0 0 N-CA-C 114.424 0.529 . . . . 74.239999999999995 114.424 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.679 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 43.4 m -92.52 -28.92 16.49 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.399 -0.471 . . . . 64.420000000000002 110.936 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.46 5.29 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.198 -0.455 . . . . 71.120000000000005 112.01 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 11' ' ' ALA . 19.1 m -117.64 145.39 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.783 0.325 . . . . 75.209999999999994 111.486 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 14.6 pt-20 -99.87 152.32 20.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.996 0.427 . . . . 71.150000000000006 110.972 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 49' ' ' ARG . 68.3 t80 -84.82 107.41 16.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.982 0.42 . . . . 74.299999999999997 111.09 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 10' ' ' ARG . 67.2 mt -76.93 -38.1 54.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.847 0.356 . . . . 55.329999999999998 111.24 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.68 -176.51 19.16 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.29 -0.481 . . . . 45.409999999999997 113.089 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.57 150.08 68.89 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.84 2.36 . . . . 61.329999999999998 112.259 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.4 mp -74.46 151.25 39.62 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.13 0.49 . . . . 71.420000000000002 111.204 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.256 1.398 0 CA-C-O 118.487 -0.768 . . . . 64.150000000000006 112.458 -178.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.757 0.313 . . . . 74.329999999999998 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.71 -42.56 17.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.791 0.329 . . . . 73.140000000000001 110.835 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 56.3 -113.12 3.82 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 114.626 0.61 . . . . 43.210000000000001 114.626 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.47 23.69 0.48 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.323 2.682 . . . . 64.519999999999996 114.922 -172.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -59.5 -30.97 68.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.187 0.518 . . . . 62.32 111.109 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.72 -146.71 12.49 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 116.088 -0.505 . . . . 63.049999999999997 112.573 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -133.36 137.0 45.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.91 0.386 . . . . 75.319999999999993 111.159 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.524 ' HG2' HG22 ' A' ' 32' ' ' VAL . 98.0 mt-30 -94.95 126.92 40.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.242 0.544 . . . . 75.310000000000002 112.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.87 123.98 49.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.961 -0.563 . . . . 74.219999999999999 110.091 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 10' ' ' ARG . 20.1 ttt180 -97.85 124.37 42.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.205 0.446 . . . . 74.109999999999999 112.205 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -69.13 126.63 30.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.915 0.388 . . . . 53.509999999999998 111.831 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.74 -55.37 4.01 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.233 0.457 . . . . 71.120000000000005 112.233 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -115.21 150.07 43.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 111.62 0.23 . . . . 73.409999999999997 111.62 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.2 Cg_endo -73.96 120.02 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.544 2.163 . . . . 73.209999999999994 113.872 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -129.78 111.04 12.23 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 73.109999999999999 111.053 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.3 mtm-85 -86.98 160.48 18.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.196 -0.456 . . . . 64.120000000000005 110.821 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.63 ' HD3' ' HG2' ' A' ' 24' ' ' GLU . 2.0 mpt_? -107.76 135.34 49.34 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.235 0.828 . . . . 75.109999999999999 113.235 -174.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.38 -45.18 56.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.439 -0.801 . . . . 74.329999999999998 109.73 169.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -111.93 120.11 42.81 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.66 -0.7 . . . . 72.049999999999997 110.114 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.07 -1.41 0.84 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.06 2.507 . . . . 75.420000000000002 113.87 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -56.43 -39.51 73.2 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.95 0.405 . . . . 74.450000000000003 111.431 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.67 163.98 14.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.597 -0.52 . . . . 70.420000000000002 109.597 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.9 tp -99.54 133.26 44.13 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.692 -0.63 . . . . 74.299999999999997 111.292 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.63 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 39.0 mt-10 -78.26 149.89 33.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.165 0.507 . . . . 71.310000000000002 111.839 -176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 84.2 mt -127.18 125.74 41.62 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.007 -0.542 . . . . 43.43 111.444 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.52 152.62 44.77 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-O 120.72 0.295 . . . . 61.310000000000002 110.359 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 42.5 Cg_endo -65.82 105.53 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.058 1.839 . . . . 75.530000000000001 112.463 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.55 10.06 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.106 -0.568 . . . . 71.219999999999999 113.433 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.03 118.29 6.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 117.008 0.404 . . . . 53.109999999999999 111.616 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.48 92.64 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.129 0.49 . . . . 71.109999999999999 110.566 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 5.9 mp -78.8 120.55 23.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 60.210000000000001 111.968 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 8' ' ' GLN . 48.3 t -93.09 111.95 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.105 -0.498 . . . . 74.129999999999995 111.654 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.07 122.45 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.328 -0.396 . . . . 73.209999999999994 110.937 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.9 p -68.07 139.73 56.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.995 0.426 . . . . 64.340000000000003 111.114 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -63.96 -32.37 73.88 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.874 0.369 . . . . 74.140000000000001 110.943 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.83 85.9 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.296 -0.411 . . . . 71.239999999999995 111.269 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.57 -43.5 93.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.002 0.43 . . . . 63.399999999999999 111.081 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.8 mt -58.98 -42.51 90.17 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.285 -0.416 . . . . 71.040000000000006 111.341 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.46 -37.12 86.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.933 0.397 . . . . 75.310000000000002 111.012 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.21 77.45 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.959 0.409 . . . . 75.409999999999997 111.484 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.572 HD11 ' HD2' ' A' ' 58' ' ' PRO . 88.9 mt -72.46 -20.86 61.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.248 -0.433 . . . . 71.129999999999995 111.526 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.61 28.61 35.04 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.323 -0.465 . . . . 71.530000000000001 112.763 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 41' ' ' LEU . 58.8 t -78.65 124.74 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.775 0.321 . . . . 61.130000000000003 111.356 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.71 139.29 53.39 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.998 0.428 . . . . 61.32 111.731 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.11 122.31 11.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.114 0.483 . . . . 61.329999999999998 111.121 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.82 -13.32 24.68 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.957 -0.64 . . . . 72.099999999999994 112.461 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.0 -25.27 49.77 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.347 -0.454 . . . . 74.400000000000006 113.408 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.433 ' OE2' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -58.91 -28.39 66.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.974 0.361 . . . . 71.510000000000005 111.974 -178.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HG3' ' OE2' ' A' ' 48' ' ' GLU . 50.1 mtm180 -56.48 -29.13 61.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.951 0.352 . . . . 72.209999999999994 111.951 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 71.0 m -133.28 84.85 46.05 Favored Pre-proline 0 N--CA 1.474 0.73 0 CA-C-O 120.953 0.406 . . . . 63.140000000000001 111.053 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.526 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 18.3 Cg_endo -57.94 -23.62 60.75 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.004 2.469 . . . . 73.239999999999995 113.491 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -60.25 -24.33 64.8 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.906 0.336 . . . . 74.519999999999996 111.906 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.3 t -66.48 -31.56 72.37 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.183 0.516 . . . . 74.019999999999996 111.609 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.12 -57.17 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.139 -0.482 . . . . 73.120000000000005 111.367 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.88 -88.88 0.5 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.257 -0.497 . . . . 51.329999999999998 113.185 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 7.4 m0 -103.18 107.33 18.1 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.343 0.497 . . . . 75.420000000000002 112.343 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -116.22 137.76 23.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.964 -0.562 . . . . 74.129999999999995 110.673 175.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.572 ' HD2' HD11 ' A' ' 41' ' ' LEU . 65.2 Cg_endo -74.67 117.76 5.07 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.311 2.008 . . . . 71.530000000000001 112.628 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.87 172.49 22.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.06 -0.59 . . . . 73.230000000000004 113.299 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 60.3 tp -97.66 114.36 26.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.93 0.395 . . . . 73.319999999999993 111.607 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 23.6 t-20 -74.53 123.08 24.12 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.382 -0.372 . . . . 61.240000000000002 111.711 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -72.63 -19.64 61.42 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.214 0.82 . . . . 71.549999999999997 113.214 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 1.5 tpm_? -66.05 -59.93 3.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.949 0.404 . . . . 75.430000000000007 111.337 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 66' ' ' GLN . 72.3 p -122.91 6.21 9.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.831 0.678 . . . . 71.25 112.831 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 0.1 OUTLIER 67.35 32.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.632 0.605 . . . . 73.310000000000002 112.632 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 83.7 mm-40 -79.19 130.57 35.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.742 0.306 . . . . 64.129999999999995 111.296 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -98.47 121.61 40.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.572 0.225 . . . . 74.5 110.707 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -175.03 -177.83 44.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.514 -0.85 . . . . 52.119999999999997 113.495 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 20.1 m-20 -88.23 119.94 29.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 73.099999999999994 111.194 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.5 p90 -114.8 145.77 34.65 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.432 -0.349 . . . . 72.209999999999994 111.07 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.53 109.46 2.76 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.426 2.084 . . . . 71.25 112.438 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.36 34.07 0.96 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.243 0.457 . . . . 32.32 114.243 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.0 p -102.87 -26.73 13.01 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.461 -0.435 . . . . 71.510000000000005 111.348 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.6 15.54 26.81 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 53.439999999999998 111.795 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 11' ' ' ALA . 24.2 m -118.73 161.3 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.933 0.397 . . . . 73.239999999999995 111.517 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.11 138.12 46.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.094 0.473 . . . . 52.399999999999999 110.919 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.463 ' CZ ' ' HA2' ' A' ' 79' ' ' GLY . 39.5 t80 -77.76 116.6 18.41 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.868 0.366 . . . . 41.409999999999997 110.963 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -86.43 -48.29 8.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.236 0.541 . . . . 74.329999999999998 110.78 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' CZ ' ' A' ' 77' ' ' PHE . . . 131.24 -165.22 23.2 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.849 -0.614 . . . . 50.049999999999997 112.502 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.55 166.36 19.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.332 2.022 . . . . 65.209999999999994 111.97 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 81' ' ' LEU . 6.3 mp -84.4 159.01 20.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 65.120000000000005 111.724 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.257 1.469 0 CA-C-N 115.806 -0.634 . . . . 73.319999999999993 111.424 177.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.578 0.228 . . . . 70.299999999999997 111.529 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.61 -47.71 73.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.021 0.378 . . . . 74.25 112.021 -176.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.14 166.16 16.46 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.009 -0.615 . . . . 42.420000000000002 113.468 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.596 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 16.6 Cg_exo -68.59 77.32 0.72 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.77 2.313 . . . . 72.409999999999997 112.837 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -67.42 -35.22 78.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.886 0.374 . . . . 65.439999999999998 111.665 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . -147.84 166.21 28.83 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.336 -0.459 . . . . 65.109999999999999 113.026 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -130.12 148.22 51.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.616 0.366 . . . . 74.439999999999998 111.112 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.775 ' HG3' HD11 ' A' ' 81' ' ' LEU . 82.2 mt-30 -103.63 143.86 32.2 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.19 0.519 . . . . 70.400000000000006 112.018 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.542 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 87.9 m-85 -132.05 125.86 32.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.934 -0.575 . . . . 74.010000000000005 110.692 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HB2' HD11 ' A' ' 78' ' ' LEU . 43.5 ttp180 -98.58 116.52 30.99 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.005 -0.435 . . . . 74.239999999999995 111.82 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 113.88 7.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.919 0.39 . . . . 72.319999999999993 111.451 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD21 ' HG3' ' A' ' 76' ' ' GLU . 84.0 mt -77.92 -39.11 43.92 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.43 0.53 . . . . 64.0 112.43 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -126.32 145.81 54.02 Favored Pre-proline 0 N--CA 1.469 0.505 0 N-CA-C 111.718 0.266 . . . . 72.129999999999995 111.718 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 36.9 Cg_endo -65.88 131.62 27.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.434 2.089 . . . . 72.230000000000004 112.345 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 92.1 t80 -133.53 117.82 17.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.48 -0.327 . . . . 71.519999999999996 111.618 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 16' ' ' ARG . 1.3 ptm180 -77.38 131.5 38.08 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.668 -0.493 . . . . 71.030000000000001 109.668 172.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.84 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -72.88 151.43 41.95 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.919 0.39 . . . . 74.219999999999999 111.983 -173.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.611 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 7.6 tp10 -46.53 -26.49 0.89 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.286 0.635 . . . . 72.340000000000003 111.581 173.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -157.05 131.9 5.33 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.692 -0.685 . . . . 75.319999999999993 110.16 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.67 -9.29 3.75 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 123.0 2.467 . . . . 73.430000000000007 113.851 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.18 -30.84 69.13 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.368 -0.378 . . . . 75.239999999999995 111.599 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -96.45 -164.35 1.14 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.14 0.495 . . . . 71.329999999999998 112.207 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 66' ' ' GLN . 43.1 tp -99.62 130.27 45.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.171 0.51 . . . . 73.239999999999995 112.046 -173.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.84 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 37.2 mt-10 -101.31 166.32 10.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.073 -0.512 . . . . 52.43 111.228 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' PHE . 90.9 mt -114.99 142.51 46.53 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.675 0.62 . . . . 51.450000000000003 112.675 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -121.63 151.2 56.7 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 122.944 0.498 . . . . 70.209999999999994 110.658 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.5 Cg_endo -71.44 129.17 15.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.382 2.055 . . . . 74.310000000000002 113.261 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.28 22.83 75.34 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.223 -0.513 . . . . 73.420000000000002 113.105 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -105.97 157.85 17.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 65.140000000000001 110.846 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.88 133.25 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.252 0.549 . . . . 63.210000000000001 111.895 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 31' ' ' LEU . 4.8 mp -121.38 139.23 53.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.094 -0.503 . . . . 54.310000000000002 110.533 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.4 HG22 ' HG2' ' A' ' 8' ' ' GLN . 57.1 t -106.26 124.86 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 120.983 0.42 . . . . 72.239999999999995 112.04 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.01 124.39 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.414 -0.357 . . . . 74.420000000000002 110.754 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.543 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 74.9 m -95.12 159.98 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.449 0.536 . . . . 65.129999999999995 112.449 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -50.79 -38.94 51.29 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.404 -0.362 . . . . 54.119999999999997 111.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.7 -37.44 41.38 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.122 0.416 . . . . 40.119999999999997 112.122 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -77.14 -49.14 15.88 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.933 0.397 . . . . 74.299999999999997 111.265 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 94.8 mt -58.52 -46.06 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.426 -0.352 . . . . 73.5 111.887 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.57 -35.71 78.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.602 0.239 . . . . 74.349999999999994 111.584 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.2 75.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.081 0.467 . . . . 65.540000000000006 111.046 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 60.5 mt -76.31 -28.7 57.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.2 0.524 . . . . 75.129999999999995 111.109 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.0 16.99 15.06 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.048 -0.523 . . . . 65.439999999999998 112.963 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 61.8 t -83.65 130.66 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.897 0.379 . . . . 70.349999999999994 111.094 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.54 152.61 25.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.252 -0.431 . . . . 44.409999999999997 111.811 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -40.62 111.97 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.786 0.435 . . . . 63.299999999999997 111.725 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.9 -17.11 7.71 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.401 -0.428 . . . . 73.319999999999993 112.501 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 -33.44 7.91 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.213 -0.518 . . . . 53.310000000000002 113.278 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -33.01 71.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.328 0.492 . . . . 73.510000000000005 112.328 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -68.06 -5.37 17.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.086 0.47 . . . . 62.32 112.009 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 89.7 m -141.37 81.94 14.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.271 -0.422 . . . . 74.040000000000006 110.444 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 18.8 Cg_endo -56.13 -16.21 16.34 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.125 2.55 . . . . 52.340000000000003 113.461 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -59.11 -31.21 68.72 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.728 0.299 . . . . 65.329999999999998 111.665 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.3 t -82.7 -23.91 33.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.732 0.301 . . . . 62.020000000000003 111.215 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.69 -44.86 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.975 0.417 . . . . 75.510000000000005 110.456 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 76.48 -76.53 1.5 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.147 -0.478 . . . . 72.409999999999997 113.389 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -121.3 129.2 52.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.945 0.402 . . . . 71.239999999999995 111.445 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -152.82 145.0 16.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.264 0.468 . . . . 63.399999999999999 112.264 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -90.07 124.86 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.928 2.419 . . . . 51.119999999999997 112.974 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.92 176.6 25.72 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.003 -0.618 . . . . 72.140000000000001 113.39 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.5 tp -97.48 132.12 43.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 74.0 110.868 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 24.5 t-20 -95.03 143.36 26.56 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.388 -0.369 . . . . 72.129999999999995 111.14 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -84.77 -55.79 3.92 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.607 0.595 . . . . 45.340000000000003 112.607 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -64.63 -56.0 16.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.229 0.455 . . . . 63.219999999999999 112.229 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 p -81.45 -17.06 50.09 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.88 0.326 . . . . 70.409999999999997 111.88 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 77.1 mtp180 61.64 18.11 9.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.004 0.522 . . . . 71.329999999999998 112.406 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 23' ' ' LEU . 96.5 mt-30 -86.53 164.68 16.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.256 0.551 . . . . 72.310000000000002 111.904 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -128.92 131.58 47.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.896 -0.593 . . . . 75.120000000000005 110.666 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.23 -170.28 43.31 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.381 -0.914 . . . . 61.399999999999999 113.764 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.18 123.19 33.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.424 0.29 . . . . 62.210000000000001 110.941 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.83 151.3 77.95 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.662 0.268 . . . . 53.140000000000001 111.432 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 88.1 Cg_endo -77.29 120.43 5.31 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.486 2.124 . . . . 64.549999999999997 112.91 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 51' ' ' PRO . . . -77.64 16.17 6.83 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.391 -0.433 . . . . 61.200000000000003 113.943 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -81.3 -20.65 40.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.251 -0.558 . . . . 61.210000000000001 111.615 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -104.88 12.3 32.67 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.368 0.507 . . . . 73.540000000000006 112.368 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 33.2 m -121.95 146.03 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 113.366 0.876 . . . . 71.329999999999998 113.366 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 5.8 mm-40 -93.68 130.74 39.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.605 -0.725 . . . . 71.430000000000007 111.524 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -70.36 100.21 1.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.041 0.448 . . . . 74.540000000000006 110.416 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 10' ' ' ARG . 64.0 mt -74.8 -47.69 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.365 -0.38 . . . . 63.329999999999998 111.376 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.78 177.02 22.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.639 -0.791 . . . . 54.399999999999999 113.885 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HB3' ' HB3' ' A' ' 4' ' ' PRO . 5.5 Cg_exo -80.27 137.61 12.06 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.545 2.83 . . . . 54.439999999999998 112.871 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 8' ' ' GLN . 5.8 mp -80.11 148.32 31.04 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.869 0.366 . . . . 52.5 111.634 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.807 -0.616 . . . . 75.420000000000002 111.208 176.638 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.736 0.303 . . . . 62.299999999999997 111.501 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.14 -158.19 0.27 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 116.601 -0.272 . . . . 73.409999999999997 111.628 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.49 -82.21 0.05 OUTLIER Glycine 0 CA--C 1.537 1.463 0 C-N-CA 119.96 -1.115 . . . . 53.140000000000001 115.302 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.96 16.01 0.15 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.183 2.589 . . . . 64.25 116.457 -167.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -62.78 -31.38 72.33 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.809 0.731 . . . . 72.129999999999995 111.002 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.17 -174.73 42.03 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.608 -0.723 . . . . 32.329999999999998 112.166 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -131.55 146.15 52.08 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.129 0.49 . . . . 75.209999999999994 111.946 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -101.43 128.33 47.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.048 -0.524 . . . . 74.25 111.416 178.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.37 128.15 53.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.318 -0.401 . . . . 72.040000000000006 110.715 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.571 ' HB2' HD11 ' A' ' 78' ' ' LEU . 55.8 ttp180 -98.11 120.97 39.45 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.144 0.424 . . . . 62.310000000000002 112.144 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . . . -74.07 114.72 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.229 -0.441 . . . . 64.329999999999998 111.313 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -82.21 -43.67 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.17 0.433 . . . . 75.150000000000006 112.17 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.65 140.93 28.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 N-CA-C 112.122 0.416 . . . . 61.329999999999998 112.122 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 35.5 Cg_endo -65.74 123.59 11.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.444 2.096 . . . . 60.130000000000003 112.935 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -116.38 113.6 23.12 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.186 -0.461 . . . . 74.510000000000005 111.313 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -89.2 147.61 24.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.471 -0.332 . . . . 75.140000000000001 110.401 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.614 ' HG2' ' HB2' ' A' ' 22' ' ' ASP . 29.3 tpt180 -119.23 124.34 46.5 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.753 0.311 . . . . 64.319999999999993 111.144 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.75 -28.07 67.06 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.213 0.53 . . . . 61.229999999999997 111.472 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -117.37 113.25 38.93 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.4 -0.364 . . . . 65.129999999999995 110.272 174.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.09 6.58 0.17 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.196 2.597 . . . . 72.420000000000002 114.551 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -71.93 -24.28 61.6 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.945 0.35 . . . . 64.319999999999993 111.945 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.614 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 6.0 m-20 -94.53 -169.72 2.1 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.753 0.311 . . . . 74.299999999999997 111.381 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 61' ' ' ASN . 45.9 tp -107.8 119.63 39.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 70.030000000000001 111.78 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.53 142.41 30.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.431 -0.35 . . . . 64.200000000000003 110.84 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 66.2 mt -116.16 141.96 47.45 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.128 0.418 . . . . 41.009999999999998 112.128 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.86 153.51 46.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 122.721 0.408 . . . . 45.020000000000003 110.766 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 29.5 Cg_endo -61.69 117.21 4.01 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.602 2.202 . . . . 74.219999999999999 113.206 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.28 16.85 33.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.154 -0.476 . . . . 60.210000000000001 113.826 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 9.6 m-20 -77.22 135.67 38.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.877 0.695 . . . . 50.329999999999998 112.877 178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.24 97.06 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.15 0.5 . . . . 63.32 110.24 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.6 mp -81.98 132.89 35.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.097 0.475 . . . . 71.129999999999995 111.902 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 81' ' ' LEU . 66.8 t -94.05 109.41 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.047 -0.524 . . . . 71.319999999999993 111.142 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 117.91 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.011 0.434 . . . . 70.040000000000006 111.281 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.7 p -68.02 141.46 56.21 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.801 0.334 . . . . 73.0 111.519 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -67.01 -23.75 65.95 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.023 0.44 . . . . 74.040000000000006 110.803 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.24 89.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.182 -0.463 . . . . 70.299999999999997 111.191 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.93 -44.16 97.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.38 . . . . 73.549999999999997 111.288 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.84 -45.14 90.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.983 0.421 . . . . 64.0 110.654 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -59.77 -40.39 88.08 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.239 -0.437 . . . . 71.230000000000004 111.265 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.23 79.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.028 0.442 . . . . 64.200000000000003 111.537 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.18 -17.63 60.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.159 -0.473 . . . . 74.150000000000006 111.192 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 18.18 38.04 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.499 -0.382 . . . . 63.340000000000003 113.396 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.57 114.43 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.024 0.379 . . . . 71.299999999999997 112.024 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.59 151.04 20.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.383 -0.371 . . . . 55.439999999999998 111.098 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 146.05 5.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.278 0.561 . . . . 73.319999999999993 111.794 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.14 -26.3 24.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.77 -0.532 . . . . 5.1200000000000001 111.77 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.86 1.47 17.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.508 -0.377 . . . . 71.219999999999999 112.673 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -38.41 90.98 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.089 0.471 . . . . 73.439999999999998 111.611 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -81.5 9.84 6.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.291 0.478 . . . . 61.130000000000003 112.291 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.0 m -122.39 72.9 39.26 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 120.85 0.357 . . . . 75.340000000000003 111.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 34.1 Cg_endo -63.66 -23.08 70.01 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.67 2.247 . . . . 74.019999999999996 112.773 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.44 -34.56 69.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.314 -0.403 . . . . 64.530000000000001 111.357 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -71.77 -41.61 68.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.93 0.395 . . . . 73.120000000000005 111.229 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.46 -38.33 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.123 -0.49 . . . . 55.049999999999997 111.594 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.95 -79.06 0.88 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.244 -0.503 . . . . 73.129999999999995 112.913 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -121.14 142.36 49.94 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.674 -0.309 . . . . 71.420000000000002 110.9 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 56.6 mtm -138.88 140.68 27.85 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.247 -0.283 . . . . 55.299999999999997 111.488 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.19 117.51 2.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.584 2.189 . . . . 75.030000000000001 112.524 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.72 178.26 26.41 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.732 -0.747 . . . . 73.200000000000003 113.77 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.24 132.67 50.25 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.961 0.41 . . . . 74.030000000000001 111.733 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.532 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.9 t-20 -99.98 149.25 23.64 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.271 -0.422 . . . . 74.439999999999998 111.348 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -92.01 -35.78 13.76 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.587 0.588 . . . . 74.310000000000002 112.587 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 13.8 tpp180 -56.72 -51.61 68.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.204 0.526 . . . . 75.209999999999994 111.315 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.9 p -100.14 -15.04 18.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.688 -0.687 . . . . 72.239999999999995 111.885 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtp180 64.2 18.08 11.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.795 0.438 . . . . 73.439999999999998 112.131 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -103.39 157.5 16.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.151 0.501 . . . . 72.209999999999994 112.228 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 67' ' ' ARG . 19.5 mtp180 -98.3 149.68 22.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.206 -0.452 . . . . 71.430000000000007 111.247 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.27 -178.72 47.62 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.93 -0.652 . . . . 74.120000000000005 112.894 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.13 124.99 40.35 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.595 0.236 . . . . 74.519999999999996 110.752 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -123.65 143.0 40.59 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 120.838 0.351 . . . . 63.439999999999998 111.668 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.66 116.07 4.24 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.659 2.239 . . . . 75.420000000000002 112.361 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -59.59 -17.57 41.5 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.715 0.646 . . . . 64.549999999999997 114.715 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.418 HG23 ' CD1' ' A' ' 74' ' ' TYR . 3.4 t -57.0 -32.46 66.14 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.799 0.666 . . . . 62.399999999999999 112.799 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.418 ' CD1' HG23 ' A' ' 73' ' ' THR . 95.9 m-85 -81.31 -16.9 51.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.663 0.616 . . . . 74.400000000000006 112.663 -177.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -108.92 145.42 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.419 0.526 . . . . 54.420000000000002 112.419 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.53 154.71 24.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.058 -0.519 . . . . 52.0 110.857 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.07 126.51 33.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.824 0.345 . . . . 71.519999999999996 111.612 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 10' ' ' ARG . 83.9 mt -100.03 -68.11 0.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.056 0.455 . . . . 73.209999999999994 111.232 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.83 -178.69 46.78 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 60.229999999999997 113.103 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.84 166.21 30.61 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.293 2.662 . . . . 44.009999999999998 113.233 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.493 HD22 HG13 ' A' ' 32' ' ' VAL . 3.4 pp -127.62 151.18 49.25 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.306 0.484 . . . . 75.209999999999994 112.306 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.254 1.317 0 CA-C-O 118.328 -0.844 . . . . 72.340000000000003 112.04 179.016 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.588 0.232 . . . . 72.299999999999997 111.077 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.16 149.35 10.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.704 0.287 . . . . 75.340000000000003 111.73 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -120.87 91.12 0.48 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.54 -0.362 . . . . 55.219999999999999 112.832 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.646 ' HD2' HD22 ' A' ' 81' ' ' LEU . 60.4 Cg_endo -70.36 176.1 7.68 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.757 2.305 . . . . 65.340000000000003 114.105 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 12.3 mm-40 -77.35 12.59 1.46 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.519 -0.764 . . . . 63.100000000000001 112.576 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . -91.39 -167.5 40.91 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.999 -0.619 . . . . 44.240000000000002 114.421 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.54 147.86 43.97 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.988 0.423 . . . . 73.310000000000002 111.412 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG2' HG22 ' A' ' 32' ' ' VAL . 45.9 mt-30 -92.75 133.11 36.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.899 0.38 . . . . 75.140000000000001 111.258 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -118.38 139.16 51.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.293 -0.412 . . . . 75.0 110.661 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 78' ' ' LEU . 36.1 ttm180 -107.99 127.69 53.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.947 -0.47 . . . . 74.120000000000005 111.984 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.37 128.2 33.99 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.457 -0.338 . . . . 74.430000000000007 110.592 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.6 mt -68.28 -62.15 1.53 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.372 0.606 . . . . 74.219999999999999 111.821 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.549 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.0 m-85 -118.19 171.91 4.67 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.979 -0.555 . . . . 63.119999999999997 110.314 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -70.8 117.73 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 120.902 1.068 . . . . 63.329999999999998 111.261 170.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 83.8 m-85 -112.86 122.1 46.65 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.306 0.574 . . . . 73.340000000000003 111.763 -177.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -82.76 153.93 25.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.238 -0.892 . . . . 54.039999999999999 111.901 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -116.73 154.81 29.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.903 0.382 . . . . 75.140000000000001 111.501 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.1 -42.33 84.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.898 0.38 . . . . 60.530000000000001 111.653 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 62.0 mtp85 -121.98 147.76 49.72 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.509 -0.314 . . . . 73.340000000000003 111.162 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 15.3 Cg_exo -69.5 -2.15 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.976 2.451 . . . . 75.019999999999996 112.844 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -80.38 -16.13 55.22 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.254 0.55 . . . . 64.340000000000003 111.355 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.81 -165.21 1.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.991 -0.55 . . . . 74.329999999999998 111.305 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 tp -125.13 123.7 40.25 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.888 0.375 . . . . 72.319999999999993 110.936 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mp0 -75.95 155.8 34.76 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.006 0.432 . . . . 65.200000000000003 111.393 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 97.5 mt -112.12 143.05 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.48 -0.327 . . . . 74.299999999999997 111.277 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.66 154.34 46.74 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 122.596 0.359 . . . . 71.439999999999998 111.116 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 120.45 7.97 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.454 2.102 . . . . 62.030000000000001 113.207 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.07 69.9 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.165 -0.47 . . . . 73.329999999999998 113.58 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.82 155.57 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.377 -0.484 . . . . 72.519999999999996 111.349 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.35 129.57 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.233 0.539 . . . . 41.549999999999997 112.056 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 4.9 mp -124.37 121.31 34.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.112 -0.494 . . . . 73.430000000000007 110.527 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.493 HG13 HD11 ' A' ' 81' ' ' LEU . 48.9 t -94.12 124.09 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.332 0.493 . . . . 65.329999999999998 112.332 -175.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.97 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 120.979 0.418 . . . . 44.340000000000003 111.265 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.492 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 50.5 m -68.28 142.39 55.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.993 0.368 . . . . 44.219999999999999 111.993 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 57.1 mtm180 -60.55 -30.43 69.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.986 0.422 . . . . 74.209999999999994 111.452 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.4 81.32 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.131 0.491 . . . . 74.310000000000002 111.009 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.83 98.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.114 -0.494 . . . . 72.349999999999994 111.298 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.3 mt -56.84 -46.82 81.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.918 0.39 . . . . 74.450000000000003 111.021 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.64 -39.69 92.22 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.396 -0.366 . . . . 54.43 111.442 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.94 91.45 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.952 0.406 . . . . 72.340000000000003 111.005 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -66.77 -28.63 68.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.234 -0.439 . . . . 73.510000000000005 111.462 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.31 27.6 9.15 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.424 -0.417 . . . . 61.25 113.042 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.3 118.48 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.96 0.41 . . . . 51.140000000000001 111.097 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.52 149.81 29.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.305 -0.407 . . . . 63.109999999999999 111.866 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.18 119.19 6.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.01 0.434 . . . . 73.299999999999997 111.086 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.77 -4.82 18.97 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.049 -0.523 . . . . 64.299999999999997 112.327 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.04 -33.28 2.41 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.697 -0.287 . . . . 62.25 113.1 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -21.19 28.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.989 0.515 . . . . 74.230000000000004 112.222 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.81 -21.25 41.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.416 -0.356 . . . . 63.530000000000001 111.714 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.54 88.42 29.21 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.664 0.269 . . . . 72.420000000000002 110.951 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.69 -16.94 26.82 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.98 2.454 . . . . 61.399999999999999 113.318 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -57.64 -22.39 45.33 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.818 0.342 . . . . 64.340000000000003 111.889 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.0 t -77.81 -9.75 59.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.798 0.333 . . . . 64.420000000000002 111.813 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 t -106.55 -37.81 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.085 0.469 . . . . 65.420000000000002 111.626 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.43 -78.19 0.84 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.227 -0.511 . . . . 53.229999999999997 112.798 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.41 54.58 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.087 0.47 . . . . 74.120000000000005 111.223 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 71.1 mtp -139.49 139.39 22.37 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.221 -0.445 . . . . 72.140000000000001 111.623 -172.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.1 Cg_endo -82.16 117.4 2.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.304 2.003 . . . . 65.310000000000002 112.464 174.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.55 171.55 25.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.775 -0.726 . . . . 65.030000000000001 113.697 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 40.0 tp -96.74 109.15 21.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.594 0.358 . . . . 61.140000000000001 111.043 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -79.72 116.61 20.0 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.46 -0.336 . . . . 71.109999999999999 111.546 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.9 -21.49 63.3 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.733 0.642 . . . . 72.420000000000002 112.733 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.49 ' CZ ' ' HA ' ' A' ' 63' ' ' ARG . 0.9 OUTLIER -60.58 -35.58 76.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.04 0.448 . . . . 73.540000000000006 111.325 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -119.57 -8.6 9.95 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.353 -0.385 . . . . 75.530000000000001 111.918 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 62.35 17.61 9.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 64.409999999999997 111.685 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -107.07 154.31 21.33 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.307 0.575 . . . . 72.310000000000002 111.931 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -101.18 134.67 43.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.948 -0.569 . . . . 72.239999999999995 111.219 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.0 172.11 34.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.979 -0.629 . . . . 73.109999999999999 112.985 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.7 113.18 25.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.906 0.384 . . . . 54.119999999999997 110.482 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.2 p90 -121.52 149.27 52.22 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.414 -0.357 . . . . 72.25 111.493 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 18.1 Cg_exo -66.29 95.15 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.355 2.037 . . . . 74.409999999999997 112.638 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.18 -19.69 40.0 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.085 -0.507 . . . . 40.140000000000001 113.534 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.0 t -61.79 -15.1 38.72 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.389 0.514 . . . . 63.219999999999999 112.389 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 35.8 m-85 -102.06 -1.54 31.44 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.623 0.601 . . . . 71.010000000000005 112.623 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.99 163.89 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.187 0.518 . . . . 73.129999999999995 112.153 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.08 148.75 41.25 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.106 -0.497 . . . . 73.510000000000005 111.714 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -79.02 118.22 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.071 -0.513 . . . . 75.019999999999996 111.642 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 10' ' ' ARG . 70.9 mt -89.97 -66.26 0.94 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 71.140000000000001 111.087 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.19 39.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.135 -0.555 . . . . 72.25 113.188 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.4 152.38 38.88 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.85 2.366 . . . . 61.310000000000002 113.083 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD22 ' HD2' ' A' ' 4' ' ' PRO . 4.9 mp -80.79 112.48 18.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.883 0.373 . . . . 72.019999999999996 111.201 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.874 -0.584 . . . . 72.310000000000002 110.113 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.719 0.295 . . . . 71.439999999999998 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.0 -71.11 0.15 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.24 0.459 . . . . 61.009999999999998 112.24 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 160.45 179.14 35.02 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.724 -0.751 . . . . 43.240000000000002 113.334 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.54 90.98 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.177 2.585 . . . . 64.409999999999997 113.066 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 mp0 -57.43 -29.77 64.44 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.396 0.517 . . . . 52.439999999999998 112.396 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.72 -172.75 44.51 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.879 -0.677 . . . . 73.040000000000006 113.328 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.22 171.3 12.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.093 0.473 . . . . 64.109999999999999 111.358 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.91 136.81 49.92 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.19 0.519 . . . . 53.32 111.811 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 94.5 m-85 -116.05 170.74 8.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.852 -0.613 . . . . 71.319999999999993 110.601 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.4 ttm180 -135.75 128.69 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.569 0.223 . . . . 63.130000000000003 111.275 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -66.08 114.67 5.4 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 63.119999999999997 111.858 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.45 -58.33 3.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.167 -0.47 . . . . 75.409999999999997 111.569 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.67 150.21 44.38 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.595 -0.275 . . . . 73.25 111.228 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 56.3 Cg_endo -70.91 118.05 5.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.16 1.906 . . . . 75.099999999999994 112.657 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.419 ' HZ ' ' NH2' ' A' ' 17' ' ' ARG . 87.4 t80 -121.44 133.3 55.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 72.549999999999997 110.979 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 16' ' ' ARG . 45.1 mtm180 -125.71 159.04 33.31 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.179 0.514 . . . . 65.230000000000004 111.598 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' NH2' ' HZ ' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -122.53 145.54 48.24 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.951 -0.568 . . . . 74.209999999999994 109.854 177.816 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.833 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 10.1 pt-20 -58.9 -21.48 57.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.053 0.454 . . . . 72.430000000000007 111.585 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.833 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 81.1 mtt180 -129.08 153.1 80.29 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.251 -0.431 . . . . 75.340000000000003 110.476 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.56 6.51 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.643 2.228 . . . . 74.439999999999998 113.032 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.19 -54.03 51.55 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.899 0.48 . . . . 44.43 112.116 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -84.76 -179.92 7.21 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.836 0.35 . . . . 60.520000000000003 111.042 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.7 tp -100.73 119.8 39.15 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.908 0.385 . . . . 74.5 111.161 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.56 138.15 37.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.409 -0.36 . . . . 75.129999999999995 110.799 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 70' ' ' PHE . 69.0 mt -122.69 138.7 54.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.866 0.365 . . . . 54.119999999999997 111.898 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.551 ' HB2' ' NE ' ' A' ' 63' ' ' ARG . 3.9 mm? -122.11 140.73 32.86 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 122.666 0.386 . . . . 42.219999999999999 110.568 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.91 106.31 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.423 2.082 . . . . 40.240000000000002 113.257 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.56 -1.05 8.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.086 0.794 . . . . 75.010000000000005 115.086 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.79 156.4 16.39 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.703 1.252 . . . . 70.400000000000006 111.903 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -101.87 133.71 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.755 -0.657 . . . . 55.399999999999999 111.401 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.1 mp -106.59 110.28 22.44 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.014 -0.539 . . . . 64.400000000000006 110.591 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.51 120.18 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.907 0.384 . . . . 73.310000000000002 111.832 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.93 135.27 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.388 -0.369 . . . . 54.439999999999998 111.473 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.7 p -91.96 148.22 22.37 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.247 -0.283 . . . . 53.030000000000001 111.283 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 24.7 ptt180 -58.43 -28.43 65.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.953 0.353 . . . . 53.25 111.953 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.35 -39.48 70.1 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.924 0.392 . . . . 61.130000000000003 111.639 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.12 77.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 51.030000000000001 111.33 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.84 -42.48 93.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 55.439999999999998 111.211 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 15.3 mm100 -61.9 -39.07 90.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.3 -0.409 . . . . 75.299999999999997 111.185 176.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.03 96.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.945 0.402 . . . . 71.540000000000006 111.346 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.448 HD11 ' HD2' ' A' ' 58' ' ' PRO . 84.2 mt -66.69 -24.72 66.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.177 0.513 . . . . 61.509999999999998 111.084 175.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.13 20.68 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.879 -0.601 . . . . 32.119999999999997 113.177 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.0 125.03 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.946 0.373 . . . . 62.340000000000003 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.38 131.2 45.24 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.577 -0.283 . . . . 63.329999999999998 111.491 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.06 126.96 28.24 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.326 0.584 . . . . 74.150000000000006 111.188 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.1 -2.89 51.36 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.071 -0.513 . . . . 74.099999999999994 112.157 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.87 -7.73 16.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.64 -0.314 . . . . 62.43 113.312 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.5 -20.07 63.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.008 0.432 . . . . 62.109999999999999 111.732 -178.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -71.2 -13.7 62.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.463 -0.335 . . . . 74.439999999999998 111.738 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.77 84.58 31.66 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.829 0.347 . . . . 44.210000000000001 111.437 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.73 -27.19 68.24 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.504 2.136 . . . . 74.219999999999999 112.937 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 73' ' ' THR . 22.0 mp0 -67.18 -17.47 64.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.102 0.477 . . . . 52.240000000000002 111.285 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.0 m -87.31 -25.21 24.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.303 -0.408 . . . . 63.439999999999998 111.415 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.08 -55.16 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.95 0.405 . . . . 73.510000000000005 111.609 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.8 -92.23 0.5 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.17 -0.538 . . . . 33.549999999999997 112.573 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -121.14 141.44 50.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 72.549999999999997 111.788 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -138.17 146.9 53.76 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 116.534 -0.303 . . . . 62.0 110.948 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' HD11 ' A' ' 41' ' ' LEU . 91.6 Cg_endo -79.19 126.65 7.1 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.341 2.028 . . . . 64.310000000000002 112.838 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.06 172.88 31.33 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.006 -0.616 . . . . 65.310000000000002 113.535 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.8 tp -97.47 119.12 35.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.263 0.225 . . . . 71.420000000000002 111.472 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.468 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.0 t-20 -90.95 121.42 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.573 -0.285 . . . . 71.140000000000001 110.593 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -73.65 -8.1 54.61 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.849 1.055 . . . . 73.510000000000005 113.849 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.551 ' NE ' ' HB2' ' A' ' 26' ' ' LEU . 57.7 mtt-85 -81.7 -54.39 5.42 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.569 -0.707 . . . . 71.230000000000004 111.117 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 64.3 p -86.81 -11.59 50.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.492 -0.322 . . . . 75.420000000000002 111.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.65 16.94 9.3 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.131 0.573 . . . . 74.439999999999998 111.681 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 64' ' ' THR . 68.3 mm-40 -107.41 152.84 23.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.049 0.452 . . . . 74.530000000000001 111.456 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 129.6 45.13 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.036 0.446 . . . . 72.420000000000002 111.199 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.91 173.62 34.56 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.156 -0.545 . . . . 73.430000000000007 113.146 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.41 118.82 28.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.903 0.382 . . . . 75.109999999999999 110.83 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB2' HD11 ' A' ' 25' ' ' LEU . 54.0 p90 -117.31 148.79 43.36 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.035 0.383 . . . . 75.340000000000003 112.035 -176.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.88 109.25 2.83 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.569 2.179 . . . . 52.219999999999999 112.347 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.65 -17.95 60.89 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 115.079 0.791 . . . . 64.109999999999999 115.079 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.601 ' HA ' ' HG3' ' A' ' 52' ' ' GLN . 12.6 t -65.55 -15.28 62.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.791 0.795 . . . . 54.420000000000002 112.408 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -99.79 2.98 44.56 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.126 0.417 . . . . 74.420000000000002 112.126 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.5 m -123.98 153.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.002 0.429 . . . . 64.340000000000003 112.102 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 12.9 pt-20 -100.38 154.59 18.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.474 -0.33 . . . . 54.240000000000002 111.304 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -89.93 113.74 25.43 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.722 0.296 . . . . 54.020000000000003 111.102 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.12 -61.72 1.7 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.981 0.419 . . . . 74.109999999999999 111.526 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.23 -155.01 26.1 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.241 -0.504 . . . . 71.239999999999995 112.784 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.33 152.62 39.49 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.7 2.266 . . . . 74.329999999999998 113.176 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.3 161.06 15.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.75 0.648 . . . . 70.519999999999996 112.75 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.441 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.352 -0.833 . . . . 63.420000000000002 111.74 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.043 0.449 . . . . 72.019999999999996 111.479 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.49 -64.23 1.31 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.002 -0.545 . . . . 74.450000000000003 110.496 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 76.12 -124.84 7.5 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 114.502 0.561 . . . . 72.209999999999994 114.502 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 13.1 Cg_exo -71.05 24.96 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 123.663 2.908 . . . . 71.120000000000005 115.0 -173.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -58.41 -30.92 67.24 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.208 0.527 . . . . 64.109999999999999 111.163 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.6 -168.51 34.76 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.0 -0.545 . . . . 73.239999999999995 112.727 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.14 135.55 49.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.965 0.412 . . . . 74.099999999999994 111.085 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HG2' HG22 ' A' ' 32' ' ' VAL . 99.2 mt-30 -97.76 136.1 38.58 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.319 0.58 . . . . 72.299999999999997 112.456 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -113.26 169.28 9.06 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.735 -0.666 . . . . 73.219999999999999 110.382 174.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.538 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 16.1 ttm-85 -119.23 127.76 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.985 -0.447 . . . . 74.019999999999996 111.692 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.575 ' HB2' HD11 ' A' ' 31' ' ' LEU . . . -81.04 116.68 21.11 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.783 0.325 . . . . 64.040000000000006 110.564 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.09 -50.41 16.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 73.129999999999995 112.226 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -124.15 156.77 65.9 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 111.868 0.321 . . . . 72.329999999999998 111.868 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 55.9 Cg_endo -72.0 128.31 13.86 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.517 2.145 . . . . 62.25 113.496 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -124.97 123.4 39.8 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.037 -0.529 . . . . 64.219999999999999 110.915 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -110.53 133.81 52.95 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.127 -0.488 . . . . 71.150000000000006 110.163 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 5.5 mmt85 -134.22 117.52 16.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.961 0.726 . . . . 73.510000000000005 112.961 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.75 -26.47 68.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.768 -0.651 . . . . 71.120000000000005 110.784 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 19' ' ' ARG . 11.8 mmt180 -88.65 112.0 47.63 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.831 -0.622 . . . . 73.340000000000003 111.18 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.94 -2.24 4.37 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.865 2.376 . . . . 62.240000000000002 113.346 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.5 -39.22 79.44 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.106 0.479 . . . . 72.140000000000001 110.906 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.553 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 10.3 t70 -92.55 -154.41 0.38 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.759 -0.655 . . . . 72.319999999999993 109.281 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.539 HD21 ' HB2' ' A' ' 61' ' ' ASN . 42.9 tp -156.0 137.78 14.31 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.448 -0.782 . . . . 74.099999999999994 112.407 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -57.62 105.9 0.29 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.746 0.307 . . . . 72.340000000000003 111.776 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.7 mt -106.84 142.43 36.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.851 0.357 . . . . 61.399999999999999 111.38 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.3 150.69 44.87 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.473 -0.33 . . . . 71.510000000000005 111.394 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 44.9 Cg_endo -66.8 115.96 3.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.381 2.054 . . . . 75.409999999999997 112.629 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.23 21.76 53.88 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.109 -0.567 . . . . 73.209999999999994 112.815 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.5 162.17 14.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.008 0.432 . . . . 74.349999999999994 111.175 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.17 131.87 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.231 0.538 . . . . 64.150000000000006 111.334 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mp -108.07 116.84 32.69 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.876 0.37 . . . . 64.420000000000002 110.998 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 8' ' ' GLN . 60.9 t -93.68 108.73 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.996 0.427 . . . . 72.230000000000004 111.654 -177.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.88 128.76 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.339 -0.392 . . . . 74.099999999999994 110.697 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -71.28 147.33 48.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.968 0.413 . . . . 70.439999999999998 111.74 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -59.04 -35.48 73.38 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.969 0.414 . . . . 73.530000000000001 110.21 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.28 89.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 53.399999999999999 111.379 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -57.73 -47.87 81.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.842 0.353 . . . . 74.099999999999994 111.557 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.83 -45.24 94.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.695 0.284 . . . . 63.420000000000002 111.453 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.48 -37.87 82.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.874 0.368 . . . . 71.430000000000007 110.972 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.46 87.64 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.893 0.378 . . . . 72.5 111.401 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB2' HG23 ' A' ' 43' ' ' VAL . 90.8 mt -66.78 -20.16 65.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.986 0.422 . . . . 73.540000000000006 111.273 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.94 22.05 53.86 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.346 -0.454 . . . . 71.140000000000001 112.803 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 41' ' ' LEU . 60.3 t -68.43 104.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.036 0.446 . . . . 70.019999999999996 110.923 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 147.0 53.39 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.047 -0.524 . . . . 71.310000000000002 112.21 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -56.99 104.76 0.17 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.071 -0.513 . . . . 44.329999999999998 110.995 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.606 ' HA2' HH21 ' A' ' 49' ' ' ARG . . . 136.06 -18.77 3.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.877 -0.601 . . . . 64.150000000000006 112.372 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.18 -12.51 36.12 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.356 -0.449 . . . . 73.239999999999995 113.833 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -27.51 69.28 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.406 0.622 . . . . 74.099999999999994 111.331 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.606 HH21 ' HA2' ' A' ' 46' ' ' GLY . 36.1 mtm180 -80.27 9.15 6.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.963 -0.562 . . . . 74.129999999999995 112.069 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' NE2' ' A' ' 52' ' ' GLN . 50.0 t -138.37 75.2 39.73 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.16 0.505 . . . . 62.299999999999997 111.106 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.6 -34.4 74.84 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.687 2.258 . . . . 74.5 113.143 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.631 ' NE2' ' SG ' ' A' ' 50' ' ' CYS . 4.7 pp0? -64.88 -29.32 70.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.028 0.381 . . . . 73.120000000000005 112.028 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.523 ' HB2' ' SG ' ' A' ' 50' ' ' CYS . 31.7 t -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.848 0.356 . . . . 74.430000000000007 110.687 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.9 -40.26 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.925 0.393 . . . . 64.540000000000006 111.244 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.14 -133.09 11.39 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.2 -0.524 . . . . 75.219999999999999 113.456 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.523 ' HE3' ' HB3' ' A' ' 69' ' ' ASP . 37.3 m95 -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.011 0.434 . . . . 74.400000000000006 111.325 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.0 mtm -121.26 140.35 31.1 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.311 -0.404 . . . . 71.230000000000004 111.436 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD2' HD11 ' A' ' 41' ' ' LEU . 92.2 Cg_endo -78.91 121.04 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.551 2.167 . . . . 53.530000000000001 112.657 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.46 170.23 27.55 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.722 -0.751 . . . . 71.409999999999997 113.98 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.81 132.16 43.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.802 0.441 . . . . 71.25 111.57 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.539 ' HB2' HD21 ' A' ' 23' ' ' LEU . 28.2 t-20 -88.6 116.45 26.85 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.48 -0.327 . . . . 72.209999999999994 110.698 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.51 -19.51 65.8 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.119 0.785 . . . . 73.450000000000003 113.119 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -73.55 -64.29 1.02 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.342 0.591 . . . . 72.519999999999996 111.536 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 78.7 p -89.01 -21.41 23.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.986 -0.552 . . . . 72.409999999999997 112.412 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 64' ' ' THR . 3.0 mpt_? 70.57 19.12 6.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.151 0.58 . . . . 74.439999999999998 111.832 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -86.25 134.6 33.75 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.344 -0.389 . . . . 54.329999999999998 110.611 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -95.02 126.51 40.41 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.54 -0.3 . . . . 73.430000000000007 110.884 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.81 -164.03 11.93 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.913 -0.66 . . . . 34.439999999999998 112.903 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -109.76 152.98 24.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.878 0.371 . . . . 72.340000000000003 110.926 176.763 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 50.3 p90 -154.24 138.36 11.08 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.391 -0.368 . . . . 62.409999999999997 111.3 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 56' ' ' TRP . 13.6 Cg_exo -70.05 118.98 6.0 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.543 2.162 . . . . 74.349999999999994 112.132 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.56 9.15 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.572 0.589 . . . . 54.100000000000001 114.572 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -60.84 -16.67 43.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.036 0.754 . . . . 73.420000000000002 113.036 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HE2' ' HG2' ' A' ' 71' ' ' PRO . 74.6 m-85 -98.37 -4.05 35.68 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.607 0.595 . . . . 72.209999999999994 112.607 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.85 160.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.432 0.53 . . . . 64.049999999999997 112.432 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 11.4 pt-20 -110.06 151.99 26.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.348 -0.387 . . . . 75.329999999999998 110.776 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -82.62 119.03 23.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.849 0.357 . . . . 71.230000000000004 111.195 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.55 -61.57 1.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 111.151 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.5 -169.16 33.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.179 -0.534 . . . . 70.150000000000006 113.088 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.72 173.24 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.611 2.207 . . . . 75.319999999999993 113.075 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 81' ' ' LEU . 6.0 mp -96.11 161.4 13.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 65.349999999999994 111.438 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.646 -0.692 . . . . 74.219999999999999 111.451 178.196 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtm . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.793 0.33 . . . . 75.140000000000001 110.615 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.81 168.68 10.66 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.39 0.615 . . . . 71.310000000000002 112.414 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.02 88.96 0.18 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.793 -0.639 . . . . 45.109999999999999 111.928 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -37.8 105.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.474 3.449 . . . . 74.010000000000005 114.713 -172.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.47 -33.19 12.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.047 -0.524 . . . . 72.140000000000001 110.749 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.17 156.24 16.04 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.305 0.482 . . . . 50.520000000000003 114.305 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -106.75 155.98 19.13 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.74 0.416 . . . . 71.219999999999999 110.945 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.48 123.28 46.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.824 0.676 . . . . 73.299999999999997 112.824 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.79 170.4 8.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.93 -0.577 . . . . 72.310000000000002 110.04 170.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -150.52 121.24 7.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.423 0.527 . . . . 74.420000000000002 112.423 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 151.48 29.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.345 0.593 . . . . 62.310000000000002 112.159 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.64 -29.41 12.33 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.284 0.476 . . . . 64.400000000000006 112.284 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -135.35 145.3 53.24 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-O 120.619 0.247 . . . . 73.510000000000005 111.329 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.0 Cg_endo -74.04 126.06 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.445 2.097 . . . . 60.210000000000001 113.902 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -143.04 112.01 6.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.05 -0.523 . . . . 75.150000000000006 110.681 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.77 142.16 47.28 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.039 -0.413 . . . . 73.200000000000003 110.825 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.698 ' HE ' ' HA ' ' A' ' 17' ' ' ARG . 0.4 OUTLIER -134.73 146.92 49.87 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.465 0.543 . . . . 74.010000000000005 112.465 -175.188 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.47 -35.65 53.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.301 -0.863 . . . . 73.239999999999995 110.976 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -81.03 142.12 51.32 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.858 -0.61 . . . . 65.540000000000006 111.738 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.54 5.87 1.45 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.806 2.337 . . . . 73.129999999999995 114.433 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.77 -8.89 59.19 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.315 0.487 . . . . 65.299999999999997 112.315 177.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -136.63 174.73 10.3 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.539 0.685 . . . . 75.140000000000001 112.552 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 58.6 tp -129.92 148.23 51.76 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.522 -0.763 . . . . 64.219999999999999 110.386 174.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.11 106.85 3.89 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.883 0.373 . . . . 74.299999999999997 111.936 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 91.8 mt -99.78 144.86 28.36 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 70.340000000000003 111.712 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 25' ' ' LEU . 4.1 mm? -123.74 155.69 66.11 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 122.889 0.475 . . . . 63.049999999999997 111.033 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.9 Cg_endo -70.61 107.9 2.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.217 1.944 . . . . 74.040000000000006 112.993 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.69 40.97 11.5 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.147 -0.549 . . . . 63.530000000000001 113.183 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -99.72 175.12 5.91 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.073 0.463 . . . . 75.329999999999998 111.57 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -119.89 134.78 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.827 0.346 . . . . 63.100000000000001 110.732 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.06 122.24 42.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.647 0.261 . . . . 60.100000000000001 111.036 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.43 111.07 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.075 0.464 . . . . 64.310000000000002 111.242 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG22 ' HA3' ' A' ' 59' ' ' GLY . 48.2 t -111.73 119.2 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.455 -0.339 . . . . 52.130000000000003 111.529 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -58.95 127.1 30.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.764 -0.198 . . . . 64.019999999999996 111.077 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -52.27 -35.86 51.22 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.848 0.314 . . . . 71.230000000000004 111.848 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.44 65.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.535 -0.302 . . . . 51.240000000000002 111.799 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.949 0.404 . . . . 64.25 111.1 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 90.3 mt -62.77 -44.86 95.09 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.291 -0.413 . . . . 72.420000000000002 110.908 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.89 -23.87 66.73 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.219 -0.446 . . . . 70.329999999999998 111.514 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.86 54.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.11 0.481 . . . . 63.409999999999997 110.882 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.8 mt -68.39 -28.37 67.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.02 -0.536 . . . . 74.409999999999997 111.404 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.7 9.95 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.225 -0.443 . . . . 60.530000000000001 113.129 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.3 t -77.28 100.58 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.03 0.443 . . . . 73.120000000000005 111.144 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.3 149.91 37.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.227 -0.442 . . . . 31.420000000000002 112.127 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -46.16 129.91 10.14 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.144 -0.48 . . . . 74.310000000000002 111.58 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.82 -50.15 0.93 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.173 -0.467 . . . . 64.450000000000003 112.097 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -21.99 65.6 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.261 -0.495 . . . . 55.109999999999999 112.253 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.93 -31.2 27.75 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.415 0.686 . . . . 63.509999999999998 111.621 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -85.65 7.04 24.84 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.251 -0.431 . . . . 75.239999999999995 111.538 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.539 ' SG ' ' HG2' ' A' ' 52' ' ' GLN . 48.5 t -146.17 68.64 12.62 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 121.019 0.437 . . . . 74.400000000000006 110.92 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.79 -15.15 47.21 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.005 2.47 . . . . 63.32 113.259 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.539 ' HG2' ' SG ' ' A' ' 50' ' ' CYS . 20.2 pt20 -61.05 -19.46 61.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.367 -0.378 . . . . 53.240000000000002 111.886 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -81.89 -12.14 58.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.402 0.519 . . . . 74.439999999999998 112.402 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.38 -59.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.114 0.483 . . . . 73.239999999999995 111.747 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 118.06 -81.89 0.32 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.056 -0.593 . . . . 74.329999999999998 113.028 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.5 m0 -118.88 117.72 29.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.132 0.466 . . . . 74.409999999999997 111.638 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.442 ' N ' ' SD ' ' A' ' 57' ' ' MET . 2.7 mpp? -120.86 138.75 28.08 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.756 -0.202 . . . . 64.420000000000002 111.038 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.37 116.97 4.22 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 55.450000000000003 112.909 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.48 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -143.68 171.21 25.42 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.71 -0.757 . . . . 73.120000000000005 114.021 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.8 tp -103.89 123.23 46.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.687 0.395 . . . . 74.409999999999997 110.992 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -85.23 128.73 34.79 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.561 0.219 . . . . 70.540000000000006 111.447 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -80.64 0.86 32.38 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.385 0.883 . . . . 61.450000000000003 113.385 -177.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -100.78 -47.73 4.72 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.777 -0.577 . . . . 74.150000000000006 111.446 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -96.92 -24.97 15.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.24 0.459 . . . . 53.409999999999997 112.24 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 63.41 23.98 13.95 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.193 0.52 . . . . 75.549999999999997 111.77 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -94.32 142.96 26.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.98 -0.555 . . . . 72.400000000000006 110.545 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -99.98 128.45 46.06 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.356 -0.384 . . . . 71.129999999999995 111.344 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.06 -178.15 40.28 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.051 -0.595 . . . . 32.149999999999999 113.109 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 3.7 m-20 -95.29 109.64 21.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.895 0.379 . . . . 71.349999999999994 110.8 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.2 p90 -100.09 142.38 24.5 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 120.843 0.354 . . . . 74.409999999999997 111.936 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 46.9 Cg_endo -68.31 111.51 2.52 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.695 2.264 . . . . 63.119999999999997 112.922 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -64.86 -8.71 35.84 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.498 0.559 . . . . 54.299999999999997 114.498 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.3 p -78.62 -13.83 59.62 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.2 0.5 . . . . 62.119999999999997 111.971 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.3 6.13 20.29 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.268 0.47 . . . . 73.430000000000007 112.268 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.534 HG22 ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -128.1 141.19 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.038 0.447 . . . . 74.299999999999997 112.187 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -92.23 159.76 15.48 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.331 -0.395 . . . . 61.100000000000001 110.428 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -105.09 124.38 49.43 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.017 0.437 . . . . 75.230000000000004 111.559 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.72 -59.62 2.13 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.146 0.498 . . . . 61.439999999999998 111.094 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.88 -172.65 27.32 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.427 -0.416 . . . . 51.039999999999999 112.749 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.3 134.92 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.23 1.953 . . . . 55.32 112.147 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.0 161.52 21.3 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 71.530000000000001 113.014 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 C--O 1.253 1.26 0 CA-C-N 115.722 -0.672 . . . . 62.219999999999999 112.509 -177.875 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 111.684 0.253 . . . . 74.5 111.684 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.9 88.91 4.7 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.62 0.6 . . . . 61.140000000000001 112.62 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.83 -161.65 24.85 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.334 -0.46 . . . . 71.430000000000007 113.904 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.31 148.91 24.3 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.923 2.416 . . . . 71.319999999999993 113.02 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -78.12 14.85 1.04 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.817 0.673 . . . . 54.109999999999999 112.817 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.14 -134.64 0.52 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.063 -0.589 . . . . 64.439999999999998 113.064 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -139.8 155.33 47.33 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.317 -0.519 . . . . 71.5 111.14 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HG3' HD11 ' A' ' 81' ' ' LEU . 48.3 mt-30 -112.36 136.62 51.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.3 0.571 . . . . 62.210000000000001 111.76 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.456 ' CE1' ' HG3' ' A' ' 51' ' ' PRO . 87.9 m-85 -113.67 173.31 6.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.746 -0.661 . . . . 73.219999999999999 110.702 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -136.34 121.26 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.733 0.302 . . . . 74.430000000000007 111.372 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -70.92 125.5 27.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.026 0.441 . . . . 64.299999999999997 111.894 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.7 mt -81.21 -45.71 15.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.104 0.409 . . . . 73.200000000000003 112.104 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -137.33 158.5 72.18 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 116.467 -0.333 . . . . 64.099999999999994 111.061 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 37.8 Cg_endo -66.71 124.74 12.75 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.229 1.953 . . . . 73.140000000000001 113.377 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -125.94 122.4 35.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 63.409999999999997 110.77 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.422 ' HD2' ' C ' ' A' ' 16' ' ' ARG . 4.1 ppt_? -135.12 156.92 48.18 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.627 0.251 . . . . 73.129999999999995 110.932 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.56 HH21 ' HD3' ' A' ' 19' ' ' ARG . 43.4 mtp180 -131.89 153.41 50.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.531 0.682 . . . . 75.219999999999999 112.803 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -69.0 -39.47 79.32 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.36 -0.836 . . . . 73.420000000000002 110.957 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.56 ' HD3' HH21 ' A' ' 17' ' ' ARG . 57.9 mtp180 -84.96 121.64 74.26 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.902 -0.59 . . . . 74.109999999999999 110.898 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.49 5.87 1.43 Allowed 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 123.454 2.77 . . . . 74.299999999999997 115.247 -168.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -76.75 -22.41 53.85 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.086 0.402 . . . . 61.450000000000003 112.086 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.3 -163.46 0.89 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.785 0.326 . . . . 72.239999999999995 111.718 -175.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 61' ' ' ASN . 58.6 tp -135.54 119.59 17.56 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.862 0.363 . . . . 70.530000000000001 111.656 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HB2' HG21 ' A' ' 64' ' ' THR . 12.1 mp0 -65.45 117.16 7.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.129 0.49 . . . . 71.140000000000001 111.769 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 55.1 mt -103.29 134.98 45.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 74.019999999999996 111.173 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.76 146.33 34.51 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 120.573 0.225 . . . . 74.239999999999995 110.989 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.04 125.04 14.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.396 2.064 . . . . 73.310000000000002 113.072 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.2 4.03 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 116.235 -0.439 . . . . 54.439999999999998 113.928 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -93.19 149.31 21.31 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 117.238 0.519 . . . . 75.510000000000005 111.105 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.59 132.5 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.321 0.582 . . . . 62.340000000000003 111.935 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.504 ' N ' HD12 ' A' ' 31' ' ' LEU . 4.9 mp -103.81 116.56 32.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.976 -0.556 . . . . 62.240000000000002 111.015 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.66 118.01 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.986 0.422 . . . . 65.420000000000002 111.672 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.65 120.47 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.938 0.399 . . . . 73.319999999999993 111.413 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -67.68 148.44 51.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.371 -0.377 . . . . 53.520000000000003 111.803 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 8.3 tpp180 -55.12 -47.35 75.15 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.453 -0.34 . . . . 62.5 111.544 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.34 -32.41 48.97 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.469 0.544 . . . . 75.010000000000005 112.469 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.48 73.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.883 0.373 . . . . 75.409999999999997 111.045 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 41' ' ' LEU . 87.6 mt -65.18 -35.02 79.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.284 -0.416 . . . . 71.230000000000004 111.095 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 13.4 mm100 -60.58 -43.98 96.73 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.952 0.406 . . . . 72.019999999999996 110.699 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.32 -40.62 96.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.288 -0.415 . . . . 35.109999999999999 111.374 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.473 HD11 ' HD2' ' A' ' 58' ' ' PRO . 94.9 mt -62.98 -18.28 63.05 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.046 0.45 . . . . 52.450000000000003 111.343 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 38.71 20.94 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.088 -0.577 . . . . 73.230000000000004 112.639 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.45 122.83 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.016 0.436 . . . . 74.310000000000002 111.725 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.59 138.75 33.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.384 -0.371 . . . . 54.240000000000002 110.273 173.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.18 117.57 3.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.208 0.528 . . . . 63.240000000000002 111.471 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.57 5.68 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.808 -0.633 . . . . 30.039999999999999 112.182 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.18 -38.62 3.74 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.7 -0.286 . . . . 72.299999999999997 112.779 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -23.8 56.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.771 0.428 . . . . 75.109999999999999 111.668 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -54.99 -21.96 13.65 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.484 -0.326 . . . . 74.099999999999994 111.715 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 53' ' ' SER . 22.1 p -115.84 81.5 9.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.966 0.412 . . . . 64.209999999999994 111.008 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 52.9 Cg_exo -54.94 -42.23 71.08 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.114 2.543 . . . . 72.150000000000006 113.183 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -60.97 -31.47 71.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.865 0.364 . . . . 75.319999999999993 111.371 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 39.3 t -73.79 -38.44 64.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.164 0.507 . . . . 74.109999999999999 111.095 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.23 -40.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.059 0.457 . . . . 73.040000000000006 110.995 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.67 -76.18 1.09 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.186 -0.53 . . . . 73.420000000000002 113.662 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -118.95 132.38 56.08 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.906 0.384 . . . . 73.519999999999996 111.33 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 68.5 mtm -144.91 131.98 10.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 O-C-N 122.208 -0.308 . . . . 55.329999999999998 111.668 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' HD11 ' A' ' 41' ' ' LEU . 97.2 Cg_endo -80.48 127.66 6.63 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.388 2.059 . . . . 72.239999999999995 112.502 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.79 176.69 34.02 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.634 -0.793 . . . . 74.030000000000001 113.614 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.73 131.29 55.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.573 0.349 . . . . 72.409999999999997 111.107 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 28.6 t-20 -96.67 149.17 22.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.457 -0.338 . . . . 74.310000000000002 111.002 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -91.98 -33.86 14.68 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.608 0.596 . . . . 65.200000000000003 112.608 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -64.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.153 0.501 . . . . 73.409999999999997 110.635 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 24' ' ' GLU . 62.3 p -75.21 -21.5 58.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.406 -0.361 . . . . 72.319999999999993 111.474 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 17.5 mtp180 58.34 20.54 7.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.63 0.604 . . . . 74.219999999999999 112.63 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.33 163.89 12.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.311 0.577 . . . . 62.119999999999997 111.712 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -107.9 129.65 55.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.672 -0.694 . . . . 73.299999999999997 110.682 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.04 -172.37 34.2 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.261 -0.971 . . . . 63.310000000000002 113.875 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.2 t70 -115.61 109.37 17.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.767 0.427 . . . . 72.409999999999997 109.881 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HB2' HD11 ' A' ' 25' ' ' LEU . 54.4 p90 -103.52 149.12 36.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 112.656 0.613 . . . . 73.420000000000002 112.656 -171.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB2' HG22 ' A' ' 73' ' ' THR . 74.2 Cg_endo -76.11 113.48 3.71 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.713 2.275 . . . . 64.329999999999998 112.412 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.01 -16.1 16.72 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.734 0.654 . . . . 70.319999999999993 114.734 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 71' ' ' PRO . 6.1 t -59.21 -33.38 70.9 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.343 0.572 . . . . 75.239999999999995 112.505 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 54.8 m-85 -89.49 5.03 47.25 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.905 0.706 . . . . 75.209999999999994 112.905 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 11' ' ' ALA . 28.2 m -127.48 148.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.149 0.499 . . . . 72.439999999999998 112.222 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.85 146.44 28.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.121 -0.491 . . . . 73.0 110.401 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -78.34 128.64 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.908 0.385 . . . . 73.319999999999993 111.674 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.66 -67.53 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.929 0.395 . . . . 73.409999999999997 110.923 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.74 -174.06 41.42 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.035 -0.602 . . . . 35.009999999999998 113.093 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.99 -176.83 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.706 2.271 . . . . 74.200000000000003 112.745 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 8' ' ' GLN . 4.6 mp -116.06 150.35 37.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 62.310000000000002 111.163 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 N-CA-C 112.449 0.537 . . . . 75.140000000000001 112.449 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.6 mmm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.818 0.342 . . . . 54.420000000000002 111.632 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.91 -27.69 43.86 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.222 0.535 . . . . 73.230000000000004 110.827 174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.64 -168.59 14.08 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.943 -0.572 . . . . 70.409999999999997 113.216 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.94 85.1 1.39 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.351 2.034 . . . . 70.049999999999997 112.377 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.79 -41.2 95.11 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.197 0.522 . . . . 73.530000000000001 111.426 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.15 167.1 26.52 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 116.032 -0.531 . . . . 54.329999999999998 112.707 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -119.94 160.92 21.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.302 0.572 . . . . 74.420000000000002 111.615 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.503 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 98.3 mt-30 -107.74 126.86 53.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.833 -0.621 . . . . 53.340000000000003 111.034 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.27 130.16 55.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.922 0.391 . . . . 73.109999999999999 110.674 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.557 ' HB2' HD11 ' A' ' 78' ' ' LEU . 37.1 ttt180 -97.59 123.32 41.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.355 -0.384 . . . . 61.25 111.846 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.49 131.8 36.99 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.045 0.45 . . . . 72.319999999999993 110.978 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.27 -60.36 2.37 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.291 0.478 . . . . 64.140000000000001 112.291 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.6 m-85 -132.57 165.11 38.76 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.571 -0.286 . . . . 73.5 111.279 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 44.6 Cg_endo -68.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.813 1.675 . . . . 74.319999999999993 113.284 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.31 152.73 37.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.938 -0.574 . . . . 65.25 110.646 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 15.4 ptt180 -135.16 140.08 45.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.485 -0.325 . . . . 72.329999999999998 111.758 -175.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -113.06 153.5 28.04 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.118 0.485 . . . . 73.010000000000005 111.619 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 12.0 pt-20 -64.76 -37.8 88.84 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.185 0.439 . . . . 64.219999999999999 112.185 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.514 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 74.9 mtp180 -110.36 126.92 27.91 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 122.334 0.254 . . . . 73.120000000000005 111.647 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 17.3 Cg_exo -68.28 -1.65 7.61 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.048 2.499 . . . . 72.040000000000006 113.505 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.5 -21.81 61.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.333 0.587 . . . . 74.239999999999995 110.546 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.81 -143.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.554 -0.748 . . . . 64.120000000000005 109.363 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 61' ' ' ASN . 18.9 tp -156.22 119.86 4.35 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.389 -0.819 . . . . 64.150000000000006 112.384 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.509 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 6.5 mp0 -65.22 151.92 44.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.328 0.585 . . . . 74.109999999999999 112.013 175.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.4 mt -118.31 134.51 54.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.818 -0.628 . . . . 61.439999999999998 110.34 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -114.94 154.99 47.02 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 120.828 0.347 . . . . 63.340000000000003 111.642 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.17 117.12 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.484 2.123 . . . . 72.230000000000004 113.22 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.68 79.83 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.2 -0.524 . . . . 65.540000000000006 113.304 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 63' ' ' ARG . 20.7 t0 -82.75 156.22 23.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.918 0.39 . . . . 72.409999999999997 111.782 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.7 t -117.36 118.89 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.103 0.477 . . . . 73.319999999999993 111.46 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.456 ' N ' HD12 ' A' ' 31' ' ' LEU . 5.2 mp -107.14 133.64 51.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.306 -0.406 . . . . 55.329999999999998 110.932 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.74 115.73 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.231 0.456 . . . . 72.140000000000001 112.231 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.38 118.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.835 0.35 . . . . 74.409999999999997 111.388 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -76.1 155.61 34.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.851 0.358 . . . . 70.409999999999997 111.947 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 38' ' ' LEU . 61.5 mtp180 -62.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.866 0.365 . . . . 74.140000000000001 110.369 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.47 80.75 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.221 -0.445 . . . . 73.439999999999998 110.914 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.62 86.34 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 71.099999999999994 110.909 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 35' ' ' ARG . 95.8 mt -59.0 -49.18 78.89 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.207 -0.451 . . . . 50.310000000000002 111.355 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -61.76 -34.56 76.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.933 0.397 . . . . 75.019999999999996 111.101 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.37 -22.11 66.76 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.893 0.378 . . . . 71.219999999999999 111.539 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD11 ' HD2' ' A' ' 58' ' ' PRO . 96.4 mt -85.64 -5.66 59.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.707 0.289 . . . . 72.400000000000006 111.516 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.77 43.88 82.49 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.791 -0.719 . . . . 71.510000000000005 112.366 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 143.66 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.933 0.397 . . . . 70.430000000000007 111.338 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.39 150.94 48.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.113 -0.494 . . . . 75.409999999999997 112.208 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.93 101.5 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.307 0.575 . . . . 74.439999999999998 112.19 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . 99.29 -9.52 61.12 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 116.085 -0.507 . . . . 71.450000000000003 113.685 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 1.24 46.7 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.167 0.427 . . . . 60.130000000000003 114.167 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -60.25 -18.23 47.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.383 0.611 . . . . 52.109999999999999 111.723 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 8.0 ptt180 -84.91 8.46 17.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.653 -0.703 . . . . 64.549999999999997 112.162 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.6 m -133.66 76.86 65.51 Favored Pre-proline 0 N--CA 1.475 0.785 0 N-CA-C 112.302 0.482 . . . . 72.310000000000002 112.302 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.16 -32.89 62.6 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.656 2.237 . . . . 71.099999999999994 113.061 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.43 -37.66 84.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.939 0.399 . . . . 74.120000000000005 111.137 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.5 t -61.8 -39.95 93.51 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.257 -0.429 . . . . 73.219999999999999 111.661 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 41' ' ' LEU . 45.3 t -75.75 -39.81 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.01 0.433 . . . . 74.209999999999994 111.546 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.22 -71.29 2.85 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.2 -0.524 . . . . 61.219999999999999 113.394 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -98.56 129.14 45.1 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.768 -0.254 . . . . 75.319999999999993 110.624 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 84.0 mtp -143.73 120.85 6.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 111.664 0.246 . . . . 71.230000000000004 111.664 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.544 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.0 Cg_endo -81.79 138.38 10.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.552 2.168 . . . . 74.439999999999998 112.375 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.17 176.77 40.81 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.743 -0.741 . . . . 71.530000000000001 113.199 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.0 tp -100.84 118.87 37.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.637 -0.331 . . . . 72.329999999999998 110.95 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.531 ' HB2' HD21 ' A' ' 23' ' ' LEU . 28.5 t-20 -87.78 100.31 12.75 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.93 -20.46 65.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.124 0.416 . . . . 64.140000000000001 112.124 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.431 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.1 tpt180 -58.83 -49.48 77.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.073 0.463 . . . . 73.349999999999994 111.31 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -110.45 -1.93 16.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.058 -0.519 . . . . 73.439999999999998 112.137 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 65' ' ' ARG . 4.7 mpt_? 63.55 20.52 12.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.759 0.423 . . . . 64.150000000000006 111.661 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -102.42 157.93 16.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.318 0.58 . . . . 61.039999999999999 111.792 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -103.8 151.25 23.28 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.96 -0.564 . . . . 75.409999999999997 110.501 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.66 -178.84 47.13 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.162 -1.018 . . . . 75.540000000000006 113.831 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.7 t70 -109.68 108.6 19.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.894 -0.41 . . . . 73.219999999999999 109.894 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 55.1 p90 -100.94 148.99 35.83 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 121.112 0.482 . . . . 72.310000000000002 112.253 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.5 101.1 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.436 2.091 . . . . 71.150000000000006 112.386 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.16 -17.45 30.73 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.242 0.457 . . . . 74.299999999999997 114.242 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -65.13 -14.2 59.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.731 0.641 . . . . 65.519999999999996 112.731 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.55 8.53 29.33 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.322 0.49 . . . . 65.430000000000007 112.322 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 m -125.22 155.86 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.157 0.503 . . . . 64.010000000000005 111.677 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -112.88 148.59 34.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.237 0.541 . . . . 64.219999999999999 111.51 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -78.16 119.25 21.28 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.077 -0.51 . . . . 74.140000000000001 111.046 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -90.17 -59.51 2.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.048 0.451 . . . . 52.439999999999998 111.291 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.23 -160.61 29.58 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.356 -0.449 . . . . 75.239999999999995 112.555 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.03 147.4 79.79 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.809 2.339 . . . . 71.430000000000007 112.775 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HB3' ' HG3' ' A' ' 8' ' ' GLN . 1.6 pp -92.65 150.62 20.58 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.654 0.613 . . . . 43.329999999999998 112.654 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 . . . . . 0 C--O 1.253 1.241 0 CA-C-N 115.565 -0.743 . . . . 73.349999999999994 110.576 176.303 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.53 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 112.349 0.5 . . . . 70.140000000000001 112.349 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.84 96.02 1.6 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.099 0.476 . . . . 51.109999999999999 112.229 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.52 -67.1 0.29 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 116.168 -0.469 . . . . 51.210000000000001 112.037 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.92 101.48 1.16 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.76 2.307 . . . . 72.019999999999996 111.967 170.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -57.35 -30.06 64.52 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.05 0.759 . . . . 75.230000000000004 113.05 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.03 163.48 27.88 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.791 -0.719 . . . . 54.140000000000001 112.086 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -136.78 156.93 47.86 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.334 0.587 . . . . 75.439999999999998 112.185 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -121.89 133.36 54.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.577 -0.738 . . . . 65.230000000000004 110.975 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.493 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 97.8 m-85 -122.91 137.51 54.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.59 -0.277 . . . . 73.099999999999994 110.879 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HB2' HD21 ' A' ' 78' ' ' LEU . 9.4 ttm180 -98.65 122.6 42.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.836 0.35 . . . . 74.120000000000005 110.585 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.51 16.66 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.951 0.352 . . . . 75.340000000000003 111.951 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.7 -46.82 8.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.813 0.34 . . . . 64.409999999999997 111.512 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.21 137.96 20.72 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 111.974 0.361 . . . . 62.439999999999998 111.974 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 73.0 Cg_endo -78.89 146.12 20.4 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.58 2.187 . . . . 51.409999999999997 113.418 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.544 ' HB2' HD12 ' A' ' 25' ' ' LEU . 92.1 m-85 -143.12 128.96 19.42 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.203 -0.453 . . . . 71.209999999999994 110.828 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -136.05 114.78 12.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.147 0.499 . . . . 74.400000000000006 110.885 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 17' ' ' ARG . 14.9 mmt180 -116.73 148.75 40.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.014 -0.539 . . . . 74.400000000000006 112.271 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.24 26.95 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.243 1.021 . . . . 61.399999999999999 110.234 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 34.1 mmt180 -133.78 129.02 20.11 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.551 -0.75 . . . . 73.439999999999998 110.461 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.6 -4.65 15.02 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.878 2.385 . . . . 72.200000000000003 114.453 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.471 ' OE1' ' HB3' ' A' ' 19' ' ' ARG . 21.2 mp0 -75.84 -38.9 57.58 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.981 -0.449 . . . . 74.439999999999998 110.583 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.77 -175.55 4.94 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.848 -0.615 . . . . 74.239999999999995 109.98 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD23 HD21 ' A' ' 25' ' ' LEU . 37.3 tp -132.29 136.11 46.7 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.719 -0.613 . . . . 74.109999999999999 112.286 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.44 117.75 13.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.569 -0.287 . . . . 72.129999999999995 110.66 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 15' ' ' PHE . 15.0 mt -135.7 136.39 40.82 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.848 0.684 . . . . 44.5 112.848 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.3 157.21 44.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.381 0.672 . . . . 73.510000000000005 110.655 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 21.9 Cg_exo -64.88 108.95 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.213 1.942 . . . . 63.520000000000003 112.633 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.19 15.35 14.44 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.462 -0.399 . . . . 73.409999999999997 113.993 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.4 151.35 30.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.182 0.491 . . . . 70.239999999999995 112.094 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.41 120.23 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.134 -0.484 . . . . 53.310000000000002 110.493 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.3 mp -103.37 124.08 48.03 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.814 0.34 . . . . 61.020000000000003 111.403 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 81' ' ' LEU . 80.1 t -94.05 116.83 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.16 -0.473 . . . . 62.140000000000001 110.968 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.38 135.93 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.889 0.376 . . . . 71.140000000000001 111.229 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.1 p -86.82 133.78 33.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.698 0.285 . . . . 75.340000000000003 110.732 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -65.7 -25.4 67.3 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.097 -0.377 . . . . 71.030000000000001 111.07 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.25 -40.79 87.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.018 0.437 . . . . 71.120000000000005 111.19 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -62.73 -47.16 84.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.992 0.425 . . . . 74.209999999999994 111.029 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.53 -43.88 89.35 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.219 -0.446 . . . . 75.310000000000002 111.267 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -62.35 -38.26 88.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.846 0.355 . . . . 73.209999999999994 111.124 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.76 68.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.002 0.43 . . . . 73.230000000000004 111.344 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 92.5 mt -81.54 -4.68 56.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.379 -0.373 . . . . 73.349999999999994 111.659 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.03 13.36 79.45 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.269 -0.491 . . . . 62.340000000000003 113.421 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.7 t -74.12 109.09 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.924 0.392 . . . . 74.040000000000006 111.531 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.78 148.29 44.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.982 0.42 . . . . 72.530000000000001 111.932 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.67 119.04 4.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.091 -0.504 . . . . 71.109999999999999 111.344 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.15 -14.16 16.26 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.481 -0.39 . . . . 53.140000000000001 112.234 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.52 -26.84 10.38 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.53 -0.367 . . . . 74.200000000000003 113.172 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -27.11 69.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.082 0.468 . . . . 73.209999999999994 111.791 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -67.41 -15.46 63.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.482 -0.326 . . . . 51.530000000000001 111.704 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.7 m -132.78 69.36 79.34 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 120.908 0.385 . . . . 41.0 110.661 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.527 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 29.1 Cg_endo -60.57 -21.57 69.2 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.101 2.534 . . . . 62.240000000000002 113.819 -172.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -55.82 -25.14 40.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.885 0.374 . . . . 71.219999999999999 111.945 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -77.71 -17.02 58.05 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.953 0.353 . . . . 65.409999999999997 111.953 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.15 -20.39 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.035 0.445 . . . . 64.510000000000005 111.524 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.67 -110.34 3.94 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.356 -0.449 . . . . 73.219999999999999 112.35 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -121.38 143.84 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.155 0.478 . . . . 71.120000000000005 110.995 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 46.7 mtm -134.44 149.42 71.04 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 111.89 0.329 . . . . 63.329999999999998 111.89 -173.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.37 123.21 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.594 2.196 . . . . 64.5 113.109 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.81 163.51 28.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.035 -0.602 . . . . 71.129999999999995 113.586 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.458 HD21 HH21 ' A' ' 65' ' ' ARG . 52.8 tp -107.22 124.7 50.13 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.556 0.342 . . . . 74.329999999999998 111.788 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -87.48 122.91 31.81 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.583 -0.28 . . . . 65.340000000000003 110.676 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -72.1 -15.0 61.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.56 0.948 . . . . 71.340000000000003 113.56 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -86.86 -67.95 0.78 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.675 -0.641 . . . . 71.099999999999994 111.246 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.3 p -71.56 -22.95 61.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.242 -0.435 . . . . 62.200000000000003 112.004 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.458 HH21 HD21 ' A' ' 60' ' ' LEU . 22.8 mmm-85 65.97 8.68 5.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.519 0.728 . . . . 65.299999999999997 112.286 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -78.53 149.49 33.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.845 0.355 . . . . 74.219999999999999 110.958 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.434 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -113.07 134.61 54.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.518 -0.31 . . . . 70.329999999999998 110.402 176.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.26 176.19 45.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.834 -0.698 . . . . 53.039999999999999 112.627 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.57 107.9 19.14 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.921 0.391 . . . . 73.310000000000002 110.518 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -97.45 140.15 21.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.553 -0.294 . . . . 75.349999999999994 111.46 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.06 116.69 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.549 2.166 . . . . 73.430000000000007 112.46 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -71.57 26.53 0.6 Allowed Glycine 0 CA--C 1.536 1.397 0 N-CA-C 114.61 0.604 . . . . 51.340000000000003 114.61 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -104.02 -32.14 9.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.538 0.669 . . . . 75.400000000000006 112.452 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.542 ' CZ ' HD13 ' A' ' 25' ' ' LEU . 20.9 p90 -88.59 4.81 45.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 111.859 0.318 . . . . 72.340000000000003 111.859 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 17.9 m -112.94 146.84 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.725 0.639 . . . . 72.400000000000006 112.725 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.504 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 9.4 pt-20 -102.98 138.67 39.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.62 -0.718 . . . . 52.509999999999998 110.146 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -75.41 115.32 14.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.833 0.349 . . . . 73.439999999999998 111.506 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 10' ' ' ARG . 82.3 mt -85.3 -55.97 3.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.19 0.519 . . . . 73.030000000000001 111.481 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.02 -155.97 26.43 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.856 -0.611 . . . . 73.239999999999995 111.962 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.69 178.61 5.41 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.66 2.24 . . . . 72.239999999999995 113.17 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.524 HD21 HG13 ' A' ' 32' ' ' VAL . 94.5 mt -75.86 144.29 41.3 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.786 0.327 . . . . 73.329999999999998 111.723 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.692 -0.67 . . . . 73.239999999999995 111.515 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.782 0.325 . . . . 72.230000000000004 111.695 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.24 -80.56 0.45 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.715 0.293 . . . . 70.209999999999994 111.193 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.91 130.88 2.96 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.212 -0.518 . . . . 64.430000000000007 113.14 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.7 102.62 1.2 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.439 2.093 . . . . 64.140000000000001 112.708 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.4 -24.4 66.48 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.244 0.545 . . . . 73.430000000000007 111.193 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . -169.55 -155.62 10.14 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.901 -0.59 . . . . 63.520000000000003 112.82 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.99 155.99 38.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.194 0.521 . . . . 63.32 111.642 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB3' HD12 ' A' ' 78' ' ' LEU . 95.9 mt-30 -94.96 123.41 38.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.16 -0.473 . . . . 41.229999999999997 111.735 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.83 125.98 54.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.363 -0.381 . . . . 61.32 110.57 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HB2' HD11 ' A' ' 78' ' ' LEU . 70.6 ttt180 -97.79 120.49 38.27 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.682 0.277 . . . . 72.400000000000006 111.725 -176.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.4 119.99 13.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 53.140000000000001 111.47 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.86 -59.89 2.49 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.321 0.489 . . . . 63.149999999999999 112.321 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -127.09 156.83 73.81 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 116.362 -0.381 . . . . 63.420000000000002 111.149 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.62 119.16 6.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.089 1.86 . . . . 74.129999999999995 113.044 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -121.82 111.75 17.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 54.25 111.029 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -89.21 125.76 35.21 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.206 0.526 . . . . 54.420000000000002 110.885 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HG2' ' HB2' ' A' ' 22' ' ' ASP . 22.7 tpt180 -70.7 153.78 42.48 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.174 -0.329 . . . . 74.439999999999998 110.949 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -45.06 -49.67 11.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.247 0.546 . . . . 72.209999999999994 110.992 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -131.0 147.33 65.88 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.47 -0.786 . . . . 71.099999999999994 110.025 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -58.38 -5.49 2.34 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 122.842 2.361 . . . . 53.530000000000001 113.742 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -53.26 -41.66 65.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.218 0.607 . . . . 73.140000000000001 112.579 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.606 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 10.7 m-20 -91.19 -162.18 0.89 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.045 0.45 . . . . 73.329999999999998 111.579 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.604 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 23.8 tp -99.92 134.77 42.35 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.924 0.392 . . . . 73.400000000000006 111.256 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.75 140.57 42.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.901 0.381 . . . . 62.439999999999998 111.661 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.0 mt -100.75 131.36 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.612 0.597 . . . . 52.140000000000001 112.612 -173.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.16 148.99 41.89 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 122.721 0.408 . . . . 72.319999999999993 110.52 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.42 105.51 0.9 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.398 2.065 . . . . 72.230000000000004 113.168 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.42 -4.61 21.58 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.148 -0.549 . . . . 62.020000000000003 113.857 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 130.89 44.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.197 0.499 . . . . 73.209999999999994 111.916 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.9 105.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.905 -0.589 . . . . 61.439999999999998 110.721 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.7 mp -89.94 130.81 36.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.57 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.29 106.22 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.327 -0.397 . . . . 74.340000000000003 111.312 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.44 118.45 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.766 0.317 . . . . 51.340000000000003 110.819 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.464 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 87.3 p -69.41 140.91 54.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 54.420000000000002 111.846 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -60.27 -28.09 67.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.197 0.522 . . . . 74.340000000000003 110.702 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.4 -44.5 96.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.983 -0.553 . . . . 65.319999999999993 110.924 174.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.38 -45.45 91.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.839 0.352 . . . . 42.409999999999997 110.915 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 96.1 mt -54.23 -43.42 70.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.398 -0.365 . . . . 74.340000000000003 111.426 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.67 -42.47 92.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.453 -0.34 . . . . 65.209999999999994 111.283 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.27 92.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.045 0.45 . . . . 74.409999999999997 111.261 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.468 HD11 ' HD2' ' A' ' 58' ' ' PRO . 78.6 mt -66.55 -25.88 66.86 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.01 -0.541 . . . . 72.420000000000002 111.642 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.0 23.23 18.19 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.229 -0.51 . . . . 75.5 112.62 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.7 t -84.15 107.29 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.985 0.422 . . . . 72.099999999999994 111.054 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.58 149.84 46.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.069 -0.514 . . . . 54.0 111.901 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.8 113.92 3.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.023 -0.535 . . . . 73.340000000000003 110.852 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.55 -10.61 11.42 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.397 -0.43 . . . . 71.049999999999997 112.521 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.45 5.46 23.1 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.514 -0.374 . . . . 55.119999999999997 112.97 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -67.21 -23.75 65.77 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.223 0.453 . . . . 73.219999999999999 112.223 -177.098 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -77.98 -2.68 38.19 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.201 0.445 . . . . 74.219999999999999 112.201 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -118.19 86.29 26.46 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 74.230000000000004 111.819 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.6 -21.84 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.118 1.878 . . . . 60.409999999999997 111.996 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.37 -48.82 79.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.904 -0.589 . . . . 63.030000000000001 110.982 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -63.88 -28.07 69.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 74.129999999999995 111.066 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 57' ' ' MET . 95.7 t -69.86 -37.99 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.96 -0.564 . . . . 65.209999999999994 111.541 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.96 -79.55 1.79 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.095 -0.574 . . . . 71.329999999999998 112.982 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -120.88 124.01 43.92 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.656 -0.32 . . . . 64.409999999999997 110.963 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.43 ' HB3' HG11 ' A' ' 54' ' ' VAL . 8.6 ptp -136.25 147.96 62.46 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 120.653 0.263 . . . . 72.109999999999999 111.449 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' HD11 ' A' ' 41' ' ' LEU . 81.7 Cg_endo -88.03 140.67 4.92 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.765 2.31 . . . . 74.129999999999995 112.802 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.27 -172.71 17.74 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.505 -0.855 . . . . 62.539999999999999 114.027 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 65.5 tp -132.83 108.68 9.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.619 0.367 . . . . 71.409999999999997 111.269 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -79.26 129.5 34.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.827 0.346 . . . . 71.329999999999998 111.205 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.07 -23.27 65.84 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.142 0.423 . . . . 52.119999999999997 112.142 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -75.38 -53.55 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.04 0.448 . . . . 72.430000000000007 111.808 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -68.37 -26.62 65.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.399 0.518 . . . . 74.540000000000006 112.399 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 64.78 10.58 6.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.105 0.479 . . . . 65.450000000000003 111.268 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -127.38 160.72 30.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.11 0.481 . . . . 73.510000000000005 111.734 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -91.29 176.85 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.656 -0.702 . . . . 70.120000000000005 110.993 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . 159.46 168.42 21.45 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.095 -0.574 . . . . 43.509999999999998 113.01 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.32 127.49 43.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.613 0.245 . . . . 73.109999999999999 111.375 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.43 156.19 79.95 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 120.698 0.285 . . . . 73.400000000000006 111.421 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.3 120.9 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.468 2.112 . . . . 74.030000000000001 112.488 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.73 1.48 15.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.382 -0.437 . . . . 70.049999999999997 114.05 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 p -74.71 -17.43 60.66 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.37 -0.488 . . . . 63.109999999999999 112.289 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -108.28 17.52 22.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.864 0.69 . . . . 74.019999999999996 112.864 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.4 m -131.66 148.63 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.982 0.42 . . . . 51.030000000000001 112.119 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -108.65 151.08 26.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.217 -0.447 . . . . 71.349999999999994 110.892 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.06 115.26 21.12 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.806 0.336 . . . . 65.209999999999994 111.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.8 mt -83.2 -59.73 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.916 0.389 . . . . 71.109999999999999 111.467 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.07 -176.56 36.76 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.089 -0.577 . . . . 64.510000000000005 113.185 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.79 157.0 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.923 2.416 . . . . 51.32 113.106 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.516 HD12 ' N ' ' A' ' 81' ' ' LEU . 4.6 mp -93.78 160.85 14.57 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.447 -0.342 . . . . 73.230000000000004 111.086 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.253 1.241 0 N-CA-C 112.038 0.385 . . . . 70.310000000000002 112.038 177.633 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.979 0.419 . . . . 71.200000000000003 111.355 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.05 -161.84 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.159 -0.473 . . . . 71.430000000000007 111.277 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.93 158.42 7.53 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.223 -0.513 . . . . 71.200000000000003 112.687 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 86.97 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.407 2.071 . . . . 63.5 113.245 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.69 -16.97 64.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.559 0.695 . . . . 74.230000000000004 110.471 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . 175.67 -140.86 5.38 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.523 -0.762 . . . . 52.219999999999999 112.214 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -130.46 143.97 51.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.225 0.536 . . . . 73.230000000000004 111.625 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -92.73 131.02 38.16 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.732 -0.667 . . . . 71.109999999999999 112.116 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -123.78 153.85 40.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 73.230000000000004 110.069 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.1 ttm180 -127.42 119.75 26.86 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.778 0.323 . . . . 71.340000000000003 111.805 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -71.54 124.08 23.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.309 -0.405 . . . . 71.319999999999993 110.961 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.5 -21.2 19.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.443 0.534 . . . . 74.120000000000005 112.443 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.98 147.57 65.94 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 112.131 0.419 . . . . 73.420000000000002 112.131 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 55.7 Cg_endo -71.06 119.63 6.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.55 2.167 . . . . 72.400000000000006 112.172 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -136.68 120.0 16.84 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.919 0.39 . . . . 73.140000000000001 111.49 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 17' ' ' ARG . 11.2 ttm180 -123.6 151.62 42.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.994 0.426 . . . . 72.099999999999994 110.999 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 18.7 mmm180 -134.24 142.23 47.29 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.466 -0.334 . . . . 71.209999999999994 110.759 177.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.32 -15.48 62.4 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.986 0.422 . . . . 64.400000000000006 111.58 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -110.76 157.35 38.75 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.385 0.274 . . . . 75.439999999999998 110.702 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.86 6.06 1.84 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.972 2.448 . . . . 74.349999999999994 113.229 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -54.95 -52.72 62.13 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.115 0.483 . . . . 72.25 111.122 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' CG ' ' HG3' ' A' ' 17' ' ' ARG . 3.4 m-20 -102.07 -173.71 2.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.566 -0.743 . . . . 54.210000000000001 111.46 -177.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.8 tp -132.56 144.62 50.52 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.387 -0.37 . . . . 74.239999999999995 110.415 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.0 113.32 3.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.127 0.489 . . . . 75.239999999999995 112.034 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.5 mt -103.26 138.74 39.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.245 -0.434 . . . . 71.549999999999997 111.25 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.499 HD23 ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -122.65 150.69 58.77 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 122.503 0.321 . . . . 71.319999999999993 110.933 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.94 117.83 4.64 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.685 2.257 . . . . 71.510000000000005 113.133 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.1 29.66 58.4 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.032 -0.531 . . . . 71.010000000000005 113.311 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.91 158.67 15.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.189 0.495 . . . . 71.239999999999995 111.155 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.04 132.56 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.135 0.493 . . . . 61.549999999999997 112.289 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.448 HD21 HD22 ' A' ' 25' ' ' LEU . 5.9 mp -121.88 111.42 17.08 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.249 -0.432 . . . . 72.25 110.975 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.558 HG13 HD21 ' A' ' 81' ' ' LEU . 18.0 t -94.96 106.05 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.839 0.352 . . . . 74.549999999999997 111.227 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.518 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.4 t -101.39 132.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.598 0.237 . . . . 75.310000000000002 111.591 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 143.07 45.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.272 0.558 . . . . 63.109999999999999 112.187 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -66.38 -33.05 74.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.056 -0.52 . . . . 71.310000000000002 111.124 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.09 73.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 74.409999999999997 111.392 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -69.68 -45.44 68.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.182 -0.463 . . . . 64.439999999999998 111.27 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.36 -39.83 80.62 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.354 -0.385 . . . . 61.119999999999997 111.507 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.27 -44.05 95.66 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.497 -0.32 . . . . 75.540000000000006 111.015 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.95 91.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.02 0.438 . . . . 75.030000000000001 111.227 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.602 HD11 ' HD2' ' A' ' 58' ' ' PRO . 81.2 mt -66.75 -29.2 69.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.251 -0.431 . . . . 63.020000000000003 111.498 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.57 31.87 12.5 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.265 -0.493 . . . . 63.210000000000001 112.833 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -73.37 123.26 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.924 0.392 . . . . 72.209999999999994 111.307 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.1 149.99 23.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.488 -0.324 . . . . 54.329999999999998 111.376 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.27 126.68 9.75 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 73.450000000000003 111.241 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -42.43 1.91 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.24 -0.505 . . . . 52.109999999999999 112.289 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.17 -26.25 61.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.035 -0.602 . . . . 74.209999999999994 112.198 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.626 ' HG3' ' HG3' ' A' ' 49' ' ' ARG . 9.3 pt-20 -52.05 -33.88 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.514 0.726 . . . . 75.510000000000005 111.297 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HG3' ' HG3' ' A' ' 48' ' ' GLU . 28.2 mtp180 -89.65 -3.04 58.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.715 -0.675 . . . . 63.240000000000002 111.654 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 65.8 m -136.83 72.45 55.32 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.434 -0.348 . . . . 75.140000000000001 111.021 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.91 -26.82 83.43 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.797 2.331 . . . . 71.030000000000001 112.836 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.745 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 73.3 mt-30 -62.95 -25.51 68.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.329 -0.396 . . . . 40.420000000000002 111.541 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.5 m -83.86 -31.41 25.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.475 -0.33 . . . . 71.540000000000006 111.787 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.45 -44.71 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.522 . . . . 74.349999999999994 110.908 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.87 -78.31 0.89 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.298 -0.477 . . . . 71.530000000000001 113.701 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -111.81 114.38 27.3 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.324 0.49 . . . . 63.32 112.324 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -126.42 134.61 26.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.372 -0.376 . . . . 72.140000000000001 111.011 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD2' HD11 ' A' ' 41' ' ' LEU . 95.7 Cg_endo -81.94 123.85 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.546 2.164 . . . . 71.310000000000002 112.205 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -148.25 176.43 27.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.634 -0.793 . . . . 62.140000000000001 113.756 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 tp -97.4 121.69 39.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.621 0.368 . . . . 75.519999999999996 110.919 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.97 121.51 34.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.747 0.308 . . . . 71.409999999999997 111.142 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -72.7 -27.04 61.83 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.19 0.811 . . . . 75.409999999999997 113.19 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.499 ' HG2' HD23 ' A' ' 26' ' ' LEU . 4.2 tpm_? -58.58 -52.58 65.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.009 0.433 . . . . 75.430000000000007 111.329 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 p -92.4 -15.83 26.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.014 -0.539 . . . . 62.329999999999998 111.506 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 60.13 24.38 13.67 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.119 -0.491 . . . . 74.099999999999994 111.681 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -118.72 161.12 20.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 71.239999999999995 111.5 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -92.45 150.67 20.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.162 -0.472 . . . . 63.539999999999999 111.524 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.85 -175.29 44.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.257 -0.496 . . . . 64.209999999999994 112.747 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.46 143.54 32.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.972 0.386 . . . . 72.439999999999998 110.528 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 55.1 p90 -139.92 143.12 33.22 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.111 0.411 . . . . 44.439999999999998 112.111 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 10.6 Cg_exo -72.41 118.32 5.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.864 2.376 . . . . 53.439999999999998 112.267 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -60.32 -14.45 33.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.451 0.54 . . . . 71.040000000000006 114.451 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.745 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 10.3 t -71.48 -5.65 34.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.619 0.6 . . . . 72.409999999999997 112.619 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -111.03 1.04 17.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.138 0.422 . . . . 74.010000000000005 112.138 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 11' ' ' ALA . 25.7 m -128.41 148.6 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.46 0.541 . . . . 61.43 112.46 -175.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 13.9 pt-20 -98.77 167.18 10.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.838 0.352 . . . . 63.420000000000002 110.717 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -99.04 123.28 43.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.946 0.403 . . . . 74.340000000000003 111.001 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 10' ' ' ARG . 74.7 mt -94.26 -46.97 6.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.945 0.402 . . . . 71.150000000000006 111.347 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.72 -179.74 18.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.267 -0.492 . . . . 32.340000000000003 113.246 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.79 142.91 40.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.484 2.122 . . . . 63.210000000000001 112.478 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.558 HD21 HG13 ' A' ' 32' ' ' VAL . 6.2 mp -68.1 133.97 49.82 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.912 0.387 . . . . 74.319999999999993 111.569 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 119.046 -0.502 . . . . 75.549999999999997 111.087 178.403 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.724 0.297 . . . . 73.230000000000004 110.979 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.79 144.81 30.0 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.969 0.414 . . . . 71.329999999999998 111.87 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.45 -145.77 13.49 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.204 -0.522 . . . . 32.130000000000003 113.283 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -89.82 -174.69 0.89 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.277 2.652 . . . . 74.040000000000006 113.13 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -118.42 -26.86 6.12 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.616 0.599 . . . . 61.130000000000003 112.616 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . -80.02 -149.27 5.55 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 115.3 0.88 . . . . 70.010000000000005 115.3 -169.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.53 163.44 14.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.931 0.396 . . . . 62.219999999999999 111.323 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -108.01 126.23 52.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.399 0.618 . . . . 72.230000000000004 112.264 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.75 169.64 9.43 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.449 -0.796 . . . . 74.219999999999999 110.179 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' HD11 ' A' ' 78' ' ' LEU . 45.3 ttt85 -136.03 124.45 23.43 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.088 -0.382 . . . . 75.299999999999997 111.92 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.68 129.17 34.24 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.831 0.348 . . . . 73.420000000000002 111.391 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.0 mt -81.77 -49.61 10.21 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.371 0.508 . . . . 53.119999999999997 112.371 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 49.4 m-85 -124.87 164.4 31.51 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-O 120.481 0.182 . . . . 73.140000000000001 111.236 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.7 Cg_endo -74.34 119.91 6.01 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.264 1.976 . . . . 71.140000000000001 113.299 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -125.15 143.1 51.1 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.397 -0.365 . . . . 74.25 111.169 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 5.9 mtp-105 -126.39 160.43 30.48 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.232 0.539 . . . . 72.239999999999995 112.415 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HE ' ' CG ' ' A' ' 22' ' ' ASP . 10.3 tpp180 -104.86 149.95 25.25 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.939 -0.573 . . . . 62.109999999999999 110.142 168.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -57.69 -37.78 74.05 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.943 0.402 . . . . 72.340000000000003 111.493 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -115.87 146.49 37.04 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.487 -0.324 . . . . 74.129999999999995 110.966 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.93 6.85 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.179 2.586 . . . . 75.219999999999999 114.762 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -62.27 -40.54 96.58 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.273 0.471 . . . . 72.010000000000005 112.273 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' CG ' ' HE ' ' A' ' 17' ' ' ARG . 1.6 m-20 -82.0 -163.29 0.64 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.605 0.594 . . . . 74.299999999999997 112.605 -175.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp -123.98 120.15 31.62 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.065 -0.516 . . . . 72.340000000000003 110.975 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -64.63 154.6 35.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.67 0.748 . . . . 71.5 113.014 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 92.8 mt -116.13 139.02 50.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.213 -0.903 . . . . 63.310000000000002 110.581 175.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD22 ' C ' ' A' ' 25' ' ' LEU . 3.9 mm? -121.31 154.92 59.16 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 122.458 0.303 . . . . 71.140000000000001 110.586 174.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.9 115.52 3.64 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.405 2.07 . . . . 73.049999999999997 112.852 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.55 22.11 35.21 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.372 -0.442 . . . . 72.340000000000003 113.393 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.39 136.27 33.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.994 0.426 . . . . 70.219999999999999 111.797 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.19 125.46 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.254 -0.43 . . . . 71.120000000000005 110.538 174.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.6 mp -121.05 127.5 51.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.974 0.416 . . . . 74.140000000000001 111.587 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.19 122.4 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.356 -0.384 . . . . 53.210000000000001 111.294 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.51 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 84.6 t -109.5 125.07 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.695 0.283 . . . . 63.219999999999999 110.769 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -60.07 129.68 42.94 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.774 0.321 . . . . 71.329999999999998 111.782 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 17.5 ptm180 -57.37 -30.39 64.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.634 0.255 . . . . 75.510000000000005 111.379 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.96 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.908 0.385 . . . . 63.310000000000002 111.371 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.46 87.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.923 0.392 . . . . 64.219999999999999 111.111 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.22 -46.23 69.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.262 0.554 . . . . 70.030000000000001 110.818 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 35' ' ' ARG . 77.2 mt-30 -59.28 -52.07 67.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.697 -0.683 . . . . 73.239999999999995 111.433 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.39 97.43 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.212 0.449 . . . . 74.239999999999995 112.212 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.7 -28.8 70.2 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.763 0.316 . . . . 75.310000000000002 111.644 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 23.78 10.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.185 -0.531 . . . . 34.119999999999997 113.424 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.93 110.49 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.017 0.437 . . . . 70.099999999999994 110.835 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.27 149.88 37.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.28 -0.418 . . . . 62.240000000000002 112.122 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -52.06 127.98 23.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.168 0.509 . . . . 71.230000000000004 110.99 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.56 -44.61 1.46 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.289 -0.725 . . . . 61.420000000000002 111.289 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.87 -20.63 66.74 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.511 -0.376 . . . . 63.310000000000002 112.455 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.76 -43.69 58.37 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.503 0.668 . . . . 64.540000000000006 111.178 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -77.66 -5.23 49.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.765 -0.652 . . . . 74.120000000000005 111.751 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.46 71.26 66.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.657 0.614 . . . . 62.240000000000002 112.657 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 -24.24 75.02 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.919 1.746 . . . . 72.540000000000006 110.324 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 22.1 pt20 -55.11 -26.14 36.2 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.744 -1.117 . . . . 70.510000000000005 111.95 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -89.06 -33.6 17.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.824 0.345 . . . . 65.129999999999995 111.746 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.56 -58.81 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.132 0.419 . . . . 71.200000000000003 112.132 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.9 -116.61 3.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.012 -0.613 . . . . 54.520000000000003 113.341 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -102.41 127.85 49.26 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.289 -0.536 . . . . 75.030000000000001 111.267 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -134.23 148.48 68.0 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 111.63 0.233 . . . . 62.25 111.63 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.2 124.68 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.705 2.27 . . . . 74.540000000000006 112.735 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.01 -174.0 22.94 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.942 -0.647 . . . . 44.350000000000001 113.796 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 29.0 tp -106.71 115.3 29.96 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.123 0.569 . . . . 62.039999999999999 112.094 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t-20 -82.62 104.02 12.57 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.773 0.321 . . . . 62.140000000000001 110.346 173.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -68.0 -9.01 42.17 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.28 0.844 . . . . 74.209999999999994 113.28 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.454 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.1 ttp85 -81.47 -29.13 33.84 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.659 -0.651 . . . . 74.129999999999995 110.902 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -113.12 -11.61 13.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.247 -0.433 . . . . 74.420000000000002 111.694 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.89 14.3 9.5 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.073 0.549 . . . . 74.319999999999993 112.008 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -96.77 145.65 25.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.105 0.479 . . . . 64.430000000000007 111.789 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -104.72 130.19 52.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.958 -0.564 . . . . 73.019999999999996 110.568 177.67 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.29 -175.75 39.34 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.685 -0.769 . . . . 70.450000000000003 113.379 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.12 117.14 27.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.723 0.297 . . . . 73.319999999999993 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 40.9 p90 -122.27 148.54 52.5 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 120.904 0.383 . . . . 73.409999999999997 111.31 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 17.0 Cg_exo -67.17 91.97 0.33 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.399 2.066 . . . . 75.120000000000005 112.657 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.558 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -66.74 -10.01 53.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.203 -0.453 . . . . 54.509999999999998 113.729 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 52' ' ' GLN . 60.3 m -61.54 -30.25 70.52 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.445 -0.444 . . . . 74.299999999999997 111.529 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HD2' ' HB2' ' A' ' 71' ' ' PRO . 59.3 m-85 -93.85 4.71 53.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.015 0.746 . . . . 72.439999999999998 113.015 -174.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 72' ' ' GLY . 16.9 m -108.19 151.03 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.158 0.504 . . . . 73.420000000000002 111.965 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -102.14 158.26 16.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 73.420000000000002 110.692 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -89.6 124.19 34.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.919 0.39 . . . . 74.299999999999997 111.251 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 10' ' ' ARG . 85.6 mt -93.52 -45.14 7.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.093 0.473 . . . . 70.040000000000006 111.196 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.28 19.95 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.085 -0.579 . . . . 52.530000000000001 113.494 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.35 174.25 8.12 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.88 2.387 . . . . 73.239999999999995 112.696 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -121.8 132.16 54.45 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.279 -0.419 . . . . 71.099999999999994 110.567 177.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 81' ' ' LEU . 1.4 pt-20 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 113.261 0.838 . . . . 53.539999999999999 113.261 -176.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.545 0.212 . . . . 62.229999999999997 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.31 152.7 12.81 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.279 0.474 . . . . 75.450000000000003 112.279 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.69 -165.49 51.36 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.196 -0.456 . . . . 54.43 113.324 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.5 98.87 0.98 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.263 1.976 . . . . 73.310000000000002 112.763 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.57 -45.6 75.1 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.389 0.614 . . . . 73.329999999999998 109.894 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.22 177.79 33.07 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.754 -0.657 . . . . 34.25 112.856 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' HB3' ' HE1' ' A' ' 77' ' ' PHE . 92.3 m-85 -127.03 138.11 53.18 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.505 -0.409 . . . . 75.439999999999998 110.635 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HG3' HD11 ' A' ' 81' ' ' LEU . 98.3 mt-30 -92.6 131.1 37.99 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.702 0.63 . . . . 72.409999999999997 112.702 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.93 163.25 17.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.393 -0.821 . . . . 70.140000000000001 109.76 170.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HB2' HD11 ' A' ' 78' ' ' LEU . 40.9 ttm180 -140.69 125.59 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.986 0.365 . . . . 75.109999999999999 111.986 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.43 127.55 32.74 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.265 0.555 . . . . 73.409999999999997 111.174 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.57 -39.01 28.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.002 0.429 . . . . 63.43 111.518 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -130.65 141.09 40.71 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.258 -0.428 . . . . 71.239999999999995 110.76 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.3 Cg_endo -65.88 120.9 8.14 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.451 2.101 . . . . 74.200000000000003 112.923 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -131.72 123.68 28.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.517 -0.311 . . . . 74.030000000000001 110.976 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -103.58 99.08 8.88 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.34 0.496 . . . . 71.319999999999993 112.34 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 27.6 mtp180 64.32 140.53 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.585 1.698 . . . . 64.200000000000003 115.585 164.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.93 -50.91 3.27 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.508 -0.923 . . . . 71.0 108.508 160.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.401 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 15.2 mmt180 -89.1 159.4 45.25 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.712 -0.676 . . . . 74.140000000000001 109.471 166.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.76 -8.49 19.7 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 121.894 1.729 . . . . 54.140000000000001 113.148 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -96.77 -19.26 19.05 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 111.997 0.369 . . . . 74.129999999999995 111.997 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 17' ' ' ARG . 23.1 m-20 -61.8 174.35 0.84 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.331 0.863 . . . . 60.420000000000002 113.331 -173.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.6 tp -99.8 151.62 21.06 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.638 -0.71 . . . . 52.119999999999997 111.295 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -97.58 127.87 43.86 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.466 -0.334 . . . . 73.400000000000006 111.172 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.92 149.04 25.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.535 0.569 . . . . 62.039999999999999 112.535 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.86 155.94 54.6 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 75.5 110.65 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.1 Cg_endo -71.32 105.19 1.68 Allowed 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 121.607 1.538 . . . . 73.450000000000003 112.387 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.48 3.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.228 -0.51 . . . . 41.140000000000001 113.195 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -106.84 174.68 5.78 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.867 0.365 . . . . 74.310000000000002 111.623 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.35 113.72 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.786 0.327 . . . . 63.219999999999999 111.388 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.2 mp -105.15 130.46 53.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.583 0.23 . . . . 74.129999999999995 111.169 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.75 111.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.896 0.379 . . . . 72.0 111.22 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.73 128.6 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 122.649 0.38 . . . . 72.439999999999998 111.246 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -72.6 142.59 48.38 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.519999999999996 111.906 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -54.76 -36.08 64.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.399 -0.364 . . . . 74.239999999999995 111.826 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.82 73.79 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 111.904 0.335 . . . . 74.319999999999993 111.904 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.788 0.328 . . . . 55.200000000000003 111.58 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -54.51 -43.36 71.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.072 0.463 . . . . 62.0 111.443 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -69.34 -33.79 73.64 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.303 -0.408 . . . . 75.209999999999994 111.515 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.48 65.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.213 0.53 . . . . 61.539999999999999 111.138 175.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD13 HG11 ' A' ' 54' ' ' VAL . 76.8 mt -86.78 -10.13 54.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.997 -0.547 . . . . 64.239999999999995 111.28 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.69 33.19 63.59 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 23.32 113.142 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.03 135.08 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.942 0.401 . . . . 71.430000000000007 111.355 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.66 130.25 35.09 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.338 -0.392 . . . . 62.350000000000001 111.586 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -49.27 116.32 1.66 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.496 . . . . 74.120000000000005 110.776 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.61 2.26 25.79 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.286 -0.483 . . . . 72.120000000000005 112.636 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.89 5.9 32.63 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.52 -0.372 . . . . 60.039999999999999 113.281 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.97 -29.7 67.38 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.02 0.378 . . . . 72.140000000000001 112.02 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -80.54 -2.7 47.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.358 0.503 . . . . 71.329999999999998 112.358 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.2 m -128.33 64.37 67.01 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 120.89 0.376 . . . . 70.340000000000003 111.811 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 38.3 Cg_endo -65.17 -22.43 61.26 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.438 2.092 . . . . 70.329999999999998 112.174 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -62.87 -21.06 65.71 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.882 -0.599 . . . . 74.25 111.909 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.9 t -87.37 -4.05 59.03 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 75.329999999999998 111.701 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 41' ' ' LEU . 57.5 t -98.83 -54.51 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.89 0.376 . . . . 72.040000000000006 111.595 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.44 -120.28 4.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.305 -0.407 . . . . 74.140000000000001 112.39 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.3 m0 -92.09 111.59 23.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.814 0.34 . . . . 54.130000000000003 110.673 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 46.4 mtm -103.84 133.04 20.47 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.351 -0.218 . . . . 74.129999999999995 111.415 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 57' ' ' MET . 19.3 Cg_exo -67.23 117.67 4.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.871 2.381 . . . . 73.329999999999998 112.349 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.94 168.54 31.83 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.796 -0.716 . . . . 72.5 113.361 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.533 HD13 ' HE ' ' A' ' 67' ' ' ARG . 37.4 tp -112.63 114.1 26.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.744 0.307 . . . . 53.109999999999999 110.461 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 23' ' ' LEU . 50.7 t-20 -81.96 104.33 12.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.672 0.272 . . . . 74.109999999999999 110.989 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 19.0 mm-40 -69.95 0.46 5.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.447 0.906 . . . . 71.409999999999997 113.447 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' A' ' 63' ' ' ARG . 2.6 tpm_? -81.42 -43.51 18.83 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.972 -0.455 . . . . 74.319999999999993 110.515 171.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.1 p -107.8 -6.78 16.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.297 -0.41 . . . . 53.119999999999997 111.677 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 44.4 mmm-85 59.22 19.44 7.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.695 0.798 . . . . 74.299999999999997 111.779 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -95.32 145.58 24.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.108 0.48 . . . . 73.530000000000001 111.825 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.533 ' HE ' HD13 ' A' ' 60' ' ' LEU . 3.9 tpp180 -99.48 140.94 32.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.08 -0.509 . . . . 75.430000000000007 111.528 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.18 177.26 39.23 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.898 . . . . 62.0 113.657 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 5.4 m-20 -89.51 128.8 36.04 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.406 0.282 . . . . 73.420000000000002 110.597 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -119.02 141.29 30.01 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 122.107 -0.37 . . . . 74.230000000000004 111.844 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.88 113.38 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.729 2.286 . . . . 62.299999999999997 112.537 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.46 23.1 1.25 Allowed Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.027 0.771 . . . . 70.319999999999993 115.027 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.4 p -93.79 -18.6 21.87 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.807 0.803 . . . . 45.130000000000003 111.571 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -107.96 9.02 28.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.914 0.338 . . . . 71.450000000000003 111.914 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' HA2' ' A' ' 72' ' ' GLY . 25.3 m -122.51 151.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 112.632 0.604 . . . . 51.450000000000003 112.632 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.4 160.63 16.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.891 -0.595 . . . . 62.439999999999998 110.921 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 7' ' ' PHE . 26.6 t80 -93.07 115.37 28.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.035 0.445 . . . . 73.209999999999994 111.632 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 10' ' ' ARG . 87.2 mt -84.61 -44.17 13.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.731 0.301 . . . . 72.510000000000005 111.548 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.05 178.04 15.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.136 -0.554 . . . . 52.420000000000002 113.623 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.54 164.17 27.25 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.081 2.521 . . . . 54.009999999999998 112.802 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.499 HD12 ' N ' ' A' ' 81' ' ' LEU . 4.7 mp -99.56 151.35 21.26 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.851 0.358 . . . . 71.420000000000002 111.384 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.148 0 N-CA-C 112.0 0.37 . . . . 73.450000000000003 112.0 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.577 ' HA2' ' HG2' ' A' ' 35' ' ' ARG . . . . . . . . 0 CA--C 1.523 0.578 0 CA-C-O 120.467 -0.074 . . . . 53.42 113.122 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.5 ' HE2' HH11 ' A' ' 35' ' ' ARG . 94.4 m-85 -141.82 157.84 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.973 0.416 . . . . 74.34 110.901 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -118.58 132.85 56.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.287 0.565 . . . . 73.32 112.248 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.92 170.83 7.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.598 -0.728 . . . . 75.51 109.578 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 35.4 ttt180 -148.33 121.5 8.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.022 -0.424 . . . . 73.35 111.386 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -69.38 125.61 27.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.956 0.408 . . . . 54.12 111.938 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -94.7 -30.27 14.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.26 0.467 . . . . 73.55 112.26 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.87 141.41 40.44 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.56 0.219 . . . . 74.33 111.391 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 70.3 Cg_endo -76.78 119.31 5.1 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.35 2.033 . . . . 63.24 113.326 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 . . . . . 0 N--CA 1.468 0.428 0 CA-C-N 116.084 -0.507 . . . . 75.2 110.712 176.421 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.2 tp . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 121.226 0.536 . . . . 73.03 111.608 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -84.92 145.17 27.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.949 -0.569 . . . . 70.2 112.491 -170.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.2 mt -119.13 127.9 53.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.196 -0.456 . . . . 75.13 111.771 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' HG ' ' HD3' ' A' ' 63' ' ' ARG . 4.3 mm? -123.36 143.44 41.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 122.559 0.344 . . . . 54.3 110.883 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.04 119.57 6.7 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.72 2.28 . . . . 75.22 113.443 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.45 -14.95 62.84 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.268 -0.424 . . . . 34.42 113.698 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -81.41 143.34 32.21 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.21 0.505 . . . . 64.23 111.744 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.64 141.19 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.318 0.58 . . . . 71.04 112.27 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.5 mp -118.7 123.95 46.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.029 -0.532 . . . . 35.22 110.731 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 81' ' ' LEU . 57.9 t -94.88 124.21 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 111.976 0.361 . . . . 74.11 111.976 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.28 139.79 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.952 0.405 . . . . 71.4 111.176 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 t -93.13 158.32 15.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.958 0.408 . . . . 70.32 111.835 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 17.3 mmm180 -55.34 -41.18 72.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.244 -0.435 . . . . 61.12 111.56 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.86 -45.84 71.08 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.01 0.374 . . . . 41.44 112.01 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.02 70.87 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.882 0.372 . . . . 74.32 111.707 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.25 -40.63 97.95 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.807 0.337 . . . . 63.12 111.826 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -66.16 -35.77 81.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.815 0.34 . . . . 74.42 111.225 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.36 73.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.035 0.445 . . . . 54.34 111.41 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -22.35 59.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.176 -0.465 . . . . 71.33 111.465 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.63 42.82 6.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.299 -0.477 . . . . 51.31 112.963 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.06 134.79 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.592 -0.358 . . . . 74.51 111.43 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.12 142.32 50.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.709 0.29 . . . . 75.34 111.133 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -60.93 108.33 0.85 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.051 0.453 . . . . 72.0 110.977 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 8.97 31.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.319 -0.467 . . . . 74.42 112.713 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.31 -29.55 6.3 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.612 -0.328 . . . . 61.23 112.644 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -31.63 64.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.971 0.508 . . . . 63.41 112.225 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -57.06 -16.43 7.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.172 0.434 . . . . 72.41 112.172 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.3 m -117.65 81.47 14.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.374 -0.375 . . . . 74.35 110.208 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.64 -36.15 97.9 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.942 2.428 . . . . 73.42 113.321 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -19.08 61.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.005 0.372 . . . . 44.41 112.005 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.2 t -82.77 -20.0 36.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.971 0.415 . . . . 53.01 111.462 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.38 -36.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.107 0.479 . . . . 62.4 111.283 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.26 -133.63 11.6 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.235 -0.439 . . . . 41.43 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.85 129.9 37.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.111 0.482 . . . . 73.41 111.274 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 69.1 mtm -131.46 140.37 38.22 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.483 -0.326 . . . . 65.11 111.615 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.47 118.97 4.0 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.689 2.259 . . . . 72.22 113.05 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.28 -174.71 23.89 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.863 -0.684 . . . . 54.41 113.892 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.06 130.48 55.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.635 0.374 . . . . 52.22 111.338 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.59 143.64 28.07 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.729 0.3 . . . . 72.24 111.414 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -79.05 -52.29 8.41 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.166 0.802 . . . . 73.11 113.166 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HD3' ' HG ' ' A' ' 26' ' ' LEU . 58.2 ttt180 -62.73 -40.47 97.29 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.843 0.683 . . . . 71.1 112.843 -175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -92.26 -17.11 25.23 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.068 0.395 . . . . 63.25 112.068 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.64 17.82 6.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.613 0.365 . . . . 72.3 111.57 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -98.71 159.14 15.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.29 0.567 . . . . 64.14 112.143 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -121.88 135.05 54.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.779 -0.646 . . . . 73.23 111.297 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.18 -171.73 44.08 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.669 -0.777 . . . . 73.33 113.04 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -88.95 121.69 31.57 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.794 -0.239 . . . . 51.3 111.228 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.555 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 50.4 p90 -111.92 143.74 29.3 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 120.566 0.222 . . . . 73.42 111.151 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.85 104.18 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.215 1.943 . . . . 62.11 111.88 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.78 36.71 1.03 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 114.255 0.462 . . . . 73.43 114.255 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -104.52 -30.22 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.125 -0.632 . . . . 55.01 111.23 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -93.43 11.25 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.217 -0.447 . . . . 75.43 111.614 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 11' ' ' ALA . 24.1 m -118.51 145.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.36 0.504 . . . . 63.4 112.36 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 15.0 pt-20 -93.07 170.72 9.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.928 0.394 . . . . 70.45 110.844 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -102.69 129.73 49.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.427 -0.351 . . . . 72.23 110.947 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.96 -51.15 3.94 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.101 0.408 . . . . 71.15 112.101 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.18 -175.1 33.27 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.714 -0.755 . . . . 61.23 113.584 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.45 146.99 12.44 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.006 2.471 . . . . 75.21 113.922 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 32' ' ' VAL . 90.2 mt . . . . . 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 74.01 111.088 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.559 0 CA-C-O 120.731 0.073 . . . . 71.32 112.972 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 94.0 m-85 -110.01 153.57 24.4 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.886 0.374 . . . . 71.54 111.154 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -116.54 126.89 53.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.148 0.499 . . . . 64.4 111.575 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.77 168.25 9.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.91 -0.586 . . . . 64.55 110.717 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.502 ' HB2' HD11 ' A' ' 78' ' ' LEU . 31.2 ttt85 -124.01 118.95 28.16 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.3 -0.25 . . . . 70.35 111.11 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.556 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -67.92 117.78 10.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.989 0.423 . . . . 72.13 111.567 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 76' ' ' GLU . 51.9 mt -89.83 -41.02 12.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.006 0.432 . . . . 73.12 111.705 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -127.76 149.53 70.76 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.261 -0.427 . . . . 74.02 111.121 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.9 Cg_endo -72.68 152.75 53.73 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.511 2.14 . . . . 60.15 113.469 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.1 t80 . . . . . 0 CA--C 1.539 0.536 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.444 179.06 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 tp . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 112.377 0.51 . . . . 73.5 112.377 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.648 ' HB2' HG21 ' A' ' 64' ' ' THR . 44.1 mt-10 -87.0 131.29 34.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.064 0.459 . . . . 51.43 111.564 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 HD21 ' A' ' 31' ' ' LEU . 64.3 mt -119.61 138.12 53.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.804 -0.634 . . . . 74.4 110.82 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 25' ' ' LEU . 3.9 mm? -118.36 145.65 37.73 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 120.836 0.351 . . . . 71.53 110.834 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.61 106.26 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.319 2.013 . . . . 72.44 113.14 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.73 -21.35 4.47 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.329 -0.462 . . . . 61.14 113.245 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.67 142.28 58.46 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.552 0.575 . . . . 63.23 112.552 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.73 98.78 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.847 -0.615 . . . . 75.14 110.517 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 75' ' ' VAL . 6.9 mp -78.78 116.54 19.19 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.91 0.386 . . . . 72.55 111.775 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.8 t -94.35 117.23 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.947 0.403 . . . . 65.41 111.5 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.462 HG22 ' HA3' ' A' ' 59' ' ' GLY . 96.1 t -115.84 123.23 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.299 -0.409 . . . . 72.44 111.132 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -66.45 131.08 45.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.832 -0.167 . . . . 43.42 110.829 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -54.68 -33.92 61.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.965 0.357 . . . . 74.21 111.965 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.79 66.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.888 0.375 . . . . 62.03 111.856 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -64.23 -34.88 79.12 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.43 111.686 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.93 -42.92 99.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.964 0.412 . . . . 53.1 111.096 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.68 -35.34 78.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.753 0.311 . . . . 61.23 110.931 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.41 -33.78 74.27 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.003 0.43 . . . . 62.44 111.489 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.635 HD21 ' HD3' ' A' ' 58' ' ' PRO . 96.1 mt -74.98 -28.75 60.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.893 0.377 . . . . 73.13 111.805 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.76 35.17 8.55 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.115 -0.564 . . . . 63.31 112.239 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -75.72 127.39 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 120.727 0.299 . . . . 50.33 111.184 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 146.16 54.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.984 0.421 . . . . 41.24 111.233 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.87 121.64 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.144 0.497 . . . . 74.31 111.223 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.39 -15.98 60.49 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.154 -0.546 . . . . 73.01 112.739 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.26 48.18 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.627 -0.321 . . . . 75.02 113.394 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -53.67 -21.11 6.3 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.461 0.648 . . . . 74.53 111.585 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.81 -11.26 25.5 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.517 0.562 . . . . 75.11 112.517 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 26.6 p -161.01 91.7 1.54 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.042 0.386 . . . . 70.33 112.042 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 50' ' ' CYS . 11.9 Cg_endo -55.05 -23.79 37.14 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.985 2.456 . . . . 74.12 112.94 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.27 74.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.747 0.308 . . . . 72.24 110.776 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.7 m -65.85 -15.37 62.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.381 0.511 . . . . 63.31 112.381 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.16 -30.33 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.991 0.424 . . . . 71.31 111.417 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.29 -92.24 1.78 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.116 -0.564 . . . . 74.54 113.145 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -108.56 131.51 54.77 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.935 0.398 . . . . 70.55 111.279 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 66.4 mtp -133.16 132.64 22.34 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.275 -0.421 . . . . 74.31 110.938 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.635 ' HD3' HD21 ' A' ' 41' ' ' LEU . 92.8 Cg_endo -87.28 118.07 1.32 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.677 2.251 . . . . 65.22 112.852 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.16 179.09 28.12 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.815 -0.707 . . . . 22.22 113.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.86 124.51 49.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.459 0.304 . . . . 71.22 111.394 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.8 t-20 -87.25 149.03 24.85 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.594 -0.275 . . . . 65.03 110.771 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -92.11 -28.61 17.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.537 0.94 . . . . 74.11 113.537 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -58.79 3.06 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.595 0.712 . . . . 74.42 110.808 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 24' ' ' GLU . 64.4 p -81.87 -21.71 37.34 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.546 -0.752 . . . . 70.44 111.634 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 13.7 mmt85 57.54 31.21 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.562 . . . . 70.41 111.98 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.31 135.77 39.44 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.811 -0.631 . . . . 73.21 110.161 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -97.58 121.22 39.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.976 -0.379 . . . . 71.04 109.976 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -169.96 -172.11 36.14 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.647 -0.787 . . . . 52.51 113.568 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.86 132.21 35.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.847 0.356 . . . . 74.31 111.255 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 25' ' ' LEU . 53.2 p90 -138.45 150.17 65.41 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.758 0.313 . . . . 71.11 111.482 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.79 110.26 2.31 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.188 1.925 . . . . 64.04 112.425 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.49 -11.5 35.05 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.598 0.599 . . . . 32.22 114.598 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -72.52 -8.18 53.82 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.517 0.658 . . . . 74.51 112.361 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -94.7 -2.91 50.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.065 0.395 . . . . 75.04 112.065 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.557 HG11 HD22 ' A' ' 31' ' ' LEU . 18.9 m -127.24 149.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 112.437 0.532 . . . . 65.21 112.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG2' HD21 ' A' ' 12' ' ' LEU . 11.6 pt-20 -104.23 158.94 16.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.345 -0.388 . . . . 75.12 110.451 173.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -89.45 127.79 35.88 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.016 0.436 . . . . 71.34 111.702 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 10' ' ' ARG . 90.2 mt -98.66 -65.9 0.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.118 0.485 . . . . 74.24 110.968 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.18 169.23 32.27 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.212 -0.518 . . . . 61.25 112.989 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 82.6 Cg_endo -76.48 160.91 34.94 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.71 2.273 . . . . 74.23 112.985 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.686 0 CA-C-O 121.862 0.839 . . . . 72.53 111.389 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.643 0 N-CA-C 113.646 0.218 . . . . 35.44 113.646 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.08 158.41 41.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.048 0.452 . . . . 71.43 111.535 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.91 130.33 56.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.66 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -122.92 146.81 47.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.209 -0.451 . . . . 63.21 110.63 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HB2' HD11 ' A' ' 78' ' ' LEU . 15.0 ttp180 -104.75 126.71 52.1 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.102 -0.374 . . . . 71.53 111.388 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.8 114.73 12.42 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.999 0.428 . . . . 62.04 111.073 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.33 -61.06 1.92 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.299 -0.41 . . . . 72.22 112.07 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -128.32 147.25 62.92 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 116.628 -0.26 . . . . 65.4 111.007 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 27' ' ' PRO . 49.6 Cg_endo -69.02 119.65 6.62 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.182 1.921 . . . . 52.32 112.996 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.715 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 77.2 t80 . . . . . 0 CA--C 1.534 0.358 0 CA-C-N 116.235 -0.439 . . . . 64.24 110.461 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 61' ' ' ASN . 32.1 tp . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 120.856 0.36 . . . . 64.15 111.785 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.36 142.74 28.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.159 -0.473 . . . . 73.31 110.02 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.715 ' HB2' ' H ' ' A' ' 15' ' ' PHE . 80.9 mt -104.94 135.03 47.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.305 0.854 . . . . 61.35 113.305 -169.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.631 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.1 mm? -111.82 139.01 21.79 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 115.745 -0.661 . . . . 64.53 110.545 175.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.544 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 60.0 Cg_endo -70.47 126.3 12.7 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.35 2.033 . . . . 60.24 113.135 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.24 65.71 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.153 -0.476 . . . . 54.22 113.936 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.7 160.63 27.39 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.179 0.514 . . . . 41.34 112.071 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.82 133.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.26 0.553 . . . . 72.3 111.433 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -108.6 122.7 47.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.701 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.02 115.91 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.08 0.467 . . . . 71.01 111.069 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.477 HG22 ' HA3' ' A' ' 59' ' ' GLY . 62.0 t -113.15 106.68 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.013 0.435 . . . . 70.51 111.78 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 m -62.23 126.43 27.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.388 -0.369 . . . . 65.12 110.384 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -58.72 -20.5 49.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.176 0.436 . . . . 74.25 112.176 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.27 -36.11 51.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.987 0.422 . . . . 75.03 111.433 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.34 -39.4 71.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.261 -0.427 . . . . 74.13 111.098 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.97 -37.89 89.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.998 0.428 . . . . 71.11 111.17 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.25 -38.56 88.13 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.084 0.468 . . . . 63.2 110.595 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.43 80.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.128 -0.487 . . . . 72.14 111.229 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.476 HD11 ' HD3' ' A' ' 58' ' ' PRO . 89.2 mt -74.03 -27.76 61.1 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.941 0.4 . . . . 60.45 111.127 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.93 55.52 2.94 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.096 -0.502 . . . . 74.22 112.428 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.77 141.01 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.061 0.458 . . . . 53.42 111.532 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.78 145.42 34.38 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.033 0.444 . . . . 73.34 111.879 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 120.73 13.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.239 -0.437 . . . . 72.41 111.153 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.83 -13.57 49.76 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.007 -0.616 . . . . 60.14 112.086 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.0 -18.78 26.03 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.455 -0.402 . . . . 62.04 113.066 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -30.95 71.98 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.131 0.491 . . . . 63.25 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -76.47 8.42 3.5 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.32 -0.4 . . . . 71.1 111.879 175.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.9 m -137.09 80.35 35.34 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 120.901 0.382 . . . . 71.2 111.135 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.12 -36.91 97.51 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.705 2.27 . . . . 71.12 113.082 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -61.25 -22.31 64.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.386 -0.37 . . . . 73.42 111.76 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.4 m -86.49 -24.16 25.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.662 -0.245 . . . . 64.34 111.588 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.81 -46.04 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.034 0.445 . . . . 75.35 111.533 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.09 -99.16 0.79 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.449 -0.405 . . . . 63.13 112.852 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -122.93 133.86 54.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.588 -0.36 . . . . 71.22 110.811 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -133.86 151.65 77.27 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 122.19 -0.319 . . . . 74.34 111.507 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD3' HD11 ' A' ' 41' ' ' LEU . 3.2 Cg_endo -86.01 137.4 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.524 . . . . 65.04 112.092 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.477 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -159.39 -179.71 34.4 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.693 -0.765 . . . . 71.33 113.859 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -101.07 117.85 35.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.666 0.387 . . . . 74.15 111.017 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.523 ' HB2' HD21 ' A' ' 23' ' ' LEU . 25.4 t-20 -85.62 111.61 20.22 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.794 0.33 . . . . 55.24 111.239 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -62.16 -28.71 69.84 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.914 0.709 . . . . 74.14 112.914 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.631 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -60.52 -54.89 40.0 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.194 0.521 . . . . 75.51 111.519 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.3 p -99.55 -8.82 24.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.988 -0.551 . . . . 55.4 112.379 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 64.23 13.58 8.02 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.743 0.417 . . . . 74.11 111.362 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -96.45 166.69 11.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.296 0.569 . . . . 55.3 112.308 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -116.26 147.79 41.14 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.55 -0.75 . . . . 64.2 111.342 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.34 40.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.858 -0.686 . . . . 53.45 113.095 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 6.6 m-20 -88.73 139.93 29.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.935 0.398 . . . . 71.4 111.363 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 25' ' ' LEU . 53.7 p90 -134.16 146.84 61.38 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.672 0.273 . . . . 74.22 111.635 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD2' HD11 ' A' ' 25' ' ' LEU . 17.4 Cg_exo -67.58 110.4 2.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.741 2.294 . . . . 53.22 112.714 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -62.19 -10.23 26.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.082 0.393 . . . . 33.32 114.082 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.3 p -76.23 -20.92 56.99 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.509 -0.406 . . . . 75.21 111.885 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -102.25 12.37 36.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.42 0.526 . . . . 74.21 112.42 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.467 HG22 ' HA2' ' A' ' 72' ' ' GLY . 32.4 m -130.23 151.09 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.123 0.487 . . . . 25.43 111.355 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -118.45 145.0 45.58 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.408 -0.36 . . . . 74.21 111.324 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -73.22 117.7 15.27 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.396 -0.365 . . . . 75.54 111.411 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 10' ' ' ARG . 85.5 mt -87.79 -58.3 2.62 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.043 0.449 . . . . 74.2 110.984 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.25 -169.75 42.46 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.137 -0.554 . . . . 3.14 112.946 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.11 -176.69 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.868 2.379 . . . . 74.51 113.411 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt . . . . . 0 CA--C 1.538 0.506 0 CA-C-N 116.338 -0.392 . . . . 74.14 111.3 179.869 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.524 0.645 0 N-CA-C 115.695 1.038 . . . . 63.24 115.695 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -125.97 179.87 5.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.971 -0.614 . . . . 64.25 110.772 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.434 ' HG3' HD23 ' A' ' 81' ' ' LEU . 86.9 mt-30 -125.25 137.56 54.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.406 0.622 . . . . 74.33 112.016 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -120.17 154.66 34.48 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.596 -0.729 . . . . 74.03 110.271 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.44 ' HB2' HD11 ' A' ' 78' ' ' LEU . 51.6 ttp180 -123.02 121.9 37.21 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.099 -0.376 . . . . 72.22 111.663 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.78 123.42 24.12 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.022 0.439 . . . . 75.22 111.622 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.8 -49.77 10.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.004 0.43 . . . . 75.04 111.662 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -127.35 153.35 77.11 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.308 -0.405 . . . . 61.24 111.336 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -68.54 131.35 22.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.342 2.028 . . . . 73.34 113.74 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.446 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 t80 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 115.533 -0.758 . . . . 72.01 110.653 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.309 0.576 . . . . 61.34 111.521 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 40.8 mt-10 -90.64 164.59 14.11 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.969 -0.56 . . . . 70.44 111.875 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 80.2 mt -121.93 147.12 46.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 73.45 111.803 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.45 HD22 ' C ' ' A' ' 25' ' ' LEU . 4.0 mm? -122.91 155.61 63.52 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 122.544 0.337 . . . . 74.14 111.179 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.51 117.82 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.161 1.907 . . . . 75.13 112.495 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.16 28.28 45.7 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.151 -0.547 . . . . 70.14 112.589 -177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -93.44 156.59 16.68 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.499 0.319 . . . . 72.11 110.578 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.26 132.91 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.839 0.352 . . . . 63.42 110.731 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.5 mp -127.29 124.04 37.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.091 0.472 . . . . 74.14 111.418 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.21 119.09 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.334 -0.394 . . . . 74.01 110.73 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.511 HG22 ' HA3' ' A' ' 59' ' ' GLY . 59.9 t -115.27 104.77 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.923 0.392 . . . . 63.24 111.651 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.556 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 70.5 m -60.99 119.8 8.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.439 -0.346 . . . . 74.23 110.15 174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -63.02 -12.49 26.41 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.628 0.603 . . . . 64.41 112.628 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.92 71.16 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.266 0.555 . . . . 71.41 110.461 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.632 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -68.19 -35.85 78.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.797 -0.638 . . . . 43.11 111.136 175.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.56 -34.35 76.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.997 0.427 . . . . 75.32 110.511 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -63.74 -36.08 82.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.332 -0.395 . . . . 74.51 110.849 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.23 -25.02 64.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.996 0.426 . . . . 70.22 111.296 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.579 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -80.72 -28.36 36.61 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.106 0.479 . . . . 61.2 111.106 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.75 45.18 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.022 -0.535 . . . . 71.11 112.504 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.56 133.89 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.59 0.589 . . . . 72.24 112.59 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.74 151.65 24.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.971 -0.559 . . . . 73.24 111.457 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -50.02 110.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.106 0.479 . . . . 74.32 111.463 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.28 -50.54 0.88 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 116.186 -0.461 . . . . 72.4 112.047 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.07 -27.18 68.45 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.072 -0.585 . . . . 55.43 112.848 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -57.5 -35.36 70.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.117 0.484 . . . . 75.23 111.432 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -100.64 4.01 42.97 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 64.22 111.606 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -142.91 82.52 12.08 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 120.875 0.369 . . . . 72.32 111.209 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 20.4 Cg_endo -58.92 -24.78 74.35 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.106 2.537 . . . . 70.53 113.228 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -57.37 -27.14 62.03 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.733 0.302 . . . . 75.31 111.743 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -82.96 -13.18 56.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.001 0.429 . . . . 74.42 111.761 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 41' ' ' LEU . 46.6 t -98.44 -38.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.037 0.446 . . . . 64.22 111.422 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -93.12 1.77 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.125 -0.559 . . . . 75.14 112.697 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -93.53 136.7 33.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.795 0.331 . . . . 74.13 110.648 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 81.5 mtp -139.76 129.15 13.79 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 111.923 0.342 . . . . 73.05 111.923 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.632 ' HG2' ' HB1' ' A' ' 37' ' ' ALA . 73.1 Cg_endo -77.52 117.85 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.531 2.154 . . . . 70.54 112.786 174.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.18 -177.8 25.36 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.797 -0.716 . . . . 74.44 113.539 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.1 tp -111.96 116.11 30.05 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.867 0.365 . . . . 74.13 111.223 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.9 t-20 -76.98 134.94 38.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.42 -0.354 . . . . 62.04 110.841 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -84.25 -40.09 18.46 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.731 0.641 . . . . 74.42 112.731 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -67.5 -30.47 70.16 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.124 0.416 . . . . 75.12 112.124 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -114.81 -28.69 6.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.92 0.341 . . . . 60.23 111.92 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 14.7 mmt85 64.14 28.93 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.159 0.504 . . . . 61.04 112.18 -176.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -91.03 143.86 26.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.993 -0.549 . . . . 61.11 111.204 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.519 ' NH1' ' H ' ' A' ' 68' ' ' GLY . 10.0 mmm180 -96.43 164.42 12.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 75.41 111.858 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.519 ' H ' ' NH1' ' A' ' 67' ' ' ARG . . . 139.61 -165.89 25.72 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.453 -0.794 . . . . 74.12 112.121 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -108.14 132.92 53.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.675 -0.309 . . . . 73.31 110.801 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -118.86 147.35 42.17 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.739 0.304 . . . . 73.22 111.199 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.87 103.6 1.75 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.384 2.056 . . . . 72.44 112.642 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -60.07 -14.99 34.48 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.503 0.561 . . . . 73.34 114.503 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -62.43 -18.4 61.62 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.841 0.682 . . . . 63.33 112.841 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.35 3.32 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.913 -0.492 . . . . 75.2 112.155 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 11' ' ' ALA . 15.0 m -120.96 159.5 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.178 0.513 . . . . 72.31 112.073 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.98 152.41 28.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.905 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -83.84 106.56 15.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.708 0.289 . . . . 73.22 111.22 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -72.65 -53.45 11.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.038 0.447 . . . . 74.43 111.099 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.58 -175.07 27.11 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.215 -0.517 . . . . 63.2 113.11 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.88 164.94 24.88 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.308 2.672 . . . . 70.22 112.636 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.434 HD23 ' HG3' ' A' ' 8' ' ' GLN . 2.3 pp . . . . . 0 CA--C 1.541 0.629 0 N-CA-C 112.048 0.388 . . . . 70.44 112.048 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 112.777 -0.129 . . . . 41.3 112.777 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -127.1 158.18 37.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.296 0.57 . . . . 74.42 111.944 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.05 127.44 56.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.902 -0.59 . . . . 73.35 111.369 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.2 163.25 14.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 64.03 110.143 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 10' ' ' ARG . 38.2 ttt180 -133.46 123.94 26.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.975 0.416 . . . . 62.44 111.59 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 25' ' ' LEU . . . -77.06 122.98 25.71 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.04 -0.527 . . . . 74.11 110.841 177.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.3 -60.11 2.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 61.51 111.915 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.452 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 91.8 m-85 -127.25 161.2 55.76 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-N 116.205 -0.452 . . . . 72.05 110.985 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_endo -63.7 135.15 47.33 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.01 1.806 . . . . 52.04 112.965 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 . . . . . 0 N--CA 1.468 0.458 0 CA-C-N 115.898 -0.592 . . . . 74.31 111.481 -177.089 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.6 tp . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.826 0.346 . . . . 65.43 111.304 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -62.48 119.97 10.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.087 0.47 . . . . 73.01 111.481 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 74.6 mt -100.35 143.11 30.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.456 . . . . 73.12 111.613 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.3 mm? -110.99 148.0 37.71 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.438 -0.346 . . . . 65.11 110.651 176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 36.2 Cg_endo -63.57 106.22 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.506 2.138 . . . . 73.11 113.311 -175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.02 34.49 23.92 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.038 -0.528 . . . . 60.2 113.62 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.43 ' CG ' ' HB2' ' A' ' 63' ' ' ARG . 33.2 t70 -105.56 158.91 16.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.175 0.487 . . . . 64.02 111.997 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -101.09 131.85 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 121.395 0.616 . . . . 61.42 112.391 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.0 mp -111.2 127.76 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.831 -0.622 . . . . 54.25 110.704 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.0 122.68 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.008 0.433 . . . . 63.44 111.517 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.79 116.46 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.277 -0.42 . . . . 75.12 111.253 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 55.4 m -89.23 156.65 18.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 72.41 111.176 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HG2' HD12 ' A' ' 38' ' ' LEU . 36.1 mtm180 -71.48 -14.66 62.2 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.722 0.268 . . . . 73.25 111.722 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.46 -35.74 20.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.011 0.434 . . . . 73.42 111.523 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.52 13.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.984 0.421 . . . . 64.45 111.56 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.542 HD12 ' HG2' ' A' ' 35' ' ' ARG . 90.0 mt -56.82 -38.43 72.6 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 75.41 112.164 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 14.8 mm100 -65.3 -37.69 87.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.904 0.383 . . . . 73.34 110.997 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -34.06 76.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.026 0.441 . . . . 62.41 110.989 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.556 HD11 ' HD2' ' A' ' 58' ' ' PRO . 75.2 mt -69.99 -28.5 65.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.104 -0.498 . . . . 75.1 111.118 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 41.81 6.05 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.353 -0.451 . . . . 75.0 112.598 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.64 129.78 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.886 0.374 . . . . 72.33 111.757 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 148.69 37.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.955 0.407 . . . . 60.41 112.029 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.55 122.43 12.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.205 -0.452 . . . . 71.24 111.151 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.13 2.77 60.59 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.023 -0.608 . . . . 73.41 112.836 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.27 -28.49 10.62 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.3 -0.476 . . . . 62.13 112.855 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -34.53 72.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.042 0.386 . . . . 64.51 112.042 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -63.56 -12.02 29.34 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.168 0.432 . . . . 74.42 112.168 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -134.55 85.55 36.86 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 120.819 0.343 . . . . 75.43 110.515 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 17.7 Cg_endo -55.94 -28.1 66.79 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.154 2.569 . . . . 74.13 113.284 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -62.4 -23.36 66.79 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.326 -0.397 . . . . 62.31 111.75 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -68.1 -45.31 74.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.097 0.475 . . . . 71.13 111.358 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.17 -46.44 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.155 -0.475 . . . . 61.44 111.459 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.0 -90.22 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.258 -0.496 . . . . 54.24 113.285 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -112.06 114.76 27.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.956 0.408 . . . . 75.42 111.906 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -124.26 138.43 30.86 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.436 -0.347 . . . . 61.11 111.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HD2' HD11 ' A' ' 41' ' ' LEU . 71.6 Cg_endo -77.93 127.94 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.411 2.074 . . . . 64.11 112.393 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.69 168.83 27.33 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.812 -0.709 . . . . 34.2 113.288 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 tp -103.88 124.02 48.19 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.764 0.316 . . . . 71.53 111.204 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -84.45 118.13 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.714 0.293 . . . . 72.52 110.666 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.3 -31.62 72.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.747 0.647 . . . . 63.43 112.747 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -63.37 -51.62 65.12 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.045 0.45 . . . . 72.23 111.847 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 82.6 p -102.43 -18.79 15.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.295 0.85 . . . . 75.21 113.295 -172.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER 69.58 17.97 7.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.934 0.494 . . . . 65.14 111.631 -173.343 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -84.13 149.27 26.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.116 0.484 . . . . 75.41 111.507 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 67' ' ' ARG . 50.1 mtp180 -111.23 150.71 29.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.122 -0.49 . . . . 74.05 110.679 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.62 164.08 27.49 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.503 -0.855 . . . . 72.44 113.647 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.03 109.58 20.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.126 -0.324 . . . . 73.23 110.126 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -106.72 143.75 27.66 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.24 0.459 . . . . 72.11 112.24 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.37 104.69 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.54 2.16 . . . . 71.33 112.079 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -61.03 -18.57 55.01 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.082 0.793 . . . . 74.12 115.082 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -58.65 -24.83 61.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.683 0.742 . . . . 74.34 112.149 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -100.66 11.66 39.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.647 0.61 . . . . 60.53 112.647 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.86 150.32 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.778 0.323 . . . . 64.21 111.078 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 14.7 pt-20 -98.94 153.72 18.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.04 0.448 . . . . 63.41 111.294 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -92.76 116.34 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.289 -0.414 . . . . 74.15 111.385 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.77 -67.42 0.78 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.883 0.373 . . . . 70.41 111.438 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.24 179.74 41.94 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.205 -0.522 . . . . 62.44 112.802 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.96 165.14 33.47 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.855 2.37 . . . . 63.2 113.369 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.994 0.426 . . . . 71.55 111.797 177.863 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.414 0 CA-C-O 120.634 0.019 . . . . 72.12 113.105 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -131.03 145.6 52.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.988 0.423 . . . . 64.12 111.507 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -93.05 134.03 35.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.146 -0.479 . . . . 61.32 111.534 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 123.99 41.17 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.524 -0.307 . . . . 72.41 110.987 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 78' ' ' LEU . 43.5 ttm180 -97.85 115.59 28.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.346 -0.221 . . . . 45.31 111.113 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.96 108.99 3.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.805 0.336 . . . . 61.11 111.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.91 -29.57 27.04 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.167 0.432 . . . . 61.33 112.167 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -124.2 135.48 26.47 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 122.353 -0.217 . . . . 73.02 111.574 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.5 Cg_endo -69.21 119.86 6.79 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.296 1.998 . . . . 61.43 112.638 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 t80 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 116.104 -0.498 . . . . 74.13 111.364 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 120.782 0.325 . . . . 44.13 111.244 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.86 138.92 46.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.193 0.52 . . . . 74.13 111.987 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 94.6 mt -106.24 137.59 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.103 -0.499 . . . . 72.24 111.598 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -120.72 142.84 35.14 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 122.452 0.301 . . . . 62.14 110.839 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 46.0 Cg_endo -66.44 117.6 4.85 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.565 2.177 . . . . 60.21 112.814 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.79 45.43 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.263 -0.494 . . . . 51.32 113.265 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.92 138.8 39.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.008 0.404 . . . . 61.25 110.742 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.96 97.68 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.98 0.419 . . . . 71.43 110.965 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.0 mp -81.1 127.15 32.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.999 0.428 . . . . 72.04 111.498 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.0 113.53 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.345 -0.388 . . . . 70.22 111.595 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -109.71 134.57 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.388 -0.369 . . . . 72.53 110.645 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -74.77 149.35 39.77 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.02 0.438 . . . . 52.15 111.586 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.5 -38.19 88.92 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.166 0.508 . . . . 64.42 110.285 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.44 80.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.735 -0.666 . . . . 73.55 111.613 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.83 -47.0 86.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.936 0.398 . . . . 71.24 111.129 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.01 -41.25 96.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.394 -0.366 . . . . 63.35 111.227 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -60.34 -37.28 80.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.953 0.406 . . . . 75.13 111.047 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.41 93.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.038 0.447 . . . . 60.35 110.838 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.78 -21.4 64.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.083 -0.508 . . . . 70.32 111.816 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.01 36.42 6.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.307 -0.473 . . . . 41.2 113.144 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.57 130.21 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.903 0.382 . . . . 44.22 111.146 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.76 150.41 20.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 62.13 111.802 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -48.44 121.37 4.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.974 0.416 . . . . 71.32 111.522 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.17 57.48 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.24 -0.505 . . . . 71.43 112.995 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.78 -28.18 4.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.319 -0.467 . . . . 74.12 112.966 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -31.29 64.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.174 0.59 . . . . 65.13 111.974 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.428 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 12.8 ptp180 -59.06 -13.69 7.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.687 0.625 . . . . 73.32 112.687 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 26.6 p -127.32 84.0 64.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 121.02 0.438 . . . . 63.44 111.276 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 -33.3 97.79 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.719 2.279 . . . . 52.21 112.562 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.679 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 90.6 mt-30 -58.64 -28.86 66.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.105 -0.498 . . . . 62.51 111.513 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 t -76.25 -33.42 59.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.853 0.358 . . . . 43.54 111.38 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.93 -58.55 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.9 0.381 . . . . 72.33 111.414 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.13 -137.15 12.46 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.515 . . . . 63.1 112.709 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.94 132.91 39.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.2 0.524 . . . . 61.52 111.686 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -132.41 147.64 66.48 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 116.12 -0.491 . . . . 55.51 111.593 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 126.4 8.56 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.503 2.135 . . . . 71.3 112.403 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.81 -175.25 24.89 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.475 -0.869 . . . . 45.4 114.131 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.88 117.12 24.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.335 0.254 . . . . 64.14 111.253 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -79.92 129.65 34.66 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.568 0.223 . . . . 62.33 110.493 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -92.39 -6.53 49.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.181 1.178 . . . . 64.32 114.181 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.64 -23.64 18.93 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.718 -0.614 . . . . 71.41 111.363 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -111.36 -16.93 13.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.04 0.448 . . . . 43.45 111.223 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 62.59 22.44 13.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.577 0.751 . . . . 73.31 111.568 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -101.21 149.19 24.25 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.073 0.463 . . . . 71.1 112.157 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -92.63 156.39 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.007 -0.542 . . . . 74.21 111.107 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.55 -172.35 44.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.593 -0.813 . . . . 70.15 113.453 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.06 125.58 54.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.611 0.364 . . . . 73.41 110.252 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -132.12 142.77 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 N-CA-C 111.93 0.345 . . . . 63.24 111.93 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.32 113.9 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.398 2.066 . . . . 72.34 112.36 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.39 33.02 0.97 Allowed Glycine 0 CA--C 1.53 1.0 0 N-CA-C 114.424 0.529 . . . . 74.24 114.424 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.679 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 43.4 m -92.52 -28.92 16.49 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.399 -0.471 . . . . 64.42 110.936 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.46 5.29 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.198 -0.455 . . . . 71.12 112.01 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 11' ' ' ALA . 19.1 m -117.64 145.39 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.783 0.325 . . . . 75.21 111.486 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 14.6 pt-20 -99.87 152.32 20.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.996 0.427 . . . . 71.15 110.972 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 49' ' ' ARG . 68.3 t80 -84.82 107.41 16.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.982 0.42 . . . . 74.3 111.09 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 10' ' ' ARG . 67.2 mt -76.93 -38.1 54.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.847 0.356 . . . . 55.33 111.24 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.68 -176.51 19.16 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.29 -0.481 . . . . 45.41 113.089 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.57 150.08 68.89 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.84 2.36 . . . . 61.33 112.259 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.4 mp . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.13 0.49 . . . . 71.42 111.204 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 112.573 -0.211 . . . . 63.05 112.573 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -133.36 137.0 45.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.91 0.386 . . . . 75.32 111.159 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.524 ' HG2' HG22 ' A' ' 32' ' ' VAL . 98.0 mt-30 -94.95 126.92 40.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.242 0.544 . . . . 75.31 112.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.87 123.98 49.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.961 -0.563 . . . . 74.22 110.091 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 10' ' ' ARG . 20.1 ttt180 -97.85 124.37 42.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.205 0.446 . . . . 74.11 112.205 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -69.13 126.63 30.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.915 0.388 . . . . 53.51 111.831 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.74 -55.37 4.01 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.233 0.457 . . . . 71.12 112.233 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -115.21 150.07 43.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 111.62 0.23 . . . . 73.41 111.62 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.2 Cg_endo -73.96 120.02 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.544 2.163 . . . . 73.21 113.872 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 73.11 111.053 175.393 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.9 tp . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 121.024 0.44 . . . . 74.3 111.292 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -78.26 149.89 33.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.165 0.507 . . . . 71.31 111.839 -176.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 84.2 mt -127.18 125.74 41.62 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.007 -0.542 . . . . 43.43 111.444 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.52 152.62 44.77 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-O 120.72 0.295 . . . . 61.31 110.359 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 42.5 Cg_endo -65.82 105.53 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.058 1.839 . . . . 75.53 112.463 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.55 10.06 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.106 -0.568 . . . . 71.22 113.433 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.03 118.29 6.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 117.008 0.404 . . . . 53.11 111.616 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.48 92.64 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.129 0.49 . . . . 71.11 110.566 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 5.9 mp -78.8 120.55 23.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 60.21 111.968 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 8' ' ' GLN . 48.3 t -93.09 111.95 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.105 -0.498 . . . . 74.13 111.654 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.07 122.45 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.328 -0.396 . . . . 73.21 110.937 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.9 p -68.07 139.73 56.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.995 0.426 . . . . 64.34 111.114 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -63.96 -32.37 73.88 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.874 0.369 . . . . 74.14 110.943 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.83 85.9 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.296 -0.411 . . . . 71.24 111.269 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.57 -43.5 93.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.002 0.43 . . . . 63.4 111.081 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.8 mt -58.98 -42.51 90.17 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.285 -0.416 . . . . 71.04 111.341 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.46 -37.12 86.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.933 0.397 . . . . 75.31 111.012 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.21 77.45 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.959 0.409 . . . . 75.41 111.484 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.572 HD11 ' HD2' ' A' ' 58' ' ' PRO . 88.9 mt -72.46 -20.86 61.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.248 -0.433 . . . . 71.13 111.526 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.61 28.61 35.04 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.323 -0.465 . . . . 71.53 112.763 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 41' ' ' LEU . 58.8 t -78.65 124.74 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.775 0.321 . . . . 61.13 111.356 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.71 139.29 53.39 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.998 0.428 . . . . 61.32 111.731 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.11 122.31 11.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.114 0.483 . . . . 61.33 111.121 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.82 -13.32 24.68 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.957 -0.64 . . . . 72.1 112.461 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.0 -25.27 49.77 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.347 -0.454 . . . . 74.4 113.408 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.433 ' OE2' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -58.91 -28.39 66.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.974 0.361 . . . . 71.51 111.974 -178.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HG3' ' OE2' ' A' ' 48' ' ' GLU . 50.1 mtm180 -56.48 -29.13 61.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.951 0.352 . . . . 72.21 111.951 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 71.0 m -133.28 84.85 46.05 Favored Pre-proline 0 N--CA 1.474 0.73 0 CA-C-O 120.953 0.406 . . . . 63.14 111.053 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.526 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 18.3 Cg_endo -57.94 -23.62 60.75 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.004 2.469 . . . . 73.24 113.491 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -60.25 -24.33 64.8 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.906 0.336 . . . . 74.52 111.906 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.3 t -66.48 -31.56 72.37 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.183 0.516 . . . . 74.02 111.609 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.12 -57.17 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.139 -0.482 . . . . 73.12 111.367 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.88 -88.88 0.5 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.257 -0.497 . . . . 51.33 113.185 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 7.4 m0 -103.18 107.33 18.1 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.343 0.497 . . . . 75.42 112.343 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -116.22 137.76 23.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.964 -0.562 . . . . 74.13 110.673 175.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.572 ' HD2' HD11 ' A' ' 41' ' ' LEU . 65.2 Cg_endo -74.67 117.76 5.07 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.311 2.008 . . . . 71.53 112.628 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.87 172.49 22.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.06 -0.59 . . . . 73.23 113.299 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 60.3 tp -97.66 114.36 26.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.93 0.395 . . . . 73.32 111.607 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 23.6 t-20 -74.53 123.08 24.12 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.382 -0.372 . . . . 61.24 111.711 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -72.63 -19.64 61.42 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.214 0.82 . . . . 71.55 113.214 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 1.5 tpm_? -66.05 -59.93 3.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.949 0.404 . . . . 75.43 111.337 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 66' ' ' GLN . 72.3 p -122.91 6.21 9.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.831 0.678 . . . . 71.25 112.831 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 0.1 OUTLIER 67.35 32.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.632 0.605 . . . . 73.31 112.632 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 83.7 mm-40 -79.19 130.57 35.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.742 0.306 . . . . 64.13 111.296 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -98.47 121.61 40.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.572 0.225 . . . . 74.5 110.707 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -175.03 -177.83 44.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.514 -0.85 . . . . 52.12 113.495 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 20.1 m-20 -88.23 119.94 29.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 73.1 111.194 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.5 p90 -114.8 145.77 34.65 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.432 -0.349 . . . . 72.21 111.07 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.53 109.46 2.76 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.426 2.084 . . . . 71.25 112.438 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.36 34.07 0.96 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.243 0.457 . . . . 32.32 114.243 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.0 p -102.87 -26.73 13.01 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.461 -0.435 . . . . 71.51 111.348 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.6 15.54 26.81 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 53.44 111.795 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 11' ' ' ALA . 24.2 m -118.73 161.3 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.933 0.397 . . . . 73.24 111.517 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.11 138.12 46.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.094 0.473 . . . . 52.4 110.919 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.463 ' CZ ' ' HA2' ' A' ' 79' ' ' GLY . 39.5 t80 -77.76 116.6 18.41 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.868 0.366 . . . . 41.41 110.963 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -86.43 -48.29 8.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.236 0.541 . . . . 74.33 110.78 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' CZ ' ' A' ' 77' ' ' PHE . . . 131.24 -165.22 23.2 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.849 -0.614 . . . . 50.05 112.502 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.55 166.36 19.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.332 2.022 . . . . 65.21 111.97 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 81' ' ' LEU . 6.3 mp . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 65.12 111.724 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.526 0.724 0 N-CA-C 113.026 -0.03 . . . . 65.11 113.026 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -130.12 148.22 51.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.616 0.366 . . . . 74.44 111.112 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.775 ' HG3' HD11 ' A' ' 81' ' ' LEU . 82.2 mt-30 -103.63 143.86 32.2 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.19 0.519 . . . . 70.4 112.018 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.542 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 87.9 m-85 -132.05 125.86 32.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.934 -0.575 . . . . 74.01 110.692 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HB2' HD11 ' A' ' 78' ' ' LEU . 43.5 ttp180 -98.58 116.52 30.99 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.005 -0.435 . . . . 74.24 111.82 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 113.88 7.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.919 0.39 . . . . 72.32 111.451 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.469 HD21 ' HG3' ' A' ' 76' ' ' GLU . 84.0 mt -77.92 -39.11 43.92 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.43 0.53 . . . . 64.0 112.43 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -126.32 145.81 54.02 Favored Pre-proline 0 N--CA 1.469 0.505 0 N-CA-C 111.718 0.266 . . . . 72.13 111.718 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 36.9 Cg_endo -65.88 131.62 27.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.434 2.089 . . . . 72.23 112.345 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 92.1 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.48 -0.327 . . . . 71.52 111.618 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 66' ' ' GLN . 43.1 tp . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.171 0.51 . . . . 73.24 112.046 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -101.31 166.32 10.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.073 -0.512 . . . . 52.43 111.228 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' PHE . 90.9 mt -114.99 142.51 46.53 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.675 0.62 . . . . 51.45 112.675 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -121.63 151.2 56.7 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 122.944 0.498 . . . . 70.21 110.658 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.5 Cg_endo -71.44 129.17 15.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.382 2.055 . . . . 74.31 113.261 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.28 22.83 75.34 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.223 -0.513 . . . . 73.42 113.105 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -105.97 157.85 17.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 65.14 110.846 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.88 133.25 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.252 0.549 . . . . 63.21 111.895 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.8 mp -121.38 139.23 53.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.094 -0.503 . . . . 54.31 110.533 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.4 HG22 ' HG2' ' A' ' 8' ' ' GLN . 57.1 t -106.26 124.86 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 120.983 0.42 . . . . 72.24 112.04 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.01 124.39 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.414 -0.357 . . . . 74.42 110.754 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.543 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 74.9 m -95.12 159.98 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.449 0.536 . . . . 65.13 112.449 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -50.79 -38.94 51.29 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.404 -0.362 . . . . 54.12 111.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.7 -37.44 41.38 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.122 0.416 . . . . 40.12 112.122 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -77.14 -49.14 15.88 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.933 0.397 . . . . 74.3 111.265 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 94.8 mt -58.52 -46.06 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.426 -0.352 . . . . 73.5 111.887 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -61.57 -35.71 78.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.602 0.239 . . . . 74.35 111.584 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.2 75.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.081 0.467 . . . . 65.54 111.046 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 60.5 mt -76.31 -28.7 57.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.2 0.524 . . . . 75.13 111.109 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.0 16.99 15.06 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.048 -0.523 . . . . 65.44 112.963 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 61.8 t -83.65 130.66 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.897 0.379 . . . . 70.35 111.094 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.54 152.61 25.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.252 -0.431 . . . . 44.41 111.811 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -40.62 111.97 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.786 0.435 . . . . 63.3 111.725 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.9 -17.11 7.71 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.401 -0.428 . . . . 73.32 112.501 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 -33.44 7.91 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.213 -0.518 . . . . 53.31 113.278 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -33.01 71.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.328 0.492 . . . . 73.51 112.328 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -68.06 -5.37 17.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.086 0.47 . . . . 62.32 112.009 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 89.7 m -141.37 81.94 14.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.271 -0.422 . . . . 74.04 110.444 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 18.8 Cg_endo -56.13 -16.21 16.34 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.125 2.55 . . . . 52.34 113.461 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -59.11 -31.21 68.72 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.728 0.299 . . . . 65.33 111.665 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.3 t -82.7 -23.91 33.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.732 0.301 . . . . 62.02 111.215 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.69 -44.86 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.975 0.417 . . . . 75.51 110.456 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 76.48 -76.53 1.5 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.147 -0.478 . . . . 72.41 113.389 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -121.3 129.2 52.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.945 0.402 . . . . 71.24 111.445 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -152.82 145.0 16.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.264 0.468 . . . . 63.4 112.264 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -90.07 124.86 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.928 2.419 . . . . 51.12 112.974 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.92 176.6 25.72 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.003 -0.618 . . . . 72.14 113.39 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.5 tp -97.48 132.12 43.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 74.0 110.868 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 24.5 t-20 -95.03 143.36 26.56 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.388 -0.369 . . . . 72.13 111.14 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -84.77 -55.79 3.92 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.607 0.595 . . . . 45.34 112.607 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -64.63 -56.0 16.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.229 0.455 . . . . 63.22 112.229 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 p -81.45 -17.06 50.09 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.88 0.326 . . . . 70.41 111.88 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 77.1 mtp180 61.64 18.11 9.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.004 0.522 . . . . 71.33 112.406 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 23' ' ' LEU . 96.5 mt-30 -86.53 164.68 16.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.256 0.551 . . . . 72.31 111.904 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -128.92 131.58 47.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.896 -0.593 . . . . 75.12 110.666 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.23 -170.28 43.31 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.381 -0.914 . . . . 61.4 113.764 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.18 123.19 33.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.424 0.29 . . . . 62.21 110.941 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.83 151.3 77.95 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.662 0.268 . . . . 53.14 111.432 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 88.1 Cg_endo -77.29 120.43 5.31 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.486 2.124 . . . . 64.55 112.91 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 51' ' ' PRO . . . -77.64 16.17 6.83 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.391 -0.433 . . . . 61.2 113.943 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -81.3 -20.65 40.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.251 -0.558 . . . . 61.21 111.615 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -104.88 12.3 32.67 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.368 0.507 . . . . 73.54 112.368 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 33.2 m -121.95 146.03 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 113.366 0.876 . . . . 71.33 113.366 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 5.8 mm-40 -93.68 130.74 39.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.605 -0.725 . . . . 71.43 111.524 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -70.36 100.21 1.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.041 0.448 . . . . 74.54 110.416 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 10' ' ' ARG . 64.0 mt -74.8 -47.69 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.365 -0.38 . . . . 63.33 111.376 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.78 177.02 22.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.639 -0.791 . . . . 54.4 113.885 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.27 137.61 12.06 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.545 2.83 . . . . 54.44 112.871 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 8' ' ' GLN . 5.8 mp . . . . . 0 N--CA 1.47 0.573 0 CA-C-O 120.869 0.366 . . . . 52.5 111.634 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.423 0 N-CA-C 112.166 -0.373 . . . . 32.33 112.166 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -131.55 146.15 52.08 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.129 0.49 . . . . 75.21 111.946 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.621 HE21 ' HB3' ' A' ' 81' ' ' LEU . 77.9 mt-30 -101.43 128.33 47.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.048 -0.524 . . . . 74.25 111.416 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.37 128.15 53.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.318 -0.401 . . . . 72.04 110.715 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.571 ' HB2' HD11 ' A' ' 78' ' ' LEU . 55.8 ttp180 -98.11 120.97 39.45 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.144 0.424 . . . . 62.31 112.144 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . . . -74.07 114.72 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.229 -0.441 . . . . 64.33 111.313 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -82.21 -43.67 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.17 0.433 . . . . 75.15 112.17 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.65 140.93 28.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 N-CA-C 112.122 0.416 . . . . 61.33 112.122 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 35.5 Cg_endo -65.74 123.59 11.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.444 2.096 . . . . 60.13 112.935 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.6 t80 . . . . . 0 CA--C 1.536 0.43 0 CA-C-N 116.186 -0.461 . . . . 74.51 111.313 179.816 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 61' ' ' ASN . 45.9 tp . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 70.03 111.78 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.53 142.41 30.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.431 -0.35 . . . . 64.2 110.84 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 66.2 mt -116.16 141.96 47.45 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.128 0.418 . . . . 41.01 112.128 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.86 153.51 46.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 122.721 0.408 . . . . 45.02 110.766 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 29.5 Cg_endo -61.69 117.21 4.01 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.602 2.202 . . . . 74.22 113.206 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.28 16.85 33.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.154 -0.476 . . . . 60.21 113.826 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 9.6 m-20 -77.22 135.67 38.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.877 0.695 . . . . 50.33 112.877 178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.24 97.06 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.15 0.5 . . . . 63.32 110.24 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.6 mp -81.98 132.89 35.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.097 0.475 . . . . 71.13 111.902 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 81' ' ' LEU . 66.8 t -94.05 109.41 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.047 -0.524 . . . . 71.32 111.142 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 117.91 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.011 0.434 . . . . 70.04 111.281 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.7 p -68.02 141.46 56.21 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.801 0.334 . . . . 73.0 111.519 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -67.01 -23.75 65.95 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.023 0.44 . . . . 74.04 110.803 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.24 89.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.182 -0.463 . . . . 70.3 111.191 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.93 -44.16 97.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.38 . . . . 73.55 111.288 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.84 -45.14 90.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.983 0.421 . . . . 64.0 110.654 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -59.77 -40.39 88.08 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.239 -0.437 . . . . 71.23 111.265 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.23 79.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.028 0.442 . . . . 64.2 111.537 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.18 -17.63 60.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.159 -0.473 . . . . 74.15 111.192 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 18.18 38.04 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.499 -0.382 . . . . 63.34 113.396 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.57 114.43 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.024 0.379 . . . . 71.3 112.024 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.59 151.04 20.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.383 -0.371 . . . . 55.44 111.098 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 146.05 5.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.278 0.561 . . . . 73.32 111.794 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.14 -26.3 24.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.77 -0.532 . . . . 5.12 111.77 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.86 1.47 17.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.508 -0.377 . . . . 71.22 112.673 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -38.41 90.98 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.089 0.471 . . . . 73.44 111.611 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -81.5 9.84 6.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.291 0.478 . . . . 61.13 112.291 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.0 m -122.39 72.9 39.26 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 120.85 0.357 . . . . 75.34 111.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 34.1 Cg_endo -63.66 -23.08 70.01 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.67 2.247 . . . . 74.02 112.773 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.44 -34.56 69.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.314 -0.403 . . . . 64.53 111.357 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -71.77 -41.61 68.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.93 0.395 . . . . 73.12 111.229 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.46 -38.33 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.123 -0.49 . . . . 55.05 111.594 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.95 -79.06 0.88 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.244 -0.503 . . . . 73.13 112.913 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -121.14 142.36 49.94 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.674 -0.309 . . . . 71.42 110.9 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 56.6 mtm -138.88 140.68 27.85 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.247 -0.283 . . . . 55.3 111.488 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.19 117.51 2.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.584 2.189 . . . . 75.03 112.524 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.72 178.26 26.41 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.732 -0.747 . . . . 73.2 113.77 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.24 132.67 50.25 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.961 0.41 . . . . 74.03 111.733 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.532 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.9 t-20 -99.98 149.25 23.64 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.271 -0.422 . . . . 74.44 111.348 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -92.01 -35.78 13.76 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.587 0.588 . . . . 74.31 112.587 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 13.8 tpp180 -56.72 -51.61 68.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.204 0.526 . . . . 75.21 111.315 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.9 p -100.14 -15.04 18.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.688 -0.687 . . . . 72.24 111.885 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtp180 64.2 18.08 11.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.795 0.438 . . . . 73.44 112.131 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -103.39 157.5 16.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.151 0.501 . . . . 72.21 112.228 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 67' ' ' ARG . 19.5 mtp180 -98.3 149.68 22.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.247 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.27 -178.72 47.62 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.93 -0.652 . . . . 74.12 112.894 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.13 124.99 40.35 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.595 0.236 . . . . 74.52 110.752 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -123.65 143.0 40.59 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 120.838 0.351 . . . . 63.44 111.668 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.66 116.07 4.24 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.659 2.239 . . . . 75.42 112.361 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -59.59 -17.57 41.5 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.715 0.646 . . . . 64.55 114.715 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.418 HG23 ' CD1' ' A' ' 74' ' ' TYR . 3.4 t -57.0 -32.46 66.14 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.799 0.666 . . . . 62.4 112.799 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.418 ' CD1' HG23 ' A' ' 73' ' ' THR . 95.9 m-85 -81.31 -16.9 51.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.663 0.616 . . . . 74.4 112.663 -177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -108.92 145.42 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.419 0.526 . . . . 54.42 112.419 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.53 154.71 24.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.058 -0.519 . . . . 52.0 110.857 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.07 126.51 33.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.824 0.345 . . . . 71.52 111.612 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 10' ' ' ARG . 83.9 mt -100.03 -68.11 0.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.056 0.455 . . . . 73.21 111.232 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.83 -178.69 46.78 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 60.23 113.103 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.84 166.21 30.61 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.293 2.662 . . . . 44.01 113.233 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.621 ' HB3' HE21 ' A' ' 8' ' ' GLN . 3.4 pp . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 112.306 0.484 . . . . 75.21 112.306 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.525 0.657 0 N-CA-C 114.421 0.529 . . . . 44.24 114.421 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.54 147.86 43.97 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.988 0.423 . . . . 73.31 111.412 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG2' HG22 ' A' ' 32' ' ' VAL . 45.9 mt-30 -92.75 133.11 36.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.899 0.38 . . . . 75.14 111.258 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -118.38 139.16 51.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.293 -0.412 . . . . 75.0 110.661 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 78' ' ' LEU . 36.1 ttm180 -107.99 127.69 53.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.947 -0.47 . . . . 74.12 111.984 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.37 128.2 33.99 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.457 -0.338 . . . . 74.43 110.592 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.6 mt -68.28 -62.15 1.53 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.372 0.606 . . . . 74.22 111.821 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.549 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.0 m-85 -118.19 171.91 4.67 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.979 -0.555 . . . . 63.12 110.314 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -70.8 117.73 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 120.902 1.068 . . . . 63.33 111.261 170.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 83.8 m-85 . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.306 0.574 . . . . 73.34 111.763 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 tp . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 120.888 0.375 . . . . 72.32 110.936 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mp0 -75.95 155.8 34.76 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.006 0.432 . . . . 65.2 111.393 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 97.5 mt -112.12 143.05 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.48 -0.327 . . . . 74.3 111.277 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.66 154.34 46.74 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 122.596 0.359 . . . . 71.44 111.116 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 120.45 7.97 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.454 2.102 . . . . 62.03 113.207 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.07 69.9 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.165 -0.47 . . . . 73.33 113.58 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.82 155.57 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.377 -0.484 . . . . 72.52 111.349 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.35 129.57 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.233 0.539 . . . . 41.55 112.056 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 4.9 mp -124.37 121.31 34.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.112 -0.494 . . . . 73.43 110.527 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.493 HG13 HD11 ' A' ' 81' ' ' LEU . 48.9 t -94.12 124.09 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.332 0.493 . . . . 65.33 112.332 -175.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.97 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 120.979 0.418 . . . . 44.34 111.265 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.492 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 50.5 m -68.28 142.39 55.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.993 0.368 . . . . 44.22 111.993 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 57.1 mtm180 -60.55 -30.43 69.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.986 0.422 . . . . 74.21 111.452 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.4 81.32 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.131 0.491 . . . . 74.31 111.009 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.83 98.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.114 -0.494 . . . . 72.35 111.298 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.3 mt -56.84 -46.82 81.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.918 0.39 . . . . 74.45 111.021 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.64 -39.69 92.22 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.396 -0.366 . . . . 54.43 111.442 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.94 91.45 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.952 0.406 . . . . 72.34 111.005 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -66.77 -28.63 68.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.234 -0.439 . . . . 73.51 111.462 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.31 27.6 9.15 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.424 -0.417 . . . . 61.25 113.042 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.3 118.48 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.96 0.41 . . . . 51.14 111.097 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.52 149.81 29.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.305 -0.407 . . . . 63.11 111.866 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.18 119.19 6.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.01 0.434 . . . . 73.3 111.086 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.77 -4.82 18.97 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.049 -0.523 . . . . 64.3 112.327 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.04 -33.28 2.41 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.697 -0.287 . . . . 62.25 113.1 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -21.19 28.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.989 0.515 . . . . 74.23 112.222 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.81 -21.25 41.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.416 -0.356 . . . . 63.53 111.714 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.54 88.42 29.21 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.664 0.269 . . . . 72.42 110.951 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.69 -16.94 26.82 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.98 2.454 . . . . 61.4 113.318 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -57.64 -22.39 45.33 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.818 0.342 . . . . 64.34 111.889 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.0 t -77.81 -9.75 59.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.798 0.333 . . . . 64.42 111.813 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 t -106.55 -37.81 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.085 0.469 . . . . 65.42 111.626 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.43 -78.19 0.84 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.227 -0.511 . . . . 53.23 112.798 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.41 54.58 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.087 0.47 . . . . 74.12 111.223 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 71.1 mtp -139.49 139.39 22.37 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.221 -0.445 . . . . 72.14 111.623 -172.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.1 Cg_endo -82.16 117.4 2.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.304 2.003 . . . . 65.31 112.464 174.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.55 171.55 25.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.775 -0.726 . . . . 65.03 113.697 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 40.0 tp -96.74 109.15 21.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.594 0.358 . . . . 61.14 111.043 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -79.72 116.61 20.0 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.46 -0.336 . . . . 71.11 111.546 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.9 -21.49 63.3 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.733 0.642 . . . . 72.42 112.733 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 63' ' ' ARG . 0.9 OUTLIER -60.58 -35.58 76.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.04 0.448 . . . . 73.54 111.325 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -119.57 -8.6 9.95 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.353 -0.385 . . . . 75.53 111.918 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 62.35 17.61 9.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 64.41 111.685 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -107.07 154.31 21.33 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.307 0.575 . . . . 72.31 111.931 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -101.18 134.67 43.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.948 -0.569 . . . . 72.24 111.219 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.0 172.11 34.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.979 -0.629 . . . . 73.11 112.985 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.7 113.18 25.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.906 0.384 . . . . 54.12 110.482 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.2 p90 -121.52 149.27 52.22 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.414 -0.357 . . . . 72.25 111.493 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 18.1 Cg_exo -66.29 95.15 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.355 2.037 . . . . 74.41 112.638 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.18 -19.69 40.0 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.085 -0.507 . . . . 40.14 113.534 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.0 t -61.79 -15.1 38.72 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.389 0.514 . . . . 63.22 112.389 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 35.8 m-85 -102.06 -1.54 31.44 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.623 0.601 . . . . 71.01 112.623 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.99 163.89 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.187 0.518 . . . . 73.13 112.153 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.08 148.75 41.25 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.106 -0.497 . . . . 73.51 111.714 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -79.02 118.22 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.071 -0.513 . . . . 75.02 111.642 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 10' ' ' ARG . 70.9 mt -89.97 -66.26 0.94 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 71.14 111.087 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.19 39.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.135 -0.555 . . . . 72.25 113.188 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.4 152.38 38.88 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.85 2.366 . . . . 61.31 113.083 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.493 HD11 HG13 ' A' ' 32' ' ' VAL . 4.9 mp . . . . . 0 N--CA 1.466 0.365 0 CA-C-O 120.883 0.373 . . . . 72.02 111.201 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.417 0 CA-C-O 120.876 0.153 . . . . 73.04 113.328 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.22 171.3 12.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.093 0.473 . . . . 64.11 111.358 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.91 136.81 49.92 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.19 0.519 . . . . 53.32 111.811 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 94.5 m-85 -116.05 170.74 8.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.852 -0.613 . . . . 71.32 110.601 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.4 ttm180 -135.75 128.69 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.569 0.223 . . . . 63.13 111.275 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -66.08 114.67 5.4 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 63.12 111.858 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.45 -58.33 3.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.167 -0.47 . . . . 75.41 111.569 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.67 150.21 44.38 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.595 -0.275 . . . . 73.25 111.228 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 56.3 Cg_endo -70.91 118.05 5.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.16 1.906 . . . . 75.1 112.657 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.4 t80 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 72.55 110.979 -178.827 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.7 tp . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 120.908 0.385 . . . . 74.5 111.161 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.56 138.15 37.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.409 -0.36 . . . . 75.13 110.799 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 70' ' ' PHE . 69.0 mt -122.69 138.7 54.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.866 0.365 . . . . 54.12 111.898 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.551 ' HB2' ' NE ' ' A' ' 63' ' ' ARG . 3.9 mm? -122.11 140.73 32.86 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 122.666 0.386 . . . . 42.22 110.568 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.91 106.31 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.423 2.082 . . . . 40.24 113.257 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.56 -1.05 8.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.086 0.794 . . . . 75.01 115.086 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.79 156.4 16.39 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.703 1.252 . . . . 70.4 111.903 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -101.87 133.71 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.755 -0.657 . . . . 55.4 111.401 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.1 mp -106.59 110.28 22.44 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.014 -0.539 . . . . 64.4 110.591 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.51 120.18 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.907 0.384 . . . . 73.31 111.832 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.93 135.27 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.388 -0.369 . . . . 54.44 111.473 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.7 p -91.96 148.22 22.37 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.247 -0.283 . . . . 53.03 111.283 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.401 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 24.7 ptt180 -58.43 -28.43 65.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.953 0.353 . . . . 53.25 111.953 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.35 -39.48 70.1 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.924 0.392 . . . . 61.13 111.639 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.12 77.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 51.03 111.33 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.84 -42.48 93.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 55.44 111.211 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 15.3 mm100 -61.9 -39.07 90.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.3 -0.409 . . . . 75.3 111.185 176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.03 96.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.945 0.402 . . . . 71.54 111.346 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD11 ' HD2' ' A' ' 58' ' ' PRO . 84.2 mt -66.69 -24.72 66.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.177 0.513 . . . . 61.51 111.084 175.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.13 20.68 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.879 -0.601 . . . . 32.12 113.177 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.0 125.03 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.946 0.373 . . . . 62.34 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.38 131.2 45.24 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.577 -0.283 . . . . 63.33 111.491 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.06 126.96 28.24 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.326 0.584 . . . . 74.15 111.188 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.1 -2.89 51.36 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.071 -0.513 . . . . 74.1 112.157 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.87 -7.73 16.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.64 -0.314 . . . . 62.43 113.312 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.5 -20.07 63.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.008 0.432 . . . . 62.11 111.732 -178.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -71.2 -13.7 62.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.463 -0.335 . . . . 74.44 111.738 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.77 84.58 31.66 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.829 0.347 . . . . 44.21 111.437 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.73 -27.19 68.24 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.504 2.136 . . . . 74.22 112.937 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 73' ' ' THR . 22.0 mp0 -67.18 -17.47 64.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.102 0.477 . . . . 52.24 111.285 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.0 m -87.31 -25.21 24.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.303 -0.408 . . . . 63.44 111.415 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.08 -55.16 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.95 0.405 . . . . 73.51 111.609 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.8 -92.23 0.5 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.17 -0.538 . . . . 33.55 112.573 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -121.14 141.44 50.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 72.55 111.788 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -138.17 146.9 53.76 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 116.534 -0.303 . . . . 62.0 110.948 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' HD11 ' A' ' 41' ' ' LEU . 91.6 Cg_endo -79.19 126.65 7.1 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.341 2.028 . . . . 64.31 112.838 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.06 172.88 31.33 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.006 -0.616 . . . . 65.31 113.535 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.8 tp -97.47 119.12 35.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.263 0.225 . . . . 71.42 111.472 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.468 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.0 t-20 -90.95 121.42 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.573 -0.285 . . . . 71.14 110.593 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -73.65 -8.1 54.61 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.849 1.055 . . . . 73.51 113.849 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.551 ' NE ' ' HB2' ' A' ' 26' ' ' LEU . 57.7 mtt-85 -81.7 -54.39 5.42 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.569 -0.707 . . . . 71.23 111.117 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 64.3 p -86.81 -11.59 50.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.492 -0.322 . . . . 75.42 111.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.65 16.94 9.3 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.131 0.573 . . . . 74.44 111.681 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 64' ' ' THR . 68.3 mm-40 -107.41 152.84 23.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.049 0.452 . . . . 74.53 111.456 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 129.6 45.13 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.036 0.446 . . . . 72.42 111.199 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.91 173.62 34.56 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.156 -0.545 . . . . 73.43 113.146 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.41 118.82 28.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.903 0.382 . . . . 75.11 110.83 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB2' HD11 ' A' ' 25' ' ' LEU . 54.0 p90 -117.31 148.79 43.36 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.035 0.383 . . . . 75.34 112.035 -176.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.88 109.25 2.83 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.569 2.179 . . . . 52.22 112.347 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.65 -17.95 60.89 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 115.079 0.791 . . . . 64.11 115.079 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.601 ' HA ' ' HG3' ' A' ' 52' ' ' GLN . 12.6 t -65.55 -15.28 62.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.791 0.795 . . . . 54.42 112.408 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -99.79 2.98 44.56 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.126 0.417 . . . . 74.42 112.126 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.5 m -123.98 153.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.002 0.429 . . . . 64.34 112.102 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 12.9 pt-20 -100.38 154.59 18.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.474 -0.33 . . . . 54.24 111.304 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -89.93 113.74 25.43 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.722 0.296 . . . . 54.02 111.102 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.12 -61.72 1.7 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.981 0.419 . . . . 74.11 111.526 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.23 -155.01 26.1 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.241 -0.504 . . . . 71.24 112.784 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.33 152.62 39.49 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.7 2.266 . . . . 74.33 113.176 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 112.75 0.648 . . . . 70.52 112.75 -178.514 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.609 0 N-CA-C 112.727 -0.149 . . . . 73.24 112.727 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.14 135.55 49.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.965 0.412 . . . . 74.1 111.085 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HG2' HG22 ' A' ' 32' ' ' VAL . 99.2 mt-30 -97.76 136.1 38.58 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.319 0.58 . . . . 72.3 112.456 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -113.26 169.28 9.06 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.735 -0.666 . . . . 73.22 110.382 174.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.538 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 16.1 ttm-85 -119.23 127.76 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.985 -0.447 . . . . 74.02 111.692 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.575 ' HB2' HD11 ' A' ' 31' ' ' LEU . . . -81.04 116.68 21.11 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.783 0.325 . . . . 64.04 110.564 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.09 -50.41 16.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 73.13 112.226 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -124.15 156.77 65.9 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 111.868 0.321 . . . . 72.33 111.868 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 55.9 Cg_endo -72.0 128.31 13.86 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.517 2.145 . . . . 62.25 113.496 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 CA--C 1.534 0.335 0 CA-C-N 116.037 -0.529 . . . . 64.22 110.915 178.245 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.539 HD21 ' HB2' ' A' ' 61' ' ' ASN . 42.9 tp . . . . . 0 CA--C 1.542 0.657 0 N-CA-C 112.407 0.521 . . . . 74.1 112.407 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -57.62 105.9 0.29 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.746 0.307 . . . . 72.34 111.776 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.7 mt -106.84 142.43 36.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.851 0.357 . . . . 61.4 111.38 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.3 150.69 44.87 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.473 -0.33 . . . . 71.51 111.394 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 44.9 Cg_endo -66.8 115.96 3.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.381 2.054 . . . . 75.41 112.629 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.23 21.76 53.88 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.109 -0.567 . . . . 73.21 112.815 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.5 162.17 14.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.008 0.432 . . . . 74.35 111.175 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.17 131.87 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.231 0.538 . . . . 64.15 111.334 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mp -108.07 116.84 32.69 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.876 0.37 . . . . 64.42 110.998 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 8' ' ' GLN . 60.9 t -93.68 108.73 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.996 0.427 . . . . 72.23 111.654 -177.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.88 128.76 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.339 -0.392 . . . . 74.1 110.697 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -71.28 147.33 48.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.968 0.413 . . . . 70.44 111.74 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -59.04 -35.48 73.38 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.969 0.414 . . . . 73.53 110.21 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.28 89.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 53.4 111.379 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -57.73 -47.87 81.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.842 0.353 . . . . 74.1 111.557 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.83 -45.24 94.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.695 0.284 . . . . 63.42 111.453 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.48 -37.87 82.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.874 0.368 . . . . 71.43 110.972 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.46 87.64 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.893 0.378 . . . . 72.5 111.401 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB2' HG23 ' A' ' 43' ' ' VAL . 90.8 mt -66.78 -20.16 65.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.986 0.422 . . . . 73.54 111.273 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.94 22.05 53.86 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.346 -0.454 . . . . 71.14 112.803 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 41' ' ' LEU . 60.3 t -68.43 104.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.036 0.446 . . . . 70.02 110.923 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 147.0 53.39 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.047 -0.524 . . . . 71.31 112.21 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -56.99 104.76 0.17 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.071 -0.513 . . . . 44.33 110.995 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.606 ' HA2' HH21 ' A' ' 49' ' ' ARG . . . 136.06 -18.77 3.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.877 -0.601 . . . . 64.15 112.372 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.18 -12.51 36.12 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.356 -0.449 . . . . 73.24 113.833 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -27.51 69.28 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.406 0.622 . . . . 74.1 111.331 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.606 HH21 ' HA2' ' A' ' 46' ' ' GLY . 36.1 mtm180 -80.27 9.15 6.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.963 -0.562 . . . . 74.13 112.069 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' NE2' ' A' ' 52' ' ' GLN . 50.0 t -138.37 75.2 39.73 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.16 0.505 . . . . 62.3 111.106 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.6 -34.4 74.84 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.687 2.258 . . . . 74.5 113.143 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.631 ' NE2' ' SG ' ' A' ' 50' ' ' CYS . 4.7 pp0? -64.88 -29.32 70.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.028 0.381 . . . . 73.12 112.028 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.523 ' HB2' ' SG ' ' A' ' 50' ' ' CYS . 31.7 t -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.848 0.356 . . . . 74.43 110.687 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.9 -40.26 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.925 0.393 . . . . 64.54 111.244 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.14 -133.09 11.39 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.2 -0.524 . . . . 75.22 113.456 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.523 ' HE3' ' HB3' ' A' ' 69' ' ' ASP . 37.3 m95 -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.011 0.434 . . . . 74.4 111.325 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.0 mtm -121.26 140.35 31.1 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.311 -0.404 . . . . 71.23 111.436 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD2' HD11 ' A' ' 41' ' ' LEU . 92.2 Cg_endo -78.91 121.04 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.551 2.167 . . . . 53.53 112.657 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.46 170.23 27.55 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.722 -0.751 . . . . 71.41 113.98 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.81 132.16 43.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.802 0.441 . . . . 71.25 111.57 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.539 ' HB2' HD21 ' A' ' 23' ' ' LEU . 28.2 t-20 -88.6 116.45 26.85 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.48 -0.327 . . . . 72.21 110.698 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.51 -19.51 65.8 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.119 0.785 . . . . 73.45 113.119 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -73.55 -64.29 1.02 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.342 0.591 . . . . 72.52 111.536 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 78.7 p -89.01 -21.41 23.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.986 -0.552 . . . . 72.41 112.412 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 64' ' ' THR . 3.0 mpt_? 70.57 19.12 6.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.151 0.58 . . . . 74.44 111.832 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -86.25 134.6 33.75 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.344 -0.389 . . . . 54.33 110.611 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -95.02 126.51 40.41 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.54 -0.3 . . . . 73.43 110.884 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.81 -164.03 11.93 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.913 -0.66 . . . . 34.44 112.903 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -109.76 152.98 24.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.878 0.371 . . . . 72.34 110.926 176.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 50.3 p90 -154.24 138.36 11.08 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.391 -0.368 . . . . 62.41 111.3 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 56' ' ' TRP . 13.6 Cg_exo -70.05 118.98 6.0 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.543 2.162 . . . . 74.35 112.132 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.56 9.15 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.572 0.589 . . . . 54.1 114.572 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -60.84 -16.67 43.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.036 0.754 . . . . 73.42 113.036 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HE2' ' HG2' ' A' ' 71' ' ' PRO . 74.6 m-85 -98.37 -4.05 35.68 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.607 0.595 . . . . 72.21 112.607 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.85 160.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.432 0.53 . . . . 64.05 112.432 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 11.4 pt-20 -110.06 151.99 26.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.348 -0.387 . . . . 75.33 110.776 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -82.62 119.03 23.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.849 0.357 . . . . 71.23 111.195 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.55 -61.57 1.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.963 0.411 . . . . 75.43 111.151 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.5 -169.16 33.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.179 -0.534 . . . . 70.15 113.088 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.72 173.24 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.611 2.207 . . . . 75.32 113.075 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 81' ' ' LEU . 6.0 mp . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 65.35 111.438 -179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.062 0 N-CA-C 114.305 0.482 . . . . 50.52 114.305 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -106.75 155.98 19.13 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.74 0.416 . . . . 71.22 110.945 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.48 123.28 46.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.824 0.676 . . . . 73.3 112.824 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.79 170.4 8.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.93 -0.577 . . . . 72.31 110.04 170.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -150.52 121.24 7.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.423 0.527 . . . . 74.42 112.423 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 151.48 29.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.345 0.593 . . . . 62.31 112.159 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.64 -29.41 12.33 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.284 0.476 . . . . 64.4 112.284 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -135.35 145.3 53.24 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-O 120.619 0.247 . . . . 73.51 111.329 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.0 Cg_endo -74.04 126.06 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.445 2.097 . . . . 60.21 113.902 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 . . . . . 0 N--CA 1.472 0.654 0 CA-C-N 116.05 -0.523 . . . . 75.15 110.681 176.814 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 58.6 tp . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 120.694 0.283 . . . . 64.22 110.386 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.11 106.85 3.89 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.883 0.373 . . . . 74.3 111.936 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 91.8 mt -99.78 144.86 28.36 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 70.34 111.712 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 25' ' ' LEU . 4.1 mm? -123.74 155.69 66.11 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 122.889 0.475 . . . . 63.05 111.033 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.9 Cg_endo -70.61 107.9 2.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.217 1.944 . . . . 74.04 112.993 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.69 40.97 11.5 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.147 -0.549 . . . . 63.53 113.183 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -99.72 175.12 5.91 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.073 0.463 . . . . 75.33 111.57 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -119.89 134.78 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.827 0.346 . . . . 63.1 110.732 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.06 122.24 42.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.647 0.261 . . . . 60.1 111.036 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.43 111.07 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.075 0.464 . . . . 64.31 111.242 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG22 ' HA3' ' A' ' 59' ' ' GLY . 48.2 t -111.73 119.2 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.455 -0.339 . . . . 52.13 111.529 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -58.95 127.1 30.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.764 -0.198 . . . . 64.02 111.077 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -52.27 -35.86 51.22 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.848 0.314 . . . . 71.23 111.848 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.44 65.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.535 -0.302 . . . . 51.24 111.799 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.949 0.404 . . . . 64.25 111.1 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 90.3 mt -62.77 -44.86 95.09 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.291 -0.413 . . . . 72.42 110.908 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.89 -23.87 66.73 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.219 -0.446 . . . . 70.33 111.514 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.86 54.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.11 0.481 . . . . 63.41 110.882 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.8 mt -68.39 -28.37 67.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.02 -0.536 . . . . 74.41 111.404 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.7 9.95 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.225 -0.443 . . . . 60.53 113.129 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.3 t -77.28 100.58 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.03 0.443 . . . . 73.12 111.144 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.3 149.91 37.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.227 -0.442 . . . . 31.42 112.127 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -46.16 129.91 10.14 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.58 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.82 -50.15 0.93 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.173 -0.467 . . . . 64.45 112.097 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -21.99 65.6 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.261 -0.495 . . . . 55.11 112.253 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.93 -31.2 27.75 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.415 0.686 . . . . 63.51 111.621 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -85.65 7.04 24.84 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.251 -0.431 . . . . 75.24 111.538 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.539 ' SG ' ' HG2' ' A' ' 52' ' ' GLN . 48.5 t -146.17 68.64 12.62 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 121.019 0.437 . . . . 74.4 110.92 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.79 -15.15 47.21 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.005 2.47 . . . . 63.32 113.259 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.539 ' HG2' ' SG ' ' A' ' 50' ' ' CYS . 20.2 pt20 -61.05 -19.46 61.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.367 -0.378 . . . . 53.24 111.886 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -81.89 -12.14 58.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.402 0.519 . . . . 74.44 112.402 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.38 -59.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.114 0.483 . . . . 73.24 111.747 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 118.06 -81.89 0.32 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.056 -0.593 . . . . 74.33 113.028 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.5 m0 -118.88 117.72 29.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.132 0.466 . . . . 74.41 111.638 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.442 ' N ' ' SD ' ' A' ' 57' ' ' MET . 2.7 mpp? -120.86 138.75 28.08 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.756 -0.202 . . . . 64.42 111.038 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.37 116.97 4.22 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 55.45 112.909 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.48 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -143.68 171.21 25.42 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.71 -0.757 . . . . 73.12 114.021 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.8 tp -103.89 123.23 46.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.687 0.395 . . . . 74.41 110.992 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -85.23 128.73 34.79 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.561 0.219 . . . . 70.54 111.447 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -80.64 0.86 32.38 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.385 0.883 . . . . 61.45 113.385 -177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -100.78 -47.73 4.72 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.777 -0.577 . . . . 74.15 111.446 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -96.92 -24.97 15.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.24 0.459 . . . . 53.41 112.24 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 63.41 23.98 13.95 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.193 0.52 . . . . 75.55 111.77 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -94.32 142.96 26.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.98 -0.555 . . . . 72.4 110.545 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -99.98 128.45 46.06 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.356 -0.384 . . . . 71.13 111.344 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.06 -178.15 40.28 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.051 -0.595 . . . . 32.15 113.109 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 3.7 m-20 -95.29 109.64 21.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.895 0.379 . . . . 71.35 110.8 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.2 p90 -100.09 142.38 24.5 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 120.843 0.354 . . . . 74.41 111.936 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 46.9 Cg_endo -68.31 111.51 2.52 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.695 2.264 . . . . 63.12 112.922 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -64.86 -8.71 35.84 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.498 0.559 . . . . 54.3 114.498 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.3 p -78.62 -13.83 59.62 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.2 0.5 . . . . 62.12 111.971 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.3 6.13 20.29 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.268 0.47 . . . . 73.43 112.268 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.534 HG22 ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -128.1 141.19 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.038 0.447 . . . . 74.3 112.187 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -92.23 159.76 15.48 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.331 -0.395 . . . . 61.1 110.428 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -105.09 124.38 49.43 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.017 0.437 . . . . 75.23 111.559 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.72 -59.62 2.13 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.146 0.498 . . . . 61.44 111.094 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.88 -172.65 27.32 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.427 -0.416 . . . . 51.04 112.749 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.3 134.92 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.23 1.953 . . . . 55.32 112.147 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp . . . . . 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 71.53 113.014 -177.055 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.919 0 CA-C-O 120.801 0.112 . . . . 64.44 113.064 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -139.8 155.33 47.33 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.317 -0.519 . . . . 71.5 111.14 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HG3' HD11 ' A' ' 81' ' ' LEU . 48.3 mt-30 -112.36 136.62 51.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.3 0.571 . . . . 62.21 111.76 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.456 ' CE1' ' HG3' ' A' ' 51' ' ' PRO . 87.9 m-85 -113.67 173.31 6.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.746 -0.661 . . . . 73.22 110.702 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -136.34 121.26 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.733 0.302 . . . . 74.43 111.372 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -70.92 125.5 27.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.026 0.441 . . . . 64.3 111.894 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.7 mt -81.21 -45.71 15.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.104 0.409 . . . . 73.2 112.104 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -137.33 158.5 72.18 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 116.467 -0.333 . . . . 64.1 111.061 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 37.8 Cg_endo -66.71 124.74 12.75 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.229 1.953 . . . . 73.14 113.377 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.5 t80 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 63.41 110.77 179.018 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 61' ' ' ASN . 58.6 tp . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 120.862 0.363 . . . . 70.53 111.656 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HB2' HG21 ' A' ' 64' ' ' THR . 12.1 mp0 -65.45 117.16 7.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.129 0.49 . . . . 71.14 111.769 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 55.1 mt -103.29 134.98 45.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 74.02 111.173 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.76 146.33 34.51 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 120.573 0.225 . . . . 74.24 110.989 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.04 125.04 14.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.396 2.064 . . . . 73.31 113.072 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.2 4.03 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 116.235 -0.439 . . . . 54.44 113.928 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -93.19 149.31 21.31 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 117.238 0.519 . . . . 75.51 111.105 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.59 132.5 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.321 0.582 . . . . 62.34 111.935 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.9 mp -103.81 116.56 32.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.976 -0.556 . . . . 62.24 111.015 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.66 118.01 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.986 0.422 . . . . 65.42 111.672 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.65 120.47 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.938 0.399 . . . . 73.32 111.413 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -67.68 148.44 51.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.371 -0.377 . . . . 53.52 111.803 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 8.3 tpp180 -55.12 -47.35 75.15 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.453 -0.34 . . . . 62.5 111.544 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.34 -32.41 48.97 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.469 0.544 . . . . 75.01 112.469 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.48 73.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.883 0.373 . . . . 75.41 111.045 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 41' ' ' LEU . 87.6 mt -65.18 -35.02 79.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.284 -0.416 . . . . 71.23 111.095 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 13.4 mm100 -60.58 -43.98 96.73 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.952 0.406 . . . . 72.02 110.699 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.32 -40.62 96.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.288 -0.415 . . . . 35.11 111.374 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.473 HD11 ' HD2' ' A' ' 58' ' ' PRO . 94.9 mt -62.98 -18.28 63.05 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.046 0.45 . . . . 52.45 111.343 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 38.71 20.94 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.088 -0.577 . . . . 73.23 112.639 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.45 122.83 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.016 0.436 . . . . 74.31 111.725 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.59 138.75 33.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.384 -0.371 . . . . 54.24 110.273 173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.18 117.57 3.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.208 0.528 . . . . 63.24 111.471 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.57 5.68 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.808 -0.633 . . . . 30.04 112.182 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.18 -38.62 3.74 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.7 -0.286 . . . . 72.3 112.779 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -23.8 56.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.771 0.428 . . . . 75.11 111.668 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -54.99 -21.96 13.65 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.484 -0.326 . . . . 74.1 111.715 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 53' ' ' SER . 22.1 p -115.84 81.5 9.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.966 0.412 . . . . 64.21 111.008 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 52.9 Cg_exo -54.94 -42.23 71.08 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.114 2.543 . . . . 72.15 113.183 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -60.97 -31.47 71.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.865 0.364 . . . . 75.32 111.371 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 39.3 t -73.79 -38.44 64.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.164 0.507 . . . . 74.11 111.095 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.23 -40.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.059 0.457 . . . . 73.04 110.995 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.67 -76.18 1.09 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.186 -0.53 . . . . 73.42 113.662 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -118.95 132.38 56.08 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.906 0.384 . . . . 73.52 111.33 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 68.5 mtm -144.91 131.98 10.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 O-C-N 122.208 -0.308 . . . . 55.33 111.668 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' HD11 ' A' ' 41' ' ' LEU . 97.2 Cg_endo -80.48 127.66 6.63 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.388 2.059 . . . . 72.24 112.502 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.79 176.69 34.02 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.634 -0.793 . . . . 74.03 113.614 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.73 131.29 55.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.573 0.349 . . . . 72.41 111.107 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 28.6 t-20 -96.67 149.17 22.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.457 -0.338 . . . . 74.31 111.002 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -91.98 -33.86 14.68 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.608 0.596 . . . . 65.2 112.608 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -64.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.153 0.501 . . . . 73.41 110.635 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 24' ' ' GLU . 62.3 p -75.21 -21.5 58.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.406 -0.361 . . . . 72.32 111.474 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 17.5 mtp180 58.34 20.54 7.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.63 0.604 . . . . 74.22 112.63 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.33 163.89 12.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.311 0.577 . . . . 62.12 111.712 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -107.9 129.65 55.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.672 -0.694 . . . . 73.3 110.682 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.04 -172.37 34.2 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.261 -0.971 . . . . 63.31 113.875 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.2 t70 -115.61 109.37 17.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.767 0.427 . . . . 72.41 109.881 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HB2' HD11 ' A' ' 25' ' ' LEU . 54.4 p90 -103.52 149.12 36.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 112.656 0.613 . . . . 73.42 112.656 -171.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB2' HG22 ' A' ' 73' ' ' THR . 74.2 Cg_endo -76.11 113.48 3.71 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.713 2.275 . . . . 64.33 112.412 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.01 -16.1 16.72 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.734 0.654 . . . . 70.32 114.734 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 71' ' ' PRO . 6.1 t -59.21 -33.38 70.9 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.343 0.572 . . . . 75.24 112.505 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 54.8 m-85 -89.49 5.03 47.25 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.905 0.706 . . . . 75.21 112.905 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 11' ' ' ALA . 28.2 m -127.48 148.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.149 0.499 . . . . 72.44 112.222 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.85 146.44 28.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.121 -0.491 . . . . 73.0 110.401 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -78.34 128.64 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.908 0.385 . . . . 73.32 111.674 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.66 -67.53 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.929 0.395 . . . . 73.41 110.923 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.74 -174.06 41.42 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.035 -0.602 . . . . 35.01 113.093 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.99 -176.83 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.706 2.271 . . . . 74.2 112.745 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 8' ' ' GLN . 4.6 mp . . . . . 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 62.31 111.163 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.43 0 N-CA-C 112.707 -0.157 . . . . 54.33 112.707 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -119.94 160.92 21.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.302 0.572 . . . . 74.42 111.615 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.503 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 98.3 mt-30 -107.74 126.86 53.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.833 -0.621 . . . . 53.34 111.034 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.27 130.16 55.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.922 0.391 . . . . 73.11 110.674 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.557 ' HB2' HD11 ' A' ' 78' ' ' LEU . 37.1 ttt180 -97.59 123.32 41.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.355 -0.384 . . . . 61.25 111.846 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.49 131.8 36.99 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.045 0.45 . . . . 72.32 110.978 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.27 -60.36 2.37 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.291 0.478 . . . . 64.14 112.291 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.6 m-85 -132.57 165.11 38.76 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.571 -0.286 . . . . 73.5 111.279 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 44.6 Cg_endo -68.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.813 1.675 . . . . 74.32 113.284 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 . . . . . 0 N--CA 1.47 0.552 0 CA-C-N 115.938 -0.574 . . . . 65.25 110.646 176.228 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 61' ' ' ASN . 18.9 tp . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 112.384 0.513 . . . . 64.15 112.384 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -65.22 151.92 44.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.328 0.585 . . . . 74.11 112.013 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.4 mt -118.31 134.51 54.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.818 -0.628 . . . . 61.44 110.34 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -114.94 154.99 47.02 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 120.828 0.347 . . . . 63.34 111.642 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.17 117.12 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.484 2.123 . . . . 72.23 113.22 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.68 79.83 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.2 -0.524 . . . . 65.54 113.304 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 63' ' ' ARG . 20.7 t0 -82.75 156.22 23.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.918 0.39 . . . . 72.41 111.782 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.7 t -117.36 118.89 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.103 0.477 . . . . 73.32 111.46 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -107.14 133.64 51.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.306 -0.406 . . . . 55.33 110.932 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.74 115.73 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.231 0.456 . . . . 72.14 112.231 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.38 118.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.835 0.35 . . . . 74.41 111.388 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -76.1 155.61 34.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.851 0.358 . . . . 70.41 111.947 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 38' ' ' LEU . 61.5 mtp180 -62.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.866 0.365 . . . . 74.14 110.369 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.47 80.75 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.221 -0.445 . . . . 73.44 110.914 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.62 86.34 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 71.1 110.909 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 35' ' ' ARG . 95.8 mt -59.0 -49.18 78.89 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.207 -0.451 . . . . 50.31 111.355 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -61.76 -34.56 76.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.933 0.397 . . . . 75.02 111.101 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.37 -22.11 66.76 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.893 0.378 . . . . 71.22 111.539 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.544 HD11 ' HD2' ' A' ' 58' ' ' PRO . 96.4 mt -85.64 -5.66 59.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.707 0.289 . . . . 72.4 111.516 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.77 43.88 82.49 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.791 -0.719 . . . . 71.51 112.366 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 143.66 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.933 0.397 . . . . 70.43 111.338 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.39 150.94 48.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.113 -0.494 . . . . 75.41 112.208 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.93 101.5 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.307 0.575 . . . . 74.44 112.19 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . 99.29 -9.52 61.12 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 116.085 -0.507 . . . . 71.45 113.685 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 1.24 46.7 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.167 0.427 . . . . 60.13 114.167 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -60.25 -18.23 47.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.383 0.611 . . . . 52.11 111.723 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 8.0 ptt180 -84.91 8.46 17.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.653 -0.703 . . . . 64.55 112.162 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.6 m -133.66 76.86 65.51 Favored Pre-proline 0 N--CA 1.475 0.785 0 N-CA-C 112.302 0.482 . . . . 72.31 112.302 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.16 -32.89 62.6 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.656 2.237 . . . . 71.1 113.061 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.43 -37.66 84.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.939 0.399 . . . . 74.12 111.137 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.5 t -61.8 -39.95 93.51 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.257 -0.429 . . . . 73.22 111.661 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 41' ' ' LEU . 45.3 t -75.75 -39.81 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.01 0.433 . . . . 74.21 111.546 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.22 -71.29 2.85 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.2 -0.524 . . . . 61.22 113.394 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -98.56 129.14 45.1 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.768 -0.254 . . . . 75.32 110.624 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 84.0 mtp -143.73 120.85 6.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 111.664 0.246 . . . . 71.23 111.664 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.544 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.0 Cg_endo -81.79 138.38 10.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.552 2.168 . . . . 74.44 112.375 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.17 176.77 40.81 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.743 -0.741 . . . . 71.53 113.199 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.0 tp -100.84 118.87 37.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.637 -0.331 . . . . 72.33 110.95 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.531 ' HB2' HD21 ' A' ' 23' ' ' LEU . 28.5 t-20 -87.78 100.31 12.75 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.93 -20.46 65.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.124 0.416 . . . . 64.14 112.124 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.431 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.1 tpt180 -58.83 -49.48 77.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.073 0.463 . . . . 73.35 111.31 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -110.45 -1.93 16.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.058 -0.519 . . . . 73.44 112.137 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 65' ' ' ARG . 4.7 mpt_? 63.55 20.52 12.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.759 0.423 . . . . 64.15 111.661 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -102.42 157.93 16.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.318 0.58 . . . . 61.04 111.792 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -103.8 151.25 23.28 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.96 -0.564 . . . . 75.41 110.501 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.66 -178.84 47.13 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.162 -1.018 . . . . 75.54 113.831 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.7 t70 -109.68 108.6 19.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.894 -0.41 . . . . 73.22 109.894 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 55.1 p90 -100.94 148.99 35.83 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 121.112 0.482 . . . . 72.31 112.253 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.5 101.1 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.436 2.091 . . . . 71.15 112.386 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.16 -17.45 30.73 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.242 0.457 . . . . 74.3 114.242 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -65.13 -14.2 59.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.731 0.641 . . . . 65.52 112.731 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.55 8.53 29.33 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.322 0.49 . . . . 65.43 112.322 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 m -125.22 155.86 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.157 0.503 . . . . 64.01 111.677 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -112.88 148.59 34.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.237 0.541 . . . . 64.22 111.51 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -78.16 119.25 21.28 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.077 -0.51 . . . . 74.14 111.046 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -90.17 -59.51 2.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.048 0.451 . . . . 52.44 111.291 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.23 -160.61 29.58 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.356 -0.449 . . . . 75.24 112.555 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.03 147.4 79.79 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.809 2.339 . . . . 71.43 112.775 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HB3' ' HG3' ' A' ' 8' ' ' GLN . 1.6 pp . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.654 0.613 . . . . 43.33 112.654 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.646 0 N-CA-C 112.086 -0.405 . . . . 54.14 112.086 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -136.78 156.93 47.86 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.334 0.587 . . . . 75.44 112.185 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -121.89 133.36 54.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.577 -0.738 . . . . 65.23 110.975 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.493 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 97.8 m-85 -122.91 137.51 54.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.59 -0.277 . . . . 73.1 110.879 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HB2' HD21 ' A' ' 78' ' ' LEU . 9.4 ttm180 -98.65 122.6 42.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.836 0.35 . . . . 74.12 110.585 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.51 16.66 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.951 0.352 . . . . 75.34 111.951 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.7 -46.82 8.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.813 0.34 . . . . 64.41 111.512 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.21 137.96 20.72 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 111.974 0.361 . . . . 62.44 111.974 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 73.0 Cg_endo -78.89 146.12 20.4 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.58 2.187 . . . . 51.41 113.418 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.544 ' HB2' HD12 ' A' ' 25' ' ' LEU . 92.1 m-85 . . . . . 0 N--CA 1.469 0.484 0 CA-C-N 116.203 -0.453 . . . . 71.21 110.828 177.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.447 HD23 HD21 ' A' ' 25' ' ' LEU . 37.3 tp . . . . . 0 N--CA 1.471 0.589 0 N-CA-C 112.286 0.476 . . . . 74.11 112.286 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.44 117.75 13.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.569 -0.287 . . . . 72.13 110.66 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 15' ' ' PHE . 15.0 mt -135.7 136.39 40.82 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.848 0.684 . . . . 44.5 112.848 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.3 157.21 44.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.381 0.672 . . . . 73.51 110.655 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 21.9 Cg_exo -64.88 108.95 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.213 1.942 . . . . 63.52 112.633 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.19 15.35 14.44 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.462 -0.399 . . . . 73.41 113.993 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.4 151.35 30.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.182 0.491 . . . . 70.24 112.094 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.41 120.23 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.134 -0.484 . . . . 53.31 110.493 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.3 mp -103.37 124.08 48.03 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.814 0.34 . . . . 61.02 111.403 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 81' ' ' LEU . 80.1 t -94.05 116.83 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.16 -0.473 . . . . 62.14 110.968 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.38 135.93 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.889 0.376 . . . . 71.14 111.229 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.1 p -86.82 133.78 33.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.698 0.285 . . . . 75.34 110.732 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -65.7 -25.4 67.3 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.097 -0.377 . . . . 71.03 111.07 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.25 -40.79 87.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.018 0.437 . . . . 71.12 111.19 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -62.73 -47.16 84.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.992 0.425 . . . . 74.21 111.029 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.53 -43.88 89.35 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.219 -0.446 . . . . 75.31 111.267 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -62.35 -38.26 88.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.846 0.355 . . . . 73.21 111.124 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.76 68.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.002 0.43 . . . . 73.23 111.344 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 92.5 mt -81.54 -4.68 56.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.379 -0.373 . . . . 73.35 111.659 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.03 13.36 79.45 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.269 -0.491 . . . . 62.34 113.421 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.7 t -74.12 109.09 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.924 0.392 . . . . 74.04 111.531 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.78 148.29 44.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.982 0.42 . . . . 72.53 111.932 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.67 119.04 4.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.091 -0.504 . . . . 71.11 111.344 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.15 -14.16 16.26 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.481 -0.39 . . . . 53.14 112.234 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.52 -26.84 10.38 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.53 -0.367 . . . . 74.2 113.172 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -27.11 69.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.082 0.468 . . . . 73.21 111.791 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -67.41 -15.46 63.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.482 -0.326 . . . . 51.53 111.704 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.7 m -132.78 69.36 79.34 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 120.908 0.385 . . . . 41.0 110.661 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.527 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 29.1 Cg_endo -60.57 -21.57 69.2 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.101 2.534 . . . . 62.24 113.819 -172.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -55.82 -25.14 40.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.885 0.374 . . . . 71.22 111.945 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -77.71 -17.02 58.05 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.953 0.353 . . . . 65.41 111.953 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.15 -20.39 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.035 0.445 . . . . 64.51 111.524 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.67 -110.34 3.94 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.356 -0.449 . . . . 73.22 112.35 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -121.38 143.84 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.155 0.478 . . . . 71.12 110.995 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 46.7 mtm -134.44 149.42 71.04 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 111.89 0.329 . . . . 63.33 111.89 -173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.37 123.21 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.594 2.196 . . . . 64.5 113.109 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.81 163.51 28.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.035 -0.602 . . . . 71.13 113.586 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.458 HD21 HH21 ' A' ' 65' ' ' ARG . 52.8 tp -107.22 124.7 50.13 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.556 0.342 . . . . 74.33 111.788 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -87.48 122.91 31.81 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.583 -0.28 . . . . 65.34 110.676 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -72.1 -15.0 61.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.56 0.948 . . . . 71.34 113.56 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -86.86 -67.95 0.78 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.675 -0.641 . . . . 71.1 111.246 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.3 p -71.56 -22.95 61.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.242 -0.435 . . . . 62.2 112.004 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.458 HH21 HD21 ' A' ' 60' ' ' LEU . 22.8 mmm-85 65.97 8.68 5.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.519 0.728 . . . . 65.3 112.286 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -78.53 149.49 33.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.845 0.355 . . . . 74.22 110.958 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -113.07 134.61 54.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.518 -0.31 . . . . 70.33 110.402 176.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.26 176.19 45.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.834 -0.698 . . . . 53.04 112.627 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.57 107.9 19.14 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.921 0.391 . . . . 73.31 110.518 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -97.45 140.15 21.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.553 -0.294 . . . . 75.35 111.46 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.06 116.69 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.549 2.166 . . . . 73.43 112.46 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -71.57 26.53 0.6 Allowed Glycine 0 CA--C 1.536 1.397 0 N-CA-C 114.61 0.604 . . . . 51.34 114.61 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -104.02 -32.14 9.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.538 0.669 . . . . 75.4 112.452 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.542 ' CZ ' HD13 ' A' ' 25' ' ' LEU . 20.9 p90 -88.59 4.81 45.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 111.859 0.318 . . . . 72.34 111.859 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 17.9 m -112.94 146.84 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.725 0.639 . . . . 72.4 112.725 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.504 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 9.4 pt-20 -102.98 138.67 39.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.62 -0.718 . . . . 52.51 110.146 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -75.41 115.32 14.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.833 0.349 . . . . 73.44 111.506 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 10' ' ' ARG . 82.3 mt -85.3 -55.97 3.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.19 0.519 . . . . 73.03 111.481 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.02 -155.97 26.43 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.856 -0.611 . . . . 73.24 111.962 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.69 178.61 5.41 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.66 2.24 . . . . 72.24 113.17 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.524 HD21 HG13 ' A' ' 32' ' ' VAL . 94.5 mt . . . . . 0 N--CA 1.471 0.605 0 CA-C-O 120.786 0.327 . . . . 73.33 111.723 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . . . . . . 0 CA--C 1.523 0.572 0 N-CA-C 112.82 -0.112 . . . . 63.52 112.82 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.99 155.99 38.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.194 0.521 . . . . 63.32 111.642 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB3' HD12 ' A' ' 78' ' ' LEU . 95.9 mt-30 -94.96 123.41 38.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.16 -0.473 . . . . 41.23 111.735 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.83 125.98 54.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.363 -0.381 . . . . 61.32 110.57 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HB2' HD11 ' A' ' 78' ' ' LEU . 70.6 ttt180 -97.79 120.49 38.27 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.682 0.277 . . . . 72.4 111.725 -176.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.4 119.99 13.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 53.14 111.47 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.86 -59.89 2.49 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.321 0.489 . . . . 63.15 112.321 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -127.09 156.83 73.81 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 116.362 -0.381 . . . . 63.42 111.149 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.62 119.16 6.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.089 1.86 . . . . 74.13 113.044 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.4 t80 . . . . . 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 54.25 111.029 179.158 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.604 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 23.8 tp . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 120.924 0.392 . . . . 73.4 111.256 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.75 140.57 42.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.901 0.381 . . . . 62.44 111.661 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.0 mt -100.75 131.36 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.612 0.597 . . . . 52.14 112.612 -173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.16 148.99 41.89 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 122.721 0.408 . . . . 72.32 110.52 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.42 105.51 0.9 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.398 2.065 . . . . 72.23 113.168 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.42 -4.61 21.58 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.148 -0.549 . . . . 62.02 113.857 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 130.89 44.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.197 0.499 . . . . 73.21 111.916 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.9 105.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.905 -0.589 . . . . 61.44 110.721 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.7 mp -89.94 130.81 36.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.57 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.29 106.22 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.327 -0.397 . . . . 74.34 111.312 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.44 118.45 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.766 0.317 . . . . 51.34 110.819 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.464 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 87.3 p -69.41 140.91 54.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 54.42 111.846 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -60.27 -28.09 67.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.197 0.522 . . . . 74.34 110.702 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.4 -44.5 96.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.983 -0.553 . . . . 65.32 110.924 174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.38 -45.45 91.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.839 0.352 . . . . 42.41 110.915 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 96.1 mt -54.23 -43.42 70.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.398 -0.365 . . . . 74.34 111.426 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.67 -42.47 92.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.453 -0.34 . . . . 65.21 111.283 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.27 92.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.045 0.45 . . . . 74.41 111.261 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.468 HD11 ' HD2' ' A' ' 58' ' ' PRO . 78.6 mt -66.55 -25.88 66.86 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.01 -0.541 . . . . 72.42 111.642 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.0 23.23 18.19 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.229 -0.51 . . . . 75.5 112.62 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.7 t -84.15 107.29 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.985 0.422 . . . . 72.1 111.054 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.58 149.84 46.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.069 -0.514 . . . . 54.0 111.901 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.8 113.92 3.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.023 -0.535 . . . . 73.34 110.852 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.55 -10.61 11.42 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.397 -0.43 . . . . 71.05 112.521 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.45 5.46 23.1 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.514 -0.374 . . . . 55.12 112.97 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -67.21 -23.75 65.77 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.223 0.453 . . . . 73.22 112.223 -177.098 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -77.98 -2.68 38.19 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.201 0.445 . . . . 74.22 112.201 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -118.19 86.29 26.46 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 74.23 111.819 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.6 -21.84 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.118 1.878 . . . . 60.41 111.996 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.37 -48.82 79.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.904 -0.589 . . . . 63.03 110.982 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -63.88 -28.07 69.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 74.13 111.066 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 57' ' ' MET . 95.7 t -69.86 -37.99 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.96 -0.564 . . . . 65.21 111.541 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.96 -79.55 1.79 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.095 -0.574 . . . . 71.33 112.982 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -120.88 124.01 43.92 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.656 -0.32 . . . . 64.41 110.963 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.43 ' HB3' HG11 ' A' ' 54' ' ' VAL . 8.6 ptp -136.25 147.96 62.46 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 120.653 0.263 . . . . 72.11 111.449 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' HD11 ' A' ' 41' ' ' LEU . 81.7 Cg_endo -88.03 140.67 4.92 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.765 2.31 . . . . 74.13 112.802 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.27 -172.71 17.74 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.505 -0.855 . . . . 62.54 114.027 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 65.5 tp -132.83 108.68 9.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.619 0.367 . . . . 71.41 111.269 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -79.26 129.5 34.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.827 0.346 . . . . 71.33 111.205 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.07 -23.27 65.84 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.142 0.423 . . . . 52.12 112.142 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -75.38 -53.55 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.04 0.448 . . . . 72.43 111.808 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -68.37 -26.62 65.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.399 0.518 . . . . 74.54 112.399 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 64.78 10.58 6.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.105 0.479 . . . . 65.45 111.268 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -127.38 160.72 30.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.11 0.481 . . . . 73.51 111.734 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -91.29 176.85 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.656 -0.702 . . . . 70.12 110.993 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . 159.46 168.42 21.45 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.095 -0.574 . . . . 43.51 113.01 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.32 127.49 43.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.613 0.245 . . . . 73.11 111.375 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.43 156.19 79.95 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 120.698 0.285 . . . . 73.4 111.421 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.3 120.9 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.468 2.112 . . . . 74.03 112.488 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.73 1.48 15.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.382 -0.437 . . . . 70.05 114.05 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 p -74.71 -17.43 60.66 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.37 -0.488 . . . . 63.11 112.289 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -108.28 17.52 22.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.864 0.69 . . . . 74.02 112.864 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.4 m -131.66 148.63 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.982 0.42 . . . . 51.03 112.119 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -108.65 151.08 26.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.217 -0.447 . . . . 71.35 110.892 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.06 115.26 21.12 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.806 0.336 . . . . 65.21 111.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.8 mt -83.2 -59.73 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.916 0.389 . . . . 71.11 111.467 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.07 -176.56 36.76 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.089 -0.577 . . . . 64.51 113.185 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.79 157.0 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.923 2.416 . . . . 51.32 113.106 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 81' ' ' LEU . 4.6 mp . . . . . 0 N--CA 1.473 0.719 0 CA-C-N 116.447 -0.342 . . . . 73.23 111.086 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . . . . . . 0 CA--C 1.522 0.5 0 N-CA-C 112.214 -0.354 . . . . 52.22 112.214 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -130.46 143.97 51.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.225 0.536 . . . . 73.23 111.625 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -92.73 131.02 38.16 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.732 -0.667 . . . . 71.11 112.116 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -123.78 153.85 40.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 73.23 110.069 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.1 ttm180 -127.42 119.75 26.86 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.778 0.323 . . . . 71.34 111.805 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -71.54 124.08 23.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.309 -0.405 . . . . 71.32 110.961 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.5 -21.2 19.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.443 0.534 . . . . 74.12 112.443 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.98 147.57 65.94 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 112.131 0.419 . . . . 73.42 112.131 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 55.7 Cg_endo -71.06 119.63 6.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.55 2.167 . . . . 72.4 112.172 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.3 t80 . . . . . 0 CA--C 1.538 0.506 0 CA-C-O 120.919 0.39 . . . . 73.14 111.49 -175.081 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.8 tp . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 110.415 -0.217 . . . . 74.24 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.0 113.32 3.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.127 0.489 . . . . 75.24 112.034 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.5 mt -103.26 138.74 39.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.245 -0.434 . . . . 71.55 111.25 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.499 HD23 ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -122.65 150.69 58.77 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 122.503 0.321 . . . . 71.32 110.933 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.94 117.83 4.64 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.685 2.257 . . . . 71.51 113.133 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.1 29.66 58.4 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.032 -0.531 . . . . 71.01 113.311 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.91 158.67 15.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.189 0.495 . . . . 71.24 111.155 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.04 132.56 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.135 0.493 . . . . 61.55 112.289 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.448 HD21 HD22 ' A' ' 25' ' ' LEU . 5.9 mp -121.88 111.42 17.08 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.249 -0.432 . . . . 72.25 110.975 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.558 HG13 HD21 ' A' ' 81' ' ' LEU . 18.0 t -94.96 106.05 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.839 0.352 . . . . 74.55 111.227 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.518 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.4 t -101.39 132.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.598 0.237 . . . . 75.31 111.591 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 143.07 45.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.272 0.558 . . . . 63.11 112.187 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -66.38 -33.05 74.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.056 -0.52 . . . . 71.31 111.124 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.09 73.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 74.41 111.392 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -69.68 -45.44 68.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.182 -0.463 . . . . 64.44 111.27 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.36 -39.83 80.62 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.354 -0.385 . . . . 61.12 111.507 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.27 -44.05 95.66 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.497 -0.32 . . . . 75.54 111.015 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.95 91.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.02 0.438 . . . . 75.03 111.227 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.602 HD11 ' HD2' ' A' ' 58' ' ' PRO . 81.2 mt -66.75 -29.2 69.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.251 -0.431 . . . . 63.02 111.498 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.57 31.87 12.5 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.265 -0.493 . . . . 63.21 112.833 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -73.37 123.26 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.924 0.392 . . . . 72.21 111.307 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.1 149.99 23.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.488 -0.324 . . . . 54.33 111.376 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.27 126.68 9.75 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 73.45 111.241 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -42.43 1.91 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.24 -0.505 . . . . 52.11 112.289 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.17 -26.25 61.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.035 -0.602 . . . . 74.21 112.198 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.626 ' HG3' ' HG3' ' A' ' 49' ' ' ARG . 9.3 pt-20 -52.05 -33.88 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.514 0.726 . . . . 75.51 111.297 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HG3' ' HG3' ' A' ' 48' ' ' GLU . 28.2 mtp180 -89.65 -3.04 58.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.715 -0.675 . . . . 63.24 111.654 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 65.8 m -136.83 72.45 55.32 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.434 -0.348 . . . . 75.14 111.021 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.91 -26.82 83.43 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.797 2.331 . . . . 71.03 112.836 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.745 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 73.3 mt-30 -62.95 -25.51 68.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.329 -0.396 . . . . 40.42 111.541 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.5 m -83.86 -31.41 25.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.475 -0.33 . . . . 71.54 111.787 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.45 -44.71 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.522 . . . . 74.35 110.908 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.87 -78.31 0.89 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.298 -0.477 . . . . 71.53 113.701 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -111.81 114.38 27.3 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.324 0.49 . . . . 63.32 112.324 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -126.42 134.61 26.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.372 -0.376 . . . . 72.14 111.011 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD2' HD11 ' A' ' 41' ' ' LEU . 95.7 Cg_endo -81.94 123.85 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.546 2.164 . . . . 71.31 112.205 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -148.25 176.43 27.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.634 -0.793 . . . . 62.14 113.756 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 tp -97.4 121.69 39.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.621 0.368 . . . . 75.52 110.919 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.97 121.51 34.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.747 0.308 . . . . 71.41 111.142 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -72.7 -27.04 61.83 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.19 0.811 . . . . 75.41 113.19 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.499 ' HG2' HD23 ' A' ' 26' ' ' LEU . 4.2 tpm_? -58.58 -52.58 65.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.009 0.433 . . . . 75.43 111.329 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 p -92.4 -15.83 26.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.014 -0.539 . . . . 62.33 111.506 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 60.13 24.38 13.67 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.119 -0.491 . . . . 74.1 111.681 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -118.72 161.12 20.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 71.24 111.5 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -92.45 150.67 20.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.162 -0.472 . . . . 63.54 111.524 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.85 -175.29 44.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.257 -0.496 . . . . 64.21 112.747 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.46 143.54 32.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.972 0.386 . . . . 72.44 110.528 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 55.1 p90 -139.92 143.12 33.22 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.111 0.411 . . . . 44.44 112.111 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 10.6 Cg_exo -72.41 118.32 5.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.864 2.376 . . . . 53.44 112.267 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -60.32 -14.45 33.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.451 0.54 . . . . 71.04 114.451 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.745 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 10.3 t -71.48 -5.65 34.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.619 0.6 . . . . 72.41 112.619 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -111.03 1.04 17.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.138 0.422 . . . . 74.01 112.138 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 11' ' ' ALA . 25.7 m -128.41 148.6 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.46 0.541 . . . . 61.43 112.46 -175.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 13.9 pt-20 -98.77 167.18 10.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.838 0.352 . . . . 63.42 110.717 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -99.04 123.28 43.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.946 0.403 . . . . 74.34 111.001 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 10' ' ' ARG . 74.7 mt -94.26 -46.97 6.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.945 0.402 . . . . 71.15 111.347 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.72 -179.74 18.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.267 -0.492 . . . . 32.34 113.246 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.79 142.91 40.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.484 2.122 . . . . 63.21 112.478 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.558 HD21 HG13 ' A' ' 32' ' ' VAL . 6.2 mp . . . . . 0 N--CA 1.471 0.609 0 CA-C-O 120.912 0.387 . . . . 74.32 111.569 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . . . . . . 0 CA--C 1.526 0.723 0 N-CA-C 115.3 0.88 . . . . 70.01 115.3 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.53 163.44 14.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.931 0.396 . . . . 62.22 111.323 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -108.01 126.23 52.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.399 0.618 . . . . 72.23 112.264 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.75 169.64 9.43 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.449 -0.796 . . . . 74.22 110.179 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' HD11 ' A' ' 78' ' ' LEU . 45.3 ttt85 -136.03 124.45 23.43 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.088 -0.382 . . . . 75.3 111.92 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.68 129.17 34.24 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.831 0.348 . . . . 73.42 111.391 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.0 mt -81.77 -49.61 10.21 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.371 0.508 . . . . 53.12 112.371 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 49.4 m-85 -124.87 164.4 31.51 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-O 120.481 0.182 . . . . 73.14 111.236 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.7 Cg_endo -74.34 119.91 6.01 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.264 1.976 . . . . 71.14 113.299 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 . . . . . 0 N--CA 1.471 0.625 0 CA-C-N 116.397 -0.365 . . . . 74.25 111.169 179.15 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp . . . . . 0 CA--C 1.54 0.579 0 CA-C-O 120.761 0.315 . . . . 72.34 110.975 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.63 154.6 35.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.67 0.748 . . . . 71.5 113.014 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 92.8 mt -116.13 139.02 50.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.213 -0.903 . . . . 63.31 110.581 175.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD22 ' C ' ' A' ' 25' ' ' LEU . 3.9 mm? -121.31 154.92 59.16 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 122.458 0.303 . . . . 71.14 110.586 174.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.9 115.52 3.64 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.405 2.07 . . . . 73.05 112.852 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.55 22.11 35.21 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.372 -0.442 . . . . 72.34 113.393 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.39 136.27 33.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.994 0.426 . . . . 70.22 111.797 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.19 125.46 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.254 -0.43 . . . . 71.12 110.538 174.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.6 mp -121.05 127.5 51.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.974 0.416 . . . . 74.14 111.587 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.19 122.4 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.356 -0.384 . . . . 53.21 111.294 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.51 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 84.6 t -109.5 125.07 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.695 0.283 . . . . 63.22 110.769 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -60.07 129.68 42.94 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.774 0.321 . . . . 71.33 111.782 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 17.5 ptm180 -57.37 -30.39 64.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.634 0.255 . . . . 75.51 111.379 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.96 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.908 0.385 . . . . 63.31 111.371 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.46 87.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.923 0.392 . . . . 64.22 111.111 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.22 -46.23 69.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.262 0.554 . . . . 70.03 110.818 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 35' ' ' ARG . 77.2 mt-30 -59.28 -52.07 67.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.697 -0.683 . . . . 73.24 111.433 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.39 97.43 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.212 0.449 . . . . 74.24 112.212 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.7 -28.8 70.2 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.763 0.316 . . . . 75.31 111.644 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 23.78 10.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.185 -0.531 . . . . 34.12 113.424 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.93 110.49 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.017 0.437 . . . . 70.1 110.835 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.27 149.88 37.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.28 -0.418 . . . . 62.24 112.122 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -52.06 127.98 23.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.168 0.509 . . . . 71.23 110.99 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.56 -44.61 1.46 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.289 -0.725 . . . . 61.42 111.289 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.87 -20.63 66.74 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.511 -0.376 . . . . 63.31 112.455 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.76 -43.69 58.37 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.503 0.668 . . . . 64.54 111.178 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -77.66 -5.23 49.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.765 -0.652 . . . . 74.12 111.751 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.46 71.26 66.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.657 0.614 . . . . 62.24 112.657 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 -24.24 75.02 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.919 1.746 . . . . 72.54 110.324 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 22.1 pt20 -55.11 -26.14 36.2 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.744 -1.117 . . . . 70.51 111.95 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -89.06 -33.6 17.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.824 0.345 . . . . 65.13 111.746 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.56 -58.81 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.132 0.419 . . . . 71.2 112.132 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.9 -116.61 3.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.012 -0.613 . . . . 54.52 113.341 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -102.41 127.85 49.26 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.289 -0.536 . . . . 75.03 111.267 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -134.23 148.48 68.0 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 111.63 0.233 . . . . 62.25 111.63 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.2 124.68 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.705 2.27 . . . . 74.54 112.735 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.01 -174.0 22.94 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.942 -0.647 . . . . 44.35 113.796 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 29.0 tp -106.71 115.3 29.96 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.123 0.569 . . . . 62.04 112.094 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t-20 -82.62 104.02 12.57 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.773 0.321 . . . . 62.14 110.346 173.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -68.0 -9.01 42.17 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.28 0.844 . . . . 74.21 113.28 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.454 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.1 ttp85 -81.47 -29.13 33.84 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.659 -0.651 . . . . 74.13 110.902 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -113.12 -11.61 13.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.247 -0.433 . . . . 74.42 111.694 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.89 14.3 9.5 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.073 0.549 . . . . 74.32 112.008 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -96.77 145.65 25.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.105 0.479 . . . . 64.43 111.789 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.45 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -104.72 130.19 52.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.958 -0.564 . . . . 73.02 110.568 177.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.29 -175.75 39.34 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.685 -0.769 . . . . 70.45 113.379 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.12 117.14 27.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.723 0.297 . . . . 73.32 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 40.9 p90 -122.27 148.54 52.5 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 120.904 0.383 . . . . 73.41 111.31 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 17.0 Cg_exo -67.17 91.97 0.33 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.399 2.066 . . . . 75.12 112.657 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.558 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -66.74 -10.01 53.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.203 -0.453 . . . . 54.51 113.729 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 52' ' ' GLN . 60.3 m -61.54 -30.25 70.52 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.445 -0.444 . . . . 74.3 111.529 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HD2' ' HB2' ' A' ' 71' ' ' PRO . 59.3 m-85 -93.85 4.71 53.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.015 0.746 . . . . 72.44 113.015 -174.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 72' ' ' GLY . 16.9 m -108.19 151.03 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.158 0.504 . . . . 73.42 111.965 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -102.14 158.26 16.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 73.42 110.692 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -89.6 124.19 34.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.919 0.39 . . . . 74.3 111.251 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 10' ' ' ARG . 85.6 mt -93.52 -45.14 7.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.093 0.473 . . . . 70.04 111.196 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.28 19.95 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.085 -0.579 . . . . 52.53 113.494 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.35 174.25 8.12 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.88 2.387 . . . . 73.24 112.696 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.486 0 CA-C-N 116.279 -0.419 . . . . 71.1 110.567 177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 CA-C-O 120.81 0.117 . . . . 34.25 112.856 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.407 ' HB3' ' HE1' ' A' ' 77' ' ' PHE . 92.3 m-85 -127.03 138.11 53.18 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.505 -0.409 . . . . 75.44 110.635 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HG3' HD11 ' A' ' 81' ' ' LEU . 98.3 mt-30 -92.6 131.1 37.99 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.702 0.63 . . . . 72.41 112.702 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.93 163.25 17.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.393 -0.821 . . . . 70.14 109.76 170.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HB2' HD11 ' A' ' 78' ' ' LEU . 40.9 ttm180 -140.69 125.59 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.986 0.365 . . . . 75.11 111.986 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.43 127.55 32.74 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.265 0.555 . . . . 73.41 111.174 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.57 -39.01 28.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.002 0.429 . . . . 63.43 111.518 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -130.65 141.09 40.71 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.258 -0.428 . . . . 71.24 110.76 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.3 Cg_endo -65.88 120.9 8.14 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.451 2.101 . . . . 74.2 112.923 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.6 t80 . . . . . 0 N--CA 1.468 0.436 0 CA-C-N 116.517 -0.311 . . . . 74.03 110.976 178.833 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.6 tp . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.054 0.454 . . . . 52.12 111.295 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -97.58 127.87 43.86 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.466 -0.334 . . . . 73.4 111.172 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.92 149.04 25.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.535 0.569 . . . . 62.04 112.535 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.86 155.94 54.6 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 75.5 110.65 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.1 Cg_endo -71.32 105.19 1.68 Allowed 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 121.607 1.538 . . . . 73.45 112.387 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.48 3.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.228 -0.51 . . . . 41.14 113.195 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -106.84 174.68 5.78 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.867 0.365 . . . . 74.31 111.623 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.35 113.72 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.786 0.327 . . . . 63.22 111.388 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.2 mp -105.15 130.46 53.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.583 0.23 . . . . 74.13 111.169 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.75 111.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.896 0.379 . . . . 72.0 111.22 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.73 128.6 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 122.649 0.38 . . . . 72.44 111.246 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -72.6 142.59 48.38 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.52 111.906 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -54.76 -36.08 64.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.399 -0.364 . . . . 74.24 111.826 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.82 73.79 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 111.904 0.335 . . . . 74.32 111.904 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.788 0.328 . . . . 55.2 111.58 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -54.51 -43.36 71.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.072 0.463 . . . . 62.0 111.443 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -69.34 -33.79 73.64 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.303 -0.408 . . . . 75.21 111.515 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.48 65.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.213 0.53 . . . . 61.54 111.138 175.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.425 HD13 HG11 ' A' ' 54' ' ' VAL . 76.8 mt -86.78 -10.13 54.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.997 -0.547 . . . . 64.24 111.28 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.69 33.19 63.59 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 23.32 113.142 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.03 135.08 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.942 0.401 . . . . 71.43 111.355 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.66 130.25 35.09 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.338 -0.392 . . . . 62.35 111.586 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -49.27 116.32 1.66 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.496 . . . . 74.12 110.776 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.61 2.26 25.79 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.286 -0.483 . . . . 72.12 112.636 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.89 5.9 32.63 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.52 -0.372 . . . . 60.04 113.281 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.97 -29.7 67.38 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.02 0.378 . . . . 72.14 112.02 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -80.54 -2.7 47.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.358 0.503 . . . . 71.33 112.358 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.2 m -128.33 64.37 67.01 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 120.89 0.376 . . . . 70.34 111.811 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 38.3 Cg_endo -65.17 -22.43 61.26 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.438 2.092 . . . . 70.33 112.174 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -62.87 -21.06 65.71 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.882 -0.599 . . . . 74.25 111.909 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.9 t -87.37 -4.05 59.03 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 75.33 111.701 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 41' ' ' LEU . 57.5 t -98.83 -54.51 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.89 0.376 . . . . 72.04 111.595 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.44 -120.28 4.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.305 -0.407 . . . . 74.14 112.39 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.3 m0 -92.09 111.59 23.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.814 0.34 . . . . 54.13 110.673 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 46.4 mtm -103.84 133.04 20.47 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.351 -0.218 . . . . 74.13 111.415 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 57' ' ' MET . 19.3 Cg_exo -67.23 117.67 4.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.871 2.381 . . . . 73.33 112.349 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.94 168.54 31.83 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.796 -0.716 . . . . 72.5 113.361 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.533 HD13 ' HE ' ' A' ' 67' ' ' ARG . 37.4 tp -112.63 114.1 26.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.744 0.307 . . . . 53.11 110.461 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 23' ' ' LEU . 50.7 t-20 -81.96 104.33 12.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.672 0.272 . . . . 74.11 110.989 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 19.0 mm-40 -69.95 0.46 5.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.447 0.906 . . . . 71.41 113.447 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.556 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 2.6 tpm_? -81.42 -43.51 18.83 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.972 -0.455 . . . . 74.32 110.515 171.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.1 p -107.8 -6.78 16.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.297 -0.41 . . . . 53.12 111.677 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 44.4 mmm-85 59.22 19.44 7.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.695 0.798 . . . . 74.3 111.779 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -95.32 145.58 24.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.108 0.48 . . . . 73.53 111.825 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.533 ' HE ' HD13 ' A' ' 60' ' ' LEU . 3.9 tpp180 -99.48 140.94 32.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.08 -0.509 . . . . 75.43 111.528 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.18 177.26 39.23 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.898 . . . . 62.0 113.657 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 5.4 m-20 -89.51 128.8 36.04 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.406 0.282 . . . . 73.42 110.597 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -119.02 141.29 30.01 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 122.107 -0.37 . . . . 74.23 111.844 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.88 113.38 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.729 2.286 . . . . 62.3 112.537 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.46 23.1 1.25 Allowed Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.027 0.771 . . . . 70.32 115.027 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.4 p -93.79 -18.6 21.87 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.807 0.803 . . . . 45.13 111.571 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -107.96 9.02 28.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.914 0.338 . . . . 71.45 111.914 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' HA2' ' A' ' 72' ' ' GLY . 25.3 m -122.51 151.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 112.632 0.604 . . . . 51.45 112.632 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.4 160.63 16.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.891 -0.595 . . . . 62.44 110.921 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 7' ' ' PHE . 26.6 t80 -93.07 115.37 28.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.035 0.445 . . . . 73.21 111.632 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 10' ' ' ARG . 87.2 mt -84.61 -44.17 13.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.731 0.301 . . . . 72.51 111.548 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.05 178.04 15.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.136 -0.554 . . . . 52.42 113.623 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.54 164.17 27.25 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.081 2.521 . . . . 54.01 112.802 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 81' ' ' LEU . 4.7 mp . . . . . 0 N--CA 1.473 0.676 0 CA-C-O 120.851 0.358 . . . . 71.42 111.384 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.1 mpp? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.736 0.303 . . . . 75.12 111.261 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.92 -42.49 17.61 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.91 0.386 . . . . 63.2 111.6 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 161.11 177.32 34.11 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.395 -0.431 . . . . 63.11 113.08 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -81.16 107.52 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.168 2.579 . . . . 75.12 112.522 177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -74.44 -22.9 58.89 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.063 0.459 . . . . 73.5 111.875 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.577 ' HA2' ' HG2' ' A' ' 35' ' ' ARG . . . -177.05 -152.8 10.18 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.999 -0.62 . . . . 53.42 113.122 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.5 ' HE2' HH11 ' A' ' 35' ' ' ARG . 94.4 m-85 -141.82 157.84 44.52 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.973 0.416 . . . . 74.34 110.901 178.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -118.58 132.85 56.2 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.287 0.565 . . . . 73.32 112.248 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -111.92 170.83 7.88 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.598 -0.728 . . . . 75.51 109.578 173.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 35.4 ttt180 -148.33 121.5 8.92 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 122.022 -0.424 . . . . 73.35 111.386 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.533 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -69.38 125.61 27.21 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.956 0.408 . . . . 54.12 111.938 -176.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.1 mt -94.7 -30.27 14.38 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.26 0.467 . . . . 73.55 112.26 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -126.87 141.41 40.44 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-O 120.56 0.219 . . . . 74.33 111.391 -176.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.541 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 70.3 Cg_endo -76.78 119.31 5.1 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.35 2.033 . . . . 63.24 113.326 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -136.91 125.87 24.28 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.084 -0.507 . . . . 75.2 110.712 176.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -74.43 148.04 41.48 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.148 -0.478 . . . . 54.53 111.045 -178.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.615 ' HG3' ' HB2' ' A' ' 24' ' ' GLU . 66.7 mtm180 -56.62 115.51 2.58 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.033 0.444 . . . . 53.13 111.922 176.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.33 -42.56 92.79 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.433 0.635 . . . . 64.4 110.48 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -124.99 153.58 71.19 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.504 -0.771 . . . . 71.11 109.962 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -52.75 -29.9 44.26 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 122.459 2.106 . . . . 73.25 113.521 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -92.68 5.9 49.36 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 112.188 0.44 . . . . 71.14 112.188 177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 17' ' ' ARG . 36.3 t70 -91.62 150.16 21.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.527 -0.546 . . . . 72.35 109.527 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.555 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.2 tp -105.56 134.46 48.65 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 121.226 0.536 . . . . 73.03 111.608 -178.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.615 ' HB2' ' HG3' ' A' ' 17' ' ' ARG . 13.5 tt0 -84.92 145.17 27.91 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.949 -0.569 . . . . 70.2 112.491 -170.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.541 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.2 mt -119.13 127.9 53.78 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 116.196 -0.456 . . . . 75.13 111.771 -177.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' HG ' ' HD3' ' A' ' 63' ' ' ARG . 4.3 mm? -123.36 143.44 41.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 122.559 0.344 . . . . 54.3 110.883 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.04 119.57 6.7 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.72 2.28 . . . . 75.22 113.443 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.45 -14.95 62.84 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 116.268 -0.424 . . . . 34.42 113.698 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -81.41 143.34 32.21 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 117.21 0.505 . . . . 64.23 111.744 -175.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.64 141.19 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 121.318 0.58 . . . . 71.04 112.27 -175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.5 mp -118.7 123.95 46.14 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.029 -0.532 . . . . 35.22 110.731 176.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 81' ' ' LEU . 57.9 t -94.88 124.21 47.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 111.976 0.361 . . . . 74.11 111.976 -176.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.4 t -126.28 139.79 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 120.952 0.405 . . . . 71.4 111.176 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.1 t -93.13 158.32 15.83 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.958 0.408 . . . . 70.32 111.835 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.577 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 17.3 mmm180 -55.34 -41.18 72.14 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.244 -0.435 . . . . 61.12 111.56 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.86 -45.84 71.08 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.01 0.374 . . . . 41.44 112.01 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.12 -51.02 70.87 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.882 0.372 . . . . 74.32 111.707 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.25 -40.63 97.95 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.807 0.337 . . . . 63.12 111.826 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -66.16 -35.77 81.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.815 0.34 . . . . 74.42 111.225 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.63 -32.36 73.38 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.035 0.445 . . . . 54.34 111.41 175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 84.4 mt -73.97 -22.35 59.67 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.176 -0.465 . . . . 71.33 111.465 176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.63 42.82 6.71 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.299 -0.477 . . . . 51.31 112.963 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.2 t -85.06 134.79 26.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 122.592 -0.358 . . . . 74.51 111.43 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -71.12 142.32 50.77 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.709 0.29 . . . . 75.34 111.133 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -60.93 108.33 0.85 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.051 0.453 . . . . 72.0 110.977 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 8.97 31.71 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 121.319 -0.467 . . . . 74.42 112.713 -174.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.31 -29.55 6.3 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.612 -0.328 . . . . 61.23 112.644 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.41 -31.63 64.08 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.971 0.508 . . . . 63.41 112.225 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -57.06 -16.43 7.3 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.172 0.434 . . . . 72.41 112.172 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.3 m -117.65 81.47 14.79 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.374 -0.375 . . . . 74.35 110.208 174.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -56.64 -36.15 97.9 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 122.942 2.428 . . . . 73.42 113.321 -173.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -19.08 61.38 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.005 0.372 . . . . 44.41 112.005 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.2 t -82.77 -20.0 36.73 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.971 0.415 . . . . 53.01 111.462 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.5 t -95.38 -36.2 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-O 121.107 0.479 . . . . 62.4 111.283 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.26 -133.63 11.6 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 116.235 -0.439 . . . . 41.43 113.005 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.85 129.9 37.71 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.111 0.482 . . . . 73.41 111.274 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 69.1 mtm -131.46 140.37 38.22 Favored Pre-proline 0 N--CA 1.471 0.608 0 CA-C-N 116.483 -0.326 . . . . 65.11 111.615 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.47 118.97 4.0 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.689 2.259 . . . . 72.22 113.05 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.28 -174.71 23.89 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 120.863 -0.684 . . . . 54.41 113.892 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.1 tp -110.06 130.48 55.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 122.635 0.374 . . . . 52.22 111.338 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -97.59 143.64 28.07 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.729 0.3 . . . . 72.24 111.414 177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -79.05 -52.29 8.41 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 113.166 0.802 . . . . 73.11 113.166 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.466 ' HD3' ' HG ' ' A' ' 26' ' ' LEU . 58.2 ttt180 -62.73 -40.47 97.29 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.843 0.683 . . . . 71.1 112.843 -175.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.4 p -92.26 -17.11 25.23 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.068 0.395 . . . . 63.25 112.068 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.64 17.82 6.57 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.613 0.365 . . . . 72.3 111.57 -174.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -98.71 159.14 15.15 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.29 0.567 . . . . 64.14 112.143 -176.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -121.88 135.05 54.87 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.779 -0.646 . . . . 73.23 111.297 -177.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.18 -171.73 44.08 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 120.669 -0.777 . . . . 73.33 113.04 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -88.95 121.69 31.57 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.794 -0.239 . . . . 51.3 111.228 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.555 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 50.4 p90 -111.92 143.74 29.3 Favored Pre-proline 0 N--CA 1.47 0.533 0 CA-C-O 120.566 0.222 . . . . 73.42 111.151 178.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.85 104.18 0.79 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 122.215 1.943 . . . . 62.11 111.88 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.78 36.71 1.03 Allowed Glycine 0 CA--C 1.529 0.929 0 N-CA-C 114.255 0.462 . . . . 73.43 114.255 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.6 p -104.52 -30.22 10.17 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 122.125 -0.632 . . . . 55.01 111.23 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -93.43 11.25 29.1 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 116.217 -0.447 . . . . 75.43 111.614 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 11' ' ' ALA . 24.1 m -118.51 145.06 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 112.36 0.504 . . . . 63.4 112.36 -174.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 15.0 pt-20 -93.07 170.72 9.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.928 0.394 . . . . 70.45 110.844 174.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -102.69 129.73 49.39 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.427 -0.351 . . . . 72.23 110.947 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.3 mt -98.96 -51.15 3.94 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.101 0.408 . . . . 71.15 112.101 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.18 -175.1 33.27 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 120.714 -0.755 . . . . 61.23 113.584 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.45 146.99 12.44 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.006 2.471 . . . . 75.21 113.922 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 32' ' ' VAL . 90.2 mt -78.02 116.91 18.85 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.017 -0.538 . . . . 74.01 111.088 175.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 . . . . . 0 C--O 1.255 1.382 0 CA-C-O 118.737 -0.649 . . . . 64.4 111.195 177.412 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 50.9 ttm . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 120.644 0.259 . . . . 74.23 111.161 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.86 -57.61 3.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.904 0.383 . . . . 74.23 111.542 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 143.16 -175.45 23.24 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.387 -0.435 . . . . 55.13 112.975 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.94 47.64 1.78 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.072 2.515 . . . . 74.21 113.045 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -57.86 -33.24 68.46 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.264 0.554 . . . . 64.02 111.743 -178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -164.86 161.23 34.52 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 121.302 -0.475 . . . . 71.32 112.972 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' HA ' ' HA ' ' A' ' 80' ' ' PRO . 94.0 m-85 -110.01 153.57 24.4 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.886 0.374 . . . . 71.54 111.154 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -116.54 126.89 53.96 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.148 0.499 . . . . 64.4 111.575 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -111.77 168.25 9.72 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.91 -0.586 . . . . 64.55 110.717 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.502 ' HB2' HD11 ' A' ' 78' ' ' LEU . 31.2 ttt85 -124.01 118.95 28.16 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 122.3 -0.25 . . . . 70.35 111.11 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.556 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -67.92 117.78 10.25 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.989 0.423 . . . . 72.13 111.567 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD21 ' HG2' ' A' ' 76' ' ' GLU . 51.9 mt -89.83 -41.02 12.07 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.006 0.432 . . . . 73.12 111.705 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -127.76 149.53 70.76 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.261 -0.427 . . . . 74.02 111.121 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.9 Cg_endo -72.68 152.75 53.73 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.511 2.14 . . . . 60.15 113.469 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 80.1 t80 -143.42 129.95 20.12 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.201 -0.454 . . . . 73.34 110.444 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 67.5 mtt180 -104.06 160.12 15.11 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.06 0.457 . . . . 64.53 112.15 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.816 ' HG3' ' HG3' ' A' ' 24' ' ' GLU . 59.9 mtm180 -97.91 128.14 44.31 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.59 0.589 . . . . 75.1 112.59 -175.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.791 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 10.5 pt-20 -87.03 -19.58 28.44 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.363 0.601 . . . . 62.41 110.315 169.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.791 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 89.2 mtt180 -132.77 153.25 80.99 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-N 115.797 -0.638 . . . . 75.12 111.111 -178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.12 -27.97 84.94 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.407 2.071 . . . . 71.43 112.816 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -78.42 -5.89 53.68 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.433 0.531 . . . . 60.33 112.433 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.557 ' HB3' ' HG2' ' A' ' 17' ' ' ARG . 4.3 t0 -84.87 177.36 8.0 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 110.121 -0.326 . . . . 61.24 110.121 -178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 44.6 tp -129.84 126.12 37.29 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.695 -0.628 . . . . 73.5 112.377 -177.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.816 ' HG3' ' HG3' ' A' ' 17' ' ' ARG . 44.1 mt-10 -87.0 131.29 34.13 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.064 0.459 . . . . 51.43 111.564 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 HD21 ' A' ' 31' ' ' LEU . 64.3 mt -119.61 138.12 53.43 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.804 -0.634 . . . . 74.4 110.82 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.405 HD22 ' C ' ' A' ' 25' ' ' LEU . 3.9 mm? -118.36 145.65 37.73 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 120.836 0.351 . . . . 71.53 110.834 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.61 106.26 0.59 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.319 2.013 . . . . 72.44 113.14 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.73 -21.35 4.47 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.329 -0.462 . . . . 61.14 113.245 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -63.67 142.28 58.46 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.552 0.575 . . . . 63.23 112.552 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.4 t -95.73 98.78 8.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-N 115.847 -0.615 . . . . 75.14 110.517 174.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD22 HG11 ' A' ' 75' ' ' VAL . 6.9 mp -78.78 116.54 19.19 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.91 0.386 . . . . 72.55 111.775 -175.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 67.8 t -94.35 117.23 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.947 0.403 . . . . 65.41 111.5 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.462 HG22 ' HA3' ' A' ' 59' ' ' GLY . 96.1 t -115.84 123.23 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-N 116.299 -0.409 . . . . 72.44 111.132 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.1 m -66.45 131.08 45.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.832 -0.167 . . . . 43.42 110.829 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 34.5 ttp180 -54.68 -33.92 61.53 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.965 0.357 . . . . 74.21 111.965 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.82 -35.79 66.75 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 120.888 0.375 . . . . 62.03 111.856 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.481 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -64.23 -34.88 79.12 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 120.81 0.338 . . . . 72.43 111.686 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.93 -42.92 99.08 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.964 0.412 . . . . 53.1 111.096 178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -67.68 -35.34 78.65 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.753 0.311 . . . . 61.23 110.931 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.41 -33.78 74.27 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.003 0.43 . . . . 62.44 111.489 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.635 HD21 ' HD3' ' A' ' 58' ' ' PRO . 96.1 mt -74.98 -28.75 60.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.893 0.377 . . . . 73.13 111.805 176.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.76 35.17 8.55 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.115 -0.564 . . . . 63.31 112.239 -174.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -75.72 127.39 37.13 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-O 120.727 0.299 . . . . 50.33 111.184 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.3 146.16 54.91 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.984 0.421 . . . . 41.24 111.233 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.87 121.64 12.25 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.144 0.497 . . . . 74.31 111.223 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.39 -15.98 60.49 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.154 -0.546 . . . . 73.01 112.739 -175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.61 -17.26 48.18 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.627 -0.321 . . . . 75.02 113.394 178.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -53.67 -21.11 6.3 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.461 0.648 . . . . 74.53 111.585 175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -63.81 -11.26 25.5 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.517 0.562 . . . . 75.11 112.517 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 26.6 p -161.01 91.7 1.54 Allowed Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 112.042 0.386 . . . . 70.33 112.042 178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 50' ' ' CYS . 11.9 Cg_endo -55.05 -23.79 37.14 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.985 2.456 . . . . 74.12 112.94 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.19 -43.27 74.21 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.747 0.308 . . . . 72.24 110.776 177.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 73.7 m -65.85 -15.37 62.84 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.381 0.511 . . . . 63.31 112.381 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.1 t -85.16 -30.33 6.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-O 120.991 0.424 . . . . 71.31 111.417 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.29 -92.24 1.78 Allowed Glycine 0 CA--C 1.525 0.703 0 C-N-CA 121.116 -0.564 . . . . 74.54 113.145 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 11.8 m0 -108.56 131.51 54.77 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.935 0.398 . . . . 70.55 111.279 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 66.4 mtp -133.16 132.64 22.34 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-N 116.275 -0.421 . . . . 74.31 110.938 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.635 ' HD3' HD21 ' A' ' 41' ' ' LEU . 92.8 Cg_endo -87.28 118.07 1.32 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 122.677 2.251 . . . . 65.22 112.852 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.462 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.16 179.09 28.12 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.815 -0.707 . . . . 22.22 113.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.7 tp -103.86 124.51 49.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 122.459 0.304 . . . . 71.22 111.394 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.8 t-20 -87.25 149.03 24.85 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 116.594 -0.275 . . . . 65.03 110.771 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -92.11 -28.61 17.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.537 0.94 . . . . 74.11 113.537 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.89 -58.79 3.06 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.595 0.712 . . . . 74.42 110.808 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 24' ' ' GLU . 64.4 p -81.87 -21.71 37.34 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.546 -0.752 . . . . 70.44 111.634 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 13.7 mmt85 57.54 31.21 19.95 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.279 0.562 . . . . 70.41 111.98 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -98.31 135.77 39.44 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.811 -0.631 . . . . 73.21 110.161 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -97.58 121.22 39.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 109.976 -0.379 . . . . 71.04 109.976 174.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -169.96 -172.11 36.14 Favored Glycine 0 CA--C 1.524 0.599 0 C-N-CA 120.647 -0.787 . . . . 52.51 113.568 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -89.86 132.21 35.39 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 120.847 0.356 . . . . 74.31 111.255 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.418 ' HB2' HD11 ' A' ' 25' ' ' LEU . 53.2 p90 -138.45 150.17 65.41 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.758 0.313 . . . . 71.11 111.482 -178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.79 110.26 2.31 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.188 1.925 . . . . 64.04 112.425 174.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.49 -11.5 35.05 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 114.598 0.599 . . . . 32.22 114.598 -175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.0 t -72.52 -8.18 53.82 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 117.517 0.658 . . . . 74.51 112.361 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -94.7 -2.91 50.3 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.065 0.395 . . . . 75.04 112.065 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.557 HG11 HD22 ' A' ' 31' ' ' LEU . 18.9 m -127.24 149.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 112.437 0.532 . . . . 65.21 112.437 -175.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.418 ' HG2' HD21 ' A' ' 12' ' ' LEU . 11.6 pt-20 -104.23 158.94 16.1 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.345 -0.388 . . . . 75.12 110.451 173.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -89.45 127.79 35.88 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.016 0.436 . . . . 71.34 111.702 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' A' ' 10' ' ' ARG . 90.2 mt -98.66 -65.9 0.93 Allowed 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.118 0.485 . . . . 74.24 110.968 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.18 169.23 32.27 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.212 -0.518 . . . . 61.25 112.989 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.537 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 82.6 Cg_endo -76.48 160.91 34.94 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.71 2.273 . . . . 74.23 112.985 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.413 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -95.44 98.8 10.82 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 121.862 0.839 . . . . 72.53 111.389 177.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 1' ' ' MET . 14.4 tp10 . . . . . 0 C--O 1.253 1.257 0 CA-C-N 115.384 -0.826 . . . . 72.21 111.909 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 120.775 0.321 . . . . 73.24 111.473 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.85 130.17 11.3 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.889 0.376 . . . . 74.22 111.519 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . -132.55 -113.26 1.45 Allowed Glycine 0 CA--C 1.533 1.207 0 CA-C-N 116.267 -0.424 . . . . 61.41 113.313 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 32.4 Cg_endo -103.34 35.76 0.05 OUTLIER 'Trans proline' 0 CA--C 1.547 1.174 0 C-N-CA 123.707 2.938 . . . . 62.21 114.877 -177.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.0 mp0 -58.57 -32.01 68.53 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.807 0.669 . . . . 62.14 112.807 -177.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.15 168.12 41.05 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.562 -0.828 . . . . 35.44 113.646 -178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -132.08 158.41 41.65 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.048 0.452 . . . . 71.43 111.535 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.91 130.33 56.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.243 -0.435 . . . . 72.41 111.66 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -122.92 146.81 47.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.209 -0.451 . . . . 63.21 110.63 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HB2' HD11 ' A' ' 78' ' ' LEU . 15.0 ttp180 -104.75 126.71 52.1 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.102 -0.374 . . . . 71.53 111.388 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.444 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.8 114.73 12.42 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.999 0.428 . . . . 62.04 111.073 177.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.33 -61.06 1.92 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.299 -0.41 . . . . 72.22 112.07 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -128.32 147.25 62.92 Favored Pre-proline 0 CA--C 1.536 0.422 0 CA-C-N 116.628 -0.26 . . . . 65.4 111.007 -176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 27' ' ' PRO . 49.6 Cg_endo -69.02 119.65 6.62 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.182 1.921 . . . . 52.32 112.996 -178.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.715 ' H ' ' HB2' ' A' ' 25' ' ' LEU . 77.2 t80 -112.34 111.4 22.23 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.235 -0.439 . . . . 64.24 110.461 177.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -73.47 134.78 44.0 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 121.318 0.58 . . . . 72.41 112.102 -177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.418 HH21 ' HA ' ' A' ' 70' ' ' PHE . 26.9 mmt180 -89.53 171.1 9.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.001 -0.545 . . . . 74.51 110.817 173.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' HB2' ' HD3' ' A' ' 19' ' ' ARG . 30.4 mm-40 -85.08 -51.51 6.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.307 -0.406 . . . . 74.43 110.454 178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.536 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -130.73 160.77 64.83 Favored Pre-proline 0 CA--C 1.545 0.765 0 CA-C-N 116.343 -0.39 . . . . 43.33 110.792 178.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 19' ' ' ARG . 49.0 Cg_endo -66.83 5.42 0.79 Allowed 'Trans proline' 0 CA--C 1.546 1.092 0 C-N-CA 122.968 2.445 . . . . 61.22 114.547 -178.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -66.11 -32.63 74.19 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 122.042 -0.411 . . . . 72.33 111.331 173.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -103.83 -178.46 3.67 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.95 0.405 . . . . 73.04 111.294 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 61' ' ' ASN . 32.1 tp -100.16 132.35 45.58 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.856 0.36 . . . . 64.15 111.785 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.36 142.74 28.13 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.159 -0.473 . . . . 73.31 110.02 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.715 ' HB2' ' H ' ' A' ' 15' ' ' PHE . 80.9 mt -104.94 135.03 47.06 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.305 0.854 . . . . 61.35 113.305 -169.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.631 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.1 mm? -111.82 139.01 21.79 Favored Pre-proline 0 N--CA 1.47 0.553 0 CA-C-N 115.745 -0.661 . . . . 64.53 110.545 175.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.544 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 60.0 Cg_endo -70.47 126.3 12.7 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.35 2.033 . . . . 60.24 113.135 -176.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.34 -14.24 65.71 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.153 -0.476 . . . . 54.22 113.936 177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -78.7 160.63 27.39 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 121.179 0.514 . . . . 41.34 112.071 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -108.82 133.25 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.26 0.553 . . . . 72.3 111.433 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -108.6 122.7 47.63 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.206 -0.452 . . . . 72.12 110.701 176.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -94.02 115.91 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.08 0.467 . . . . 71.01 111.069 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.477 HG22 ' HA3' ' A' ' 59' ' ' GLY . 62.0 t -113.15 106.68 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.013 0.435 . . . . 70.51 111.78 -178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 38.0 m -62.23 126.43 27.31 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.388 -0.369 . . . . 65.12 110.384 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -58.72 -20.5 49.56 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.176 0.436 . . . . 74.25 112.176 -172.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.27 -36.11 51.82 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.987 0.422 . . . . 75.03 111.433 175.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -71.34 -39.4 71.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.261 -0.427 . . . . 74.13 111.098 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.97 -37.89 89.15 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 120.998 0.428 . . . . 71.11 111.17 177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -66.25 -38.56 88.13 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.084 0.468 . . . . 63.2 110.595 174.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.49 -36.43 80.45 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.128 -0.487 . . . . 72.14 111.229 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.476 HD11 ' HD3' ' A' ' 58' ' ' PRO . 89.2 mt -74.03 -27.76 61.1 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.941 0.4 . . . . 60.45 111.127 175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.93 55.52 2.94 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 116.096 -0.502 . . . . 74.22 112.428 -176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 63.8 t -84.77 141.01 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 121.061 0.458 . . . . 53.42 111.532 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -78.78 145.42 34.38 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.033 0.444 . . . . 73.34 111.879 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -66.03 120.73 13.66 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.239 -0.437 . . . . 72.41 111.153 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.83 -13.57 49.76 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.007 -0.616 . . . . 60.14 112.086 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.0 -18.78 26.03 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.455 -0.402 . . . . 62.04 113.066 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.4 -30.95 71.98 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.131 0.491 . . . . 63.25 111.154 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -76.47 8.42 3.5 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 116.32 -0.4 . . . . 71.1 111.879 175.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 64.9 m -137.09 80.35 35.34 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 120.901 0.382 . . . . 71.2 111.135 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.12 -36.91 97.51 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 122.705 2.27 . . . . 71.12 113.082 -175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -61.25 -22.31 64.7 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.386 -0.37 . . . . 73.42 111.76 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.4 m -86.49 -24.16 25.68 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.662 -0.245 . . . . 64.34 111.588 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.5 t -80.81 -46.04 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.034 0.445 . . . . 75.35 111.533 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.09 -99.16 0.79 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 121.449 -0.405 . . . . 63.13 112.852 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 55.9 p-90 -122.93 133.86 54.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.588 -0.36 . . . . 71.22 110.811 176.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -133.86 151.65 77.27 Favored Pre-proline 0 N--CA 1.473 0.687 0 O-C-N 122.19 -0.319 . . . . 74.34 111.507 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.476 ' HD3' HD11 ' A' ' 41' ' ' LEU . 3.2 Cg_endo -86.01 137.4 5.4 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.087 2.524 . . . . 65.04 112.092 173.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.477 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -159.39 -179.71 34.4 Favored Glycine 0 CA--C 1.529 0.909 0 C-N-CA 120.693 -0.765 . . . . 71.33 113.859 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -101.07 117.85 35.84 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 122.666 0.387 . . . . 74.15 111.017 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.523 ' HB2' HD21 ' A' ' 23' ' ' LEU . 25.4 t-20 -85.62 111.61 20.22 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.794 0.33 . . . . 55.24 111.239 178.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -62.16 -28.71 69.84 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.914 0.709 . . . . 74.14 112.914 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.631 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.9 OUTLIER -60.52 -54.89 40.0 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.194 0.521 . . . . 75.51 111.519 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.3 p -99.55 -8.82 24.03 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.988 -0.551 . . . . 55.4 112.379 -174.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 64.23 13.58 8.02 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.743 0.417 . . . . 74.11 111.362 -176.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -96.45 166.69 11.57 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.296 0.569 . . . . 55.3 112.308 -175.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 28.1 mtp180 -116.26 147.79 41.14 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.55 -0.75 . . . . 64.2 111.342 -177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 166.66 -179.34 40.61 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 120.858 -0.686 . . . . 53.45 113.095 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 6.6 m-20 -88.73 139.93 29.97 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.935 0.398 . . . . 71.4 111.363 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.471 ' HB2' HD21 ' A' ' 25' ' ' LEU . 53.7 p90 -134.16 146.84 61.38 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.672 0.273 . . . . 74.22 111.635 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.518 ' HD2' HD11 ' A' ' 25' ' ' LEU . 17.4 Cg_exo -67.58 110.4 2.07 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.741 2.294 . . . . 53.22 112.714 176.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.467 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -62.19 -10.23 26.65 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 114.082 0.393 . . . . 33.32 114.082 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.3 p -76.23 -20.92 56.99 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 122.509 -0.406 . . . . 75.21 111.885 178.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -102.25 12.37 36.78 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.42 0.526 . . . . 74.21 112.42 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.467 HG22 ' HA2' ' A' ' 72' ' ' GLY . 32.4 m -130.23 151.09 35.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.123 0.487 . . . . 25.43 111.355 177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -118.45 145.0 45.58 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.408 -0.36 . . . . 74.21 111.324 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 92.3 t80 -73.22 117.7 15.27 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.396 -0.365 . . . . 75.54 111.411 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.531 HD11 ' HB2' ' A' ' 10' ' ' ARG . 85.5 mt -87.79 -58.3 2.62 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.043 0.449 . . . . 74.2 110.984 178.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.25 -169.75 42.46 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.137 -0.554 . . . . 3.14 112.946 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.11 -176.69 3.26 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 122.868 2.379 . . . . 74.51 113.411 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.47 116.69 24.78 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.338 -0.392 . . . . 74.14 111.3 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 . . . . . 0 C--O 1.254 1.314 0 CA-C-O 119.27 -0.395 . . . . 63.04 111.893 178.997 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.465 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.966 0.413 . . . . 73.12 111.611 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.52 -68.92 0.48 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.403 -0.362 . . . . 54.23 110.943 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 131.92 -175.24 19.85 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.983 -0.627 . . . . 64.0 113.638 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -100.92 40.69 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.645 2.896 . . . . 73.25 113.766 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.1 -32.17 66.02 Favored 'General case' 0 N--CA 1.475 0.796 0 O-C-N 122.181 -0.324 . . . . 54.4 111.464 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . 110.38 -163.22 12.38 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 115.695 1.038 . . . . 63.24 115.695 169.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -125.97 179.87 5.02 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.971 -0.614 . . . . 64.25 110.772 -176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.434 ' HG3' HD23 ' A' ' 81' ' ' LEU . 86.9 mt-30 -125.25 137.56 54.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.406 0.622 . . . . 74.33 112.016 177.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -120.17 154.66 34.48 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.596 -0.729 . . . . 74.03 110.271 176.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' HB2' HD11 ' A' ' 78' ' ' LEU . 51.6 ttp180 -123.02 121.9 37.21 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.099 -0.376 . . . . 72.22 111.663 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -73.78 123.42 24.12 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.022 0.439 . . . . 75.22 111.622 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.8 -49.77 10.0 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.004 0.43 . . . . 75.04 111.662 -177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -127.35 153.35 77.11 Favored Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 116.308 -0.405 . . . . 61.24 111.336 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -68.54 131.35 22.83 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.342 2.028 . . . . 73.34 113.74 -177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.446 ' HD2' ' HA ' ' A' ' 24' ' ' GLU . 48.3 t80 -111.37 131.19 55.37 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.533 -0.758 . . . . 72.01 110.653 176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.517 ' O ' ' HD2' ' A' ' 16' ' ' ARG . 5.5 ppt_? -108.28 139.47 42.93 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.172 0.511 . . . . 74.23 111.617 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.602 ' HG2' ' HB2' ' A' ' 22' ' ' ASP . 28.8 tpt180 -117.08 142.39 47.04 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.262 -0.427 . . . . 74.34 111.194 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.61 7.81 2.76 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.238 0.459 . . . . 74.34 112.238 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.524 ' H ' ' HG3' ' A' ' 17' ' ' ARG . 53.4 mtt-85 -144.59 143.65 22.23 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 123.183 0.593 . . . . 75.14 110.665 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.41 -4.21 14.45 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.511 2.141 . . . . 73.43 112.73 176.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -72.84 -53.75 10.62 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.232 -0.44 . . . . 73.24 112.073 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.602 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 3.3 m-20 -70.65 169.44 14.36 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.0 0.429 . . . . 75.14 111.542 -176.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.5 tp -100.05 119.91 39.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.309 0.576 . . . . 61.34 111.521 -176.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 15' ' ' PHE . 40.8 mt-10 -90.64 164.59 14.11 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.969 -0.56 . . . . 70.44 111.875 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 80.2 mt -121.93 147.12 46.44 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.281 -0.418 . . . . 73.45 111.803 -174.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.45 HD22 ' C ' ' A' ' 25' ' ' LEU . 4.0 mm? -122.91 155.61 63.52 Favored Pre-proline 0 N--CA 1.473 0.712 0 C-N-CA 122.544 0.337 . . . . 74.14 111.179 177.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -66.51 117.82 5.04 Favored 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 122.161 1.907 . . . . 75.13 112.495 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.16 28.28 45.7 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.151 -0.547 . . . . 70.14 112.589 -177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -93.44 156.59 16.68 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 122.499 0.319 . . . . 72.11 110.578 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.26 132.91 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.839 0.352 . . . . 63.42 110.731 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.5 mp -127.29 124.04 37.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.091 0.472 . . . . 74.14 111.418 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.21 119.09 41.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 116.334 -0.394 . . . . 74.01 110.73 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.511 HG22 ' HA3' ' A' ' 59' ' ' GLY . 59.9 t -115.27 104.77 17.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.923 0.392 . . . . 63.24 111.651 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.556 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 70.5 m -60.99 119.8 8.99 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.439 -0.346 . . . . 74.23 110.15 174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -63.02 -12.49 26.41 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.628 0.603 . . . . 64.41 112.628 -170.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.92 71.16 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.266 0.555 . . . . 71.41 110.461 171.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.632 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -68.19 -35.85 78.65 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.797 -0.638 . . . . 43.11 111.136 175.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.1 mt -62.56 -34.35 76.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.997 0.427 . . . . 75.32 110.511 174.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -63.74 -36.08 82.68 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 116.332 -0.395 . . . . 74.51 110.849 172.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.23 -25.02 64.98 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.996 0.426 . . . . 70.22 111.296 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.579 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -80.72 -28.36 36.61 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.106 0.479 . . . . 61.2 111.106 172.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.08 36.75 45.18 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 116.022 -0.535 . . . . 71.11 112.504 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.1 t -59.56 133.89 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 N-CA-C 112.59 0.589 . . . . 72.24 112.59 -176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -84.74 151.65 24.25 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.971 -0.559 . . . . 73.24 111.457 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -50.02 110.71 0.42 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.106 0.479 . . . . 74.32 111.463 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.28 -50.54 0.88 Allowed Glycine 0 CA--C 1.525 0.695 0 CA-C-N 116.186 -0.461 . . . . 72.4 112.047 -174.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.07 -27.18 68.45 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 121.072 -0.585 . . . . 55.43 112.848 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -57.5 -35.36 70.12 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.117 0.484 . . . . 75.23 111.432 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.3 ptt180 -100.64 4.01 42.97 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.378 -0.374 . . . . 64.22 111.606 178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -142.91 82.52 12.08 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 120.875 0.369 . . . . 72.32 111.209 -179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.534 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 20.4 Cg_endo -58.92 -24.78 74.35 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.106 2.537 . . . . 70.53 113.228 -175.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -57.37 -27.14 62.03 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 120.733 0.302 . . . . 75.31 111.743 178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.7 t -82.96 -13.18 56.49 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.001 0.429 . . . . 74.42 111.761 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.572 HG11 HD13 ' A' ' 41' ' ' LEU . 46.6 t -98.44 -38.34 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.037 0.446 . . . . 64.22 111.422 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 92.04 -93.12 1.77 Allowed Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.125 -0.559 . . . . 75.14 112.697 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -93.53 136.7 33.55 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.795 0.331 . . . . 74.13 110.648 176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.481 ' SD ' ' HB3' ' A' ' 51' ' ' PRO . 81.5 mtp -139.76 129.15 13.79 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 111.923 0.342 . . . . 73.05 111.923 -176.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.632 ' HG2' ' HB1' ' A' ' 37' ' ' ALA . 73.1 Cg_endo -77.52 117.85 4.42 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.531 2.154 . . . . 70.54 112.786 174.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -151.18 -177.8 25.36 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 120.797 -0.716 . . . . 74.44 113.539 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.1 tp -111.96 116.11 30.05 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.867 0.365 . . . . 74.13 111.223 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.532 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 26.9 t-20 -76.98 134.94 38.7 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 116.42 -0.354 . . . . 62.04 110.841 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -84.25 -40.09 18.46 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 112.731 0.641 . . . . 74.42 112.731 -177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -67.5 -30.47 70.16 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.124 0.416 . . . . 75.12 112.124 -175.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.8 p -114.81 -28.69 6.99 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 111.92 0.341 . . . . 60.23 111.92 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.532 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 14.7 mmt85 64.14 28.93 14.14 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.159 0.504 . . . . 61.04 112.18 -176.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -91.03 143.86 26.26 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.993 -0.549 . . . . 61.11 111.204 173.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.519 ' NH1' ' H ' ' A' ' 68' ' ' GLY . 10.0 mmm180 -96.43 164.42 12.64 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.462 0.649 . . . . 75.41 111.858 177.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.519 ' H ' ' NH1' ' A' ' 67' ' ' ARG . . . 139.61 -165.89 25.72 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 115.453 -0.794 . . . . 74.12 112.121 -176.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -108.14 132.92 53.11 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.675 -0.309 . . . . 73.31 110.801 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -118.86 147.35 42.17 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-O 120.739 0.304 . . . . 73.22 111.199 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.87 103.6 1.75 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.384 2.056 . . . . 72.44 112.642 177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -60.07 -14.99 34.48 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.503 0.561 . . . . 73.34 114.503 -176.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.1 t -62.43 -18.4 61.62 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.841 0.682 . . . . 63.33 112.841 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -100.35 3.32 43.2 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.913 -0.492 . . . . 75.2 112.155 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG12 ' HA ' ' A' ' 11' ' ' ALA . 15.0 m -120.96 159.5 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-O 121.178 0.513 . . . . 72.31 112.073 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -111.98 152.41 28.14 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.905 175.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -83.84 106.56 15.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.708 0.289 . . . . 73.22 111.22 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.44 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -72.65 -53.45 11.77 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.038 0.447 . . . . 74.43 111.099 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 147.58 -175.07 27.11 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.215 -0.517 . . . . 63.2 113.11 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.88 164.94 24.88 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.308 2.672 . . . . 70.22 112.636 176.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.434 HD23 ' HG3' ' A' ' 8' ' ' GLN . 2.3 pp -127.06 158.12 37.83 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.048 0.388 . . . . 70.44 112.048 178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 . . . . . 0 C--O 1.253 1.245 0 CA-C-O 118.742 -0.647 . . . . 65.12 110.88 174.456 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.0 mtm . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 120.731 0.3 . . . . 74.43 111.129 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.65 104.09 16.22 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.915 0.388 . . . . 43.41 111.346 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -80.75 -171.95 44.98 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 120.974 -0.632 . . . . 70.13 113.403 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.17 39.54 0.61 Allowed 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 123.087 2.525 . . . . 75.33 113.823 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -62.18 -28.57 69.76 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.019 0.378 . . . . 73.41 112.019 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . -128.32 147.14 17.28 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.119 -0.562 . . . . 41.3 112.777 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -127.1 158.18 37.71 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.296 0.57 . . . . 74.42 111.944 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.05 127.44 56.22 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.902 -0.59 . . . . 73.35 111.369 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -111.2 163.25 14.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.208 -0.451 . . . . 64.03 110.143 174.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HB3' ' CG ' ' A' ' 76' ' ' GLU . 38.2 ttt180 -133.46 123.94 26.17 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.975 0.416 . . . . 62.44 111.59 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 25' ' ' LEU . . . -77.06 122.98 25.71 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.04 -0.527 . . . . 74.11 110.841 177.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.1 mt -71.3 -60.11 2.41 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.087 0.47 . . . . 61.51 111.915 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.452 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 91.8 m-85 -127.25 161.2 55.76 Favored Pre-proline 0 N--CA 1.471 0.605 0 CA-C-N 116.205 -0.452 . . . . 72.05 110.985 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 32.2 Cg_endo -63.7 135.15 47.33 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.01 1.806 . . . . 52.04 112.965 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -133.85 130.78 38.36 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.898 -0.592 . . . . 74.31 111.481 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -135.41 141.83 45.53 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.277 -0.419 . . . . 71.34 110.914 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 18' ' ' GLU . 19.1 tpp180 -107.87 167.41 10.0 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.825 0.345 . . . . 74.2 110.779 177.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.543 ' N ' ' HG3' ' A' ' 17' ' ' ARG . 6.5 mm-40 -70.1 -10.99 60.55 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.027 0.442 . . . . 72.23 111.533 174.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.581 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . 22.4 mmm180 -136.31 137.55 24.73 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 123.147 0.579 . . . . 74.4 110.531 177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.87 5.43 2.98 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.603 2.202 . . . . 65.42 113.207 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.581 ' HG2' ' HB3' ' A' ' 19' ' ' ARG . 6.9 mm-40 -62.42 -25.88 68.19 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.213 0.53 . . . . 75.13 110.688 176.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -81.52 -158.43 0.22 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 115.527 -0.76 . . . . 64.24 110.179 171.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 45.6 tp -133.11 118.92 19.29 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 122.088 -0.382 . . . . 65.43 111.304 177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -62.48 119.97 10.18 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.087 0.47 . . . . 73.01 111.481 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 74.6 mt -100.35 143.11 30.93 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.196 -0.456 . . . . 73.12 111.613 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.508 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.3 mm? -110.99 148.0 37.71 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 116.438 -0.346 . . . . 65.11 110.651 176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.493 ' HB3' ' HD3' ' A' ' 14' ' ' PRO . 36.2 Cg_endo -63.57 106.22 0.58 Allowed 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.506 2.138 . . . . 73.11 113.311 -175.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.02 34.49 23.92 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 116.038 -0.528 . . . . 60.2 113.62 178.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.43 ' CG ' ' HB2' ' A' ' 63' ' ' ARG . 33.2 t70 -105.56 158.91 16.35 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 117.175 0.487 . . . . 64.02 111.997 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.2 t -101.09 131.85 47.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 CA-C-O 121.395 0.616 . . . . 61.42 112.391 -176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.449 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.0 mp -111.2 127.76 55.7 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.831 -0.622 . . . . 54.25 110.704 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 62.0 t -96.0 122.68 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.008 0.433 . . . . 63.44 111.517 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.8 t -131.79 116.46 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 CA-C-N 116.277 -0.42 . . . . 75.12 111.253 179.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.505 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 55.4 m -89.23 156.65 18.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.022 0.439 . . . . 72.41 111.176 177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.542 ' HG2' HD12 ' A' ' 38' ' ' LEU . 36.1 mtm180 -71.48 -14.66 62.2 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.722 0.268 . . . . 73.25 111.722 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -49.46 -35.74 20.52 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-O 121.011 0.434 . . . . 73.42 111.523 173.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.73 -43.52 13.3 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.984 0.421 . . . . 64.45 111.56 174.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.542 HD12 ' HG2' ' A' ' 35' ' ' ARG . 90.0 mt -56.82 -38.43 72.6 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.164 0.431 . . . . 75.41 112.164 -177.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 14.8 mm100 -65.3 -37.69 87.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 120.904 0.383 . . . . 73.34 110.997 178.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 -34.06 76.73 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.026 0.441 . . . . 62.41 110.989 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.556 HD11 ' HD2' ' A' ' 58' ' ' PRO . 75.2 mt -69.99 -28.5 65.57 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.104 -0.498 . . . . 75.1 111.118 176.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.33 41.81 6.05 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.353 -0.451 . . . . 75.0 112.598 -177.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.64 129.78 37.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.886 0.374 . . . . 72.33 111.757 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.36 148.69 37.25 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.955 0.407 . . . . 60.41 112.029 178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -57.55 122.43 12.68 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.205 -0.452 . . . . 71.24 111.151 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 96.13 2.77 60.59 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.023 -0.608 . . . . 73.41 112.836 -177.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.27 -28.49 10.62 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.3 -0.476 . . . . 62.13 112.855 177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -34.53 72.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.042 0.386 . . . . 64.51 112.042 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -63.56 -12.02 29.34 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.168 0.432 . . . . 74.42 112.168 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.0 m -134.55 85.55 36.86 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 120.819 0.343 . . . . 75.43 110.515 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 17.7 Cg_endo -55.94 -28.1 66.79 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.154 2.569 . . . . 74.13 113.284 -175.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -62.4 -23.36 66.79 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.326 -0.397 . . . . 62.31 111.75 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 t -68.1 -45.31 74.09 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.097 0.475 . . . . 71.13 111.358 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 40.7 t -76.17 -46.44 33.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.155 -0.475 . . . . 61.44 111.459 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.0 -90.22 0.58 Allowed Glycine 0 CA--C 1.527 0.796 0 C-N-CA 121.258 -0.496 . . . . 54.24 113.285 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -112.06 114.76 27.8 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.956 0.408 . . . . 75.42 111.906 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -124.26 138.43 30.86 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 116.436 -0.347 . . . . 61.11 111.167 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HD2' HD11 ' A' ' 41' ' ' LEU . 71.6 Cg_endo -77.93 127.94 8.89 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.411 2.074 . . . . 64.11 112.393 175.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -145.69 168.83 27.33 Favored Glycine 0 CA--C 1.522 0.531 0 C-N-CA 120.812 -0.709 . . . . 34.2 113.288 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 tp -103.88 124.02 48.19 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.764 0.316 . . . . 71.53 111.204 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -84.45 118.13 24.09 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 120.714 0.293 . . . . 72.52 110.666 176.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -66.3 -31.62 72.52 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 112.747 0.647 . . . . 63.43 112.747 -174.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.508 ' HG2' ' HG ' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -63.37 -51.62 65.12 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.045 0.45 . . . . 72.23 111.847 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 82.6 p -102.43 -18.79 15.21 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.295 0.85 . . . . 75.21 113.295 -172.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 64' ' ' THR . 0.0 OUTLIER 69.58 17.97 7.79 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 122.934 0.494 . . . . 65.14 111.631 -173.343 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 -84.13 149.27 26.29 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.116 0.484 . . . . 75.41 111.507 177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 67' ' ' ARG . 50.1 mtp180 -111.23 150.71 29.19 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.122 -0.49 . . . . 74.05 110.679 176.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.62 164.08 27.49 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.503 -0.855 . . . . 72.44 113.647 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -89.03 109.58 20.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 110.126 -0.324 . . . . 73.23 110.126 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -106.72 143.75 27.66 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 112.24 0.459 . . . . 72.11 112.24 -175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.37 104.69 1.3 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.54 2.16 . . . . 71.33 112.079 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -61.03 -18.57 55.01 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 115.082 0.793 . . . . 74.12 115.082 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -58.65 -24.83 61.96 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 117.683 0.742 . . . . 74.34 112.149 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -100.66 11.66 39.05 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.647 0.61 . . . . 60.53 112.647 -176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.7 m -130.86 150.32 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.778 0.323 . . . . 64.21 111.078 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 14.7 pt-20 -98.94 153.72 18.61 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.04 0.448 . . . . 63.41 111.294 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 93.2 t80 -92.76 116.34 28.93 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.289 -0.414 . . . . 74.15 111.385 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.77 -67.42 0.78 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.883 0.373 . . . . 70.41 111.438 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.24 179.74 41.94 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.205 -0.522 . . . . 62.44 112.802 -178.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.96 165.14 33.47 Favored 'Trans proline' 0 CA--C 1.543 0.963 0 C-N-CA 122.855 2.37 . . . . 63.2 113.369 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.18 149.4 33.74 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.994 0.426 . . . . 71.55 111.797 177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 C--O 1.255 1.368 0 CA-C-O 118.728 -0.653 . . . . 72.24 110.867 178.429 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 120.484 0.183 . . . . 75.14 111.157 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.43 177.84 7.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.933 0.397 . . . . 60.12 111.967 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 146.71 148.22 4.72 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.511 -0.376 . . . . 62.31 112.762 -176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -76.2 51.28 3.12 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.004 2.47 . . . . 74.33 112.594 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -69.31 -20.61 63.89 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.277 0.473 . . . . 64.22 112.277 -176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.7 -145.02 5.49 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.928 -0.653 . . . . 72.12 113.105 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -131.03 145.6 52.09 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 120.988 0.423 . . . . 64.12 111.507 -177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -93.05 134.03 35.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.146 -0.479 . . . . 61.32 111.534 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 123.99 41.17 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.524 -0.307 . . . . 72.41 110.987 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.496 ' HB2' HD11 ' A' ' 78' ' ' LEU . 43.5 ttm180 -97.85 115.59 28.37 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.346 -0.221 . . . . 45.31 111.113 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.96 108.99 3.73 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.805 0.336 . . . . 61.11 111.242 178.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.91 -29.57 27.04 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.167 0.432 . . . . 61.33 112.167 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -124.2 135.48 26.47 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 122.353 -0.217 . . . . 73.02 111.574 -177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.532 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.5 Cg_endo -69.21 119.86 6.79 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 122.296 1.998 . . . . 61.43 112.638 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -122.47 111.62 17.06 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.104 -0.498 . . . . 74.13 111.364 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -104.63 120.25 40.88 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.009 0.433 . . . . 64.04 110.641 173.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 17' ' ' ARG . 7.2 tpt180 -74.56 151.39 39.44 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.915 0.388 . . . . 71.43 111.558 -179.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -55.26 -47.67 75.12 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.263 0.554 . . . . 72.52 110.92 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.423 ' H ' ' HG3' ' A' ' 17' ' ' ARG . 24.6 mmm180 -106.39 151.34 40.26 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.643 -0.708 . . . . 75.33 111.442 177.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -73.9 5.61 3.36 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.821 2.347 . . . . 72.43 113.206 177.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -66.81 -34.4 77.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 122.96 0.504 . . . . 62.01 112.101 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.8 -160.5 0.49 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 122.701 0.401 . . . . 70.55 111.5 177.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.9 tp -125.99 123.91 39.54 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.782 0.325 . . . . 44.13 111.244 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -72.86 138.92 46.59 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.193 0.52 . . . . 74.13 111.987 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 94.6 mt -106.24 137.59 43.93 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.103 -0.499 . . . . 72.24 111.598 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -120.72 142.84 35.14 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 122.452 0.301 . . . . 62.14 110.839 176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 46.0 Cg_endo -66.44 117.6 4.85 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.565 2.177 . . . . 60.21 112.814 -176.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.87 -7.79 45.43 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.263 -0.494 . . . . 51.32 113.265 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -77.92 138.8 39.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 117.008 0.404 . . . . 61.25 110.742 178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.9 t -110.96 97.68 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 120.98 0.419 . . . . 71.43 110.965 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.429 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.0 mp -81.1 127.15 32.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.999 0.428 . . . . 72.04 111.498 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.5 t -94.0 113.53 28.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.345 -0.388 . . . . 70.22 111.595 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 67.5 t -109.71 134.57 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-N 116.388 -0.369 . . . . 72.53 110.645 177.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -74.77 149.35 39.77 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.02 0.438 . . . . 52.15 111.586 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.5 -38.19 88.92 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.166 0.508 . . . . 64.42 110.285 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.48 -38.44 80.85 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.735 -0.666 . . . . 73.55 111.613 177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.83 -47.0 86.34 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.936 0.398 . . . . 71.24 111.129 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.01 -41.25 96.18 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.394 -0.366 . . . . 63.35 111.227 176.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -60.34 -37.28 80.13 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 120.953 0.406 . . . . 75.13 111.047 175.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.03 -39.41 93.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.038 0.447 . . . . 60.35 110.838 175.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 94.7 mt -68.78 -21.4 64.34 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.083 -0.508 . . . . 70.32 111.816 176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.01 36.42 6.36 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.307 -0.473 . . . . 41.2 113.144 -178.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.57 130.21 39.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 120.903 0.382 . . . . 44.22 111.146 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.76 150.41 20.23 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.445 -0.343 . . . . 62.13 111.802 -178.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -48.44 121.37 4.39 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.974 0.416 . . . . 71.32 111.522 178.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.58 6.17 57.48 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.24 -0.505 . . . . 71.43 112.995 -177.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -110.78 -28.18 4.04 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.319 -0.467 . . . . 74.12 112.966 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -31.29 64.46 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.174 0.59 . . . . 65.13 111.974 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.428 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 12.8 ptp180 -59.06 -13.69 7.58 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.687 0.625 . . . . 73.32 112.687 -178.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 26.6 p -127.32 84.0 64.57 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 121.02 0.438 . . . . 63.44 111.276 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.43 -33.3 97.79 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 122.719 2.279 . . . . 52.21 112.562 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.679 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 90.6 mt-30 -58.64 -28.86 66.06 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.105 -0.498 . . . . 62.51 111.513 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.7 t -76.25 -33.42 59.17 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.853 0.358 . . . . 43.54 111.38 178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.1 t -71.93 -58.55 4.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 120.9 0.381 . . . . 72.33 111.414 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.13 -137.15 12.46 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 121.22 -0.515 . . . . 63.1 112.709 -178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -76.94 132.91 39.3 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.2 0.524 . . . . 61.52 111.686 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -132.41 147.64 66.48 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 116.12 -0.491 . . . . 55.51 111.593 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.12 126.4 8.56 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.503 2.135 . . . . 71.3 112.403 174.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.81 -175.25 24.89 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 120.475 -0.869 . . . . 45.4 114.131 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.2 tp -122.88 117.12 24.86 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.335 0.254 . . . . 64.14 111.253 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -79.92 129.65 34.66 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.568 0.223 . . . . 62.33 110.493 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -92.39 -6.53 49.88 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 114.181 1.178 . . . . 64.32 114.181 -171.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -92.64 -23.64 18.93 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.718 -0.614 . . . . 71.41 111.363 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.6 p -111.36 -16.93 13.25 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.04 0.448 . . . . 43.45 111.223 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.7 mmm-85 62.59 22.44 13.31 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.577 0.751 . . . . 73.31 111.568 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -101.21 149.19 24.25 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.073 0.463 . . . . 71.1 112.157 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -92.63 156.39 17.12 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.007 -0.542 . . . . 74.21 111.107 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 171.55 -172.35 44.53 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 120.593 -0.813 . . . . 70.15 113.453 178.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -112.06 125.58 54.25 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 122.611 0.364 . . . . 73.41 110.252 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -132.12 142.77 46.29 Favored Pre-proline 0 N--CA 1.471 0.589 0 N-CA-C 111.93 0.345 . . . . 63.24 111.93 -175.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.32 113.9 3.46 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.398 2.066 . . . . 72.34 112.36 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.39 33.02 0.97 Allowed Glycine 0 CA--C 1.53 1.0 0 N-CA-C 114.424 0.529 . . . . 74.24 114.424 -177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.679 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 43.4 m -92.52 -28.92 16.49 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 122.399 -0.471 . . . . 64.42 110.936 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -96.46 5.29 51.15 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 116.198 -0.455 . . . . 71.12 112.01 -177.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 11' ' ' ALA . 19.1 m -117.64 145.39 23.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.783 0.325 . . . . 75.21 111.486 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 14.6 pt-20 -99.87 152.32 20.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.996 0.427 . . . . 71.15 110.972 176.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.428 ' CD2' ' HA ' ' A' ' 49' ' ' ARG . 68.3 t80 -84.82 107.41 16.98 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 120.982 0.42 . . . . 74.3 111.09 178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 10' ' ' ARG . 67.2 mt -76.93 -38.1 54.05 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.847 0.356 . . . . 55.33 111.24 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.68 -176.51 19.16 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.29 -0.481 . . . . 45.41 113.089 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.57 150.08 68.89 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.84 2.36 . . . . 61.33 112.259 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 81' ' ' LEU . 7.4 mp -74.46 151.25 39.62 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.13 0.49 . . . . 71.42 111.204 177.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 . . . . . 0 C--O 1.256 1.398 0 CA-C-O 118.487 -0.768 . . . . 64.15 112.458 -178.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 tpt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.757 0.313 . . . . 74.33 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.71 -42.56 17.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 120.791 0.329 . . . . 73.14 110.835 174.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 56.3 -113.12 3.82 Favored Glycine 0 CA--C 1.534 1.254 0 N-CA-C 114.626 0.61 . . . . 43.21 114.626 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.47 23.69 0.48 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.323 2.682 . . . . 64.52 114.922 -172.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -59.5 -30.97 68.94 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.187 0.518 . . . . 62.32 111.109 173.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 161.72 -146.71 12.49 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 116.088 -0.505 . . . . 63.05 112.573 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -133.36 137.0 45.68 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.91 0.386 . . . . 75.32 111.159 178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.524 ' HG2' HG22 ' A' ' 32' ' ' VAL . 98.0 mt-30 -94.95 126.92 40.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.242 0.544 . . . . 75.31 112.109 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -115.87 123.98 49.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 115.961 -0.563 . . . . 74.22 110.091 176.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 10' ' ' ARG . 20.1 ttt180 -97.85 124.37 42.23 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.205 0.446 . . . . 74.11 112.205 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -69.13 126.63 30.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.915 0.388 . . . . 53.51 111.831 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 69.4 mt -85.74 -55.37 4.01 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.233 0.457 . . . . 71.12 112.233 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -115.21 150.07 43.75 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 111.62 0.23 . . . . 73.41 111.62 -178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 61.2 Cg_endo -73.96 120.02 6.15 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.544 2.163 . . . . 73.21 113.872 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -129.78 111.04 12.23 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.139 -0.482 . . . . 73.11 111.053 175.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 61.3 mtm-85 -86.98 160.48 18.64 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 116.196 -0.456 . . . . 64.12 110.821 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.63 ' HD3' ' HG2' ' A' ' 24' ' ' GLU . 2.0 mpt_? -107.76 135.34 49.34 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.235 0.828 . . . . 75.11 113.235 -174.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -73.38 -45.18 56.42 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.439 -0.801 . . . . 74.33 109.73 169.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -111.93 120.11 42.81 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 115.66 -0.7 . . . . 72.05 110.114 174.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.07 -1.41 0.84 Allowed 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.06 2.507 . . . . 75.42 113.87 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -56.43 -39.51 73.2 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.95 0.405 . . . . 74.45 111.431 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.67 163.98 14.9 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.597 -0.52 . . . . 70.42 109.597 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 39.9 tp -99.54 133.26 44.13 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.692 -0.63 . . . . 74.3 111.292 -178.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.63 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 39.0 mt-10 -78.26 149.89 33.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.165 0.507 . . . . 71.31 111.839 -176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 84.2 mt -127.18 125.74 41.62 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.007 -0.542 . . . . 43.43 111.444 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.52 152.62 44.77 Favored Pre-proline 0 N--CA 1.472 0.639 0 CA-C-O 120.72 0.295 . . . . 61.31 110.359 172.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.504 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 42.5 Cg_endo -65.82 105.53 0.81 Allowed 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.058 1.839 . . . . 75.53 112.463 -176.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.25 -15.55 10.06 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 121.106 -0.568 . . . . 71.22 113.433 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -60.03 118.29 6.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 117.008 0.404 . . . . 53.11 111.616 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.3 t -94.48 92.64 3.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.129 0.49 . . . . 71.11 110.566 175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 5.9 mp -78.8 120.55 23.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.094 0.473 . . . . 60.21 111.968 -175.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 8' ' ' GLN . 48.3 t -93.09 111.95 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.105 -0.498 . . . . 74.13 111.654 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.7 t -103.07 122.45 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.328 -0.396 . . . . 73.21 110.937 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 92.9 p -68.07 139.73 56.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.995 0.426 . . . . 64.34 111.114 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 49.6 ttt85 -63.96 -32.37 73.88 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.874 0.369 . . . . 74.14 110.943 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.83 85.9 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.296 -0.411 . . . . 71.24 111.269 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.57 -43.5 93.6 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 121.002 0.43 . . . . 63.4 111.081 176.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 97.8 mt -58.98 -42.51 90.17 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.285 -0.416 . . . . 71.04 111.341 177.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.3 mm-40 -64.46 -37.12 86.43 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.933 0.397 . . . . 75.31 111.012 176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.37 -34.21 77.45 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.959 0.409 . . . . 75.41 111.484 176.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.572 HD11 ' HD2' ' A' ' 58' ' ' PRO . 88.9 mt -72.46 -20.86 61.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.248 -0.433 . . . . 71.13 111.526 176.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 83.61 28.61 35.04 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 121.323 -0.465 . . . . 71.53 112.763 -176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.533 HG23 ' HB2' ' A' ' 41' ' ' LEU . 58.8 t -78.65 124.74 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-O 120.775 0.321 . . . . 61.13 111.356 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -69.71 139.29 53.39 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 120.998 0.428 . . . . 61.32 111.731 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.11 122.31 11.39 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.114 0.483 . . . . 61.33 111.121 176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.82 -13.32 24.68 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.957 -0.64 . . . . 72.1 112.461 -174.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.0 -25.27 49.77 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.347 -0.454 . . . . 74.4 113.408 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.433 ' OE2' ' HG3' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -58.91 -28.39 66.17 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 111.974 0.361 . . . . 71.51 111.974 -178.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HG3' ' OE2' ' A' ' 48' ' ' GLU . 50.1 mtm180 -56.48 -29.13 61.41 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.951 0.352 . . . . 72.21 111.951 176.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . 71.0 m -133.28 84.85 46.05 Favored Pre-proline 0 N--CA 1.474 0.73 0 CA-C-O 120.953 0.406 . . . . 63.14 111.053 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.526 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 18.3 Cg_endo -57.94 -23.62 60.75 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.004 2.469 . . . . 73.24 113.491 -176.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -60.25 -24.33 64.8 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 111.906 0.336 . . . . 74.52 111.906 179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.3 t -66.48 -31.56 72.37 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.183 0.516 . . . . 74.02 111.609 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.8 t -92.12 -57.17 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.139 -0.482 . . . . 73.12 111.367 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.88 -88.88 0.5 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.257 -0.497 . . . . 51.33 113.185 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 7.4 m0 -103.18 107.33 18.1 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.343 0.497 . . . . 75.42 112.343 -178.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.432 ' N ' ' SD ' ' A' ' 57' ' ' MET . 3.0 mpp? -116.22 137.76 23.72 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.964 -0.562 . . . . 74.13 110.673 175.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.572 ' HD2' HD11 ' A' ' 41' ' ' LEU . 65.2 Cg_endo -74.67 117.76 5.07 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.311 2.008 . . . . 71.53 112.628 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -137.87 172.49 22.83 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.06 -0.59 . . . . 73.23 113.299 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 60.3 tp -97.66 114.36 26.31 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.93 0.395 . . . . 73.32 111.607 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.435 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 23.6 t-20 -74.53 123.08 24.12 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 116.382 -0.372 . . . . 61.24 111.711 178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -72.63 -19.64 61.42 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.214 0.82 . . . . 71.55 113.214 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.411 ' HB3' ' OD1' ' A' ' 61' ' ' ASN . 1.5 tpm_? -66.05 -59.93 3.32 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.949 0.404 . . . . 75.43 111.337 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 66' ' ' GLN . 72.3 p -122.91 6.21 9.33 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.831 0.678 . . . . 71.25 112.831 -177.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 0.1 OUTLIER 67.35 32.45 5.88 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 112.632 0.605 . . . . 73.31 112.632 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.514 ' HG2' ' OG1' ' A' ' 64' ' ' THR . 83.7 mm-40 -79.19 130.57 35.62 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.742 0.306 . . . . 64.13 111.296 174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -98.47 121.61 40.62 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.572 0.225 . . . . 74.5 110.707 173.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -175.03 -177.83 44.43 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.514 -0.85 . . . . 52.12 113.495 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 20.1 m-20 -88.23 119.94 29.11 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 120.893 0.378 . . . . 73.1 111.194 -178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.472 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.5 p90 -114.8 145.77 34.65 Favored Pre-proline 0 N--CA 1.47 0.556 0 CA-C-N 116.432 -0.349 . . . . 72.21 111.07 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.53 109.46 2.76 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.426 2.084 . . . . 71.25 112.438 178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.36 34.07 0.96 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 114.243 0.457 . . . . 32.32 114.243 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.0 p -102.87 -26.73 13.01 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 122.461 -0.435 . . . . 71.51 111.348 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -105.6 15.54 26.81 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.831 0.348 . . . . 53.44 111.795 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 11' ' ' ALA . 24.2 m -118.73 161.3 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-O 120.933 0.397 . . . . 73.24 111.517 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.11 138.12 46.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.094 0.473 . . . . 52.4 110.919 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.463 ' CZ ' ' HA2' ' A' ' 79' ' ' GLY . 39.5 t80 -77.76 116.6 18.41 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.868 0.366 . . . . 41.41 110.963 177.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -86.43 -48.29 8.56 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.236 0.541 . . . . 74.33 110.78 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' CZ ' ' A' ' 77' ' ' PHE . . . 131.24 -165.22 23.2 Favored Glycine 0 CA--C 1.523 0.59 0 CA-C-N 115.849 -0.614 . . . . 50.05 112.502 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.55 166.36 19.99 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.332 2.022 . . . . 65.21 111.97 175.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 81' ' ' LEU . 6.3 mp -84.4 159.01 20.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.098 0.475 . . . . 65.12 111.724 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.257 1.469 0 CA-C-N 115.806 -0.634 . . . . 73.32 111.424 177.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 pmm? . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.578 0.228 . . . . 70.3 111.529 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.61 -47.71 73.07 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.021 0.378 . . . . 74.25 112.021 -176.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 113.14 166.16 16.46 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 121.009 -0.615 . . . . 42.42 113.468 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.596 ' HB3' ' HB3' ' A' ' 80' ' ' PRO . 16.6 Cg_exo -68.59 77.32 0.72 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 122.77 2.313 . . . . 72.41 112.837 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -67.42 -35.22 78.82 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 120.886 0.374 . . . . 65.44 111.665 178.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.543 ' HA2' ' HA ' ' A' ' 34' ' ' SER . . . -147.84 166.21 28.83 Favored Glycine 0 CA--C 1.526 0.724 0 C-N-CA 121.336 -0.459 . . . . 65.11 113.026 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -130.12 148.22 51.94 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 122.616 0.366 . . . . 74.44 111.112 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.775 ' HG3' HD11 ' A' ' 81' ' ' LEU . 82.2 mt-30 -103.63 143.86 32.2 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.19 0.519 . . . . 70.4 112.018 178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.542 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 87.9 m-85 -132.05 125.86 32.44 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.934 -0.575 . . . . 74.01 110.692 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HB2' HD11 ' A' ' 78' ' ' LEU . 43.5 ttp180 -98.58 116.52 30.99 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 122.005 -0.435 . . . . 74.24 111.82 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.03 113.88 7.66 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 120.919 0.39 . . . . 72.32 111.451 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.469 HD21 ' HG3' ' A' ' 76' ' ' GLU . 84.0 mt -77.92 -39.11 43.92 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.43 0.53 . . . . 64.0 112.43 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -126.32 145.81 54.02 Favored Pre-proline 0 N--CA 1.469 0.505 0 N-CA-C 111.718 0.266 . . . . 72.13 111.718 -176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.529 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 36.9 Cg_endo -65.88 131.62 27.87 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.434 2.089 . . . . 72.23 112.345 177.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.487 ' HB3' ' HB2' ' A' ' 25' ' ' LEU . 92.1 t80 -133.53 117.82 17.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.48 -0.327 . . . . 71.52 111.618 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 16' ' ' ARG . 1.3 ptm180 -77.38 131.5 38.08 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.668 -0.493 . . . . 71.03 109.668 172.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.84 ' HB2' ' HG2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -72.88 151.43 41.95 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.919 0.39 . . . . 74.22 111.983 -173.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.611 ' H ' ' HD3' ' A' ' 17' ' ' ARG . 7.6 tp10 -46.53 -26.49 0.89 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.286 0.635 . . . . 72.34 111.581 173.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -157.05 131.9 5.33 Favored Pre-proline 0 CA--C 1.542 0.667 0 CA-C-N 115.692 -0.685 . . . . 75.32 110.16 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.67 -9.29 3.75 Favored 'Trans proline' 0 N--CA 1.486 1.058 0 C-N-CA 123.0 2.467 . . . . 73.43 113.851 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.18 -30.84 69.13 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.368 -0.378 . . . . 75.24 111.599 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -96.45 -164.35 1.14 Allowed 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.14 0.495 . . . . 71.33 112.207 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.44 HD13 ' HB2' ' A' ' 66' ' ' GLN . 43.1 tp -99.62 130.27 45.84 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.171 0.51 . . . . 73.24 112.046 -173.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.84 ' HG2' ' HB2' ' A' ' 17' ' ' ARG . 37.2 mt-10 -101.31 166.32 10.82 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.073 -0.512 . . . . 52.43 111.228 -178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 15' ' ' PHE . 90.9 mt -114.99 142.51 46.53 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.675 0.62 . . . . 51.45 112.675 -174.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -121.63 151.2 56.7 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 122.944 0.498 . . . . 70.21 110.658 175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.5 Cg_endo -71.44 129.17 15.44 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.382 2.055 . . . . 74.31 113.261 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.28 22.83 75.34 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.223 -0.513 . . . . 73.42 113.105 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 t0 -105.97 157.85 17.21 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.747 0.308 . . . . 65.14 110.846 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.88 133.25 66.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 121.252 0.549 . . . . 63.21 111.895 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.432 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.8 mp -121.38 139.23 53.72 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.094 -0.503 . . . . 54.31 110.533 176.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.4 HG22 ' HG2' ' A' ' 8' ' ' GLN . 57.1 t -106.26 124.86 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-O 120.983 0.42 . . . . 72.24 112.04 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -125.01 124.39 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.414 -0.357 . . . . 74.42 110.754 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.543 ' HA ' ' HA2' ' A' ' 6' ' ' GLY . 74.9 m -95.12 159.98 14.77 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.449 0.536 . . . . 65.13 112.449 -176.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 78.8 mtt180 -50.79 -38.94 51.29 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 116.404 -0.362 . . . . 54.12 111.925 177.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -50.7 -37.44 41.38 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.122 0.416 . . . . 40.12 112.122 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.441 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -77.14 -49.14 15.88 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.933 0.397 . . . . 74.3 111.265 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 94.8 mt -58.52 -46.06 87.53 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.426 -0.352 . . . . 73.5 111.887 -178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -61.57 -35.71 78.58 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.602 0.239 . . . . 74.35 111.584 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.2 75.3 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.081 0.467 . . . . 65.54 111.046 176.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 60.5 mt -76.31 -28.7 57.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.2 0.524 . . . . 75.13 111.109 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.0 16.99 15.06 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.048 -0.523 . . . . 65.44 112.963 -176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 61.8 t -83.65 130.66 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.897 0.379 . . . . 70.35 111.094 178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.54 152.61 25.24 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.252 -0.431 . . . . 44.41 111.811 -177.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -40.62 111.97 0.25 Allowed 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 122.786 0.435 . . . . 63.3 111.725 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 123.9 -17.11 7.71 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.401 -0.428 . . . . 73.32 112.501 -175.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.7 -33.44 7.91 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.213 -0.518 . . . . 53.31 113.278 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.24 -33.01 71.68 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 112.328 0.492 . . . . 73.51 112.328 -177.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -68.06 -5.37 17.23 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.086 0.47 . . . . 62.32 112.009 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 89.7 m -141.37 81.94 14.95 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.271 -0.422 . . . . 74.04 110.444 171.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.402 ' HB2' ' O ' ' A' ' 72' ' ' GLY . 18.8 Cg_endo -56.13 -16.21 16.34 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.125 2.55 . . . . 52.34 113.461 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -59.11 -31.21 68.72 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.728 0.299 . . . . 65.33 111.665 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.3 t -82.7 -23.91 33.89 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 120.732 0.301 . . . . 62.02 111.215 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 58.4 t -71.69 -44.86 68.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-O 120.975 0.417 . . . . 75.51 110.456 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 76.48 -76.53 1.5 Allowed Glycine 0 CA--C 1.525 0.706 0 CA-C-N 116.147 -0.478 . . . . 72.41 113.389 176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 38.0 p-90 -121.3 129.2 52.99 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.945 0.402 . . . . 71.24 111.445 -178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -152.82 145.0 16.87 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 112.264 0.468 . . . . 63.4 112.264 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -90.07 124.86 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.928 2.419 . . . . 51.12 112.974 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.92 176.6 25.72 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.003 -0.618 . . . . 72.14 113.39 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.5 tp -97.48 132.12 43.47 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.797 0.332 . . . . 74.0 110.868 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 24.5 t-20 -95.03 143.36 26.56 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.388 -0.369 . . . . 72.13 111.14 178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -84.77 -55.79 3.92 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.607 0.595 . . . . 45.34 112.607 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 48.2 ttt180 -64.63 -56.0 16.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.229 0.455 . . . . 63.22 112.229 -174.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.4 p -81.45 -17.06 50.09 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 111.88 0.326 . . . . 70.41 111.88 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 77.1 mtp180 61.64 18.11 9.25 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.004 0.522 . . . . 71.33 112.406 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.44 ' HB2' HD13 ' A' ' 23' ' ' LEU . 96.5 mt-30 -86.53 164.68 16.77 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.256 0.551 . . . . 72.31 111.904 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 41.9 mtm180 -128.92 131.58 47.57 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.896 -0.593 . . . . 75.12 110.666 178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 172.23 -170.28 43.31 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.381 -0.914 . . . . 61.4 113.764 177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -89.18 123.19 33.2 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 122.424 0.29 . . . . 62.21 110.941 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -129.83 151.3 77.95 Favored Pre-proline 0 CA--C 1.542 0.638 0 CA-C-O 120.662 0.268 . . . . 53.14 111.432 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 88.1 Cg_endo -77.29 120.43 5.31 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.486 2.124 . . . . 64.55 112.91 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 51' ' ' PRO . . . -77.64 16.17 6.83 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.391 -0.433 . . . . 61.2 113.943 -178.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 23.1 m -81.3 -20.65 40.36 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.251 -0.558 . . . . 61.21 111.615 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -104.88 12.3 32.67 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.368 0.507 . . . . 73.54 112.368 -176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.542 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 33.2 m -121.95 146.03 27.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 113.366 0.876 . . . . 71.33 113.366 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 9' ' ' TYR . 5.8 mm-40 -93.68 130.74 39.51 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.605 -0.725 . . . . 71.43 111.524 176.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -70.36 100.21 1.7 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.041 0.448 . . . . 74.54 110.416 173.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.427 HD11 ' HB2' ' A' ' 10' ' ' ARG . 64.0 mt -74.8 -47.69 29.31 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 116.365 -0.38 . . . . 63.33 111.376 -177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.78 177.02 22.63 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 120.639 -0.791 . . . . 54.4 113.885 177.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.596 ' HB3' ' HB3' ' A' ' 4' ' ' PRO . 5.5 Cg_exo -80.27 137.61 12.06 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.545 2.83 . . . . 54.44 112.871 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.775 HD11 ' HG3' ' A' ' 8' ' ' GLN . 5.8 mp -80.11 148.32 31.04 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.869 0.366 . . . . 52.5 111.634 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.807 -0.616 . . . . 75.42 111.208 176.638 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.736 0.303 . . . . 62.3 111.501 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.14 -158.19 0.27 Allowed 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 116.601 -0.272 . . . . 73.41 111.628 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -173.49 -82.21 0.05 OUTLIER Glycine 0 CA--C 1.537 1.463 0 C-N-CA 119.96 -1.115 . . . . 53.14 115.302 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.96 16.01 0.15 Allowed 'Trans proline' 0 CA--C 1.549 1.257 0 C-N-CA 123.183 2.589 . . . . 64.25 116.457 -167.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -62.78 -31.38 72.33 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 118.809 0.731 . . . . 72.13 111.002 176.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.17 -174.73 42.03 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.608 -0.723 . . . . 32.33 112.166 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -131.55 146.15 52.08 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.129 0.49 . . . . 75.21 111.946 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.621 HE21 ' HB3' ' A' ' 81' ' ' LEU . 77.9 mt-30 -101.43 128.33 47.68 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 116.048 -0.524 . . . . 74.25 111.416 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.37 128.15 53.8 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.318 -0.401 . . . . 72.04 110.715 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.571 ' HB2' HD11 ' A' ' 78' ' ' LEU . 55.8 ttp180 -98.11 120.97 39.45 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.144 0.424 . . . . 62.31 112.144 -176.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB3' ' HB2' ' A' ' 29' ' ' ASP . . . -74.07 114.72 12.72 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.229 -0.441 . . . . 64.33 111.313 177.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.3 mt -82.21 -43.67 17.35 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.17 0.433 . . . . 75.15 112.17 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -117.65 140.93 28.18 Favored Pre-proline 0 N--CA 1.472 0.656 0 N-CA-C 112.122 0.416 . . . . 61.33 112.122 -175.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.533 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 35.5 Cg_endo -65.74 123.59 11.58 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.444 2.096 . . . . 60.13 112.935 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -116.38 113.6 23.12 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.186 -0.461 . . . . 74.51 111.313 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ptm180 -89.2 147.61 24.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.471 -0.332 . . . . 75.14 110.401 173.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.614 ' HG2' ' HB2' ' A' ' 22' ' ' ASP . 29.3 tpt180 -119.23 124.34 46.5 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.753 0.311 . . . . 64.32 111.144 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -59.75 -28.07 67.06 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 121.213 0.53 . . . . 61.23 111.472 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -117.37 113.25 38.93 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 116.4 -0.364 . . . . 65.13 110.272 174.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.09 6.58 0.17 Allowed 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.196 2.597 . . . . 72.42 114.551 -174.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -71.93 -24.28 61.6 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 111.945 0.35 . . . . 64.32 111.945 178.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.614 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 6.0 m-20 -94.53 -169.72 2.1 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.753 0.311 . . . . 74.3 111.381 178.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.532 HD21 ' HB2' ' A' ' 61' ' ' ASN . 45.9 tp -107.8 119.63 39.98 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.871 0.367 . . . . 70.03 111.78 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -84.53 142.41 30.04 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.431 -0.35 . . . . 64.2 110.84 176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 66.2 mt -116.16 141.96 47.45 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.128 0.418 . . . . 41.01 112.128 -173.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.86 153.51 46.97 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 122.721 0.408 . . . . 45.02 110.766 175.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.533 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 29.5 Cg_endo -61.69 117.21 4.01 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.602 2.202 . . . . 74.22 113.206 -176.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.28 16.85 33.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-N 116.154 -0.476 . . . . 60.21 113.826 177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.52 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 9.6 m-20 -77.22 135.67 38.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.877 0.695 . . . . 50.33 112.877 178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -100.24 97.06 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.15 0.5 . . . . 63.32 110.24 172.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.6 mp -81.98 132.89 35.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.097 0.475 . . . . 71.13 111.902 -176.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.493 HG13 HD22 ' A' ' 81' ' ' LEU . 66.8 t -94.05 109.41 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-N 116.047 -0.524 . . . . 71.32 111.142 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -118.19 117.91 56.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 121.011 0.434 . . . . 70.04 111.281 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.7 p -68.02 141.46 56.21 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.801 0.334 . . . . 73.0 111.519 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -67.01 -23.75 65.95 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.023 0.44 . . . . 74.04 110.803 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.52 -38.24 89.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.182 -0.463 . . . . 70.3 111.191 174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.93 -44.16 97.62 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.899 0.38 . . . . 73.55 111.288 177.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.84 -45.14 90.76 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.983 0.421 . . . . 64.0 110.654 175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -59.77 -40.39 88.08 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.239 -0.437 . . . . 71.23 111.265 176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.23 79.78 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.028 0.442 . . . . 64.2 111.537 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 90.2 mt -75.18 -17.63 60.34 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.159 -0.473 . . . . 74.15 111.192 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.0 18.18 38.04 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 121.499 -0.382 . . . . 63.34 113.396 179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.6 t -83.57 114.43 24.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 N-CA-C 112.024 0.379 . . . . 71.3 112.024 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -91.59 151.04 20.89 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.383 -0.371 . . . . 55.44 111.098 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.14 146.05 5.33 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.278 0.561 . . . . 73.32 111.794 179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.14 -26.3 24.78 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.77 -0.532 . . . . 5.12 111.77 -172.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.86 1.47 17.5 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.508 -0.377 . . . . 71.22 112.673 174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.89 -38.41 90.98 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.089 0.471 . . . . 73.44 111.611 -176.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -81.5 9.84 6.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.291 0.478 . . . . 61.13 112.291 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 94.0 m -122.39 72.9 39.26 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-O 120.85 0.357 . . . . 75.34 111.897 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.465 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 34.1 Cg_endo -63.66 -23.08 70.01 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.67 2.247 . . . . 74.02 112.773 -178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -57.44 -34.56 69.09 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.314 -0.403 . . . . 64.53 111.357 176.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 t -71.77 -41.61 68.15 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.93 0.395 . . . . 73.12 111.229 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.3 t -65.46 -38.33 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 116.123 -0.49 . . . . 55.05 111.594 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.95 -79.06 0.88 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 121.244 -0.503 . . . . 73.13 112.913 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -121.14 142.36 49.94 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 122.674 -0.309 . . . . 71.42 110.9 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 56.6 mtm -138.88 140.68 27.85 Favored Pre-proline 0 N--CA 1.471 0.604 0 O-C-N 122.247 -0.283 . . . . 55.3 111.488 178.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -83.19 117.51 2.52 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.584 2.189 . . . . 75.03 112.524 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -148.72 178.26 26.41 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.732 -0.747 . . . . 73.2 113.77 -178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 59.4 tp -104.24 132.67 50.25 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.961 0.41 . . . . 74.03 111.733 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.532 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.9 t-20 -99.98 149.25 23.64 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 116.271 -0.422 . . . . 74.44 111.348 178.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -92.01 -35.78 13.76 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 112.587 0.588 . . . . 74.31 112.587 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.416 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 13.8 tpp180 -56.72 -51.61 68.15 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.204 0.526 . . . . 75.21 111.315 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.9 p -100.14 -15.04 18.3 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.688 -0.687 . . . . 72.24 111.885 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.438 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 62.4 mtp180 64.2 18.08 11.06 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 122.795 0.438 . . . . 73.44 112.131 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -103.39 157.5 16.99 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.151 0.501 . . . . 72.21 112.228 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.444 HH11 ' HD2' ' A' ' 67' ' ' ARG . 19.5 mtp180 -98.3 149.68 22.36 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.206 -0.452 . . . . 71.43 111.247 174.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.27 -178.72 47.62 Favored Glycine 0 CA--C 1.522 0.521 0 C-N-CA 120.93 -0.652 . . . . 74.12 112.894 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.13 124.99 40.35 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.595 0.236 . . . . 74.52 110.752 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -123.65 143.0 40.59 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 120.838 0.351 . . . . 63.44 111.668 -178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.66 116.07 4.24 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.659 2.239 . . . . 75.42 112.361 174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -59.59 -17.57 41.5 Favored Glycine 0 CA--C 1.532 1.136 0 N-CA-C 114.715 0.646 . . . . 64.55 114.715 -174.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.418 HG23 ' CD1' ' A' ' 74' ' ' TYR . 3.4 t -57.0 -32.46 66.14 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.799 0.666 . . . . 62.4 112.799 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.418 ' CD1' HG23 ' A' ' 73' ' ' THR . 95.9 m-85 -81.31 -16.9 51.08 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 112.663 0.616 . . . . 74.4 112.663 -177.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -108.92 145.42 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 112.419 0.526 . . . . 54.42 112.419 -175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -111.53 154.71 24.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.058 -0.519 . . . . 52.0 110.857 174.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -84.07 126.51 33.14 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.824 0.345 . . . . 71.52 111.612 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 10' ' ' ARG . 83.9 mt -100.03 -68.11 0.82 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.056 0.455 . . . . 73.21 111.232 178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -176.83 -178.69 46.78 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.232 -0.508 . . . . 60.23 113.103 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -72.84 166.21 30.61 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.293 2.662 . . . . 44.01 113.233 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.621 ' HB3' HE21 ' A' ' 8' ' ' GLN . 3.4 pp -127.62 151.18 49.25 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.306 0.484 . . . . 75.21 112.306 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 . . . . . 0 C--O 1.254 1.317 0 CA-C-O 118.328 -0.844 . . . . 72.34 112.04 179.016 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.588 0.232 . . . . 72.3 111.077 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.16 149.35 10.39 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.704 0.287 . . . . 75.34 111.73 -177.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -120.87 91.12 0.48 Allowed Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.54 -0.362 . . . . 55.22 112.832 177.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.646 ' HD2' HD22 ' A' ' 81' ' ' LEU . 60.4 Cg_endo -70.36 176.1 7.68 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.757 2.305 . . . . 65.34 114.105 -177.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 35' ' ' ARG . 12.3 mm-40 -77.35 12.59 1.46 Allowed 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 115.519 -0.764 . . . . 63.1 112.576 -178.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . -91.39 -167.5 40.91 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 120.999 -0.619 . . . . 44.24 114.421 -173.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -119.54 147.86 43.97 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 120.988 0.423 . . . . 73.31 111.412 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.484 ' HG2' HG22 ' A' ' 32' ' ' VAL . 45.9 mt-30 -92.75 133.11 36.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.899 0.38 . . . . 75.14 111.258 176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -118.38 139.16 51.8 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.293 -0.412 . . . . 75.0 110.661 176.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.504 ' HB2' HD11 ' A' ' 78' ' ' LEU . 36.1 ttm180 -107.99 127.69 53.99 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.947 -0.47 . . . . 74.12 111.984 -178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.37 128.2 33.99 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.457 -0.338 . . . . 74.43 110.592 175.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.6 mt -68.28 -62.15 1.53 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.372 0.606 . . . . 74.22 111.821 -176.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.549 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.0 m-85 -118.19 171.91 4.67 Favored Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.979 -0.555 . . . . 63.12 110.314 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -70.8 117.73 5.3 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 120.902 1.068 . . . . 63.33 111.261 170.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.496 ' HB2' ' HB2' ' A' ' 25' ' ' LEU . 83.8 m-85 -112.86 122.1 46.65 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.306 0.574 . . . . 73.34 111.763 -177.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -82.76 153.93 25.01 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.238 -0.892 . . . . 54.04 111.901 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -116.73 154.81 29.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.903 0.382 . . . . 75.14 111.501 178.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.1 -42.33 84.76 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.898 0.38 . . . . 60.53 111.653 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 62.0 mtp85 -121.98 147.76 49.72 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-N 116.509 -0.314 . . . . 73.34 111.162 -177.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 15.3 Cg_exo -69.5 -2.15 9.49 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.976 2.451 . . . . 75.02 112.844 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -80.38 -16.13 55.22 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.254 0.55 . . . . 64.34 111.355 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.81 -165.21 1.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.991 -0.55 . . . . 74.33 111.305 178.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 43.4 tp -125.13 123.7 40.25 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.888 0.375 . . . . 72.32 110.936 175.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 mp0 -75.95 155.8 34.76 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.006 0.432 . . . . 65.2 111.393 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 97.5 mt -112.12 143.05 43.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.48 -0.327 . . . . 74.3 111.277 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -114.66 154.34 46.74 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 122.596 0.359 . . . . 71.44 111.116 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -62.77 120.45 7.97 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 122.454 2.102 . . . . 62.03 113.207 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.73 20.07 69.9 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 116.165 -0.47 . . . . 73.33 113.58 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -86.82 155.57 20.24 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.377 -0.484 . . . . 72.52 111.349 -177.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.9 t -108.35 129.57 62.48 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-O 121.233 0.539 . . . . 41.55 112.056 -175.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' HA ' ' O ' ' A' ' 60' ' ' LEU . 4.9 mp -124.37 121.31 34.58 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.112 -0.494 . . . . 73.43 110.527 175.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.493 HG13 HD11 ' A' ' 81' ' ' LEU . 48.9 t -94.12 124.09 46.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.332 0.493 . . . . 65.33 112.332 -175.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.5 t -114.97 118.28 58.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 120.979 0.418 . . . . 44.34 111.265 177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.492 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 50.5 m -68.28 142.39 55.58 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 111.993 0.368 . . . . 44.22 111.993 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' A' ' 5' ' ' GLU . 57.1 mtm180 -60.55 -30.43 69.77 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 120.986 0.422 . . . . 74.21 111.452 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.57 -45.4 81.32 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.131 0.491 . . . . 74.31 111.009 173.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -40.83 98.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.114 -0.494 . . . . 72.35 111.298 177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.3 mt -56.84 -46.82 81.47 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.918 0.39 . . . . 74.45 111.021 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -61.64 -39.69 92.22 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.396 -0.366 . . . . 54.43 111.442 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.97 -43.94 91.45 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.952 0.406 . . . . 72.34 111.005 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 58' ' ' PRO . 91.3 mt -66.77 -28.63 68.55 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.234 -0.439 . . . . 73.51 111.462 175.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.31 27.6 9.15 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.424 -0.417 . . . . 61.25 113.042 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.2 t -91.3 118.48 36.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.96 0.41 . . . . 51.14 111.097 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.52 149.81 29.86 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.305 -0.407 . . . . 63.11 111.866 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -58.18 119.19 6.4 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.01 0.434 . . . . 73.3 111.086 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.77 -4.82 18.97 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-N 116.049 -0.523 . . . . 64.3 112.327 -173.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.04 -33.28 2.41 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 121.697 -0.287 . . . . 62.25 113.1 178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.98 -21.19 28.5 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 122.989 0.515 . . . . 74.23 112.222 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -57.81 -21.25 41.1 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 116.416 -0.356 . . . . 63.53 111.714 176.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.54 88.42 29.21 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.664 0.269 . . . . 72.42 110.951 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -57.69 -16.94 26.82 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.98 2.454 . . . . 61.4 113.318 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -57.64 -22.39 45.33 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.818 0.342 . . . . 64.34 111.889 175.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.0 t -77.81 -9.75 59.2 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.798 0.333 . . . . 64.42 111.813 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.1 t -106.55 -37.81 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 CA-C-O 121.085 0.469 . . . . 65.42 111.626 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.43 -78.19 0.84 Allowed Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.227 -0.511 . . . . 53.23 112.798 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -120.85 137.41 54.58 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.087 0.47 . . . . 74.12 111.223 177.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 71.1 mtp -139.49 139.39 22.37 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-N 116.221 -0.445 . . . . 72.14 111.623 -172.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.538 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.1 Cg_endo -82.16 117.4 2.84 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.304 2.003 . . . . 65.31 112.464 174.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.55 171.55 25.21 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 120.775 -0.726 . . . . 65.03 113.697 -178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 40.0 tp -96.74 109.15 21.87 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.594 0.358 . . . . 61.14 111.043 -178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -79.72 116.61 20.0 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.46 -0.336 . . . . 71.11 111.546 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -69.9 -21.49 63.3 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.733 0.642 . . . . 72.42 112.733 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.49 ' HA ' ' CZ ' ' A' ' 63' ' ' ARG . 0.9 OUTLIER -60.58 -35.58 76.43 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.04 0.448 . . . . 73.54 111.325 176.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 82.0 p -119.57 -8.6 9.95 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.353 -0.385 . . . . 75.53 111.918 -179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.6 mmm-85 62.35 17.61 9.55 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.381 0.672 . . . . 64.41 111.685 -173.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -107.07 154.31 21.33 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.307 0.575 . . . . 72.31 111.931 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 48.9 ttp180 -101.18 134.67 43.85 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.948 -0.569 . . . . 72.24 111.219 -177.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.0 172.11 34.52 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 120.979 -0.629 . . . . 73.11 112.985 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.7 113.18 25.2 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 120.906 0.384 . . . . 54.12 110.482 178.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.2 p90 -121.52 149.27 52.22 Favored Pre-proline 0 N--CA 1.47 0.551 0 CA-C-N 116.414 -0.357 . . . . 72.25 111.493 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' HB2' ' CD2' ' A' ' 74' ' ' TYR . 18.1 Cg_exo -66.29 95.15 0.31 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.355 2.037 . . . . 74.41 112.638 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.18 -19.69 40.0 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 116.085 -0.507 . . . . 40.14 113.534 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.0 t -61.79 -15.1 38.72 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 112.389 0.514 . . . . 63.22 112.389 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' HB3' ' CE2' ' A' ' 15' ' ' PHE . 35.8 m-85 -102.06 -1.54 31.44 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.623 0.601 . . . . 71.01 112.623 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.3 m -113.99 163.89 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 CA-C-O 121.187 0.518 . . . . 73.13 112.153 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -117.08 148.75 41.25 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.106 -0.497 . . . . 73.51 111.714 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -79.02 118.22 20.81 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.071 -0.513 . . . . 75.02 111.642 178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.504 HD11 ' HB2' ' A' ' 10' ' ' ARG . 70.9 mt -89.97 -66.26 0.94 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 71.14 111.087 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.19 39.02 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 121.135 -0.555 . . . . 72.25 113.188 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.4 152.38 38.88 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.85 2.366 . . . . 61.31 113.083 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD22 ' HD2' ' A' ' 4' ' ' PRO . 4.9 mp -80.79 112.48 18.21 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.883 0.373 . . . . 72.02 111.201 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.874 -0.584 . . . . 72.31 110.113 179.905 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.719 0.295 . . . . 71.44 111.311 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.0 -71.11 0.15 Allowed 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.24 0.459 . . . . 61.01 112.24 -177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 160.45 179.14 35.02 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 120.724 -0.751 . . . . 43.24 113.334 178.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.54 90.98 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.177 2.585 . . . . 64.41 113.066 176.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 35' ' ' ARG . 1.1 mp0 -57.43 -29.77 64.44 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.396 0.517 . . . . 52.44 112.396 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.72 -172.75 44.51 Favored Glycine 0 CA--C 1.521 0.417 0 C-N-CA 120.879 -0.677 . . . . 73.04 113.328 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -129.22 171.3 12.58 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.093 0.473 . . . . 64.11 111.358 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -129.91 136.81 49.92 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.19 0.519 . . . . 53.32 111.811 -177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 94.5 m-85 -116.05 170.74 8.26 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.852 -0.613 . . . . 71.32 110.601 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.462 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.4 ttm180 -135.75 128.69 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.569 0.223 . . . . 63.13 111.275 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.529 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -66.08 114.67 5.4 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.915 0.388 . . . . 63.12 111.858 178.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.3 mt -81.45 -58.33 3.08 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.167 -0.47 . . . . 75.41 111.569 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -115.67 150.21 44.38 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 116.595 -0.275 . . . . 73.25 111.228 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 56.3 Cg_endo -70.91 118.05 5.48 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.16 1.906 . . . . 75.1 112.657 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.419 ' HZ ' ' NH2' ' A' ' 17' ' ' ARG . 87.4 t80 -121.44 133.3 55.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 72.55 110.979 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 16' ' ' ARG . 45.1 mtm180 -125.71 159.04 33.31 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.179 0.514 . . . . 65.23 111.598 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.419 ' NH2' ' HZ ' ' A' ' 15' ' ' PHE . 1.0 OUTLIER -122.53 145.54 48.24 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 115.951 -0.568 . . . . 74.21 109.854 177.816 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.833 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 10.1 pt-20 -58.9 -21.48 57.72 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.053 0.454 . . . . 72.43 111.585 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.833 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 81.1 mtt180 -129.08 153.1 80.29 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.251 -0.431 . . . . 75.34 110.476 -179.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.56 6.51 1.55 Allowed 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.643 2.228 . . . . 74.44 113.032 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -58.19 -54.03 51.55 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 122.899 0.48 . . . . 44.43 112.116 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -84.76 -179.92 7.21 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 120.836 0.35 . . . . 60.52 111.042 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.7 tp -100.73 119.8 39.15 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.908 0.385 . . . . 74.5 111.161 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -79.56 138.15 37.38 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.409 -0.36 . . . . 75.13 110.799 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 70' ' ' PHE . 69.0 mt -122.69 138.7 54.53 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.866 0.365 . . . . 54.12 111.898 -174.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.551 ' HB2' ' NE ' ' A' ' 63' ' ' ARG . 3.9 mm? -122.11 140.73 32.86 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 122.666 0.386 . . . . 42.22 110.568 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -57.91 106.31 0.25 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.423 2.082 . . . . 40.24 113.257 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 125.56 -1.05 8.07 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 115.086 0.794 . . . . 75.01 115.086 175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -94.79 156.4 16.39 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.703 1.252 . . . . 70.4 111.903 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 69.8 t -101.87 133.71 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.755 -0.657 . . . . 55.4 111.401 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.1 mp -106.59 110.28 22.44 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.014 -0.539 . . . . 64.4 110.591 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.51 120.18 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.907 0.384 . . . . 73.31 111.832 -177.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 47.2 t -125.93 135.27 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 116.388 -0.369 . . . . 54.44 111.473 -178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 97.7 p -91.96 148.22 22.37 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.247 -0.283 . . . . 53.03 111.283 178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 5' ' ' GLU . 24.7 ptt180 -58.43 -28.43 65.26 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 111.953 0.353 . . . . 53.25 111.953 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.35 -39.48 70.1 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 120.924 0.392 . . . . 61.13 111.639 177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.17 -45.12 77.93 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.036 -0.529 . . . . 51.03 111.33 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 91.2 mt -59.84 -42.48 93.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.198 -0.456 . . . . 55.44 111.211 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 15.3 mm100 -61.9 -39.07 90.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.3 -0.409 . . . . 75.3 111.185 176.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -43.03 96.4 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 120.945 0.402 . . . . 71.54 111.346 177.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.448 HD11 ' HD2' ' A' ' 58' ' ' PRO . 84.2 mt -66.69 -24.72 66.3 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.177 0.513 . . . . 61.51 111.084 175.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.13 20.68 52.25 Favored Glycine 0 CA--C 1.526 0.759 0 CA-C-N 115.879 -0.601 . . . . 32.12 113.177 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.3 t -66.0 125.03 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.946 0.373 . . . . 62.34 111.049 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.38 131.2 45.24 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 116.577 -0.283 . . . . 63.33 111.491 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -56.06 126.96 28.24 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.326 0.584 . . . . 74.15 111.188 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.1 -2.89 51.36 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 116.071 -0.513 . . . . 74.1 112.157 -173.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.87 -7.73 16.92 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.64 -0.314 . . . . 62.43 113.312 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -69.5 -20.07 63.72 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 121.008 0.432 . . . . 62.11 111.732 -178.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 67.8 mtp180 -71.2 -13.7 62.01 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.463 -0.335 . . . . 74.44 111.738 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 60.9 m -119.77 84.58 31.66 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-O 120.829 0.347 . . . . 44.21 111.437 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -63.73 -27.19 68.24 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.504 2.136 . . . . 74.22 112.937 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HG3' ' HA ' ' A' ' 73' ' ' THR . 22.0 mp0 -67.18 -17.47 64.85 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.102 0.477 . . . . 52.24 111.285 178.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.0 m -87.31 -25.21 24.02 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.303 -0.408 . . . . 63.44 111.415 177.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.7 t -88.08 -55.16 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 120.95 0.405 . . . . 73.51 111.609 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.8 -92.23 0.5 Allowed Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.17 -0.538 . . . . 33.55 112.573 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -121.14 141.44 50.82 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.01 0.433 . . . . 72.55 111.788 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -138.17 146.9 53.76 Favored Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 116.534 -0.303 . . . . 62.0 110.948 177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' HD11 ' A' ' 41' ' ' LEU . 91.6 Cg_endo -79.19 126.65 7.1 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.341 2.028 . . . . 64.31 112.838 175.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.06 172.88 31.33 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.006 -0.616 . . . . 65.31 113.535 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.8 tp -97.47 119.12 35.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 122.263 0.225 . . . . 71.42 111.472 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.468 ' HB2' HD21 ' A' ' 23' ' ' LEU . 26.0 t-20 -90.95 121.42 32.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 116.573 -0.285 . . . . 71.14 110.593 176.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -73.65 -8.1 54.61 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 113.849 1.055 . . . . 73.51 113.849 -173.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.551 ' NE ' ' HB2' ' A' ' 26' ' ' LEU . 57.7 mtt-85 -81.7 -54.39 5.42 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.569 -0.707 . . . . 71.23 111.117 177.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.416 ' O ' ' HG2' ' A' ' 66' ' ' GLN . 64.3 p -86.81 -11.59 50.49 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.492 -0.322 . . . . 75.42 111.382 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 62.65 16.94 9.3 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.131 0.573 . . . . 74.44 111.681 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' A' ' 64' ' ' THR . 68.3 mm-40 -107.41 152.84 23.64 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.049 0.452 . . . . 74.53 111.456 -178.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.62 129.6 45.13 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.036 0.446 . . . . 72.42 111.199 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -156.91 173.62 34.56 Favored Glycine 0 CA--C 1.525 0.664 0 C-N-CA 121.156 -0.545 . . . . 73.43 113.146 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -88.41 118.82 28.3 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.903 0.382 . . . . 75.11 110.83 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.459 ' HB2' HD11 ' A' ' 25' ' ' LEU . 54.0 p90 -117.31 148.79 43.36 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.035 0.383 . . . . 75.34 112.035 -176.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.88 109.25 2.83 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.569 2.179 . . . . 52.22 112.347 173.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -63.65 -17.95 60.89 Favored Glycine 0 CA--C 1.531 1.068 0 N-CA-C 115.079 0.791 . . . . 64.11 115.079 -173.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.601 ' HA ' ' HG3' ' A' ' 52' ' ' GLN . 12.6 t -65.55 -15.28 62.55 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 117.791 0.795 . . . . 54.42 112.408 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -99.79 2.98 44.56 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.126 0.417 . . . . 74.42 112.126 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.529 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.5 m -123.98 153.07 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.002 0.429 . . . . 64.34 112.102 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.462 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 12.9 pt-20 -100.38 154.59 18.39 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.474 -0.33 . . . . 54.24 111.304 176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -89.93 113.74 25.43 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.722 0.296 . . . . 54.02 111.102 178.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.2 mt -85.12 -61.72 1.7 Allowed 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.981 0.419 . . . . 74.11 111.526 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.23 -155.01 26.1 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.241 -0.504 . . . . 71.24 112.784 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.33 152.62 39.49 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.7 2.266 . . . . 74.33 113.176 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -91.3 161.06 15.19 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.75 0.648 . . . . 70.52 112.75 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.441 ' H ' ' CD ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.126 0 CA-C-O 118.352 -0.833 . . . . 63.42 111.74 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.043 0.449 . . . . 72.02 111.479 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.49 -64.23 1.31 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.002 -0.545 . . . . 74.45 110.496 177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.45 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 76.12 -124.84 7.5 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 114.502 0.561 . . . . 72.21 114.502 177.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 13.1 Cg_exo -71.05 24.96 0.21 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 123.663 2.908 . . . . 71.12 115.0 -173.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -58.41 -30.92 67.24 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.208 0.527 . . . . 64.11 111.163 177.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.6 -168.51 34.76 Favored Glycine 0 CA--C 1.524 0.609 0 CA-C-N 116.0 -0.545 . . . . 73.24 112.727 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.14 135.55 49.93 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.965 0.412 . . . . 74.1 111.085 179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.423 ' HG2' HG22 ' A' ' 32' ' ' VAL . 99.2 mt-30 -97.76 136.1 38.58 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.319 0.58 . . . . 72.3 112.456 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -113.26 169.28 9.06 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.735 -0.666 . . . . 73.22 110.382 174.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.538 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 16.1 ttm-85 -119.23 127.76 53.57 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 121.985 -0.447 . . . . 74.02 111.692 178.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.575 ' HB2' HD11 ' A' ' 31' ' ' LEU . . . -81.04 116.68 21.11 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.783 0.325 . . . . 64.04 110.564 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 77.1 mt -75.09 -50.41 16.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.226 0.454 . . . . 73.13 112.226 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -124.15 156.77 65.9 Favored Pre-proline 0 N--CA 1.473 0.685 0 N-CA-C 111.868 0.321 . . . . 72.33 111.868 -176.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 55.9 Cg_endo -72.0 128.31 13.86 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.517 2.145 . . . . 62.25 113.496 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -124.97 123.4 39.8 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.037 -0.529 . . . . 64.22 110.915 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 12.7 ptt180 -110.53 133.81 52.95 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.127 -0.488 . . . . 71.15 110.163 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.553 ' HG3' ' HB3' ' A' ' 22' ' ' ASP . 5.5 mmt85 -134.22 117.52 16.57 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.961 0.726 . . . . 73.51 112.961 -175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -64.75 -26.47 68.37 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.768 -0.651 . . . . 71.12 110.784 172.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 19' ' ' ARG . 11.8 mmt180 -88.65 112.0 47.63 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-N 115.831 -0.622 . . . . 73.34 111.18 174.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -63.94 -2.24 4.37 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.865 2.376 . . . . 62.24 113.346 -179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -58.5 -39.22 79.44 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.106 0.479 . . . . 72.14 110.906 172.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.553 ' HB3' ' HG3' ' A' ' 17' ' ' ARG . 10.3 t70 -92.55 -154.41 0.38 Allowed 'General case' 0 CA--C 1.551 0.988 0 CA-C-N 115.759 -0.655 . . . . 72.32 109.281 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.539 HD21 ' HB2' ' A' ' 61' ' ' ASN . 42.9 tp -156.0 137.78 14.31 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.448 -0.782 . . . . 74.1 112.407 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -57.62 105.9 0.29 Allowed 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.746 0.307 . . . . 72.34 111.776 174.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 67.7 mt -106.84 142.43 36.48 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.851 0.357 . . . . 61.4 111.38 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -115.3 150.69 44.87 Favored Pre-proline 0 N--CA 1.474 0.771 0 CA-C-N 116.473 -0.33 . . . . 71.51 111.394 -178.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 44.9 Cg_endo -66.8 115.96 3.86 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.381 2.054 . . . . 75.41 112.629 -178.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.23 21.76 53.88 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.109 -0.567 . . . . 73.21 112.815 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.5 162.17 14.66 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.008 0.432 . . . . 74.35 111.175 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 62.8 t -114.17 131.87 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.231 0.538 . . . . 64.15 111.334 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD11 ' HB2' ' A' ' 11' ' ' ALA . 6.1 mp -108.07 116.84 32.69 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.876 0.37 . . . . 64.42 110.998 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.423 HG22 ' HG2' ' A' ' 8' ' ' GLN . 60.9 t -93.68 108.73 20.92 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.996 0.427 . . . . 72.23 111.654 -177.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.9 t -105.88 128.76 59.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-N 116.339 -0.392 . . . . 74.1 110.697 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 87.7 p -71.28 147.33 48.26 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.968 0.413 . . . . 70.44 111.74 -178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 -59.04 -35.48 73.38 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.969 0.414 . . . . 73.53 110.21 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.28 89.95 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.783 -0.644 . . . . 53.4 111.379 176.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -57.73 -47.87 81.2 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 120.842 0.353 . . . . 74.1 111.557 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.8 mt -61.83 -45.24 94.65 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.695 0.284 . . . . 63.42 111.453 178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -60.48 -37.87 82.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.874 0.368 . . . . 71.43 110.972 176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.92 -40.46 87.64 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.893 0.378 . . . . 72.5 111.401 176.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HB2' HG23 ' A' ' 43' ' ' VAL . 90.8 mt -66.78 -20.16 65.89 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.986 0.422 . . . . 73.54 111.273 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.94 22.05 53.86 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 121.346 -0.454 . . . . 71.14 112.803 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 41' ' ' LEU . 60.3 t -68.43 104.45 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.036 0.446 . . . . 70.02 110.923 179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.52 147.0 53.39 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.047 -0.524 . . . . 71.31 112.21 -178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -56.99 104.76 0.17 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.071 -0.513 . . . . 44.33 110.995 178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.606 ' HA2' HH21 ' A' ' 49' ' ' ARG . . . 136.06 -18.77 3.73 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.877 -0.601 . . . . 64.15 112.372 -173.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -101.18 -12.51 36.12 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.356 -0.449 . . . . 73.24 113.833 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -27.51 69.28 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.406 0.622 . . . . 74.1 111.331 -178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.606 HH21 ' HA2' ' A' ' 46' ' ' GLY . 36.1 mtm180 -80.27 9.15 6.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.963 -0.562 . . . . 74.13 112.069 176.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.631 ' SG ' ' NE2' ' A' ' 52' ' ' GLN . 50.0 t -138.37 75.2 39.73 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-O 121.16 0.505 . . . . 62.3 111.106 176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -62.6 -34.4 74.84 Favored 'Trans proline' 0 CA--C 1.538 0.698 0 C-N-CA 122.687 2.258 . . . . 74.5 113.143 -175.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.631 ' NE2' ' SG ' ' A' ' 50' ' ' CYS . 4.7 pp0? -64.88 -29.32 70.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.028 0.381 . . . . 73.12 112.028 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.523 ' HB2' ' SG ' ' A' ' 50' ' ' CYS . 31.7 t -74.28 -37.72 63.62 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.848 0.356 . . . . 74.43 110.687 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.8 t -66.9 -40.26 85.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 120.925 0.393 . . . . 64.54 111.244 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.14 -133.09 11.39 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.2 -0.524 . . . . 75.22 113.456 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.523 ' HE3' ' HB3' ' A' ' 69' ' ' ASP . 37.3 m95 -73.03 116.95 14.17 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.011 0.434 . . . . 74.4 111.325 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 63.0 mtm -121.26 140.35 31.1 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.311 -0.404 . . . . 71.23 111.436 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD2' HD11 ' A' ' 41' ' ' LEU . 92.2 Cg_endo -78.91 121.04 4.85 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 122.551 2.167 . . . . 53.53 112.657 175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.46 170.23 27.55 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.722 -0.751 . . . . 71.41 113.98 -178.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 66.4 tp -97.81 132.16 43.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 122.802 0.441 . . . . 71.25 111.57 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.539 ' HB2' HD21 ' A' ' 23' ' ' LEU . 28.2 t-20 -88.6 116.45 26.85 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.48 -0.327 . . . . 72.21 110.698 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -66.51 -19.51 65.8 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.119 0.785 . . . . 73.45 113.119 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -73.55 -64.29 1.02 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.342 0.591 . . . . 72.52 111.536 177.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 65' ' ' ARG . 78.7 p -89.01 -21.41 23.5 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.986 -0.552 . . . . 72.41 112.412 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 64' ' ' THR . 3.0 mpt_? 70.57 19.12 6.28 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.151 0.58 . . . . 74.44 111.832 -174.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -86.25 134.6 33.75 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.344 -0.389 . . . . 54.33 110.611 173.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 58.4 mtm-85 -95.02 126.51 40.41 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.54 -0.3 . . . . 73.43 110.884 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -151.81 -164.03 11.93 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 120.913 -0.66 . . . . 34.44 112.903 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.523 ' HB3' ' HE3' ' A' ' 56' ' ' TRP . 0.3 OUTLIER -109.76 152.98 24.98 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.878 0.371 . . . . 72.34 110.926 176.763 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 50.3 p90 -154.24 138.36 11.08 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.391 -0.368 . . . . 62.41 111.3 178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' HG3' ' CE2' ' A' ' 56' ' ' TRP . 13.6 Cg_exo -70.05 118.98 6.0 Favored 'Trans proline' 0 CA--C 1.541 0.84 0 C-N-CA 122.543 2.162 . . . . 74.35 112.132 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -53.09 -20.56 9.15 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 114.572 0.589 . . . . 54.1 114.572 -177.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 10.0 t -60.84 -16.67 43.76 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.036 0.754 . . . . 73.42 113.036 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HE2' ' HG2' ' A' ' 71' ' ' PRO . 74.6 m-85 -98.37 -4.05 35.68 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.607 0.595 . . . . 72.21 112.607 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.7 m -129.85 160.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 112.432 0.53 . . . . 64.05 112.432 -176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.538 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 11.4 pt-20 -110.06 151.99 26.52 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.348 -0.387 . . . . 75.33 110.776 174.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -82.62 119.03 23.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.849 0.357 . . . . 71.23 111.195 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 92.0 mt -90.55 -61.57 1.65 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.963 0.411 . . . . 75.43 111.151 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.5 -169.16 33.85 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 121.179 -0.534 . . . . 70.15 113.088 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.72 173.24 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 122.611 2.207 . . . . 75.32 113.075 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 81' ' ' LEU . 6.0 mp -96.11 161.4 13.99 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 65.35 111.438 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 118.646 -0.692 . . . . 74.22 111.451 178.196 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtm . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 120.793 0.33 . . . . 75.14 110.615 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.81 168.68 10.66 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.39 0.615 . . . . 71.31 112.414 -176.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.02 88.96 0.18 Allowed Glycine 0 CA--C 1.528 0.888 0 CA-C-N 115.793 -0.639 . . . . 45.11 111.928 176.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -37.8 105.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 124.474 3.449 . . . . 74.01 114.713 -172.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -95.47 -33.19 12.54 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.047 -0.524 . . . . 72.14 110.749 175.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.17 156.24 16.04 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 114.305 0.482 . . . . 50.52 114.305 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -106.75 155.98 19.13 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.74 0.416 . . . . 71.22 110.945 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -103.48 123.28 46.59 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.824 0.676 . . . . 73.3 112.824 -174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -109.79 170.4 8.09 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.93 -0.577 . . . . 72.31 110.04 170.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -150.52 121.24 7.53 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.423 0.527 . . . . 74.42 112.423 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.22 151.48 29.63 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.345 0.593 . . . . 62.31 112.159 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.0 mt -100.64 -29.41 12.33 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.284 0.476 . . . . 64.4 112.284 -179.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -135.35 145.3 53.24 Favored Pre-proline 0 N--CA 1.473 0.686 0 CA-C-O 120.619 0.247 . . . . 73.51 111.329 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.0 Cg_endo -74.04 126.06 10.29 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.445 2.097 . . . . 60.21 113.902 -178.151 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -143.04 112.01 6.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.05 -0.523 . . . . 75.15 110.681 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.77 142.16 47.28 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.039 -0.413 . . . . 73.2 110.825 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.698 ' HA ' ' HE ' ' A' ' 17' ' ' ARG . 0.4 OUTLIER -134.73 146.92 49.87 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.465 0.543 . . . . 74.01 112.465 -175.188 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.47 -35.65 53.57 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.301 -0.863 . . . . 73.24 110.976 175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -81.03 142.12 51.32 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.858 -0.61 . . . . 65.54 111.738 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -69.54 5.87 1.45 Allowed 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.806 2.337 . . . . 73.13 114.433 -176.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -78.77 -8.89 59.19 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.315 0.487 . . . . 65.3 112.315 177.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -136.63 174.73 10.3 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.539 0.685 . . . . 75.14 112.552 -176.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 70' ' ' PHE . 58.6 tp -129.92 148.23 51.76 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.522 -0.763 . . . . 64.22 110.386 174.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -71.11 106.85 3.89 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.883 0.373 . . . . 74.3 111.936 -178.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 91.8 mt -99.78 144.86 28.36 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.237 -0.438 . . . . 70.34 111.712 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.449 HD22 ' C ' ' A' ' 25' ' ' LEU . 4.1 mm? -123.74 155.69 66.11 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 122.889 0.475 . . . . 63.05 111.033 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.9 Cg_endo -70.61 107.9 2.12 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.217 1.944 . . . . 74.04 112.993 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 80.69 40.97 11.5 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 121.147 -0.549 . . . . 63.53 113.183 178.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 54.9 p-10 -99.72 175.12 5.91 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.073 0.463 . . . . 75.33 111.57 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 97.6 t -119.89 134.78 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 120.827 0.346 . . . . 63.1 110.732 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 5.6 mp -118.06 122.24 42.63 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 120.647 0.261 . . . . 60.1 111.036 177.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.2 t -93.43 111.07 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 121.075 0.464 . . . . 64.31 111.242 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG22 ' HA3' ' A' ' 59' ' ' GLY . 48.2 t -111.73 119.2 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 116.455 -0.339 . . . . 52.13 111.529 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.3 m -58.95 127.1 30.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.764 -0.198 . . . . 64.02 111.077 178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -52.27 -35.86 51.22 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.848 0.314 . . . . 71.23 111.848 -179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -52.68 -43.44 65.58 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.535 -0.302 . . . . 51.24 111.799 176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.63 92.22 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 120.949 0.404 . . . . 64.25 111.1 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.427 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 90.3 mt -62.77 -44.86 95.09 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.291 -0.413 . . . . 72.42 110.908 178.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.89 -23.87 66.73 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.219 -0.446 . . . . 70.33 111.514 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.5 -41.86 54.22 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.11 0.481 . . . . 63.41 110.882 173.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 67.8 mt -68.39 -28.37 67.04 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.02 -0.536 . . . . 74.41 111.404 176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.58 23.7 9.95 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-N 116.225 -0.443 . . . . 60.53 113.129 -178.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.427 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.3 t -77.28 100.58 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-O 121.03 0.443 . . . . 73.12 111.144 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.3 149.91 37.02 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.227 -0.442 . . . . 31.42 112.127 -178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -46.16 129.91 10.14 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.144 -0.48 . . . . 74.31 111.58 178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.82 -50.15 0.93 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 116.173 -0.467 . . . . 64.45 112.097 -173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.66 -21.99 65.6 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 121.261 -0.495 . . . . 55.11 112.253 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -51.93 -31.2 27.75 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.415 0.686 . . . . 63.51 111.621 173.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 34.6 mtm180 -85.65 7.04 24.84 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.251 -0.431 . . . . 75.24 111.538 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.539 ' SG ' ' HG2' ' A' ' 52' ' ' GLN . 48.5 t -146.17 68.64 12.62 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 121.019 0.437 . . . . 74.4 110.92 -179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.79 -15.15 47.21 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.005 2.47 . . . . 63.32 113.259 -175.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.539 ' HG2' ' SG ' ' A' ' 50' ' ' CYS . 20.2 pt20 -61.05 -19.46 61.41 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.367 -0.378 . . . . 53.24 111.886 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.4 t -81.89 -12.14 58.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.402 0.519 . . . . 74.44 112.402 -179.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.38 -59.06 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 CA-C-O 121.114 0.483 . . . . 73.24 111.747 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 71' ' ' PRO . . . 118.06 -81.89 0.32 Allowed Glycine 0 CA--C 1.523 0.562 0 C-N-CA 121.056 -0.593 . . . . 74.33 113.028 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.5 m0 -118.88 117.72 29.61 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 117.132 0.466 . . . . 74.41 111.638 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.442 ' N ' ' SD ' ' A' ' 57' ' ' MET . 2.7 mpp? -120.86 138.75 28.08 Favored Pre-proline 0 CA--C 1.543 0.686 0 CA-C-N 116.756 -0.202 . . . . 64.42 111.038 177.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.37 116.97 4.22 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.58 2.187 . . . . 55.45 112.909 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.48 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -143.68 171.21 25.42 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 120.71 -0.757 . . . . 73.12 114.021 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.8 tp -103.89 123.23 46.76 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 122.687 0.395 . . . . 74.41 110.992 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -85.23 128.73 34.79 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.561 0.219 . . . . 70.54 111.447 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -80.64 0.86 32.38 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.385 0.883 . . . . 61.45 113.385 -177.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -100.78 -47.73 4.72 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.777 -0.577 . . . . 74.15 111.446 174.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -96.92 -24.97 15.59 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.24 0.459 . . . . 53.41 112.24 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.3 mmt85 63.41 23.98 13.95 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.193 0.52 . . . . 75.55 111.77 -175.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -94.32 142.96 26.82 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.98 -0.555 . . . . 72.4 110.545 172.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.7 mtt85 -99.98 128.45 46.06 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.356 -0.384 . . . . 71.13 111.344 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.06 -178.15 40.28 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 121.051 -0.595 . . . . 32.15 113.109 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 3.7 m-20 -95.29 109.64 21.74 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.895 0.379 . . . . 71.35 110.8 -178.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 45.2 p90 -100.09 142.38 24.5 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 120.843 0.354 . . . . 74.41 111.936 -177.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 46.9 Cg_endo -68.31 111.51 2.52 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 C-N-CA 122.695 2.264 . . . . 63.12 112.922 177.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.534 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -64.86 -8.71 35.84 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.498 0.559 . . . . 54.3 114.498 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 43.3 p -78.62 -13.83 59.62 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 117.2 0.5 . . . . 62.12 111.971 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -111.3 6.13 20.29 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.268 0.47 . . . . 73.43 112.268 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.534 HG22 ' HA2' ' A' ' 72' ' ' GLY . 20.6 m -128.1 141.19 47.12 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 CA-C-O 121.038 0.447 . . . . 74.3 112.187 -177.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -92.23 159.76 15.48 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.331 -0.395 . . . . 61.1 110.428 174.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -105.09 124.38 49.43 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.017 0.437 . . . . 75.23 111.559 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 65.1 mt -90.72 -59.62 2.13 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.146 0.498 . . . . 61.44 111.094 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.88 -172.65 27.32 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.427 -0.416 . . . . 51.04 112.749 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.3 134.92 35.09 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.23 1.953 . . . . 55.32 112.147 176.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.0 161.52 21.3 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 113.014 0.746 . . . . 71.53 113.014 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 . . . . . 0 C--O 1.253 1.26 0 CA-C-N 115.722 -0.672 . . . . 62.22 112.509 -177.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 111.684 0.253 . . . . 74.5 111.684 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.9 88.91 4.7 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.62 0.6 . . . . 61.14 112.62 -174.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 93.83 -161.65 24.85 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 121.334 -0.46 . . . . 71.43 113.904 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.31 148.91 24.3 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.923 2.416 . . . . 71.32 113.02 178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -78.12 14.85 1.04 Allowed 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 112.817 0.673 . . . . 54.11 112.817 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.14 -134.64 0.52 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.063 -0.589 . . . . 64.44 113.064 176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -139.8 155.33 47.33 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 122.317 -0.519 . . . . 71.5 111.14 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.483 ' HG3' HD11 ' A' ' 81' ' ' LEU . 48.3 mt-30 -112.36 136.62 51.6 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.3 0.571 . . . . 62.21 111.76 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.456 ' CE1' ' HG3' ' A' ' 51' ' ' PRO . 87.9 m-85 -113.67 173.31 6.48 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.746 -0.661 . . . . 73.22 110.702 176.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -136.34 121.26 18.73 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.733 0.302 . . . . 74.43 111.372 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -70.92 125.5 27.01 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.026 0.441 . . . . 64.3 111.894 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 65.7 mt -81.21 -45.71 15.93 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.104 0.409 . . . . 73.2 112.104 -177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -137.33 158.5 72.18 Favored Pre-proline 0 N--CA 1.47 0.544 0 CA-C-N 116.467 -0.333 . . . . 64.1 111.061 -178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 37.8 Cg_endo -66.71 124.74 12.75 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.229 1.953 . . . . 73.14 113.377 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -125.94 122.4 35.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.926 -0.579 . . . . 63.41 110.77 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.422 ' HD2' ' C ' ' A' ' 16' ' ' ARG . 4.1 ppt_? -135.12 156.92 48.18 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 120.627 0.251 . . . . 73.13 110.932 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.56 HH21 ' HD3' ' A' ' 19' ' ' ARG . 43.4 mtp180 -131.89 153.41 50.26 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.531 0.682 . . . . 75.22 112.803 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -69.0 -39.47 79.32 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.36 -0.836 . . . . 73.42 110.957 177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.56 ' HD3' HH21 ' A' ' 17' ' ' ARG . 57.9 mtp180 -84.96 121.64 74.26 Favored Pre-proline 0 CA--C 1.546 0.794 0 CA-C-N 115.902 -0.59 . . . . 74.11 110.898 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -69.49 5.87 1.43 Allowed 'Trans proline' 0 N--CA 1.489 1.244 0 C-N-CA 123.454 2.77 . . . . 74.3 115.247 -168.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -76.75 -22.41 53.85 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.086 0.402 . . . . 61.45 112.086 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.3 -163.46 0.89 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.785 0.326 . . . . 72.24 111.718 -175.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.467 HD21 ' HB2' ' A' ' 61' ' ' ASN . 58.6 tp -135.54 119.59 17.56 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.862 0.363 . . . . 70.53 111.656 -179.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.429 ' HB2' HG21 ' A' ' 64' ' ' THR . 12.1 mp0 -65.45 117.16 7.56 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.129 0.49 . . . . 71.14 111.769 176.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 55.1 mt -103.29 134.98 45.77 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.142 -0.481 . . . . 74.02 111.173 178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -111.76 146.33 34.51 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-O 120.573 0.225 . . . . 74.24 110.989 177.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.04 125.04 14.48 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.396 2.064 . . . . 73.31 113.072 -176.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.2 4.03 71.95 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 116.235 -0.439 . . . . 54.44 113.928 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -93.19 149.31 21.31 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 117.238 0.519 . . . . 75.51 111.105 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 70.0 t -98.59 132.5 43.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 121.321 0.582 . . . . 62.34 111.935 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.504 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.9 mp -103.81 116.56 32.53 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.976 -0.556 . . . . 62.24 111.015 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.66 118.01 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 120.986 0.422 . . . . 65.42 111.672 -178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 87.9 t -115.65 120.47 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.938 0.399 . . . . 73.32 111.413 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.0 m -67.68 148.44 51.33 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.371 -0.377 . . . . 53.52 111.803 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.473 ' O ' ' HG2' ' A' ' 39' ' ' GLN . 8.3 tpp180 -55.12 -47.35 75.15 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.453 -0.34 . . . . 62.5 111.544 -178.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.34 -32.41 48.97 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.469 0.544 . . . . 75.01 112.469 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.48 73.53 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.883 0.373 . . . . 75.41 111.045 178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.471 HD23 HD12 ' A' ' 41' ' ' LEU . 87.6 mt -65.18 -35.02 79.78 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.284 -0.416 . . . . 71.23 111.095 177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 35' ' ' ARG . 13.4 mm100 -60.58 -43.98 96.73 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.952 0.406 . . . . 72.02 110.699 174.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.32 -40.62 96.26 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.288 -0.415 . . . . 35.11 111.374 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.473 HD11 ' HD2' ' A' ' 58' ' ' PRO . 94.9 mt -62.98 -18.28 63.05 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.046 0.45 . . . . 52.45 111.343 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.33 38.71 20.94 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.088 -0.577 . . . . 73.23 112.639 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 59.2 t -104.45 122.83 57.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.016 0.436 . . . . 74.31 111.725 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.59 138.75 33.23 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.384 -0.371 . . . . 54.24 110.273 173.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -53.18 117.57 3.13 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.208 0.528 . . . . 63.24 111.471 -174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.33 -13.57 5.68 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 115.808 -0.633 . . . . 30.04 112.182 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -99.18 -38.62 3.74 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.7 -0.286 . . . . 72.3 112.779 178.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.07 -23.8 56.05 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 122.771 0.428 . . . . 75.11 111.668 177.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 57.1 mtp180 -54.99 -21.96 13.65 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.484 -0.326 . . . . 74.1 111.715 175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 53' ' ' SER . 22.1 p -115.84 81.5 9.68 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-O 120.966 0.412 . . . . 64.21 111.008 175.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HG3' ' CE1' ' A' ' 9' ' ' TYR . 52.9 Cg_exo -54.94 -42.23 71.08 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.114 2.543 . . . . 72.15 113.183 -177.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -60.97 -31.47 71.04 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.865 0.364 . . . . 75.32 111.371 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB3' ' SG ' ' A' ' 50' ' ' CYS . 39.3 t -73.79 -38.44 64.64 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.164 0.507 . . . . 74.11 111.095 178.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -67.23 -40.86 85.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-O 121.059 0.457 . . . . 73.04 110.995 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.67 -76.18 1.09 Allowed Glycine 0 CA--C 1.525 0.688 0 C-N-CA 121.186 -0.53 . . . . 73.42 113.662 175.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 22.0 p-90 -118.95 132.38 56.08 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.906 0.384 . . . . 73.52 111.33 -176.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 68.5 mtm -144.91 131.98 10.15 Favored Pre-proline 0 N--CA 1.471 0.606 0 O-C-N 122.208 -0.308 . . . . 55.33 111.668 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.473 ' HD2' HD11 ' A' ' 41' ' ' LEU . 97.2 Cg_endo -80.48 127.66 6.63 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.388 2.059 . . . . 72.24 112.502 174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -156.79 176.69 34.02 Favored Glycine 0 CA--C 1.526 0.762 0 C-N-CA 120.634 -0.793 . . . . 74.03 113.614 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 61.3 tp -108.73 131.29 55.08 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 122.573 0.349 . . . . 72.41 111.107 -179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 65' ' ' ARG . 28.6 t-20 -96.67 149.17 22.1 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.457 -0.338 . . . . 74.31 111.002 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -91.98 -33.86 14.68 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.608 0.596 . . . . 65.2 112.608 -178.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.05 -64.68 0.8 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.153 0.501 . . . . 73.41 110.635 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 24' ' ' GLU . 62.3 p -75.21 -21.5 58.62 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.406 -0.361 . . . . 72.32 111.474 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' ASN . 17.5 mtp180 58.34 20.54 7.39 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.63 0.604 . . . . 74.22 112.63 -177.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.33 163.89 12.52 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 121.311 0.577 . . . . 62.12 111.712 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 16.0 mtp180 -107.9 129.65 55.07 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.672 -0.694 . . . . 73.3 110.682 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.04 -172.37 34.2 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.261 -0.971 . . . . 63.31 113.875 -178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.2 t70 -115.61 109.37 17.67 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.767 0.427 . . . . 72.41 109.881 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HB2' HD11 ' A' ' 25' ' ' LEU . 54.4 p90 -103.52 149.12 36.72 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 112.656 0.613 . . . . 73.42 112.656 -171.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HB2' HG22 ' A' ' 73' ' ' THR . 74.2 Cg_endo -76.11 113.48 3.71 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.713 2.275 . . . . 64.33 112.412 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -57.01 -16.1 16.72 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 114.734 0.654 . . . . 70.32 114.734 -176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 71' ' ' PRO . 6.1 t -59.21 -33.38 70.9 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 117.343 0.572 . . . . 75.24 112.505 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.445 ' HD2' ' HG2' ' A' ' 71' ' ' PRO . 54.8 m-85 -89.49 5.03 47.25 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.905 0.706 . . . . 75.21 112.905 -176.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 11' ' ' ALA . 28.2 m -127.48 148.16 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.149 0.499 . . . . 72.44 112.222 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -102.85 146.44 28.28 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.121 -0.491 . . . . 73.0 110.401 173.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -78.34 128.64 33.97 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.908 0.385 . . . . 73.32 111.674 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 91.2 mt -94.66 -67.53 0.85 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.929 0.395 . . . . 73.41 110.923 177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.74 -174.06 41.42 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 121.035 -0.602 . . . . 35.01 113.093 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -77.99 -176.83 3.45 Favored 'Trans proline' 0 CA--C 1.541 0.872 0 C-N-CA 122.706 2.271 . . . . 74.2 112.745 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 8' ' ' GLN . 4.6 mp -116.06 150.35 37.44 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.799 0.333 . . . . 62.31 111.163 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 N-CA-C 112.449 0.537 . . . . 75.14 112.449 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.6 mmm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 120.818 0.342 . . . . 54.42 111.632 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.91 -27.69 43.86 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.222 0.535 . . . . 73.23 110.827 174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 107.64 -168.59 14.08 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 115.943 -0.572 . . . . 70.41 113.216 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.94 85.1 1.39 Allowed 'Trans proline' 0 CA--C 1.538 0.681 0 C-N-CA 122.351 2.034 . . . . 70.05 112.377 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -60.79 -41.2 95.11 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.197 0.522 . . . . 73.53 111.426 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.15 167.1 26.52 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 116.032 -0.531 . . . . 54.33 112.707 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -119.94 160.92 21.78 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.302 0.572 . . . . 74.42 111.615 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.503 ' HG3' ' HB3' ' A' ' 81' ' ' LEU . 98.3 mt-30 -107.74 126.86 53.13 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.833 -0.621 . . . . 53.34 111.034 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -110.27 130.16 55.6 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.922 0.391 . . . . 73.11 110.674 176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.557 ' HB2' HD11 ' A' ' 78' ' ' LEU . 37.1 ttt180 -97.59 123.32 41.43 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.355 -0.384 . . . . 61.25 111.846 -175.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.49 131.8 36.99 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 121.045 0.45 . . . . 72.32 110.978 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.27 -60.36 2.37 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.291 0.478 . . . . 64.14 112.291 -175.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.516 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 89.6 m-85 -132.57 165.11 38.76 Favored Pre-proline 0 N--CA 1.473 0.685 0 CA-C-N 116.571 -0.286 . . . . 73.5 111.279 -175.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 44.6 Cg_endo -68.42 118.87 5.93 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 121.813 1.675 . . . . 74.32 113.284 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -120.31 152.73 37.41 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.938 -0.574 . . . . 65.25 110.646 176.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 15.4 ptt180 -135.16 140.08 45.1 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.485 -0.325 . . . . 72.33 111.758 -175.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -113.06 153.5 28.04 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.118 0.485 . . . . 73.01 111.619 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.514 ' HG3' ' HG3' ' A' ' 19' ' ' ARG . 12.0 pt-20 -64.76 -37.8 88.84 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.185 0.439 . . . . 64.22 112.185 176.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.514 ' HG3' ' HG3' ' A' ' 18' ' ' GLU . 74.9 mtp180 -110.36 126.92 27.91 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 122.334 0.254 . . . . 73.12 111.647 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 19' ' ' ARG . 17.3 Cg_exo -68.28 -1.65 7.61 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.048 2.499 . . . . 72.04 113.505 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.5 -21.81 61.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.333 0.587 . . . . 74.24 110.546 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.81 -143.62 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.554 -0.748 . . . . 64.12 109.363 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' A' ' 61' ' ' ASN . 18.9 tp -156.22 119.86 4.35 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.389 -0.819 . . . . 64.15 112.384 176.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.509 ' HG3' ' HA ' ' A' ' 16' ' ' ARG . 6.5 mp0 -65.22 151.92 44.94 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.328 0.585 . . . . 74.11 112.013 175.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.62 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 89.4 mt -118.31 134.51 54.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.818 -0.628 . . . . 61.44 110.34 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HG ' ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -114.94 154.99 47.02 Favored Pre-proline 0 N--CA 1.476 0.837 0 CA-C-O 120.828 0.347 . . . . 63.34 111.642 -179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.17 117.12 4.06 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.484 2.123 . . . . 72.23 113.22 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.64 20.68 79.83 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.2 -0.524 . . . . 65.54 113.304 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' OD1' ' HB2' ' A' ' 63' ' ' ARG . 20.7 t0 -82.75 156.22 23.85 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.918 0.39 . . . . 72.41 111.782 -178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 71.7 t -117.36 118.89 60.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.103 0.477 . . . . 73.32 111.46 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.2 mp -107.14 133.64 51.43 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.306 -0.406 . . . . 55.33 110.932 177.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.74 115.73 33.24 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 N-CA-C 112.231 0.456 . . . . 72.14 112.231 -175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.7 t -127.38 118.91 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 120.835 0.35 . . . . 74.41 111.388 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.3 p -76.1 155.61 34.57 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 120.851 0.358 . . . . 70.41 111.947 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 38' ' ' LEU . 61.5 mtp180 -62.04 -26.5 68.29 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-O 120.866 0.365 . . . . 74.14 110.369 175.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.47 80.75 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.221 -0.445 . . . . 73.44 110.914 175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.62 -41.62 86.34 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 71.1 110.909 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 35' ' ' ARG . 95.8 mt -59.0 -49.18 78.89 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.207 -0.451 . . . . 50.31 111.355 176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -61.76 -34.56 76.07 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.933 0.397 . . . . 75.02 111.101 176.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.37 -22.11 66.76 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.893 0.378 . . . . 71.22 111.539 176.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.544 HD11 ' HD2' ' A' ' 58' ' ' PRO . 96.4 mt -85.64 -5.66 59.24 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.707 0.289 . . . . 72.4 111.516 175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.77 43.88 82.49 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.791 -0.719 . . . . 71.51 112.366 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 97.6 t -76.41 143.66 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 120.933 0.397 . . . . 70.43 111.338 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.39 150.94 48.27 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.113 -0.494 . . . . 75.41 112.208 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -52.93 101.5 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.801 0 CA-C-O 121.307 0.575 . . . . 74.44 112.19 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.477 ' O ' ' HG2' ' A' ' 49' ' ' ARG . . . 99.29 -9.52 61.12 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 116.085 -0.507 . . . . 71.45 113.685 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.73 1.24 46.7 Favored Glycine 0 CA--C 1.531 1.079 0 N-CA-C 114.167 0.427 . . . . 60.13 114.167 -177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -60.25 -18.23 47.5 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.383 0.611 . . . . 52.11 111.723 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 46' ' ' GLY . 8.0 ptt180 -84.91 8.46 17.46 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.653 -0.703 . . . . 64.55 112.162 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.6 m -133.66 76.86 65.51 Favored Pre-proline 0 N--CA 1.475 0.785 0 N-CA-C 112.302 0.482 . . . . 72.31 112.302 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.16 -32.89 62.6 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.656 2.237 . . . . 71.1 113.061 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -61.43 -37.66 84.31 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.939 0.399 . . . . 74.12 111.137 177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 47.5 t -61.8 -39.95 93.51 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.257 -0.429 . . . . 73.22 111.661 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.446 HG11 HD13 ' A' ' 41' ' ' LEU . 45.3 t -75.75 -39.81 39.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-O 121.01 0.433 . . . . 74.21 111.546 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 86.22 -71.29 2.85 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.2 -0.524 . . . . 61.22 113.394 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -98.56 129.14 45.1 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 122.768 -0.254 . . . . 75.32 110.624 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 84.0 mtp -143.73 120.85 6.67 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 111.664 0.246 . . . . 71.23 111.664 -176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.544 ' HD2' HD11 ' A' ' 41' ' ' LEU . 87.0 Cg_endo -81.79 138.38 10.49 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.552 2.168 . . . . 74.44 112.375 176.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -165.17 176.77 40.81 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 120.743 -0.741 . . . . 71.53 113.199 -179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 46.0 tp -100.84 118.87 37.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.637 -0.331 . . . . 72.33 110.95 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.531 ' HB2' HD21 ' A' ' 23' ' ' LEU . 28.5 t-20 -87.78 100.31 12.75 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.402 -0.363 . . . . 75.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -66.93 -20.46 65.91 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.124 0.416 . . . . 64.14 112.124 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.431 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 9.1 tpt180 -58.83 -49.48 77.57 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.073 0.463 . . . . 73.35 111.31 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -110.45 -1.93 16.8 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.058 -0.519 . . . . 73.44 112.137 -177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 65' ' ' ARG . 4.7 mpt_? 63.55 20.52 12.29 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 122.759 0.423 . . . . 64.15 111.661 -177.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -102.42 157.93 16.57 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.318 0.58 . . . . 61.04 111.792 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -103.8 151.25 23.28 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.96 -0.564 . . . . 75.41 110.501 176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.66 -178.84 47.13 Favored Glycine 0 CA--C 1.523 0.538 0 C-N-CA 120.162 -1.018 . . . . 75.54 113.831 177.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 58' ' ' PRO . 18.7 t70 -109.68 108.6 19.05 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.894 -0.41 . . . . 73.22 109.894 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 23' ' ' LEU . 55.1 p90 -100.94 148.99 35.83 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 121.112 0.482 . . . . 72.31 112.253 -173.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.5 101.1 0.97 Allowed 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.436 2.091 . . . . 71.15 112.386 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.16 -17.45 30.73 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.242 0.457 . . . . 74.3 114.242 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.8 t -65.13 -14.2 59.98 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.731 0.641 . . . . 65.52 112.731 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -107.55 8.53 29.33 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.322 0.49 . . . . 65.43 112.322 -179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.9 m -125.22 155.86 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.157 0.503 . . . . 64.01 111.677 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -112.88 148.59 34.61 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.237 0.541 . . . . 64.22 111.51 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -78.16 119.25 21.28 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.077 -0.51 . . . . 74.14 111.046 178.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.7 mt -90.17 -59.51 2.17 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.048 0.451 . . . . 52.44 111.291 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 154.23 -160.61 29.58 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.356 -0.449 . . . . 75.24 112.555 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.03 147.4 79.79 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.809 2.339 . . . . 71.43 112.775 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HB3' ' HG3' ' A' ' 8' ' ' GLN . 1.6 pp -92.65 150.62 20.58 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 112.654 0.613 . . . . 43.33 112.654 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 46.7 tt0 . . . . . 0 C--O 1.253 1.241 0 CA-C-N 115.565 -0.743 . . . . 73.35 110.576 176.303 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.53 ' SD ' ' C ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 112.349 0.5 . . . . 70.14 112.349 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.84 96.02 1.6 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.099 0.476 . . . . 51.11 112.229 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 157.52 -67.1 0.29 Allowed Glycine 0 CA--C 1.525 0.681 0 CA-C-N 116.168 -0.469 . . . . 51.21 112.037 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.92 101.48 1.16 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 122.76 2.307 . . . . 72.02 111.967 170.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -57.35 -30.06 64.52 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 113.05 0.759 . . . . 75.23 113.05 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.03 163.48 27.88 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.791 -0.719 . . . . 54.14 112.086 -174.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -136.78 156.93 47.86 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.334 0.587 . . . . 75.44 112.185 -177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -121.89 133.36 54.86 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.577 -0.738 . . . . 65.23 110.975 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.493 ' HB3' ' HB ' ' A' ' 75' ' ' VAL . 97.8 m-85 -122.91 137.51 54.92 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.59 -0.277 . . . . 73.1 110.879 178.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.555 ' HB2' HD21 ' A' ' 78' ' ' LEU . 9.4 ttm180 -98.65 122.6 42.07 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.836 0.35 . . . . 74.12 110.585 178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.99 120.51 16.66 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 111.951 0.352 . . . . 75.34 111.951 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 73.3 mt -90.7 -46.82 8.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.813 0.34 . . . . 64.41 111.512 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -110.21 137.96 20.72 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 111.974 0.361 . . . . 62.44 111.974 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.537 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 73.0 Cg_endo -78.89 146.12 20.4 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.58 2.187 . . . . 51.41 113.418 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.544 ' HB2' HD12 ' A' ' 25' ' ' LEU . 92.1 m-85 -143.12 128.96 19.42 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.203 -0.453 . . . . 71.21 110.828 177.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -136.05 114.78 12.0 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.147 0.499 . . . . 74.4 110.885 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 17' ' ' ARG . 14.9 mmt180 -116.73 148.75 40.82 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.014 -0.539 . . . . 74.4 112.271 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -86.24 26.95 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.243 1.021 . . . . 61.4 110.234 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HB3' ' OE1' ' A' ' 21' ' ' GLU . 34.1 mmt180 -133.78 129.02 20.11 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.551 -0.75 . . . . 73.44 110.461 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.6 -4.65 15.02 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.878 2.385 . . . . 72.2 114.453 -172.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.471 ' OE1' ' HB3' ' A' ' 19' ' ' ARG . 21.2 mp0 -75.84 -38.9 57.58 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.981 -0.449 . . . . 74.44 110.583 178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.77 -175.55 4.94 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.848 -0.615 . . . . 74.24 109.98 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.447 HD23 HD21 ' A' ' 25' ' ' LEU . 37.3 tp -132.29 136.11 46.7 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.719 -0.613 . . . . 74.11 112.286 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -71.44 117.75 13.38 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.569 -0.287 . . . . 72.13 110.66 176.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 15' ' ' PHE . 15.0 mt -135.7 136.39 40.82 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.848 0.684 . . . . 44.5 112.848 -168.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.3 157.21 44.44 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 123.381 0.672 . . . . 73.51 110.655 175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 21.9 Cg_exo -64.88 108.95 1.18 Allowed 'Trans proline' 0 CA--C 1.541 0.826 0 C-N-CA 122.213 1.942 . . . . 63.52 112.633 176.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.19 15.35 14.44 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 121.462 -0.399 . . . . 73.41 113.993 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -79.4 151.35 30.98 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 117.182 0.491 . . . . 70.24 112.094 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.3 t -102.41 120.23 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.134 -0.484 . . . . 53.31 110.493 174.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 HD12 ' N ' ' A' ' 31' ' ' LEU . 6.3 mp -103.37 124.08 48.03 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.814 0.34 . . . . 61.02 111.403 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.524 HG13 HD21 ' A' ' 81' ' ' LEU . 80.1 t -94.05 116.83 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.16 -0.473 . . . . 62.14 110.968 177.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.0 t -118.38 135.93 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 120.889 0.376 . . . . 71.14 111.229 179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 85.1 p -86.82 133.78 33.61 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.698 0.285 . . . . 75.34 110.732 178.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -65.7 -25.4 67.3 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.097 -0.377 . . . . 71.03 111.07 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.25 -40.79 87.07 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.018 0.437 . . . . 71.12 111.19 176.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -62.73 -47.16 84.77 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.992 0.425 . . . . 74.21 111.029 176.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 74.7 mt -58.53 -43.88 89.35 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.219 -0.446 . . . . 75.31 111.267 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -62.35 -38.26 88.83 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.846 0.355 . . . . 73.21 111.124 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.76 -27.76 68.53 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.002 0.43 . . . . 73.23 111.344 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 37' ' ' ALA . 92.5 mt -81.54 -4.68 56.67 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.379 -0.373 . . . . 73.35 111.659 176.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.03 13.36 79.45 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 121.269 -0.491 . . . . 62.34 113.421 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 52.7 t -74.12 109.09 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.924 0.392 . . . . 74.04 111.531 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.78 148.29 44.72 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.982 0.42 . . . . 72.53 111.932 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.67 119.04 4.41 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.091 -0.504 . . . . 71.11 111.344 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.15 -14.16 16.26 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.481 -0.39 . . . . 53.14 112.234 -173.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -96.52 -26.84 10.38 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 121.53 -0.367 . . . . 74.2 113.172 178.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -27.11 69.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 121.082 0.468 . . . . 73.21 111.791 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.4 ptt180 -67.41 -15.46 63.69 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.482 -0.326 . . . . 51.53 111.704 175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.7 m -132.78 69.36 79.34 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-O 120.908 0.385 . . . . 41.0 110.661 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.527 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 29.1 Cg_endo -60.57 -21.57 69.2 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.101 2.534 . . . . 62.24 113.819 -172.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -55.82 -25.14 40.28 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-O 120.885 0.374 . . . . 71.22 111.945 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.4 t -77.71 -17.02 58.05 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 111.953 0.353 . . . . 65.41 111.953 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.9 t -96.15 -20.39 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.035 0.445 . . . . 64.51 111.524 -178.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.67 -110.34 3.94 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.356 -0.449 . . . . 73.22 112.35 -176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -121.38 143.84 48.99 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 117.155 0.478 . . . . 71.12 110.995 174.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 46.7 mtm -134.44 149.42 71.04 Favored Pre-proline 0 N--CA 1.474 0.744 0 N-CA-C 111.89 0.329 . . . . 63.33 111.89 -173.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.37 123.21 10.0 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.594 2.196 . . . . 64.5 113.109 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -146.81 163.51 28.57 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.035 -0.602 . . . . 71.13 113.586 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.458 HD21 HH21 ' A' ' 65' ' ' ARG . 52.8 tp -107.22 124.7 50.13 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.556 0.342 . . . . 74.33 111.788 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -87.48 122.91 31.81 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 116.583 -0.28 . . . . 65.34 110.676 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -72.1 -15.0 61.99 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.56 0.948 . . . . 71.34 113.56 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -86.86 -67.95 0.78 Allowed 'General case' 0 N--CA 1.474 0.76 0 O-C-N 121.675 -0.641 . . . . 71.1 111.246 173.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.3 p -71.56 -22.95 61.68 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.242 -0.435 . . . . 62.2 112.004 -177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.458 HH21 HD21 ' A' ' 60' ' ' LEU . 22.8 mmm-85 65.97 8.68 5.57 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.519 0.728 . . . . 65.3 112.286 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -78.53 149.49 33.08 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.845 0.355 . . . . 74.22 110.958 176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.434 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -113.07 134.61 54.45 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.518 -0.31 . . . . 70.33 110.402 176.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -173.26 176.19 45.99 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 120.834 -0.698 . . . . 53.04 112.627 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -88.57 107.9 19.14 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 120.921 0.391 . . . . 73.31 110.518 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -97.45 140.15 21.84 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.553 -0.294 . . . . 75.35 111.46 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.06 116.69 3.63 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.549 2.166 . . . . 73.43 112.46 176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -71.57 26.53 0.6 Allowed Glycine 0 CA--C 1.536 1.397 0 N-CA-C 114.61 0.604 . . . . 51.34 114.61 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -104.02 -32.14 9.36 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 117.538 0.669 . . . . 75.4 112.452 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.542 ' CZ ' HD13 ' A' ' 25' ' ' LEU . 20.9 p90 -88.59 4.81 45.63 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 111.859 0.318 . . . . 72.34 111.859 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 9' ' ' TYR . 17.9 m -112.94 146.84 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 112.725 0.639 . . . . 72.4 112.725 -174.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.504 ' CG ' ' HB3' ' A' ' 10' ' ' ARG . 9.4 pt-20 -102.98 138.67 39.54 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 115.62 -0.718 . . . . 52.51 110.146 171.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -75.41 115.32 14.94 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 120.833 0.349 . . . . 73.44 111.506 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 10' ' ' ARG . 82.3 mt -85.3 -55.97 3.76 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.19 0.519 . . . . 73.03 111.481 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.02 -155.97 26.43 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.856 -0.611 . . . . 73.24 111.962 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.69 178.61 5.41 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.66 2.24 . . . . 72.24 113.17 177.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.524 HD21 HG13 ' A' ' 32' ' ' VAL . 94.5 mt -75.86 144.29 41.3 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.786 0.327 . . . . 73.33 111.723 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.692 -0.67 . . . . 73.24 111.515 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.782 0.325 . . . . 72.23 111.695 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.24 -80.56 0.45 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.715 0.293 . . . . 70.21 111.193 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 135.91 130.88 2.96 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.212 -0.518 . . . . 64.43 113.14 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.7 102.62 1.2 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.439 2.093 . . . . 64.14 112.708 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -61.4 -24.4 66.48 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.244 0.545 . . . . 73.43 111.193 175.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 34' ' ' SER . . . -169.55 -155.62 10.14 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-N 115.901 -0.59 . . . . 63.52 112.82 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -124.99 155.99 38.79 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.194 0.521 . . . . 63.32 111.642 -178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.496 ' HB3' HD12 ' A' ' 78' ' ' LEU . 95.9 mt-30 -94.96 123.41 38.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.16 -0.473 . . . . 41.23 111.735 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -113.83 125.98 54.68 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.363 -0.381 . . . . 61.32 110.57 174.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.524 ' HB2' HD11 ' A' ' 78' ' ' LEU . 70.6 ttt180 -97.79 120.49 38.27 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.682 0.277 . . . . 72.4 111.725 -176.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.448 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -68.4 119.99 13.79 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.905 0.383 . . . . 53.14 111.47 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 mt -72.86 -59.89 2.49 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.321 0.489 . . . . 63.15 112.321 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -127.09 156.83 73.81 Favored Pre-proline 0 N--CA 1.47 0.572 0 CA-C-N 116.362 -0.381 . . . . 63.42 111.149 -175.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.62 119.16 6.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.089 1.86 . . . . 74.13 113.044 -179.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -121.82 111.75 17.51 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.957 -0.565 . . . . 54.25 111.029 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.8 ptt180 -89.21 125.76 35.21 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.206 0.526 . . . . 54.42 110.885 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HG2' ' HB2' ' A' ' 22' ' ' ASP . 22.7 tpt180 -70.7 153.78 42.48 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 122.174 -0.329 . . . . 74.44 110.949 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -45.06 -49.67 11.41 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.247 0.546 . . . . 72.21 110.992 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -131.0 147.33 65.88 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.47 -0.786 . . . . 71.1 110.025 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -58.38 -5.49 2.34 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 122.842 2.361 . . . . 53.53 113.742 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -53.26 -41.66 65.73 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.218 0.607 . . . . 73.14 112.579 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.606 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 10.7 m-20 -91.19 -162.18 0.89 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.045 0.45 . . . . 73.33 111.579 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.604 ' HB2' ' HA3' ' A' ' 68' ' ' GLY . 23.8 tp -99.92 134.77 42.35 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.924 0.392 . . . . 73.4 111.256 -177.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -108.75 140.57 42.0 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.901 0.381 . . . . 62.44 111.661 -176.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 79.0 mt -100.75 131.36 46.69 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.612 0.597 . . . . 52.14 112.612 -173.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -115.16 148.99 41.89 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 122.721 0.408 . . . . 72.32 110.52 173.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -66.42 105.51 0.9 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.398 2.065 . . . . 72.23 113.168 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.42 -4.61 21.58 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 121.148 -0.549 . . . . 62.02 113.857 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -68.4 130.89 44.21 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 117.197 0.499 . . . . 73.21 111.916 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.2 t -96.9 105.2 16.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 115.905 -0.589 . . . . 61.44 110.721 173.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 31' ' ' LEU . 5.7 mp -89.94 130.81 36.1 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.57 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 51.8 t -94.29 106.22 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-N 116.327 -0.397 . . . . 74.34 111.312 176.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.8 t -105.44 118.45 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-O 120.766 0.317 . . . . 51.34 110.819 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.464 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 87.3 p -69.41 140.91 54.18 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.18 0.514 . . . . 54.42 111.846 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 61.3 ttp85 -60.27 -28.09 67.78 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.197 0.522 . . . . 74.34 110.702 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.4 -44.5 96.3 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.983 -0.553 . . . . 65.32 110.924 174.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . . . -59.38 -45.45 91.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.839 0.352 . . . . 42.41 110.915 176.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.439 ' HB3' ' HB ' ' A' ' 43' ' ' VAL . 96.1 mt -54.23 -43.42 70.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.398 -0.365 . . . . 74.34 111.426 176.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 28.3 mm-40 -59.67 -42.47 92.97 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.453 -0.34 . . . . 65.21 111.283 176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.25 -39.27 92.29 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 121.045 0.45 . . . . 74.41 111.261 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.468 HD11 ' HD2' ' A' ' 58' ' ' PRO . 78.6 mt -66.55 -25.88 66.86 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.01 -0.541 . . . . 72.42 111.642 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.0 23.23 18.19 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.229 -0.51 . . . . 75.5 112.62 -176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.439 ' HB ' ' HB3' ' A' ' 38' ' ' LEU . 47.7 t -84.15 107.29 15.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-O 120.985 0.422 . . . . 72.1 111.054 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.58 149.84 46.68 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.069 -0.514 . . . . 54.0 111.901 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.8 113.92 3.32 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.023 -0.535 . . . . 73.34 110.852 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 119.55 -10.61 11.42 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.397 -0.43 . . . . 71.05 112.521 -173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.45 5.46 23.1 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.514 -0.374 . . . . 55.12 112.97 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -67.21 -23.75 65.77 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.223 0.453 . . . . 73.22 112.223 -177.098 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 31.0 mtm105 -77.98 -2.68 38.19 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.201 0.445 . . . . 74.22 112.201 -178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -118.19 86.29 26.46 Favored Pre-proline 0 N--CA 1.47 0.561 0 CA-C-O 120.951 0.405 . . . . 74.23 111.819 178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.6 -21.84 51.8 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.118 1.878 . . . . 60.41 111.996 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -61.37 -48.82 79.53 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.904 -0.589 . . . . 63.03 110.982 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -63.88 -28.07 69.59 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.14 -0.482 . . . . 74.13 111.066 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG11 ' HB3' ' A' ' 57' ' ' MET . 95.7 t -69.86 -37.99 74.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 115.96 -0.564 . . . . 65.21 111.541 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.96 -79.55 1.79 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.095 -0.574 . . . . 71.33 112.982 -179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 12.7 m0 -120.88 124.01 43.92 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 122.656 -0.32 . . . . 64.41 110.963 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.43 ' HB3' HG11 ' A' ' 54' ' ' VAL . 8.6 ptp -136.25 147.96 62.46 Favored Pre-proline 0 N--CA 1.472 0.667 0 CA-C-O 120.653 0.263 . . . . 72.11 111.449 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' HD11 ' A' ' 41' ' ' LEU . 81.7 Cg_endo -88.03 140.67 4.92 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.765 2.31 . . . . 74.13 112.802 175.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -147.27 -172.71 17.74 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 120.505 -0.855 . . . . 62.54 114.027 -178.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 65.5 tp -132.83 108.68 9.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.619 0.367 . . . . 71.41 111.269 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -79.26 129.5 34.52 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.827 0.346 . . . . 71.33 111.205 176.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -67.07 -23.27 65.84 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 112.142 0.423 . . . . 52.12 112.142 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -75.38 -53.55 8.54 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.04 0.448 . . . . 72.43 111.808 173.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -68.37 -26.62 65.67 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.399 0.518 . . . . 74.54 112.399 -175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 64.78 10.58 6.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.105 0.479 . . . . 65.45 111.268 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 -127.38 160.72 30.56 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.11 0.481 . . . . 73.51 111.734 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 71.8 mtp180 -91.29 176.85 6.42 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.656 -0.702 . . . . 70.12 110.993 177.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . 159.46 168.42 21.45 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 121.095 -0.574 . . . . 43.51 113.01 177.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -97.32 127.49 43.33 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.613 0.245 . . . . 73.11 111.375 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.43 156.19 79.95 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 120.698 0.285 . . . . 73.4 111.421 -178.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -74.3 120.9 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 122.468 2.112 . . . . 74.03 112.488 175.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -69.73 1.48 15.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 121.382 -0.437 . . . . 70.05 114.05 -177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 p -74.71 -17.43 60.66 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 122.37 -0.488 . . . . 63.11 112.289 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -108.28 17.52 22.11 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.864 0.69 . . . . 74.02 112.864 -177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' A' ' 11' ' ' ALA . 29.4 m -131.66 148.63 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-O 120.982 0.42 . . . . 51.03 112.119 179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -108.65 151.08 26.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.217 -0.447 . . . . 71.35 110.892 175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -82.06 115.26 21.12 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.806 0.336 . . . . 65.21 111.34 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.524 HD11 ' HB2' ' A' ' 10' ' ' ARG . 92.8 mt -83.2 -59.73 2.37 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.916 0.389 . . . . 71.11 111.467 178.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 160.07 -176.56 36.76 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.089 -0.577 . . . . 64.51 113.185 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -81.79 157.0 18.39 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.923 2.416 . . . . 51.32 113.106 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 81' ' ' LEU . 4.6 mp -93.78 160.85 14.57 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 116.447 -0.342 . . . . 73.23 111.086 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 C--O 1.253 1.241 0 N-CA-C 112.038 0.385 . . . . 70.31 112.038 177.633 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.979 0.419 . . . . 71.2 111.355 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -119.05 -161.84 0.87 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.159 -0.473 . . . . 71.43 111.277 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.93 158.42 7.53 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.223 -0.513 . . . . 71.2 112.687 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.15 86.97 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.407 2.071 . . . . 63.5 113.245 -178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.69 -16.97 64.41 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.559 0.695 . . . . 74.23 110.471 173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . 175.67 -140.86 5.38 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.523 -0.762 . . . . 52.22 112.214 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -130.46 143.97 51.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.225 0.536 . . . . 73.23 111.625 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -92.73 131.02 38.16 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.732 -0.667 . . . . 71.11 112.116 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -123.78 153.85 40.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.436 -0.802 . . . . 73.23 110.069 175.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB3' ' HG2' ' A' ' 76' ' ' GLU . 41.1 ttm180 -127.42 119.75 26.86 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.778 0.323 . . . . 71.34 111.805 -178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HA ' HG12 ' A' ' 75' ' ' VAL . . . -71.54 124.08 23.87 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.309 -0.405 . . . . 71.32 110.961 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.5 mt -94.5 -21.2 19.04 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.443 0.534 . . . . 74.12 112.443 -176.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -132.98 147.57 65.94 Favored Pre-proline 0 N--CA 1.475 0.784 0 N-CA-C 112.131 0.419 . . . . 73.42 112.131 -177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 55.7 Cg_endo -71.06 119.63 6.45 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.55 2.167 . . . . 72.4 112.172 175.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -136.68 120.0 16.84 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.919 0.39 . . . . 73.14 111.49 -175.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 17' ' ' ARG . 11.2 ttm180 -123.6 151.62 42.78 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.994 0.426 . . . . 72.1 110.999 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.463 ' HG3' ' CG ' ' A' ' 22' ' ' ASP . 18.7 mmm180 -134.24 142.23 47.29 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.466 -0.334 . . . . 71.21 110.759 177.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -71.32 -15.48 62.4 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-O 120.986 0.422 . . . . 64.4 111.58 -175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -110.76 157.35 38.75 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.385 0.274 . . . . 75.44 110.702 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -70.86 6.06 1.84 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 122.972 2.448 . . . . 74.35 113.229 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -54.95 -52.72 62.13 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.115 0.483 . . . . 72.25 111.122 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.463 ' CG ' ' HG3' ' A' ' 17' ' ' ARG . 3.4 m-20 -102.07 -173.71 2.41 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.566 -0.743 . . . . 54.21 111.46 -177.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 33.8 tp -132.56 144.62 50.52 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.387 -0.37 . . . . 74.24 110.415 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.0 113.32 3.41 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.127 0.489 . . . . 75.24 112.034 -176.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.585 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 63.5 mt -103.26 138.74 39.63 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.245 -0.434 . . . . 71.55 111.25 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.499 HD23 ' HG2' ' A' ' 63' ' ' ARG . 4.4 mm? -122.65 150.69 58.77 Favored Pre-proline 0 N--CA 1.474 0.754 0 C-N-CA 122.503 0.321 . . . . 71.32 110.933 178.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -60.94 117.83 4.64 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.685 2.257 . . . . 71.51 113.133 -177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.1 29.66 58.4 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 116.032 -0.531 . . . . 71.01 113.311 -179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -96.91 158.67 15.32 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.189 0.495 . . . . 71.24 111.155 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.9 t -102.04 132.56 47.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.135 0.493 . . . . 61.55 112.289 -174.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.448 HD21 HD22 ' A' ' 25' ' ' LEU . 5.9 mp -121.88 111.42 17.08 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.249 -0.432 . . . . 72.25 110.975 178.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.558 HG13 HD21 ' A' ' 81' ' ' LEU . 18.0 t -94.96 106.05 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 120.839 0.352 . . . . 74.55 111.227 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.518 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 61.4 t -101.39 132.61 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 120.598 0.237 . . . . 75.31 111.591 -179.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.3 t -74.06 143.07 45.63 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.272 0.558 . . . . 63.11 112.187 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -66.38 -33.05 74.84 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.056 -0.52 . . . . 71.31 111.124 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.16 -32.09 73.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.009 0.433 . . . . 74.41 111.392 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' HB1' ' HG2' ' A' ' 58' ' ' PRO . . . -69.68 -45.44 68.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.182 -0.463 . . . . 64.44 111.27 177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.8 mt -58.36 -39.83 80.62 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.354 -0.385 . . . . 61.12 111.507 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.7 mm100 -60.27 -44.05 95.66 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.497 -0.32 . . . . 75.54 111.015 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.85 -39.95 91.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.02 0.438 . . . . 75.03 111.227 176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.602 HD11 ' HD2' ' A' ' 58' ' ' PRO . 81.2 mt -66.75 -29.2 69.11 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.251 -0.431 . . . . 63.02 111.498 176.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.57 31.87 12.5 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.265 -0.493 . . . . 63.21 112.833 -176.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 41' ' ' LEU . 61.8 t -73.37 123.26 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-O 120.924 0.392 . . . . 72.21 111.307 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -88.1 149.99 23.62 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 116.488 -0.324 . . . . 54.33 111.376 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -47.27 126.68 9.75 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.916 0.388 . . . . 73.45 111.241 177.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -42.43 1.91 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 121.24 -0.505 . . . . 52.11 112.289 -174.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.17 -26.25 61.08 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.035 -0.602 . . . . 74.21 112.198 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.626 ' HG3' ' HG3' ' A' ' 49' ' ' ARG . 9.3 pt-20 -52.05 -33.88 40.86 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.514 0.726 . . . . 75.51 111.297 172.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.626 ' HG3' ' HG3' ' A' ' 48' ' ' GLU . 28.2 mtp180 -89.65 -3.04 58.43 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.715 -0.675 . . . . 63.24 111.654 -176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 65.8 m -136.83 72.45 55.32 Favored Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.434 -0.348 . . . . 75.14 111.021 -179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -59.91 -26.82 83.43 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.797 2.331 . . . . 71.03 112.836 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.745 ' HG2' ' HA ' ' A' ' 73' ' ' THR . 73.3 mt-30 -62.95 -25.51 68.38 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.329 -0.396 . . . . 40.42 111.541 178.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 69.5 m -83.86 -31.41 25.77 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 116.475 -0.33 . . . . 71.54 111.787 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 44.9 t -75.45 -44.71 41.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-O 121.195 0.522 . . . . 74.35 110.908 177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.87 -78.31 0.89 Allowed Glycine 0 CA--C 1.528 0.861 0 C-N-CA 121.298 -0.477 . . . . 71.53 113.701 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -111.81 114.38 27.3 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 112.324 0.49 . . . . 63.32 112.324 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -126.42 134.61 26.19 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 116.372 -0.376 . . . . 72.14 111.011 175.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HD2' HD11 ' A' ' 41' ' ' LEU . 95.7 Cg_endo -81.94 123.85 4.25 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.546 2.164 . . . . 71.31 112.205 172.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.442 ' HA3' HG22 ' A' ' 33' ' ' VAL . . . -148.25 176.43 27.07 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.634 -0.793 . . . . 62.14 113.756 -178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 64.2 tp -97.4 121.69 39.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.621 0.368 . . . . 75.52 110.919 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -92.97 121.51 34.39 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.747 0.308 . . . . 71.41 111.142 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 -72.7 -27.04 61.83 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.19 0.811 . . . . 75.41 113.19 -174.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.499 ' HG2' HD23 ' A' ' 26' ' ' LEU . 4.2 tpm_? -58.58 -52.58 65.04 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.009 0.433 . . . . 75.43 111.329 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 p -92.4 -15.83 26.72 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.014 -0.539 . . . . 62.33 111.506 -178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 46.9 mtp85 60.13 24.38 13.67 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 116.119 -0.491 . . . . 74.1 111.681 -175.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -118.72 161.12 20.63 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.052 0.453 . . . . 71.24 111.5 178.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -92.45 150.67 20.65 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.162 -0.472 . . . . 63.54 111.524 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.85 -175.29 44.04 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 121.257 -0.496 . . . . 64.21 112.747 177.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -102.46 143.54 32.06 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 116.972 0.386 . . . . 72.44 110.528 176.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.465 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 55.1 p90 -139.92 143.12 33.22 Favored Pre-proline 0 CA--C 1.539 0.54 0 N-CA-C 112.111 0.411 . . . . 44.44 112.111 -179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 10.6 Cg_exo -72.41 118.32 5.54 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 122.864 2.376 . . . . 53.44 112.267 174.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.412 ' HA2' HG22 ' A' ' 75' ' ' VAL . . . -60.32 -14.45 33.76 Favored Glycine 0 CA--C 1.528 0.899 0 N-CA-C 114.451 0.54 . . . . 71.04 114.451 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.745 ' HA ' ' HG2' ' A' ' 52' ' ' GLN . 10.3 t -71.48 -5.65 34.58 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 112.619 0.6 . . . . 72.41 112.619 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -111.03 1.04 17.17 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.138 0.422 . . . . 74.01 112.138 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 11' ' ' ALA . 25.7 m -128.41 148.6 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 N-CA-C 112.46 0.541 . . . . 61.43 112.46 -175.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HG2' ' HB3' ' A' ' 10' ' ' ARG . 13.9 pt-20 -98.77 167.18 10.93 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.838 0.352 . . . . 63.42 110.717 173.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -99.04 123.28 43.23 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.946 0.403 . . . . 74.34 111.001 178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 10' ' ' ARG . 74.7 mt -94.26 -46.97 6.83 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.945 0.402 . . . . 71.15 111.347 179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.72 -179.74 18.93 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.267 -0.492 . . . . 32.34 113.246 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.79 142.91 40.34 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.484 2.122 . . . . 63.21 112.478 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.558 HD21 HG13 ' A' ' 32' ' ' VAL . 6.2 mp -68.1 133.97 49.82 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.912 0.387 . . . . 74.32 111.569 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 119.046 -0.502 . . . . 75.55 111.087 178.403 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 120.724 0.297 . . . . 73.23 110.979 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.79 144.81 30.0 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.969 0.414 . . . . 71.33 111.87 -178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 153.45 -145.77 13.49 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 121.204 -0.522 . . . . 32.13 113.283 179.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -89.82 -174.69 0.89 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.277 2.652 . . . . 74.04 113.13 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -118.42 -26.86 6.12 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.616 0.599 . . . . 61.13 112.616 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 33' ' ' VAL . . . -80.02 -149.27 5.55 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 115.3 0.88 . . . . 70.01 115.3 -169.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.53 163.44 14.48 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 120.931 0.396 . . . . 62.22 111.323 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -108.01 126.23 52.47 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.399 0.618 . . . . 72.23 112.264 -177.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -117.75 169.64 9.43 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.449 -0.796 . . . . 74.22 110.179 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' HD11 ' A' ' 78' ' ' LEU . 45.3 ttt85 -136.03 124.45 23.43 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.088 -0.382 . . . . 75.3 111.92 -177.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.68 129.17 34.24 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.831 0.348 . . . . 73.42 111.391 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 67.0 mt -81.77 -49.61 10.21 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 112.371 0.508 . . . . 53.12 112.371 -176.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.476 ' HB3' ' HD2' ' A' ' 14' ' ' PRO . 49.4 m-85 -124.87 164.4 31.51 Favored Pre-proline 0 N--CA 1.476 0.851 0 CA-C-O 120.481 0.182 . . . . 73.14 111.236 -176.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 65.7 Cg_endo -74.34 119.91 6.01 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.264 1.976 . . . . 71.14 113.299 174.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -125.15 143.1 51.1 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.397 -0.365 . . . . 74.25 111.169 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' HG2' ' HG3' ' A' ' 24' ' ' GLU . 5.9 mtp-105 -126.39 160.43 30.48 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.232 0.539 . . . . 72.24 112.415 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.451 ' HE ' ' CG ' ' A' ' 22' ' ' ASP . 10.3 tpp180 -104.86 149.95 25.25 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.939 -0.573 . . . . 62.11 110.142 168.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -57.69 -37.78 74.05 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.943 0.402 . . . . 72.34 111.493 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -115.87 146.49 37.04 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-N 116.487 -0.324 . . . . 74.13 110.966 177.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -67.93 6.85 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.179 2.586 . . . . 75.22 114.762 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -62.27 -40.54 96.58 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.273 0.471 . . . . 72.01 112.273 -178.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' CG ' ' HE ' ' A' ' 17' ' ' ARG . 1.6 m-20 -82.0 -163.29 0.64 Allowed 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.605 0.594 . . . . 74.3 112.605 -175.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 59.6 tp -123.98 120.15 31.62 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.065 -0.516 . . . . 72.34 110.975 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.427 ' HG3' ' HG2' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -64.63 154.6 35.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.67 0.748 . . . . 71.5 113.014 -179.551 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 14' ' ' PRO . 92.8 mt -116.13 139.02 50.74 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.213 -0.903 . . . . 63.31 110.581 175.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD22 ' C ' ' A' ' 25' ' ' LEU . 3.9 mm? -121.31 154.92 59.16 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 122.458 0.303 . . . . 71.14 110.586 174.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.9 115.52 3.64 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.405 2.07 . . . . 73.05 112.852 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.55 22.11 35.21 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.372 -0.442 . . . . 72.34 113.393 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.39 136.27 33.12 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.994 0.426 . . . . 70.22 111.797 177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.9 t -95.19 125.46 47.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-N 116.254 -0.43 . . . . 71.12 110.538 174.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.484 ' HG ' ' HA ' ' A' ' 61' ' ' ASN . 5.6 mp -121.05 127.5 51.75 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.974 0.416 . . . . 74.14 111.587 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -98.19 122.4 49.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.356 -0.384 . . . . 53.21 111.294 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.51 ' O ' ' HA3' ' A' ' 6' ' ' GLY . 84.6 t -109.5 125.07 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 CA-C-O 120.695 0.283 . . . . 63.22 110.769 176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 67.7 m -60.07 129.68 42.94 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.774 0.321 . . . . 71.33 111.782 -179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' O ' ' HG3' ' A' ' 39' ' ' GLN . 17.5 ptm180 -57.37 -30.39 64.84 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 120.634 0.255 . . . . 75.51 111.379 -179.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.86 -40.96 77.11 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.908 0.385 . . . . 63.31 111.371 173.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.16 -46.46 87.08 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.923 0.392 . . . . 64.22 111.111 178.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.6 mt -53.22 -46.23 69.0 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.262 0.554 . . . . 70.03 110.818 175.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 35' ' ' ARG . 77.2 mt-30 -59.28 -52.07 67.23 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.697 -0.683 . . . . 73.24 111.433 177.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.39 97.43 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.212 0.449 . . . . 74.24 112.212 -178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.7 -28.8 70.2 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.763 0.316 . . . . 75.31 111.644 179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.25 23.78 10.16 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.185 -0.531 . . . . 34.12 113.424 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.5 t -68.93 110.49 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.017 0.437 . . . . 70.1 110.835 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -76.27 149.88 37.06 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.28 -0.418 . . . . 62.24 112.122 -178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -52.06 127.98 23.16 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.168 0.509 . . . . 71.23 110.99 176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.56 -44.61 1.46 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.289 -0.725 . . . . 61.42 111.289 -169.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.87 -20.63 66.74 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 121.511 -0.376 . . . . 63.31 112.455 175.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -50.76 -43.69 58.37 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.503 0.668 . . . . 64.54 111.178 174.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -77.66 -5.23 49.69 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.765 -0.652 . . . . 74.12 111.751 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 97.8 m -135.46 71.26 66.43 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.657 0.614 . . . . 62.24 112.657 -177.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.77 -24.24 75.02 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 121.919 1.746 . . . . 72.54 110.324 169.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.604 ' HA ' ' HA ' ' A' ' 73' ' ' THR . 22.1 pt20 -55.11 -26.14 36.2 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.744 -1.117 . . . . 70.51 111.95 172.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.2 t -89.06 -33.6 17.08 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 120.824 0.345 . . . . 65.13 111.746 178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.56 -58.81 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 112.132 0.419 . . . . 71.2 112.132 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.9 -116.61 3.03 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.012 -0.613 . . . . 54.52 113.341 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . . . . . . . . . 39.2 m0 -102.41 127.85 49.26 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 122.289 -0.536 . . . . 75.03 111.267 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 57.6 mtm -134.23 148.48 68.0 Favored Pre-proline 0 N--CA 1.472 0.664 0 N-CA-C 111.63 0.233 . . . . 62.25 111.63 -176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -82.2 124.68 4.36 Favored 'Trans proline' 0 CA--C 1.545 1.062 0 C-N-CA 122.705 2.27 . . . . 74.54 112.735 174.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -153.01 -174.0 22.94 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.942 -0.647 . . . . 44.35 113.796 -178.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 29.0 tp -106.71 115.3 29.96 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.123 0.569 . . . . 62.04 112.094 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.484 ' HA ' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t-20 -82.62 104.02 12.57 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.773 0.321 . . . . 62.14 110.346 173.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -68.0 -9.01 42.17 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.28 0.844 . . . . 74.21 113.28 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.454 HH11 ' HD2' ' A' ' 63' ' ' ARG . 16.1 ttp85 -81.47 -29.13 33.84 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.659 -0.651 . . . . 74.13 110.902 177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.5 p -113.12 -11.61 13.28 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 116.247 -0.433 . . . . 74.42 111.694 178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 65.89 14.3 9.5 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.073 0.549 . . . . 74.32 112.008 -176.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 68.3 mm-40 -96.77 145.65 25.63 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.105 0.479 . . . . 64.43 111.789 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' N ' ' HD3' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -104.72 130.19 52.81 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.958 -0.564 . . . . 73.02 110.568 177.67 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.29 -175.75 39.34 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.685 -0.769 . . . . 70.45 113.379 -179.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -89.12 117.14 27.9 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.723 0.297 . . . . 73.32 111.046 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.434 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 40.9 p90 -122.27 148.54 52.5 Favored Pre-proline 0 CA--C 1.541 0.598 0 CA-C-O 120.904 0.383 . . . . 73.41 111.31 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 70' ' ' PHE . 17.0 Cg_exo -67.17 91.97 0.33 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.399 2.066 . . . . 75.12 112.657 176.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.558 ' O ' HG22 ' A' ' 75' ' ' VAL . . . -66.74 -10.01 53.72 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-N 116.203 -0.453 . . . . 54.51 113.729 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.604 ' HA ' ' HA ' ' A' ' 52' ' ' GLN . 60.3 m -61.54 -30.25 70.52 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.445 -0.444 . . . . 74.3 111.529 176.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.408 ' HD2' ' HB2' ' A' ' 71' ' ' PRO . 59.3 m-85 -93.85 4.71 53.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 113.015 0.746 . . . . 72.44 113.015 -174.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 72' ' ' GLY . 16.9 m -108.19 151.03 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-O 121.158 0.504 . . . . 73.42 111.965 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -102.14 158.26 16.29 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.969 -0.559 . . . . 73.42 110.692 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -89.6 124.19 34.34 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.919 0.39 . . . . 74.3 111.251 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 10' ' ' ARG . 85.6 mt -93.52 -45.14 7.89 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.093 0.473 . . . . 70.04 111.196 178.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 146.23 176.28 19.95 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 121.085 -0.579 . . . . 52.53 113.494 178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.35 174.25 8.12 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.88 2.387 . . . . 73.24 112.696 176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.48 ' O ' ' HG3' ' A' ' 82' ' ' GLU . 0.1 OUTLIER -121.8 132.16 54.45 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.279 -0.419 . . . . 71.1 110.567 177.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.48 ' HG3' ' O ' ' A' ' 81' ' ' LEU . 1.4 pt-20 . . . . . 0 C--O 1.255 1.373 0 N-CA-C 113.261 0.838 . . . . 53.54 113.261 -176.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 120.545 0.212 . . . . 62.23 111.072 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.31 152.7 12.81 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.279 0.474 . . . . 75.45 112.279 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 78.69 -165.49 51.36 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 116.196 -0.456 . . . . 54.43 113.324 178.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.5 98.87 0.98 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.263 1.976 . . . . 73.31 112.763 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -67.57 -45.6 75.1 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.389 0.614 . . . . 73.33 109.894 177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.22 177.79 33.07 Favored Glycine 0 CA--C 1.526 0.765 0 CA-C-N 115.754 -0.657 . . . . 34.25 112.856 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.407 ' HB3' ' HE1' ' A' ' 77' ' ' PHE . 92.3 m-85 -127.03 138.11 53.18 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.505 -0.409 . . . . 75.44 110.635 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.485 ' HG3' HD11 ' A' ' 81' ' ' LEU . 98.3 mt-30 -92.6 131.1 37.99 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.702 0.63 . . . . 72.41 112.702 -177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -119.93 163.25 17.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.393 -0.821 . . . . 70.14 109.76 170.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.481 ' HB2' HD11 ' A' ' 78' ' ' LEU . 40.9 ttm180 -140.69 125.59 18.24 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 111.986 0.365 . . . . 75.11 111.986 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.43 127.55 32.74 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.265 0.555 . . . . 73.41 111.174 177.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.1 mt -80.57 -39.01 28.45 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.002 0.429 . . . . 63.43 111.518 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -130.65 141.09 40.71 Favored Pre-proline 0 N--CA 1.469 0.49 0 CA-C-N 116.258 -0.428 . . . . 71.24 110.76 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.451 ' HB3' ' HD3' ' A' ' 27' ' ' PRO . 41.3 Cg_endo -65.88 120.9 8.14 Favored 'Trans proline' 0 CA--C 1.536 0.587 0 C-N-CA 122.451 2.101 . . . . 74.2 112.923 -176.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -131.72 123.68 28.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.517 -0.311 . . . . 74.03 110.976 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -103.58 99.08 8.88 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.34 0.496 . . . . 71.32 112.34 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' HA ' ' HB2' ' A' ' 22' ' ' ASP . 27.6 mtp180 64.32 140.53 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 115.585 1.698 . . . . 64.2 115.585 164.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -103.93 -50.91 3.27 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 108.508 -0.923 . . . . 71.0 108.508 160.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.401 ' HB2' ' OD1' ' A' ' 22' ' ' ASP . 15.2 mmt180 -89.1 159.4 45.25 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-N 115.712 -0.676 . . . . 74.14 109.471 166.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.76 -8.49 19.7 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 121.894 1.729 . . . . 54.14 113.148 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -96.77 -19.26 19.05 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 111.997 0.369 . . . . 74.13 111.997 -177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.485 ' HB2' ' HA ' ' A' ' 17' ' ' ARG . 23.1 m-20 -61.8 174.35 0.84 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 113.331 0.863 . . . . 60.42 113.331 -173.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.563 HD21 ' HB2' ' A' ' 61' ' ' ASN . 40.6 tp -99.8 151.62 21.06 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.638 -0.71 . . . . 52.12 111.295 -177.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -97.58 127.87 43.86 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 116.466 -0.334 . . . . 73.4 111.172 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 67.0 mt -103.92 149.04 25.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 112.535 0.569 . . . . 62.04 112.535 -174.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -119.86 155.94 54.6 Favored Pre-proline 0 N--CA 1.476 0.861 0 C-N-CA 123.173 0.589 . . . . 75.5 110.65 178.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' A' ' 14' ' ' PRO . 60.1 Cg_endo -71.32 105.19 1.68 Allowed 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 121.607 1.538 . . . . 73.45 112.387 178.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.13 49.48 3.99 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 121.228 -0.51 . . . . 41.14 113.195 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -106.84 174.68 5.78 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 120.867 0.365 . . . . 74.31 111.623 176.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.6 t -123.35 113.72 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.786 0.327 . . . . 63.22 111.388 178.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.495 HD12 ' N ' ' A' ' 31' ' ' LEU . 4.2 mp -105.15 130.46 53.31 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.583 0.23 . . . . 74.13 111.169 178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.6 t -103.75 111.79 34.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 120.896 0.379 . . . . 72.0 111.22 177.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.0 t -102.73 128.6 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 122.649 0.38 . . . . 72.44 111.246 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.8 p -72.6 142.59 48.38 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.052 0.453 . . . . 74.52 111.906 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 25.2 ptt180 -54.76 -36.08 64.46 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.399 -0.364 . . . . 74.24 111.826 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.82 73.79 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 111.904 0.335 . . . . 74.32 111.904 177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.788 0.328 . . . . 55.2 111.58 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 96.9 mt -54.51 -43.36 71.8 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.072 0.463 . . . . 62.0 111.443 178.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -69.34 -33.79 73.64 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.303 -0.408 . . . . 75.21 111.515 178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.8 -22.48 65.18 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.213 0.53 . . . . 61.54 111.138 175.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.425 HD13 HG11 ' A' ' 54' ' ' VAL . 76.8 mt -86.78 -10.13 54.28 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.997 -0.547 . . . . 64.24 111.28 174.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 71.69 33.19 63.59 Favored Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.239 -0.505 . . . . 23.32 113.142 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 67.9 t -70.03 135.08 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.942 0.401 . . . . 71.43 111.355 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.66 130.25 35.09 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.338 -0.392 . . . . 62.35 111.586 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -49.27 116.32 1.66 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.11 -0.496 . . . . 74.12 110.776 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 112.61 2.26 25.79 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.286 -0.483 . . . . 72.12 112.636 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.89 5.9 32.63 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 121.52 -0.372 . . . . 60.04 113.281 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -58.97 -29.7 67.38 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.02 0.378 . . . . 72.14 112.02 -178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 52.5 mtm180 -80.54 -2.7 47.26 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 112.358 0.503 . . . . 71.33 112.358 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 80.2 m -128.33 64.37 67.01 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-O 120.89 0.376 . . . . 70.34 111.811 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.438 ' HB2' ' HA3' ' A' ' 72' ' ' GLY . 38.3 Cg_endo -65.17 -22.43 61.26 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.438 2.092 . . . . 70.33 112.174 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -62.87 -21.06 65.71 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.882 -0.599 . . . . 74.25 111.909 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.9 t -87.37 -4.05 59.03 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.845 0.355 . . . . 75.33 111.701 178.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 41' ' ' LEU . 57.5 t -98.83 -54.51 6.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.89 0.376 . . . . 72.04 111.595 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.44 -120.28 4.57 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.305 -0.407 . . . . 74.14 112.39 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 6.3 m0 -92.09 111.59 23.19 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.814 0.34 . . . . 54.13 110.673 177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.422 ' HA ' ' HD3' ' A' ' 58' ' ' PRO . 46.4 mtm -103.84 133.04 20.47 Favored Pre-proline 0 CA--C 1.541 0.619 0 O-C-N 122.351 -0.218 . . . . 74.13 111.415 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 57' ' ' MET . 19.3 Cg_exo -67.23 117.67 4.99 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.871 2.381 . . . . 73.33 112.349 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -152.94 168.54 31.83 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 120.796 -0.716 . . . . 72.5 113.361 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.533 HD13 ' HE ' ' A' ' 67' ' ' ARG . 37.4 tp -112.63 114.1 26.55 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.744 0.307 . . . . 53.11 110.461 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.563 ' HB2' HD21 ' A' ' 23' ' ' LEU . 50.7 t-20 -81.96 104.33 12.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 120.672 0.272 . . . . 74.11 110.989 -178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 65' ' ' ARG . 19.0 mm-40 -69.95 0.46 5.88 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.447 0.906 . . . . 71.41 113.447 -176.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.556 ' HA ' ' HE ' ' A' ' 63' ' ' ARG . 2.6 tpm_? -81.42 -43.51 18.83 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.972 -0.455 . . . . 74.32 110.515 171.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 76.1 p -107.8 -6.78 16.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 116.297 -0.41 . . . . 53.12 111.677 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' A' ' 62' ' ' GLU . 44.4 mmm-85 59.22 19.44 7.49 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.695 0.798 . . . . 74.3 111.779 -177.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -95.32 145.58 24.99 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.108 0.48 . . . . 73.53 111.825 -178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.533 ' HE ' HD13 ' A' ' 60' ' ' LEU . 3.9 tpp180 -99.48 140.94 32.93 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.08 -0.509 . . . . 75.43 111.528 -177.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 168.18 177.26 39.23 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 120.415 -0.898 . . . . 62.0 113.657 176.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.552 ' HB3' ' HB3' ' A' ' 56' ' ' TRP . 5.4 m-20 -89.51 128.8 36.04 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.406 0.282 . . . . 73.42 110.597 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -119.02 141.29 30.01 Favored Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 122.107 -0.37 . . . . 74.23 111.844 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -67.88 113.38 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 122.729 2.286 . . . . 62.3 112.537 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 51' ' ' PRO . . . -74.46 23.1 1.25 Allowed Glycine 0 CA--C 1.533 1.169 0 N-CA-C 115.027 0.771 . . . . 70.32 115.027 -174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 69.4 p -93.79 -18.6 21.87 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 117.807 0.803 . . . . 45.13 111.571 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -107.96 9.02 28.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 111.914 0.338 . . . . 71.45 111.914 -178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.438 HG22 ' HA2' ' A' ' 72' ' ' GLY . 25.3 m -122.51 151.07 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 112.632 0.604 . . . . 51.45 112.632 -176.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -110.4 160.63 16.41 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 115.891 -0.595 . . . . 62.44 110.921 173.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.407 ' HE1' ' HB3' ' A' ' 7' ' ' PHE . 26.6 t80 -93.07 115.37 28.04 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.035 0.445 . . . . 73.21 111.632 -177.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.481 HD11 ' HB2' ' A' ' 10' ' ' ARG . 87.2 mt -84.61 -44.17 13.74 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.731 0.301 . . . . 72.51 111.548 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.05 178.04 15.13 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 121.136 -0.554 . . . . 52.42 113.623 177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.54 164.17 27.25 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.081 2.521 . . . . 54.01 112.802 177.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 81' ' ' LEU . 4.7 mp -99.56 151.35 21.26 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.851 0.358 . . . . 71.42 111.384 -178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.148 0 N-CA-C 112.0 0.37 . . . . 73.45 112.0 -179.689 . . . . . . . . 1 1 . 1 stop_ save_